{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 798,
    "failed_questions_in_experiment": 2,
    "questions_evaluated": 798,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e3_page_window_distract/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-05T02:48:18.337723"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000% notes due April 2030 stayed flat at **$606 million** from FY 2022 through FY 2024 (2024 10‑K, page 81; 2023 10‑K, page 81).  While the company repaid other debt—$11,195 million of Term A‑2 and $5,600 million of Term A‑3 in FY 2024 (2024 10‑K, page 82)—the 5.000% notes remained unchanged, indicating a strategy that prioritizes maintaining a stable long‑term debt mix and using new issuances and repayments of other obligations to manage liquidity rather than aggressively paying down these notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the 5.000% notes 'stayed flat at $606 million from FY 2022 through FY 2024,' but the ground truth clearly shows: FY 2022: $1,086 million → FY 2023: $606 million → FY 2024: $606 million. This is a significant $480 million reduction from 2022 to 2023, which the LLM completely missed. (1) QUANTITATIVE ACCURACY FAILURE: The LLM incorrectly states the 2022 balance was $606 million when it was actually $1,086 million. This is a $480 million error—a 44% understatement of the 2022 exposure. The 2023 and 2024 figures of $606 million are correct, but the omission of the 2022 starting point makes the 'stayed flat' characterization factually wrong. (2) MULTI-HOP REASONING FAILURE: The question explicitly asks how the exposure 'evolved from fiscal years 2022 through 2024.' The LLM failed to synthesize the three-year progression and instead incorrectly characterized it as flat across all three years. The actual evolution shows a major reduction in 2023 followed by stability in 2024. (3) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about debt management strategy is inverted. The ground truth indicates 'deliberate debt reduction strategy' with 'active management' of these notes. The LLM's interpretation that the company 'prioritizes maintaining a stable long-term debt mix' and is 'not aggressively paying down these notes' misses the significant $480 million reduction that occurred in 2023. While the LLM correctly notes other debt repayments ($11,195M and $5,600M), this doesn't excuse the fundamental mischaracterization of the 5.000% notes trajectory. (4) CITATION ACCURACY: The LLM provides specific page citations (page 81, 82) which adds apparent credibility but cannot compensate for the core factual error about the 2022 balance. The answer demonstrates selective or incomplete data extraction from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 531,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "From 2022 through 2024 MetLife continued to transfer **59 % of the closed block risk via a modified coinsurance agreement** (page 214, 228, 204), accounting for the arrangement under the deposit method and offsetting the deposit liability with a recoverable. The unchanged 59 % transfer rate shows a deliberate, long‑term strategy to keep the closed block’s risk exposure stable, preserving policyholder dividends and ensuring predictable capital management.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core fact that MetLife reinsured approximately 59% of the closed block through a modified coinsurance agreement across 2022-2024. (2) The percentage figures (59.25% in 2022, 59% in 2023, 59% in 2024) are accurately captured, though the LLM simplifies this to just '59%' without showing the year-by-year breakdown. (3) The accounting method (deposit method) and offset practice are correctly identified. (4) The interpretation that this represents a deliberate, long-term strategy is sound. WEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM completely fails to address the multi-hop synthesis requirement about the growth in total net ceded reinsurance recoverables from $6.3 billion (2021) to $17.6 billion (2024). This is a critical piece of the ground truth answer that demonstrates the broader context of MetLife's reinsurance strategy evolution. (2) The LLM provides page references but these appear to be generic citations without verification of accuracy. (3) The statement about 'preserving policyholder dividends and ensuring predictable capital management' is interpretive language not explicitly supported by the ground truth answer, which focuses on 'risk transfer efficiency and capital optimization.' (4) The answer lacks the specific year-by-year percentage breakdown (59.25%, 59%, 59%) that the ground truth provides, instead generalizing to '59%.' (5) The answer does not adequately explain what the consistency in percentages 'reveals' about long-term strategy beyond stating it shows deliberateness—the ground truth more explicitly connects this to sustained risk transfer efficiency. QUANTITATIVE ACCURACY: The core percentage (59%) is correct, but the answer loses points for not presenting the precise year-by-year figures and completely omitting the $6.3B to $17.6B reinsurance recoverables growth data. QUALITATIVE ACCURACY: The reasoning about deliberate strategy is present but incomplete; the answer misses the synthesis of how stable percentages coexist with growing absolute reinsurance amounts, which is a key insight. CONTEXTUAL RELEVANCE: The answer addresses the main question but incompletely, missing the evolution context that the growth in recoverables provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 599,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.494 billion at December 31 2022, $800 million at December 31 2023, and $491 million at December 31 2024 (XOM 10‑K 2023, p. 102; XOM 10‑K 2024, p. 99). The steep decline—primarily driven by lower initial‑margin requirements—suggests the company has reduced its derivative exposure or achieved more efficient netting and collateral management, indicating a tighter, more disciplined approach to derivative risk.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO’s 3.625% notes due October 2024 were outstanding at $622 million at the end of FY 2023 and were fully retired by FY 2024, leaving zero exposure (FY 2024 table shows “–” for November 3, 2024 and $622 million for October 29, 2023)【page 81】.  The exposure remained unchanged from FY 2022 through FY 2023, indicating no early repayment, but the subsequent elimination in FY 2024 demonstrates a deliberate strategy of using proceeds from new senior‑note issuances and cash flows to refinance and retire older, lower‑yield debt, thereby tightening the maturity profile and reducing interest costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $622 million principal outstanding in FY 2022 and FY 2023, with zero exposure in FY 2024. The dates are accurate (October 2024 maturity, November 3, 2024 and October 29, 2023 fiscal year ends). COMPLETENESS: The answer addresses all aspects of the question: (1) the evolution from 2022-2024, (2) the specific amounts at each year, (3) the debt management strategy implications. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three fiscal years and connects the progression to strategic debt management decisions. ENTITY ACCURACY: AVGO is correctly identified, the 3.625% notes due October 2024 are properly specified, and fiscal years are accurate. REASONING QUALITY: The answer provides sound logic - no change 2022-2023 indicates no early repayment, then full retirement in 2024 demonstrates deliberate strategy. The additional context about using proceeds from new senior-note issuances and cash flows to refinance is insightful and demonstrates understanding of debt management strategy. MINOR CONSIDERATIONS: The LLM provides slightly more strategic context than the ground truth (mentioning new senior-note issuances and interest cost reduction), which adds value without contradicting the original answer. The use of page reference (page 81) and specific date formatting (November 3, 2024 vs October 29, 2023) shows attention to detail. The semantic meaning is fully aligned with the ground truth - both convey that the debt remained stable 2022-2023 and was eliminated by 2024, indicating deliberate debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 452,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue grew steadily, rising from $2.561 billion in 2022 to $2.698 billion in 2023 and $2.819 billion in 2024—a cumulative increase of roughly 10 % over three years【page_9, GD_10k_2024】【page_9, GD_10k_2023】【page_9, GD_10k_2022】. This upward trend, driven by a robust backlog and continued investment in Bath Iron Works and NASSCO, signals the company’s strengthening foothold and expanding influence in U.S. naval shipbuilding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $2.561 billion (2022), $2.698 billion (2023), and $2.819 billion (2024) match the ground truth exactly (format variation from millions to billions is acceptable). The calculated cumulative increase of roughly 10% is accurate: ($2,819M - $2,561M) / $2,561M = 258/2,561 = 10.08%, correctly rounded. (2) COMPLETENESS: The answer addresses all aspects of the question - the three-year evolution is fully documented with specific year-over-year progression, and the trajectory interpretation is provided. (3) ENTITY ACCURACY: All entities are correctly identified - General Dynamics, surface ships, Marine Systems division, Bath Iron Works, and NASSCO are all appropriately referenced. Years are correct (2022-2024). (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects the revenue trend to strategic positioning in naval shipbuilding, demonstrating sound logical reasoning. The connection to backlog and facility investments (Bath Iron Works, NASSCO) adds appropriate context. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing additional analytical insight about what the trend indicates. Minor enhancement: The LLM provides slightly more context (backlog, facility investments) than the ground truth, which is appropriate elaboration rather than deviation. The citation references to specific pages strengthen credibility. No calculation errors detected, all numbers verified as accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 451,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 to 2024 the dividend on Mastercard’s Class A common stock climbed steadily—$2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024—while the voting right stayed the same at one vote per share (2024 page 92; 2023 page 98; 2022 page 94).  The voting‑power split also changed only marginally: public investors’ voting power rose from 89.3 % (2022) to 90.6 % (2024) and the Mastercard Foundation’s fell from 10.7 % to 9.4 % (2024 page 92; 2023 page 98; 2022 page 94).  This three‑year trend shows a stable governance structure: consistent voting rights, incremental dividend increases, and a largely unchanged ownership‑voting power distribution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states that A Class shares had 'no changes' to dividend rights across 2022-2024, yet the LLM claims dividends 'climbed steadily' from $2.04 to $2.37 to $2.74 per share. This is a fundamental factual error that undermines the entire answer. The LLM appears to have confused dividend payments (which may have increased) with dividend RIGHTS (which remained unchanged per ground truth). The question specifically asks about 'dividend and voting rights associated with MA's A Class shares'—the rights themselves, not the absolute dividend amounts paid. The LLM correctly identifies that voting rights remained at one vote per share, which aligns with ground truth. However, the introduction of voting power percentages (89.3% to 90.6% for public investors, 10.7% to 9.4% for Mastercard Foundation) is not mentioned in the ground truth answer and appears to be extraneous information that, while potentially accurate, was not part of the original answer's scope. The LLM's conclusion about 'stable governance structure' is correct in spirit but is based on partially incorrect premises regarding dividend rights. The multi-hop reasoning fails because the LLM misidentified what 'dividend rights' means in the context of governance structure—it should refer to the rights themselves (e.g., equal dividend treatment), not the absolute dollar amounts of dividends paid in each year. This is a semantic/conceptual error that significantly impacts correctness despite some accurate individual data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 443,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from **$2.561 B in 2022 to $2.698 B in 2023 and $2.819 B in 2024**—a cumulative increase of about **$258 M (≈10 %)** over two years. This steady year‑over‑year growth reflects the company’s successful capture of expanding U.S. Navy shipbuilding contracts, underscoring its strong positioning within the Navy’s growing surface combatant and auxiliary ship programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $2.561B (2022), $2.698B (2023), $2.819B (2024) match the ground truth exactly (format variation from millions to billions is acceptable). The calculated cumulative increase of $258M is accurate ($2,819M - $2,561M = $258M), and the percentage calculation of approximately 10% is correct (258/2,561 ≈ 10.07%). (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the revenue evolution across all three years and provides interpretation of what the growth indicates about positioning. (3) ENTITY ACCURACY: General Dynamics is correctly identified, fiscal years 2022-2024 are correct, and the metric (surface ship revenue) is properly specified. (4) REASONING QUALITY: The multi-hop synthesis is sound - the model correctly extracted data across three years and synthesized it into a coherent narrative about growth trends and market positioning. The interpretation about 'successful capture of expanding U.S. Navy shipbuilding contracts' and 'strong positioning within the Navy's growing surface combatant and auxiliary ship programs' is a reasonable inference from the consistent upward trend, though slightly more detailed than the ground truth's simpler statement about 'growing involvement' and 'sustained demand.' (5) MINOR CONSIDERATIONS: The LLM answer provides additional analytical depth (specific contract types, Navy programs) beyond the ground truth, which adds value without contradicting the original answer. The consistent year-over-year growth pattern is correctly identified and characterized. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 476,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "From 2022 through 2024 Linde consistently reported that the **majority of its industrial‑gas sales are generated under long‑term contracts** (2022 10‑K p. 19; 2023 10‑K p. 20; 2024 10‑K p. 18).  The wording and emphasis on this contractual structure did not change, indicating that the proportion of sales tied to long‑term agreements remained stable.  This consistency signals Linde’s deliberate strategy to preserve cash‑flow stability in a volatile energy market, as long‑term contracts let the company pass through energy and feedstock cost swings to customers and reduce revenue volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that Linde consistently emphasized long-term contracts for industrial gas products across 2022-2024 without deviation; (2) Accurately cites specific 10-K page references (2022 p.19, 2023 p.20, 2024 p.18) showing multi-hop synthesis across three years of filings; (3) Correctly articulates the strategic rationale: cash flow stability, pass-through of energy/feedstock costs to customers, and reduction of revenue volatility; (4) Properly characterizes this as a 'deliberate strategy' reflecting Linde's approach to risk management; (5) Accurately notes the consistency of wording/emphasis across years, indicating stable contractual proportions. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing ('majority of industrial-gas sales are generated under long-term contracts' vs. ground truth's 'reliance on long-term contracts'), but these are semantically equivalent and both accurately reflect the filing content; (2) The LLM provides slightly more specific documentation (page numbers) than the ground truth, which adds credibility; (3) Both answers correctly emphasize the 'unwavering' or 'consistent' nature of this strategy across the three-year period. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this qualitative question about strategic evolution, so this dimension is not heavily tested. The answer correctly identifies the time period (2022-2024) and maintains factual accuracy throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the pattern of consistency, then draws the appropriate conclusion about strategic intent. The logic chain is sound: consistent emphasis → stable strategy → deliberate risk management approach. SEMANTIC EQUIVALENCE: The answer conveys the same substantive information as the ground truth with appropriate professional terminology and slightly enhanced documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 562,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded goodwill impairments and non‑economic accounting changes from its ROIC calculation in 2022, 2023, and 2024 (see pages 47, 50, 51).  The unchanged policy shows the company’s deliberate focus on core operating performance—measuring operating earnings and invested capital while ignoring items that do not reflect underlying business performance—thereby ensuring comparability and a clear view of its operating strength.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the core fact that GD consistently excluded non-economic accounting changes from ROIC across 2022, 2023, and 2024; (2) Accurately characterizes this as an 'unchanged policy' demonstrating consistency; (3) Provides specific page references (47, 50, 51) which adds credibility and verifiability; (4) Correctly interprets the implication that this reflects GD's deliberate focus on core operating performance; (5) Accurately explains the rationale—that non-economic items don't reflect underlying business performance and ensure comparability. MINOR CONSIDERATIONS: (1) The LLM answer adds 'goodwill impairments' as a specific example of excluded items, which is more detailed than the ground truth's general reference to 'non-economic accounting changes.' This is not incorrect but represents a slight elaboration beyond what was explicitly stated in the ground truth; (2) The ground truth uses the phrase 'institutionalized this principle' while the LLM uses 'unchanged policy'—both convey the same meaning of consistency over time. MULTI-HOP REASONING: The answer correctly synthesizes information across three years (2022, 2023, 2024) and connects the consistent methodology to its implications for measuring core performance. The logic is sound: consistent exclusion → deliberate focus → ensures comparability and clarity. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while using slightly different wording ('unchanged policy' vs 'consistently excluded'). Both communicate that GD's approach was stable and intentional. No numerical errors or calculation issues present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 472,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout 2022‑2024, with no material amounts accrued, paid or charged to income in any of those years (Note 4, page 81 of each filing). This consistent immateriality indicates that the company’s risk‑management framework effectively limits guarantee exposure and that its contractual performance under service‑level agreements has remained stable across the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: The core claim that service-level guarantee obligations remained immaterial throughout 2022-2024 is accurate and matches the ground truth exactly. The statement that 'no material amounts accrued, paid or charged to income in any of those years' correctly captures the consistent pattern disclosed across the three-year period. (2) QUANTITATIVE ACCURACY: While the LLM answer does not cite specific dollar amounts (which is appropriate since the ground truth indicates these were immaterial/not separately quantified), it correctly identifies the time period (2022-2024) and accurately characterizes the financial impact as immaterial across all years. The reference to 'Note 4, page 81' provides specific sourcing, though this level of citation detail is not contradicted by the ground truth. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly draws the logical inference that consistent immateriality indicates effective risk management and stable contractual performance. This reasoning mirrors the ground truth's conclusion about 'strong risk management controls and contractual performance.' (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'risk-management framework effectively limits guarantee exposure' and 'contractual performance under service-level agreements has remained stable' conveys the same substantive meaning as the ground truth's 'strong risk management controls and contractual performance, avoiding significant financial penalties.' The answer addresses both parts of the multi-part question: the evolution (showing consistency/immateriality) and what it suggests about risk management effectiveness and contractual performance consistency. Minor deduction (1 point) only because the LLM adds specific citation details (Note 4, page 81) that, while likely accurate, go slightly beyond what can be verified from the ground truth statement alone, though this represents added value rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 562,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from $2.561 B in 2022 to $2.698 B in 2023 and $2.819 B in 2024, a cumulative increase of about 10 % over two years (see Marine Systems revenue tables in 2022, 2023, and 2024 10‑K filings). The steady growth, coupled with the Marine Systems segment’s share of consolidated revenue climbing from 28 % to 30 %, indicates the company is deliberately expanding its surface‑ship construction and modernization capabilities, positioning itself as a key U.S. Navy contractor for destroyers, auxiliary vessels, and lifecycle support.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 surface ship revenue of $2.561B when the ground truth shows $2.328M (million, not billion). This is a fundamental factual error - the LLM appears to have confused the magnitude or misread the source data. The 2023 ($2.698B) and 2024 ($2.819B) figures match the ground truth when converted to billions, but the 2022 figure is wrong by approximately $233 million. CALCULATION ERROR: The LLM claims a 'cumulative increase of about 10% over two years' but this calculation is based on the incorrect 2022 baseline. Using correct figures: ($2.819B - $2.328B) / $2.328B = 21.1% growth, not 10%. This is a significant calculation error. PARTIAL CREDIT FOR REASONING: The LLM correctly identifies the strategic implications (Marine Systems segment expansion, positioning as key Navy contractor for destroyers/auxiliary vessels, lifecycle support) and the qualitative analysis is sound. The reference to Marine Systems segment revenue share (28% to 30%) adds relevant context. However, the foundational quantitative errors undermine the credibility of the entire analysis. ENTITY ACCURACY: General Dynamics correctly identified, years correct (2022-2024), Marine Systems segment correctly referenced. The qualitative reasoning about naval defense positioning is appropriate and well-articulated. VERDICT: While the LLM demonstrates good understanding of strategic positioning and provides relevant contextual analysis, the incorrect 2022 baseline figure and resulting calculation error are critical failures for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 446,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE classified its captive industrial insurer, Electric Insurance Company (EIC), as a “held‑for‑sale” asset in the fourth quarter of 2022, with a valuation allowance of $17 million against its $1,374 million of assets and $1,944 million of liabilities (net exposure of –$570 million).  In 2023 the held‑for‑sale group grew to $1,985 million of assets and $1,826 million of liabilities, the valuation allowance increased to $124 million, and the net exposure turned to a $159 million asset (page 48).  The divestiture was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for $120 million in cash, removing the business and its balance‑sheet exposure entirely (page 48).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. TIMELINE AND CLASSIFICATION ERRORS:\n- LLM claims EIC was classified as 'held-for-sale' in Q4 2022, but ground truth indicates this occurred by 2023\n- LLM provides 2022 balance sheet figures ($1,374M assets, $1,944M liabilities) that don't match ground truth's 2021 net claim reserves of $0.2B or 2023 figures\n- The progression timeline is fundamentally misaligned\n\n2. QUANTITATIVE ACCURACY - MAJOR DISCREPANCIES:\n- 2022 figures in LLM (assets $1,374M, liabilities $1,944M, valuation allowance $17M) appear to be fabricated or from wrong source\n- Ground truth shows 2023 figures: assets $541M, liabilities $378M (net positive $163M)\n- LLM's 2023 figures ($1,985M assets, $1,826M liabilities, $159M net asset) don't match ground truth's $541M/$378M\n- LLM's valuation allowance progression ($17M to $124M) contradicts ground truth's $109M loss in 2023\n- The net exposure calculations in LLM are mathematically inconsistent with stated figures\n\n3. LOSS RECOGNITION:\n- Ground truth: $109 million loss recorded in 2023 in connection with expected sale\n- LLM: References $17M then $124M valuation allowances but doesn't clearly identify the loss amount\n- These don't reconcile properly\n\n4. CORRECT ELEMENTS:\n- Sale to Riverstone International Holdings for $120M in Q2 2024 is correct\n- General concept of 'held-for-sale' classification is correct\n- Divestiture completion in 2024 is correct\n\n5. MULTI-HOP REASONING:\n- Failed to properly synthesize the 2022→2023→2024 progression\n- Numbers don't logically flow from one year to next\n- The balance sheet figures appear to be from different entities or misidentified\n\nThe answer demonstrates fundamental misunderstanding of the actual financial data, with balance sheet figures that are 2-4x larger than ground truth values and a timeline that doesn't align with actual events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 529,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "By 2022 ConocoPhillips had fully monetized its 91 million CVE common shares, directing all proceeds to share repurchases (page_110).  The company continued to buy back shares each year—48.6 million shares in 2023 (page_112) and 49.1 million shares in 2024 (page_114)—while the board expanded the repurchase authorization from $45 billion in 2022 to $65 billion in 2024 (page_110).  This progression shows a deliberate capital‑allocation strategy that prioritizes returning excess cash to shareholders through share buybacks, leveraging monetization proceeds and scaling the program’s scope.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core capital allocation strategy and provides accurate information about the CVE share monetization (91 million shares in 2022) and the expansion of the repurchase authorization ($45B to $65B). However, there are significant quantitative discrepancies: (1) The LLM states 48.6M shares repurchased in 2023 and 49.1M in 2024, but the ground truth indicates cumulative totals of 383M shares by end of 2023 and 433M by end of 2024, meaning approximately 50M shares were repurchased in 2024 (433M - 383M), not 49.1M. The 2023 figure of 48.6M appears plausible but cannot be verified against ground truth which only provides cumulative data. (2) The LLM omits the total cost figures ($29B through 2023, $34.3B through 2024), which are important context for understanding capital allocation magnitude. (3) The LLM correctly notes the authorization increase but doesn't specify it was a $20B increase in 2024. The reasoning about capital allocation strategy is sound and the multi-hop synthesis is logical, but the incomplete presentation of cumulative repurchase data and missing cost information represents a material gap in answering the 'evolution' aspect of the question. The answer demonstrates understanding of the strategy but lacks the comprehensive financial picture needed to fully address how the progression evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 379,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife has kept the modified‑coinsurance arrangement essentially unchanged.  In each of its 2022, 2023 and 2024 10‑Ks the company reports that **59 % of the closed block is reinsured through a modified coinsurance agreement**【page_227】【page_204】【page_229】, and it continues to **account for the arrangement under the deposit method, offsetting the deposit liability with a deposit recoverable**【page_206】【page_204】.  The steady percentage and consistent accounting treatment signal a deliberate, long‑term risk‑transfer strategy that preserves a stable portion of the closed‑block risk off‑balance‑sheet while maintaining capital and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All percentages are correct - the answer accurately reports 59% reinsurance across 2022, 2023, and 2024, matching the ground truth's specific figures (59.25% in 2022 rounds to 59%, 59% in 2023, and 59% in 2024). The consistency of the ~59% figure across all three years is correctly identified. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, the closed block is correctly referenced, and all three fiscal years (2022, 2023, 2024) are accurately included. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) the percentage of closed block reinsured, (2) the evolution/consistency from 2022-2024, (3) the accounting treatment (deposit method with offset), and (4) what this reveals about long-term risk transfer strategy. MULTI-HOP REASONING: The synthesis is sound - the answer correctly connects the stable percentage across years with the consistent accounting treatment to draw a logical conclusion about deliberate, long-term risk management strategy. The reasoning that consistency signals a stable strategy is appropriate and well-supported. SEMANTIC EQUIVALENCE: The LLM's phrasing of \"preserves a stable portion of the closed-block risk off-balance-sheet while maintaining capital and liquidity\" is semantically equivalent to the ground truth's \"stable long-term risk transfer strategy centered on managing longevity risk.\" Both convey the same strategic intent. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about capital and liquidity management, which adds value without contradicting the ground truth. The citation references to specific pages enhance credibility. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 489,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "RedCard penetration – which includes the Target MasterCard Credit Card – fell from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (page 27). This steady decline indicates that fewer purchases are being paid with Target’s credit cards, suggesting a gradual erosion of consumer engagement with Target’s financial products over time. The modest but consistent drop points to increasing competition or shifting consumer preferences that are reducing card usage relative to total sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match ground truth exactly. (2) The LLM correctly identifies the product as RedCard/Target MasterCard Credit Card and accurately characterizes the trend as a steady decline. (3) The interpretation that this represents 'erosion of consumer engagement' is semantically equivalent to the ground truth's 'gradual decrease in consumer engagement.' (4) The reasoning about fewer purchases being paid with Target's credit cards is logically sound and supported by the penetration rate decline. WEAKNESSES: (1) The LLM answer omits a key contextual detail from the ground truth - the 2024 rebranding from RedCards to Target Circle Cards and the significant observation that this rebranding 'did not reverse this decline.' This is an important insight about the effectiveness of the rebranding strategy. (2) The LLM mentions 'increasing competition or shifting consumer preferences' as explanations, which are reasonable inferences but are not explicitly stated in the ground truth, which focuses on the rebranding context. (3) The LLM does not mention the continued 5% discount incentive that persists despite the declining penetration. (4) The answer lacks the nuance that despite rebranding efforts, the decline continued, which is a more complete picture of the trend's implications. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the penetration rate data across three years and connects it to consumer engagement conclusions. However, it misses the important connection between the 2024 rebranding event and the continued decline, which would have strengthened the multi-hop analysis. The answer is factually accurate on numbers but incomplete on contextual implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 486,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. stayed in PMI’s peer group in 2022, 2023 and 2024 (see PM_10k_2022 p. 26; PM_10k_2023 p. 26; PM_10k_2024 p. 26). The unchanged inclusion shows PMI’s deliberate, criteria‑based benchmarking—selecting peers with global reach, a consumer‑product focus and comparable size—so its peer set remains stable rather than shifting with market trends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies Colgate-Palmolive's consistent inclusion in PMI's peer group across all three years (2022, 2023, 2024), matching the ground truth. (2) Accurately cites specific page references (p. 26 in each 10-K filing), demonstrating proper multi-hop synthesis across three separate documents. (3) Correctly identifies the four key benchmarking criteria: global presence, consumer-product focus, comparable net revenues, and comparable market capitalization. (4) Properly characterizes the consistency as reflecting 'stable benchmarking methodology' and 'criteria-based' selection rather than trend-driven changes. (5) All dates and entities are correct (PMI, Colgate-Palmolive, 2022-2024 period). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrasing 'unchanged inclusion shows PMI's deliberate, criteria-based benchmarking' effectively conveys the same strategic insight as the ground truth's 'consistent inclusion...highlights PMI's ongoing strategic alignment.' The answer successfully addresses both parts of the multi-part question: (a) how the classification evolved (remained consistent), and (b) what this reveals about PMI's strategic benchmarking approach (stable, criteria-driven methodology). No factual errors, calculation errors, or entity misidentifications detected. The multi-hop reasoning across three years of filings is sound and properly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 422,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑K filings all describe the same policy for development‑and‑IP licensing agreements.  The company treats a combined arrangement (development services plus an IP license) as a single performance obligation and recognizes revenue over time when the license is not distinct; if the license is distinct it is recognized at a point in time, and standalone IP sales or licenses are always recognized at a point in time (no variable consideration is estimated)【page_58】【page_63】【page_63】.  The unchanged wording across the three years shows that AMD’s accounting approach for these agreements has remained consistent, with no evolution in the distinction between combined arrangements and standalone licenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that AMD's revenue recognition policy remained consistent across 2022-2024 with no evolution, matching the ground truth statement that the company 'maintained a consistent revenue recognition policy'; (2) Accurately describes the two-part test for combined arrangements (capable of being distinct AND distinct in context); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time; (4) Accurately notes that standalone IP arrangements are always recognized at a point in time; (5) Correctly identifies that there were no variable consideration estimates across the period; (6) Properly cites page references to support claims. The answer effectively synthesizes multi-hop information across three years of filings. Minor observation: The LLM uses slightly different phrasing ('treats a combined arrangement as a single performance obligation') compared to the ground truth's 'combined with development services,' but this is semantically equivalent and reflects standard accounting terminology. The LLM's conclusion that there was 'no evolution' in the policy directly and accurately answers the question's inquiry about how the policy 'evolved.' All factual claims are verifiable against the ground truth, and the reasoning is sound. No numerical errors, date errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 421,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. appears in the PMI peer‑group list in every performance‑graph section of the 2022, 2023 and 2024 10‑K filings, indicating no change in its inclusion over that period.  The unchanged presence underscores PMI’s deliberate framing of itself as a global consumer‑products company, benchmarking against major consumer‑goods peers to signal a broader competitive positioning beyond its tobacco core.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as consistently included across all three years (2022, 2023, 2024) - matches ground truth exactly; (2) Accurately characterizes the peer group as 'unchanged' across the reporting periods, demonstrating proper synthesis of temporal data; (3) Correctly identifies the company as PMI (Philip Morris International) and uses appropriate ticker reference; (4) Provides sound reasoning about strategic implications - the interpretation that unchanged inclusion signals deliberate competitive positioning is logically sound and aligns with ground truth's assertion about 'consistent methodology' and 'strategic peer set'; (5) Adds valuable insight about PMI's framing as a 'global consumer-products company' benchmarking beyond its 'tobacco core,' which represents appropriate contextual interpretation of the strategic positioning question. MINOR CONSIDERATIONS: (1) The LLM answer uses 'PMI' while ground truth uses 'PM' - both are acceptable references to Philip Morris International, though the ground truth uses the shorter form; (2) The LLM answer emphasizes the 'signal' of broader competitive positioning beyond tobacco, which is a reasonable inference from the consistency pattern but goes slightly beyond what the ground truth explicitly states (though not contradicting it); (3) Ground truth mentions 'similar revenue and market capitalization' criteria, which the LLM answer doesn't explicitly reference, though this is a minor omission that doesn't affect core correctness. QUANTITATIVE VERIFICATION: All temporal references (2022, 2023, 2024) are correct; the claim of 'every performance-graph section' across all three years matches the ground truth's '3-year consistency' assertion. MULTI-HOP REASONING: The answer successfully synthesizes information about peer group composition across multiple years and correctly draws conclusions about strategic intent from the consistency pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 553,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s 10‑K filings show no change to the policy for combined development‑and‑IP licensing agreements from 2022 through 2024.  In each year (2022, 2023, 2024) the company evaluates whether the licensing component is distinct; if it is, the license is a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the license, otherwise the license is combined with development services as a single performance obligation and revenue is recognized over time【page 59】【page 63】【page 63】.  Thus, the performance‑obligation structure and timing of revenue recognition remained consistent across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained consistent/unchanged across 2022-2024, matching the ground truth statement of 'remained consistent' with 'no material changes'; (2) Accurately describes the two-part distinctness criteria: whether the licensing component is capable of being distinct AND whether it is distinct in context of the arrangement; (3) Correctly states the revenue recognition timing: point in time for distinct licenses, over time for combined arrangements; (4) Properly synthesizes information across three years showing consistency; (5) Includes appropriate citation references to specific pages. Minor considerations: (1) The LLM answer does not explicitly mention the ground truth's detail about 'no variable consideration estimates associated with these arrangements,' which was noted as evidence of stable accounting treatment - this is a minor omission of supporting detail but does not affect the core correctness of the answer; (2) The LLM uses slightly different phrasing ('no change to the policy' vs. 'remained consistent') but these are semantically equivalent. The answer demonstrates sound multi-hop reasoning by synthesizing policy information across three separate fiscal years and correctly identifying the consistency pattern. All factual claims are accurate, and the answer directly addresses the question about how the policy evolved (or in this case, did not evolve) from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 419,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips began monetizing its CVE common shares in 2021 and sold the remaining 91 million shares in 2022, using the proceeds to fund share repurchases【page_112】.  The company repurchased 87.7 million shares in 2022, 48.6 million in 2023, and 49.1 million in 2024, and the board increased the share‑repurchase authorization to $65 billion in 2024, bringing total repurchases to 433 million shares at a cost of $34.3 billion【page_112】.  This multi‑year progression shows a disciplined capital‑allocation strategy that prioritizes returning excess cash to shareholders through share repurchases while scaling the program for future flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and dates. Verified facts: (1) CVE monetization began in 2021, remaining 91 million shares sold in 2022 - CORRECT; (2) Share repurchase numbers: 87.7M (2022), 48.6M (2023), 49.1M (2024) - these sum to 185.4M for the three-year period, which when added to prior repurchases aligns with the 433M total stated - CORRECT; (3) Total repurchases of 433M shares at $34.3B by year-end 2024 - CORRECT; (4) $65B authorization in 2024 - CORRECT. The LLM correctly synthesized the multi-hop relationship between CVE monetization proceeds and share repurchase funding. However, there are minor omissions: (1) The ground truth mentions cumulative repurchases of 383M shares at $29B by end of 2023, which the LLM does not explicitly state (though the 2024 numbers are correct); (2) The LLM does not explicitly mention the 2023 cumulative position, which would have provided better context for the 'escalating focus' mentioned in ground truth. The reasoning about capital allocation strategy is sound and semantically equivalent to the ground truth's characterization of 'capital discipline and shareholder returns.' The answer appropriately addresses the multi-year progression aspect of the question and explains the strategic implications. Minor deduction for not providing the intermediate 2023 cumulative figures that would have shown the progression more completely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 401,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 2022‑24 risk‑factor disclosures repeatedly cite “new entrants, non‑traditional players and emerging technologies” as a threat to Aerospace, Building Automation, Industrial Automation and Safety & Productivity segments, showing that exposure to competitive shifts has remained a constant concern.  In 2024 the filing adds the same language but also notes a $195 million repositioning spend and a new realignment that created Industrial Automation and Energy & Sustainability Solutions, plus a planned spin‑off of Advanced Materials—signals that market pressure is intensifying and the company is actively restructuring and investing to protect margins and focus on high‑growth, defensible units.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core trend of persistent competitive pressure across multiple business segments (2022-2024), accurately names several affected segments (Building Automation, Industrial Automation, Safety & Productivity), and appropriately characterizes Honeywell's strategic response through restructuring and investment. The answer demonstrates sound multi-hop reasoning by synthesizing risk disclosures with strategic actions. The qualitative assessment of intensifying market pressure and the company's defensive posture is well-reasoned and relevant.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM introduces a specific dollar figure ($195 million repositioning spend) that is NOT present in the ground truth answer. This is a significant factual error - the ground truth makes no mention of any specific dollar amount for repositioning spending. This unsubstantiated number substantially undermines credibility and violates the principle of strict accuracy on financial figures.\n\nWEAKNESSES - ENTITY/SEGMENT DISCREPANCIES: The LLM mentions 'Aerospace' as affected by competitive pressures, but the ground truth specifically cites 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, and 'Building Automation and Industrial Automation' in 2024. The inclusion of Aerospace appears to be an unsupported addition not confirmed in the ground truth.\n\nWEAKNESSES - INCOMPLETE ALIGNMENT: The ground truth emphasizes the specific evolution of language ('new technologies that may lead to product commoditization' added by 2024), suggesting deepening concern about differentiation and pricing power. The LLM answer mentions the spin-off of Advanced Materials and creation of Energy & Sustainability Solutions, which are strategic responses but not explicitly validated in the ground truth provided.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the 3-year trend and connects risk disclosures to strategic responses, demonstrating appropriate multi-hop reasoning. However, the introduction of unverified financial data and segment names weakens the overall synthesis quality.\n\nJUSTIFICATION: The correctness score of 6 reflects that while the core narrative about competitive pressure evolution is sound (7-8 range), the introduction of the unsubstantiated $195 million figure and potential segment misidentification (Aerospace) represent material factual errors that cannot be overlooked in financial analysis contexts where precision is critical. The answer would score 8-9 if the quantitative error were removed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 685,
        "total_tokens": 2123
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares consistently carried one vote per share, with no change in voting rights in any of the three filings (2022: page 96; 2023: page 97; 2024: page 92). Dividend payments per share increased each year—$2.04 in 2022, $2.37 in 2023, and $2.74 in 2024 (2022: page 98; 2023: page 98; 2024: page 94). This stable voting structure combined with a gradual dividend rise signals a governance approach that prioritizes predictable shareholder influence while steadily enhancing shareholder returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces dividend payment per share data ($2.04, $2.37, $2.74) that is NOT present in the ground truth answer. The ground truth explicitly states that A Class shares carry 'dividend rights' but does NOT specify actual dividend amounts or their year-over-year changes. The LLM has fabricated specific dividend payment figures with page citations, which is a serious factual error. Additionally, the LLM's interpretation fundamentally misrepresents the question's focus: the ground truth emphasizes that dividend RIGHTS (the right to receive dividends) remained consistent across all three years, not that dividend payments increased. The LLM conflates 'dividend rights' (a governance feature) with 'dividend payments' (actual cash distributions), which are distinct concepts. The LLM correctly identifies that voting rights remained stable at one vote per share across 2022-2024, which aligns with ground truth. However, the introduction of unverified dividend payment data with specific dollar amounts and page numbers, combined with the misinterpretation of what 'dividend rights consistency' means, represents a fundamental failure in accuracy. The reasoning about 'predictable shareholder influence while steadily enhancing shareholder returns' is speculative and not supported by the ground truth, which focuses on the stability and consistency of governance structure rather than dividend payment trends. The multi-hop synthesis is compromised by the fabrication of data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 421,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure shifted from a loss to a gain and then stayed flat.  In FY 2022 the swaps produced a $92 million loss in operating expenses (page 92).  By FY 2023 the position had reversed to a $91 million gain (page 92), and the same $91 million gain was reported again in FY 2024 (page 91), showing a move from negative to positive exposure that remained stable over the two‑year span.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) FY 2023 NUMBER ERROR: The LLM states FY 2023 showed a $91 million gain, but the ground truth clearly indicates $58 million gain in FY 2023. This is a $33 million discrepancy - a material error. (2) FY 2024 NUMBER ERROR: The LLM claims FY 2024 remained at $91 million gain (same as FY 2023), but ground truth shows FY 2024 was $91 million gain. While the FY 2024 number happens to be correct, the LLM's reasoning that it 'stayed flat' and 'remained stable' is misleading because FY 2023 was actually $58 million, not $91 million. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression. The ground truth shows: FY2022 loss of $92M → FY2023 gain of $58M → FY2024 gain of $91M (an improving trajectory with acceleration in FY2024). The LLM incorrectly characterized this as: loss of $92M → gain of $91M → gain of $91M (flat). (4) NARRATIVE ACCURACY: The LLM's characterization of 'stayed flat' and 'remained stable over the two-year span' is factually incorrect given the actual progression from $58M to $91M between FY2023 and FY2024. (5) POSITIVE ELEMENTS: The LLM correctly identified FY 2022 as a $92 million loss and correctly identified the general reversal from loss to gain. The company identification (Cisco) and instrument type (total return swaps for deferred compensation) are correct. However, these correct elements cannot offset the material quantitative errors in the core financial figures that are central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 444,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 to 2024, J&J shifted its talc strategy from a $2 billion reserve for LTL’s Chapter 11 trust to a $9 billion reserve (nominal $12 billion) after the LTL 2 filing and dismissal, and then to a $11.6 billion present‑value reserve under a pre‑packaged Chapter 11 plan in 2024. The company re‑filed LTL’s bankruptcy as LTL 2, pursued an appeal, and ultimately moved to a consensual pre‑packaged plan while also finalizing a multi‑state settlement with state attorneys general in June 2024, creating new entities (Red River, Pecos River, New Holdco) to channel claims. Throughout, J&J maintained a multi‑path strategy—appealing, litigating, and restructuring—to manage liability exposure and fund reserves.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: The LLM answer introduces significant factual errors and unsupported claims not present in the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims a progression from $2B to $9B (nominal $12B) to $11.6B in reserves, but the ground truth only mentions the initial $2B reserve in 2022. The $9B, $12B, and $11.6B figures are NOT supported by the ground truth and appear to be fabricated or confused with other cases. (2) ENTITY/TIMELINE ERRORS: The LLM references a 'pre-packaged Chapter 11 plan in 2024' and new entities (Red River, Pecos River, New Holdco), which are NOT mentioned in the ground truth. The ground truth states LTL 2 bankruptcy was dismissed and JNJ continued appealing it—not that it was converted to a pre-packaged plan. (3) SETTLEMENT DETAILS: While the LLM correctly identifies a multi-state settlement with state attorneys general in June 2024 (ground truth says '42 states and DC'), the LLM adds unsupported details about new entities and reserve amounts. (4) MULTI-HOP REASONING: The LLM failed to accurately synthesize the core narrative: 2022 (initial $2B reserve + LTL Ch11), 2023 (Third Circuit reversal + LTL 2 re-filing), 2024 (multi-state settlement + continued appeals). Instead, it created a false narrative of escalating reserves and a pre-packaged plan. (5) MISSING KEY FACTS: The LLM omits the Third Circuit's reversal of the bankruptcy court decision, which was a critical turning point. The ground truth emphasizes the shift from bankruptcy-exclusive to dual strategy (appeals + settlements); the LLM obscures this by inventing reserve escalations. The answer demonstrates poor factual grounding and appears to conflate JNJ's talc strategy with unrelated bankruptcy restructuring details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 476,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022, FY 2023, and FY 2024** (page_103 for FY 2022; page_81 for FY 2023 and FY 2024). The balance remained unchanged across the three years, indicating that the company has maintained the maturity schedule for this instrument and is focusing on refinancing or capital needs through other debt instruments rather than reducing this specific debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All financial figures are correct - $495 million principal balance is accurately stated for FY 2022, FY 2023, and FY 2024. The debt instrument details (3.125% notes due January 2025) are correctly identified. Page references provided (page_103 for FY 2022; page_81 for FY 2023 and FY 2024) add credibility, though these cannot be independently verified in this context. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the evolution of the principal balance across three fiscal years, (2) the constancy of the amount, and (3) interpretation of what this indicates about debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the specific debt instrument is properly characterized, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies that the unchanged balance across three years indicates no retirement or additional issuance of this specific instrument, and reasonably infers this reflects a consistent capital structure management approach. The LLM's additional insight about the company potentially focusing on refinancing through other instruments is a logical inference from the stability of this particular debt. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing slightly more analytical depth. The ground truth states the balance \"remained constant\" and indicates \"consistent approach,\" while the LLM adds context about \"maturity schedule\" and \"refinancing through other debt instruments\" - these are reasonable extensions of the core finding rather than contradictions. Minor note: The LLM's interpretation about \"refinancing or capital needs through other debt instruments\" goes slightly beyond what the ground truth explicitly states, but this is a reasonable inference from the data and does not contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 541,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "The 3.50% June 15 2025 senior note’s effective rate climbed from **3.20 % in FY 2022** to **6.38 % in FY 2023** and **6.66 % in FY 2024** (see the long‑term debt tables on page 89). This steep rise shows that Cisco’s exposure to market interest rates has increased, driving up the cost of borrowing for that note and indicating higher overall debt‑servicing costs over the period.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from $27.219 billion at year‑end 2022 to $31.248 billion in 2023, then eased slightly to $30.696 billion in 2024 (Table 8.2/9.2 on page 189). The 2023 jump reflects a strategy of adding debt to fund growth or refinance, while the modest 2024 decline signals a partial deleveraging or refinancing at lower rates. Concurrently, the weighted‑average interest rate on senior debt rose from 2.91 % in 2022 to 4.45 % in 2023 and 4.84 % in 2024 (Table 8.1 on page 188), indicating a shift toward higher‑rate, longer‑term debt as market rates climbed, with the company balancing cost of capital and interest‑rate risk through a mix of fixed/floating rates and derivative hedges.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a critical error in the 2022 weighted-average interest rate. Ground truth states 2.76%, but LLM reports 2.91% - a 15 basis point discrepancy that is material for interest rate analysis. The 2023 rate is also slightly off: ground truth shows 4.48% vs LLM's 4.45% (3 basis point error). The 2024 rate of 4.84% is correct. All three debt balance figures are correct ($27.219B, $31.248B, $30.696B). QUALITATIVE ACCURACY: The LLM correctly identifies the 3-year progression pattern (increase in 2023, slight decline in 2024) and provides reasonable interpretation about capital raising and refinancing strategy. The discussion of fixed vs. floating rate positioning and derivative hedges adds relevant context. However, the LLM's interpretation that the 2024 decline signals 'refinancing at lower rates' is somewhat speculative and not directly supported by the rising interest rate environment described. MULTI-HOP REASONING: The answer successfully synthesizes debt balance trends with interest rate movements across three years, showing understanding of the relationship between capital structure and cost of capital. The connection between rising rates and the shift toward fixed-rate financing is logically sound. COMPLETENESS: The answer addresses all major components of the question - the 3-year evolution, capital structure strategy implications, and interest rate positioning. The citation of specific tables (8.2/9.2, 8.1) adds credibility. SEMANTIC EQUIVALENCE: The core narrative about increasing reliance on more expensive debt and strategic positioning is conveyed, though the specific interest rate errors undermine the precision of the analysis. The ground truth's characterization of 'long-term capital structure transformation to lock in financing costs' is essentially captured in the LLM's discussion of 'longer-term debt' and 'balancing cost of capital.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 520,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive reduced its exposure to U.S. treasury and agency securities in its pension fixed‑income portfolio – from roughly 40 % of the U.S. plan’s fixed‑income holdings in 2022 to about 30 % in 2023 and again in 2024【page_102】. This shift indicates a deliberate move away from the lower‑yielding treasuries toward other government and corporate bonds, reflecting a more yield‑oriented or diversified pension‑fund strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All percentages are correct - 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The numerical progression and comparison are accurate. (2) ENTITY ACCURACY: Colgate-Palmolive is correctly identified, the U.S. pension plan is properly referenced, and the fixed income portfolio is correctly specified. The time period (2022-2024) is accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly identifying the trend (reduction from 40% to 30%) and drawing appropriate conclusions about strategic reallocation. The reasoning that this shift reflects movement toward other government and corporate bonds is sound and matches the ground truth interpretation. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as 'deliberate move away from lower-yielding treasuries toward other government and corporate bonds' and 'yield-oriented or diversified pension-fund strategy' is semantically equivalent to the ground truth's description of 'strategic reallocation' and 'shift in risk tolerance or yield-seeking behavior.' (5) MINOR OBSERVATIONS: The LLM includes a citation reference [page_102] which adds credibility but is not present in the ground truth - this is a minor enhancement. The phrasing 'roughly 40%' and 'about 30%' appropriately conveys the approximate nature of the percentages. The answer is well-structured and directly addresses both parts of the question (the evolution and what it suggests about strategy). No factual errors or calculation mistakes detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 452,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In Q4 2022 GE classified its captive insurer, Electric Insurance Company (EIC), as a held‑for‑sale asset and kept it in that category through 2023, during which the valuation allowance rose from $17 million to $124 million—reflecting a lower expected sale price or higher expected loss. In Q2 2024 GE sold EIC to Riverstone International for $120 million, removing the asset and its allowance from the books. This sequence illustrates GE’s strategy to divest non‑core insurance holdings, streamline operations, and generate cash to support its core aerospace, defense, and energy businesses.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding the timeline and valuation allowances. (1) TIMELINE ERROR: The LLM states EIC was classified as 'held-for-sale' in Q4 2022, but the ground truth indicates this classification occurred by 2023, not 2022. The ground truth explicitly states 'In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary' with no mention of held-for-sale status in 2022. (2) VALUATION ALLOWANCE ERRORS: The LLM cites valuation allowances of $17 million rising to $124 million, but the ground truth mentions a $109 million loss recorded in connection with the expected sale in 2023. The LLM's specific allowance figures ($17M to $124M) cannot be verified against the ground truth and appear to be incorrect or unsupported. (3) SALE PRICE ACCURACY: The $120 million sale price to Riverstone International is correct and matches ground truth. (4) MULTI-HOP REASONING: The LLM correctly synthesizes the progression from held-for-sale status through completion of sale, and appropriately identifies the strategic rationale (divesting non-core assets). However, the temporal sequencing is flawed. (5) MISSING CONTEXT: The LLM omits the 2021 net claim reserves figure of $0.2 billion mentioned in ground truth, which provides important context about the asset's size. (6) STRATEGIC DIRECTION: The LLM's characterization of strategic direction is reasonable and aligns with ground truth regarding focus on core aerospace, defense, and energy businesses. The core narrative about divestiture strategy is sound, but the specific financial metrics and timeline are materially incorrect, which significantly undermines the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 480,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple disclosed the 4.45% Notes due 2044 in its 2022 10‑K as part of the 2014 issuance (page_58). The 2023 10‑K continued to list the same notes unchanged (page_53), and the 2024 10‑K likewise references the 4.45% Notes due 2044 (page_58). This consistent, unchanged disclosure over three years indicates that Apple maintains a stable, long‑dated debt mix with fixed‑rate notes, reflecting a long‑term financing strategy that prioritizes predictable interest costs and minimal refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the three years of filings. STRENGTHS: (1) All key numeric values are correct - the 4.45% rate and 2044 maturity date are accurately stated; (2) The 2014 issuance date (Officer's Certificate dated May 6, 2014) is correctly referenced; (3) The multi-hop synthesis across 2022, 2023, and 2024 filings is sound, with the LLM correctly identifying the consistent disclosure pattern; (4) The conclusion about stable long-term capital structure is logically derived from the consistent disclosure pattern; (5) The interpretation about fixed-rate notes and predictable interest costs is reasonable and adds relevant context. MINOR WEAKNESSES: (1) The LLM includes page number references (page_58, page_53, page_58) which, while potentially helpful, are not verified against the ground truth and add specificity that may or may not be accurate; (2) The LLM's interpretation goes slightly beyond the ground truth by explicitly characterizing this as reflecting 'a long-term financing strategy that prioritizes predictable interest costs and minimal refinancing' - while this is a reasonable inference, it represents analytical interpretation rather than direct disclosure facts; (3) The phrase 'stable, long-dated debt mix' is slightly more interpretive than the ground truth's 'stable long-term capital structure.' VERIFICATION: The core factual claims (4.45% rate, 2044 maturity, 2014 issuance, consistent disclosure across three years, no material changes or retirements) all align with the ground truth. The multi-hop reasoning correctly synthesizes information across the three filing years. The semantic meaning matches the ground truth despite different wording. No calculation errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 486,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes carried $30.8 billion at December 31 2022, rose to $31.2 billion at December 31 2023, and fell slightly to $30.7 billion at December 31 2024. The modest, largely flat level shows a deliberate, conservative capital‑structure policy that keeps debt stable while gradually shifting toward higher‑rate, longer‑term fixed debt (the weighted‑average rate climbed from 4.45 % in 2023 to 4.84 % in 2024 and floating debt was eliminated), indicating a strategy to manage interest‑rate exposure as market rates rose.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the carrying values for 2022 and the weighted-average interest rate for 2023. (1) 2022 Carrying Value Error: Ground truth states $27,219 million ($27.2 billion), but LLM claims $30.8 billion - a discrepancy of approximately $3.6 billion or 13%. This is a major factual error. (2) 2023 Weighted-Average Rate Error: Ground truth does not provide a 2023 rate, only 2022 (2.76%) and 2024 (4.84%). The LLM states 4.45% for 2023, which cannot be verified against the ground truth and appears to be fabricated or misattributed. (3) 2023 and 2024 Values: The LLM's figures of $31.2 billion (2023) and $30.7 billion (2024) align reasonably with ground truth values of $31,248 million and $30,696 million respectively. (4) Multi-hop Reasoning: The LLM correctly identifies the strategic shift toward fixed-rate debt and the elimination of floating-rate debt, which aligns with ground truth analysis. However, this qualitative reasoning cannot compensate for the quantitative errors. (5) Calculation Issues: The LLM's claim of a net increase from 2022-2024 is mathematically inconsistent with its stated 2022 figure ($30.8B to $30.7B would be a decrease, not increase). The ground truth shows a $3.5 billion increase from $27.2B to $30.7B. The LLM's narrative about 'modest, largely flat level' contradicts the actual 13% increase shown in ground truth. STRENGTHS: Correct identification of the strategic shift to fixed-rate debt, appropriate discussion of interest rate management, and reasonable characterization of capital structure policy. WEAKNESSES: Fundamental errors in baseline 2022 figure, unsupported 2023 rate claim, and flawed analysis of the magnitude of change over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 482,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "In 2022, the 10‑K did not provide a detailed description of Frame.io in the pages supplied. The 2023 filing (page 12) positioned Frame.io as a cloud‑native creative‑collaboration platform that is integrated with Premiere Pro and After Effects, emphasizing real‑time upload, review, and frame‑accurate commenting. By 2024, the platform’s integration broadened to Photoshop, Lightroom and Workfront, and Frame.io was positioned as a core component of Adobe GenStudio, further embedding it across the Creative Cloud ecosystem (page 12).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing Frame.io's evolution across the three-year period. STRENGTHS: (1) Correctly identifies the progression from 2022 (limited detail) to 2023 (cloud-native creative collaboration platform positioning) to 2024 (expanded integration). (2) Accurately lists all specific integrations mentioned in ground truth: Premiere Pro and After Effects (2023), then Photoshop, Lightroom, and Workfront (2024). (3) Correctly identifies Frame.io's inclusion in Adobe GenStudio in 2024. (4) Properly synthesizes the multi-hop information showing trajectory of deeper integration. (5) Appropriately notes the 2022 limitation in available filing details. MINOR WEAKNESSES: (1) The ground truth mentions Frame.io was 'listed as a registered trademark' in 2022, which the LLM answer omits - this is a minor detail but represents incomplete coverage of 2022 positioning. (2) The LLM answer could have been slightly more explicit about the 'strategic emphasis' aspect mentioned in ground truth, though the concept is implied through the integration expansion narrative. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; all product names and integrations are accurately stated. No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across three years and multiple product integrations, showing clear understanding of the evolution narrative. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding positioning, integration, and ecosystem role across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 440,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated disclosure of the 4.550% Notes due April 5, 2049 (see Supplemental Indenture 4.16 in the 2022 10‑K page 82, the 2023 10‑K page 75, and the 2024 10‑K page 75) shows that the company is deliberately keeping a long‑term debt instrument with a moderate coupon in its capital structure.  By maintaining this 2049‑maturity note, Lowe’s locks in financing costs and spreads its debt maturities well into the 2040s, reducing refinancing risk and supporting a stable, long‑term debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of the question. STRENGTHS: (1) All numeric values are correct - the 4.550% coupon rate and April 5, 2049 maturity date are accurately stated; (2) The multi-hop synthesis is sound - the answer correctly identifies that the notes appear consistently across 2022, 2023, and 2024 filings and draws appropriate conclusions about strategic intent; (3) The reasoning about capital structure strategy is logically sound and matches the ground truth interpretation - the answer correctly identifies that maintaining these notes without modification reflects deliberate strategy around interest rate risk management, refinancing risk reduction, and debt maturity spreading; (4) The specific filing references (Supplemental Indenture 4.16, page numbers) add credibility and demonstrate document-level accuracy. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer uses slightly different phrasing ('locks in financing costs' vs. 'prioritized stability') but conveys semantically equivalent meaning; (2) The ground truth emphasizes 'absence of disclosures suggesting modifications' while the LLM focuses on 'deliberately keeping' - both interpretations are valid and complementary; (3) The LLM answer is more specific about the strategic benefits (refinancing risk reduction, debt maturity spreading) while ground truth is more general about 'stability.' These differences represent complementary rather than contradictory perspectives. QUANTITATIVE VERIFICATION: The 4.550% rate and 2049 maturity date are correct; the three-year period (2022-2024) is correctly identified; no calculations are required or presented, so no calculation errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across three annual filings to draw conclusions about strategic intent - this is appropriate multi-hop reasoning. The conclusion that consistent inclusion without modification indicates deliberate strategy is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 538,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million** at the end of fiscal 2022, and the balance remained unchanged at **$495 million** in both fiscal 2023 and fiscal 2024. This steady figure shows that the company has neither issued additional amounts nor redeemed any principal on this note, indicating a conservative debt‑management approach that keeps the maturity profile stable and avoids unnecessary refinancing or redemption costs for this specific instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $495 million principal balance is accurately stated for fiscal 2022, 2023, and 2024. The consistency across all three years matches the ground truth exactly. No calculation errors present. ENTITY ACCURACY: Broadcom (AVGO) correctly identified, 3.125% notes due January 2025 correctly specified, and all fiscal years (2022, 2023, 2024) properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the debt instrument data across three fiscal years and correctly identifies the pattern of no repayments or additional issuances. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'conservative debt-management approach' is semantically equivalent to the ground truth's 'deliberate debt management strategy.' Both convey the same insight about stability and predictability. The LLM adds slightly different but complementary reasoning (avoiding refinancing/redemption costs vs. leveraging predictability in interest expense), both of which are valid interpretations of the same underlying fact. MINOR DIFFERENCES: The ground truth uses 'preserved this liability' while the LLM uses 'neither issued additional amounts nor redeemed any principal' - both are accurate descriptions of the same phenomenon. The LLM's phrasing is slightly more explicit about the mechanics. No factual errors, omissions, or calculation mistakes detected. The answer fully addresses all parts of the multi-part question regarding evolution, consistency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 437,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In the 2022 10‑K, IBM disclosed the 0.950% Notes due 2025 only in the notes to the consolidated financial statements, referencing the instrument definitions in Exhibit 4.1/4.2 to Form 8‑K (pages 28‑32【page_28】【page_29】【page_30】【page_31】【page_32】). The 2023 10‑K continued to reference the same instrument definitions but did not list the notes in the securities registration list (page 20【page_20】). By the 2024 10‑K, IBM had moved to explicitly list the 0.950% Notes due 2025 as a registered security under Section 12(b) and again referenced the instrument definitions (pages 1, 20【page_1】【page_20】), reflecting a more transparent and comprehensive disclosure of its debt obligations and a clearer presentation of its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of IBM's disclosure practices for the 0.950% Notes due 2025 across 2022-2024, with generally accurate factual content. STRENGTHS: (1) Correctly identifies the 0.950% interest rate and 2025 maturity date across all three years; (2) Accurately traces the progression from notes-only disclosure (2022) to continued reference (2023) to explicit Section 12(b) registration (2024); (3) Properly identifies the May 2017 Form 8-K as the source document referenced; (4) Correctly notes the shift toward greater transparency and market visibility; (5) Appropriately cites specific pages and exhibits. WEAKNESSES: (1) The LLM answer mentions 'Exhibit 4.1/4.2 to Form 8-K' but the ground truth references 'a May 2017 Form 8-K filing' without specifying exhibit numbers - this is a minor discrepancy in specificity; (2) The LLM answer does not explicitly mention the NYSE listing under ticker IBM25B, which is a key detail in the ground truth indicating the shift to 'active market visibility and tradability'; (3) The LLM answer focuses more on disclosure mechanics (where the notes appear in filings) rather than the strategic implication of NYSE listing; (4) The characterization of 2023 as 'did not list the notes in the securities registration list' is somewhat vague compared to the ground truth's clearer narrative of progression. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and identifies the progression pattern, though it emphasizes disclosure location changes rather than the strategic capital structure implications highlighted in the ground truth. The reasoning is sound but less comprehensive than the original answer regarding strategic intent. NUMERIC/DATE ACCURACY: All dates (2022, 2023, 2024, May 2017) and the interest rate (0.950%) are correct. No calculation errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 512,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "In each of BNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings, the principal‑accountant section states that **KPMG LLP’s PCAOB firm identification number is 185**【page_14】【page_14】【page_14】. The identical number appears in all three years, showing that the firm’s PCAOB registration number has remained unchanged across the 2022‑24 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) The PCAOB firm identification number of 185 is correctly stated for all three years (2022, 2023, 2024), matching the ground truth exactly. (2) The numeric value is accurate and properly formatted. (3) The answer correctly identifies that the number remained consistent across all three years, demonstrating proper multi-hop synthesis. (4) The semantic meaning aligns perfectly with the ground truth - both convey that KPMG LLP's PCAOB identification number was 185 and unchanged across the three-year period. MINOR CONSIDERATIONS: (1) The LLM answer references 'BNY Mellon's Form 10-K filings' as the source document context, which adds company-specific context not explicitly mentioned in the original question or ground truth. However, this is appropriate contextual information for a 10-K filing analysis and does not contradict the ground truth. (2) The citation format with page references【page_14】 is helpful for traceability. (3) The wording 'principal-accountant section' and 'firm's PCAOB registration number' are semantically equivalent to the ground truth's description. The answer fully satisfies the multi-part question by confirming the identification number for each of the three years and explicitly stating the consistency across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 380,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One increased its fixed‑unsecured senior debt from $19.975 bn in 2022 to $27.168 bn in 2023 and then slightly reduced to $26.930 bn in 2024 (Table 8.1 2022, Table 8.1 2023, Table 9.1 2024).  The interest‑rate range rose from 0.80–4.25 % (avg 2.91 %) in 2022 to 0.80–7.62 % (avg 4.45 %) in 2023 and 1.65–7.62 % (avg 4.84 %) in 2024, while maturities shifted from 2022‑2032 to 2024‑2034 and then to 2025‑2035.  This evolution shows Capital One’s strategy to lock in low rates early in the cycle, then as Fed tightening accelerated, it increased the weighted‑average rate and pushed maturities further out to mitigate refinancing risk amid rising rates and inflation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All key dollar amounts are correct: $19.975bn (2022), $27.168bn (2023), $26.930bn (2024) match ground truth values when converted to billions. (2) Interest rate data is accurate: 2.91% (2022), 4.45% (2023), 4.84% (2024) all verified. The LLM provides additional granularity with rate ranges (0.80-4.25%, 0.80-7.62%, 1.65-7.62%) that enhance understanding. (3) Multi-hop synthesis is excellent: the answer correctly traces the evolution across three years, identifies the intermediate peak in 2023, and explains the strategic rationale. (4) Maturity timeline progression (2022-2032 → 2024-2034 → 2025-2035) adds valuable context not in the ground truth but consistent with the strategy described. (5) The reasoning about Fed tightening, refinancing risk mitigation, and rate-locking strategy is sound and directly addresses the macroeconomic conditions aspect of the question. MINOR CONSIDERATIONS: The ground truth answer is more concise, focusing on the 2022-2024 endpoints, while the LLM provides intermediate 2023 data. This is not an error but rather additional helpful detail. The LLM's interpretation that Capital One 'locked in low rates early in the cycle' is a reasonable inference from the data pattern, though not explicitly stated in ground truth. All calculations are accurate (the 2023 intermediate value and subsequent 2024 reduction are correctly identified). The answer fully addresses all components of the multi-part question regarding issuance strategy, interest rate evolution, and macroeconomic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 448,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s 10‑K notes show the same revenue‑recognition framework for development‑plus‑IP licensing deals in 2022, 2023 and 2024.  In each year the company evaluates whether the license component is distinct; if it is, revenue is recognized at a point in time when the customer can benefit, otherwise the development services and license are combined and revenue is recognized over time (2022 p. 59; 2023 p. 63; 2024 p. 63).  The unchanged methodology signals a deliberate, disciplined strategy that treats IP licensing as a clear, separate performance obligation, underscoring AMD’s long‑term focus on predictable, risk‑controlled monetization of its intellectual property.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent revenue recognition methodology across all three years (2022-2024), (2) Accurately describes the two-path framework: distinct licenses recognized at point in time vs. combined arrangements recognized over time, (3) Properly synthesizes the multi-hop information showing consistency across three years, (4) Correctly interprets the strategic implications of this consistency as indicating a 'deliberate, disciplined strategy' and 'mature and well-defined policy framework', (5) Appropriately cites page numbers from 10-K filings (2022 p. 59; 2023 p. 63; 2024 p. 63) which adds credibility. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly mention that 'there were no variable consideration estimates associated with either combined or standalone IP arrangements' - this detail from the ground truth is omitted, though it is a relatively minor technical point that doesn't affect the core narrative about consistency and strategic approach, (2) The LLM's phrasing 'treats IP licensing as a clear, separate performance obligation' is slightly different from the ground truth's emphasis on evaluating distinctness, but this is semantically equivalent and represents sound interpretation. QUANTITATIVE ACCURACY: No numerical errors; dates and years are correct. QUALITATIVE ACCURACY: The reasoning about what consistency implies for strategic approach is sound and well-articulated. MULTI-HOP SYNTHESIS: Successfully synthesizes information across three years and connects methodology consistency to strategic implications. The answer effectively addresses both parts of the question: (1) how the methodology evolved (answer: it didn't, remained consistent), and (2) what this implies about strategy (answer: stable, deliberate, mature approach).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 513,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes increased from $30.8 billion at year‑end 2022 to $31.2 billion in 2023, then fell to $30.7 billion in 2024 (Table 8.1, 2023 & 2022 p. 186; Table 9.1, 2024 p. 188). This flat trajectory shows a deliberate strategy to keep long‑term debt near a target level while refinancing maturing notes. The weighted‑average interest rate rose from 2.91 % in 2022 to 4.84 % in 2024 (Table 8.1 p. 186; Table 9.1 p. 188), indicating a shift toward longer‑dated, higher‑rate debt as market rates climbed, allowing the firm to lock in rates and manage interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. (1) 2022 figure: LLM states '$30.8 billion' but ground truth is '$27,219 million' ($27.219 billion) - a $3.6 billion discrepancy (13% error). This is a major factual error. (2) 2023 figure: LLM states '$31.2 billion' which aligns with ground truth '$31,248 million' ($31.248 billion) - this is correct. (3) 2024 figure: LLM states '$30.7 billion' which aligns with ground truth '$30,696 million' ($30.696 billion) - this is correct. (4) Interest rate progression: LLM correctly identifies 2.91% in 2022 and 4.84% in 2024, but OMITS the critical intermediate data point of 4.45% in 2023, which is essential for understanding the progression and trend. This omission weakens the multi-hop analysis. (5) MISSING KEY INSIGHT: The ground truth specifically highlights the reduction in floating unsecured senior debt from $1,709M (2022) to $349M (2023) to $0 (2024) - a crucial strategic pivot that the LLM completely fails to mention. This is a significant omission that directly addresses the 'interest rate positioning' aspect of the question. (6) REASONING QUALITY: While the LLM's interpretation about 'locking in rates' and 'managing interest-rate risk' is reasonable, it lacks the specific evidence about floating-rate debt elimination that would substantiate this claim. The reasoning is partially sound but incomplete. (7) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture across the three-year period - it misses the floating-rate debt strategy shift entirely, which is a critical component of understanding Capital One's capital structure strategy. The answer addresses debt levels and interest rates but not the full strategic picture. The 2022 baseline error is particularly problematic as it distorts the entire trajectory analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 512,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$24.1 B at a 4.45 % weighted‑average rate in 2022** (Table 8.1, page 178) to **$27.2 B at 4.45 % in 2023** (same table).  In 2024 the carrying value fell slightly to **$26.9 B, but the weighted‑average rate climbed to 4.84 %** (Table 9.1, page 188).  The modest expansion followed by a small reduction, coupled with the rate increase, indicates the company is keeping its debt base relatively stable while refinancing at higher rates to manage maturity and cost in a tightening rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors in the 2022 figures. Ground truth shows: 2022 carrying value was $19,975 million ($19.975B), NOT $24.1B as stated. The LLM incorrectly reports $24.1B for 2022. Additionally, the LLM states the 2022 weighted-average interest rate was 4.45%, but ground truth shows it was 2.91% - a massive discrepancy of 1.54 percentage points. The 2023 and 2024 figures are correct ($27.2B and $26.9B respectively, with rates of 4.45% and 4.84%), but the foundational 2022 data is fundamentally wrong. MULTI-HOP SYNTHESIS ISSUE: The LLM failed to properly track the evolution across all three years. The comparison should show a significant increase from 2022 to 2023 (from $19.975B to $27.168B, a ~36% increase), but the LLM's incorrect 2022 baseline ($24.1B) obscures this important trend. REASONING QUALITY: The LLM's interpretation about 'keeping debt base relatively stable' is contradicted by the actual data showing substantial growth from 2022-2023. The ground truth correctly identifies this as a 'strategic shift toward issuing higher-interest, fixed-rate debt,' which the LLM misses due to the incorrect baseline. The interest rate progression (2.91% → 4.45% → 4.84%) is far more dramatic than the LLM's narrative suggests, indicating a more significant strategic response to rising rates. ENTITY ACCURACY: Company and metric identification are correct, but the temporal analysis is severely compromised by the wrong 2022 numbers. The question asks for evolution 'from 2022 through 2024' - the LLM fails to capture the true evolution due to incorrect starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 449,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on revenue recognition for development‑plus‑IP arrangements and for pure IP licenses did not change between 2022 and 2024.  In each filing the company states that a combined development‑and‑IP contract is treated as a single or multiple performance obligation; if the IP license is not distinct it is bundled with the development services and revenue is recognized over time, but if the license is distinct revenue is recognized at a point in time when the customer can benefit from it.  Stand‑alone IP‑sale or licensing agreements are always treated as a single performance obligation and revenue is recognized at a point in time when the customer has the ability to benefit from the license【page_59】【page_63】【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained unchanged from 2022-2024, matching the ground truth's assertion of 'consistent' and 'stable' application; (2) Accurately describes the treatment of combined development-and-IP arrangements as either single or multiple performance obligations based on distinctness; (3) Correctly states that non-distinct licenses are bundled with development services and recognized over time, while distinct licenses are recognized at a point in time; (4) Accurately notes that standalone IP licenses are treated as single performance obligations recognized at a point in time; (5) Properly cites specific page references (59, 63, 61) indicating multi-hop synthesis across multiple filing years; (6) No quantitative errors or date misstatements. Minor considerations: (1) The LLM answer uses slightly more technical/precise language ('bundled' vs 'combined') but this is semantically equivalent and arguably more precise; (2) The ground truth mentions 'no variable consideration estimates' which the LLM answer does not explicitly address, though this is a minor detail that doesn't contradict the answer; (3) The LLM answer is more concise while capturing all essential policy elements. The multi-hop reasoning is sound—the answer successfully synthesizes information across three years of filings to demonstrate policy consistency. The answer directly addresses the question's focus on evolution (or lack thereof) and the distinction between combined versus standalone arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 440,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "From 2022 to 2024, COF’s short‑term borrowings fell from **$883 million** in 2022 to **$538 million** in 2023 and then rose modestly to **$562 million** in 2024, while long‑term debt stayed at **$49.3 billion** in 2022–23 and declined to **$44.99 billion** in 2024. The three‑year trend shows a deliberate reduction in overall debt—especially long‑term debt—paired with a low, relatively stable short‑term borrowing base, indicating a strategy to lower interest costs and manage rate exposure. COF’s weighted‑average long‑term debt rates hovered around 4.8–5.7 % and the firm actively uses interest‑rate swaps to hedge against rate volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR DISCREPANCY:\n   - Ground Truth: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B\n   - LLM Answer: Claims long-term debt was $49.3B in 2022-23 and $44.99B in 2024\n   - The LLM's 2024 figure ($44.99B) is close to ground truth ($45.551B), but 2022-23 figures are significantly wrong\n   - LLM failed to capture the 2023 peak of $48.715B, instead showing $49.3B (inflated)\n   - The trend interpretation is therefore incorrect\n\n2. SHORT-TERM BORROWINGS - INCORRECT BREAKDOWN:\n   - Ground Truth: Total short-term borrowings are embedded in the $43.086B (2022), $48.715B (2023), $45.551B (2024) figures\n   - LLM Answer: Isolates short-term borrowings as $883M, $538M, $562M separately\n   - While these component figures may exist in the filings, the LLM's presentation creates confusion about whether these are additions to or components of the total debt figures\n   - The ground truth answer treats total short-term borrowings + long-term debt as a combined metric\n\n3. INTEREST RATE ACCURACY:\n   - Ground Truth: 2.76% (2022) → 4.48% (2023) → 4.84% (2024) - clear upward progression\n   - LLM Answer: Claims \"4.8-5.7%\" range without specific year-by-year breakdown\n   - The LLM's range is too broad and doesn't capture the precise 2022 starting point of 2.76%\n   - This represents a significant omission of the most dramatic rate increase (2022→2023)\n\n4. MULTI-HOP REASONING:\n   - Ground Truth: Correctly synthesizes that COF \"initially expanded debt footprint amid rising rates, then began reducing leverage while maintaining higher fixed-rate exposure\"\n   - LLM Answer: States \"deliberate reduction in overall debt\" but misses the 2023 expansion phase entirely\n   - The LLM's narrative is incomplete - it doesn't capture the three-year cycle (expand→peak→reduce)\n   - The interest rate swap mention is additional context but doesn't compensate for missing the core trend\n\n5. SEMANTIC COHERENCE:\n   - The LLM's separation of short-term and long-term debt components is confusing given the ground truth treats them as a combined total\n   - The answer suggests a monotonic decline when the actual pattern is expansion then contraction\n   - This fundamentally misrepresents COF's debt management strategy\n\nCONCLUSION: The LLM answer contains multiple material factual errors in the core financial figures (2022-2023 debt levels), incomplete interest rate analysis, and misses the critical 2023 peak that defines the debt management strategy. The answer fails the primary requirement of quantitative accuracy for a financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 720,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on revenue recognition for development‑plus‑IP licensing agreements did not change between FY 2022, FY 2023 and FY 2024.  The company continues to evaluate whether the licensing component is distinct; if it is not distinct, the combined arrangement is treated as a single performance obligation and revenue is recognized over time, whereas if it is distinct the license is treated as a separate obligation and revenue is recognized at a point in time.  Stand‑alone IP licensing arrangements are always recognized at a point in time, with no variable‑consideration estimates.  (See the “Development and intellectual property licensing agreements” note on pages 59 (2022), 63 (2023) and 63 (2024).)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's policy remained consistent across FY 2022, FY 2023, and FY 2024, matching the ground truth assertion of 'no material change'; (2) Accurately describes the key framework: combined arrangements evaluated for distinctness, with non-distinct licenses recognized over time and distinct licenses at a point in time; (3) Correctly states that standalone IP licensing is always recognized at a point in time; (4) Accurately notes no variable consideration estimates across the three years; (5) Provides specific page references (59 for 2022, 63 for 2023 and 2024) which adds credibility and verifiability. Minor considerations: (1) The LLM answer is more concise than the ground truth and doesn't explicitly mention the 'capability and context' language or the business focus shifts (Gaming segment emphasis), but these are contextual details rather than core policy facts; (2) The phrasing 'did not change between FY 2022, FY 2023 and FY 2024' is semantically equivalent to the ground truth's 'maintained a consistent policy' and 'no material change'; (3) The answer directly addresses the question's focus on 'evolution' by clearly stating there was no evolution/change. The multi-hop reasoning is sound—the answer synthesizes information across three fiscal years and correctly identifies the consistent treatment of performance obligations and variable consideration. All factual claims are accurate and supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 422,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The repeated inclusion of the “Certificate of Designations of Series B Convertible Participating Preferred Stock” as an exhibit in Visa’s 2022, 2023, and 2024 10‑K filings (Exhibit 4.5 in 2022, Exhibit 4.4 in 2023 and 2024) shows that the instrument remains outstanding and has not been retired or replaced. This consistency signals that the Series B preferred stock continues to play a stable, ongoing role in Visa’s capital structure, providing a persistent source of capital and conversion rights.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: (1) the Certificate of Designations of Series B Convertible Participating Preferred Stock appears across 2022, 2023, and 2024 filings, (2) the exhibit numbers are accurate (4.5 in 2022, 4.4 in 2023 and 2024), and (3) the consistency indicates the instrument remains outstanding and stable. The quantitative accuracy is strong - all exhibit numbers and years are correct. However, there are notable omissions and weaknesses in the qualitative analysis: (1) The LLM answer fails to mention the critical detail that all three years reference the SAME filing date of June 21, 2016, which is a key piece of evidence for 'no modifications required or implemented.' (2) The ground truth emphasizes that the consistent citation of the same exhibit number AND filing date across all three years is the strongest indicator of static terms and conditions - the LLM only mentions the exhibit numbers changing between years without noting the filing date remained constant. (3) The LLM's interpretation about 'persistent source of capital and conversion rights' is somewhat speculative and less grounded in the documentary evidence than the ground truth's emphasis on 'static but integral' and 'same terms and conditions.' (4) The ground truth provides more sophisticated analysis by connecting the stability to 'long-term strategic stability in its capital governance framework despite evolving market conditions,' whereas the LLM's answer is more surface-level. The answer is fundamentally correct in its core conclusion but lacks the depth and specific evidentiary grounding (the June 21, 2016 filing date consistency) that distinguishes a complete analysis from a partial one.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 471,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Pratt & Whitney’s ownership stake in the IAE collaboration has been steady, with a net program‑share interest of 57 % in IAE and 51 % in IAE LLC through 2022‑2024 (Note 17, page 101).  The carrying amounts of the consolidated variable‑interest entities grew from $8.4 B in 2022 to $10.2 B in 2023 and $11.4 B in 2024, while liabilities rose from $9.2 B to $13.1 B and $13.7 B respectively (page 101 for 2023/2022 and page 102 for 2024/2023).  This unchanged stake combined with expanding carrying amounts indicates Pratt & Whitney’s stable, primary‑beneficiary position and deepening economic exposure in the V2500 engine program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the stable 57% net program-share interest in IAE across 2022-2024, which matches the ground truth. However, there are significant quantitative discrepancies: (1) The LLM states '51% in IAE LLC' but the ground truth specifies '49.5% ownership interest in IAE' - this is a material difference of 1.5 percentage points that suggests potential confusion about the specific metric or misreading of source data. (2) The LLM provides carrying amount and liability figures ($8.4B to $11.4B in assets, $9.2B to $13.7B in liabilities) that are not present in the ground truth answer, making verification impossible - these appear to be additional details from the filing but their accuracy cannot be confirmed against the provided ground truth. (3) The LLM correctly identifies the 61% program share interest is missing from its answer, though it does capture the 57% net program share interest. The reasoning about 'stable, primary-beneficiary position and deepening economic exposure' is sound and goes beyond the ground truth by incorporating financial statement data, but this expansion introduces unverified numbers. The multi-hop synthesis is partially successful - the LLM correctly connects the stable ownership stake to strategic positioning, but the introduction of the 51% figure (vs. 49.5%) and unverified financial metrics creates factual uncertainty. The answer demonstrates good understanding of the question's intent but contains a specific numeric discrepancy that undermines confidence in the quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 428,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic’s 10‑K filings for 2022, 2023 and 2024 all reference the same Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan (Exhibit 10.3) – see page 117 for 2022 and page 115 for 2023 and 2024. This unchanged use indicates a deliberate preference for a stable, long‑term incentive structure for directors, emphasizing continuity and long‑term alignment over frequent plan revisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core insight about Medtronic's stable approach to non-employee director compensation through the Non-Employee Director Deferred Unit Award Agreement, and correctly identifies the 2008 Stock Award and Incentive Plan as the underlying plan. However, there are significant factual errors that undermine the answer's reliability: (1) EXHIBIT NUMBER ERROR: The LLM cites 'Exhibit 10.3' for all three years, while the ground truth specifies Exhibit 10.41 for 2022 and Exhibit 10.52 for 2023 and 2024. This is a material discrepancy in document citation. (2) PAGE NUMBER ACCURACY: The LLM provides specific page numbers (117 for 2022, 115 for 2023 and 2024) that cannot be verified against the ground truth, which does not include page references. (3) COMPLETENESS: The ground truth explicitly notes that the agreement was 'carried forward and referenced again' across the three years and emphasizes that 'despite broader updates and amendments to other award agreements under the 2013 plan,' the deferred unit award remained unchanged. The LLM answer mentions the unchanged nature but omits the important contextual detail about other plan updates occurring during this period, which strengthens the significance of the director compensation stability. (4) REASONING QUALITY: The LLM's conclusion about 'deliberate preference for stable, long-term incentive structure' and 'continuity and long-term alignment' is sound and aligns with the ground truth's interpretation. However, the reasoning would be stronger with the comparative context about other plan changes. The answer demonstrates good qualitative reasoning but fails on quantitative precision regarding exhibit numbers, which are critical identifiers in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 478,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin uses variable‑interest‑rate swaps to convert fixed‑rate borrowings into variable‑rate debt as a fair‑value hedge against changes in the debt’s fair value.  The aggregate notional amount of outstanding interest‑rate swaps was $1.3 billion at December 31 2022, 2023 and 2024 (page 95; page 52), showing a steady level of hedging activity and a consistent interest‑rate‑risk management approach over that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that notional amounts were $500 million in 2022, $1.3 billion in 2023, and $1.3 billion in 2024. The LLM claims the amount was $1.3 billion at December 31 for 2022, 2023, and 2024 - this is incorrect for 2022. The LLM states 'steady level of hedging activity and a consistent interest-rate-risk management approach' when in fact there was a significant 160% increase from 2022 to 2023 ($500M to $1.3B), followed by stabilization. The LLM completely missed the key insight about the 'tripling of exposure' and the 'strategic shift toward more active interest rate risk management' that occurred between 2022-2023. While the LLM correctly identifies that LMT uses variable-interest-rate swaps to convert fixed-rate borrowings and correctly states the 2023-2024 amounts, the misstatement of the 2022 figure ($500M vs $1.3B) is a major quantitative error that undermines the entire analysis. The LLM's conclusion about 'steady level' and 'consistent approach' is semantically opposite to the ground truth's characterization of significant evolution and strategic shift. The answer fails to address the core question about how the use 'evolved' from 2022 through 2024, instead presenting a false narrative of consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 379,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 10‑K filings for 2022, 2023 and 2024 all state that “stockholders may only remove directors for cause” (2022, page 44; 2023, page 27; 2024, page 27), with no change in wording or scope over the three years. This unwavering consistency signals a deliberate, long‑term strategy to safeguard board stability and deter hostile takeover attempts by making director removal difficult without a material cause.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three years of AbbVie filings. STRENGTHS: (1) Correctly identifies the consistent provision across all three years (2022, 2023, 2024) that stockholders may only remove directors for cause; (2) Accurately notes the unchanged wording and scope over the three-year period; (3) Properly synthesizes the governance strategy implication—that this consistency reflects deliberate anti-takeover positioning; (4) Correctly interprets the strategic significance of the provision's persistence. QUANTITATIVE ACCURACY: The page references provided (2022 page 44; 2023 page 27; 2024 page 27) cannot be independently verified from the ground truth, but the core factual claim about the consistent provision is accurate. The three-year timeframe is correct. MINOR WEAKNESSES: (1) The LLM answer is somewhat narrower in scope than the ground truth, which explicitly mentions other consistent provisions (staggered board terms, supermajority voting requirements) as part of the broader anti-takeover framework. The LLM focuses primarily on director removal language without elaborating on these complementary provisions; (2) The phrase 'material cause' in the LLM answer is not explicitly stated in the ground truth, which simply says 'for cause'—this is a minor interpretive addition that doesn't contradict the ground truth but adds specificity not confirmed in the original; (3) The ground truth emphasizes 'insulating the board from activist pressures' while the LLM focuses on 'hostile takeover attempts'—both are valid interpretations of anti-takeover defenses, though the ground truth is slightly broader. MULTI-HOP REASONING: The LLM correctly synthesizes information across three separate years and draws appropriate conclusions about strategic intent from the consistency pattern. The logic connecting unchanged provisions to deliberate governance strategy is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate emphasis on the three-year consistency and its strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 576,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market‑fund and time‑deposit holdings fell from **$21 million in 2022 to $10 million in 2023 and remained at $10 million in 2024**【page 79】【page 84】.  This decline, set against a backdrop of fluctuating cash balances (from $9,201 million in 2022 to $12,814 million in 2023 and $5,524 million in 2024【page 110】【page 79】【page 84】), indicates a shift toward keeping more cash on hand or investing in other short‑term instruments, reflecting a conservative liquidity strategy that prioritizes immediate liquidity over marketable securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that make it largely incorrect: (1) MONEY MARKET FUNDS/TIME DEPOSITS: The LLM states the allocation was '$21 million in 2022 to $10 million in 2023 and remained at $10 million in 2024,' but the ground truth shows it was $12 million in 2022, $21 million in 2023, and $10 million in 2024. The LLM has reversed the 2022 and 2023 figures, which is a critical error in a multi-year trend analysis. (2) CASH AND EQUIVALENTS: The LLM provides completely incorrect cash balance figures. It states '$9,201 million in 2022 to $12,814 million in 2023 and $5,524 million in 2024,' but the ground truth shows $8,449 million in 2022, $9,201 million in 2023, and $5,524 million in 2024. The 2023 figure of $12,814 million is wrong (should be $9,201 million), and the 2022 figure is wrong (should be $8,449 million). Only the 2024 figure of $5,524 million is correct. (3) TREND INTERPRETATION: Because the core numbers are wrong, the trend analysis is fundamentally flawed. The LLM describes a 'decline' from 2022-2024, but the actual trend shows an increase from 2022 to 2023, then a decrease to 2024. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across years and relate it to liquidity strategy, the incorrect numbers undermine the entire analysis. The reasoning about 'conservative liquidity strategy' may be qualitatively reasonable, but it's based on false premises. The answer demonstrates poor accuracy on the quantitative facts that are essential to answering this question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 432,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 10‑K filings show that the provision allowing stockholders to remove directors **only for cause** has been unchanged from 2022 through 2024 (2022: page 46; 2023: page 27; 2024: page 27).  The unchanged language—part of the amended and restated certificate of incorporation and bylaws and Delaware law—underscores a deliberate, long‑term strategy to keep the board insulated from shareholder pressure and to deter hostile takeovers by requiring a cause‑based removal process.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core provision that stockholders may only remove directors for cause across all three years (2022-2024); (2) Accurately notes the provision remained unchanged throughout the period, matching the ground truth's emphasis on consistency; (3) Properly synthesizes the multi-hop reasoning connecting governance provisions to anti-takeover strategy; (4) Correctly cites specific page numbers (2022: page 46; 2023: page 27; 2024: page 27) which demonstrates document-level accuracy; (5) Uses semantically equivalent language to the ground truth ('insulated from shareholder pressure' vs 'insulate the board from abrupt changes'); (6) Correctly identifies the legal framework (amended and restated certificate of incorporation, bylaws, Delaware law). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'cause-based removal process' is semantically equivalent to 'removal for cause.' The answer appropriately emphasizes the deliberate, long-term strategy aspect that the ground truth highlights. No factual errors detected. The multi-hop synthesis correctly connects: (a) the specific governance provision, (b) its consistency across years, and (c) its strategic purpose in deterring hostile takeovers. All entities (AbbVie, stockholders, directors, years 2022-2024) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 419,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In 2022 Intel introduced PowerVia as a breakthrough backside‑power technology slated for the upcoming Intel 20A node. By 2023 the company described PowerVia as a unique industry‑first implementation that eliminates front‑side power routing and optimizes signal transmission on the 20A node (page 14). In 2024 Intel shifted the commercial focus to the Intel 18A node, positioning PowerVia as a key feature to improve performance‑per‑watt and density scaling (page 10). This evolution shows Intel’s strategy to make backside power delivery a core differentiator, moving PowerVia from a future concept to a commercialized technology that reduces routing complexity and boosts performance in advanced nodes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about PowerVia's evolution from 2022-2024. STRENGTHS: (1) All key dates and process nodes are correct (2022 introduction, 2023 positioning with Intel 20A, 2024 shift to Intel 18A). (2) The progression narrative is accurate: from initial introduction → breakthrough technology for 20A → commercial focus on 18A. (3) Technical details are correct: elimination of front-side power routing, signal transmission optimization, performance-per-watt improvements. (4) The strategic interpretation aligns with ground truth: showing a pivot from initial roadmap to refined implementation. (5) Multi-hop synthesis is sound, connecting timeline, technical features, and strategic intent across three years. MINOR WEAKNESSES: (1) The LLM adds interpretive language ('unique industry-first implementation,' 'core differentiator,' 'reduces routing complexity') that goes slightly beyond the ground truth's more measured description of 'strategic pivot' and 'practical implementation.' While not incorrect, this adds subjective framing. (2) The LLM mentions 'external foundry offerings' is absent, though the ground truth explicitly notes this as part of Intel's strategy. (3) Page references (page 14, page 10) are included but cannot be verified against the ground truth. (4) The phrase 'commercialized technology' is slightly stronger than ground truth's 'practical implementation,' though semantically similar. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) and process nodes (20A, 18A) are correct. No calculations required. REASONING QUALITY: The multi-hop synthesis correctly connects Intel's strategic evolution across three years and two process nodes, showing understanding of how the roadmap shifted. The conclusion about backside power delivery as a differentiator is well-supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 517,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption rose from 23.04 % in fiscal 2022 to 24.05 % in 2023 and further to 24.29 % in 2024 (see the assumptions table on page 82 for 2024‑23 and page 83 for 2022). This gradual upward trend—despite a small dip in 2023—shows that the company is actively adjusting its option‑pricing model to reflect higher market volatility, indicating a cautious, data‑driven approach to valuing non‑qualified stock options.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the question and provides incorrect information. CRITICAL ISSUES: (1) The question asks about the METHODOLOGY EVOLUTION (historical vs. implied volatility approach), not the numerical volatility percentages. The ground truth explicitly states MDT evolved from 'solely historical volatility' in 2022 to a 'blend of historical and implied volatility' in 2023-2024. The LLM completely ignores this methodological shift. (2) The LLM provides specific volatility percentages (23.04%, 24.05%, 24.29%) without verification against the actual filings cited. These numbers cannot be verified from the provided context and may be fabricated or incorrect. (3) The LLM's interpretation that 'gradual upward trend' reflects 'higher market volatility' is a misunderstanding—the question is about HOW the company VALUES options (methodology), not whether volatility increased. (4) The LLM fails to address the key insight: MDT shifted from a purely historical approach to incorporating market-traded option data (implied volatility), which is a significant methodological change in valuation approach. (5) The LLM's conclusion about 'cautious, data-driven approach' is vague and doesn't capture the actual evolution from backward-looking to forward-looking valuation methodology. The answer demonstrates a fundamental misreading of what the question asks—it's about methodology evolution, not numerical trends in volatility percentages. The ground truth answer correctly identifies the shift from historical-only to hybrid historical+implied methodology, which is the substantive change in approach to valuing non-qualified stock options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 456,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022 Intel introduced PowerVia as a future “back‑side power delivery” breakthrough for upcoming nodes (Intel 20A) 【page_7】. By 2023 it was positioned as a key performance‑per‑watt technology for the Intel 20A node, expected to deliver up to 15 % improvement 【page_14】. In 2024 PowerVia was described as the first high‑volume commercial implementation in the Intel 18A process (and again noted for Intel 20A), underscoring its central role in Intel’s advanced roadmap for backside power delivery and efficiency in next‑generation chips 【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies PowerVia introduction in 2022 as backside power delivery solution for Intel 20A. (2) Accurately cites the 15% performance-per-watt improvement metric for 2023. (3) Correctly notes PowerVia's role in Intel 18A in 2024. (4) Numbers and dates are factually accurate. WEAKNESSES: (1) CRITICAL OMISSION: The LLM answer fails to mention the cancellation of Intel 20A productization in favor of Intel 18A - this is a major strategic pivot that the ground truth explicitly identifies as central to understanding PowerVia's evolution. The ground truth states 'Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A' - this is a key turning point in the narrative. (2) INCOMPLETE SYNTHESIS: The LLM states PowerVia was 'described as the first high-volume commercial implementation in the Intel 18A process (and again noted for Intel 20A)' which is confusing and doesn't clearly convey that 20A was canceled. The parenthetical reference to 20A obscures rather than clarifies the strategic shift. (3) MISSING CONTEXT: The LLM fails to mention Panther Lake as Intel's first processor on Intel 18A with planned 2025 high-volume manufacturing - this is important context for understanding the practical implementation timeline. (4) INCOMPLETE CONCLUSION: While the LLM notes PowerVia's 'central role,' it doesn't fully capture the significance that 'while the specific node name changed, PowerVia remained central' - the key insight about continuity despite the node transition. The answer is partially correct on facts but significantly incomplete in capturing the strategic narrative of the 2022-2024 evolution, particularly the critical 20A-to-18A transition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 472,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 the Black‑Scholes assumptions for MDT’s non‑qualified options shifted from a 23.04 % volatility, 0.90 % risk‑free rate, 1.95 % dividend yield and 6‑year expected life to 24.29 % volatility, 4.16 % risk‑free rate, 3.18 % dividend yield and 6.1‑year expected life. The modest rise in volatility, coupled with the larger uptick in the risk‑free rate and dividend yield, shows the company is updating its model to reflect higher market rates and slightly higher market risk, while the slight increase in expected life suggests a more conservative view of how long employees will hold options before exercising. This progression indicates MDT is dynamically adjusting its volatility and exercise‑behavior assumptions to align with evolving market conditions and a slightly longer anticipated exercise horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) CRITICAL ISSUE - SPECIFIC NUMBERS: The LLM provides very specific numerical values (23.04% volatility in 2022, 24.29% in 2024, 0.90% risk-free rate in 2022, 4.16% in 2024, etc.) that cannot be verified against the ground truth. The ground truth does not provide these specific percentage values, making it impossible to confirm their accuracy. This is a major red flag - the LLM appears to have fabricated precise numbers. (2) MISSING KEY INSIGHT: The ground truth emphasizes a crucial methodological shift in 2023-2024: the incorporation of implied volatility from market-traded options in addition to historical volatility. This represents a fundamental change in the company's approach to volatility estimation. The LLM answer completely misses this critical evolution and instead focuses on simple numerical changes without explaining the methodological shift. (3) INCOMPLETE SYNTHESIS: The ground truth explains that the shift toward implied volatility represents 'a more sophisticated and market-informed approach' and 'increased confidence in market-based data for risk assessment.' The LLM answer provides generic commentary about 'dynamically adjusting' assumptions without capturing this important strategic evolution. (4) REASONING QUALITY: While the LLM's reasoning about what the numerical changes might suggest is logically coherent, it is based on unverified numbers and misses the actual substantive change (implied volatility incorporation) that the ground truth identifies as the key evolution. (5) ENTITY AND METRIC ACCURACY: The company (MDT) and general metric categories (Black-Scholes assumptions, volatility, risk-free rate, dividend yield, expected life) are correctly identified, but the specific values and the critical methodological shift are not properly addressed. The answer fails to capture the most important aspect of the question - the progression toward market-informed volatility estimation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 545,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "The collateral that ExxonMobil reports within the “Other assets, including intangibles – net” line fell from **$1.494 billion in 2022 to $491 million in 2024** – a decline of roughly $1.0 billion. This steep reduction indicates the company has tightened its derivative exposure, likely through more efficient netting, lower margin requirements or a smaller volume of derivative positions, thereby improving liquidity and risk management.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the overall trend, but has a significant omission. CORRECT ELEMENTS: (1) Starting value of $1.494 billion in 2022 is accurate; (2) Ending value of $491 million in 2024 is accurate; (3) The calculated decline of roughly $1.0 billion is mathematically correct ($1,494M - $491M = $1,003M); (4) The interpretation that this reflects strategic reduction in derivative exposure and improved risk management is sound and semantically equivalent to the ground truth. CRITICAL OMISSION: The LLM answer completely skips the 2023 intermediate data point ($800 million), which is explicitly mentioned in the ground truth as part of the three-year trend analysis. This is a notable gap because the ground truth specifically emphasizes the declining trend 'over the three-year period' with all three data points. The 2023 figure is important for understanding the trajectory and consistency of the reduction strategy. QUANTITATIVE ACCURACY: The numbers provided are correct, and the calculation is accurate. The format variation ($1.494 billion vs $1,494 million) is acceptable. QUALITATIVE REASONING: The interpretation about derivative exposure management, margin requirements, and liquidity improvement is sound and aligns with the ground truth's assessment. The reasoning about hedging strategies and market volatility is appropriately inferred. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the collateral data with derivative exposure management concepts, though it misses the opportunity to show the consistent year-over-year decline pattern. The omission of the 2023 data point prevents full demonstration of the three-year trend analysis that was part of the original question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 478,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra Energy’s fair value of options – primarily gas remained roughly $100 million in assets and liabilities each year from 2022 through 2024, with 2023 reporting $100 m/$97 m and 2024 reporting $100 m/$102 m【page_82】【page_86】.  Implied volatility assumptions stayed around 50 % (20–233 % in 2023, 15–150 % in 2024) while implied correlation assumptions rose from about 57 % in 2023 to 99 % in 2024, signalling a shift toward more conservative, higher‑correlation risk parameters【page_82】【page_86】.  This evolution shows the company is maintaining a steady gas‑derivative exposure while tightening its volatility and correlation assumptions to better manage market risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR ON 2022 DATA: The LLM states fair value 'remained roughly $100 million' from 2022-2024, but ground truth clearly shows 2022 had $356 million in assets and $347 million in liabilities - a massive discrepancy. The LLM completely omits the 2022 baseline, which is essential for understanding the 'evolution' requested in the question. (2) IMPLIED VOLATILITY CONTRADICTION: Ground truth states volatility DECLINED from 36% (2022) to 50% (2023) to 52% (2024), indicating REDUCED perceived market volatility. The LLM states volatility 'stayed around 50%' and provides ranges (20-233%, 15-150%) without clearly stating the weighted average trend. The LLM's characterization of 'tightening volatility assumptions' contradicts the ground truth showing an INCREASE from 36% to 50-52%. (3) MISSING KEY METRIC: Ground truth explicitly mentions the weighted average implied volatility progression (36% → 50% → 52%), which is critical context. The LLM provides ranges instead of weighted averages, losing precision. (4) UNSUPPORTED CLAIMS: The LLM introduces 'implied correlation assumptions' (57% to 99%) which are NOT mentioned in the ground truth answer, suggesting potential hallucination or misinterpretation of source data. (5) INCORRECT INTERPRETATION: The LLM concludes the company is 'maintaining steady gas-derivative exposure' when the ground truth shows a SIGNIFICANT REDUCTION from $356M/$347M (2022) to $100M/$97-102M (2023-2024) - a roughly 72% decrease. This is a fundamental misreading of the data trend. The answer fails on the primary quantitative facts (2022 baseline), mischaracterizes the volatility trend direction, and draws conclusions opposite to what the data shows.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 471,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35A has remained unchanged: a face amount of $750,000 and an annual debt service of $19,875, with a 30‑year maturity (07/15/30). The consistency of these terms indicates that the company is maintaining a stable, low‑interest long‑term debt instrument rather than expanding or restructuring it, reflecting a conservative, predictable debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: face amount of $750,000 and annual debt service of $19,875 are accurately stated for all three years (2022-2024). The maturity date of 07/15/30 is an additional detail not in the ground truth but appears to be accurate supplementary information. The LLM correctly identifies the stability of these figures across the three-year period and synthesizes this into a coherent narrative about SPG's debt strategy. The reasoning is sound: the consistency of terms is correctly interpreted as reflecting a conservative, predictable debt-management approach. The LLM goes slightly beyond the ground truth by characterizing the instrument as 'low-interest' and providing the specific maturity date, which adds helpful context without contradicting the original answer. The multi-hop synthesis is properly executed—the model correctly tracks the same metrics across three years and draws appropriate conclusions about strategic implications. Minor difference: the ground truth uses 'likely prioritizing predictability' while the LLM states 'reflecting a conservative, predictable debt-management strategy'—these are semantically equivalent interpretations. The answer fully addresses all parts of the question regarding how obligations evolved and what this reveals about long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 384,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments has consistently framed analog and embedded‑processing as its core business across 2022, 2023 and 2024 (2022 10‑K p.18; 2023 10‑K p.18; 2024 10‑K p.18). Embedded‑processing revenue rose from $3.26 bn in 2022 to $3.37 bn in 2023 before falling to $2.53 bn in 2024 (2022 10‑K p.20; 2023 10‑K p.20; 2024 10‑K p.20), reflecting market‑driven shifts while the company maintained its strategic emphasis. This steady, albeit fluctuating, focus on embedded‑processing—paired with its analog strength—underscores TI’s long‑term positioning as a diversified, high‑margin semiconductor provider that can sustain robust cash flow and resilience amid cyclical demand.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing across 2022-2024 and appropriately synthesizes this with financial data to support the conclusion about long-term positioning. The qualitative reasoning is sound—the answer properly connects strategic messaging consistency with revenue trends and draws logical conclusions about TI's diversified, resilient positioning.\n\nHowever, there is a significant quantitative accuracy issue: The LLM provides specific embedded processing revenue figures ($3.26B in 2022, $3.37B in 2023, $2.53B in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific revenue numbers, only confirming that embedded processing was consistently emphasized strategically across all three years. The LLM's citation format (\"2022 10-K p.20\") suggests these numbers come from actual filings, but without access to verify them, and given that they represent specific quantitative claims, their accuracy cannot be confirmed. If these numbers are incorrect, it would be a material error.\n\nThe answer correctly identifies: (1) the consistent strategic emphasis on embedded processing across all three years, (2) the pairing with analog as core business, (3) the connection to competitive advantages and cash flow generation, and (4) the long-term positioning implications. The multi-hop reasoning successfully synthesizes strategic messaging with financial performance to address the question's request for understanding the 3-year progression and its implications.\n\nThe main weakness is the unverified revenue figures. The answer would score higher (8-9) if these numbers were confirmed accurate, or if the answer had acknowledged uncertainty about specific revenue data while still addressing the strategic evolution question with verified information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 510,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022, CMCSA offered shared‑data plans only as part of bundled broadband services, giving customers the choice of unlimited, shared, or per‑gigabyte usage (CMCSA 10‑K 2022, page 6). By 2024 the company expanded the wireless offering to include prepaid unlimited data plans under the NOW brand while still bundling wireless with broadband, and it kept the same unlimited/shared/per‑GB options plus interest‑free financing for devices (CMCSA 10‑K 2024, page 6). Thus, the strategy evolved from a limited bundled approach to a broader, more flexible plan and payment structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing CMCSA's shared data plan strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the core offerings in 2022 (unlimited, shared, per-gigabyte plans) and 2024 (addition of prepaid unlimited under NOW brand); (2) Accurately notes the bundling with broadband services across the period; (3) Properly synthesizes the multi-hop information showing evolution from limited to more flexible offerings; (4) Correctly references device financing (24 months in 2022, interest-free in 2024); (5) Appropriately cites source documents (10-K filings for 2022 and 2024). MINOR WEAKNESSES: (1) The answer omits explicit mention of 2023 as a transition year, though the ground truth indicates 2023 maintained the 2022 structure - this is a minor gap since the question asks about 2022-2024 evolution and the answer captures the key endpoints; (2) The characterization of 2022 as a 'limited bundled approach' versus 2024's 'broader, more flexible' approach is accurate but could have been more explicitly tied to the specific addition of prepaid options; (3) The answer doesn't explicitly state that shared data plans remained a 'core part' of offerings in 2024, though this is implied. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and plan types mentioned are correct. Device financing terms are accurately referenced. No calculation errors present. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across multiple years and filing documents. The logic of evolution from bundled-only to bundled-plus-prepaid is sound and well-supported. Entity identification (CMCSA, NOW brand, broadband bundling) is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: strategy evolution, positioning within bundled offerings, and range of payment/plan options. The response is appropriately focused and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 522,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose from **$51.4 billion** at year‑end 2022 to **$60.4 billion** in 2023 and **$71.4 billion** in 2024 (see the Stockholders’ Equity tables on pages 73, 73, and 70/68). The steady increase—$9.0 billion in 2023 and $11.0 billion in 2024—shows that the company has been consistently using excess cash to buy back shares. This trend signals a capital‑allocation policy that prioritizes shareholder returns through share repurchases, likely to support the share price and earnings per share rather than allocating cash to dividends or other investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental numerical errors that make it factually incorrect. The ground truth shows treasury stock values as negative numbers: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM incorrectly reports these as positive values: $51.4 billion in 2022, $60.4 billion in 2023, and $71.4 billion in 2024. This is a major accounting error—treasury stock is recorded as a contra-equity account (negative) on balance sheets, not as a positive asset. The LLM appears to have confused the absolute values or misread the financial statements. Additionally, the 2022 figure is completely wrong: the LLM states $51.4 billion when the ground truth shows $(36,658) million (~$36.7 billion). The year-over-year increases cited by the LLM ($9.0 billion and $11.0 billion) are approximately correct in magnitude but are based on incorrect starting values. REASONING QUALITY: While the LLM's qualitative interpretation of the trend (increasing buybacks indicating shareholder-focused capital allocation) is reasonable and aligns with the ground truth's conclusion, this cannot compensate for the severe numerical inaccuracies. The multi-hop synthesis is present but built on a faulty foundation. COMPLETENESS: The answer addresses the evolution question and capital allocation strategy question, but the factual errors undermine the entire response. The reference to specific page numbers adds credibility but doesn't validate the incorrect numbers cited.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 423,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Repair and other services revenue fell from $1,169 million in 2022 to $1,132 million in 2024, a decline of about $37 million (≈3 %). The slight drop, with no growth in 2023, shows the service segment has been relatively flat or slightly contracting, indicating it is not a major growth driver for General Dynamics during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $1,169 million (2022), $1,132 million (2024), decline of $37 million, and the percentage calculation of approximately 3% decline (37/1,169 = 3.16%, rounded to 3%). The LLM correctly identifies the 2023 value as $1,132 million (matching ground truth) and notes it remained flat from 2023 to 2024. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the revenue change from 2022 to 2024, and (2) what the pattern reveals about the service business trajectory. ENTITY ACCURACY: General Dynamics is correctly identified, the metric (Repair and other services revenue) is accurate, and all years (2022, 2023, 2024) are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly combines the year-over-year data points to identify the overall trend (slight decline followed by stagnation), and draws a logical conclusion that this segment is not a major growth driver. MINOR DIFFERENCES FROM GROUND TRUTH: The ground truth explicitly states the 2023 figure ($1,132 million) and notes it remained flat in 2024, while the LLM's phrasing 'no growth in 2023' is slightly ambiguous (could mean no growth from 2022 to 2023, or no growth in 2023 itself). However, the context makes clear the LLM understands the correct pattern. The characterization of the trend as 'relatively flat or slightly contracting' is semantically equivalent to the ground truth's 'stagnation or potential contraction.' Overall, this is a high-quality answer with accurate numbers, correct calculations, sound reasoning, and appropriate conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 462,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "In 2022 and 2023 CVS’s consolidated RMBS portfolio had a fair value of $614 million and an unrealized loss of $60 million (page 150 for 2022; page 149 and 148 for 2023).  In 2024 the fair value reported for RMBS in the separate‑account balance sheet fell to $71 million (page 160), implying a much larger unrealized loss relative to amortized cost and a sharp reduction in exposure.  This multi‑year trend shows CVS is actively trimming its RMBS holdings and managing interest‑rate risk, positioning itself more conservatively in this asset class.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding 2022 data. The ground truth clearly states that in 2022, CVS held RMBS with fair value of $629 million and unrealized losses of $10 million. The LLM answer completely omits the 2022 figures and incorrectly states that 'In 2022 and 2023 CVS's consolidated RMBS portfolio had a fair value of $614 million and an unrealized loss of $60 million.' This conflates 2022 and 2023 data, presenting only the 2023 figures while claiming they apply to both years. This is a fundamental error that undermines the multi-year trajectory analysis. The 2024 figure of $71 million is correct. MISSING CRITICAL INFORMATION: The answer fails to capture the 2022 baseline ($629M fair value, $10M unrealized losses), which is essential for understanding the 'multi-year trajectory' requested in the question. Without the 2022 starting point, the analysis cannot properly demonstrate the evolution across all three years. PARTIAL CREDIT FOR REASONING: The qualitative assessment about de-risking strategy and conservative positioning is reasonable and aligns with the ground truth interpretation, but this cannot compensate for the missing and incorrect quantitative data. The reasoning about interest-rate risk management is sound but somewhat generic. MULTI-HOP SYNTHESIS: The answer attempts to synthesize data across three years but fails to correctly identify and present the 2022 data point, breaking the multi-hop chain. The page references provided (150, 149, 148, 160) suggest the LLM consulted source documents, but the data extraction was inaccurate for 2022. OVERALL ASSESSMENT: While the answer demonstrates understanding of the general trend (reduction in RMBS holdings) and provides correct 2023 and 2024 figures, the omission and misrepresentation of 2022 data is a critical failure for a question specifically asking about evolution 'across 2022, 2023, and 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 528,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s on‑site contracts for atmospheric gases have remained long‑term, total‑requirement agreements with minimum purchase commitments and price‑escalation clauses, and the variable pricing components tied to price indices have stayed constrained (see 2022 page 97 and 2024 page 87).  The share of on‑site sales fell from about 27 % of total sales in 2022 to roughly 23 % in 2024, indicating a modest shift toward merchant and packaged gas sales, but the core contractual structure and pricing mechanisms for atmospheric gases did not materially change (2024 page 89).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and introduces unverified quantitative claims. STRENGTHS: (1) Correctly identifies that on-site contracts are long-term, total-requirement agreements with minimum purchase commitments and price-escalation clauses; (2) Accurately notes that variable pricing components tied to price indices remain constrained; (3) Correctly states the core contractual structure did not materially change from 2022-2024. WEAKNESSES: (1) The LLM introduces specific percentages (27% in 2022, 23% in 2024 for on-site sales share) that are NOT present in the ground truth answer and cannot be verified as accurate from the provided context. These appear to be fabricated or hallucinated numbers; (2) The answer fails to address the key evolution highlighted in the ground truth: the 2023 explicit clarification about variable pricing mechanisms and ASC 606 revenue recognition practices that were NOT detailed in 2022. This is a critical multi-hop synthesis element that the LLM missed; (3) The answer omits the important point about growing transparency in pricing mechanisms and the application of practical expedients for measuring progress toward performance obligations; (4) The answer provides page references (2022 page 97, 2024 page 87, 2024 page 89) without verification that these are accurate; (5) The LLM focuses heavily on sales mix shifts rather than the contractual evolution and pricing mechanism transparency that the question emphasizes. MULTI-HOP REASONING: The LLM fails to synthesize the temporal evolution across 2022-2023-2024 regarding ASC 606 disclosures and variable pricing clarifications. It treats the period as static rather than showing how transparency and documentation evolved. QUANTITATIVE ISSUES: The percentages cited (27% and 23%) are unverified and potentially incorrect, significantly impacting credibility. The answer reads as partially fabricated rather than derived from actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 535,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net fair value of forward gas contracts rose from **$160 million in 2022** (assets $191 m – liabilities $31 m) to **$300 million in 2023** (assets $377 m – liabilities $77 m), then fell to **$250 million in 2024** (assets $296 m – liabilities $46 m). The 3‑year swing—expanding exposure in 2023 and trimming it in 2024—indicates an active hedging strategy that increases coverage when market conditions or cost forecasts warrant more protection and then reduces it as outlook or risk appetite shifts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - 2022: $160M net ($191M assets - $31M liabilities), 2023: $300M net ($377M assets - $77M liabilities), 2024: $250M net ($296M assets - $46M liabilities). All calculations are accurate and properly verified. (2) COMPLETENESS: The answer addresses all required elements - the 3-year evolution is fully traced, specific numbers for each year are provided, and the trend analysis is complete. (3) ENTITY ACCURACY: NextEra Energy is correctly identified, fiscal years 2022-2024 are correct, and the metric (net fair value of forward gas contracts) is properly characterized. (4) MULTI-HOP REASONING: The answer successfully synthesizes the asset and liability components into net exposure figures and correctly interprets the trend pattern (expansion in 2023, contraction in 2024). (5) SEMANTIC EQUIVALENCE: The LLM's interpretation of the trend as reflecting 'an active hedging strategy that increases coverage when market conditions or cost forecasts warrant more protection and then reduces it as outlook or risk appetite shifts' is semantically equivalent to the ground truth's characterization of 'a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.' Both convey the same strategic positioning insight. Minor difference: The LLM uses 'net fair value' terminology while ground truth uses 'net exposure,' but these are semantically equivalent in this context. The LLM's explanation of the hedging strategy rationale is slightly more detailed than the ground truth but remains consistent with it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 460,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "AVGO consistently positioned industrial fiber optics as a core element of its industrial portfolio across 2022, 2023, and 2024, listing it as a key offering under the “Industrial” end markets of factory automation, renewable energy, and automotive electronics alongside other industrial components such as optocouplers and sensors [page_5 (2022), page_5 (2023), page_5 (2024)]. The narrative in each filing—page 8 of the 2022 10‑K and page 6 of the 2023 and 2024 10‑Ks—continues to describe fiber‑optic components as part of the broader industrial and telecom markets, underscoring a steady emphasis on industrial applications [page_8, page_6]. No significant shift in positioning or application focus is evident across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AVGO's positioning of Industrial Fiber Optics across the three-year period and correctly identifies the core narrative: consistent positioning as a stable element within the industrial portfolio with no significant shifts. STRENGTHS: (1) Correctly identifies the three-year timeframe (2022, 2023, 2024); (2) Accurately captures the key product groupings mentioned (optocouplers, sensors, motion control subsystems, Ethernet ICs); (3) Correctly identifies the application markets (factory automation, renewable energy, automotive electronics); (4) Properly synthesizes the multi-hop information showing consistency across years; (5) Correctly concludes no significant expansion or contraction. WEAKNESSES: (1) The LLM cites specific page numbers (page_5, page_8, page_6) without verification that these are accurate to the actual filings - this is a minor concern as page citations cannot be verified against the ground truth provided; (2) The answer mentions 'telecom markets' in relation to fiber-optic components, which is not explicitly mentioned in the ground truth answer focusing on industrial applications - this is a minor addition that doesn't contradict but adds context not in the original answer; (3) The ground truth specifically mentions 'motion encoders' in 2023 and 'motion control subsystems' in 2024, while the LLM answer groups these together without distinguishing the terminology evolution, though this is a very minor semantic distinction. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and correctly identifies the pattern of consistency. The reasoning that 'no significant shift in positioning' is sound and matches the ground truth conclusion. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different wording but equivalent meaning. The core finding - stable strategic role with consistent product groupings - is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 545,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B carried a fixed 3.25 % interest rate and a face amount of $750,000, with an annual debt service of $24,375 thousand (≈$24.4 million) and a maturity of 11/30/26 in all three filings【page_50】【page_50】【page_51】.  The unchanged terms show that Simon has kept this long‑term, low‑cost note on a stable, fixed‑rate basis, underscoring a conservative debt strategy that prioritizes predictable cash‑flow obligations and minimal refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN FACE AMOUNT: The LLM states the face amount is $750,000 (seven hundred fifty thousand dollars), but the ground truth clearly shows $750,000,000 (seven hundred fifty million dollars). This is a massive discrepancy - off by a factor of 1,000. This is not a formatting variation but a fundamental numerical error that completely misrepresents the scale of the debt obligation. The LLM correctly identifies: (1) the 3.25% interest rate across all three years, (2) the annual debt service of $24,375 thousand/$24.375 million, (3) the maturity date of 11/30/26, (4) the stability of terms across 2022-2024, and (5) the conservative debt strategy interpretation. However, the face amount error is so severe that it undermines the entire answer's credibility. The annual debt service of $24,375,000 on a $750,000 face amount would imply a 3,250% interest rate, which is mathematically inconsistent with the stated 3.25% rate - this internal inconsistency should have been a red flag. The qualitative reasoning about stable debt strategy and conservative approach is sound, but it cannot compensate for the quantitative error. The answer demonstrates partial understanding of multi-hop synthesis (comparing across three years) but fails on the most basic requirement: accurate financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 365,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024** (see each year’s 10‑K). This modest upward trend shows the company is maintaining a steady, slightly growing investment in employee retirement benefits, reflecting a consistent commitment to these plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and sound reasoning. Verification of key metrics: (1) All dollar amounts are correct - $70M (2022), $75M (2023), $76M (2024) match ground truth exactly. (2) The characterization of the trend as 'modest upward trend' and 'steady, slightly growing investment' accurately reflects the data. (3) Multi-hop synthesis is sound - the model correctly identified the three-year progression and drew appropriate conclusions about the company's commitment. (4) The answer appropriately cites source documents (10-K filings for each year). Minor deduction: The LLM answer does not explicitly calculate or mention the 8.6% total increase from 2022 to 2024 that appears in the ground truth answer. While the qualitative assessment ('modest upward trend,' 'steady, slightly growing') captures the essence of this metric, the specific percentage calculation is omitted. This is a minor omission since the answer still conveys the correct magnitude and direction of change. The semantic equivalence is strong - both answers communicate the same core message about Texas Instruments' consistent and modest increase in defined contribution plan expenses over the three-year period. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 354,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023 and 2024.  The same wording appears in each year’s discussion of ROIC, indicating that the company treats these items as non‑reflective of operating performance.  This consistency shows a deliberate, transparent performance‑evaluation methodology that isolates core operating results and ensures comparability across periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: Both answers correctly identify that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024. The core factual claim is identical and accurate. (2) QUANTITATIVE ACCURACY: No numeric values, percentages, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. The years (2022, 2023, 2024) are correctly cited in both answers. (3) QUALITATIVE ACCURACY: The LLM answer provides slightly more detailed reasoning than the ground truth by noting 'the same wording appears in each year's discussion' and emphasizing 'transparent performance-evaluation methodology' and 'ensures comparability across periods.' These additions are logical extensions of the core finding and enhance the analysis without contradicting the ground truth. The LLM correctly identifies this as a deliberate, consistent approach. (4) MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024 and what this reveals about methodology. The LLM successfully synthesizes that consistency across three years indicates a stable, disciplined approach—exactly matching the ground truth's conclusion. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'consistent exclusion suggests...disciplined approach' (ground truth) vs. 'consistency shows a deliberate, transparent performance-evaluation methodology' (LLM answer) conveys equivalent meaning with slightly different emphasis. Both correctly characterize the consistency as revealing something positive about GD's methodology. Minor deduction (1 point) only because the LLM adds interpretive language ('transparent,' 'ensures comparability') that, while reasonable, goes slightly beyond what the ground truth explicitly states, though this is a strength rather than a weakness in practical terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 522,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate‑Accounts assets fell from **$3.313 billion** at December 31 2022 to **$3.204 billion** at December 31 2023, then rose to **$3.311 billion** at December 31 2024 (page 157 for 2022‑23; page 108 for 2024). The modest dip followed by a rebound to near‑2022 levels indicates that CVS has kept a relatively stable asset base for its long‑term insurance products, reflecting a steady investment positioning rather than a significant erosion or shift in those holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports 2022 Separate Accounts Assets as $3.313 billion, but the ground truth clearly states $5,087 million ($5.087 billion). This is a massive discrepancy of approximately $1.774 billion or 35% understatement. The 2023 figure of $3.204 billion is also incorrect (ground truth: $3,250 million). The 2024 figure of $3.311 billion matches the ground truth. (2) CALCULATION/TREND ANALYSIS ERROR: Because the 2022 baseline is wrong, the entire trend analysis is flawed. The LLM characterizes the movement as 'modest dip followed by a rebound to near-2022 levels,' which is incorrect. The actual trend shows a dramatic 36% decline from 2022 to 2023 ($5,087M to $3,250M), followed by a marginal 1.9% recovery in 2024. (3) INTERPRETATION FAILURE: The LLM's conclusion that CVS 'kept a relatively stable asset base' and 'steady investment positioning' directly contradicts the ground truth's assessment of 'significant decline in 2023 followed by stabilization.' The LLM misses the strategic significance of the substantial 2023 reduction. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the three-year trend, it does so with incorrect foundational data, making the entire synthesis invalid. The question asks what the trend 'suggests about the company's investment positioning,' and the LLM provides an incorrect interpretation based on wrong numbers. (5) CONTEXTUAL RELEVANCE: The answer does address the right company (CVS), the right metric (Separate Accounts Assets), and the right time period (2022-2024), but the factual errors are so severe that contextual relevance cannot compensate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 479,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. (originally dated Oct 22 2012) was amended in 2022 with a Third Amendment (filed as Exhibit (10)JJ to the Oct 29 2022 10‑Q) and further modified in 2023 by a Letter Agreement (filed as Exhibit 10.21.4 to the Apr 29 2023 10‑Q) (page 75). The 2024 10‑K incorporates the base agreement and these two post‑2022 amendments as exhibits, marking key contractual milestones in the program’s evolution (pages 69‑75).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Ground truth states: (1) Original agreement dated October 22, 2012 with first amendment dated February 24, 2015, and (2) a second amendment dated November 19, 2019 was explicitly listed in 2024. The LLM answer incorrectly claims: (1) a 'Third Amendment' was filed in October 2022 (no such amendment is mentioned in ground truth), (2) a 'Letter Agreement' was filed in April 2023 (not mentioned in ground truth), and (3) references specific exhibit numbers and page numbers (69-75) that cannot be verified against the ground truth. The LLM appears to have fabricated amendment details and filing information. The ground truth clearly identifies only two amendments: one from February 24, 2015 and one from November 19, 2019. The LLM's claim of a 'Third Amendment' in 2022 and a separate 'Letter Agreement' in 2023 are not supported by the knowledge graph. Additionally, the LLM provides specific exhibit citations and page numbers that appear to be hallucinated. While the LLM correctly identifies the original agreement date (October 22, 2012) and the parties involved (Target and TD Bank USA, N.A.), the core substance of how the agreement evolved is fundamentally misrepresented. The answer fails the multi-hop synthesis requirement by providing incorrect information about the amendments and their dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 387,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In 2022 Linde presented rare gases simply as a co‑product of its atmospheric‑gas manufacturing, noting that they were part of the same cryogenic air‑separation process that produced oxygen, nitrogen and argon (page 94). By 2024 the company positioned rare‑gas production as a differentiated, patented capability, emphasizing its leadership in non‑cryogenic air‑separation technologies that enable higher purity and lower‑cost rare‑gas output (page 4). Linde also highlighted that this technology is integrated with its engineering and distribution platforms—leveraging shared air‑separation processes and the on‑site, merchant and packaged gas channels to deliver rare gases alongside other industrial gases.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Linde's rare gases strategy from 2022 to 2024 and correctly identifies key technological differentiators. STRENGTHS: (1) Accurately identifies the shift from viewing rare gases as co-products to positioning them as differentiated capabilities; (2) Correctly names specific rare gases (krypton, neon, xenon) and technologies (non-cryogenic air separation, VPSA, membrane separation); (3) Properly synthesizes the integration across distribution channels (on-site, merchant, packaged); (4) Correctly notes the progression toward technology-driven positioning; (5) Appropriately references page numbers for sourcing. WEAKNESSES: (1) The answer emphasizes 'patented capability' and 'higher purity and lower-cost output' which are not explicitly mentioned in the ground truth—these appear to be inferences rather than direct facts from filings; (2) Omits the 2023 intermediate positioning that emphasized proprietary technologies and long-term contracts with price escalation clauses, which represents an important step in the evolution; (3) Does not explicitly mention the shift from 'product-centric to technology- and integration-driven approach' that the ground truth identifies as the key progression; (4) The characterization of 'patented capability' is not substantiated in the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects technological innovations to distribution integration, though it skips the 2023 transition point. SEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding the evolution toward technology differentiation and integration, but the specific claims about 'patented' status and cost/purity improvements lack grounding in the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 491,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply over the three‑year period: it was $1.494 billion at year‑end 2022, dropped to $800 million in 2023, and fell further to $491 million in 2024【page_102】【page_99】.  The decline reflects a shrinking exposure to derivative positions that are tied to advances to equity companies, indicating that the company has reduced its derivative activity or tightened its netting and margin strategy for those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and properly handled. The temporal sequence and year assignments are accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how collateral evolved from 2022-2024, and (2) what this trend suggests about derivative liability exposure. ENTITY ACCURACY: ExxonMobil correctly identified, master netting arrangements properly referenced, equity company relationships correctly contextualized, and all years properly specified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral figures to derivative exposure reduction and interprets this as de-risking/portfolio optimization. The logic that declining collateral reflects reduced derivative activity or tightened margin strategy is reasonable and consistent with the ground truth's interpretation of strategic reduction in exposure. SEMANTIC EQUIVALENCE: The LLM's phrasing 'shrinking exposure to derivative positions' and 'reduced its derivative activity or tightened its netting and margin strategy' conveys essentially the same meaning as the ground truth's 'strategic reduction in exposure' and 'de-risking or portfolio optimization efforts.' Minor differences in wording are stylistic rather than substantive. The inclusion of page references adds credibility without affecting accuracy. No calculation errors detected. The answer fully synthesizes information across the three-year period as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 474,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s long‑term contract coverage rose from about **92 % of its net generating capacity in 2022** (2022 10‑K, p. 19) to **94 % in 2023** (2023 10‑K, p. 19) and remained at that level in 2024 (2024 10‑K, p. 19). This steady, high‑level coverage demonstrates a deliberate risk‑mitigation strategy that locks in revenue and reduces exposure to spot‑market volatility in increasingly competitive electricity markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct (92% in 2022, 94% in 2023 and 2024), matching the ground truth exactly. The numeric progression is accurately captured. ENTITY ACCURACY: NEER (NextEra Energy Resources) is correctly identified, fiscal years 2022-2024 are properly referenced, and the metric (long-term bilateral contracts as percentage of net generating capacity) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of 10-K filings, correctly identifying the trend (steady increase from 92% to 94%, then plateau). SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberate risk-mitigation' and 'locks in revenue and reduces exposure to spot-market volatility' aligns well with the ground truth's description of 'strategic emphasis on revenue stability and risk mitigation.' MINOR DIFFERENCES: The ground truth explicitly mentions 'shorter-term bilateral contracts as a hedge when long-term agreements are not in place,' which the LLM answer does not include. This is a minor omission of contextual detail but does not affect the core factual accuracy. The LLM answer is slightly more concise but captures the essential trend and strategic implication. The citation format (10-K page references) adds credibility and specificity. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 416,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of $495 million at the end of fiscal 2022 (page 103), which remained unchanged at $495 million at the end of fiscal 2023 and again at $495 million at the end of fiscal 2024 (page 81). This shows that AVGO has not repaid or refinanced this instrument, reflecting a strategy of keeping the debt mix stable while managing overall leverage through other debt instruments or cash flow.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - $495 million principal balance consistently reported across fiscal 2022, 2023, and 2024. (2) Quantitative accuracy is high - the LLM correctly identifies the unchanged balance across all three years. (3) Entity identification is accurate - correctly identifies AVGO, the 3.125% notes due January 2025, and the relevant fiscal years. (4) Page references provided (103, 81) add credibility. WEAKNESSES: (1) The interpretation of debt management strategy differs from ground truth. The LLM states AVGO 'has not repaid or refinanced this instrument, reflecting a strategy of keeping the debt mix stable while managing overall leverage through other debt instruments or cash flow.' The ground truth suggests AVGO 'may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.' These are subtly different interpretations - the LLM's explanation is more generic about debt management, while the ground truth specifically highlights the likely refinancing or cash settlement approach as the company approaches maturity. (2) The LLM answer lacks the specific insight about approaching maturity and what that implies for the company's likely actions. The ground truth emphasizes that despite approaching maturity (January 2025), there was no principal reduction, which is a more pointed observation about the company's strategy. (3) The reasoning about 'keeping the debt mix stable' is somewhat speculative and less directly supported than the ground truth's focus on refinancing/cash settlement as the likely approach given the imminent maturity date. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three fiscal years to show the unchanged balance, meeting the multi-hop requirement. However, the strategic interpretation could be more precise and forward-looking given the maturity date context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 513,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 37B stayed unchanged: the interest rate remained 2.25 %, the face amount stayed at $700,000, and the maturity date stayed on January 15, 2032. This lack of change shows Simon Property Group’s preference for a stable, low‑cost long‑term debt profile, keeping predictable debt‑service obligations and avoiding refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FACE AMOUNT: The LLM states the face amount as $700,000 when the ground truth clearly indicates $700,000,000 (700 million dollars). This is a significant quantitative error - off by a factor of 1,000. The interest rate (2.25%) and maturity date (January 15, 2032) are correct. The LLM correctly identifies that the notes remained unchanged across 2022-2024, which is accurate. QUALITATIVE ASSESSMENT: The reasoning about Simon's debt strategy is sound and semantically equivalent to the ground truth - both discuss stability, predictable financing costs, and long-term debt management. The LLM adds a valid point about 'avoiding refinancing risk' which is a reasonable inference. However, the ground truth provides slightly more context about alignment with real estate portfolio cash flows. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the three-year progression and connects it to strategic implications, demonstrating adequate multi-hop reasoning. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution and strategic implications. The major issue is the face amount error ($700K vs $700M), which is a fundamental factual mistake that would significantly impact any financial analysis. This error alone warrants a lower correctness score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 372,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Texas Industries’ Melaka, Malaysia site remained an analog‑only manufacturing facility throughout the 2022‑24 period (2022: “Melaka, Malaysia ** – Analog”; 2023: “Melaka, Malaysia † – Analog”; 2024: “Melaka, Malaysia * – Analog”)【page_16】【page_16】【page_16】.  The footnote designation changed from ** to † to * (all indicating a leased/owned portion), but the product focus did not shift to embedded processing.  This three‑year consistency shows TI’s continued emphasis on analog products at Melaka, with no expansion into embedded processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies Texas Instruments (though uses 'Texas Industries' which is a minor naming variation - the ticker TXN is correct); (2) Accurately captures the three-year period (2022-2024) with consistent analog-only focus; (3) Correctly notes that Melaka, Malaysia maintained analog operations without expansion into embedded processing across all three years; (4) Properly identifies the footnote designation changes (** to † to *) while correctly noting these don't represent product focus changes; (5) Demonstrates sound multi-hop reasoning by synthesizing information across three separate years and comparing product line presence; (6) Correctly interprets the data structure (presence marked with 'X' or product name, absence by omission) to conclude no embedded processing operations. MINOR ISSUES: (1) 'Texas Industries' is technically incorrect - should be 'Texas Instruments' (though ticker TXN is correct, suggesting the model knew the right company); (2) The characterization of footnotes as 'indicating a leased/owned portion' is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation of footnote variations. VERIFICATION: All core facts match ground truth - consistent analog-only operations 2022-2024, no embedded processing expansion, stable operational strategy. The answer fully addresses both parts of the multi-part question (evolution of footprint AND what it reveals about product focus). Calculations and date references are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 432,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s real‑time payment infrastructure grew from 12 markets in 2022 to 13 markets in 2023 and 2024 (2022 page 11; 2023 page 11; 2024 page 11).  Over the same period the company maintained a multi‑layered security program—adding an enterprise‑resilience program, insurance coverage, regular testing, dedicated security operations, fusion and intelligence centers, and the use of tokenization, fraud‑scoring and technical standards—to protect the expanding global network (2022 page 12; 2023 page 12; 2024 page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core quantitative facts: 12 markets in 2022, 13 markets in 2023-2024. (2) Accurately lists multiple security components (tokenization, fraud-scoring, technical standards, enterprise-resilience program, insurance coverage, testing, security operations centers). (3) Properly cites page references for verification. (4) Correctly identifies the multi-layered approach as the core security framework. WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM fails to address a critical multi-hop element from the ground truth: the 2024 China joint venture expansion and its implications for security scaling. The ground truth explicitly states 'expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further.' The LLM completely omits this significant market expansion and its security implications. (2) LACKS EVOLUTION NARRATIVE - While the ground truth shows clear evolution (2022 baseline → 2023 expansion → 2024 China entry requiring further scaling), the LLM presents the security components as largely static across the period ('maintained a multi-layered security program'), missing the dynamic evolution aspect of the question. (3) MISSING CONTEXTUAL DETAILS - The ground truth mentions 'intelligent routing with real-time application of fraud scoring' (2023 specific), 'third-party service risks,' and 'public-private partnerships' - the LLM omits these nuanced developments. (4) WEAK CAUSAL LINKAGE - The question asks HOW the approach 'evolved in response to' expanding infrastructure. The LLM lists components but doesn't establish clear causal relationships between market expansion and security evolution. The ground truth better connects the dots: more markets → need for intelligent routing → need for scaling in China → framework adaptation. QUANTITATIVE ACCURACY: 7/10 - Numbers are correct (12→13 markets) but the answer is incomplete regarding the full scope of expansion (missing China). QUALITATIVE ACCURACY: 5/10 - Lists correct security components but fails to synthesize the evolution narrative and misses the China expansion as a key driver of security framework scaling. CONTEXTUAL RELEVANCE: 6/10 - Addresses the question partially but misses the critical 2024 China development that fundamentally changes the security scaling story.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 633,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics produced **449 new LAVs for the Canadian Army in 2022** (page 10, 2022 10‑K), **360 new LAVs in 2023** (page 11, 2023 10‑K), and **399 new LAVs in 2024** (page 10, 2024 10‑K). The dip from 2022 to 2023 followed by a rebound in 2024 shows the company is fine‑tuning its production schedule while still maintaining a strong, ongoing commitment to the Canadian LAV program, underscoring its strategic focus on sustaining and expanding that market segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains completely inverted production volume numbers across all three years. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units (consistent upward trajectory). LLM claims: 2022=449 units, 2023=360 units, 2024=399 units (inverted sequence). This is a fundamental factual error that reverses the entire narrative. The LLM incorrectly describes a 'dip from 2022 to 2023 followed by a rebound in 2024' when the actual data shows consistent growth throughout the period. The ground truth indicates strategic expansion and growing commitment, while the LLM's inverted numbers would suggest production volatility and inconsistency. All three numeric values are wrong (off by 89-49 units depending on year), making this a complete failure on quantitative accuracy. The reasoning about 'fine-tuning production schedule' is contradicted by the actual data showing steady increases. While the LLM correctly identifies General Dynamics, the Canadian Army, and LAV programs, and addresses the question's structure, the inverted numbers fundamentally undermine the entire analysis. This appears to be a data retrieval or ordering error where the LLM reversed the chronological sequence of production volumes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 350,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s target allocation to hedge‑fund limited‑partnership investments in its pension plan rose from **3 % in 2022** to **4 % in 2024** (up from 3 % in 2023 as well)【page_174】【page_169】. This modest 1‑percentage‑point increase over three years signals a deliberate shift toward higher‑risk, higher‑return assets, reflecting a more active and diversified pension‑fund strategy aimed at improving expected returns while still maintaining overall portfolio balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary quantitative metrics. The ground truth specifies dollar amounts ($214M in 2022, $225M in 2023, $252M in 2024), but the LLM provides percentage allocations (3% in 2022, 3% in 2023, 4% in 2024) instead. These are different metrics entirely - one measures absolute dollar allocation, the other measures relative portfolio allocation percentage. The LLM's claim of a 1-percentage-point increase contradicts the ground truth's 17.8% dollar increase over three years. While the LLM correctly identifies the general trend direction (upward), it provides the wrong type of metric and wrong numerical values. The LLM also mischaracterizes the trajectory: the ground truth shows 'relatively stable' allocation from 2022-2023 with a more significant jump to 2024, whereas the LLM suggests a consistent 1-point increase pattern. The reasoning about 'higher-risk, higher-return assets' and 'more active and diversified' strategy is speculative and not supported by the ground truth, which describes the approach as 'consistent' rather than representing a deliberate strategic shift. The answer fails on quantitative accuracy (wrong metrics and numbers), entity accuracy (confuses percentage allocation with dollar allocation), and multi-hop synthesis (does not correctly synthesize the three-year trajectory from the source data).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 382,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration rate fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】. This gradual decline suggests that while the card remains widely used, its share of total purchases is shrinking relative to overall sales growth, indicating a modest slowdown in consumer adoption or engagement as other payment methods or sales channels expand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the 2024 penetration rate as 18.6%, but the ground truth clearly indicates it should be 17.8%. This is a factual error of 0.8 percentage points on a key metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY ASSESSMENT: The error in the 2024 figure is significant because (1) it's a specific numeric claim that is verifiably wrong, (2) it affects the trend analysis - the decline from 19.8% to 18.6% (0.8pp) is less steep than the actual decline to 17.8% (1.0pp), and (3) this impacts the interpretation of the trend's severity. QUALITATIVE REASONING: The LLM's interpretation of the trend is reasonable and partially aligns with the ground truth - both acknowledge a declining penetration rate suggesting weakening consumer adoption. However, the LLM's explanation is less comprehensive than the ground truth, which provides more context about RedCard sales increasing in dollar terms while total sales grew faster, and mentions specific factors like competition and discount sensitivity. The LLM's reasoning about 'other payment methods or sales channels' is somewhat generic compared to the ground truth's more detailed analysis. COMPLETENESS: The LLM addresses the main question about penetration rate evolution and provides some interpretation of what the trend suggests, but misses the deeper insight about the disconnect between dollar sales growth and penetration decline. The answer is incomplete in not fully exploring the implications of the trend. ENTITY ACCURACY: Correctly identifies the Target MasterCard Credit Card and the time period (2022-2024). OVERALL: The answer contains a material factual error (18.6% vs 17.8% for 2024) that cannot be overlooked in a financial analysis context where precision is critical. While the overall narrative direction is correct, the specific numeric error and less comprehensive analysis warrant a below-average score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 525,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra’s fair‑value exposure for FPL Cost Recovery Clauses rose sharply from a net $1 million in 2022 (observable $(5) + unobservable $7) to $38 million in 2023 (observable $4 + unobservable $34) and remained at $38 million in 2024. The composition shifted markedly: observable inputs jumped from $4 to $38 million (31 + 6 + 1) while unobservable inputs stayed roughly flat at $34 million, indicating a move toward more observable inputs【page_55】【page_54】【page_56】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent the data: (1) YEAR ASSIGNMENT ERROR: The LLM states 2023 figures ($38M) when the ground truth shows $38M occurred in 2024, not 2023. The LLM also claims 2024 'remained at $38 million' which is contradictory to its own statement that 2023 was $38M. (2) OBSERVABLE INPUTS ERRORS: Ground truth shows observable inputs were -$5M (2022), -$12M (2023), and +$4M (2024). The LLM incorrectly states observable inputs as $(5) in 2022 (correct), then jumps to $4 in 2023 (should be -$12M), and claims they 'jumped from $4 to $38 million' which is nonsensical and contradicts the ground truth showing observable inputs at +$4M in 2024, not $38M. (3) UNOBSERVABLE INPUTS ERRORS: Ground truth shows +$6M (2022), +$24M (2023), +$34M (2024). The LLM states unobservable as $7 in 2022 (should be $6M) and $34 in 2023 (should be $24M), then claims they 'stayed roughly flat at $34 million' which misses the progression from $6M to $24M to $34M. (4) TOTAL FAIR VALUE ERRORS: The LLM completely misaligns the year-to-year progression, stating $1M (2022), $38M (2023), $38M (2024) when ground truth shows $1M (2022), $12M (2023), $38M (2024). The 2023 figure is entirely wrong. (5) TREND ANALYSIS ERROR: The LLM concludes there was 'a move toward more observable inputs' when the ground truth indicates growing reliance on unobservable inputs (from $6M to $24M to $34M as a percentage of total). The LLM's calculation '31 + 6 + 1' is unexplained and appears to be an erroneous attempt at decomposition. (6) MULTI-HOP SYNTHESIS: The answer fails to correctly synthesize the three-year evolution, mixing up years and misrepresenting the compositional shift. The core narrative about evolution from 2022-2024 is fundamentally broken.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 488,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike has maintained a strong competitive edge over Anta from 2022 through 2024, consistently emphasizing product innovation with technologies such as Flyknit, FlyEase, and React that continue to drive performance and sustainability (2024 page_6). Its brand‑engagement strategy remains centered on digital experiences, athlete endorsements, and direct‑to‑consumer channels, with a modest shift toward more digital commerce and fewer physical stores (2024 page_8; 2024 page_6; 2022 page_6). These sustained emphases underscore Nike’s continued advantage over Anta in both innovation and consumer engagement (2024 page_8).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors when compared to the ground truth:\n\n1. MISSING CRITICAL EVOLUTION NARRATIVE: The ground truth explicitly documents a strategic evolution from 2022→2023→2024, with 2023 being a pivotal year where NKE 'elevated the importance of innovation and development ahead of performance and reliability.' The LLM answer completely misses this temporal progression and the significance of the 2023 strategic shift.\n\n2. INCORRECT PRODUCT EMPHASIS: The LLM lists specific technologies (Flyknit, FlyEase, React) as 2024 differentiators, but the ground truth indicates NKE's 2022 emphasis was on 'quality, performance, and reliability' with 'new product style and design innovation.' The LLM conflates different years' strategies without proper temporal distinction.\n\n3. INCOMPLETE COMPETITIVE POSITIONING ANALYSIS: The ground truth emphasizes that Anta 'remained a named competitor across all three years' and that NKE's strategy evolved 'in response to competitive pressures' from Anta and others using 'localized and digitally native strategies.' The LLM merely states Nike has 'maintained a strong competitive edge' without explaining the competitive dynamics or Anta's strategic positioning.\n\n4. MISSING KEY STRATEGIC SHIFT: The ground truth's core insight is the 2023 elevation of 'innovation and development' as a response to competitive pressure. The LLM treats innovation as constant across all years, missing this critical strategic inflection point.\n\n5. INCOMPLETE BRAND ENGAGEMENT ANALYSIS: While the LLM mentions digital experiences and athlete endorsements (correct), it misses the ground truth's emphasis on how these became 'critical components' specifically in 2024 as part of the multi-year differentiation strategy.\n\n6. VAGUE COMPARATIVE ANALYSIS: The LLM states Nike has 'maintained a strong competitive edge' but provides no substantive evidence of how the competitive positioning evolved or why. The ground truth explains the 'multi-year strategic effort' and the specific competitive threats.\n\n7. CITATION ISSUES: While the LLM provides page citations, these cannot be verified against the ground truth's knowledge graph structure, and the specific claims about technologies and strategies lack the temporal precision required.\n\nThe answer demonstrates partial understanding of Nike's brand engagement strategies but fundamentally fails to capture the evolution of competitive positioning and the strategic response to Anta's competitive threat across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 679,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 through 2024 the equity‑compensation tables show no shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan.  In 2022 the “available for future issuance” column lists only the 2009 LTIP, 2014 ESPP and 2018 Director Plan (page 63), in 2023 it lists the same three plans (page 61), and in 2024 it lists the 2024 LTIP, 2014 ESPP and 2018 Director Plan (page 59).  This steady absence of future‑issuance capacity indicates that TI is no longer allocating new shares under the 2003 plan and is effectively phasing it out, using it only for existing awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses when compared to the ground truth. STRENGTHS: (1) The LLM correctly identifies that the 2003 Director Compensation Plan had no shares available for future issuance across all three years (2022-2024), which is factually accurate. (2) The page references provided (63, 61, 59) demonstrate specific citation of source documents. (3) The conclusion about phase-out and use only for existing awards aligns with the ground truth's interpretation. (4) The identification of which plans were listed in each year is mostly accurate. WEAKNESSES: (1) The LLM answer contradicts the ground truth on a key point: the ground truth states 'In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it,' but the LLM claims the 2003 plan had no shares available for future issuance in 2022. This is a material factual discrepancy. (2) The ground truth indicates the 2003 plan was 'no longer listed among those with remaining shares available for future issuance' by 2023, implying it WAS listed in 2022, but the LLM states it was absent from the 'available for future issuance' column in 2022. (3) The LLM's interpretation that the plan had 'steady absence' from 2022-2024 conflicts with the ground truth's narrative of evolution/change from 2022 to 2023 to 2024. (4) The ground truth emphasizes the plan was 'still referenced for outstanding grants' in 2023, which the LLM doesn't explicitly address. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the shift toward newer plans (2024 LTIP), but mischaracterizes the starting point (2022) of the evolution. The reasoning about phase-out is sound but based on incomplete/inaccurate premise about 2022 status. QUANTITATIVE ACCURACY: The page numbers and plan names are correctly cited, but the characterization of share availability in 2022 appears to be factually incorrect based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 541,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA’s advertising business already offered technology, tools, data‑driven services and marketplace solutions in 2022 (page 6, 2022). By 2023 it expanded this ecosystem by launching the NOW TV service, adding the Xumo Stream Box (formerly Flex) and integrating advanced search and voice‑activated remote control into its X1 and Sky Q platforms, thereby deepening its data‑driven advertising capabilities (page 6, 2023). In 2024 the company further enhanced its technology stack with DOCSIS 4.0 to deliver multigigabit symmetrical broadband speeds and continued to broaden marketplace solutions for advertisers (page 7, 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information with significant deviations from the ground truth. CORRECT ELEMENTS: (1) The 2022 baseline is accurate - CMCSA did offer technology, tools, data-driven services, and marketplace solutions. (2) The general trajectory of expansion from 2022-2024 is directionally correct. SIGNIFICANT ERRORS: (1) The LLM introduces NOW TV service, Xumo Stream Box, X1, and Sky Q platforms as 2023 enhancements to advertising capabilities - these are NOT mentioned in the ground truth as advertising-specific enhancements and appear to be product/service offerings rather than advertising technology evolution. (2) The LLM mentions DOCSIS 4.0 in 2024 as an advertising enhancement - this is a broadband technology unrelated to advertising services and is NOT part of the ground truth answer about advertising evolution. (3) The LLM fails to mention critical ground truth elements: cloud-based platforms (2023), integrated search functionality across content sources (2023), enhanced digital advertising tools (2024), and strengthened representation agreements with third parties for advertiser reach and targeting (2024). MULTI-HOP REASONING ISSUE: The LLM appears to have conflated general product/service evolution with advertising business evolution. The question specifically asks about 'integration and expansion of data-driven services within its advertising offerings' - the LLM's answer discusses product launches (NOW TV, Xumo) and broadband technology (DOCSIS 4.0) rather than advertising-specific enhancements. SYNTHESIS PROBLEM: The LLM failed to properly synthesize information about advertising technology evolution and instead provided information about broader company product evolution. The ground truth emphasizes cloud infrastructure, data analytics, search functionality, and representation agreements - none of which appear in the LLM answer. The answer is partially responsive but fundamentally misses the core advertising business evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 544,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) exposure has shrunk markedly.  At December 31 2022 the company held $1,018 million of CMBS with $98 million in unrealized losses; by December 31 2023 the fair value fell to $975 million and unrealized losses dropped to $2 million (2023 10‑K, pp. 148‑149).  In 2024 the CMBS fair value in the consolidated balance sheet is only $3 million (Separate Accounts, p. 160) with virtually no unrealized losses, indicating a deliberate move to a lower‑risk, more conservative position in this asset class.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years examined. Specific errors: (1) 2022: LLM states $1,018M fair value with $98M unrealized losses, but ground truth shows $574M fair value with $12M unrealized losses - a massive discrepancy of $444M in fair value and $86M in losses. (2) 2023: LLM reports $975M fair value with $2M unrealized losses, but ground truth indicates $675M fair value with $100M unrealized losses - another $300M error in fair value and $98M error in losses direction (losses increased, not decreased). (3) 2024: LLM states $3M fair value with minimal losses, while ground truth shows $6M fair value - closer but still incorrect. The LLM's narrative of declining exposure is directionally correct in concept, but the actual numbers are dramatically wrong. The LLM incorrectly characterizes 2023 as showing 'unrealized losses dropped to $2 million' when ground truth shows losses surged to $100M - this is a critical misrepresentation of the risk trend. The conclusion about de-risking is reasonable but is based on false premises. The LLM appears to have cited specific page numbers (pp. 148-149, p. 160) suggesting confidence in sources, but the data provided is factually incorrect. This represents a complete failure on quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 390,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022 (page 5), 2023 (page 6), and 2024 (page 6) all list a “merchandise and other discounts” benefit for employees, but none of the documents disclose a specific discount rate or dollar value. Because the scope of the benefit remains the same and no change in value is reported, the filings suggest Target keeps a stable, predictable discount as part of its broader employee‑compensation strategy rather than frequently adjusting it.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer demonstrates a fundamental misunderstanding of the question and fails to address the core inquiry about how merchandise discounts evolved across the three years. CRITICAL ISSUES: (1) The LLM correctly identifies that merchandise discounts appear in all three years' filings and notes no specific discount rate is disclosed—this is accurate. However, the LLM then concludes that 'the scope of the benefit remains the same' and 'no change in value is reported,' which directly contradicts the ground truth. (2) The ground truth explicitly documents significant evolution: wage ranges expanded from $15/hour (2022) to $15-$24/hour (2023), and the benefits package evolved from basic offerings to include financial wellness components (401(k) matching, tuition reimbursement) in 2023, and mental health/virtual healthcare in 2024. The LLM completely missed this multi-year progression. (3) The question asks about 'scope and value' evolution and what it 'suggests about the company's employee benefit strategy'—the ground truth answers this by showing a strategic shift toward holistic well-being while maintaining traditional perks. The LLM provides no such strategic analysis. (4) The LLM's conclusion that Target 'keeps a stable, predictable discount' is unsupported by the evidence and misses the broader context of how merchandise discounts fit within an expanding benefits ecosystem. QUANTITATIVE ACCURACY: The LLM correctly identifies page numbers and years (7/10)—these are accurate. However, it fails to synthesize the wage and benefits evolution data that should have been extracted from the filings. QUALITATIVE ACCURACY: Very poor (2/10). The LLM demonstrates weak multi-hop reasoning by failing to connect merchandise discounts to the broader benefits strategy evolution. It treats the discount in isolation rather than as part of an integrated compensation package that changed significantly across the three years. CONTEXTUAL RELEVANCE: Low (4/10). While the LLM addresses merchandise discounts, it fundamentally misses the question's focus on evolution and strategic implications. The answer is technically about the right topic but answers the wrong question—it addresses whether the discount changed in isolation rather than how it evolved within Target's broader employee benefits strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 619,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "From 2022 to 2024, Linde consistently listed cultural challenges as a key integration risk (page_12). The 2024 filing added an explicit reference to integration across different cultures and languages in foreign acquisitions (page_10), underscoring a heightened focus on cross‑cultural integration. This evolution signals a strategic emphasis on proactive cultural alignment to mitigate cross‑border integration risks and preserve synergies.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Linde consistently highlighted cultural challenges from 2022-2024 and notes the evolution toward explicit cross-cultural/language focus in 2024. However, it falls significantly short of the ground truth's depth and nuance. STRENGTHS: (1) Correctly identifies the company (Linde) and time period (2022-2024); (2) Acknowledges cultural challenges as a persistent concern; (3) Notes the 2024 evolution toward explicit cross-cultural integration language; (4) Mentions synergies preservation. CRITICAL WEAKNESSES: (1) The LLM answer lacks the three-year progression narrative that is central to the ground truth - it jumps from 'consistently listed' to 2024 without explaining the 2023 evolution; (2) Missing the 2023 expansion regarding global regulatory/compliance risks and how cultural differences compound legal complexities; (3) Fails to capture the strategic reframing from operational hurdles (2022) to financial outcomes and strategic risk management (2024); (4) The page references (page_12, page_10) cannot be verified against the ground truth and appear to be fabricated specificity; (5) The answer is more superficial, stating what happened without explaining the strategic significance of the evolution. MULTI-HOP REASONING: The ground truth demonstrates sophisticated multi-hop synthesis across three years showing how framing evolved from operational to strategic/financial. The LLM answer provides a simpler, more linear observation without the nuanced progression. The LLM's conclusion about 'proactive cultural alignment' is reasonable but doesn't capture the deeper insight about risk management and financial outcome framing that distinguishes the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 470,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022 to $491 million in 2024** – a decline of about **$1.0 billion**. This drop indicates the company has reduced the amount of derivative exposure that requires initial‑margin collateral or has improved its netting efficiency, suggesting more effective management of its derivative risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the overall trend, but has a significant completeness issue. CORRECT ELEMENTS: (1) Starting value of $1.494 billion in 2022 is accurate (matches $1,494 million in ground truth); (2) Ending value of $491 million in 2024 is correct; (3) The calculated decline of approximately $1.0 billion is accurate ($1,494M - $491M = $1,003M); (4) The interpretation about reduced derivative exposure and improved netting efficiency is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure or improved offsetting mechanisms'; (5) Number formatting variations are acceptable ($1.494 billion = $1,494 million). CRITICAL OMISSION: The LLM answer completely omits the 2023 intermediate data point ($800 million), which is explicitly mentioned in the ground truth as part of the 'consistent decline' pattern across the three-year period. This omission weakens the completeness of the multi-hop analysis, as the question asks about the trend from 2022 to 2024, and the intermediate year provides important context for understanding the consistency of the decline. The LLM's reasoning about derivative exposure management is sound and matches the ground truth's interpretation, but the missing 2023 data point represents incomplete synthesis of the available information. The answer would have been stronger with all three data points to fully demonstrate the 'consistent decline' pattern mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 413,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "AVGO’s 2022 10‑K described the Security Insights Platform as a mainframe‑focused tool that “quickly interprets and assesses security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis, with the data available for use with in‑house SIEM tools”【page_11】. The 2023 filing repeats the same wording, showing no change in positioning or capabilities【page_11】. In 2024 the description is identical, but the platform is now explicitly referenced as part of the broader “Enterprise Security” portfolio, underscoring its role in an integrated cyber‑defense strategy while still offering the same risk‑identification, remediation, and SIEM‑integration features【page_10】. Thus, the platform’s core functions and external‑tool integration remained constant, with only a clearer alignment to the company’s overall cybersecurity framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer contradicts the ground truth on a critical point. Ground truth states that by 2023, the platform was 'more explicitly tied to AVGO's broader cybersecurity portfolio' and by 2024 was 'contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps.' However, the LLM claims the 2023 filing 'repeats the same wording, showing no change in positioning' and only in 2024 is it 'explicitly referenced as part of the broader Enterprise Security portfolio.' This represents a fundamental mischaracterization of the evolution timeline. The LLM incorrectly suggests stasis in 2023 when the ground truth indicates meaningful evolution occurred between 2022-2023. Additionally, the LLM's characterization of the 2024 positioning as 'Enterprise Security portfolio' differs from the ground truth's more specific description of integration with 'Cybersecurity, AIOps, and DevOps' within an 'expanded mainframe software suite.' The LLM correctly identifies the core technical features (risk assessment, remediation steps, SIEM integration) and the general direction toward integration, but fails to capture the nuanced progression across the three-year period. The answer demonstrates partial understanding but contains significant errors in the multi-hop synthesis of how the platform's positioning evolved year-to-year. The page citations provided (page_11, page_10) cannot be verified against the ground truth but the substantive claims about the evolution timeline are demonstrably incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 428,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 32B has stayed unchanged: the face value remains $750,000 and the coupon rate is 3.38 % with a maturity of June 15 2027 (see 2022 page 50, 2023 page 50, and 2024 page 51).  The unchanged terms show that the company is keeping this long‑term, fixed‑rate debt stable rather than refinancing or altering its exposure, underscoring a conservative, low‑cost debt‑management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a major quantitative error that fundamentally undermines the response. The face value is stated as $750,000 when the ground truth clearly shows $750,000,000 (750 million dollars). This is a 1,000x error - a difference of $749.25 million. While the interest rate (3.38%), maturity date (June 15, 2027), and the observation that terms remained unchanged across 2022-2024 are all correct, this massive numerical error is unacceptable for a financial question where precision is critical. The LLM correctly identifies that the company maintained stable debt terms without refinancing, which demonstrates sound reasoning about debt management strategy. The reference to specific page numbers (2022 page 50, 2023 page 50, 2024 page 51) adds credibility but does not excuse the fundamental calculation/transcription error. The qualitative analysis about conservative, low-cost debt management is reasonable and aligns with the ground truth's characterization of a 'stable long-term debt strategy.' However, in financial analysis, a $749+ million error in principal amount is disqualifying. This appears to be a transcription error where the LLM dropped three zeros from the face value. The answer would have scored 8-9 if the face value had been correctly stated as $750,000,000 or $750 million.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 371,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022‑2024 the filings show that Lumen has steadily expanded its fiber‑to‑the‑premises network, adding fiber‑based service in more of Comcast’s footprint and offering higher‑speed plans that surpass traditional DSL.  The competitive threat has therefore grown as Lumen’s fiber rollout brings multigigabit options into many of Comcast’s markets.  While the documents note that competitors—including Lumen—may bundle broadband with voice or TV services, they do not provide specific details on Lumen’s bundling strategy; the primary concern remains the incremental fiber coverage and the higher‑speed packages it can now deliver.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in addressing the full scope of the original answer. STRENGTHS: (1) Correctly identifies Lumen as a key competitor to CMCSA (Comcast) in broadband; (2) Accurately notes fiber-to-the-premises expansion and higher-speed service offerings as core competitive strategies; (3) Correctly references the 2022-2024 timeframe; (4) Appropriately acknowledges bundling as a competitive factor. WEAKNESSES: (1) The LLM answer explicitly states 'they do not provide specific details on Lumen's bundling strategy' and downplays bundling as a concern, whereas the original answer emphasizes that bundling was an explicit and consistent competitive strategy across all three years (2022, 2023, 2024); (2) The original answer provides a year-by-year evolution showing escalation and intensification of competitive pressure, while the LLM answer uses vaguer language ('steadily expanded') without capturing the progression or escalation narrative; (3) The original answer explicitly notes 'continued focus on fiber expansion and bundled offerings as a core competitive strategy' in 2024, but the LLM answer minimizes the bundling component; (4) The original answer indicates 'possibly intensifying' competitive threat, while the LLM answer presents it more as steady/linear rather than escalating. MULTI-HOP REASONING: The LLM answer demonstrates adequate synthesis of information across the three-year period but fails to fully integrate the bundling strategy component that appears consistently in the ground truth. The reasoning about fiber expansion is sound but incomplete. SEMANTIC ISSUES: The LLM's characterization that documents 'do not provide specific details on Lumen's bundling strategy' contradicts the original answer's assertion that bundling was explicitly called out across multiple years. This represents a material difference in interpretation of the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 524,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (RedCard/Target Circle Card penetration)【page_27】. The steady decline indicates that fewer customers are adopting the cards, suggesting the loyalty‑driven payment strategy is becoming less effective at driving card usage and incremental sales【page_27】【page_29】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the 2024 penetration rate was 18.6%, but the ground truth shows it was 17.8%. This is a factual error of 0.8 percentage points on a key metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY ASSESSMENT: The error in the 2024 figure is significant because it directly contradicts the ground truth and affects the interpretation of the trend. The LLM correctly identifies the overall downward trend but with an inaccurate endpoint. QUALITATIVE ACCURACY: The reasoning about the trend is sound - the LLM correctly interprets the declining penetration as suggesting reduced effectiveness of the loyalty-driven payment strategy. The synthesis across multiple pages (27, 29) is appropriate. The identification of the cards as RedCard/Target Circle Card is contextually relevant. COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates and what the trend suggests about strategy effectiveness. However, the incorrect 2024 figure undermines the accuracy of the trend analysis. MULTI-HOP REASONING: The model successfully synthesizes information about the penetration rates across three years and connects this to strategic implications, which is appropriate for the question. The logic linking declining penetration to reduced strategy effectiveness is sound. SEMANTIC EQUIVALENCE: The wording appropriately conveys the concept of declining effectiveness, though the factual error in the 2024 number prevents full semantic equivalence with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 431,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s presence in the Republic of Congo moved from ownership to divestiture between 2022 and 2024.  In 2022 the company held a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Congo portion of the Lianzi field (2022 10‑K, p. 31).  By 2024 Chevron announced the sale of both interests—31.5 % in Haute Mer and 15.75 % in Lianzi—effective January 2025, signaling a strategic pullback from the region and a reduction in capital commitment there (2024 10‑K, p. 43).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: 31.5% working interest in Haute Mer, 15.75% interest in Lianzi, and the January 2025 effective date for the sale. The answer correctly identifies the shift from ownership to divestiture and provides appropriate document citations (2022 10-K p. 31, 2024 10-K p. 43). However, the answer has notable omissions compared to the ground truth: (1) It fails to mention the 2023 investment of approximately $0.7 billion in offshore development and natural gas projects across Africa including Congo, which is a key data point showing the evolution of engagement; (2) It does not explicitly note that Congo was listed as a key operational country in 2022, providing context for the strategic importance; (3) The answer lacks the characterization of the 2023 investment as signaling 'continued capital commitment' before the 2024 divestiture, which is important for understanding the full arc of engagement evolution. The multi-hop reasoning is partially sound—it correctly synthesizes information across 2022 and 2024 filings to show the transition—but it misses the critical 2023 intermediate step that demonstrates the full evolution requested in the question. The answer is semantically clear and well-structured, but incomplete in addressing all dimensions of how engagement 'evolved' from 2022 through 2024. The omission of the $0.7 billion investment data is a significant gap in completeness for a question specifically asking about 'investment levels' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 430,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NEE’s net short gas‑option position grew from (1,307 MMBtu) in 2022 to (1,452 MMBtu) in 2023, then eased to (1,131 MMBtu) in 2024 (see Notional Volumes tables, pages 85 and 87).  The net fair value of gas options stayed essentially flat at a slight liability of about $2 million in both 2023 and 2024, while the weighted‑average implied volatility remained at 52 % (see Options‑primarily‑gas tables, pages 85 and 86).  This stability in fair value and implied volatility indicates that NEE’s hedging strategy kept the market‑perceived risk level unchanged even as the notional exposure contracted.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth across multiple critical dimensions:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - Ground truth reports fair values in MILLIONS of dollars ($356M assets, $347M liabilities in 2022; $100M assets, $97M liabilities in 2023; $100M assets, $102M liabilities in 2024)\n   - LLM reports notional volumes in MMBtu (1,307 MMBtu in 2022, 1,452 MMBtu in 2023, 1,131 MMBtu in 2024) - completely different metric\n   - LLM claims fair value was \"essentially flat at a slight liability of about $2 million in both 2023 and 2024\" - this contradicts ground truth showing $100M assets and $97M liabilities in 2023, and $100M assets and $102M liabilities in 2024\n   - LLM reports implied volatility at 52% for both 2023 and 2024, but ground truth shows 50% in 2023 and 52% in 2024 (minor but still incorrect for 2023)\n   - LLM completely omits 2022 data entirely\n\n2. ENTITY/METRIC CONFUSION:\n   - Ground truth focuses on fair value of options (asset/liability positions in dollars)\n   - LLM focuses on notional volumes (MMBtu quantities) - these are different metrics entirely\n   - The question asks about \"fair value and implied volatility\" - LLM addresses volatility but uses wrong fair value metric\n\n3. COMPLETENESS:\n   - Ground truth provides complete 3-year trajectory (2022-2024) with all key metrics\n   - LLM omits 2022 entirely, missing the \"sharp reduction\" that is central to understanding the evolution\n   - LLM fails to capture the significant drop from 2022 to 2023 ($356M to $100M in assets)\n\n4. REASONING QUALITY:\n   - Ground truth correctly synthesizes the evolution: sharp reduction 2022→2023, stabilization 2023→2024, with volatility increasing then moderating\n   - LLM's conclusion about \"stability in fair value\" is incorrect - it misidentifies the magnitude of fair values\n   - LLM's interpretation about \"hedging strategy kept market-perceived risk level unchanged\" is unsupported by the actual fair value changes\n\n5. SEMANTIC ALIGNMENT:\n   - The answers address fundamentally different aspects of gas options exposure\n   - Ground truth: fair value evolution (dollar amounts) + implied volatility\n   - LLM: notional volumes + implied volatility\n   - These are not semantically equivalent approaches to the question\n\nThe LLM appears to have accessed different tables or sections of the filing (notional volumes tables vs. options fair value tables) and conflated different metrics, resulting in an answer that, while internally referencing specific pages, provides incorrect quantitative data that contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 697,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 10‑K filings show a consistent treatment of FlyEase: it is listed among the company’s suite of technologies in both the 2022 and 2024 reports, appearing in the “Product Research, Design and Development” section as part of the broader “proliferation of technologies” (see 2022 page 6 and 2024 page 6).  The unchanged mention indicates that FlyEase remains an integrated, but not headline, element of Nike’s innovation portfolio—used to enhance product performance and accessibility rather than serving as a flagship technology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about FlyEase's evolution from 2022 to 2024. Key issues: (1) CONTRADICTS GROUND TRUTH: The LLM claims FlyEase treatment was 'unchanged' and 'consistent' between 2022 and 2024, directly contradicting the ground truth which documents a clear progression from 'newly introduced' (2022) → 'expanded presence' (2023) → 'fully embedded' (2024). (2) MISSING CRITICAL INFORMATION: The LLM completely omits the 2023 data point, which is essential to understanding the evolution trajectory. The ground truth explicitly identifies 2023 as a pivotal year showing 'deliberate effort to scale the technology.' (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution across three years (2022-2024), requiring synthesis of temporal progression. The LLM only compares 2022 and 2024, missing the intermediate step that demonstrates the progression pattern. (4) INCORRECT CONCLUSION: The LLM concludes FlyEase remains 'not headline' and is 'unchanged,' when the ground truth shows it evolved to become a 'foundational element' and 'core technology' by 2024. (5) CITATION ISSUES: While the LLM cites page numbers, it provides no evidence of the claimed 'unchanged mention' across years. (6) MISSES STRATEGIC SIGNIFICANCE: The LLM fails to recognize that the progression from 'newly introduced' to 'fully embedded' indicates a deliberate strategic escalation, not stasis. The answer demonstrates poor multi-hop reasoning by failing to synthesize the three-year timeline and incorrectly characterizes the relationship between the data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 445,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35A stayed unchanged: a $750 000 face amount, a 2.65 % interest rate, and a maturity of July 15 2030 (page_50 for 2022 & 2023, page_51 for 2024). This constancy shows the company is pursuing a conservative long‑term debt strategy that relies on stable, low‑cost, fixed‑rate financing rather than frequent refinancing or restructuring of existing notes (page_50, page_51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - $750,000 face amount, 2.65% interest rate, July 15, 2030 maturity date are all accurately stated and match the ground truth. The format variation ($750,000 vs $750 000) is acceptable and does not affect accuracy. COMPLETENESS: The answer addresses the core question about how the obligations evolved (remained constant) and what this reveals about debt strategy (conservative, stable approach). The answer correctly identifies that there was no refinancing or restructuring across the three-year period. ENTITY ACCURACY: SPG is correctly identified, the specific debt instrument (Unsecured Notes - 35A) is properly named, and the time period (2022-2024) is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the consistency of the financial metrics across three years to draw a logical conclusion about SPG's debt strategy. The inference that stability indicates a conservative approach avoiding frequent refinancing is well-supported by the data presented. MINOR OBSERVATIONS: The LLM answer omits the specific annual debt service amount ($19,875) mentioned in the ground truth, which is a minor detail that doesn't significantly impact the core answer. The page references provided (page_50, page_51) add credibility though they cannot be independently verified. The semantic equivalence is strong - both answers convey that the notes remained unchanged and this reflects a stable, conservative debt management approach. The LLM's phrasing of 'stable, low-cost, fixed-rate financing' effectively captures the strategic implications without being overly verbose.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 472,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments’ MD&A (pages 18–20 of each filing) repeatedly frames embedded‑processing as a core pillar of its business model, stressing its importance in industrial and automotive markets alongside analog products. Segment results show embedded‑processing revenue grew modestly from $3.26 B in 2022 to $3.37 B in 2023, then fell to $2.53 B in 2024, yet the company continues to highlight the segment as a key source of high‑margin cash flow. This consistent emphasis signals that TI’s long‑term growth strategy hinges on leveraging its manufacturing and channel advantages in analog and embedded‑processing products to maximize free‑cash‑flow‑per‑share and deliver sustainable shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic narrative about embedded processing as a pillar of TI's business model across 2022-2024, and appropriately connects this to free cash flow per share maximization. The answer demonstrates good multi-hop reasoning by synthesizing information across three years and linking strategic positioning to financial objectives. The qualitative framing about manufacturing/channel advantages and sustainable shareholder value aligns well with the ground truth's characterization of embedded processing as 'stable, high-margin, and scalable.' CRITICAL WEAKNESSES: The LLM provides specific revenue figures ($3.26B in 2022, $3.37B in 2023, $2.53B in 2024) that cannot be verified against the ground truth, which contains no such quantitative data. These numbers appear to be hallucinated or sourced from unverified data. The ground truth emphasizes the CONSISTENCY of TI's strategic messaging across all three years without providing segment-level revenue data. The LLM's introduction of specific dollar amounts creates a false sense of precision and introduces unverifiable quantitative claims. REASONING ASSESSMENT: The multi-hop synthesis is sound in connecting strategic emphasis → competitive advantages → free cash flow per share objectives. However, the addition of unverified revenue figures undermines the answer's credibility. The observation about revenue decline from 2023 to 2024 (if accurate) would be relevant context, but cannot be confirmed. SEMANTIC ISSUES: The ground truth emphasizes that TI 'consistently emphasized' and 'reiterated' the same strategic focus, suggesting stability in messaging. The LLM's framing of a revenue decline while maintaining strategic emphasis is not contradictory, but the specific numbers lack grounding in the provided ground truth. The answer would be stronger if it acknowledged the consistency of messaging without introducing unverified financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 529,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "In 2022, Marvel was not a top‑level tile on Disney+; by 2023 Disney+ had elevated Marvel to a top‑level tile alongside Disney, Pixar, Star Wars and National Geographic (page_7), and by 2024 Marvel remained a key intangible asset, with its trademarks listed among the indefinite‑lived intangibles (page_114). This evolution shows Disney’s strategy of monetizing high‑value IP to attract and retain subscribers, thereby justifying investment in and amortization of intangible assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Marvel became a top-level tile by 2023 and remained an indefinite-lived intangible asset in 2024. (2) The list of other tiles (Disney, Pixar, Star Wars, National Geographic) appears accurate. (3) The core financial strategy point about monetizing IP to drive subscriber growth is sound. (4) Page references (page_7, page_114) suggest proper source documentation.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to mention the Disney+ subscriber base of 123 million as of September 28, 2024, which is explicitly stated in the ground truth and directly supports the financial strategy narrative. (2) INCOMPLETE SYNTHESIS: The answer doesn't address the 2022 baseline adequately - the ground truth notes Marvel was listed as an indefinite-lived intangible asset in 2022, which the LLM doesn't explicitly confirm. (3) MISSING STRATEGIC CONTEXT: The ground truth mentions Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategic pattern. The LLM doesn't capture this forward-looking strategic element. (4) VAGUE LANGUAGE: The LLM states Marvel 'remained a key intangible asset' in 2024 but doesn't clearly establish the continuity from 2022 or explain why this matters financially. (5) INCOMPLETE ANSWER TO MULTI-PART QUESTION: The question asks what the evolution 'indicates about its financial strategy in driving subscriber growth' - the LLM provides only a generic statement about 'monetizing high-value IP' without connecting to actual subscriber metrics or financial outcomes.\n\nNUMERIC/FACTUAL VERIFICATION: The 123 million subscriber figure from the ground truth is not mentioned in the LLM answer, which is a significant omission for a question specifically asking about 'driving subscriber growth.' The years (2022, 2023, 2024) are correct. The tile designation and intangible asset classification are accurate.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop reasoning by connecting Marvel's UI prominence to subscriber strategy, but fails to complete the full chain of reasoning that includes actual subscriber numbers and the broader strategic pattern (ESPN+ tile launch).\n\nSCORE JUSTIFICATION: The answer is partially correct on core facts but significantly incomplete in addressing the full scope of the question, particularly regarding subscriber growth metrics and the broader strategic evolution. The omission of the 123 million subscriber figure is particularly problematic given the question's explicit focus on 'driving subscriber growth.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 679,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife continued to reinsure 59 % of its closed block under a modified‑coinsurance agreement each year from 2022 through 2024.  The net ceded reinsurance recoverables linked to that agreement grew markedly, rising from $6.1 billion at December 31 2022 to $16.7 billion at December 31 2023 and to $17.6 billion at December 31 2024, reflecting the expanding scope of the modified‑coinsurance arrangement.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) PERCENTAGE CLAIM: The LLM states the percentage remained at 59% from 2022-2024, but ground truth shows 2022 was 59.25%, declining to 59% in 2023-2024. While the difference is minor, the claim of consistency is factually incorrect. (2) REINSURANCE RECOVERABLE BALANCES - CRITICAL ERROR: The LLM cites completely different numbers than ground truth: LLM reports $6.1B (2022), $16.7B (2023), $17.6B (2024), while ground truth shows $3.6B (2022), $4.4B (2023), $4.2B (2024). These are not minor formatting differences - they represent a 40-75% overstatement of actual balances. The LLM numbers are nearly 4x larger than the ground truth figures. (3) METRIC CONFUSION: The LLM references 'net ceded reinsurance recoverables' while ground truth specifies 'unsecured reinsurance recoverable balances.' These may be different metrics entirely, suggesting the LLM pulled data from the wrong line item or misidentified the relevant metric. (4) TREND ANALYSIS: Ground truth shows a modest increase from 2022-2023 ($3.6B to $4.4B) followed by a slight decline in 2024 ($4.2B), indicating stability with minor fluctuations. The LLM's narrative of 'marked growth' and 'expanding scope' is contradicted by the actual data pattern. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution across three years, presenting inflated numbers that don't match the source data. The answer is contextually relevant to the question asked but fundamentally incorrect in its core quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 445,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed‑security (RMBS) portfolio fell from $721 million in 2022 to $614 million in 2023 (a decline of $107 million)【page_149】, and the fair value of RMBS held in its separate accounts rose to $71 million in 2024 from $51 million in 2023【page_160】. This 3‑year trend shows a cautious, risk‑averse stance: the company is trimming duration exposure while keeping high‑quality, agency‑guaranteed RMBS in separate accounts to preserve liquidity and meet regulatory capital requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) 2022 RMBS value: LLM states $721 million, but ground truth shows $629 million - a $92 million discrepancy. (2) 2023 RMBS value: LLM correctly states $614 million, matching ground truth. (3) 2024 RMBS value: LLM states $71 million in separate accounts rose from $51 million in 2023, but ground truth indicates the total RMBS declined sharply to $71 million in 2024 (not a rise from $51M). The LLM appears to have confused separate account holdings with total RMBS holdings. (4) Unrealized losses: Ground truth mentions unrealized losses of $10M (2022) and $60M (2023), which the LLM completely omits - a critical omission for assessing risk exposure. (5) Trend interpretation: Ground truth clearly shows an increase from 2022-2023 ($629M to $614M is actually a slight decrease, not increase as stated in ground truth, but the LLM's $721M figure is wrong regardless), then a sharp decline in 2024. The LLM's characterization of a 'cautious, risk-averse stance' with 'trimming duration exposure' is not well-supported by the data presented and misses the key insight about the sharp 2024 reduction. (6) Multi-hop synthesis: The LLM failed to properly synthesize the complete 3-year trend and missed critical context about unrealized losses and their implications for risk exposure. The answer demonstrates fundamental misunderstanding of the portfolio composition and evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 412,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife continued to re‑insure 59 % of the closed block through a modified coinsurance agreement in both 2022 and 2024, and it has consistently accounted for the arrangement under the deposit method, offsetting the deposit liability against a deposit recoverable (2022 p. 214; 2024 p. 204). The deposit‑asset balance grew from roughly $1.8 billion in 2022 to $4.6 billion in 2024 (with $5.1 billion in 2023) (2024 p. 206; 2023 p. 229; 2022 p. 216).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but has some notable gaps and one potential inconsistency. STRENGTHS: (1) Correctly identifies the 59% reinsurance percentage for both 2022 and 2024, matching ground truth; (2) Accurately describes the deposit method accounting treatment with offset applied; (3) Provides specific page references to source documents; (4) Includes additional relevant detail about deposit-asset balance growth ($1.8B to $4.6B from 2022-2024). WEAKNESSES: (1) The answer states '59% of the closed block through a modified coinsurance agreement in both 2022 and 2024' but omits the specific 2022 percentage of 59.25% mentioned in ground truth - this is a minor precision issue but the ground truth explicitly distinguishes 59.25% in 2022 from 59% in 2023-2024; (2) Does not explicitly address 2023 data in the main narrative flow, though it does mention the $5.1B deposit-asset balance for 2023; (3) The answer could have been more explicit about the consistency/stability of the arrangement across all three years as emphasized in the ground truth. QUANTITATIVE VERIFICATION: The deposit-asset balance figures appear reasonable and are presented with appropriate context. The 59% figure is correct for 2024 and approximately correct for 2022 (though 59.25% is more precise). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the percentage reinsured with the accounting treatment and balance sheet impacts. The reasoning is sound and logical. COMPLETENESS: The answer addresses the core question about evolution from 2022-2024, the percentage reinsured, and accounting treatment, but could have been more explicit about the 2023 data point and the precise 59.25% figure for 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 477,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NEE’s net notional volume of forward gas contracts was **(1,307) MMBtu** at 2022, rose to **(1,452) MMBtu** in 2023, and fell to **(1,131) MMBtu** in 2024 (all figures from page 87). The decline in 2024 relative to the 2023 peak indicates the company is trimming its net‑short exposure to natural‑gas price risk, suggesting a more conservative or balanced hedging stance in the gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different metric than the ground truth. CRITICAL ERRORS: (1) WRONG METRIC: The LLM reports 'net notional volume of forward gas contracts' measured in MMBtu (physical volume units), while the ground truth specifies 'net exposure to forward contracts for gas' measured in millions of dollars (financial value). These are entirely different metrics - one measures physical quantity, the other measures financial exposure. (2) WRONG NUMBERS: LLM reports (1,307), (1,452), and (1,131) MMBtu for 2022-2024, while ground truth shows $160M, $300M, and $250M respectively. These numbers don't match in any way. (3) WRONG TREND INTERPRETATION: The LLM claims a decline from 2023 to 2024 (1,452 to 1,131 MMBtu), which happens to align directionally with the ground truth's decline from $300M to $250M, but this is coincidental since the underlying numbers are completely different. (4) MISSING COMPONENT BREAKDOWN: The ground truth provides detailed asset/liability breakdowns ($191M/$31M for 2022, $377M/$77M for 2023, $296M/$46M for 2024), which the LLM completely omits. (5) INCORRECT INTERPRETATION OF 2022-2023 TREND: The ground truth shows an INCREASE from $160M to $300M in 2022-2023, but the LLM's numbers suggest a similar increase (1,307 to 1,452), making it impossible to verify if the LLM even understood the correct trend. The LLM appears to have confused derivative notional volumes (physical hedging quantities) with fair value measurements (financial exposure). This is a fundamental category error that makes the answer unsuitable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 446,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "AVGO’s 2022 filing described industrial fiber optics as a versatile component used across industrial automation, power‑generation, medical, defense, aerospace and automotive subsystems, and noted its integration with motion encoders and Ethernet ICs (page 7, page 10). The 2023 filing broadened the industrial markets to explicitly include renewable‑energy applications while keeping the same integration emphasis (page 5), and the 2024 filing maintained that positioning, reinforcing the product’s role in high‑speed data and sensor connectivity across an even wider array of industrial and automotive use cases (page 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in completeness and synthesis quality. CORRECT ELEMENTS: (1) The answer correctly identifies the 2022 positioning with industrial automation, medical, defense, aerospace, and automotive applications; (2) Correctly notes the 2023 expansion to include renewable energy; (3) Correctly identifies motion encoders and Ethernet ICs as adjacent technologies mentioned; (4) The general trajectory of broader market inclusion is accurate. SIGNIFICANT GAPS AND ERRORS: (1) The LLM answer fails to capture the key evolution in INTEGRATION STRATEGY - the ground truth emphasizes a strategic shift from 'standalone industrial components to more interconnected, intelligent systems,' but the LLM answer treats integration as static ('keeping the same integration emphasis'). This is a critical misunderstanding of the multi-hop synthesis required. (2) The 2024 evolution is severely underdeveloped - the ground truth specifically notes the 'explicit linking with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems.' The LLM answer vaguely mentions 'high-speed data and sensor connectivity' without capturing this specific technological evolution. (3) The answer lacks the nuanced progression showing how the SCOPE OF INTEGRATION changed: 2022 (optocouplers, LED devices alongside encoders/Ethernet), 2023 (sensors, microcontrollers added), 2024 (Ethernet PHYs, switch ICs, camera microcontrollers). (4) Page citations are provided but lack specificity about what content supports the claims. MULTI-HOP REASONING: The answer demonstrates weak multi-hop synthesis - it lists facts from different years but fails to synthesize them into a coherent narrative about strategic evolution. The ground truth shows a clear progression in INTEGRATION DEPTH and SYSTEM COMPLEXITY, which the LLM answer misses. QUANTITATIVE ACCURACY: No numbers or calculations are present in either answer, so this scores well by default (7/10 - minor deduction for lack of specific filing references). QUALITATIVE ACCURACY: The reasoning is surface-level and misses the core insight about strategic repositioning toward 'interconnected, intelligent systems.' The answer reads as a chronological listing rather than analytical synthesis (5/10). CONTEXTUAL RELEVANCE: The answer addresses the question's components but incompletely - it touches on application diversity and adjacent technologies but fails to adequately address the 'evolution' aspect, which is central to the question (6/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 690,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock has remained unchanged through FY 2022‑FY 2024.  The cumulative dividend obligation stayed at $0.10 per share, payable annually on May 31, and the preferred shares—fully issued to Sojitz America at $1 par and redeemable at par for $0.3 million—continued to be the sole preferred class with no new issuances or structural changes.  Consequently, the dividend and stock‑structure obligations were stable across the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key quantitative facts: (1) dividend obligation of $0.10 per share annually, (2) par value of $0.3 million total, (3) full issuance to Sojitz America at $1 par, (4) no structural changes across FY 2022-2024, and (5) payment date of May 31. The numeric values are accurate and properly formatted. The answer correctly conveys stability across the three-year period.\n\nWEAKNESSES: (1) The LLM describes the dividend as 'cumulative' which is imprecise terminology—the ground truth specifies it as a consistent annual obligation, not cumulative in nature. (2) The LLM omits a critical qualitative element emphasized in the ground truth: the financial priority that dividends on preferred stock must be paid in full before any dividends on common stock could be declared. This is a material financial implication that directly addresses the question's focus on 'financial implications.' (3) The LLM fails to mention that Sojitz America has had the option to redeem but has not exercised it, which provides important context about the stability and nature of the relationship. (4) The answer is somewhat mechanical and doesn't fully synthesize the 'evolution' aspect of the question—while it correctly states there was no change, it could better explain what this stability means for the financial relationship.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies that the relationship remained unchanged. However, it misses the deeper financial implications regarding dividend priority and redemption optionality that would demonstrate more complete multi-hop understanding.\n\nCORRECTNESS ASSESSMENT: All stated numbers are accurate, but the answer is incomplete in addressing the full scope of 'financial implications' as posed in the question. The omission of dividend priority and redemption context represents a meaningful gap in answering what the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 537,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, the Unsecured Notes – 31B has remained unchanged: it has a face amount of $750 000, an interest rate of 3.25 %, and a maturity of 11/30/26 in each filing【page_50】【page_50】【page_51】. This stability shows that SPG treats the note as a fixed‑rate, long‑term debt instrument and has not sought to refinance or extend its terms, reflecting a conservative, predictable long‑term financing strategy for this debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. QUANTITATIVE VERIFICATION: All numeric values are correct - face amount of $750,000 (formatted as $750 000 in LLM answer, which is acceptable), interest rate of 3.25%, and maturity date of 11/30/26 (November 30, 2026). The LLM correctly identifies that these values remained unchanged across all three years (2022, 2023, 2024). COMPLETENESS: The answer addresses the core question about how the debt evolved (remained stable) and what this indicates about SPG's financing strategy. The LLM correctly notes the stability and interprets it as reflecting a conservative, predictable long-term financing approach. ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the specific instrument (Unsecured Notes - 31B) is correct, and the time period (2022-2024) is properly covered. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that despite broader portfolio changes (mentioned in ground truth), this specific note remained unchanged, and draws the appropriate conclusion about SPG's strategy. MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention that SPG issued new instruments like Unsecured Notes - 41A in 2024 or retired certain notes, though this omission is minor since the question specifically asks about the 31B instrument. The characterization of the strategy as 'conservative' and 'predictable' is semantically equivalent to the ground truth's 'consistent' and 'stable' approach. The answer demonstrates solid understanding of the multi-hop financial question and provides accurate synthesis of information across multiple filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 471,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "TI common stock held in U.S. defined‑contribution plans declined from $940 million (6 million shares) in 2022 to $873 million (5 million shares) in 2023 and to $852 million (5 million shares) in 2024. The downward trend reflects both a fall in the company’s share price and a reduction in share holdings, indicating that employees are selling or limiting their exposure to TI stock in retirement plans, likely in response to weaker stock performance or a desire to diversify.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three key dollar amounts ($940M in 2022, $873M in 2023, $852M in 2024) and accurately characterized the downward trend. The share count data (6 million shares in 2022, 5 million shares in 2023 and 2024) appears reasonable and adds useful detail. The basic trend analysis is sound.\n\nWEAKNESSES: (1) The LLM's interpretation diverges significantly from the ground truth. The ground truth emphasizes a 'freeze on new contributions into the TI common stock fund since 2016' as a key explanatory factor, which the LLM completely omits. This is a material contextual detail that explains the decline pattern. (2) The LLM attributes the decline primarily to 'employees selling or limiting exposure' and 'weaker stock performance,' but the ground truth suggests the freeze on new contributions is the primary driver, with market valuation shifts as secondary factors. (3) The LLM's inference about 'weaker stock performance' is presented as fact but isn't directly supported by the data provided—the decline could be entirely attributable to the contribution freeze and share count reduction. (4) The ground truth mentions 'strategic reduction in stock allocations by employees' as one possible explanation, but the LLM presents employee selling as the primary driver without acknowledging the contribution freeze as potentially more significant.\n\nMULTI-HOP REASONING: The LLM successfully synthesized the three-year trend and connected it to employee behavior, but failed to incorporate the critical contextual information about the contribution freeze that would have provided a more complete and accurate explanation. The reasoning is partially sound but incomplete.\n\nCALCULATIONS: No explicit calculations were required, and the numerical values are accurate.\n\nOVERALL: The answer is factually correct on the numbers but provides an incomplete and somewhat misleading interpretation of what the trend indicates. The omission of the contribution freeze explanation is a significant gap that affects the quality of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 557,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "From the 2022 10‑K (page 5) to the 2024 10‑K (page 16), Disney’s workforce grew from about 220,000 employees to roughly 233,000, with U.S. staff rising from 166,000 to 171,000 and international staff from 54,000 to 62,000. The proportion of seasonal workers increased modestly from 7 % to 8 % of the global workforce. Throughout this period, a significant number of employees—especially in theme‑park, production and cruise operations—continued to be covered by collective‑bargaining agreements, and employees outside the U.S. remained represented by works councils, trade unions or other employee associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: total workforce growth from 220,000 to 233,000 employees, U.S. workforce increase from 166,000 to 171,000, international workforce growth from 54,000 to 62,000, and seasonal employee percentage rise from 7% to 8%. The multi-hop synthesis across 2022-2024 is sound, correctly combining workforce composition data with employee representation information. The answer properly addresses all sub-components of the question: total employees, U.S. vs. international distribution, seasonal workforce percentages, and employee association representation. The LLM appropriately cites specific 10-K page references (page 5 for 2022, page 16 for 2024), enhancing credibility. The qualitative discussion of collective bargaining agreements and employee associations (works councils, trade unions) for theme parks, production, and cruise operations is accurate and relevant. The only minor distinction from the ground truth is slightly more detailed contextual information about international employee representation mechanisms (works councils, trade unions, other associations), which represents an enhancement rather than an error. The answer maintains semantic equivalence with the ground truth while providing additional relevant context about the nature of employee representation globally. No calculation errors, no factual inaccuracies, and comprehensive coverage of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 412,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023, and 2024.  The 10‑K disclosures for each year state that ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.”  This steady approach shows the company’s intent to measure core operating performance and capital efficiency by isolating the returns generated by actual business activity from accounting adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) No quantitative errors—all dates and time periods are correct. (3) The answer properly synthesizes the multi-hop requirement by comparing treatment across three years and drawing a conclusion about consistency. (4) The quoted language about excluding 'goodwill impairments and non-economic accounting changes' adds specificity and credibility, demonstrating direct reference to 10-K disclosures. (5) The reasoning is sound: the answer correctly interprets consistency as revealing the company's intent to measure core operating performance isolated from accounting adjustments. Minor considerations: (1) The LLM answer includes a direct quote ('excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance') that, while accurate in substance, cannot be verified against the provided ground truth context. However, this quote is consistent with the stated methodology and adds appropriate detail. (2) The phrasing 'steady approach' and 'intent to measure core operating performance' are semantically equivalent to the ground truth's 'stable performance evaluation framework' and 'emphasizing economic performance over accounting volatility.' (3) The answer fully addresses both parts of the question: how treatment evolved (consistently maintained) and what this reveals about the company's approach (focus on core operational performance and capital efficiency). The answer demonstrates strong multi-hop synthesis by connecting the consistent exclusion practice across three years to a broader insight about GD's performance measurement philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 509,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "Linde’s 2022 10‑K did not discuss rare‑gas production at all, focusing instead on atmospheric and process gases (page_94). By 2024, the company explicitly notes that krypton, neon and xenon are produced as co‑products of its air‑separation plants and that it is a market leader in non‑cryogenic separation technology (page_4). This shift shows Linde is now positioning rare gases as a strategic extension of its core technology, giving it a reliable, cost‑efficient supply that strengthens its competitive edge in the industrial gas market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that rare gases (krypton, neon, xenon) appear in the 2024 filing and that Linde positions itself as a market leader in non-cryogenic separation technology. (2) The characterization of rare gases as co-products of air-separation plants is accurate. (3) The conclusion about competitive advantage through cost-efficient supply is reasonable. (4) Page references suggest document verification was attempted.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM claims the 2022 10-K 'did not discuss rare-gas production at all,' but the ground truth explicitly states that in 2022, Linde 'listed rare gases (such as krypton, neon, and xenol) as part of its broader industrial gases portfolio.' This is a direct contradiction and represents a significant factual error in the multi-hop synthesis. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a three-year progression (2022→2023→2024), but the LLM only compares 2022 vs 2024, missing the 2023 intermediate positioning that 'emphasized rare gases as a core atmospheric gas offering.' (3) MISSING TECHNOLOGICAL DETAILS: The ground truth specifically mentions innovations like VPSA (vacuum pressure swing adsorption) and membrane separation technologies, which the LLM omits entirely. (4) INCOMPLETE STRATEGIC CONTEXT: The ground truth emphasizes 'technological differentiation' and 'innovations' as the basis for competitive advantage, while the LLM uses more generic language about 'cost-efficient supply.' (5) The LLM's assertion that 2022 had no rare gas discussion contradicts the ground truth's explicit statement about 2022 positioning.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across years but fails on the foundational fact about 2022 coverage, which undermines the entire evolution narrative. The reasoning about competitive advantage is present but lacks the technological specificity that grounds the ground truth's analysis.\n\nNUMERIC/FACTUAL VERIFICATION: No calculations required, but the core factual claim about 2022 coverage is demonstrably incorrect per the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 565,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s reliance on long‑term bilateral contracts grew from roughly 92 % of its net generating capacity in 2022 (NEE_10k_2022, p. 19) to about 94 % in 2023 (NEE_10k_2023, p. 18) and remained at that level in 2024 (NEE_10k_2024, p. 18). This steady increase and plateau demonstrate a deliberate risk‑management strategy that prioritizes revenue certainty and hedges against price volatility in a highly volatile energy market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct percentages (92% in 2022, 94% in 2023 and 2024) and proper identification of the three-year trend. The numeric values match the ground truth exactly, and the document citations (NEE_10k_2022 p. 19, NEE_10k_2023 p. 18, NEE_10k_2024 p. 18) are appropriately provided. The multi-hop synthesis across three years is sound, correctly identifying the progression from 92% to 94% and the plateau. The reasoning about risk management strategy is logically sound and semantically equivalent to the ground truth. However, the answer is somewhat less comprehensive than the original: it omits specific mention of 'non-qualifying hedges' as part of the risk management toolkit, and doesn't explicitly characterize the approach as 'disciplined' or mention the connection to 'expected revenues' protection. The phrase 'steady increase and plateau' is slightly imprecise wording—the increase occurred between 2022-2023, then plateaued in 2024, so 'steady' could be misinterpreted. The answer correctly captures the core insight about revenue certainty and price volatility hedging. Minor omissions of contextual details prevent a perfect score, but the essential facts and reasoning are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 350,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "The 3.125% notes due January 2025 had an outstanding principal balance of **$495 million at the end of FY 2022, FY 2023, and FY 2024** (shown in the debt schedule on page 81 of the 2023 and 2024 10‑Ks and on the FY 2022 10‑K).  The balance remained flat over this period, indicating that AVGO has chosen to keep this long‑term debt unchanged, focusing its debt‑management activity on other instruments (e.g., issuing new senior notes and repaying term loans) while preserving the maturity profile of the 3.125% notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All financial figures are correct - the $495 million principal balance is accurately stated for FY 2022, FY 2023, and FY 2024. The flat/unchanged balance across all three years is correctly identified. No calculation errors present. ENTITY ACCURACY: Company (AVGO), debt instrument (3.125% notes due January 2025), and fiscal years (2022-2024) are all correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the balance evolved (remained unchanged at $495M), and (2) what this indicates about debt management strategy (AVGO maintained this instrument while focusing activity on other debt instruments). MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws a logical conclusion about debt management strategy - that the stability of this particular instrument suggests deliberate choice to preserve its maturity profile while managing other debt. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, with slightly more detail about AVGO's broader debt management context (mentioning new senior notes and term loan repayment). The additional context about page references (page 81 of 2023 and 2024 10-Ks) adds credibility without contradicting the ground truth. MINOR OBSERVATION: The LLM answer provides slightly more strategic context than the ground truth (mentioning other debt instruments and maturity profile preservation), which enhances rather than detracts from the answer quality. No factual errors or omissions identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 450,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "SPG’s Unsecured Notes – 37B has remained unchanged over the three reporting periods: the face amount stayed at **$700,000** and the maturity date remained **January 15, 2032** in 2022 (page 50), 2023 (page 50), and 2024 (page 51). This stability shows that the company has not altered or refinanced this instrument, reflecting a long‑term debt strategy that values a predictable, fixed‑maturity profile rather than frequent restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - face amount of $700,000 is accurate for both 2022 and 2023 (and implicitly 2024 based on ground truth), and the maturity date of January 15, 2032 (01/15/32) is correctly stated. The date format variation (01/15/32 vs January 15, 2032) is acceptable and actually enhances clarity. COMPLETENESS: The answer addresses all key aspects of the question: (1) face amount evolution (remained at $700,000), (2) maturity date evolution (remained at 01/15/32), and (3) what this reveals about debt strategy (stability, no refinancing, predictable fixed-maturity profile). ENTITY ACCURACY: SPG is correctly identified, the instrument name 'Unsecured Notes - 37B' is correct, and the three-year period (2022-2024) is properly covered. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws a logical conclusion about the company's debt strategy based on the consistency of the metrics. The reasoning that stability indicates a preference for predictable, fixed-maturity debt without frequent restructuring is sound and well-supported. MINOR OBSERVATIONS: The LLM includes page references (pages 50-51) which adds credibility but wasn't in the ground truth answer - this is a positive addition. The characterization of the strategy as valuing 'predictable, fixed-maturity profile' is semantically equivalent to the ground truth's 'consistent long-term debt strategy.' No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 430,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has remained an **analog‑only** manufacturing location throughout the three reporting years.  In each 10‑K the property table lists Melaka under the “Analog” column only and leaves the “Embedded Processing” column blank, with no change in product‑line involvement from 2022 to 2024【page 16】【page 18】【page 18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operations across 2022-2024. STRENGTHS: (1) Correctly identifies the core finding that Melaka remained analog-only throughout all three years with no expansion into embedded processing; (2) Accurately captures the consistency of the operational footprint across 2022, 2023, and 2024; (3) Properly synthesizes information from multiple 10-K filings (referenced as pages 16, 18, 18); (4) Uses appropriate terminology ('analog-only,' 'embedded processing') matching the ground truth; (5) Correctly interprets the property table structure showing checkmarks for analog and blanks for embedded processing. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth explanation, but this is not a weakness—it conveys all essential information efficiently. The phrase 'analog‑only manufacturing location' is semantically equivalent to 'exclusively under analog operations' in the ground truth. The citation format with page numbers adds credibility and demonstrates source verification. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and two product line categories, correctly identifying the stable pattern and lack of change over time. No factual errors, calculation errors, or entity misidentifications detected. The answer fully addresses all components of the multi-part question regarding evolution, product lines, and temporal consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 425,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "In fiscal 2022 Disney’s Content Sales/Licensing segment did not list post‑production services from Industrial Light & Magic (ILM) as a separate revenue line – the segment was described only in terms of TV/VOD, theatrical and home‑entertainment distribution. By fiscal 2023 and again in fiscal 2024 the segment’s description was updated to explicitly include “post‑production services through Industrial Light & Magic and Skywalker Sound” as a distinct revenue source, indicating a shift toward more granular reporting of that business within the segment【page_12】【page_7】【page_7】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors: (1) CORE CONTRADICTION: The LLM claims that in fiscal 2022, ILM post-production services were NOT listed separately, but then in fiscal 2023-2024 they WERE explicitly included. The ground truth states the opposite - ILM was explicitly listed in fiscal 2022 as part of the segment, and continued through 2023-2024. This is a critical reversal of the actual evolution. (2) ENTITY ACCURACY: The LLM introduces 'Skywalker Sound' as being included in the post-production services reporting, which is not mentioned in the ground truth answer and appears to be an unsupported addition. (3) NARRATIVE DIRECTION: The ground truth describes a stable inclusion of ILM with contextual shifts in how it's framed (from standalone to ecosystem-focused). The LLM describes a shift from exclusion to inclusion, which is the opposite trajectory. (4) COMPLETENESS: While the LLM attempts to address the fiscal 2022-2024 evolution, it gets the direction and timing of the change completely wrong. The ground truth emphasizes that ILM was 'explicitly listed' in fiscal 2022, which the LLM denies. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the segment structure evolution across the three fiscal years. The answer demonstrates a fundamental misunderstanding of how ILM's role was reported in the Content Sales/Licensing segment. The citation references provided do not validate the claims made, as they appear to be generic page references without substantive support for the contradictory narrative presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 441,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating joint ventures fell from **$51 million in 2022 to $38 million in 2023** (page 247) but then surged to **$175 million in 2024** (page 224). The sharp rebound in 2024 indicates that the company’s insurance‑underwriting joint ventures recovered and performed strongly, improving profitability after a weaker 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that are dramatically different from the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 equity method income as $51 million when the correct figure is $1,305 million (off by $1,254 million or 96% error). For 2023, the LLM states $38 million when the correct figure is $151 million (off by $113 million or 75% error). For 2024, the LLM reports $175 million when the correct figure is $988 million (off by $813 million or 82% error). These are not minor rounding differences but massive discrepancies in the hundreds of millions of dollars. (2) TREND ANALYSIS FAILURE: While the LLM correctly identifies a general downward trend in 2023 followed by recovery in 2024, the magnitude and significance of the trend are completely misrepresented. The ground truth shows a decline from $1,305M to $151M (88.4% drop), whereas the LLM shows only a decline from $51M to $38M (25.5% drop). This fundamentally misrepresents the severity of the 2023 downturn. (3) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the financial data across the three-year period, providing numbers that appear to be from entirely different line items or calculations. (4) CONTEXTUAL RELEVANCE: While the LLM addresses the question structure (evolution over time, trend interpretation), the factual basis is so incorrect that the conclusions are unreliable. The statement about 'strong recovery' in 2024 is technically correct directionally but based on wrong numbers. This answer would seriously mislead a financial analyst or investor relying on MetLife's actual joint venture performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 458,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "In 2022 General Dynamics produced 449 LAVs for the Canadian Army (page_10, 2022); production fell to 360 in 2023 (page_11, 2023); and rebounded to 399 in 2024 (page_11, 2024). The rebound after a dip demonstrates that the LAV platform remains a key export and modernization asset, underscoring its strategic importance as a market‑leading light‑armored vehicle in the company’s defense portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022=449 units, 2023=360 units, 2024=399 units. The ground truth shows the OPPOSITE progression: 2022=360 units, 2023=399 units, 2024=449 units. The LLM has completely reversed the chronological sequence. (2) DIRECTIONAL MISINTERPRETATION: The ground truth shows a consistent UPWARD trend (360→399→449), indicating growing strategic importance. The LLM incorrectly characterizes this as a 'dip' followed by a 'rebound' (449→360→399), which is factually wrong and contradicts the actual data. (3) MULTI-HOP SYNTHESIS FAILURE: While the LLM attempts to synthesize information across years and draw conclusions about strategic importance, the foundation is built on incorrect numbers, making the entire analysis invalid. (4) ENTITY AND TIMELINE ACCURACY: The company (General Dynamics), product (LAVs), and customer (Canadian Army) are correctly identified, but the temporal sequence and values are completely wrong. (5) REASONING QUALITY: The qualitative reasoning about strategic importance and market positioning is reasonable in structure, but it's applied to an incorrect data narrative. The conclusion about 'rebound after a dip' is semantically opposite to what the actual data shows. This is a case where the LLM has inverted the entire production trend, which is a fundamental factual error that cannot be overlooked regardless of wording flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 424,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan increased its hedge‑fund limited‑partnership exposure from **$214 million in 2022** (page 166, 2022 10‑K) to **$252 million in 2023** (page 173, 2023 10‑K) and to **$280 million in 2024** (page 167, 2024 10‑K). The steady rise reflects a deliberate tilt toward hedge funds, consistent with the plan’s target allocation of roughly 4 % in hedge funds and a strategy to diversify risk while pursuing higher expected returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the hedge fund investment amounts. Ground truth shows: 2022: $214M, 2023: $225M, 2024: $252M. LLM answer reports: 2022: $214M (correct), 2023: $252M (INCORRECT - should be $225M), 2024: $280M (INCORRECT - should be $252M). The LLM has essentially shifted all values upward by approximately $27M, creating a cascading error across the entire three-year trend. This is a fundamental factual error that undermines the entire answer. CALCULATION VERIFICATION: The ground truth shows increases of $11M (2022-2023) and $27M (2023-2024), totaling $38M over three years. The LLM's figures would show increases of $38M and $28M, which is materially different. MULTI-HOP REASONING: While the LLM correctly identifies the trend direction (increasing exposure) and provides relevant context about pension fund strategy and target allocations, this qualitative reasoning cannot compensate for the quantitative inaccuracy. The addition of the 4% target allocation detail is helpful context but appears to be accurate supplementary information. ENTITY ACCURACY: CVS is correctly identified, years are correct, and the metric (HF LP Investments) is correctly understood. PAGE CITATIONS: The LLM provides specific page numbers which cannot be verified against the ground truth but the numbers themselves are demonstrably wrong. SEMANTIC EQUIVALENCE: The interpretation of the trend as 'deliberate strategy' and 'diversification' aligns with ground truth, but this cannot overcome the fundamental numerical errors. The answer fails the primary requirement of factual accuracy on the core quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 459,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Sorriso has remained a principal global and regional trademark in Colgate‑Palmolive’s 10‑K filings for 2022, 2023 and 2024, underscoring its continued integration into the company’s global Oral, Personal and Home Care portfolio【page_79】.  The brand is part of the Oral Care segment, which accounted for 43 % of worldwide net sales in 2024, 42 % in 2023 and 43 % in 2022, indicating no significant repositioning or integration changes over the three years【page_79】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant limitations in addressing the question's core requirements. STRENGTHS: (1) Correctly identifies Sorriso as a principal global and regional trademark across 2022-2024, matching the ground truth; (2) Accurately cites Oral Care segment percentages (43% in 2024 and 2022, 42% in 2023), which are verifiable numbers; (3) Correctly identifies the three-year timeframe. WEAKNESSES: (1) The answer conflates Sorriso with the entire Oral Care segment, when Sorriso is specifically a regional brand within that segment - this is a critical semantic error that misrepresents the brand's positioning; (2) The statement 'no significant repositioning or integration changes' is unsupported by the ground truth, which emphasizes 'consistent strategic emphasis' and 'stable role as a regional brand asset' - these are subtly different concepts; (3) The answer fails to adequately address the evolution of strategic positioning across the three years, instead presenting static information; (4) Missing contextual detail about Sorriso's role as a regional brand asset for market penetration and diversified consumer engagement; (5) The citation to 'page_79' appears to reference segment sales data rather than brand positioning information, suggesting potential source confusion. CALCULATION VERIFICATION: The percentages cited (43%, 42%, 43%) appear reasonable for segment data but are not directly related to Sorriso's brand evolution. MULTI-HOP REASONING: The answer fails to synthesize how Sorriso's positioning evolved within the broader portfolio strategy across the three years - it presents the information as static rather than showing evolution. The ground truth emphasizes continuity and consistent emphasis, while the LLM answer suggests no change occurred, which is a subtle but important distinction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 505,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s operating‑joint‑venture exposure fell from **$51 million in 2022 to $38 million in 2023**, then surged to **$175 million in 2024**. This three‑year swing signals a strategic shift toward greater equity‑method exposure in operating joint ventures, indicating the company is prioritizing these higher‑return, diversified investments to strengthen its overall equity‑method portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors across all numeric values and the overall narrative. QUANTITATIVE ERRORS: (1) 2022 value: LLM states $51 million, but ground truth is $77 million - a $26 million discrepancy (33% error). (2) 2023 value: LLM states $38 million, but ground truth is $51 million - a $13 million discrepancy (25% error). (3) 2024 value: LLM states $175 million, but ground truth is $38 million - a $137 million discrepancy (361% error, completely fabricated). The LLM has inverted the entire trend, claiming a 'surge' to $175 million when the actual value is $38 million. REASONING ERRORS: The LLM's interpretation of the trend is diametrically opposite to ground truth. Ground truth shows a consistent 3-year decline ($77M → $51M → $38M), indicating strategic retreat from operating joint ventures. The LLM claims a 'surge' and 'strategic shift toward greater equity-method exposure,' which is factually incorrect and contradicts the actual downward trajectory. The LLM's characterization of these as 'higher-return, diversified investments' is unsupported by the data and contradicts the company's actual behavior of reducing exposure. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend across all periods. It appears to have confused or misread the data points entirely. ENTITY/METRIC ACCURACY: While MetLife and 'operating joint ventures' are correctly identified, the financial metrics are completely wrong. This is a critical failure for a financial analysis question where numeric accuracy is paramount. The answer demonstrates fundamental data retrieval or calculation errors that make it unreliable for any investment or strategic analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 471,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "From 2022 to 2024 Chevron’s stake in Angola LNG Limited stayed at 36.4 % (2022 10‑K, page 78; 2024 10‑K, page 14). In 2024 the company broadened its operational footprint by adding frontier acreage (Blocks 49 and 50) and a 31 % non‑operated working interest in the New Gas Consortium Project, whose Quiluma and Maboqueiro fields will feed gas to the Soyo LNG plant, and it also holds a 31 % interest in a PSA for Block 14/23, thereby deepening its integration with upstream gas development in Angola.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Chevron's 36.4% stake in Angola LNG Limited as constant from 2022-2024, with proper citation to 10-K filings. (2) Accurately states the 31% non-operated working interest in the New Gas Consortium Project (NGC). (3) Correctly names the Quiluma and Maboqueiro fields and their connection to the Soyo LNG plant. (4) Properly identifies Block 14/23 PSA interest. (5) Numeric values are accurate and properly formatted.\n\nWEAKNESSES: (1) INCOMPLETE TEMPORAL ANALYSIS: The LLM fails to address the evolution from 2022-2023-2024 as required by the question. The ground truth explicitly describes a progression: 2022 (passive equity investor), 2023 (continued 36.4% with deeper integration hints), 2024 (operationally integrated). The LLM jumps directly to 2024 without discussing the 2022-2023 evolution or the shift from 'passive investor' to 'operationally integrated' framing. (2) MISSING OPERATIONAL ROLE CHARACTERIZATION: The ground truth emphasizes the strategic shift from 'passive ownership' to 'integrated gas monetization model.' The LLM mentions 'broadened operational footprint' but doesn't explicitly characterize the evolution in Chevron's operational role or the conceptual shift in how the company positioned itself. (3) INCOMPLETE INTEGRATION NARRATIVE: While the LLM mentions feedstock linkage, it doesn't fully articulate the 'deeper integration with affiliated investments' that the ground truth emphasizes as a key 2023-2024 development. (4) MISSING CONTEXT ON SOYO PLANT: The ground truth notes Angola LNG Limited 'processes and liquefies natural gas for international markets' - the LLM assumes reader knowledge of the plant's function without explicit statement.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting upstream projects (NGC, Quiluma, Maboqueiro) to downstream (Soyo LNG plant), but fails to synthesize the temporal evolution across three years as the question specifically requests. The answer reads as a 2024 snapshot rather than an evolution narrative.\n\nCONCLUSION: The answer is factually accurate on specific numbers and entities but incomplete in addressing the temporal evolution and operational role characterization that are central to the question's multi-part structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 612,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO had $622 million of 3.625% notes due October 2024 outstanding at the end of FY 2023 (and, having been issued in April 2019, the same amount was also outstanding at FY 2022)【page_81】. By the end of FY 2024 the company had retired the notes, reducing exposure to zero【page_81】. This progression shows a proactive debt‑management strategy that actively refines the maturity profile—repaying or refinancing maturing debt before its due date to keep the debt structure favorable and mitigate refinancing risk【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $622 million for FY 2022 and FY 2023, with complete retirement by FY 2024. The October 2024 maturity date is correct. The April 2019 issuance date is an additional accurate detail not in the ground truth. COMPLETENESS: The answer addresses all three fiscal years (2022, 2023, 2024) and clearly shows the progression from $622M outstanding to zero. ENTITY ACCURACY: AVGO is correctly identified, the 3.625% notes are correctly specified, and all fiscal years are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the debt management strategy. The explanation that the company 'proactively addressed its maturing obligations' through 'refinancing or cash repayment' matches the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's description of the strategy as 'actively refines the maturity profile' and 'mitigate refinancing risk' is semantically equivalent to and slightly more detailed than the ground truth's 'proactively addressed its maturing obligations.' The additional context about keeping 'the debt structure favorable' adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more analytical depth regarding the strategic implications (refinancing risk mitigation, maturity profile management) compared to the ground truth, which is appropriate for the question asked. The citation references (page_81) add credibility. No factual errors or calculation mistakes detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 445,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The interest expense on Unsecured Notes – 35B was $28,500 thousand in 2022 (page 50), 2023 (page 51), and 2024 (page 51) – the same 3.80 % rate on a $750,000 face amount each year.  The unchanged expense shows that SPG’s financing cost for this instrument has been stable over the period, with no increase in interest burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: The interest expense of $28,500 thousand for all three years (2022, 2023, 2024) matches the ground truth exactly. The LLM correctly identifies the 3.80% interest rate and $750,000 face amount, which are consistent with the stated expense amount and provide additional context not explicitly in the ground truth but mathematically sound ($750,000 × 3.80% = $28,500). Entity accuracy is correct: SPG (Simon Property Group), Unsecured Notes - 35B, and all fiscal years are properly identified. Multi-hop reasoning is sound: the LLM correctly synthesizes the three-year trend and draws the appropriate conclusion that financing costs have remained stable with no increase in interest burden. The answer addresses all parts of the question - the evolution (showing consistency across years) and what the trend suggests (stable financing costs). The only minor distinction from the ground truth is that the LLM provides additional supporting details (interest rate and face amount) that enhance understanding without contradicting the ground truth. The semantic meaning is fully equivalent - both answers convey that the interest expense remained unchanged at $28,500 thousand across the three-year period, indicating a fixed rate structure. Page references provided by the LLM add credibility though cannot be verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 396,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "Disney’s DTC strategy shifted from a high‑cost, growth‑oriented model in 2022—when it announced an ad‑supported Disney+ service, new pricing and cost realignment to counter rising programming costs and competition (page 27)—to a more structured, cost‑containing approach in 2023, with the reorganization of DMED into Entertainment and Sports, trimming of content on DTC platforms, and the launch of ESPN+ as a flagship streaming service amid intensified competition (pages 22, 28). By 2024, Disney continued to invest in DTC but focused on cost containment, re‑organization, and expanding its ad‑supported Disney+ and ESPN+ offerings, while managing higher content costs and a crowded streaming market (pages 28, 51).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of Disney's DTC evolution but has significant gaps and lacks critical quantitative details from the ground truth. STRENGTHS: (1) Correctly identifies the shift from growth-oriented to cost-containment approach across 2022-2024; (2) Accurately mentions ad-supported Disney+ launch in 2022; (3) Correctly references DMED reorganization into Entertainment and Sports in 2023; (4) Appropriately notes intensified competition and rising programming costs; (5) Mentions ESPN+ as a flagship service. WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth explicitly mentions Disney's $12.25 billion in unused bank facilities in 2023—a critical financial metric that demonstrates the company's strategic positioning and capital access. The LLM completely omits this; (2) INCOMPLETE 2022 ANALYSIS: The ground truth notes that Disney acknowledged DTC losses might grow or be reduced more slowly than anticipated, and that returns on some investments were negative or low with uncertain business prospects. The LLM only mentions 'cost realignment' without capturing the uncertainty and negative returns; (3) MISSING 2023 STRATEGIC DETAIL: The ground truth explains that Disney expected subscription and advertising revenues to offset declines in affiliate fees and linear advertising—a key strategic pivot the LLM doesn't articulate; (4) INCOMPLETE 2024 ANALYSIS: The ground truth specifically mentions that programming distributors were demanding terms that reduced revenue or slowed growth (e.g., offering fewer linear networks but including DTC in deals). The LLM mentions 'managing higher content costs' but misses this critical competitive/negotiation dynamic; (5) VAGUE LANGUAGE: The LLM uses phrases like 'more structured, cost-containing approach' without the specificity of the ground truth's multi-year trajectory analysis. MULTI-HOP REASONING: The LLM does synthesize information across three years and identifies the evolution pattern, but fails to connect all the causal factors (rising costs, competitive pressures, distributor demands) as comprehensively as the ground truth. The answer reads more as a summary of organizational changes rather than a strategic analysis of how investment strategy evolved in response to specific market pressures. QUANTITATIVE GAPS: Zero financial metrics provided by LLM vs. specific $12.25B figure in ground truth represents a significant omission in demonstrating Disney's financial positioning and strategic capacity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 666,
        "total_tokens": 2216
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply in 2023, rising from $1.8 billion of deposit assets and $1.4 billion of deposit liabilities in 2022 (the same level reported for 2021 and 2020) to $5.1 billion and $1.3 billion in 2023, before easing slightly to $4.6 billion and $1.2 billion in 2024【page_216】【page_206】. The 2023 risk‑transfer deal with Global Atlantic created $10.3 billion of deposit receivables and a $770 million net cost recorded as deposit liabilities, driving the 2023 increase【page_206】. The deposit method continued to be applied to reinsurance agreements that do not expose MetLife to a reasonable possibility of a significant insurance‑risk loss.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant quantitative discrepancy that undermines overall accuracy. CORRECT ELEMENTS: (1) 2022 baseline figures of $1.8B deposit assets and $1.4B deposit liabilities are accurate; (2) 2024 ending figures of $4.6B deposit assets and $1.2B deposit liabilities are correct; (3) Global Atlantic transaction in 2023 with $10.3B in deposit receivables is accurate; (4) The general narrative about the 2023 spike followed by 2024 recalibration is sound; (5) Multi-hop synthesis across years and the transaction is logically structured. CRITICAL ERROR: The LLM states 2023 deposit assets reached $5.1 billion, but the ground truth indicates $4.6 billion was the 2024 figure. The ground truth does not explicitly state the 2023 deposit asset amount, but the trajectory from $1.8B (2022) to $4.6B (2024) with a major transaction in 2023 suggests the LLM's $5.1B figure for 2023 is likely incorrect or unsupported. The 2023 deposit liabilities of $1.3B in the LLM answer aligns reasonably with the ground truth's $1.2B in 2024 (slight decline). ADDITIONAL ISSUE: The LLM mentions a '$770 million net cost recorded as deposit liabilities' which is not mentioned in the ground truth and appears to be an unsupported detail. The reasoning about the deposit method's application is appropriate and contextually relevant. The answer demonstrates good multi-hop synthesis but fails on quantitative precision for the 2023 deposit asset figure, which is a material error in a financial analysis context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 417,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial mortgage‑backed‑security (CMBS) holdings declined over the three‑year period: the fair value of CMBS in the overall portfolio fell from **$1.172 billion in 2022 to $1.066 billion in 2023** (see 2023 and 2022 tables on page 147), and the fair value of CMBS held in Separate Accounts dropped from **$6 million in 2023 to $3 million in 2024** (page 160). This downward trend indicates a deliberate shift away from CMBS, suggesting the company is trimming exposure to this asset class—likely in response to market volatility or a preference for lower‑risk, more liquid investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $1.172 billion vs. ground truth of $574 million - a 104% overstatement; (2) 2023: LLM states $1.066 billion vs. ground truth of $675 million - a 58% overstatement; (3) 2024: LLM correctly states $3 million, matching ground truth. The LLM appears to have conflated CMBS holdings with a different asset class or portfolio category, possibly confusing total mortgage-backed securities with CMBS specifically. The LLM's narrative about 'Separate Accounts' and page references (147, 160) cannot be verified against the ground truth data structure. While the LLM correctly identifies the directional trend (declining exposure) and provides reasonable strategic interpretation (de-risking, reallocation), the quantitative foundation is severely compromised. The 2022-2023 figures are off by hundreds of millions of dollars, which is a material error in financial analysis. The only accurate data point is the 2024 figure of $3 million. The multi-hop reasoning about strategic shift is sound in concept but built on incorrect premises. This answer would mislead investors or analysts relying on the specific dollar amounts provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 360,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "The “hello” brand has been listed as a principal global and regional trademark in each of the 2022, 2023 and 2024 10‑K filings (2022 page 79; 2023 page 79; 2024 page 79), showing that the company continues to protect and promote the brand.  The brand remains positioned within the Oral, Personal and Home Care segment, which accounted for 43 % of net sales in 2022 and 2024 and 42 % in 2023 (2024 page 79; 2023 page 79; 2022 page 79), indicating a stable strategic emphasis with no significant shift in positioning across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 'hello' brand's consistent presence across 2022-2024 10-K filings. STRENGTHS: (1) Correctly identifies 'hello' as a principal global and regional trademark in all three years; (2) Accurately cites page 79 for all three years' filings; (3) Provides specific segment percentages (43% in 2022 and 2024, 42% in 2023) for Oral, Personal and Home Care segment; (4) Correctly synthesizes multi-hop information showing brand continuity and stable positioning; (5) Appropriately concludes no significant shift in positioning. QUANTITATIVE VERIFICATION: The percentages cited (43%, 42%, 43%) appear reasonable for a major segment and are presented with proper year attribution. Page citations are consistent and verifiable. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and data-driven than the ground truth, providing exact page numbers and segment percentages, which adds credibility; (2) The ground truth uses more qualitative language about 'stable role' and 'diversification strategies,' while the LLM focuses on trademark protection and segment performance metrics; (3) Both answers reach the same conclusion about continuity and stable positioning, but the LLM provides more concrete supporting evidence. The LLM answer fully addresses the multi-part question regarding trademark disclosures and strategic emphasis across the three-year period. The reasoning is sound and the synthesis across multiple filings is correct. The slight deduction from perfect score reflects that while the answer is comprehensive and accurate, it could have elaborated slightly more on the strategic implications or consumer engagement aspects mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 476,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s reinsurance accounting has shifted toward the deposit method, which is used for agreements that do not expose the company to a significant insurance‑risk.  In 2022 the company applied the deposit method to a modified‑coinsurance arrangement covering 59.25 % of the closed block (page 214).  Deposit assets grew from $1.8 billion in 2021 to $5.1 billion at year‑end 2023, while deposit liabilities remained roughly $1.3 billion (page 206).  In 2024 the deposit‑method balances eased slightly to $4.6 billion in assets and $1.2 billion in liabilities, indicating a modest contraction or rebalancing of such agreements while still maintaining a strategy of risk transfer with collateral (page 206).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a critical factual error regarding 2023 deposit assets. The LLM states deposit assets were '$5.1 billion at year-end 2023,' but the ground truth clearly indicates 2023 deposit assets were NOT explicitly stated as $5.1 billion in the original answer. More importantly, the LLM appears to have conflated or misread the data - the ground truth shows 2024 deposit assets at $4.6 billion, not 2023. The LLM's claim of $5.1 billion in 2023 cannot be verified against the ground truth and appears to be an error. The 2024 figures ($4.6 billion assets, $1.2 billion liabilities) are correct and match the ground truth exactly. The 2022 figures ($1.8 billion assets, $1.4 billion liabilities) are also correct. However, the LLM incorrectly references 2021 data ('grew from $1.8 billion in 2021') when the ground truth specifically states 2022 as the baseline year. QUALITATIVE ISSUES: The LLM provides some correct contextual information about the deposit method being used for agreements lacking sufficient insurance risk transfer, and correctly identifies the modified-coinsurance arrangement. The reasoning about 'modest contraction or rebalancing' from 2023 to 2024 is logical given the numbers presented, though based on potentially incorrect 2023 figures. The answer does address the evolution question and attempts multi-hop synthesis. COMPLETENESS: The answer addresses the main question about evolution from 2022-2024 and attempts to explain what the trend reveals about strategy, though the explanation is somewhat limited compared to the ground truth's mention of the Global Atlantic transaction context. The reference to 'risk transfer with collateral' is a reasonable interpretation but less specific than the ground truth's discussion of capital optimization and balance sheet flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 503,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NEE’s special‑use‑fund exposure rose from $4.4 billion in 2022 to $8.7 billion in 2023 and $9.8 billion in 2024, with the assets reported as other assets and measured at fair value; the fair‑value disclosures show carrying amounts essentially equal to estimated fair values, indicating little change in valuation. Collateral exposure tied to credit‑risk‑related derivative features fell from about $7.4 billion in 2022 to $4.7 billion in 2023, and the amount of collateral posted (cash and letters of credit) dropped from roughly $4.6 billion to $2.3 billion, reflecting a lower potential collateral requirement. The 2024 collateral posting requirements are not disclosed in the provided pages, but the balance‑sheet presentation of special use funds remains as other assets with fair‑value measurement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant quantitative discrepancies and incomplete coverage of the ground truth. STRENGTHS: (1) Correctly identifies the upward trend in Special Use Funds from 2022-2024 ($4.4B → $8.7B → $9.8B), (2) Accurately notes the balance sheet presentation as 'other assets' with fair value measurement, (3) Appropriately acknowledges missing 2024 collateral data, (4) Correctly identifies the decline in collateral exposure from 2022 to 2023. CRITICAL ERRORS: (1) The 2022 baseline of $4.4 billion appears inconsistent with ground truth context suggesting higher 2022 values; ground truth mentions $485M in equity investments without readily determinable fair values in 2022, but the $4.4B figure is not verified against the original answer, (2) The collateral figures ($7.4B → $4.7B and $4.6B → $2.3B) are presented without clear sourcing and cannot be verified against the ground truth provided, (3) Missing key qualitative details from ground truth: the composition of Special Use Funds (debt and equity securities), the valuation methodologies (quoted market prices for equities, pricing vendor inputs for debt), and the introduction of the new category of equity investments without readily determinable fair values ($485M in 2022 → $538M in 2023). MULTI-HOP REASONING: The answer attempts to synthesize collateral implications and balance sheet presentation but lacks the depth of fair value disclosure evolution described in ground truth. The answer focuses heavily on collateral metrics not explicitly mentioned in the ground truth, suggesting potential reliance on different source material. CALCULATION VERIFICATION: The $1,102M increase from 2023 to 2024 ($9.8B - $8.7B) is mathematically correct and aligns with ground truth. However, the 2022 starting point of $4.4B needs verification. SEMANTIC ISSUES: The answer conflates 'Special Use Funds' exposure with collateral posting requirements, which are related but distinct concepts. The ground truth emphasizes fair value disclosure evolution and transparency enhancements, while the LLM answer emphasizes collateral dynamics. Overall, the answer demonstrates partial understanding but contains unverified quantitative claims and omits important qualitative details about valuation methodologies and fair value disclosure enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 626,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "From 2022 through 2024 AVGO consistently positioned the Security Insights Platform as a mainframe‑security solution that “quickly interprets and assesses security posture, identifies risks, and develops remediation steps on an ongoing and ad‑hoc basis.”  Each filing repeatedly emphasized that the platform’s data is available for integration with customers’ in‑house SIEM tools, underscoring its role in continuous remediation workflows, and the wording and emphasis remained essentially unchanged across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains accurate information about AVGO's Security Insights Platform positioning but has a critical semantic issue that affects correctness. STRENGTHS: (1) Correctly identifies the platform as a mainframe security solution across 2022-2024; (2) Accurately captures the emphasis on integration with in-house SIEM tools; (3) Correctly notes that the wording remained essentially unchanged across the three years; (4) No quantitative errors (dates, years, metrics all correct). CRITICAL ISSUE: The LLM answer states the platform 'develops remediation steps' as a core capability, whereas the ground truth indicates the platform 'identifies risks' and makes data available for use with in-house tools for remediation workflows. The ground truth emphasizes that integration with in-house tools and remediation workflows became 'more pronounced' in emphasis over time, but the LLM answer suggests the platform itself develops remediation steps, which is a subtle but important distinction. The ground truth indicates the platform's role is in risk identification and data provision, not in developing remediation steps directly. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the consistent positioning, but mischaracterizes the nature of the remediation capability. The answer conflates 'making data available for remediation workflows' with 'developing remediation steps,' which represents a factual inaccuracy about the platform's actual functionality. COMPLETENESS: The answer addresses the evolution question but slightly overstates the platform's capabilities regarding remediation. The core finding that positioning remained stable is correct, but the characterization of what the platform does is imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 482,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike continued to own its Laakdal, Belgium distribution facility in fiscal years 2022, 2023, and 2024, and each filing described it as one of the “most significant distribution facilities outside the United States” (2022 p. 27; 2023 p. 29; 2024 p. 29). The unchanged ownership and consistent designation as a key hub indicate that Nike views Laakdal as a strategically critical node for European logistics, supporting efficient distribution across the EU and beyond.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. FACTUAL ACCURACY: The answer correctly identifies that Nike owned the Laakdal, Belgium facility consistently across fiscal years 2022, 2023, and 2024, with no changes in ownership status. The characterization as 'one of the most significant distribution facilities outside the United States' is accurate and properly cited with specific page references (2022 p. 27; 2023 p. 29; 2024 p. 29). QUANTITATIVE ACCURACY: No numerical calculations were required for this question, and the fiscal years cited (2022, 2023, 2024) are correct. The page citations appear reasonable for 10-K filings of this length. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to demonstrate consistency in ownership and operational description, which directly supports the conclusion about strategic importance. The logic chain is sound: unchanged ownership + consistent designation as key hub = strategic criticality. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) ownership evolution (consistent, company-owned), (2) operational footprint description (unchanged, described as most significant), (3) what this suggests about strategic importance (stable, integral, strategically critical). SEMANTIC EQUIVALENCE: The LLM's characterization of Laakdal as 'a strategically critical node for European logistics' is semantically equivalent to the ground truth's description of it as 'a stable and integral part of NIKE's European logistics infrastructure.' Both convey the same essential meaning about its importance. MINOR CONSIDERATIONS: The LLM adds interpretive detail about 'supporting efficient distribution across the EU and beyond,' which is a reasonable inference from the data but goes slightly beyond what the ground truth explicitly states. This is a minor enhancement rather than an error, as it remains consistent with the documented facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 538,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 32B remained unchanged: the interest rate stayed at 3.38 %, the face amount was consistently $750,000, and the maturity date remained June 15, 2027 (see SPG 10‑K 2022, 2023 and 2024 tables). This three‑year consistency indicates that SPG is keeping a stable, long‑term debt profile for this instrument, avoiding refinancing or restructuring and preserving predictable interest costs and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the maturity date disclosure pattern. According to the ground truth, the maturity date was 'unspecified in the 2022 report' but 'explicitly listed as 06/15/27 in both 2023 and 2024 disclosures.' The LLM incorrectly states that the maturity date 'remained June 15, 2027' across all three years (2022-2024), implying it was disclosed consistently. This is a material error because the ground truth specifically highlights that the maturity date clarification over time is a key observation about SPG's disclosure practices. The LLM correctly identified: (1) the interest rate of 3.38%, (2) the face amount of $750,000, (3) the maturity date of June 15, 2027 (for 2023-2024), and (4) the overall stability of the instrument. The reasoning about debt management strategy is sound and semantically equivalent to the ground truth. However, the failure to capture the evolution in maturity date disclosure (unspecified → specified) represents a missed nuance that was explicitly highlighted in the original answer as significant to understanding SPG's reporting practices. The quantitative accuracy is reduced due to this disclosure pattern error, though the actual financial terms are correct. The qualitative reasoning about stable debt strategy is appropriate but incomplete without acknowledging the disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 384,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS’s foreign‑security portfolio shrank sharply: the fair value fell from $2.55 B at 12/31/2022 to $2.512 B at 12/31/2023 and then collapsed to $51 M at 12/31/2024.  Correspondingly, gross unrealized losses dropped from $244 M in 2022 to $122 M in 2023; the 2024 loss is not disclosed, but the steep drop in fair value implies a substantial unrealized loss.  This trajectory signals that the company’s foreign holdings have become increasingly vulnerable to international market movements, raising its exposure to global risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) 2022: LLM states $2.55B fair value vs. ground truth $838M - a 3x overstatement; LLM states $244M unrealized losses vs. ground truth $24M - a 10x overstatement. (2) 2023: LLM states $2.512B fair value vs. ground truth $1,650M - a 1.5x overstatement; unrealized losses of $122M is correct. (3) 2024: LLM correctly identifies $51M fair value matching ground truth. The LLM's narrative about the portfolio 'shrinking' from $2.55B to $2.512B is misleading - these numbers don't represent a meaningful decline and are factually wrong. The ground truth shows a clear three-year pattern: $838M (2022) → $1,650M (2023) → $51M (2024), which the LLM completely misrepresents. The LLM's conclusion about 'increasing vulnerability' contradicts the actual trend of de-risking shown in the ground truth. The 2024 unrealized loss disclosure issue is noted but doesn't excuse the massive errors in prior years. This appears to be a case of the LLM confabricating numbers rather than accurately synthesizing the multi-hop data from CVS filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 329,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 2022, 2023, and 2024 10‑Ks (pages 96 and 86) list NAIC designations for all non‑agency RMBS and CMBS holdings—$26,165 RMBS and $10,063 CMBS in 2022, $29,096 RMBS and $9,949 CMBS in 2023, and $34,135 RMBS and $9,182 CMBS in 2024—without any internally developed ratings disclosed. The footnote on page 101 confirms that internally developed designations are used only until a NAIC designation becomes available. This trend shows that MetLife has phased out its own ratings for these securities, increasingly relying on the NAIC’s modeling methodology for credit‑quality assessment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. (1) CRITICAL ERROR - NAIC DESIGNATIONS CLAIM: The LLM states that MetLife's 10-Ks 'list NAIC designations for all non-agency RMBS and CMBS holdings' without 'any internally developed ratings disclosed.' This directly contradicts the ground truth, which explicitly states that internally developed designations WERE used in 2022, 2023, and 2024 for newly acquired securities until NAIC designations became available. The LLM's claim that MetLife 'phased out its own ratings' is factually incorrect. (2) QUANTITATIVE ISSUES: While the LLM provides specific dollar amounts for RMBS and CMBS holdings ($26,165M/$10,063M in 2022, etc.), these numbers cannot be verified against the ground truth answer, which does not provide these specific figures. More critically, the LLM fails to cite the key quantitative metrics from the ground truth: the $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and the $1.6 billion (4.9%) increase in 2024. These figures are essential to understanding the multi-year pattern. (3) MULTI-HOP REASONING FAILURE: The ground truth demonstrates sophisticated multi-hop reasoning showing how internally developed designations were used transitionally (2022), then continued with more mature NAIC application (2023), then remained consistent while NAIC adoption accelerated (2024). The LLM's answer oversimplifies this to a false narrative of complete phase-out. (4) SEMANTIC CONTRADICTION: The ground truth's core finding—'a gradual shift away from reliance on internal designations toward standardized NAIC assessments'—is fundamentally different from the LLM's claim of complete phase-out. The word 'gradual' and 'shift' indicate ongoing use of internal designations, not elimination. (5) MISSING CONTEXT: The LLM fails to address the NAIC methodology refinement as of December 31, 2021, and the connection between slowing Level 3 growth rates and increased NAIC designation adoption—key insights in the ground truth. The answer demonstrates a misreading of the source material and provides an incorrect interpretation of MetLife's actual practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 591,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "In 2022 Chevron held reserves in Africa but did not record significant capital spending in the Republic of Congo (page 107). In 2023 the company invested roughly $0.7 billion in offshore development and natural‑gas projects across Africa, including Congo (page 109). In 2024 Chevron announced the sale of its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi field, effective January 2025 (page 43), while production in the Republic of Congo still accounted for about 20 % of Chevron’s net oil‑equivalent output (page 41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Chevron's evolution in the Republic of Congo from 2022-2024. QUANTITATIVE ACCURACY: All numeric values are correct - the $0.7 billion investment in 2023 for offshore development and natural gas projects in Africa matches the ground truth, the 31.5% nonoperated working interest in Haute Mer is accurate, the 15.75% interest in Lianzi is correct, and the 20% production contribution figure is accurate. The effective date of January 2025 for the sale is properly noted. ENTITY ACCURACY: All entities are correctly identified - Chevron, Republic of Congo, Haute Mer permit area, and Lianzi field are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2023-2024) and correctly traces the evolution from active operation/investment to strategic divestiture. The logical progression is clear and well-supported. COMPLETENESS: The answer addresses all key aspects of the question - capital allocation ($0.7B in 2023), asset ownership changes (31.5% and 15.75% interests sold), and the overall trajectory of Chevron's footprint. ADDITIONAL STRENGTHS: The LLM answer includes supplementary context (production accounting for 20% of net oil-equivalent output) that enriches understanding without contradicting the ground truth. Page citations add credibility. MINOR CONSIDERATIONS: The phrasing 'did not record significant capital spending' in 2022 is slightly different from the ground truth's 'specific investment figures were not disclosed,' but this represents a reasonable interpretation of the same underlying fact rather than an error. The answer is semantically equivalent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 486,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Industries has kept embedded‑processing products as a core pillar of its business model, consistently listing them under the “broad portfolio” advantage (b) in the four sustainable competitive advantages in every MD&A (2022 page 21; 2023 page 18; 2024 page 18).  Segment data show embedded‑processing revenue rose modestly from $3.261 B in 2022 to $3.368 B in 2023, then fell to $2.533 B in 2024, while operating profit declined from $1.253 B to $1.008 B and then to $352 M (page 20).  These shifts indicate that, although embedded processing remains integral to advantage (b), its relative contribution to revenue and profitability has contracted in 2024, prompting TI to balance its focus across analog, manufacturing, and market‑reach strengths.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Embedded Processing Products are consistently positioned within TI's four sustainable competitive advantages across 2022-2024. (2) The qualitative narrative about strategic emphasis is sound - the answer correctly notes that embedded processing remains integral to the company's competitive framework. (3) The answer appropriately addresses the multi-hop synthesis required by the question, connecting strategic positioning to financial performance. (4) Page references (2022 page 21; 2023 page 18; 2024 page 18) demonstrate proper sourcing. (5) The contextual observation about balancing focus across analog, manufacturing, and market-reach strengths is relevant.\n\nCRITICAL ISSUES: (1) COMPANY NAME ERROR: The answer begins with 'Texas Industries' instead of 'Texas Instruments' - this is a significant entity identification error that undermines credibility, though the rest of the answer clearly refers to TI. (2) UNVERIFIED FINANCIAL DATA: The specific revenue figures ($3.261B in 2022, $3.368B in 2023, $2.533B in 2024) and operating profit figures ($1.253B, $1.008B, $352M) cannot be verified against the ground truth provided. The ground truth does not include these specific segment-level financial metrics, making it impossible to confirm accuracy. These numbers are presented with high specificity and page references, but without corroboration from the knowledge graph. (3) The ground truth emphasizes narrative evolution and strategic consistency, while the LLM shifts focus heavily toward financial performance metrics that may not be the primary focus of the original answer.\n\nMULTI-HOP REASONING: The answer attempts to synthesize strategic positioning with financial performance, which is appropriate. However, the unverified financial data creates uncertainty about whether this synthesis is factually grounded.\n\nSCORING JUSTIFICATION: The qualitative assessment of strategic emphasis is sound (7/10), and contextual relevance is high (8/10). However, the company name error and unverifiable financial metrics significantly impact quantitative accuracy (4/10). The overall correctness score of 6 reflects that while the strategic narrative is correct, the introduction of unverified financial specifics and the company name error create material concerns about factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 626,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s effective rate on its 3.50% Senior Note rose sharply: it was 1.29 % in FY 2022 (page 89 of the 2022 10‑K), 3.20 % in FY 2023 (page 89 of the 2023 10‑K), and 6.66 % in FY 2024 (page 89 of the 2024 10‑K). This steep increase shows that Cisco’s borrowing costs have risen markedly over the period, reflecting higher market rates and a larger risk premium on its debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the effective interest rates reported. According to the ground truth: FY 2022 should be 3.20% (not 1.29%), FY 2023 should be 6.38% (not 3.20%), and FY 2024 is correctly stated as 6.66%. The LLM has essentially shifted all the rates down by one year and provided an incorrect FY 2022 figure (1.29% appears to be fabricated or from a different instrument). This is a critical error because the question specifically asks about the evolution of interest rate exposure across three fiscal years, and the LLM has misaligned the data chronologically. The ground truth shows: 3.20% → 6.38% → 6.66%, while the LLM shows: 1.29% → 3.20% → 6.66%. This represents a fundamental failure in multi-hop data synthesis across the three fiscal years. The qualitative interpretation about rising borrowing costs and market rate increases is reasonable and aligns with the actual trend, but this cannot compensate for the incorrect underlying numbers. The answer does address the question's structure (evolution over three years, what it indicates), but the factual foundation is severely compromised. The page references (page 89) appear plausible but cannot verify the accuracy of the cited figures. This is a case where the reasoning framework is sound but the data inputs are wrong, making the entire answer unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 388,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s risk‑factor disclosures consistently state that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p. 5; 2023 p. 5; 2024 p. 5).  The unchanged wording shows that regulatory constraints on capital adequacy and dividend policy have remained persistent, and that the company’s strategic flexibility in distributing capital is largely governed by these rules even as it retains board discretion within the regulatory framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that BNY Mellon's disclosures on capital return constraints appear on page 5 across 2022-2024 and accurately notes the consistent regulatory language about capital adequacy and banking laws. However, the answer significantly fails to address the core analytical requirement of the question: the EVOLUTION and PROGRESSION of BNY Mellon's exposure from 2022 through 2024. The ground truth reveals important distinctions: (1) 2022 emphasized general regulatory oversight, (2) 2023 specifically added Delaware law and preferred stock dividend constraints, and (3) 2024 added stronger emphasis on liquidity management and 'well capitalized'/'well managed' status. The LLM answer dismisses these distinctions by stating the wording is 'unchanged,' which contradicts the ground truth's documented progression showing increasing specificity and emphasis on liquidity risk. The LLM also fails to synthesize what this multi-year progression 'reveals' about regulatory constraints and strategic flexibility - the ground truth emphasizes the 'sustained focus with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.' Instead, the LLM provides a static snapshot stating constraints 'have remained persistent' without capturing the evolution. The answer is partially correct on the basic facts (regulatory constraints exist, board discretion applies) but fundamentally misses the multi-hop analytical requirement to track and interpret the progression across three years. This represents incomplete synthesis of the multi-year evolution that was central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 459,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "Repair and other services revenue fell by $37 million (about 3 %) from $1,169 million in 2022 to $1,132 million in 2023, but stayed unchanged at $1,132 million in 2024. The flatness reflects the segment’s reliance on long‑term maintenance and modernization contracts that deliver a predictable, stable revenue stream, with no new contracts or backlog changes to drive growth【page_9】. This pattern indicates a strategic focus on sustaining existing service contracts and lifecycle support rather than pursuing aggressive expansion, underscoring the segment’s stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $1,169M (2022), $1,132M (2023), $1,132M (2024). (2) Calculation is accurate: $37M decline = 3.16% (rounded to ~3%), correctly computed. (3) Correctly identifies the flat revenue pattern in 2024. (4) Properly addresses the multi-part question structure. WEAKNESSES: (1) The LLM's explanation diverges significantly from the ground truth reasoning. The LLM attributes the pattern to 'reliance on long-term maintenance contracts' and 'no new contracts or backlog changes,' but the ground truth suggests alternative explanations: market saturation, resource reallocation to higher-priority programs (like nuclear-powered submarines and surface ships), or operational constraints. (2) The LLM's characterization of the segment as having 'stability' and 'predictable revenue stream' is somewhat contradictory to the ground truth's interpretation that the stagnation suggests 'limited growth or strategic prioritization' and potential resource reallocation away from this segment. (3) The LLM does not mention the comparative context that other areas (nuclear-powered submarines and surface ships) showed growth, which is important context for understanding why this segment remained flat. (4) The LLM's reasoning about 'sustaining existing service contracts' is speculative and not grounded in the ground truth's more cautious interpretation. The answer provides a plausible but different narrative than the ground truth, which emphasizes uncertainty about the causes (market saturation vs. reallocation vs. constraints). MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year trend but fails to synthesize the comparative context with other business segments mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 475,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑method stake in healthcare businesses jumped from **$1.5 billion in 2022** (to $1.4 billion in 2023) to **$3.8 billion in 2024** (see UNH 10‑K 2023, p. 52 and UNH 10‑K 2024, p. 54), underscoring a strategic shift toward deeper ownership and influence in established healthcare operations.  The 2024 filing notes that venture investments remain part of the company’s equity‑securities portfolio but are not disclosed separately, indicating that while venture activity continues, the focus has moved to larger equity‑method positions that allow greater integration and long‑term partnership in the sector.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 equity method investment figure. The LLM states '$1.5 billion in 2022' but the ground truth clearly indicates it was '$1.4 billion in 2022.' The LLM then contradicts itself by stating '(to $1.4 billion in 2023)' which aligns with ground truth but conflicts with the opening claim of $1.5 billion in 2022. This is a major quantitative accuracy failure. CORRECT ELEMENTS: The LLM correctly identifies the 2024 figure of $3.8 billion and accurately captures the strategic shift toward deeper equity-method investments. The characterization of venture investments as part of the equity securities portfolio (not separately disclosed) is appropriate. MISSING INFORMATION: The LLM answer fails to address the venture investments and equity securities portfolio evolution mentioned in the ground truth ($3.7B in 2022 → $4.9B in 2023 → $4.9B in 2024). The question specifically asks about 'venture investments and equity method investments' but the LLM only addresses equity method investments while dismissing venture investments as 'not disclosed separately.' This is incomplete synthesis of the multi-hop question. REASONING ISSUES: While the strategic narrative about deeper integration is sound, the answer doesn't fully synthesize the complete picture of how both investment types evolved. The multi-hop reasoning is partially successful but incomplete. The internal contradiction about the 2022 figure ($1.5B vs $1.4B) undermines credibility. CONTEXTUAL RELEVANCE: The answer appropriately addresses the strategic emphasis shift but incompletely addresses the full scope of investment evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 467,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every year examined: it is included on page 21 of the 2022 10‑K, and again on page 26 of both the 2023 and 2024 10‑Ks. The unchanged presence shows that PMI’s peer‑group criteria—global presence, consumer‑product focus, and comparable net revenues and market capitalization—are applied consistently, and that Colgate‑Palmolive continues to meet those standards, underscoring PMI’s systematic, criteria‑driven benchmarking approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across all three years (2022, 2023, 2024); (2) Accurately cites specific page references (page 21 for 2022 10-K, page 26 for 2023 and 2024 10-Ks); (3) Correctly identifies the four peer group criteria: global presence, consumer-product focus, net revenues, and market capitalization; (4) Properly synthesizes the multi-hop information showing year-over-year consistency; (5) Correctly interprets this consistency as evidence of a systematic, criteria-driven benchmarking approach. MINOR WEAKNESSES: (1) The LLM answer lists only three criteria explicitly ('global presence, consumer-product focus, and comparable net revenues and market capitalization') rather than clearly separating all four characteristics, though the information is technically present; (2) The answer could have been slightly more explicit about the strategic implication that PMI deliberately excludes direct tobacco industry peers from its peer group comparison, which the ground truth mentions; (3) The phrase 'continues to meet those standards' is slightly inferential rather than directly stated in the ground truth. QUANTITATIVE ACCURACY: Page numbers and years are correct. No calculations are required for this question. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and properly identifies the benchmarking framework's consistency. The multi-hop synthesis (combining peer group membership data across years with criteria information) is sound. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution (showing no change), consistency, and what this reveals about PMI's strategic benchmarking framework. Overall, this is a strong answer with only minor omissions in emphasis rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 523,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s 10‑Ks from 2022 through 2024 consistently warn that fraud and abusive behaviors are a risk that has grown as the company expanded its credit‑product portfolio and deepened reliance on third‑party lenders.  In 2022 the firm noted that “fraud and abusive behaviors are complex, require continuous improvement, and may not be effective in detecting and preventing fraud, particularly new and continually evolving forms of fraud or in connection with new or expanded product offerings”【page_26】, a sentiment echoed in 2023 (e.g., “failure to deal effectively with fraud, abusive behaviors…may increase our loss rate”【page_23】; “fraud and abusive behaviors…may not be effective”【page_26】) and again in 2024 (e.g., “failure to deal effectively with fraud, abusive behaviors…may increase our loss rate”【page_23】; “fraud and abusive behaviors…may not be effective”【page_24】).  Each filing also highlights that credit products expose the company to additional risks and that it “generally relies on the activities and charters of unaffiliated financial institutions to provide PayPal and Venmo branded consumer credit and merchant financing offerings”【page_24 (2022)】【page_24 (2023)】【page_23 (2024)】【page_21 (2024)】, underscoring that the expanding credit business and third‑party dependencies have amplified exposure to abusive behaviors.  The repeated emphasis on the complexity and limited effectiveness of fraud‑mitigation measures suggests that, despite growth, PayPal’s ability to curb abusive activity has not markedly improved over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and PayPal as the subject company; (2) Accurately captures the core narrative that fraud/abusive behavior exposure increased in complexity and scale; (3) Properly synthesizes the multi-hop relationship between credit product expansion, third-party dependencies, and fraud risk; (4) Correctly notes the repeated emphasis on limited mitigation effectiveness across all three years; (5) Provides specific textual citations from 10-K filings with page references, demonstrating document-level accuracy; (6) The quote about fraud being 'complex, require continuous improvement, and may not be effective' is accurately captured. MINOR GAPS: (1) The LLM answer does not mention the specific €40 billion BNPL loan receivables agreement in Europe that the ground truth highlights as a significant 2023 expansion event - this is a notable omission of a concrete quantitative detail; (2) The LLM does not address the 2024 regulatory uncertainty regarding loan receivables post-sale validity mentioned in the ground truth, which is a specific risk factor that distinguishes 2024 from prior years; (3) The answer could have been more explicit about the scale/complexity evolution (e.g., noting how BNPL expansion introduced 'much larger scale' risks). QUANTITATIVE ACCURACY: The answer contains no numerical errors. The €40 billion figure from ground truth is absent, but this is an omission rather than an inaccuracy. MULTI-HOP REASONING: The synthesis is sound - the answer correctly connects credit expansion → third-party reliance → increased fraud exposure → limited mitigation effectiveness. SEMANTIC EQUIVALENCE: The core message matches: PayPal's fraud mitigation effectiveness has not kept pace with the growing complexity and scale of risks. The conclusion that 'ability to curb abusive activity has not markedly improved' is semantically equivalent to the ground truth's assessment that 'evolving nature and scale...have outpaced mitigation effectiveness.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 567,
        "total_tokens": 2280
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume rose from **214 mmBtu in 2022 to 339 mmBtu in 2023** (page 117) and then fell sharply to **176 mmBtu in 2024** (page 114).  While total hedge volume stayed roughly flat (431 mmBtu in 2022, 448 mmBtu in 2023, 431 mmBtu in 2024), the mix shifted from a heavier option position in 2023 to a greater reliance on swaps in 2024.  This three‑year pattern indicates a flexible, market‑responsive risk‑management strategy that increased option use when volatility or price uncertainty peaked in 2023, then scaled back as conditions eased or the company re‑balanced its hedging mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL QUANTITATIVE ERROR: The LLM reports 2022 natural gas options as 214 mmBtu, but the ground truth clearly states 253 million mmBtu. This is a significant discrepancy (off by 39 mmBtu or ~15%). The 2023 figure of 339 mmBtu is correct, and the 2024 figure of 176 mmBtu is also correct. The LLM correctly identifies the three-year trend pattern (increase then decrease) and the strategic interpretation about market responsiveness. However, the incorrect 2022 baseline undermines the accuracy of the trend analysis. The LLM also introduces additional context about total hedge volumes (431/448/431 mmBtu) and the shift from options to swaps, which adds useful detail but cannot be verified against the ground truth provided. The reasoning about market volatility and hedging strategy adjustment is sound and aligns with the ground truth interpretation. The semantic understanding of the question and the multi-hop synthesis across years is appropriate. However, the fundamental error in the 2022 number (214 vs 253) is a material factual mistake that significantly impacts the credibility of the quantitative analysis. The qualitative reasoning about risk management strategy is reasonable but is built on a partially incorrect numerical foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 352,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024** (TXN_10k_2024, p. 41; TXN_10k_2023, p. 42; TXN_10k_2022, p. 43). The modest upward trend indicates the company is steadily increasing its investment in defined‑contribution benefits, reflecting a strategic shift toward a more flexible, cost‑controllable retirement offering. Meanwhile, its non‑qualified defined‑benefit pension plan remains closed to new participants and unfunded, underscoring a move away from traditional defined‑benefit obligations (TXN_10k_2024, p. 46).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All financial numbers are correct: $70M (2022), $75M (2023), $76M (2024) match ground truth exactly. (2) Numeric trend analysis is accurate - the steady increase is correctly identified. (3) Entity identification is correct (Texas Instruments, U.S. defined contribution plans, non-qualified defined benefit pension plan). (4) Document citations provided with specific page numbers add credibility. (5) The characterization of the non-qualified plan as 'closed to new participants and unfunded' is accurate.\n\nWEAKNESSES: (1) The LLM answer describes the trend as a 'strategic shift toward a more flexible, cost-controllable retirement offering' but the ground truth emphasizes this reflects 'a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan.' The LLM's framing suggests cost-control motivation, while ground truth frames it as supporting employees who opted out. (2) The LLM answer omits the important historical context that 'defined benefit plans were closed to new participants in 1997,' which the ground truth includes as relevant to understanding the long-term strategy. (3) The LLM answer doesn't explicitly mention the 'enhanced defined contribution plan' that employees participate in as an alternative, which ground truth identifies as key to understanding the strategic relationship. (4) The phrase 'strategic shift' in the LLM answer is somewhat misleading - the ground truth suggests this is a continuation of a long-standing structure since 1997, not a recent shift.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and connects the defined contribution expense trend to the non-qualified defined benefit plan status. However, it misses the nuance that this represents a continuation of strategy (since 1997) rather than a new shift, and doesn't fully capture the relationship between employees opting out of the defined benefit plan and participating in the enhanced defined contribution plan.\n\nCALCULATIONS: No calculations required; trend identification is correct.\n\nJUSTIFICATION: The answer is substantially correct on numbers and basic reasoning but falls short on capturing the full strategic context and historical perspective that the ground truth emphasizes. The characterization of motivation (cost-control vs. supporting opted-out employees) differs subtly but meaningfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 656,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM’s weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % at December 31 2022 and remained unchanged at 6.3 % at December 31 2023 (2023 10‑K, page 88). In the 2024 investment‑policy study the assumption was raised to 6.5 % at December 31 2024 (2024 10‑K, page 88). The increase reflects a more optimistic view of future asset performance and a willingness to accept higher risk to improve the plans’ funded status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2022 FIGURE: The LLM answer states the 2022 rate was 6.3%, but the ground truth clearly indicates it was 5.4% in 2022. This is a significant factual error that undermines the core analysis. The LLM correctly identifies 6.3% for 2023 and 6.5% for 2024, and properly cites the 10-K pages (88). However, the missing 2022 baseline of 5.4% is essential to the question's multi-hop analysis, which specifically asks about evolution 'from 2022 through 2024.' The LLM's statement that the rate 'remained unchanged at 6.3%' between 2022-2023 is incorrect—there was actually a significant jump from 5.4% to 6.3% between 2022-2023. The qualitative interpretation about optimism and risk tolerance is reasonable and aligns with the ground truth, but it's based on incomplete/incorrect data. The LLM failed to capture the full three-year trend and the magnitude of the initial increase. The answer demonstrates partial understanding of the pension assumptions topic but contains a fundamental numerical error that prevents accurate assessment of the actual evolution pattern. The reasoning about implications is sound but cannot be fully validated given the incorrect baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 336,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a $92 million loss in FY 2022 to gains of $58 million in FY 2023 and $91 million in FY 2024, while the notional exposure grew from $651 million to $985 million. This shift shows Cisco is expanding and refining its hedging program, effectively offsetting compensation volatility and underscoring a proactive risk‑management strategy for deferred‑pay obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Cisco's total return swaps evolution. QUANTITATIVE VERIFICATION: All financial figures are correct - FY2022 loss of $92 million, FY2023 gain of $58 million, FY2024 gain of $91 million. The LLM also includes additional notional exposure data ($651 million to $985 million) that enriches the answer beyond the ground truth baseline, showing deeper research. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year progression and identifies the directional shift from loss to gains. REASONING QUALITY: The LLM provides sound interpretation - characterizing the swing as reflecting improved market conditions or strategic adjustments, and adding context about hedging program expansion and risk management. The interpretation that the growing notional exposure indicates 'expanding and refining its hedging program' is a reasonable inference from the data. COMPLETENESS: The answer addresses all key aspects of the question: (1) the financial exposure evolution across three years, (2) realized gains/losses, and (3) implications for risk management/compensation strategy. MINOR CONSIDERATIONS: The LLM's additional detail about notional exposure growth, while accurate and valuable, goes slightly beyond what was explicitly in the ground truth answer, but this represents enhancement rather than error. The characterization of the strategy as 'proactive risk-management' is well-supported by the data progression. No calculation errors detected. All entities (Cisco, fiscal years, financial metrics) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 444,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across 2022‑2024 PayPal’s margin‑risk exposure did not change. In each year’s revenue note (2022 page 81, 2023 page 76, 2024 page 77) PayPal states it is the principal, controls pricing, and therefore bears full margin risk, while the costs of using third‑party processors are recorded as transaction expense independent of the fee it charges customers. The identical wording and accounting treatment in all three years indicate that PayPal’s control over pricing, use of processors, and transaction‑expense recognition remained consistent, with no evolution in margin‑risk exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies that PayPal's margin risk exposure remained consistent across 2022-2024, matching the ground truth's core finding. (2) Accurately cites specific page numbers from revenue notes (2022 p.81, 2023 p.76, 2024 p.77) demonstrating multi-hop synthesis across three years of filings. (3) Correctly identifies the three key elements: PayPal as principal, pricing control, and transaction expense recognition. (4) Accurately states that processor costs are recorded as transaction expense independent of customer fees. (5) Properly concludes no structural changes occurred. MINOR WEAKNESSES: (1) The LLM answer states 'identical wording' across all three years, which is slightly stronger than the ground truth's 'consistent' language - the ground truth allows for some variation in how the concept was expressed ('emphasized,' 'reiterated,' 'clarified,' 'confirmed') while the LLM suggests verbatim repetition. (2) The LLM answer doesn't explicitly mention the 2023 clarification about tiered pricing not constituting a future material right, which was a specific detail in the ground truth. (3) The LLM doesn't acknowledge the 2024 adoption of new segment reporting disclosures mentioned in the ground truth, though it correctly notes this didn't change the fundamental margin risk exposure. QUANTITATIVE VERIFICATION: Page numbers cited (81, 76, 77) are plausible for revenue notes in 10-K filings and appear consistent with typical SEC filing structures. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years of filings and correctly identifies the consistent pattern, which is the core multi-hop requirement. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM's conclusion that margin risk exposure 'did not change' is semantically equivalent to the ground truth's statement of 'consistent exposure...without structural changes.' Both convey the same fundamental finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 559,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola LNG natural‑gas output fell slightly from 49 MMCFD in 2022 to 48 MMCFD in 2023 and stayed flat at 48 MMCFD in 2024【page_9】. This steady, near‑constant volume indicates Chevron is prioritizing a reliable, long‑term supply to Angola LNG rather than pursuing aggressive expansion, underscoring its strategy of maintaining steady LNG output and securing long‑term contracts in the market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. QUANTITATIVE ERRORS: The LLM reports Angola LNG natural gas volumes as 49 MMCFD (2022), 48 MMCFD (2023), and 48 MMCFD (2024), showing a decline. The ground truth states 592 million cubic feet per day (2022), 596 million cubic feet per day (2023), and 609 million cubic feet per day (2024), showing a steady increase. These are dramatically different numbers - the LLM's figures are off by approximately 12x (49 vs 592, 48 vs 596, 48 vs 609). This is not a minor formatting difference but a fundamental misreporting of the data. DIRECTIONAL ERROR: The LLM claims volumes 'fell slightly' and 'stayed flat,' directly contradicting the ground truth's 'increased steadily' trajectory. This reverses the entire narrative of the trend. REASONING FAILURE: The LLM's interpretation that flat volumes indicate 'prioritizing reliable, long-term supply' rather than 'aggressive expansion' contradicts the actual upward trend in the ground truth. The ground truth correctly identifies the increasing volumes as indicating 'growing operational emphasis on LNG production.' ENTITY/METRIC CONFUSION: While the LLM correctly identifies Chevron and Angola LNG, it appears to have confused or misreported the actual production volume metrics. The ground truth's figures (592-609 MMCFD) are consistent with typical LNG operational scales, while the LLM's figures (48-49 MMCFD) are implausibly low for a major LNG operation. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year trend data needed to answer the strategic positioning question. The conclusion about strategy is therefore based on incorrect data. This is a critical failure in a multi-hop financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 476,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In 2022 and 2023 Southern Power disclosed scheduled payments under outdoor‑lighting leases in the operating‑lease maturity‑analysis table, with amounts of roughly $87–$90 per year and $240 thereafter. In 2024 the same table format was used, but the scheduled payments were lower ($15 per year through 2029, $170 thereafter) and the note about immateriality shifted to Georgia Power and Mississippi Power, leaving Southern Power’s payments as material. The consistent, separate reporting and unchanged materiality note for Southern Power signals that these contracts have become a structurally important, material component of the company’s lease portfolio and cash‑flow projections.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($87-$90 per year, $240 thereafter, $15 per year through 2029, $170 thereafter) that are not mentioned in the ground truth and appear to be fabricated. These numbers cannot be verified and represent a critical failure in quantitative accuracy. (2) ENTITY/STRUCTURAL ERRORS: The ground truth clearly states that in 2022, outdoor lighting contracts were noted as IMMATERIAL at Mississippi Power. The LLM claims Southern Power's payments were 'material' in 2024 and that 'the note about immateriality shifted to Georgia Power and Mississippi Power, leaving Southern Power's payments as material.' This directly contradicts the ground truth, which indicates the immateriality was noted in 2022 and the contracts evolved to become MORE material/integrated over time—not that Southern Power's payments became material while others became immaterial. (3) MULTI-HOP REASONING FAILURE: The ground truth describes a clear three-year progression: 2022 (immaterial, noted separately), 2023 (included in maturity analyses alongside other arrangements), 2024 (explicitly integrated into lease income reporting). The LLM's narrative about shifting immateriality notes between companies is not supported by the ground truth and represents a fundamental misunderstanding of the disclosure evolution. (4) SEMANTIC MISALIGNMENT: While the LLM attempts to address the evolution question, it does so by inventing specific numbers and mischaracterizing the materiality trajectory. The ground truth emphasizes growing materiality and structural integration; the LLM's claim about 'unchanged materiality note' contradicts this progression. (5) FABRICATION RISK: The specific dollar amounts provided by the LLM appear to be hallucinated, as they are not mentioned in the ground truth and would be critical to verify in actual filings. This represents a severe accuracy failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 549,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has consistently been used only for its Analog segment and not for Embedded Processing across the three years.  In the 2022, 2023 and 2024 10‑Ks the properties table lists an “X” under Analog and no “X” under Embedded Processing for Melaka【page_16 of TXN_10k_2022】【page_16 of TXN_10k_2023】【page_16 of TXN_10k_2024】.  Thus, the operational footprint in Melaka did not change in terms of segment involvement during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Correctness Assessment: (1) WHAT WAS CORRECT: The LLM correctly identifies that Texas Instruments' Melaka, Malaysia facility was used exclusively for the Analog segment across all three years (2022, 2023, 2024) with no involvement in Embedded Processing. This matches the ground truth exactly. The answer properly synthesizes the multi-hop information across three separate 10-K filings. (2) QUANTITATIVE ACCURACY: No numeric calculations were required for this question, but the LLM correctly references the specific document pages (page 16 of each year's 10-K) where the properties table appears, demonstrating accurate source identification. The use of 'X' marks to indicate segment involvement is the correct methodology from SEC filings. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate years and two segments (Analog and Embedded Processing), correctly concluding that the operational footprint remained unchanged. The reasoning is sound: the presence of 'X' under Analog and absence under Embedded Processing for all three years logically supports the conclusion of consistency. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more specificity (citing the actual document pages and the 'X' marking system), which adds credibility without contradicting the original answer. Both conclude that Melaka's role was limited to Analog operations with no expansion into Embedded Processing. Minor observation: The LLM provides more methodological detail about how the information was verified (properties table, X marks), which enhances the answer's credibility, though the ground truth is more concise. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 485,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600% Notes remained a $700 million, 1.600% senior unsecured debt issued on March 29, 2021, with semi‑annual interest payments on April 15 and October 15 and a par call date of March 15, 2026【page_48】. No principal repayments or term changes occurred during that period, and the notes were used to refinance higher‑cost debt under the 2021 Multicurrency Credit Facility【page_110】【page_111】【page_115】. This stability indicates AMT’s strategy of keeping a predictable, low‑cost long‑term debt profile while using new issuances to retire more expensive borrowing.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the principal amount ($700 million), the interest payment schedule (semi-annual on April 15 and October 15), and the par call date (March 15, 2026). The issuance date (March 29, 2021) and characterization as senior unsecured debt are accurate. CRITICAL WEAKNESSES: (1) The LLM completely omits the key multi-year progression data that is central to the question - specifically the adjustments to principal amount that decreased from (2.6) in 2023 to (1.5) in 2024. This is a major factual omission that directly addresses the 'multi-year progression' aspect of the question. (2) The LLM states 'No principal repayments or term changes occurred during that period,' which contradicts the ground truth showing adjustments of (2.6) and (1.5) in 2023 and 2024 respectively. These are not zero adjustments. (3) The LLM introduces information about refinancing higher-cost debt under the 2021 Multicurrency Credit Facility, which while potentially accurate, is not part of the ground truth answer and represents synthesis beyond what was verified. (4) The LLM's interpretation of debt management strategy focuses on 'predictable, low-cost long-term debt profile' but misses the actual insight from the ground truth: that the decreasing adjustments suggest 'a reduction in modifications or adjustments to the note structure over time.' MULTI-HOP REASONING: The question requires synthesizing information across 2022-2024 to show evolution. The LLM fails to properly synthesize the year-by-year adjustment data that demonstrates this evolution. The ground truth explicitly tracks the progression of adjustments (2.6 → 1.5), which the LLM completely overlooks. QUANTITATIVE ACCURACY: While the stable figures ($700M, dates, rates) are correct, the failure to include or address the adjustment amounts (2.6) and (1.5) represents a significant quantitative omission. OVERALL ASSESSMENT: The answer provides some correct baseline information but fundamentally fails to address the core of the question - the multi-year progression and what it indicates about debt management strategy. The omission of adjustment data and the incorrect statement about 'no principal repayments or term changes' are material errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 599,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco’s 5.90 % senior note stayed at a $2 billion principal and an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024, while total long‑term debt rose from $8.9 billion to $20.1 billion after a $13.5 billion senior‑note issuance in 2024. The note’s unchanged amount and rate, coupled with its shrinking share of the debt mix, show that Cisco is locking in a stable, long‑dated cost of capital for that instrument while expanding its overall debt base with newer, diversified fixed‑rate notes and hedges—reflecting a long‑term strategy of predictable financing costs and maturity flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 5.90% Note principal amount ($2 billion), effective interest rate (6.11%), and that these remained constant across FY 2022-2024. The qualitative reasoning about Cisco's long-term financing strategy is sound and well-articulated. The answer appropriately addresses the multi-hop nature of the question by synthesizing debt composition changes with the note's role.\n\nCRITICAL ERRORS: (1) Total long-term debt figures are significantly incorrect. Ground truth shows $8,416M (2022) and $19,621M (2024), but LLM states $8.9B and $20.1B. The 2022 figure is off by ~$484M (5.7% error) and 2024 is off by ~$379M (1.9% error). (2) The LLM introduces a $13.5B senior note issuance in 2024 that is not mentioned in the ground truth answer, making this an unsupported claim. (3) Short-term debt changes are completely omitted (ground truth shows $499M to $488M), which is part of the complete debt composition picture.\n\nPARTIAL ACCURACY: The LLM correctly captures the core insight that the note's share of total debt is shrinking while absolute amounts remain constant, and correctly interprets this as part of a diversification strategy. However, the specific numbers undermine the precision of this analysis.\n\nMULTI-HOP REASONING: The answer demonstrates good synthesis of the relationship between the fixed note and overall debt strategy, but the quantitative inaccuracies weaken the foundation of this reasoning. The mention of 'newer, diversified fixed-rate notes' is reasonable inference but not explicitly supported by the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 436,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics produced 399 new LAVs for the Canadian Army in 2022, 360 in 2023, and 449 in 2024 (GD_10k_2022.pdf page_11; GD_10k_2023.pdf page_11; GD_10k_2024.pdf page_10). The dip in 2023 followed by a sharp increase in 2024 signals a strategic pivot to ramp up LAV production, underscoring the company’s renewed focus on expanding its LAV portfolio and solidifying its position in the Canadian market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely undermine its credibility: (1) QUANTITATIVE ACCURACY FAILURE: The LLM reversed the 2022 and 2023 production volumes. Ground truth shows 360 units in 2022 and 399 units in 2023, but the LLM states 399 in 2022 and 360 in 2023. This is a direct contradiction of the factual record. The 2024 figure of 449 units is correct. (2) REASONING ERROR: The LLM's interpretation of the data is backwards. It claims there was a 'dip in 2023 followed by a sharp increase in 2024,' but the actual data shows consistent growth: 360→399→449. The LLM's narrative of a 'strategic pivot' and 'renewed focus' is based on the incorrect premise that 2023 was lower than 2022, when in fact 2023 showed growth. (3) MISSING CRITICAL INFORMATION: The LLM completely omits the LRSS (Light Armoured Vehicle Reconnaissance Surveillance System) program mentioned in the ground truth, which added 66 specialized LAVs in 2024. This is a significant omission that fails to capture the full scope of GD's strategic expansion. (4) INCOMPLETE SYNTHESIS: While the LLM attempts multi-hop reasoning across three years, it fails to correctly synthesize the progression, leading to an inverted narrative. The correct interpretation is steady growth indicating strengthening commitment, not a dip-and-recovery pattern. The citation format appears fabricated (specific page numbers that cannot be verified). The answer demonstrates poor data accuracy on the most fundamental requirement: getting the numbers right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 427,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes has remained a persistent concern as CMS continued to freeze or cut benchmarks, alter risk‑adjustment calculations, and conduct audits that can trigger retrospective adjustments (page_23–25, page_18–22, page_18–22). In response, the company has progressively adjusted member benefits and premiums on a selective basis, discontinued plans in certain counties, intensified medical and operating cost management, and in 2024 increased its focus on cost‑management and efficiency initiatives across its Medicare Advantage portfolio (page_23–25, page_18–22, page_18–22).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core issue: CMS risk adjustment payment changes as a persistent concern across all three years; (2) Accurately captures the company's strategic responses: selective benefit/premium adjustments, county withdrawals, cost management intensification, and bid recalibration; (3) Properly synthesizes the evolution from 2022 through 2024, showing continuity of exposure and adaptive responses; (4) Correctly identifies specific mechanisms (benchmarks freezes/cuts, risk-adjustment calculation changes, audits, retrospective adjustments, beneficiary health status data submissions); (5) No quantitative errors - no specific dollar amounts or percentages were claimed that could be verified as incorrect; (6) Appropriate use of page references suggests source documentation. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, which provides marginally more narrative detail about the 'sustained operational agility' concept; (2) The phrasing 'progressively adjusted' is reasonable but the ground truth emphasizes 'consistent' pressures and responses rather than necessarily progressive changes - though this is a semantic nuance rather than factual error; (3) The answer could have been slightly more explicit about the year-by-year evolution (2022 specific actions, 2023 reiteration, 2024 continuation), though the three-year synthesis is still clear. MULTI-HOP REASONING: The answer successfully combines information across three fiscal years and multiple strategic dimensions (payment mechanisms, operational responses, market participation), demonstrating sound synthesis. The connection between CMS actions and company responses is logically sound and well-articulated. ENTITY ACCURACY: UnitedHealth Group correctly identified, Medicare Advantage correctly specified, CMS correctly referenced, time period (2022-2024) accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 546,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes stayed flat at **$1.5 billion** from 2022 through 2024 (the 2022 and 2023 filings show $1,500 m, and the 2024 filing shows $1,500 m again)【107】【104】. This unchanged balance indicates a deliberate long‑term debt strategy that prioritizes a stable, predictable mix of fixed‑rate, long‑maturity debt—locking in a consistent interest rate while keeping the debt profile steady as the company adds newer, higher‑rate notes for other purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All numbers are correct - the $1.5 billion carrying value is accurately stated for all three years (2022, 2023, 2024), with proper format consistency ($1,500m = $1.5 billion). The citations [107] and [104] suggest proper source documentation. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt strategy (deliberate, stable approach). ENTITY ACCURACY: Company (PayPal/PYPL) correctly identified, years (2022-2024) correct, financial metric (fixed-rate 2.850% notes) correctly specified. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized that constant exposure across three years indicates strategic intent. The interpretation that this represents a deliberate strategy to maintain stable, predictable fixed-rate debt is logically sound and aligns with the ground truth's characterization of \"consistent long-term debt strategy\" and \"strategic intent to preserve this liability structure.\" SEMANTIC EQUIVALENCE: The LLM's phrasing \"deliberate long-term debt strategy that prioritizes a stable, predictable mix of fixed-rate, long-maturity debt\" is semantically equivalent to the ground truth's \"consistent long-term debt strategy\" and \"strategic intent to preserve this liability structure.\" The additional context about \"locking in a consistent interest rate while keeping the debt profile steady\" adds reasonable interpretive value without contradicting the ground truth. MINOR CONSIDERATION: The LLM adds interpretive language about \"newer, higher-rate notes for other purposes\" which is reasonable inference but not explicitly stated in the ground truth. This is a minor enhancement rather than an error. Overall, the answer demonstrates accurate fact retrieval, correct calculations, proper multi-hop synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 538,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron’s stake in Angola LNG Limited has shifted from a large‑balance investment to a more operational, monetized asset.  In 2022 the company carried a $1.963 billion investment and earned $1.857 billion of equity income, which fell to a $1.762 billion investment and $513 million equity income in 2023 (Note 15, page 82).  By 2024, Chevron’s 36.4 % share of the 1.1 Bcf/d LNG plant in Soyo was recognized as a proved‑reserve asset, signalling a move from passive investment to active gas monetization and long‑term LNG export strategy in Angola (pages 13‑14).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and potential inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies Chevron's 36.4% ownership stake in Angola LNG Limited; (2) Correctly notes the 1.1 Bcf/d capacity of the LNG plant in Soyo; (3) Appropriately characterizes the evolution from passive investment to active monetization; (4) Mentions the strategic shift toward gas monetization. WEAKNESSES: (1) QUANTITATIVE ISSUES - The LLM provides specific financial figures ($1.963B investment in 2022, $1.857B equity income, $1.762B investment in 2023, $513M equity income) that cannot be verified against the ground truth, which does not provide these specific numbers. These figures may be accurate from the 10-K filings, but their inclusion without ground truth verification creates uncertainty; (2) INCOMPLETE SYNTHESIS - The LLM answer focuses heavily on financial metrics and balance sheet treatment but completely omits the critical strategic evolution described in the ground truth: the expansion of upstream gas portfolio in Blocks 49 and 50, and the advancement of the Quiluma and Maboqueiro (Q&M) gas fields within the New Gas Consortium Project. These are essential to understanding the 'multi-year progression' and 'long-term natural gas monetization strategy'; (3) MISSING CONTEXT - The ground truth emphasizes that Angola LNG evolved from a 'standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.' The LLM answer does not capture this integrated hub concept or the upstream development component; (4) CHARACTERIZATION DIFFERENCE - The LLM describes the shift as moving from 'large-balance investment to operational, monetized asset' and from 'passive investment to active gas monetization,' which is somewhat accurate but misses the specific upstream integration strategy that defines the true evolution; (5) PAGE REFERENCES - The LLM cites specific pages (82, 13-14) which suggests reliance on actual filing data, but these cannot be independently verified against the ground truth provided. The multi-hop reasoning is partially sound but incomplete, as it fails to synthesize the upstream development component that is central to understanding Chevron's long-term strategy in Angola.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 630,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust‑investment portfolio grew steadily from 2022 to 2024: domestic‑equity holdings increased from $829 million (2022, page 283) to $988 million (2023, pages 281–282) to $1,099 million (2024, page 273), while private‑equity positions rose from $161 million to $169 million to $181 million over the same period. This consistent upward trend—particularly the larger jump in domestic equity—indicates a deliberate long‑term capital‑allocation strategy that prioritizes higher‑return domestic growth and private‑market exposure within its trust investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are fundamental to answering the question. Verification against ground truth: (1) 2022 Domestic Equity: LLM states $829M, but ground truth shows $1,016M - ERROR of $187M (18% understatement). (2) 2023 Domestic Equity: LLM states $988M, but ground truth shows $829M - ERROR of $159M (19% overstatement). (3) 2022 Private Equity: LLM states $161M, but ground truth shows $150M - ERROR of $11M (7% overstatement). (4) 2023 Private Equity: LLM states $169M, but ground truth shows $161M - ERROR of $8M (5% overstatement). (5) 2024 figures appear correct ($1,099M domestic equity, $181M private equity). The LLM has essentially transposed or confused the 2022 and 2023 domestic equity figures, which completely distorts the narrative of the investment evolution. The ground truth shows domestic equity DECREASED from 2022 to 2023 ($1,016M to $829M), then REBOUNDED in 2024 ($1,099M), whereas the LLM incorrectly portrays a consistent upward trend throughout. This fundamental misrepresentation of the data pattern undermines the entire analysis. The LLM's conclusion about 'consistent upward trend' is factually incorrect based on the actual data. The reasoning about capital allocation strategy is reasonable in tone but is built on incorrect premises. Multi-hop synthesis failed because the core data points were misidentified. The answer does address the question's components but with severely compromised accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 421,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "The “Eliminations/ Reclassifications” column shows a growing negative impact on total net sales and revenue: $ (107) million in 2022, $ (151) million in 2023, and $ (296) million in 2024.  The trend indicates that GM is eliminating more intra‑group revenue and reclassifying revenue across its automotive, GM Financial, and other segments, reflecting increasing complexity and evolving internal reporting practices over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM reports: 2022=$107M, 2023=$151M, 2024=$296M. Specifically: (1) 2022 figure is wrong ($107M vs correct $105M - off by $2M), (2) 2023 figure is significantly wrong ($151M vs correct $107M - off by $44M or 41% error), (3) 2024 figure is correct at $296M. The LLM swapped or misread the 2022 and 2023 values, and introduced an entirely incorrect 2023 figure. This is a fundamental failure on the primary quantitative requirement. The trend analysis is also incorrect as a result - the LLM describes a monotonic increase ($107M→$151M→$296M) when the actual trend shows a much smaller increase from 2022-2023 ($105M→$107M) followed by a sharp jump in 2024 ($107M→$296M). The qualitative reasoning about increasing complexity and evolving reporting practices is reasonable and contextually appropriate, but it is built on incorrect numerical foundations. The multi-hop synthesis aspect (understanding the three-year evolution) is conceptually sound but factually compromised by the data errors. The answer demonstrates understanding of what eliminations/reclassifications represent but fails the strict requirement for numerical accuracy in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 380,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In 2022, Netflix amended and restated its Performance Bonus Plan and filed it as Exhibit 10.5 (8‑K) (page 68). The 2023 10‑K incorporated that same exhibit by reference (page 69). By the 2024 filing, the plan remained incorporated by reference and was positioned within a broader compensation framework that also includes the 2020 Stock Plan (Exhibit 10.10†) and the Executive Severance and Retention Incentive Plan (Exhibit 10.16†) (page 68).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) CRITICAL DATE ERROR: The LLM states the Performance Bonus Plan was 'amended and restated' in 2022 and filed as Exhibit 10.5, but the ground truth clearly indicates the amendment and restatement occurred in 2023 (filed December 9, 2022, appearing in 2023 filings). The 2022 filing showed it as a historical exhibit (Exhibit 10.6†) from 2014 with no updates. (2) EXHIBIT NUMBER INCONSISTENCY: The LLM claims Exhibit 10.5 in 2022, but ground truth shows Exhibit 10.6† for 2022 and Exhibit 10.5† for 2023-2024. (3) FILING DOCUMENT CONFUSION: The LLM references '8-K' and specific page numbers (68, 69) that cannot be verified against the ground truth, which focuses on 10-K filings. (4) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key strategic insight from ground truth - that 2023 represented an active revision/formalization (amendment and restatement), while 2024 showed stabilization with no further changes. Instead, the LLM presents a misleading timeline suggesting 2022 was when the amendment occurred. (5) MISSING CONTEXT: The LLM does not adequately explain the documentation status progression (historical exhibit → amended/restated → carried forward) that is central to the question. The answer does mention integration with other compensation frameworks, which is relevant, but this cannot compensate for the fundamental chronological and factual errors regarding when the amendment occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 422,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK continued to reference its Business Relationships and Related Party Transactions Policy in the proxy each year, with the same wording and no material changes noted in the 2022, 2023, and 2024 10‑K filings. The corporate‑governance disclosures—particularly director independence and the composition of the Audit, Corporate Governance, Nominating & Social Responsibility, and Human Resources & Compensation committees—remain unchanged across the three filings, underscoring a consistent governance framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but has notable weaknesses in completeness and precision. CORRECT ELEMENTS: (1) The identification of BK as the company is correct; (2) The three years (2022, 2023, 2024) are correctly identified; (3) The committee names are accurately listed (Audit, Corporate Governance/Nominating & Social Responsibility, Human Resources & Compensation); (4) The general assertion of consistency across years is directionally correct. WEAKNESSES: (1) The LLM states the policy was referenced 'in the proxy each year' but the ground truth specifically locates it in Item 13 of the 10-K filings, not proxy statements—this is a material distinction in document type; (2) The LLM claims 'no material changes noted' and that disclosures 'remain unchanged,' which is overstated. The ground truth indicates consistency in placement and linkage but does not claim the disclosures were entirely unchanged; (3) The LLM lacks specificity about the linkage between the policy and director independence discussions that the ground truth emphasizes; (4) The answer does not explicitly mention that the policy was disclosed 'within the context of Item 13' or 'Corporate Governance and Board Information,' which are key contextual details from the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the connection between the policy and governance structures, but the reasoning is less precise than the ground truth regarding the specific filing locations and the nature of the consistency (placement/linkage consistency vs. complete unchanging content). QUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this question, so this dimension scores well for not introducing false data. OVERALL: The answer is partially correct but lacks the precision and specificity of the ground truth, particularly regarding document location (10-K Item 13 vs. proxy) and the nuanced nature of the consistency claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 539,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities fell in both fair value and carrying amount over the three‑year period: fair value declined from $679 million in 2022 to $596 million in 2023 and to $508 million in 2024, while carrying value fell from $696 million to $603 million and then to $512 million (see UNH 10‑K tables on pages 53 for each year). The parallel decline reflects a drop in market value—largely driven by rising interest rates—yet the carrying amounts remain close to fair value, indicating that UnitedHealth is not recording significant impairment and is maintaining a conservative, amortized‑cost approach consistent with its held‑to‑maturity strategy. This trend suggests the company prioritizes long‑term, low‑risk debt holdings and relies on fair‑value benchmarks without materially adjusting the book value of those securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect fair value and carrying value figures for 2022. Ground truth shows: Fair value 2022=$643M (LLM claims $679M, error of $36M or 5.6%), Carrying value 2022=$641M (LLM claims $696M, error of $55M or 8.6%). The 2023 and 2024 figures are correct (Fair value: $596M and $508M; Carrying value: $603M and $512M). This represents a significant quantitative accuracy failure on the baseline year data. MULTI-HOP SYNTHESIS ISSUES: While the LLM correctly identifies the declining trend across all three years, the incorrect 2022 baseline undermines the entire trend analysis. The LLM's interpretation about interest rate impacts and amortized-cost approach is reasonable but not grounded in the ground truth answer, which specifically mentions 'shift away from Level 3 unobservable inputs by 2023 and 2024' - a key insight the LLM completely omits. MISSING KEY INSIGHT: The ground truth emphasizes the strategic shift toward 'greater reliance on more liquid or observable market pricing' (implying movement away from Level 3 inputs), which is a critical component of understanding the company's investment strategy evolution. The LLM's discussion of interest rates and impairment is plausible but represents speculation rather than grounded analysis. PARTIAL CREDIT: The LLM correctly identifies the overall declining trend, correctly states 2023 and 2024 values, and provides reasonable (if speculative) interpretation of the company's strategy. However, the 2022 baseline errors are material and the omission of the Level 3 input shift is a significant gap in addressing the question's core requirement about 'valuation assumptions.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 461,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal’s 2022 10‑K noted that its BNPL loan receivables were part of its credit portfolio and exposed the company to default risk and potential charge‑offs (page_24).  In June 2023, PayPal entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables, thereby transferring that credit risk to a third party (page_25).  By 2024 the sale was underway and the company had further reduced its exposure to bad transactions, underscoring a risk‑mitigation strategy that increasingly relies on asset sales and forward‑flow arrangements to off‑load credit risk (page_23).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: the €40 billion BNPL receivables sale agreement in June 2023, the 2022 exposure to default risk, and the 2024 continuation of the strategy. The numeric values and dates are accurate. However, the answer has some limitations: (1) It provides less nuanced detail about the evolution of PayPal's risk disclosure across the three years compared to the ground truth, which specifically notes that 2022 highlighted 'fraud and abusive behaviors' impacts on loss rates, 2023 showed the strategic pivot through the sale, and 2024 acknowledged conditions that could delay benefits. (2) The LLM answer is more concise and less comprehensive in explaining the full arc of risk mitigation strategy evolution. (3) The ground truth emphasizes that PayPal 'continued to emphasize the risks' in 2024 while noting conditional aspects of the sale, whereas the LLM states the sale 'was underway' and the company 'had further reduced' exposure - this is slightly less precise about the conditional nature of the benefits. (4) The ground truth provides better context about the ongoing challenges of fraud and abuse in the ecosystem, which the LLM omits. The multi-hop reasoning is sound - the LLM correctly synthesizes information across three years and connects the June 2023 agreement to the broader risk mitigation strategy. The page references appear reasonable though cannot be independently verified. Overall, the core facts are correct but the answer lacks some of the nuanced understanding of how PayPal's risk posture and disclosure evolved across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 441,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell sharply: net crude‑oil production dropped from 17 MBD in 2022 to 15 MBD in 2023 and to 4 MBD in 2024, while natural‑gas output fell from 94 MMCFD in 2022 to 87 MMCFD in 2023 and to 22 MMCFD in 2024 (Net Production tables, page 9 of the 2023 and 2024 10‑Ks). This decline reflects Chevron’s strategic exit from Myanmar, announced in January 2022, and its shift away from that market toward other regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding 2024 production volumes. Ground truth states Chevron completely withdrew from Myanmar in April 2024, implying zero production by end of 2024. However, the LLM claims crude oil production was 4 MBD in 2024 and natural gas was 22 MMCFD in 2024. These figures contradict the complete withdrawal claim and the ground truth. The 2022-2023 crude oil figures (17 MBD to 15 MBD) are correct, but the 2024 data is fundamentally wrong. PARTIAL CREDIT FOR NATURAL GAS DATA: The LLM provides natural gas production figures (94 MMCFD in 2022, 87 MMCFD in 2023, 22 MMCFD in 2024) that are not mentioned in the ground truth, making verification impossible. These appear to be fabricated or from unreliable sources. STRATEGIC NARRATIVE ISSUES: The LLM correctly identifies the strategic exit but incorrectly dates the announcement to January 2022 (ground truth does not specify this date). The claim of 'shift away from that market toward other regions' is vague and not substantiated by the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize production data with strategic intent, but the quantitative errors undermine the entire analysis. The complete withdrawal in April 2024 should result in zero or near-zero production for that year, not 4 MBD crude and 22 MMCFD gas. COMPLETENESS: The answer addresses the evolution question but fails on accuracy. It does identify the strategic shift (portfolio optimization/risk management) but with incorrect supporting data. The citation to 'Net Production tables, page 9' cannot be verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 458,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & Notebooks was the second‑largest sector within TI’s Personal Electronics market in 2022 and 2023, making up a substantial share of the 15 % of TI revenue from that market (page_5 of 2022; page_5 of 2023). By 2024, PC & Notebooks had slipped to seventh in the sector ranking, while Personal Electronics grew to 20 % of TI revenue (page_5 of 2024). This decline in relative importance signals TI’s strategic shift away from traditional PC & Notebook sales toward higher‑growth consumer‑computing segments such as infotainment, automotive and mobile phones.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM contains a critical factual error regarding 2022 data. The ground truth states Personal Electronics was 24% of TI revenue in 2022, but the LLM claims it was 15% in 2022 (stating '15% of TI revenue from that market (page_5 of 2022)'). This is a significant discrepancy. The LLM correctly identifies 2023 as 15% and 2024 as 20%, but the 2022 figure is fundamentally wrong. (2) ENTITY/RANKING ACCURACY - The LLM claims PC & Notebooks was 'second-largest sector' in 2022 and 2023, but provides no supporting evidence and this contradicts the ground truth which doesn't specify ranking positions for those years. The claim that PC & Notebooks 'slipped to seventh' in 2024 is not mentioned in the ground truth. (3) MULTI-HOP REASONING - The LLM attempts to synthesize the trend but does so from incorrect baseline data. The conclusion about strategic shift is directionally similar to ground truth but is built on faulty premises. (4) COMPLETENESS - The LLM addresses the evolution question but misses the accurate 2022 baseline (24%), which is crucial for understanding the full trend. The ground truth shows: 24% (2022) → 15% (2023) → 20% (2024), while LLM implies: 15% (2022) → 15% (2023) → 20% (2024). (5) STRATEGIC INTERPRETATION - The LLM's conclusion about shift toward 'infotainment, automotive and mobile phones' partially aligns with ground truth's mention of 'Automotive and Industrial markets' but adds 'infotainment' which isn't in the ground truth. The reasoning quality is compromised by the incorrect starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 435,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "General Motors’ 2022, 2023 and 2024 10‑Ks all state that the indemnification obligations to Stellantis – arising from the 2017 sale of the Opel/Vauxhall business – are “subject to time limitations, thresholds and/or caps” and that the company “is unable to estimate any reasonably possible material loss or range of loss that may result from these actions either directly or through an indemnification claim from Stellantis”【page_90】【page_93】【page_93】.  In each year the company notes only an “immaterial amount” for recalls that Stellantis has conducted or will conduct (including Takata‑inflator recalls) and reiterates that any further indemnification is considered remote, with no material accruals or new liabilities disclosed【page_90】【page_93】【page_93】.  Thus, from 2022 through 2024 GM’s indemnification exposure to Stellantis remained essentially unchanged, with no material accruals or significant potential future exposure identified.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and misses key evolution details that distinguish it from the ground truth. CRITICAL ISSUES: (1) The LLM claims indemnification obligations 'remained essentially unchanged' from 2022-2024, which directly contradicts the ground truth showing clear evolution and increasing specificity. (2) The LLM completely omits the 2024 disclosure of accruals related to the European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era - this is a material addition to the narrative that represents emerging regulatory risk exposure. (3) The LLM fails to capture the progression from 'no specific indemnification accruals or liabilities disclosed' in 2022 to specific regulatory investigations and accruals by 2024. (4) While the LLM correctly notes that amounts are 'immaterial' and future losses are 'remote,' it misses the key insight that the NATURE and SPECIFICITY of obligations evolved significantly, with regulatory investigations becoming a concrete liability factor by 2024. CORRECT ELEMENTS: The LLM accurately identifies that obligations are subject to time limitations, thresholds and caps; correctly notes the inability to estimate reasonably possible material losses; accurately states that Takata-related recalls are considered remote; and correctly characterizes amounts as immaterial. However, these correct elements are presented in a framework that fundamentally mischaracterizes the trend as 'essentially unchanged' when the ground truth shows increasing specificity and emerging regulatory risk exposure. The answer fails the multi-hop synthesis requirement by not properly tracking how the nature of disclosed obligations evolved across the three-year period, particularly the emergence of specific regulatory investigations by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 495,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower issued the 1.450% Senior Notes due 2026 in a supplemental indenture dated September 27, 2021 (see page 70).  No additional 1.450% Senior Notes due 2026 appear in the 2022, 2023 or 2024 filings, indicating the company’s preference for a few large, long‑term tranches and a disciplined, low‑coupon debt strategy rather than frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.450% Senior Notes due 2026 and the September 27, 2021 date, which matches the ground truth. However, there are significant issues with completeness and reasoning: (1) CORRECT ELEMENTS: The date (September 27, 2021) and coupon rate (1.450%) are accurate. The identification of the notes as part of a long-term debt strategy is reasonable. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states the notes were 'consistently referenced across all three years—2022, 2023, and 2024' with specific exhibit references (Exhibit 4.25 in 2022, 4.22 in 2023, 4.21 in 2024). The LLM answer claims 'No additional 1.450% Senior Notes due 2026 appear in the 2022, 2023 or 2024 filings,' which misses the critical point that the SAME notes were continuously referenced across all three years, not absent. This is a fundamental misunderstanding of the multi-hop question. (3) REASONING FLAW: The LLM's conclusion about 'preference for a few large, long-term tranches' is speculative and not directly supported by the ground truth, which emphasizes continuity and stability of the same instrument across years. The LLM conflates 'no new issuances' with 'no references,' which are different concepts. (4) MISSING CONTEXT: The ground truth emphasizes the consistent documentation structure (Supplemental Indenture No. 10) and the deliberate, stable debt management strategy. The LLM answer fails to capture this key insight about the evolution pattern across the three years. The answer partially addresses the question but misses the core multi-hop synthesis requirement of tracking how the same notes remained active across 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 455,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan remained the core framework for executive awards, and each year from 2022 through 2024 the company added new deferred‑stock and performance‑share agreements that reference that plan.  In 2022 it filed a 2022 Form of Performance Share Unit Agreement (Exhibit 10.21) and a 2022 Form of Restricted Stock Unit Agreement (Exhibit 10.22) [page 18]; in 2023 it filed a 2023 Form of Performance Share Unit Agreement (Exhibit 10.23) and a 2023 Form of Restricted Stock Unit Agreement (Exhibit 10.24) [page 19]; and in 2024 it filed a 2024 Form of Performance Share Unit Agreement (Exhibit 10.25) and a 2024 Form of Restricted Stock Unit Agreement (Exhibit 10.26) [page 20].  These successive agreements illustrate the company’s continued use of the 2019 LTI Plan to award deferred equity and performance‑based shares each year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG FORMS IN 2022: The LLM states the company filed '2022 Form of Performance Share Unit Agreement' and '2022 Form of Restricted Stock Unit Agreement' in 2022, but the ground truth indicates it was the '2019 Form of Performance Share Unit Agreement' and '2019 Form of Restricted Stock Unit Agreement' in 2022. (2) MISSING CRITICAL 2023 DETAIL: The ground truth specifically mentions the introduction of the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' in 2023, which is a director-specific instrument. The LLM completely omits this important distinction and instead lists generic 2023 forms. (3) WRONG FORMS IN 2023-2024: The LLM claims 2023 and 2024 forms were filed in those respective years (2023 Form PSU, 2024 Form PSU, etc.), but the ground truth indicates that by 2024, the company incorporated '2022 Form of Performance Share Unit Agreement' - not a 2024 form. This suggests the LLM fabricated exhibit numbers and form dates that don't match the actual filing progression. (4) MISSING STRATEGIC CONTEXT: The ground truth emphasizes the expansion to director-level compensation in 2023 and the refinement/evolution of forms over time. The LLM provides a superficial year-by-year listing without capturing this strategic evolution. (5) EXHIBIT CITATIONS: The LLM provides specific exhibit numbers (10.21, 10.22, etc.) and page numbers that cannot be verified against the ground truth and appear to be fabricated. The ground truth does not provide these specific exhibit citations. The LLM answer fundamentally misrepresents the timeline and nature of the forms introduced each year, making it factually incorrect on the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 483,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics’ Combat Systems segment has consistently highlighted OTS’s role in supplying critical aerostructures for both legacy and next‑generation missiles—including hypersonic rocket cases—across 2022‑24 (2022 page 12; 2023 page 12; 2024 page 12).  Over the three years the company expanded its metal‑parts and propellant production capacities (2023 page 12; 2024 page 12), scaling the volume of aerostructured components it can deliver.  This steady focus and capacity growth signals GD’s deliberate positioning as a key aerostructure supplier for next‑generation missile subsystems, aligning with the DoD’s emphasis on hypersonic and advanced missile technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the key revenue percentage metrics that are central to the ground truth answer. The ground truth explicitly states Combat Systems was 20% of consolidated revenue in 2023 and declined to 19% in 2024—these are crucial quantitative data points that directly answer the question about 'strategic positioning' trends. The LLM provides no revenue share data whatsoever. (2) ENTITY CONFUSION: The LLM introduces 'OTS' (apparently Orbital Tracking Systems or similar) without clear explanation of what this entity is or its relationship to General Dynamics' Combat Systems segment. The ground truth makes no mention of 'OTS' as a distinct entity. This creates ambiguity about whether the LLM is discussing GD's internal operations or a subsidiary/supplier relationship. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks what the 3-year trend 'reveals about strategic positioning.' The ground truth answers this by showing: (a) consistent focus on aerostructures, (b) explicit mention in all three years, (c) slight revenue share decline (20%→19%), and (d) conclusion about 'sustained positioning despite fluctuations.' The LLM addresses capacity expansion and product focus but misses the revenue share trend analysis entirely. (4) WHAT WAS CORRECT: The LLM correctly identifies the 2022-2024 timeframe, correctly notes consistent focus on aerostructures for next-generation missiles, and appropriately mentions hypersonic applications and DoD alignment. The reference to page numbers (page 12 across years) suggests proper source documentation. (5) MISSING CRITICAL DATA: The LLM should have included the 20% (2023) and 19% (2024) revenue percentages to properly address the 'trend' aspect of the question. Without these metrics, the answer is incomplete for a financial analysis question. The capacity expansion information, while relevant, does not substitute for the missing revenue share analysis that forms the core of understanding strategic positioning changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 551,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "PMI has consistently described Jackpot as an **“important local cigarette brand” in the Philippines** in its 2022, 2023 and 2024 10‑K filings (page 5 of each year).  The wording and emphasis did not change, indicating that the brand remains a stable, low‑price local asset that supports PMI’s broader regional strategy of maintaining a balanced mix of international and local brands to capture market share in price‑sensitive markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Jackpot was mentioned consistently across 2022, 2023, and 2024 10-K filings as an important local cigarette brand in the Philippines. The core factual claim about consistent positioning across three years aligns with the ground truth. The LLM appropriately notes the brand's role in a balanced portfolio strategy for price-sensitive markets.\n\nWEAKNESSES: (1) The LLM provides specific page references ('page 5 of each year') without verification that these are accurate - this is a potential factual claim that cannot be validated and weakens credibility. (2) The LLM characterizes Jackpot as 'low-price' without explicit support from the ground truth, which only mentions it as a 'local' brand. This is an inference not directly supported by the provided ground truth. (3) The LLM omits important context from the ground truth: the mention of Fortune as a companion local brand, the 2023 reference to 'broader global restructuring and integration of Swedish Match,' and the 2024 context about PMI's expansion to 95 markets with smoke-free products and emphasis on IQOS and ZYN. (4) The LLM's answer is less comprehensive in addressing the 'multi-year progression' aspect - it notes consistency but doesn't capture the nuance that PMI maintained Jackpot despite broader strategic shifts toward smoke-free products. (5) The phrase 'wording and emphasis did not change' is presented as fact but the ground truth doesn't explicitly confirm identical wording across all three years.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years to identify a pattern (consistent positioning), which is appropriate for the question. However, it misses the deeper synthesis about how this consistency relates to PMI's broader strategic evolution (smoke-free expansion, Swedish Match integration, market diversification).\n\nSEMANTIC EQUIVALENCE: The core message about Jackpot's stable, strategic role is semantically equivalent to the ground truth, but the LLM's answer is narrower and less contextually rich than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 562,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "Chevron had no reported capital deployment or asset disposition in the Republic of Congo in 2022 (10‑K, p. 31). In 2023 the company invested roughly $0.7 billion in offshore development and natural‑gas projects in Nigeria, Angola and the Republic of Congo, underscoring a development focus (10‑K, p. 109). By 2024, Chevron announced the divestiture of its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi project, signaling a shift away from that asset (10‑K, p. 43).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the key financial figures and asset disposition details. Correct elements: (1) The $0.7 billion investment figure for 2023 in offshore development and natural gas projects in Africa (including Republic of Congo) is accurate; (2) The 31.5% nonoperated working interest in Haute Mer permit area divestiture is correct; (3) The 15.75% interest in Lianzi project divestiture is correct; (4) The timing of the divestiture announcement in 2024 (with January 2025 execution) is appropriately captured. However, there are notable issues: (1) The claim that Chevron had 'no reported capital deployment or asset disposition in the Republic of Congo in 2022' contradicts the ground truth, which states the Republic of Congo was 'listed as one of its key operational areas, signaling ongoing presence and strategic importance' in 2022. The LLM's statement is too absolute and misses the operational continuity aspect; (2) The LLM specifies Nigeria and Angola alongside Republic of Congo for the 2023 investment, which adds geographic specificity not explicitly contradicted but represents a narrower interpretation than the ground truth's broader 'Africa' framing; (3) The LLM correctly identifies the 3-year trajectory shift from operations to divestiture, though it frames 2022 as having 'no reported' activity rather than acknowledging ongoing operational presence. The multi-hop reasoning is sound in connecting the 2023 investment to the 2024 divestiture decision, showing strategic evolution. The answer is largely correct on quantitative metrics but slightly incomplete on the qualitative assessment of 2022 operational status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 458,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Between 2022 and 2024, Southern Company shifted from recording no lease income from outdoor‑lighting contracts to recognizing $136 million in operating‑lease income, indicating that the contracts had become material to the company (page_232). The contracts retain initial terms of up to 10 years with month‑to‑month renewal, and the payment structure now includes both scheduled lease payments and $417 million in variable lease income, whereas in 2022 Southern Company had none (page_232, page_240). Across subsidiaries, lease income for Alabama Power, Georgia Power, Mississippi Power, Southern Power, and Southern Company Gas also changed, but the undiscounted cash flows for Georgia Power and Mississippi Power remained immaterial (page_233).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Southern Company recognized '$136 million in operating-lease income' and '$417 million in variable lease income' - these specific dollar amounts are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth makes no reference to these specific financial figures. (2) MATERIALITY CONTRADICTION: The LLM states contracts 'had become material to the company' by 2024, but the ground truth explicitly states that 'undisclosed cash flows for Georgia Power and Mississippi Power remained immaterial' in 2024, directly contradicting the LLM's claim of materiality. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that disclosure expanded from 2022 to 2024 and mentions multiple subsidiaries (Alabama Power, Georgia Power, Mississippi Power, Southern Power), it fails to accurately capture the ground truth's core finding: the shift was primarily about DISCLOSURE TRANSPARENCY and STANDARDIZATION, not about materiality changes or specific revenue amounts. (4) STRUCTURAL ACCURACY: The LLM correctly identifies the lease structure elements (initial terms, renewal provisions) but presents them as new information when the ground truth focuses on disclosure evolution. (5) MISSING CONTEXT: The LLM misses the key insight that in 2022 contracts were 'immaterial with no significant value disclosed,' then in 2023 became part of maturity analyses, and by 2024 were standardized across subsidiaries - this is a disclosure/transparency story, not a materiality/revenue recognition story. The page references (232, 240, 233) cannot be verified against the ground truth provided. The answer demonstrates partial understanding of the multi-hop nature of the question but introduces unsupported financial figures that significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 526,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "In FY 2022 the 3.50% senior note carried $500 million with an effective rate of 3.20 %; in FY 2023 the carrying amount stayed at $500 million while the effective rate rose to 6.38 %; and in FY 2024 it remained $500 million with an effective rate of 6.66 %. The unchanged carrying amount shows the note was not redeemed or amortized, whereas the sharp rise in effective rate reflects a steep increase in market interest rates, indicating higher borrowing costs and a tightening of credit conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $500 million carrying amount across all three years (FY2022, FY2023, FY2024), effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. COMPLETENESS: The answer addresses all required elements - the evolution of carrying amount, the progression of effective interest rates across the three-year period, and interpretation of what this indicates about debt valuation and market conditions. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note (described as 'senior note'), and all three fiscal years. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the pattern - stable carrying amount indicating no redemption/amortization, combined with rising effective rates reflecting market conditions. INTERPRETATION: The LLM's explanation that the unchanged carrying amount shows the note was not redeemed or amortized is accurate and insightful. The interpretation that rising effective rates reflect increased market interest rates and tightening credit conditions is a reasonable and sound inference from the data pattern. MINOR DISTINCTION: The ground truth uses more neutral language ('shift in market conditions or internal risk assessments'), while the LLM provides a more specific interpretation ('steep increase in market interest rates, indicating higher borrowing costs and tightening of credit conditions'). Both interpretations are valid and consistent with the data, though the LLM's is slightly more specific. The LLM answer is semantically equivalent to the ground truth and provides equally valid analytical insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 484,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s Unsecured Notes – 35A has remained unchanged across the three filings: a face amount of $750,000, an interest rate of 2.65 %, and a maturity of July 15 2030, with annual debt service consistently $19,875 (2022 10‑K page 50; 2023 10‑K page 50; 2024 10‑K page 51). This static profile shows that SPG is deliberately maintaining a low‑cost, long‑term debt instrument rather than refinancing or issuing new notes, underscoring a conservative, stability‑focused debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR QUANTITATIVE ERROR: The LLM states the face amount is $750,000 (seven hundred fifty thousand dollars), but the ground truth clearly indicates $750 MILLION. This is a 1,000x magnitude error that fundamentally misrepresents the debt exposure. The correct figure is $750,000,000 or $750 million. (2) CALCULATION ERROR: The LLM claims 'annual debt service consistently $19,875' - this appears to be derived from $750,000 × 2.65%, which would only be correct if the face amount were actually $750,000. With the correct $750 million face value, annual interest would be approximately $19.875 million (or $19,875,000), not $19,875. This calculation error compounds the initial magnitude error. (3) INCOMPLETE CONTEXT: While the LLM correctly identifies the interest rate (2.65%), maturity date (July 15, 2030), and consistency across years, it fails to address the broader debt management strategy context mentioned in the ground truth. The ground truth notes that this stability 'contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities.' The LLM's statement that SPG is 'deliberately maintaining a low-cost, long-term debt instrument rather than refinancing or issuing new notes' actually contradicts the ground truth, which indicates they ARE issuing new notes alongside maintaining this instrument. (4) REASONING FLAW: The LLM's conclusion about a 'conservative, stability-focused debt-management strategy' is partially correct but incomplete - the ground truth reveals a more nuanced strategy of maintaining stable instruments WHILE selectively refinancing and adding new debt. The LLM's answer demonstrates a fundamental misunderstanding of the magnitude of the debt exposure and provides an incomplete picture of the company's actual debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 517,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products at the heart of its “analog + embedded processing” strategy and lists them as part of the broad‑portfolio advantage (b) in the four sustainable competitive advantages in each MD&A (2022 p. 21; 2023 p. 18‑19; 2024 p. 18‑19).  However, the segment’s revenue fell from $3.26 billion in 2022 to $2.53 billion in 2024 and operating profit dropped from $1.25 billion to $352 million (segment tables p. 20 of 2022, 2023, 2024), indicating that the company is facing headwinds in that area even as it continues to invest in R&D and capital expenditures to shore up the advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Embedded Processing Products are listed as part of the broad-portfolio advantage (advantage b) in TI's four sustainable competitive advantages across 2022-2024, and correctly cites the MD&A page references. The qualitative assessment that the strategic framing remained consistent is accurate and aligns with the ground truth. However, there are significant quantitative accuracy issues: (1) The LLM provides specific revenue and operating profit figures ($3.26B to $2.53B revenue; $1.25B to $352M operating profit) that cannot be verified against the ground truth, which does not provide these specific numbers. (2) The ground truth emphasizes the consistent language about 'more opportunity per customer and more value for our investments' being repeated identically across all three years - the LLM does not mention this key qualitative consistency. (3) The LLM introduces financial performance data (segment revenue decline, operating profit decline) that, while potentially accurate from the filings, goes beyond what the ground truth addresses and shifts the focus from strategic emphasis evolution to financial headwinds. The ground truth focuses on the stability and consistency of strategic messaging, while the LLM pivots to performance metrics. The LLM answer is partially correct in identifying the positioning of Embedded Processing within the competitive advantages framework, but it diverges from the ground truth's core finding about consistent strategic messaging and adds unverified financial data. The answer addresses the question but with a different emphasis and introduces numbers that lack ground truth validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 458,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "In 2022, CMCSA offered domestic shared‑data plans alongside unlimited and per‑gigabyte options, while international customers were limited to gigabyte plans [page_5][page_6][page_7][page_8][page_9], and the 2023 filing shows no change to this mix [page_3][page_4][page_5][page_6][page_7]. By 2024, the company broadened plan flexibility by adding prepaid unlimited data plans under the NOW brand for domestic customers and giving international customers an unlimited data option, while expanding its international wireless footprint to the United Kingdom (and Italy) via third‑party and its own mobile core network [page_3][page_5][page_6][page_7].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - 2022 characterization: LLM claims CMCSA offered domestic shared-data plans alongside unlimited and per-gigabyte options in 2022. Ground truth states shared data plans were offered EXCLUSIVELY as part of bundled service offerings to residential customers with broadband subscriptions. The LLM incorrectly suggests unlimited and per-gigabyte options existed in 2022.\n   - International expansion timing: LLM claims international customers had gigabyte plans in 2022 and received unlimited options by 2024. Ground truth makes no mention of international offerings in 2022, only that 2024 saw international expansion.\n   - Geographic specificity: LLM mentions UK and Italy specifically, but ground truth only references international expansion without naming specific countries.\n\n2. INCOMPLETE/MISSING INFORMATION:\n   - LLM fails to clearly establish that 2023 maintained the bundled structure with emphasis on flexibility (unlimited, shared, or per-gigabyte choices).\n   - LLM doesn't clearly articulate that the NOW brand prepaid unlimited plans were a 2024 innovation.\n   - The progression of plan flexibility is muddled in the LLM answer.\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM attempts to synthesize information across three years but mischaracterizes the 2022 baseline, which undermines the entire evolution narrative.\n   - The connection between domestic and international offerings is unclear and potentially inaccurate.\n\n4. SEMANTIC PROBLEMS:\n   - The LLM's statement about 2022 offerings contradicts the ground truth's explicit statement about exclusivity of shared data plans in bundled offerings.\n   - The framing suggests a different product evolution than what the ground truth indicates.\n\n5. CITATION ISSUES:\n   - While the LLM provides page references, the actual content cited appears to contradict the ground truth, suggesting either misinterpretation of source material or hallucinated citations.\n\nThe answer gets some elements right (NOW brand in 2024, international expansion, prepaid unlimited plans) but fundamentally mischaracterizes the 2022 baseline and the nature of the evolution, making the overall narrative incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 613,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "PayPal’s risk disclosures show a clear escalation of abusive‑behaviour exposure as its credit‑product portfolio and reliance on third‑party lenders have grown. In 2022 the company warned that third parties could abuse its platform and that its credit products added risk (page_27). By 2023 the filings added detail on credit‑risk models and the risk of default and fraud from those third‑party lenders (page_27). In 2024 the disclosures further stressed the complexity of fraud detection, the need for continuous improvement, and the expanding dependence on third‑party lenders—underscoring a more intricate risk landscape in its digital‑payments ecosystem (page_21).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the general progression of PayPal's risk exposure from 2022-2024 and appropriately emphasizes the increasing complexity of fraud detection and third-party lender dependence. The semantic framing of escalating sophistication in abusive behaviors aligns with the ground truth narrative. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The LLM completely omits the €40 billion BNPL loan receivables agreement mentioned in the ground truth as a crucial 2023 development. This is a major factual omission that significantly impacts the completeness of the answer. (2) VAGUE SPECIFICITY: While the ground truth provides concrete examples (fictitious account creation, stolen financial instruments, account takeovers, synthetic identity fraud), the LLM uses generic language like 'complexity of fraud detection' without citing specific fraud tactics. (3) MISSING LEGAL CONTEXT: The ground truth mentions 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' in 2024—a significant regulatory/legal development that the LLM fails to address. (4) PAGE REFERENCES: The LLM cites page numbers (page_27, page_21) but provides no substantive detail from those pages, making the citations appear superficial. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks what the progression 'indicates about the growing complexity of risk management'—the LLM touches on this but doesn't synthesize the specific evolution pathway as comprehensively as the ground truth (from basic fraud detection → large-scale loan portfolio exposure → sophisticated synthetic identity fraud + legal uncertainty). The answer reads as a general summary rather than a detailed multi-hop analysis connecting specific risk developments across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 493,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "Gilead’s 2023 10‑K (page 11) and 2024 10‑K (page 10) both describe the El Segundo, California site as the company’s hub for **clinical and commercial manufacturing and processing of its cell‑therapy products**.  The consistent wording shows that the facility’s role has broadened from purely clinical work to include commercial production, reflecting ongoing investment in its cell‑therapy manufacturing capacity.  The 2022 10‑K pages provided do not contain a facility‑specific description, so the filings indicate continuity rather than a major change in use or new capital projects for El Segundo during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies El Segundo as a key facility for cell therapy manufacturing and accurately cites the 2023 and 2024 10-K filings. However, there are significant gaps in addressing the full scope of the question:\n\n(1) WHAT WAS CORRECT:\n- Correctly identifies El Segundo as a clinical and commercial manufacturing facility for cell therapy products\n- Accurately cites 2023 and 2024 10-K pages (11 and 10 respectively)\n- Correctly notes the consistent wording across filings\n- Properly identifies the facility's role in both clinical and commercial production\n\n(2) WHAT WAS INCOMPLETE/INCORRECT:\n- The LLM states '2022 10-K pages provided do not contain a facility-specific description,' but the ground truth explicitly states that in 2022, GILD identified El Segundo as a principal manufacturing facility for clinical and commercial manufacturing of cell therapy products. This is a factual error - the 2022 data should have been available and analyzed.\n- The LLM fails to address the 2022 baseline, which is critical for evaluating how utilization 'evolved from 2022 through 2024'\n- Missing discussion of other facilities mentioned in ground truth (Santa Monica, Frederick) that provide context for El Segundo's role\n- Does not address 'strategic facility investments' mentioned in the question\n- Does not discuss facility ownership/lease arrangements or third-party manufacturers mentioned in ground truth as part of 2024 context\n- The claim of 'continuity rather than a major change' is correct but undersupported by missing 2022 analysis\n\n(3) MULTI-HOP REASONING:\nThe LLM only synthesizes 2023-2024 data, failing to complete the three-year analysis required. The multi-hop synthesis is incomplete because it omits the 2022 starting point, which is essential for evaluating evolution over the period.\n\n(4) JUSTIFICATION:\nWhile the LLM correctly identifies the facility's role in 2023-2024, it fails to provide the complete three-year evolution requested. The statement about 2022 data not being provided appears to be an excuse rather than a limitation, as the ground truth clearly shows 2022 information was available. This represents a significant gap in addressing the full scope of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 598,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "The 2.750% Senior Notes first appeared in Costco’s 2022 10‑K (Exhibit 4.6) as notes due May 18 2024, and the same maturity is listed in the 2023 and 2024 filings (Exhibit 4.6 on each year’s page 66).  The unchanged maturity shows Costco has kept a predictable, long‑term debt profile and has avoided frequent refinancing, underscoring a conservative debt‑management strategy focused on stable cash‑flow planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. STRENGTHS: (1) All quantitative data is correct - the maturity date of May 18, 2024 is accurately cited across all three years (2022, 2023, 2024), and the interest rate of 2.750% is correctly identified. (2) The multi-hop synthesis is sound - the answer correctly traces the notes across three separate filings and identifies the consistency pattern. (3) The exhibit references (Exhibit 4.6) and page numbers (page 66) are appropriately cited, demonstrating proper source documentation. (4) The interpretation of debt management strategy is logically sound - the unchanged maturity across years does indeed suggest a static, predictable approach without refinancing. (5) The semantic meaning matches the ground truth: both convey that the notes remained unchanged with a fixed May 18, 2024 maturity date, and both characterize this as reflecting a conservative, stable debt management approach. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing ('long-term debt profile' vs 'static approach to this specific debt instrument') but these are semantically equivalent. (2) The LLM answer emphasizes 'stable cash-flow planning' while the ground truth emphasizes 'predictable debt repayment' - both are valid interpretations of the same underlying strategy. (3) The LLM answer is slightly more concise than the ground truth but captures all essential information. No factual errors, calculation errors, or entity misidentifications detected. The answer fully addresses the multi-part question about maturity structure evolution and debt management strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 456,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of Angola LNG natural‑gas production was 49 MMCF day in 2022, fell to 48 MMCF day in 2023, and stayed at 48 MMCF day in 2024. The modest decline shows a stable but not expanding gas output in Africa, indicating Chevron is maintaining its existing Angola production while focusing growth elsewhere or managing natural decline.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and critical errors across all dimensions: (1) QUANTITATIVE ACCURACY - SEVERELY INCORRECT: The LLM reports Angola LNG production as 49 MMCF/day (2022), 48 MMCF/day (2023), and 48 MMCF/day (2024). The ground truth shows 7,107 MMCF/day (2022), 7,148 MMCF/day (2023), and 7,569 MMCF/day (2024). The LLM's numbers are off by a factor of approximately 145x - this is not a minor formatting difference but a catastrophic numerical error. The LLM appears to have confused Chevron's equity share percentage (approximately 49%) with actual production volumes in MMCF/day. (2) DIRECTIONAL TREND - INVERTED: The ground truth shows a clear upward trajectory (7,107 → 7,148 → 7,569), indicating increasing production. The LLM incorrectly reports a declining trend (49 → 48 → 48), which is the opposite direction and contradicts the actual data. (3) STRATEGIC INTERPRETATION - CONTRADICTORY: The ground truth correctly interprets the upward trend as indicating 'strengthening production output' and 'maintained or expanded operational focus.' The LLM's interpretation of 'modest decline' and 'stable but not expanding' is based on the incorrect numbers and reaches the wrong conclusion about Chevron's strategy. (4) ENTITY/METRIC CONFUSION: The LLM appears to have conflated Chevron's ownership stake (49%) with production volumes, a fundamental misunderstanding of the data. (5) MULTI-HOP SYNTHESIS: The question requires synthesizing production data across three years (2022-2024) and interpreting strategic implications. The LLM failed at the first step by providing completely incorrect numbers, making all subsequent analysis invalid. This is a complete failure to answer the question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 469,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from **$651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024** (page 92).  Correspondingly, the related operating‑expense effect shifted from a **$92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024** (page 91).  This trend shows Cisco has expanded its use of total‑return swaps as an economic hedge, converting a previously negative impact into a positive one and demonstrating a proactive strategy to dampen market‑linked volatility in deferred‑compensation costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - the loss of $92 million in FY 2022, gain of $58 million in FY 2023, and gain of $91 million in FY 2024 match the ground truth exactly. The notional exposure figures ($651M, $792M, $985M) are also accurate and provide additional context not explicitly in the ground truth but consistent with it. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and connects the notional exposure amounts to the operating expense effects, demonstrating proper multi-hop reasoning. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metrics (Total Return Swaps-Deferred Compensation, operating expense effects) are properly identified. REASONING QUALITY: The interpretation is sound - the answer correctly identifies the trajectory from loss to gains and appropriately characterizes this as indicating improved market conditions or strategic management. The phrase 'economic hedge' and 'dampen market-linked volatility' are semantically equivalent to the ground truth's characterization of 'transformation from net liability to net benefit.' MINOR CONSIDERATIONS: The LLM provides additional detail (notional exposure amounts and page references) beyond the ground truth, which enhances rather than detracts from the answer. The wording 'proactive strategy to dampen market-linked volatility' is a reasonable interpretation of the ground truth's 'strategic shift in how Cisco manages its deferred compensation obligations.' All core facts, calculations, and conclusions are accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 465,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "Lowe’s supplier‑sustainability framework grew steadily from 2022 to 2024. In 2022 the company relied on its human‑rights policy, conflict‑minerals policy and Vendor Code of Conduct to set environmental and human‑rights standards for suppliers (page_9_2022). By 2023 it updated its wood‑sourcing policy to add country‑specific risk levels, enhanced monitoring, and a new forestry grievance process, tightening oversight (page_9_2023). In 2024 Lowe’s expanded its supplier‑sustainability toolkit by increasing independently certified product offerings—such as ENERGY STAR and WaterSense—and continued to monitor supplier practices, reinforcing its commitment to environmental and human‑rights standards (page_9_2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 evolution of Lowe's supplier practices. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and the progression of policies; (2) Accurately captures key 2022 elements: human rights policy, conflict minerals policy, and Vendor Code of Conduct; (3) Correctly notes 2023 updates: country-specific risk levels, enhanced monitoring, and forestry grievance process; (4) Properly identifies 2024 enhancements: independently certified products (ENERGY STAR, WaterSense) and continued monitoring; (5) Appropriately synthesizes multi-hop information across three years showing evolution; (6) Includes source citations (page references) showing document traceability. MINOR GAPS: (1) The LLM answer mentions 'conflict minerals policy' in 2022, which is not explicitly mentioned in the ground truth (though not contradicted); (2) The ground truth emphasizes 'wood sourcing policy' more prominently in 2022, while the LLM answer focuses more on the broader framework; (3) The ground truth specifically mentions 'well-managed, non-endangered forests' language for 2022 wood sourcing, which the LLM omits; (4) The ground truth emphasizes 'risk-based framework' language for 2024, while LLM uses 'toolkit' terminology. QUANTITATIVE ACCURACY: No numerical errors detected; dates and years are all correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution across three years and identifies the progression from foundational policies to enhanced monitoring to expanded certifications. The multi-hop synthesis is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question (policy updates, monitoring enhancements, third-party certifications) and shows the evolution clearly. The answer is well-structured and appropriately detailed for the question scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 514,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 to 2024, CMCSA’s broadband and wireless services faced a growing threat from wireless telecoms that expanded their technology mix to include 4G, 5G, and fixed‑wireless broadband while also deploying fiber and satellite options. The threat intensified as competitors such as AT&T, Verizon, Frontier, Lumen, BT and Virgin Media began bundling broadband/wireless plans with unlimited data and DTC streaming services, offering lower‑priced or free streaming tiers to lure customers. By 2024, the filings highlighted that these bundled offerings—often tied to unlimited data usage and integrated streaming—were a key competitive pressure, with wireless carriers leveraging 5G fixed‑wireless and fiber to undercut CMCSA’s pricing and service packages.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) Correctly identifies the 2022-2024 timeframe and intensifying competitive threat; (2) Accurately names AT&T, T-Mobile, and Verizon as major wireless competitors; (3) Correctly identifies 4G, 5G, and fixed wireless as key technologies; (4) Accurately describes bundling strategies with DTC streaming services as a competitive tool; (5) Correctly notes the evolution from 2022 (4G/5G threat) through 2024 (bundling emphasis). PROBLEMATIC ELEMENTS: (1) INTRODUCES UNSUPPORTED COMPETITORS: The LLM names Frontier, Lumen, BT, and Virgin Media as competitors to CMCSA's broadband/wireless services. The ground truth does not mention these companies in this context. While some may be legitimate competitors in certain markets, the ground truth specifically names only AT&T, T-Mobile, and Verizon as the major wireless competitors highlighted in CMCSA's filings. This represents factual overreach. (2) ADDS UNSUPPORTED TECHNOLOGIES: The LLM mentions 'fiber and satellite options' as part of the competitive threat evolution. The ground truth does not reference satellite as a competitive threat from wireless telecoms in the 2022-2024 period. Fiber is mentioned in the LLM answer but not in the ground truth's description of wireless company strategies. (3) VAGUE CLAIMS: References to 'unlimited data usage' and 'lower-priced or free streaming tiers' lack specific grounding in the ground truth, which focuses on the general bundling strategy without these specific details. MULTI-HOP REASONING: The LLM correctly synthesizes information across the three-year period and identifies the progression of competitive threats. However, the addition of unsupported competitors and technologies suggests the model may have hallucinated details or drawn from general knowledge rather than strictly from the filings. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral. SEMANTIC EQUIVALENCE: The core message about intensifying wireless competition through technology and bundling is preserved, but the introduction of unsupported entities undermines factual accuracy. The answer would score higher if limited to the named competitors (AT&T, T-Mobile, Verizon) and documented technologies (4G, 5G, fixed wireless) from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 639,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s 10‑K notes for 2022, 2023 and 2024 all state that the company is the **principal** on each transaction, sets the fee schedule independently of the cost of any payment‑processor services it uses, and therefore bears the full margin risk (see 2022 pages 80‑82 and 2023‑24 pages 75‑77).  The fee structure remains a mix of fixed and variable (percentage‑of‑transaction) components with a tiered, volume‑based discount that is not a material right (2022 p. 80‑81, 2023 p. 75‑76, 2024 p. 75‑76).  Incentives to merchants and consumers are still treated as revenue reductions or marketing expense, and processor fees are recorded as transaction expense (2022 p. 80‑81, 2023 p. 75‑76, 2024 p. 75‑76).  The unchanged wording over three years shows PayPal has maintained tight control over pricing and cost management, keeping its margin‑risk exposure stable.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes multi-hop information across three years (2022-2024). STRENGTHS: (1) Correctly identifies PayPal as principal on transactions across all three years; (2) Accurately states that PayPal sets fees independently of processor costs and bears full margin risk consistently; (3) Properly cites specific page numbers from 10-K filings (2022 pp. 80-82, 2023-24 pp. 75-77); (4) Correctly notes that incentives are treated as revenue reductions/marketing expense; (5) Accurately states processor fees are recorded as transaction expense; (6) Correctly identifies the fee structure as mixed fixed/variable with tiered volume-based discounts; (7) Sound multi-hop reasoning showing stable margin risk exposure over three years. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 2024 expansion regarding contractual compensation from sellers violating terms (fraud, counterfeiting) that the ground truth identifies as a new revenue stream potentially affecting margin dynamics - this is a notable omission of a specific 2024 development; (2) The answer could have been more explicit about the 2023 expansion of incentive discussions (discounts, rebates, rewards) adding complexity to margin management, though it does mention incentives are treated as revenue reductions; (3) The phrase 'unchanged wording over three years' is slightly imprecise since the ground truth indicates evolving discussions of incentives and new revenue streams, even if the core margin risk stance remained consistent. QUANTITATIVE VERIFICATION: All page number citations appear reasonable and consistent with typical 10-K filing structures. No numerical calculations are required for this question, so quantitative accuracy focuses on proper citation and factual claims, which are sound. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and multiple filing sections, correctly identifying the consistent strategic stance while acknowledging the evolving complexity of incentive structures and cost management. The reasoning that 'unchanged wording shows tight control' is logically sound, though slightly understates the evolution in revenue streams and incentive complexity noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 615,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease accounting policy did not change between FY 2022, FY 2023 and FY 2024.  In each year the company “recognizes free‑rent periods on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise”【2024 page_45】【2023 page_45】【2022 page_45】.  The lease term is defined consistently as the non‑cancelable period plus any options to extend that the Company is reasonably certain to exercise【2024 page_46】【2023 page_46】【2022 page_46】, and the right‑of‑use (ROU) asset is initially measured as the present value of the lease payments (including any free‑rent periods) discounted at the incremental borrowing rate【2024 page_46】【2023 page_46】【2022 page_46】.  Thus, the accounting treatment and disclosure around free‑rent periods, lease‑term assumptions, and the impact on ROU asset valuation remained unchanged across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Costco's lease accounting policy remained consistent across FY 2022, 2023, and 2024 - matching the ground truth assertion of 'stable and consistent approach'; (2) Accurately quotes the straight-line recognition policy for free-rent periods over the original lease term and reasonably certain extension options; (3) Correctly identifies the lease term definition as non-cancelable period plus extension options the company is reasonably certain to exercise; (4) Accurately states that ROU assets are measured as present value of lease payments discounted at incremental borrowing rate; (5) Provides specific page citations (pages 45-46) for each fiscal year, demonstrating multi-hop synthesis across three years of filings; (6) No quantitative errors or incorrect numbers. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth, which also mentions variable lease payments for periodic rent increases based on price indices or sales volume - however, this omission is minor since the question specifically asks about free-rent periods and lease term assumptions, not variable lease payments; (2) The ground truth mentions 'material residual value guarantees or restrictive covenants' which the LLM does not address, but this is tangential to the core question about free-rent periods and ROU asset valuation. The LLM successfully synthesizes information across three fiscal years and correctly identifies the consistency of accounting treatment, which is the primary focus of the question. The answer is factually correct, well-structured, and appropriately detailed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 462,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s exposure to margin risk stayed essentially unchanged from 2022 through 2024: it continued to act as the principal on payment transactions and bear full margin risk (page_77, 2022; page_75, 2023; page_77, 2024).  The company maintained a tiered, volume‑based pricing model and open‑ended, transaction‑level contracts that automatically renew without material rights, and it kept using payment processors with the associated fees recorded as transaction expense (page_77, 2022; page_75, 2023; page_77, 2024).  No material changes to the pricing model, processor usage, or contract structure were disclosed across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that PayPal's core margin risk exposure remained structurally consistent from 2022-2024, with accurate statements about the company acting as principal, bearing full margin risk, maintaining tiered volume-based pricing, and using payment processors with fees as transaction expense. The page citations appear reasonable and the basic facts are accurate. However, the answer has significant gaps in completeness and nuance compared to the ground truth: (1) The LLM completely omits the 2023 change regarding how incentives provided to users were recognized as revenue reductions based on performance targets or amortized over contractual terms—this is a material disclosure change that the ground truth identifies as introducing 'more variability into its margin structure.' (2) The LLM fails to mention the 2024 adoption of new segment reporting disclosures under ASU 2023-07, which the ground truth notes 'increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units.' (3) The LLM's conclusion that 'No material changes...were disclosed' directly contradicts the ground truth's identification of these specific changes, even though the ground truth characterizes them as maintaining 'structural stability' while being 'operationally nuanced.' The LLM answer is too simplistic—it captures the headline that margin risk exposure was stable, but misses the important operational and disclosure evolution that occurred, particularly in 2023 and 2024. The answer addresses the core question but incompletely, missing key multi-hop synthesis elements about how the company's disclosure and operational practices evolved even as the fundamental model remained stable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 479,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90% senior note has remained at a constant $2,000 million outstanding in FY 2022, FY 2023 and FY 2024, with an effective interest rate of 6.11% in each year. The unchanged utilization and stable effective rate indicate that Cisco has kept its exposure to this high‑rate debt steady, reflecting a disciplined long‑term debt strategy and that the financing cost for this portion of debt has remained essentially unchanged over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) QUANTITATIVE ACCURACY: All numeric values are correct - the $2,000 million outstanding balance is accurately stated for all three fiscal years (2022, 2023, 2024), and the 6.11% effective interest rate is correctly reported as constant across the period. No calculation errors present. (2) COMPLETENESS: The answer addresses all key aspects of the question - it covers the utilization (principal amount), effective interest rate, the evolution (or lack thereof) across the three-year period, and provides interpretation of what this indicates about Cisco's debt strategy and financing costs. (3) ENTITY ACCURACY: Cisco is correctly identified, the 5.90% Note is properly referenced, fiscal years 2022-2024 are correct, and the maturity date (February 2039) is implicitly understood through the ground truth context. (4) REASONING: The multi-hop synthesis is sound - the answer correctly identifies that stability in both principal and rate indicates consistent debt management without refinancing, and appropriately characterizes this as reflecting a disciplined long-term debt strategy. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of 'unchanged utilization' and 'stable effective rate' conveys the same meaning as the ground truth's 'maintained without modification.' The phrase 'kept its exposure to this high-rate debt steady' is a reasonable interpretation, though the ground truth doesn't explicitly characterize 6.11% as 'high-rate' - this is a minor interpretive addition that doesn't contradict the facts. Minor deduction: The LLM could have been slightly more explicit about the maturity date (February 2039) for complete context, though this is not essential to answering the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 485,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Lowe’s intellectual‑property disclosures in fiscal 2022 and 2024 both list Kobalt as a private‑brand product name alongside STAINMASTER and allen+roth, using identical wording and context【page_7】【page_7】. This unchanged presentation indicates a steady strategic emphasis on Kobalt as a core private‑brand offering over the period, with no shift or expansion in positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Kobalt was listed as a private brand alongside STAINMASTER and allen+roth in both fiscal 2022 and 2024, and accurately concludes that positioning remained stable with no shift or expansion. However, there are significant completeness issues: (1) The question explicitly asks about evolution 'from fiscal 2022 through fiscal 2024,' requiring analysis of all three years (2022, 2023, and 2024). The LLM answer only addresses 2022 and 2024, completely omitting fiscal 2023 data. The ground truth specifically mentions that 'In fiscal 2023 and 2024, Kobalt retained its position,' indicating fiscal 2023 was analyzed. (2) The LLM answer states 'using identical wording and context' but provides no specific evidence or quotes to support this claim, weakening the analytical rigor. (3) The citation format ['page_7']['page_7'] appears to reference the same page twice, which is suspicious and suggests incomplete source documentation. (4) While the conclusion about 'steady strategic emphasis' and 'no shift or expansion' aligns with the ground truth, the reasoning is incomplete because it fails to systematically address all three fiscal years as requested. The answer demonstrates partial understanding but fails to fully synthesize the multi-hop requirement of analyzing the evolution across the complete three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 379,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 37B has not changed – it carries a 2.25 % coupon, a $700,000 face amount, and matures on January 15 2032. The unchanged, low‑rate, long‑dated debt reflects the company’s preference for stable, predictable long‑term financing rather than frequent refinancing or restructuring.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all quantitative data correct: 2.25% interest rate, $700,000 face amount, and January 15, 2032 maturity date are all accurate. The answer correctly identifies that these terms remained unchanged from 2022 through 2024, which is the core factual requirement. The number formatting is acceptable ($700,000 vs $700 million in ground truth - note: ground truth states $700,000 which appears to be in thousands, making the actual face value $700 million; the LLM correctly uses $700,000). The multi-hop synthesis is sound - the model correctly identified that stability across three years indicates a strategic preference for fixed-rate, long-term financing without restructuring. The reasoning about 'confidence in debt management' and 'favorable market conditions' is semantically equivalent to the LLM's framing of 'preference for stable, predictable long-term financing.' Minor deduction: The LLM answer is slightly less comprehensive than ground truth in explicitly noting that this stability 'reflects confidence in its debt management approach and favorable market conditions,' though the LLM does capture the essence of this through its discussion of stable, predictable financing preferences. The answer fully addresses all parts of the multi-part question regarding interest rate evolution, face amount changes, maturity date consistency, and strategic implications. No calculation errors present. Entity identification (Simon Property Group, Unsecured Notes - 37B) is correct throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 426,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three years, Texas Instruments’ Melaka, Malaysia site remained an **analog‑only** facility with no embedded‑processing activity.  \n- 2022: the property table (page 16) lists “Melaka, Malaysia **” with an X under Analog and none under Embedded Processing.  \n- 2023: the table (page 16) again shows “Melaka, Malaysia *” with an X only under Analog.  \n- 2024: the same table (page 16) lists “Melaka, Malaysia *” with an X under Analog and no Embedded Processing designation.  \n\nThus, the operational footprint in Melaka did not change in terms of segment involvement over 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Melaka, Malaysia remained an analog-only facility across all three years (2022, 2023, 2024) with no Embedded Processing involvement; (2) Accurately cites the property table on page 16 as the source for each year's data; (3) Properly uses the 'X' notation to indicate Analog segment presence and explicitly notes the absence of Embedded Processing designation; (4) Correctly synthesizes the multi-hop information across three fiscal years to reach the conclusion that operational footprint remained stable and unchanged; (5) The reasoning is sound and logically structured, moving chronologically through each year. Minor observation: The LLM uses slightly different notation markers (**, *, *) when referencing the table entries, which may reflect actual footnote variations in the source documents but doesn't affect the core factual accuracy. The answer directly addresses all aspects of the multi-part question: the evolution (or lack thereof) across the three years, the specific business segments involved, and the consistency of the operational focus. The semantic meaning aligns perfectly with the ground truth answer, conveying that Melaka maintained a specialized, stable role exclusively in Analog operations throughout the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 373,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "From 2022 through 2024 PayPal’s outstanding principal on the fixed‑rate 2.850% notes remained unchanged at **$1.5 billion** (see the 2023‑2024 table on page 104 and the 2022‑2023 table on page 107).  The notes mature in 2029, and the company’s future‑principal‑payment schedule (page 104) confirms the $1.5 billion will be due that year.  This steady exposure shows PayPal is maintaining a stable debt mix and maturity profile, rather than expanding its exposure to higher‑rate debt, reflecting a disciplined long‑term debt‑management strategy focused on predictable interest‑rate risk and maturity matching.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All numbers are correct - the $1.5 billion principal amount is accurate for the 2.850% notes across 2022-2024, and the 2029 maturity date is correct. The answer properly cites specific page references (pages 104 and 107) which adds credibility. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the exposure evolved (remained constant at $1.5B), and (2) what this indicates about debt management strategy (disciplined, stable approach). ENTITY ACCURACY: PayPal/PYPL correctly identified, the specific debt instrument (2.850% notes) properly referenced, and the time period (2022-2024) accurately covered. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer synthesizes information about the constant principal amount with the maturity schedule and contrasts this with broader debt management context. The interpretation that stability indicates disciplined management is logical and well-reasoned. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'disciplined long-term debt-management strategy focused on predictable interest-rate risk and maturity matching' is semantically equivalent to the ground truth's statement about 'consistent long-term liability with no principal repayments' and 'maintained its long-term debt structure.' The LLM adds slightly more detail about the maturity schedule and future payment obligations, which enhances rather than detracts from the answer. MINOR CONSIDERATIONS: The ground truth mentions the contrast with retirement of 1.350% notes and introduction of new high-interest notes in 2024, which the LLM answer does not explicitly reference. However, the LLM does acknowledge this implicitly by noting PayPal is 'not expanding its exposure to higher-rate debt,' which captures the essence of this comparison. This is a very minor omission that does not significantly impact the overall quality of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 537,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead has consistently described its Hoofddorp, Netherlands site as a **commercial manufacturing and processing hub for cell‑therapy products**.  In the 2022 10‑K (page 32), the 2023 10‑K (page 11), and the 2024 10‑K (page 10) the facility’s role is unchanged, with no shift to clinical manufacturing or expansion of scope.  This steady use reflects a stable, ongoing position for Hoofddorp within Gilead’s global cell‑therapy manufacturing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Hoofddorp as a commercial manufacturing and processing hub for cell therapy products and accurately cites the relevant 10-K filings (2022, 2023, 2024). However, there are significant issues with the multi-hop synthesis and completeness:\n\n(1) WHAT WAS CORRECT:\n- Correctly identifies Hoofddorp, Netherlands facility\n- Correctly identifies the role as commercial manufacturing and processing of cell therapy products\n- Correctly references the three-year period (2022, 2023, 2024)\n- Correctly notes consistency across the period\n- Page citations appear reasonable (though not verified against actual filings)\n\n(2) WHAT WAS INCORRECT/INCOMPLETE:\n- The LLM answer states the facility's role is \"unchanged\" across all three years, but the ground truth indicates an EVOLUTION: In 2022, Gilead identified it as a \"principal manufacturing facility\" (general designation), while in 2023 and 2024, it was explicitly stated to be utilized for \"commercial manufacturing and processing of cell therapy products\" (specific functional role). This is a meaningful progression from general to specific designation.\n- The LLM answer misses the key insight that the ground truth emphasizes: the progression from identification as principal facility (2022) to explicit commercial cell therapy manufacturing role (2023-2024) represents a \"consistent and growing emphasis\" and \"deepening of its strategic role.\"\n- The answer characterizes the evolution as \"steady use\" and \"stable, ongoing position\" rather than recognizing the progression from general to specific strategic designation.\n\n(3) MULTI-HOP REASONING ASSESSMENT:\n- The LLM failed to properly synthesize the year-by-year evolution described in the ground truth\n- It collapsed the three-year progression into a single static characterization\n- It did not capture the distinction between 2022 (principal facility identification) and 2023-2024 (specific cell therapy manufacturing role)\n\n(4) QUANTITATIVE ACCURACY:\n- No numerical errors in dates or page numbers cited\n- No calculations required\n\n(5) JUSTIFICATION:\nThe answer is partially correct on the basic facts but fundamentally misses the core insight of the question: how the facility's role EVOLVED. The ground truth emphasizes progression and deepening strategic importance, while the LLM answer emphasizes stasis and consistency. This represents a failure in multi-hop synthesis despite getting the basic facts right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 660,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco has consistently classified its 1.375% Senior Notes due June 2027 as long‑term debt, with a carrying amount of $1.25 billion in 2022, 2023, and 2024 (page 52).  The current‑portion of long‑term debt rose from $73 million in 2022 to $799 million in 2023 and then fell sharply to $103 million in 2024, reflecting the repayment of the 2.750% Senior Notes due May 2024; the 1.375% notes themselves were never part of the current portion (page 52).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect current portion amounts for 2023. Ground truth states $1,081 million in 2023, but LLM claims $799 million - a difference of $282 million. This is a significant factual error. (2) CONTRADICTORY CLAIMS - The LLM states 'the 1.375% notes themselves were never part of the current portion' but this directly contradicts the ground truth which explicitly shows the current portion of these notes was $73M (2022), $1,081M (2023), and $103M (2024). The LLM's assertion that these notes were never classified as current portion is factually incorrect. (3) PRINCIPAL AMOUNT - The LLM correctly identifies $1.25 billion ($1,250 million) as the consistent principal amount across all three years, which matches ground truth. (4) MULTI-HOP REASONING - While the LLM attempts to explain the changes through reference to other debt instruments (2.750% Senior Notes due May 2024), it fundamentally mischaracterizes the treatment of the 1.375% notes themselves. The core question asks specifically about how the 1.375% notes evolved in terms of current portion classification, and the LLM's answer directly contradicts the ground truth on this key metric. (5) MISSING CONTEXT - The LLM fails to capture the significant spike to $1,081 million in 2023 and the subsequent drop to $103 million in 2024, which are central to understanding the evolution of these notes' classification. The answer demonstrates a fundamental misunderstanding of the debt composition changes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 430,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "From 2022 through 2024, PayPal’s fixed‑rate 2.850% notes (issued in September 2019 with a 10/1/2029 maturity) stayed unchanged at a principal balance of $1.5 billion and an effective interest rate of 2.96% in each year’s notes schedule. No repayments, redemptions, or new issuances altered that balance, so the company’s long‑term debt mix remained stable. This reflects a strategy of preserving a low‑cost, long‑term debt core while issuing newer, higher‑rate notes to fund other corporate purposes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key quantitative details correct: the $1.5 billion principal balance, 2.850% fixed rate, 2.96% effective interest rate, September 2019 issuance date, and October 1, 2029 maturity date are all accurate. The answer correctly identifies that the obligation remained unchanged across 2022-2024 and accurately characterizes the lack of repayments, redemptions, or new issuances for this specific tranche. The multi-hop synthesis is sound, correctly connecting the debt characteristics across the three-year period. The reasoning about debt management strategy is logically sound and semantically equivalent to the ground truth. However, there is a minor omission: the LLM answer does not explicitly mention that this note was part of a larger $5.0 billion September 2019 issuance, which provides important context about the scale of the original debt issuance. Additionally, while the LLM correctly notes that PayPal issued 'newer, higher-rate notes,' the ground truth more explicitly emphasizes that the company 'prioritized refinancing or issuing new debt with different maturities and rates' while maintaining this particular tranche, which is a slightly more nuanced characterization of the strategy. The LLM's characterization of this as a 'low-cost, long-term debt core' is reasonable but slightly different from the ground truth's emphasis on 'capital structure stability.' These are minor semantic differences rather than factual errors. Overall, the answer is substantially correct and addresses the core question effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 436,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s fair‑value of gas‑related options dropped sharply from $356 million (assets) and $347 million (liabilities) in 2022 to $100 million and $102 million in 2023, and remained at that level in 2024, while the net notional volume of natural‑gas options fell from 1,452 MMBtu in 2023 to 1,131 MMBtu in 2024.  At the same time, the weighted‑average implied volatility used in valuing those Level 3 options rose from 36 % in 2022/23 to 50 % in 2024, indicating that the company is trimming its gas‑option exposure while preparing for higher expected price swings in gas markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) VOLATILITY NUMBERS INCORRECT: The LLM states volatility 'rose from 36% in 2022/23 to 50% in 2024' but ground truth shows: 36% (2022) → 50% (2023) → 52% (2024). The LLM conflates 2022/23 and misses the 52% figure for 2024, fundamentally misrepresenting the volatility trend. (2) LIABILITY FIGURES INCONSISTENT: Ground truth shows 2023 liabilities at $97 million, but LLM states $102 million for 2023. The LLM correctly identifies $102 million for 2024 liabilities, but the 2023 figure is wrong. (3) ASSET FIGURES PARTIALLY CORRECT: The LLM correctly identifies $356M (2022 assets) and $100M (2023-2024 assets). (4) ADDITIONAL DATA INTRODUCED: The LLM introduces net notional volume data (1,452 MMBtu in 2023 declining to 1,131 MMBtu in 2024) that is not in the ground truth answer. While this may be accurate supplementary information, it wasn't part of the original answer and suggests the LLM may be conflating different data sources. (5) INTERPRETATION ERROR: The LLM concludes volatility 'rose' when the ground truth shows a more complex pattern (36%→50%→52%), and the LLM's characterization of 'preparing for higher expected price swings' contradicts the ground truth's assessment of 'reduction in expected market volatility.' (6) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize fair value trends with volatility assumptions, but the volatility numbers are incorrect, undermining the entire analytical conclusion. The core narrative of 'de-risking' in the ground truth is contradicted by the LLM's 'preparing for higher expected price swings' interpretation based on faulty volatility data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 446,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt investments produced a net loss of **$67 million in 2024**, a net loss of **$21 million in 2023**, and a net gain of **$9 million in 2022** (Other Income (Loss), Net – AFS debt investments, page 46). These swings pushed the overall other income (loss), net to **$ (306) million in 2024, $ (248) million in 2023, and $ 392 million in 2022**, showing that the portfolio’s unrealized gains and losses were highly volatile, with a modest gain in 2022 turning into sizable losses in the following two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides specific, verifiable financial data that directly addresses the question. STRENGTHS: (1) Provides precise dollar amounts for AFS debt investment performance across all three fiscal years (2022: $9M gain, 2023: $21M loss, 2024: $67M loss), which align with the ground truth narrative of a shift from gains to losses. (2) Includes corresponding other income (loss), net figures for all three years, showing the broader financial impact. (3) Correctly identifies the trend of volatility and the transition from modest gains to sizable losses, matching the ground truth's characterization. (4) Properly cites source documentation (page 46), enhancing credibility. (5) Synthesizes multi-hop information effectively by connecting AFS debt investment performance to overall other income (loss), net impact. (6) The reasoning is sound: demonstrates how AFS debt investments contributed to portfolio volatility and negatively impacted non-operational income streams. MINOR CONSIDERATIONS: (1) The ground truth emphasizes 'recurring negative impact over two consecutive years' and 'increasing volatility,' while the LLM answer focuses more on the specific numbers and the swing from gains to losses. Both perspectives are valid and complementary. (2) The LLM answer could have slightly more explicitly discussed the offsetting gains from equity and private investments mentioned in the ground truth, though this is a minor omission. (3) The quantitative data provided by the LLM is more specific and verifiable than the ground truth's more general characterization. VERIFICATION: The progression from $9M gain → $21M loss → $67M loss clearly demonstrates the volatility pattern described in both answers. The overall other income figures show the broader context of how these AFS debt investments fit into Cisco's total non-operational income picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 515,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe’s first issued its 4.550% notes in the 2019 supplemental indenture (Exhibit 4.16, page 82).  The 2022 filing (Exhibit 4.21, page 77) added new 4.250% and 4.450% notes but did not issue additional 4.550% notes.  In 2023 the company issued a new supplemental indenture (Exhibit 4.23, page 78) that introduced 4.800% notes, and the 2024 filing shows no new 4.550% notes.  This pattern indicates Lowe’s is gradually raising coupon rates on new debt to keep pace with market rates while maintaining long‑dated maturities, reflecting a disciplined long‑term debt strategy that balances cost and maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) INCORRECT CORE CLAIM: The ground truth states that Lowe's consistently referenced the 4.550% Notes due April 5, 2049 across 2022, 2023, and 2024 with NO CHANGES in documentation or terms. The LLM claims the 2022 filing 'did not issue additional 4.550% notes' and that 2023 introduced new 4.800% notes - this mischaracterizes the question, which asks about the evolution of the 4.550% Notes specifically, not about other debt instruments. (2) EXHIBIT REFERENCES UNVERIFIED: The LLM cites specific exhibit numbers and page numbers (Exhibit 4.16 page 82, Exhibit 4.21 page 77, etc.) that cannot be verified against the ground truth and appear to be fabricated or incorrectly cited. (3) MISINTERPRETATION OF PATTERN: The ground truth indicates STABILITY and consistency in the 4.550% Notes across three years with no modifications. The LLM incorrectly interprets this as a pattern of 'gradually raising coupon rates on new debt' - conflating the issuance of OTHER debt instruments with the evolution of the 4.550% Notes themselves. (4) LOGICAL FLAW: The LLM's conclusion about 'disciplined long-term debt strategy' may be reasonable in general, but it's based on a misreading of what happened with the 4.550% Notes specifically. The ground truth answer correctly identifies that the 4.550% Notes showed NO EVOLUTION - they remained unchanged across the three-year period. (5) INCOMPLETE SYNTHESIS: The LLM failed to recognize that the question specifically asks about the 4.550% Notes' evolution, not about Lowe's overall debt strategy with multiple instruments. The correct answer is that there WAS NO EVOLUTION in the 4.550% Notes themselves - they were consistently referenced with identical terms and documentation across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 504,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 35B stayed unchanged: the face amount remained $750,000 and the coupon rate stayed at 3.80 % (maturity July 15 2050)【page_50】【page_50】【page_51】. This stability shows the company’s long‑term debt strategy of keeping a predictable, low‑cost, long‑dated unsecured note profile, thereby minimizing refinancing risk and maintaining steady interest expense.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: face value of $750,000,000 (LLM states $750,000 which appears to be a formatting/transcription error - should be $750,000,000 or $750M), interest rate of 3.80%, and maturity date of July 15, 2050. The multi-hop synthesis is sound - the answer correctly identifies that the debt instrument remained unchanged across 2022-2024, demonstrating stability. The reasoning about SPG's long-term debt strategy is logically sound and well-supported. Minor issues: (1) The face value appears to have a transcription error ($750,000 vs. $750,000,000) - this is a significant numerical discrepancy that should be noted, though the magnitude of the error suggests it may be a formatting issue rather than fundamental misunderstanding. (2) The original answer mentions 'maturity date was extended from 07/15/50 in 2022 to the same date in 2024' which is somewhat confusing phrasing (it wasn't extended, it remained the same), and the LLM correctly interprets this as unchanged. (3) The LLM provides slightly more specific strategic interpretation (minimizing refinancing risk, maintaining steady interest expense) which adds value beyond the ground truth. The answer successfully synthesizes information across multiple years and correctly identifies the stability of this debt instrument as a strategic choice. The quantitative accuracy is high except for the apparent face value transcription error, which prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 419,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 10‑K risk disclosures for 2022 (page 25), 2023 (page 23) and 2024 (page 21) all repeat the same core warnings: bad transaction risk can raise loss rates; credit‑product defaults and funding constraints remain a key exposure; cross‑border trade is vulnerable to currency, tariff and regulatory shifts; and reliance on third‑party processors, lenders and service providers creates operational risk. The unchanged wording over three years shows that PayPal’s exposure to bad transactions has not materially eased, and its risk‑management strategy continues to focus on monitoring credit performance, diversifying third‑party relationships, and sustaining operational resilience amid regulatory and economic pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the key evolution of PayPal's bad transaction risk exposure from 2022-2024. CRITICAL ERRORS: (1) The LLM claims the risk disclosures show 'unchanged wording over three years' and that exposure 'has not materially eased,' which directly contradicts the ground truth. The ground truth explicitly documents a strategic transformation: from internal risk absorption in 2022 to external risk mitigation through the €40 billion BNPL loan receivable sale agreement in 2023. (2) The LLM completely omits the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables - a major quantitative fact and strategic pivot point. This is a critical multi-hop synthesis failure. (3) The LLM misses the legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables introduced in 2024, which represents a new risk dimension. (4) The LLM's characterization of the trend as 'unchanged' is fundamentally incorrect - the ground truth shows clear evolution from 2022 (internal credit defaults via Synchrony) → 2023 (strategic asset sales) → 2024 (legal contingency planning). WHAT WAS CORRECT: The LLM correctly identifies that bad transaction risk, credit product defaults, cross-border trade vulnerabilities, and third-party dependencies are recurring themes across the three years. However, this surface-level observation misses the critical strategic shifts. MULTI-HOP REASONING: The LLM failed to synthesize the evolution across years and connect the strategic asset sale to risk management strategy transformation. The answer reads as a static description rather than capturing the dynamic risk management evolution. The ground truth reveals a sophisticated, proactive strategy shift that the LLM completely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 493,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s competitive stance versus BJ’s remained consistent, with the company continuing to list BJ’s as a key competitor in its competition disclosures across 2022‑2024 (2022 page_7; 2023 page_8; 2024 page_9). However, the emphasis on private‑label differentiation evolved: in 2022 the company spoke generally of private‑label merchandise (2022 page_5), whereas by 2023 and 2024 it highlighted Kirkland Signature as a high‑quality, lower‑price brand that drives margin and member loyalty and that the firm expects to increase its sales penetration (2023 page_7; 2024 page_8). This shift underscores a sharpened focus on Kirkland Signature as a key differentiator against BJ’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental contradiction with the ground truth that significantly undermines its correctness. CRITICAL ERROR: The LLM claims there was a 'shift' or 'evolution' in Costco's emphasis on Kirkland Signature from 2022 to 2023-2024, stating that '2022 the company spoke generally of private-label merchandise' whereas 'by 2023 and 2024 it highlighted Kirkland Signature as a high-quality, lower-price brand.' This directly contradicts the ground truth, which explicitly states: 'the depth and framing of its differentiation strategy...remained stable' and 'By 2024, the messaging remained consistent, with no significant shift in strategy.' The ground truth clearly indicates that Kirkland Signature positioning was CONSISTENT across all three years (2022-2024), not evolving or shifting as the LLM claims. QUANTITATIVE ISSUES: The LLM provides page numbers (2022 page_7, 2023 page_8, 2024 page_9, etc.) that cannot be verified against the ground truth and appear to be fabricated or hallucinated references. These specific page citations are presented as factual evidence but lack grounding. REASONING FLAW: The LLM's core conclusion—that there was a 'sharpened focus' on Kirkland Signature as a differentiator—is logically inconsistent with the ground truth's assertion of stable, consistent messaging. The LLM mischaracterizes the evolution of competitive positioning by inventing a narrative of change where the ground truth indicates continuity. WHAT WAS CORRECT: The LLM correctly identifies that BJ's Wholesale Club was mentioned as a competitor across the three-year period and that Kirkland Signature was positioned as a high-quality, lower-price brand driving margins and member loyalty. However, these correct elements are embedded within an incorrect overall narrative about the nature of change (or lack thereof) in strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 503,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra’s fair‑value of gas forward contracts dropped sharply over the three years: assets fell from $1.452 billion in 2022 to $377 million in 2023 and $296 million in 2024, while liabilities declined from $77 million to $77 million and then to $46 million. The net exposure therefore shrank from roughly $1.38 billion in 2022 to $300 million in 2023 and $250 million in 2024, indicating a deliberate move toward a more conservative natural‑gas risk posture and a smaller hedge footprint.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors across all quantitative dimensions. (1) CRITICAL NUMBER ERRORS: The LLM claims assets were $1.452 billion in 2022, but ground truth shows $191 million - a massive discrepancy of over 7x. The LLM also incorrectly states 2023 assets were $377 million when this was actually the peak year (correct per ground truth), but this doesn't excuse the 2022 error. The 2024 figure of $296 million is correct. For liabilities, the LLM claims $77 million in both 2022 and 2023, but ground truth shows $31 million in 2022 and an implied higher value in 2023 (before the $46 million in 2024). The $46 million 2024 figure is correct. (2) CALCULATION ERRORS: The LLM's net exposure calculations are fundamentally flawed due to incorrect asset figures. The claimed $1.38 billion net in 2022 is mathematically impossible given the actual $191 million asset figure. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 3-year progression. Ground truth shows assets increased from $191M to $296M (net growth), with a 2023 spike to $377M, indicating strategic expansion. The LLM incorrectly characterizes this as a 'sharp drop' and 'deliberate move toward conservative posture' - the opposite of what the data shows. (4) ENTITY/METRIC ACCURACY: While NextEra Energy is correctly identified, the financial metrics are fundamentally misrepresented. The LLM appears to have confused or fabricated the 2022 asset figure entirely. (5) SEMANTIC CONTRADICTION: The LLM's conclusion about 'conservative risk posture' directly contradicts the ground truth interpretation of 'strategic expansion in gas market participation.' This is not a wording difference but a fundamental misreading of the data trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 478,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure fell sharply from $2.56 billion in 2022 to $251 million in 2023, and the company had no forward swaps on its books in 2024 (the fair‑value measurement table shows zero). This decline reflects a shift from a large cash‑flow hedge on forecasted debt issuances to a smaller, more targeted hedge and ultimately to a different hedging instrument—fixed‑to‑floating swaps as fair‑value hedges—as market conditions and the company’s debt‑issuance profile evolved, indicating a more flexible interest‑rate risk‑management strategy. (page_61, page_54, page_46)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error that fundamentally undermines its credibility. The claim that Lowe's held $2.56 billion in forward interest rate swaps in 2022 is NOT supported by the ground truth, which states that in 2022, Lowe's 'referenced forward interest rate swaps in the context of cash flow hedges' with impacts noted over 2019-2021, but does NOT cite a $2.56 billion figure for 2022. This appears to be a fabricated number. The LLM correctly identifies the $251 million figure for 2023 and the absence of forward swaps in 2024, which aligns with ground truth. However, the introduction of an unsupported $2.56 billion 2022 figure creates a false narrative of a 'sharp decline' that cannot be verified. Additionally, the LLM introduces claims about 'fixed-to-floating swaps as fair-value hedges' that are not mentioned in the ground truth answer, suggesting either hallucination or synthesis from unreliable sources. The ground truth emphasizes a 'deliberate use and subsequent release' of forward interest rate swaps, while the LLM reframes this as a shift to different instruments without clear evidence. The reasoning about 'forecasted debt issuances' and 'market conditions' is plausible but not explicitly supported by the provided ground truth. STRENGTHS: The LLM correctly identifies the 2023 ($251M) and 2024 (zero) positions and recognizes the overall trajectory of declining/eliminated forward swap exposure. The general conclusion about evolving risk management strategy is directionally correct. WEAKNESSES: The $2.56B 2022 figure is unsubstantiated and appears fabricated; introduction of fixed-to-floating swaps lacks ground truth support; the multi-hop synthesis is compromised by unreliable data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 478,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 to 2024, CMCSA kept expanding its fiber‑to‑the‑premises network, adding symmetrical speeds up to 10 Gbps for residential customers and up to 100 Gbps for business, while rolling out 2 Gbps downstream speeds on its HFC network in 2022 and deploying DOCSIS 4.0 in 2023 to deliver multigigabit symmetrical speeds【2024 page_7】【2024 page_6】. These upgrades enabled CMCSA to offer higher‑speed broadband packages in markets where Lumen is also building fiber, thereby strengthening its competitive position in overlapping service areas【2024 page_8】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer has significant issues with addressing the core question. STRENGTHS: (1) The technical specifications mentioned (10 Gbps symmetrical for residential, 100 Gbps for business, 2 Gbps downstream on HFC, DOCSIS 4.0 in 2023) appear to be factually accurate details about CMCSA's infrastructure. (2) The answer correctly identifies both CMCSA and Lumen as competitors. (3) The timeframe (2022-2024) is correct. CRITICAL WEAKNESSES: (1) The answer focuses almost entirely on CMCSA's own infrastructure expansion and competitive response, rather than analyzing how CMCSA's competitive positioning AGAINST Lumen evolved. The ground truth emphasizes Lumen's consistent expansion across all three years and its growing influence as a fiber-based competitor. (2) The LLM answer fails to address the multi-hop synthesis requirement: it should track Lumen's competitive actions/positioning across 2022-2024, not just CMCSA's responses. (3) The answer lacks the temporal evolution analysis that the ground truth provides - showing how Lumen's competitive threat intensified from 2022 through 2024. (4) Missing key ground truth elements: the consistent mention of Lumen across all three years as a wireline telecommunications company building fiber infrastructure, the progression of competitive pressure, and the impact on CMCSA's market positioning and service strategies. (5) The answer is more of a CMCSA-centric narrative rather than a comparative analysis of competitive positioning between the two companies. The question specifically asks 'how did the competitive positioning of CMCSA against Lumen evolve' - requiring a comparative framework that the LLM answer does not provide. While the technical details about CMCSA's infrastructure may be accurate, the answer fundamentally misses the comparative competitive analysis that was requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 501,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 to 2024 PayPal sharpened its “one‑click” checkout promise by weaving consumer‑credit products more tightly into the payment flow—adding buy‑now‑pay‑later and installment options that can be chosen at checkout (2022 page 8; 2024 page 8) and expanding the markets where those products are available.  The company also broadened its global reach, now serving roughly 200 markets with 150 currencies for payments, 56 for withdrawals and 24 for balances (2024 page 5‑6), up from the 150‑currency, 56‑withdrawal, 24‑balance framework noted in 2022.  Finally, PayPal moved from a primarily online focus to a full omnichannel offering, adding in‑person POS tools such as Zettle by PayPal, card readers and unbranded processing via Braintree and PayPal Complete Payments (2024 page 7‑8).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding currency support progression. The LLM states PayPal expanded from '150-currency' framework in 2022 to 'roughly 200 markets with 150 currencies' in 2024. However, the ground truth clearly indicates: 2022 had 'over 100 currencies', 2023 expanded to 'approximately 150', and 2024 maintained approximately 150 currencies. The LLM incorrectly suggests currency support remained flat (150 in both 2022 and 2024), when the actual progression was 100+ → 150 → 150. Additionally, the LLM introduces '200 markets' which is not mentioned in the ground truth and appears to conflate markets with currencies. The withdrawal (56) and balance (24) currency figures are correctly cited but the baseline comparison is flawed. QUALITATIVE ASSESSMENT: The LLM correctly identifies the three main evolution areas: (1) BNPL/consumer credit integration into checkout, (2) global currency expansion, and (3) omnichannel merchant solutions (Zettle, Braintree). The semantic understanding of the strategic shift is sound. However, the execution contains the critical numerical error that undermines credibility. MULTI-HOP REASONING: The answer appropriately synthesizes information across the three-year period and correctly identifies the progression from online-focused to omnichannel. The connection between BNPL integration and checkout experience is well-articulated. MISSING ELEMENTS: The answer omits mention of PayPal- and Venmo-branded debit and credit cards introduced in 2024, which is a notable component of the financial services integration strategy mentioned in the ground truth. The answer also lacks the framing of this as a 'strategic shift from global scale and usability to enhanced financial services integration' that provides important context. CITATION ISSUES: While page references are provided, they cannot be verified against the ground truth knowledge graph, and the specific page numbers may not align with actual filing content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 547,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target Debit Card penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024 (RedCard penetration in 2022–2023, Target Circle Card penetration in 2024)【page_27】【page_29】. This downward trend indicates a shrinking share of purchases made with the card, suggesting its incremental sales‑driving influence is weakening over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM reports: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is wrong (19.8% vs 18.6%) and the 2024 figure is wrong (18.6% vs 17.8%). These are not minor rounding differences but represent material misstatements of the actual data. The LLM shifted all values upward by approximately 1.2 percentage points for 2023-2024, which distorts the severity of the decline. QUALITATIVE ASSESSMENT: The LLM correctly identifies the downward trend and appropriately concludes this suggests weakening incremental sales influence. The reasoning about shrinking purchase share is sound. However, the answer misses the key insight from the ground truth about 'consistent decline over three years' and the specific mention of the 5% discount value proposition and Target's internal linkage to increased sales. The parenthetical note about RedCard vs Target Circle Card naming conventions shows some awareness of product evolution but doesn't add substantive value. MULTI-HOP SYNTHESIS: The answer adequately synthesizes the trend across three years and connects it to sales implications, though the execution is undermined by the incorrect numbers. OVERALL: While the directional conclusion (declining penetration = weakening sales driver) is correct, the fundamental quantitative errors are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 424,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed between 2022 and 2024.  The company still evaluates whether the license is distinct; if it is, revenue is recognized at a point in time when the customer can benefit, and if it is not, the license is combined with the development services and revenue is recognized over time.  Stand‑alone licensing arrangements are always recognized at a point in time, and no variable‑consideration estimates are applied to either type of agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core policy framework and its consistency across 2022-2024. Key strengths: (1) Accurately captures the distinction-based approach (distinct licenses at point in time, non-distinct combined with development services over time), (2) Correctly states the policy remained unchanged across the three-year period, (3) No quantitative errors or incorrect numbers/dates, (4) Properly identifies that standalone licensing is recognized at a point in time. Minor weaknesses: (1) The LLM adds a detail about 'no variable-consideration estimates' that is not explicitly mentioned in the ground truth, which could be seen as either additional accurate detail or potential overreach beyond what was confirmed in filings, (2) The ground truth emphasizes 'consistency in policy suggests a stable approach to IP monetization' as a concluding observation about the significance of this stability, while the LLM simply states the policy 'has not changed' - this is semantically similar but the LLM misses the nuance about what this consistency implies, (3) The LLM's phrasing 'Stand-alone licensing arrangements are always recognized at a point in time' is slightly more definitive than the ground truth's framing, though factually aligned. The answer demonstrates sound multi-hop reasoning by synthesizing the policy across three years and correctly identifying the key distinction mechanism. The response is well-structured and directly addresses the question about evolution (or lack thereof) in the revenue recognition approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 427,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "FlyEase has remained a consistent pillar of Nike’s innovation strategy.  In each of the FY 2022, FY 2023 and FY 2024 10‑K filings, the technology is listed alongside other core innovations—Air, Zoom, Flyknit, React, etc.—in the Product Research, Design and Development section, underscoring its ongoing role as a key, integrated technology rather than a one‑off or niche offering (2022 10‑K, page 6; 2023 10‑K, page 6; 2024 10‑K, page 6).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim about FlyEase's evolution. Ground truth establishes a clear three-year progression: (1) FY2022 - newly introduced/emerging technology, (2) FY2023 - transitioned to being listed alongside established technologies like Air and Zoom, (3) FY2024 - moved to mature technologies category with React and Air Max. The LLM answer claims FlyEase 'remained a consistent pillar' and was 'listed alongside other core innovations' in all three years without differentiation. This is factually incorrect - the ground truth explicitly describes a progression from 'novel concept' to 'foundational technology,' not consistency. The LLM fails to capture the key insight that FlyEase's positioning evolved from emerging to established to mature status. While the LLM correctly identifies the fiscal years (2022, 2023, 2024) and mentions page 6 of the 10-Ks, it misses the critical evolution narrative. The answer also lacks the nuanced distinction between how FlyEase was presented in each year - the ground truth shows it was NOT listed the same way across all three years, but rather showed progression in strategic positioning. The LLM's characterization of FlyEase as 'consistent' and 'integrated' from the start contradicts the ground truth's narrative of transition and maturation. This represents a fundamental misunderstanding of the multi-hop synthesis required - the question specifically asks about 'evolution' and the LLM failed to identify or describe any meaningful evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 425,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "AMT’s 1.250% Notes have been steadily reduced: the outstanding principal fell from roughly $558.7 million in 2022 (558.7 = 551.9 + 6.8 million, per the 2023 table) to $551.9 million in 2023 (page 111) and to $517.7 million in 2024 (page 115). This downward trend indicates a deliberate debt‑reduction strategy, with the company repaying or redeeming the notes to lower interest costs and improve its maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect principal amounts for 2022. Ground truth states $609.1 million in 2022, but the LLM claims $558.7 million (derived from a calculation of 551.9 + 6.8). This is a significant factual error of approximately $50.4 million. The LLM's 2023 ($551.9M) and 2024 ($517.7M) figures are correct. The LLM's calculation methodology (551.9 + 6.8 = 558.7) is mathematically sound but based on an incorrect premise about what the 2022 figure should be. MULTI-HOP REASONING: The LLM correctly identifies the downward trend and appropriately synthesizes the debt reduction strategy across the three-year period. The reasoning about deliberate debt reduction and interest cost management is sound and aligns with the ground truth interpretation. COMPLETENESS ISSUES: The LLM omits important contextual details present in the ground truth: (1) the consistent interest payment terms (May payments, February 2033 maturity), (2) the specific characterization of the strategy as 'managed amortization or repurchase,' and (3) the precise magnitude of the total reduction ($609.1M to $517.7M = $91.4M decline). ENTITY ACCURACY: Company (AMT), note type (1.250%), and years are correctly identified. The page references (111, 115) suggest proper source documentation, though the 2022 figure derivation appears flawed. The semantic interpretation of debt management strategy is appropriate, but the foundational numerical error undermines the credibility of the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 417,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were valued at $870 million in FY 2023 and $851 million in FY 2024, a modest decline that left the carrying amount unchanged at $1.0 billion and the effective interest rate steady at 3.54% (page 67; page 72). The notes are classified as Level 2 debt securities and are carried at amortized cost, with no redemption or amortization during this period. This steady valuation and treatment demonstrate NVIDIA’s long‑term debt strategy of maintaining a stable, low‑coupon, long‑maturity debt profile to support growth while preserving liquidity and predictable interest expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect numbers. Ground truth shows FY2022: $1,066M, FY2023: $851M, FY2024: $1,000M. The LLM states FY2023: $870M and FY2024: $851M - these are reversed and incorrect. The LLM claims the carrying amount is $1.0 billion in both years, but ground truth shows $1,066M in 2022 and $1,000M in 2024, indicating significant changes. (2) TEMPORAL COVERAGE - The question explicitly asks about the evolution from FY2022 through FY2024 (three-year trajectory). The LLM only addresses FY2023-FY2024, completely omitting the critical FY2022 data point ($1,066M) which is essential to understanding the multi-year trajectory. This is a major gap in multi-hop synthesis. (3) VALUATION TRAJECTORY MISREPRESENTATION - Ground truth shows: 2022→2023 decline ($1,066M to $851M), then 2023→2024 recovery ($851M to $1,000M). The LLM's numbers ($870M to $851M) suggest only a modest decline and miss the recovery pattern entirely, fundamentally mischaracterizing the trajectory. (4) CALCULATION ERRORS - The LLM states values 'left the carrying amount unchanged at $1.0 billion' but provides different numbers ($870M vs $851M), creating internal inconsistency. (5) MISSING CONTEXT - The LLM fails to explain the significant 2022-2023 decline or the 2023-2024 recovery, which are crucial to understanding NVIDIA's debt strategy. The ground truth explicitly notes these fluctuations as evidence of 'managing liability values through market fluctuations.' (6) PARTIAL CREDIT - The LLM correctly identifies the 3.54% effective interest rate and Level 2 classification, and the general strategic narrative about maintaining stable debt is reasonable, but these cannot overcome the fundamental numeric errors and incomplete temporal analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 489,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "From 2022 to 2024 Netflix expanded its membership strategy by first adding games to its streaming library and launching a lower‑priced ad‑supported subscription tier in 2022, then continuing to roll out games and the ad‑supported plan in 2023, and in 2024 adding live programming and a new ad‑supported tier while adjusting pricing to reflect the broader content mix. In each year the risk disclosures warned that if new features, pricing changes or content offerings are not perceived as valuable, members could churn or new members may not join, and that competition and enforcement of multi‑household usage could further erode acquisition and retention.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the timeline of Netflix's strategy evolution. CRITICAL ERRORS: (1) The LLM states games and ad-supported tier were both launched in 2022, but the ground truth indicates games were introduced in 2022 while the ad-supported tier was introduced in 2023. This is a fundamental chronological error that misrepresents Netflix's strategic rollout. (2) The LLM claims 'a new ad-supported tier' was added in 2024, but the ground truth does not mention a new ad-supported tier in 2024 - only that live programming was added. This suggests confusion about what features were introduced when. CORRECT ELEMENTS: (1) Games were introduced in 2022 - correct. (2) Ad-supported tier was introduced (though LLM incorrectly dates it to 2022 instead of 2023). (3) Live programming was added by 2024 - correct. (4) Risk disclosures about member perception, churn, and acquisition challenges are accurately captured. (5) The mention of competition and multi-household usage enforcement as additional risks is a reasonable synthesis, though not explicitly detailed in the ground truth. MULTI-HOP REASONING: The LLM attempted to synthesize information across three years but failed to maintain accurate chronological sequencing of feature rollouts. The ground truth clearly delineates: 2022 (games), 2023 (ad-supported tier), 2024 (live programming). The LLM conflates 2022 and 2023 activities. SEMANTIC ISSUES: While the LLM captures the general theme of evolving membership strategies and associated risks, the specific timeline errors undermine the accuracy of the multi-hop synthesis. The answer demonstrates partial understanding but contains material factual errors that would mislead readers about Netflix's strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 482,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑style exposure grew from $3.7 B in equity securities in 2022 to $4.9 B in 2023 and remained at that level in 2024 (page 52).  Equity‑method investments in healthcare operating businesses fell slightly from $1.5 B in 2022 to $1.4 B in 2023 but then surged to $3.8 B in 2024, more than doubling the 2022 figure (page 52).  This pattern shows the company is keeping a steady overall venture portfolio while aggressively expanding its stake in operating healthcare firms, underscoring a strategic focus on deepening its footprint and influence in the sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a critical factual error in the 2022 equity method investments figure. The ground truth states $1.3 billion in 2022, but the LLM claims $1.5 billion. This is a material discrepancy ($200 million difference) that affects the accuracy of the comparison and the 'more than doubling' calculation. The LLM's statement that equity method investments 'more than doubled' from 2022 to 2024 is mathematically correct if using $1.5B ($1.5B to $3.8B = 2.53x), but this is based on the wrong starting figure. Using the correct $1.3B figure, the increase is still substantial (2.92x), but the error undermines quantitative precision. All other numbers are correct: equity securities at $3.7B (2022), $4.9B (2023-2024), and equity method investments at $1.4B (2023) and $3.8B (2024). COMPLETENESS: The answer addresses the main components of the question - the evolution of both equity securities and equity method investments across the three-year period, and provides strategic interpretation. ENTITY ACCURACY: Company name, metrics, and years are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the contrasting trends (steady equity securities vs. surging equity method investments) and draws a reasonable strategic conclusion about deepening engagement in operating healthcare businesses. The characterization of 'keeping a steady overall venture portfolio while aggressively expanding' is a valid interpretation. SEMANTIC EQUIVALENCE: The strategic conclusion aligns with the ground truth's assessment of 'deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses.' The reasoning quality is good despite the quantitative error. The primary weakness is the $1.5B vs. $1.3B discrepancy in 2022 equity method investments, which is a factual error that cannot be overlooked in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 524,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s relationship with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the company’s authorized redeemable preferred stock (par $1, redeemable at $0.3 million) and the cumulative dividend of $0.10 per share is payable annually on May 31, with no common‑stock dividends allowed until the preferred dividend is fully paid. The preferred‑stock terms and dividend obligations did not vary across the three fiscal years. Sojitz America’s role in Nike’s international operations stayed the same as a provider of import‑export financing services that support Nike’s global supply chain and financing, with no shift in responsibilities or influence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the preferred stock has 'par $1, redeemable at $0.3 million' which is contradictory and confusing. The ground truth clearly states par value of $0.3 million. The LLM's phrasing suggests par value of $1 with redemption at $0.3M, which is factually incorrect and creates ambiguity about the actual financial terms. (2) CRITICAL OMISSION - The LLM completely misses the key evolution highlighted in the ground truth: the explicit shift in FY 2024 where Nike highlighted Sojitz America's strategic importance in providing import-export financing services 'since 1972' amid rising global trade risks. The ground truth emphasizes this represents an evolution 'from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024.' The LLM states 'no shift in responsibilities or influence,' which directly contradicts the ground truth's core finding about the strategic evolution. (3) MULTI-HOP REASONING FAILURE - The question specifically asks about how the relationship 'evolved' across the three fiscal years. The ground truth identifies a meaningful evolution in how Nike characterized Sojitz America's role (from financial to strategic/operational emphasis). The LLM fails to capture this temporal evolution and instead claims consistency throughout. (4) SEMANTIC CONTRADICTION - The LLM's statement that the role 'stayed the same' and there was 'no shift in responsibilities' directly contradicts the ground truth's assertion of an evolution in how the relationship was characterized and emphasized. (5) DIVIDEND DETAILS - The LLM correctly identifies the $0.10 per share annual dividend and May 31 payment date, which are accurate details not explicitly stated in the ground truth but appear consistent. However, this minor accuracy does not offset the major factual errors and omissions regarding the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 521,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 carried **$1,637 million** at the end of FY 2022, remained essentially unchanged at **$1,637 million** at the end of FY 2023, and declined to **$1,604 million** at the end of FY 2024 (NVDA 10‑K 2022, p. 78; NVDA 10‑K 2023, p. 67; NVDA 10‑K 2024, p. 67). This slight downward trend signals a modest reduction in long‑term debt, reflecting a stable and manageable long‑term debt profile for the company.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports FY2022 carrying value as $1,637 million when ground truth shows $2,147 million (error of $510M or 24%). FY2023 is reported as $1,637 million when ground truth shows $1,604 million (error of $33M). FY2024 is reported as $1,604 million when ground truth shows $2,000 million (error of $396M or 25%). (2) TREND ANALYSIS COMPLETELY INVERTED: The LLM describes a 'slight downward trend' and 'modest reduction in long-term debt' when the actual trend shows: decrease from $2,147M to $1,604M (2022-2023), then a SIGNIFICANT INCREASE to $2,000M (2023-2024). The ground truth explicitly identifies this as 'temporary reduction in 2023 followed by strategic repositioning to increase long-term liabilities in 2024.' The LLM's characterization is the opposite of reality. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year trend across fiscal years 2022-2024. The conclusion about 'stable and manageable' debt profile is contradicted by the actual $396M increase from 2023 to 2024. (4) ENTITY ACCURACY: While the note description (3.50% Notes Due 2050) and company (NVIDIA) are correct, the financial metrics are entirely wrong. The LLM appears to have confused or misread the carrying values across years. This is a complete failure to provide accurate financial information on a straightforward multi-year trend question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 424,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt fell from $175 million in 2022 to $119 million in 2023 but surged to $465 million in 2024, a shift that reflects a growing use of commercial paper backed by its unsecured revolving credit facility.  Across all three years the company reiterated that its global funding mix—short‑term and long‑term debt, collateral financing, junior subordinated securities, PABs, credit and committed facilities, and a shelf registration—provides flexibility, limits dependence on any single market, and generally lowers the cost of funds.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data about MetLife's short-term debt evolution (2022: $175M → 2023: $119M → 2024: $465M) that is not present in the ground truth answer. This represents a significant enhancement with concrete numbers showing the trajectory of commercial paper usage. The LLM correctly identifies the core funding strategy elements (commercial paper, unsecured revolving credit facility, diverse funding sources) and accurately conveys that the company maintained consistent messaging about diversification and cost reduction across all three years. The quantitative accuracy is strong - the specific dollar amounts and year-to-year comparisons appear precise and well-documented. The qualitative reasoning is sound, correctly synthesizing that despite fluctuations in short-term debt levels, the underlying strategy remained stable. The answer comprehensively addresses all parts of the multi-part question: (1) evolution of dependence on global funding markets, (2) use of short-term debt/commercial paper, and (3) reliance on diverse funding sources to lower capital costs. Minor deduction: The ground truth emphasizes 'consistent mention' and 'stable reliance' more explicitly, while the LLM focuses more on quantitative changes. However, the LLM's inclusion of specific numbers actually provides more substantive evidence of this stability/evolution than the ground truth. The answer is well-structured, factually accurate, and demonstrates proper multi-hop synthesis across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 421,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantees remained non‑material throughout 2022‑24 (Note 4, page 81).  The company’s short‑term notes payable to subsidiaries rose from $8.7 B in 2022 to $9.9 B in 2023 and then fell sharply to $2.0 B in 2024, while long‑term notes payable to subsidiaries jumped from $0 B in 2023 to $14.4 B in 2024 (page 78).  This shift reflects a rebalancing of liquidity commitments toward longer‑term financing, reducing short‑term liquidity exposure but increasing contractual obligations over a longer horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) LLM correctly identifies that service level guarantees remained non-material throughout 2022-24, matching ground truth. (2) Correctly identifies the sharp drop in short-term notes payable to $2.0B in 2024. (3) Adds valuable detail about long-term notes payable ($14.4B in 2024), which ground truth doesn't explicitly mention but represents important additional context. (4) Reasoning about liquidity rebalancing is sound and insightful. (5) Properly cites sources (Note 4, page 81; page 78). CRITICAL ERRORS: (1) SHORT-TERM NOTES PAYABLE 2022 FIGURE: LLM states $8.7B but ground truth clearly states $8.1B - this is a $600M discrepancy (7.4% error). (2) INCOMPLETE GROUND TRUTH SYNTHESIS: Ground truth explicitly mentions the 2023 figure of $9.9B, which LLM correctly includes, but the 2022 figure is materially wrong. (3) MISSING CONTEXT: LLM doesn't fully address the 'volatility in notes payable suggests shifting liquidity strategies' insight from ground truth, though it does provide a reasonable interpretation. QUANTITATIVE ACCURACY ISSUES: The $8.7B vs $8.1B discrepancy is significant for a financial analysis question where precision is critical. This represents a factual error in a key data point. QUALITATIVE ASSESSMENT: The reasoning about liquidity rebalancing and the shift from short-term to long-term financing is sound and actually enhances the ground truth answer. The multi-hop synthesis (connecting service level guarantees to notes payable evolution) is properly executed. OVERALL: The answer demonstrates good understanding of the question and provides valuable additional detail (long-term notes), but contains a material quantitative error in the 2022 short-term notes payable figure that undermines confidence in the numerical analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 483,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 through 2024, American Express remained the fourth‑largest general‑purpose card network worldwide, but it faced mounting regulatory scrutiny over interchange‑fee caps, network‑licensing rules and its new Category III status, prompting the company to exit EU and Australian licensing businesses and to tighten compliance, risk‑management and governance frameworks (see pages 12, 13, 34, 35).  Competitive pressure from Visa, Mastercard, China UnionPay and alternative payment platforms intensified, leading AmEx to invest in digital services, loyalty programs and innovation to preserve its premium positioning (page 12).  In response, the company adjusted pricing and product offerings, strengthened its compliance infrastructure, and focused on regulatory compliance to mitigate impacts on its network operations (pages 34, 35).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key factual elements: (1) Amex as fourth-largest general-purpose card network, (2) Category III regulatory status, (3) EU and Australian licensing business exits, (4) competitive pressures from Visa, Mastercard, China UnionPay, and alternative platforms, (5) strategic responses including digital investment and compliance strengthening. All numeric references and entity identifications are accurate. The answer appropriately synthesizes multi-hop information across regulatory, competitive, and strategic dimensions.\n\nWEAKNESSES: The LLM answer lacks important contextual depth present in the ground truth: (1) Missing the temporal evolution narrative showing the shift FROM market-driven competition TO regulatory navigation (2022→2024 trajectory). (2) Omits specific mention of alternative payment platforms like Alipay, PayPal, Venmo, and NPCI that were highlighted in the original answer as part of the competitive landscape evolution. (3) Fails to capture the nuanced shift in tone/strategic posture—the ground truth emphasizes how Amex's independence and competitive edge became increasingly constrained by regulatory forces, whereas the LLM answer presents responses more as tactical adjustments rather than a fundamental strategic repositioning. (4) Does not explicitly address the uncertainty over future regulatory interpretations mentioned in ground truth. (5) Missing the emphasis on interchange fees and network routing as specific regulatory pressure points.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across regulatory, competitive, and strategic dimensions, but the synthesis is less comprehensive than the ground truth. The answer connects regulatory changes to business responses, but doesn't fully capture the evolutionary arc of how Amex's strategic posture fundamentally shifted.\n\nSEMANTIC EQUIVALENCE: While the LLM answer conveys accurate information about what happened, it misses the deeper narrative about HOW and WHY the company's positioning evolved—the transformation from independence to regulatory dependency is implied but not explicitly articulated.\n\nJUSTIFICATION: Score of 7 reflects that core facts are correct and multi-hop synthesis is present, but significant contextual and narrative elements are missing that would elevate this to an 8-9 range. The answer is factually sound but incompletely addresses the full scope of the question regarding the evolution of competitive positioning and regulatory dependency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 671,
        "total_tokens": 2302
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips has kept the same dividend‑equivalent structure for its cash‑settled PSUs for performance periods that began in 2018 or later: recipients receive an accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement (page 136, 2022 10‑K; page 124, 2023 10‑K; page 126, 2024 10‑K).  The unchanged approach from 2022 through 2024 shows the company’s commitment to long‑term incentive alignment, tying employee rewards to performance and shareholder value while providing a deferred cash benefit that reinforces long‑term ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that ConocoPhillips maintained a consistent dividend-equivalent structure for cash-settled PSUs for performance periods beginning in 2018 or later, with accrued reinvested dividends paid at settlement. The page citations (136 for 2022, 124 for 2023, 126 for 2024) appear reasonable for 10-K filings. However, the answer has significant gaps in addressing the full scope of the question:\n\n(1) INCOMPLETE MULTI-HOP SYNTHESIS: The original answer explicitly contrasts two different dividend equivalent structures—one for pre-2018 periods (no payments during performance period, began after) versus post-2018 periods (accrued reinvestment paid at settlement). The LLM answer only addresses the post-2018 structure and fails to mention the evolution FROM the pre-2018 approach, which is central to understanding how the strategy 'evolved.' This is a critical omission for a question specifically asking about evolution from 2022 to 2024.\n\n(2) MISSING CONTEXTUAL FRAMEWORK: The original answer provides important context about vesting being tied to five years or retirement eligibility, and notes the consistent classification as liabilities on the balance sheet across all three years. The LLM answer omits these details entirely.\n\n(3) INCOMPLETE ANALYSIS OF STRATEGIC INTENT: The original answer explicitly interprets the shift as 'a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized.' The LLM answer provides a more generic statement about 'commitment to long-term incentive alignment' but doesn't capture the specific strategic insight about the evolution of the dividend equivalent structure.\n\n(4) FACTUAL ACCURACY: The LLM correctly states that for 2018+ periods, recipients receive accrued reinvested dividends paid at settlement, which matches the ground truth. The statement that this approach was 'unchanged from 2022 through 2024' is accurate.\n\n(5) REASONING QUALITY: While the LLM's reasoning about deferred cash benefits reinforcing long-term ownership is sound, it doesn't address the comparative evolution that the question specifically asks about. The answer reads more like a static description of 2022-2024 policy rather than an analysis of how it evolved.\n\nThe answer is partially correct on the specific dividend structure for post-2018 periods but fails to comprehensively address the evolution question and misses key comparative and strategic elements that define the complete answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 668,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "Special‑use funds rose from about **$7.34 billion in 2022** (page 88) to **$8.83 billion in 2023** (page 87) and **$9.80 billion in 2024** (page 64).  During the same period the potential derivative collateral that would be required if credit ratings were downgraded fell from roughly **$5.2 billion in 2022** to **$2.4 billion in 2023** (page 86), and the actual collateral posted declined from **$4.62 billion** to **$2.29 billion**.  The widening liquidity cushion from the expanding special‑use funds, relative to the shrinking derivative collateral exposure, signals a stronger liquidity position that better supports the company’s derivative‑related collateral obligations over 2022‑2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the Special Use Funds figures. Ground truth shows: 2023: $8,698M and 2024: $9,800M. LLM reports: 2022: $7.34B, 2023: $8.83B, 2024: $9.80B. While the 2024 figure ($9.80B) is correct, the 2023 figure is wrong ($8.83B vs. $8.698B - a $132M discrepancy). More critically, the LLM introduces a 2022 figure ($7.34B) that is not mentioned in the ground truth, which only provides data for 2023-2024. COLLATERAL POSTING ERRORS: The LLM states actual collateral posted 'declined from $4.62 billion to $2.29 billion,' but ground truth shows it 'increased to $691 million in 2023 from $84 million in 2022.' This is a fundamental reversal of the actual trend and uses completely different numbers. The LLM's figures ($4.62B and $2.29B) do not match ground truth data at all. CORRECT ELEMENTS: The LLM correctly identifies the downgrade collateral requirement figures ($5.2B in 2022 to $2.4B in 2023) and correctly concludes that the company strengthened its liquidity position. REASONING QUALITY: The multi-hop synthesis is logically sound - comparing Special Use Funds growth against derivative collateral exposure reduction - but is undermined by the incorrect underlying numbers. The semantic interpretation of improved risk management is correct, but the quantitative foundation is flawed. MISSING CONTEXT: The LLM fails to note the specific 2022 derivative-related collateral detail mentioned in ground truth ($2.7B potential exposure in downgrade scenario), though this is a minor omission. The core issue is that the LLM provides materially incorrect financial figures that contradict the ground truth data, particularly regarding collateral posting amounts and the 2022 Special Use Funds baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 484,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600% Notes stayed at a $700 million balance at each year‑end, with amortization of $3.7 million in 2022, $2.6 million in 2023 and $1.5 million in 2024 (see the “Adjustments to Principal Amount” columns in the 2023 table on page 110 and the 2024 table on page 113). This gradual, low‑rate principal reduction indicates a conservative debt‑management approach that prioritizes liquidity and a stable debt profile while slowly trimming the 1.600% Notes balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error regarding the amortization trajectory. According to the ground truth, the adjustments to principal decreased from (3.7) million in 2022 to (2.6) million in 2024. However, the LLM claims the amortization was $3.7M in 2022, $2.6M in 2023, and $1.5M in 2024. This is incorrect on multiple counts: (1) The ground truth shows only 2022 and 2024 data points with values of (3.7) and (2.6) respectively - there is no mention of a 2023 value of $2.6M or a 2024 value of $1.5M in the original answer. (2) The LLM appears to have fabricated the $1.5M figure for 2024, which contradicts the ground truth stating (2.6) million in 2024. (3) The LLM misattributed the $2.6M figure to 2023 when it should be 2024. CORRECT ELEMENTS: The LLM correctly identified that the outstanding principal remained constant at $700 million across the years, and correctly cited the note rate of 1.600%. The general interpretation about a conservative debt management approach is reasonable and aligns with the ground truth's characterization of a 'stable long-term debt strategy.' However, the core quantitative data about the amortization trajectory is fundamentally wrong, which is the primary focus of the question. The multi-hop reasoning about debt management strategy is sound in principle but is built on incorrect numerical foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 387,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes stayed a persistent regulatory risk from 2022 through 2024, as CMS continued to reduce or freeze benchmarks and periodically alter the risk‑adjustment calculation methodology【page_25】【page_20】【page_20】. In each filing the company explained that it had responded by selectively adjusting member benefits and premiums, withdrawing plans in certain counties, and tightening medical and operating cost controls to offset the funding pressures【page_25】【page_20】【page_20】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the persistent nature of CMS risk adjustment payment changes; (2) Accurately captures the core regulatory challenge of CMS reducing/freezing benchmarks and altering risk adjustment methodologies; (3) Properly synthesizes UNH's multi-faceted strategic responses: selective benefit/premium adjustments, county exits, and cost controls; (4) Correctly identifies this as a consistent theme across all three years; (5) No quantitative errors in dates or financial metrics (none were required for this question). MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth, condensing the year-by-year evolution into a more general statement rather than explicitly walking through 2022, 2023, and 2024 separately; (2) The ground truth emphasizes the 'evolving response' and 'ongoing adjustments' more explicitly, while the LLM treats it more as a consistent pattern; (3) The LLM doesn't explicitly mention the progression of intensity (e.g., 'intensified cost management' in 2022, 'more aggressively' in 2023, 'further refine' in 2024) that the ground truth conveys. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple strategic dimensions (pricing, benefits, operations), demonstrating sound multi-hop reasoning. The citation references (page_25, page_20) suggest proper source attribution. SEMANTIC EQUIVALENCE: The core message is semantically equivalent - UNH faced consistent regulatory pressure and responded with strategic adjustments to benefits, premiums, and costs. The answer captures the essential narrative without material omissions of factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 487,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023 and 2024 all describe employee merchandise discounts simply as “merchandise and other discounts” that are part of the overall benefits package (see 2022 p. 7, 2023 p. 7, 2024 p. 7).  None of the filings disclose a change in the discount rate, eligibility criteria or program structure, indicating that Target has kept the benefit broad and unchanged over this period.  This consistency suggests a strategy that values a steady, cost‑saving benefit to support team members’ financial well‑being without pursuing incremental expansion or redesign.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical information from the ground truth. (1) CORRECTNESS ISSUES: The LLM claims that merchandise discounts remained 'unchanged' and that 'none of the filings disclose a change in the discount rate, eligibility criteria or program structure.' This directly contradicts the ground truth, which documents substantial evolution in the broader employee benefits context from 2022-2024. The ground truth shows: starting wages expanded from $15/hour (2022) to $15-$24/hour (2023); new benefits were added including sick pay, tuition-free education, free virtual healthcare, and expanded mental health services; and the framing shifted from basic benefits to a 'holistic financial and well-being strategy.' (2) QUANTITATIVE ACCURACY: The LLM correctly identifies that merchandise discounts appear on page 7 of the 2022, 2023, and 2024 filings (though this is a minor detail). However, it fails to capture the wage progression data ($15 to $15-$24) and the expansion of benefits that are quantifiable elements of the answer. (3) MULTI-HOP REASONING: The LLM fails to synthesize the evolution across the three-year period. The ground truth requires connecting: (a) merchandise discount consistency, (b) wage expansion, (c) new benefits additions, and (d) strategic framing shifts. The LLM only addresses point (a) and draws an incorrect conclusion. (4) SEMANTIC MISALIGNMENT: The LLM's conclusion that Target pursued 'no incremental expansion or redesign' is fundamentally wrong. The ground truth explicitly states the strategy evolved to position discounts 'within a broader narrative of equitable pay and belonging' with 'continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services.' The LLM missed the entire strategic evolution narrative. (5) ANSWER QUALITY: While the LLM's statement about merchandise discounts remaining consistent is technically not false, it represents an incomplete and misleading answer that ignores the substantial contextual evolution that is central to answering the question about how the 'scope and structure' evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 581,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "Across 2022‑2024, American Express kept its foreign‑government‑bond portfolio almost entirely short‑term—most of the $630 million were due within one year, with only a handful maturing in the 1–5‑year window and virtually none beyond 10 years—and the weighted‑average yield stayed near 2 % (1.74 % for 1‑year, 2.42 % for 1–5 years, 5.46 % for 5–10 years, 3.10 % for >10 years, overall 2.08 %【page_121】). The 2024 10‑K shows no significant shift in this maturity mix or yield, underscoring a cautious, liquidity‑focused risk appetite and a deliberate asset‑allocation strategy that prioritizes low‑duration, low‑yield foreign‑bond holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misrepresents the evolution of American Express's foreign government bond portfolio across 2022-2024. (1) QUANTITATIVE FAILURES: The LLM claims yields 'stayed near 2%' and cites 2022 figures (1.74%, 2.42%) as representative of the entire 3-year period, completely missing the dramatic yield increases in 2023 (6.45% for 1-year, 4.48% for 1-5 years) and the subsequent decline in 2024 (5.86%, 2.03%). The LLM also introduces unexplained yields (5.46% for 5-10 years, 3.10% for >10 years, 2.08% overall) that don't appear in the ground truth and appear to be fabricated or misattributed. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about evolution 'from 2022 through 2024' - a 3-year comparative analysis. The LLM fails to track the year-by-year progression and instead treats all three years as static/unchanged ('no significant shift'). This is a fundamental failure to synthesize temporal data across multiple periods. (3) STRATEGIC INTERPRETATION ERROR: The ground truth correctly identifies a 'shift from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024.' The LLM incorrectly characterizes the entire period as 'cautious, liquidity-focused' and 'low-yield,' missing the aggressive 2023 positioning entirely. (4) MISSING CRITICAL DATA: The LLM completely omits the 2023 and 2024 yield data that are central to answering the question. The ground truth shows yields more than tripled from 2022 to 2023 (1.74% → 6.45% for 1-year bonds), a massive strategic shift that the LLM entirely overlooks. (5) CITATION ISSUE: The reference to 'page_121' appears unsupported and doesn't validate the incorrect claims made. The answer demonstrates a fundamental misunderstanding of the question's requirement to track evolution across three distinct years and fails to capture the dynamic risk appetite changes evident in the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 535,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**—all figures reported as part of “Other assets, including intangibles – net.” The steady decline indicates that the company is reducing the collateral it must post for netting, suggesting more efficient hedging, a lower derivative exposure, or improved counterparty‑risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct—$1,494 million (2022), $800 million (2023), and $491 million (2024). The LLM properly converted the 2022 figure to $1.494 billion format, which is an acceptable and equivalent representation. The years are correctly identified. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) identifies the specific collateral metric, (2) tracks the three-year trend with all data points, (3) synthesizes the trend into meaningful interpretation about derivative exposure management. ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, the metric 'Other assets, including intangibles – net' properly referenced, and all fiscal years (2022-2024) accurate. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly interprets the downward trend and provides three plausible explanations (more efficient hedging, lower derivative exposure, improved counterparty-risk management) that align with the ground truth's characterization of 'strategic reduction in derivative-related exposure or shift in risk management practices.' The reasoning demonstrates understanding of financial risk management concepts. SEMANTIC EQUIVALENCE: The LLM's interpretation ('steady decline indicates...reducing collateral...suggesting more efficient hedging') semantically matches the ground truth's assessment of a 'downward trend indicating strategic reduction.' Minor note: The LLM provides slightly more detailed interpretation of what the trend suggests (three specific mechanisms) compared to the ground truth's more general statement, but this represents value-added analysis rather than error. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 482,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "The 2.700% senior unsecured notes were issued on March 29 2021 at a fixed 2.700% rate with a 2031 maturity and have remained unchanged through 2024 (no new issuances or amendments)【page_113】.  In 2024 AMT raised new, higher‑rate debt (5.200% and 5.450% notes) and used the proceeds to repay its 2021 Multicurrency Credit Facility, but left the 2.700% notes intact, indicating a strategy of locking in low rates early and maintaining a stable, long‑term debt base while refinancing other obligations as market rates rose【page_112】【page_114】.  This pattern shows AMT capitalized on a low‑rate environment in 2021 and then shifted to higher‑rate debt as rates climbed, using the 2.700% notes as a low‑cost anchor in its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.700% Notes issuance date (March 29, 2021), the 2031 maturity date, and the $700.0 million principal amount. It accurately notes that the notes remained unchanged through 2024 with no new issuances or amendments. The strategic interpretation about locking in low rates in 2021 and refinancing with higher-rate debt in 2024 is sound and demonstrates good multi-hop reasoning about market conditions.\n\nWEAKNESSES: (1) The LLM fails to address a critical detail from the ground truth: the interest rate spread decreased from (5.0) to (4.4) by 2024, which is a significant quantitative change that directly answers the question about how terms 'evolved.' This omission is material because the question specifically asks how terms 'evolved from 2022 through 2024.' (2) The ground truth mentions a par call date of January 15, 2031 (disclosed in 2022), which the LLM does not mention. (3) The ground truth specifies interest payment dates (April and October), which the LLM omits. (4) The LLM conflates the maturity date (April 15, 2031 per 2022 disclosure) with the par call date (January 15, 2031), creating some confusion about which date is which. (5) The LLM's statement that notes 'have remained unchanged through 2024' is partially incorrect given the spread reduction from 5.0 to 4.4.\n\nMULTI-HOP REASONING: The LLM demonstrates good synthesis by connecting the 2.700% notes strategy to broader 2024 refinancing activities (5.200% and 5.450% notes), showing understanding of how this fits into overall capital structure management. However, it misses the specific evolution of terms within the 2.700% notes themselves.\n\nQUANTITATIVE ACCURACY: Numbers are correct ($700.0M, 2.700%, 2031, March 29, 2021), but the critical spread reduction (5.0 to 4.4) is completely missing, which is a significant omission for a question about how terms 'evolved.'\n\nQUALITATIVE ACCURACY: The strategic interpretation is reasonable but incomplete. The answer provides good context about market conditions and refinancing strategy but fails to fully address the specific evolution of the 2.700% Notes' terms across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 582,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00% Notes Due 2031 carried a constant $1,250 million at the end of fiscal 2022, 2023, and 2024 (see the 2023 10‑K table on page 68 and the 2024 10‑K table on page 72). The balance, with a 6.4‑year remaining term and 2.09% effective rate, stayed unchanged, indicating the company’s intent to keep a stable, low‑interest, long‑term debt position rather than expanding or retiring this particular note—an approach that underscores a disciplined, diversified long‑term debt strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the balance was a constant $1,250 million across all three years (2022-2024), but the ground truth shows: 2022: $1.2 billion (not $1.25B), 2023: $1.044 billion at beginning and $1.057 billion at end (not $1.25B), 2024: $1.25 billion (correct). The LLM incorrectly states 2022 and 2023 values as $1.25B when they were materially different. (2) CALCULATION/SYNTHESIS ERROR: The LLM failed to recognize the actual progression and variation in the debt values across years. The ground truth shows fluctuation from $1.2B to $1.044B-$1.057B range in 2023, then to $1.25B in 2024—not a constant value. (3) MISCHARACTERIZATION: By claiming the balance 'stayed unchanged,' the LLM fundamentally misrepresents the debt evolution. The 2023 values were notably lower than 2022 and 2024, indicating actual changes in fair value or carrying value. (4) PARTIAL CREDIT: The LLM correctly identifies the note type (2.00% Notes Due 2031), correctly notes no short-term portion, and provides reasonable strategic interpretation about stable long-term debt positioning. However, the core numerical facts are wrong, which is critical for a financial question. (5) CITATION ISSUES: While the LLM cites specific 10-K pages, the numbers cited do not match the ground truth values, suggesting either misreading of source documents or hallucination. The reasoning about debt strategy is sound in principle but is built on incorrect factual foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 434,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances expanded markedly from 2022 to 2023, then eased slightly in 2024.  At the end of 2022 the company had about $1.8 billion in deposit assets and $1.4 billion in deposit liabilities (Note 6, page 216).  Those balances grew to $5.1 billion in assets and $1.3 billion in liabilities in 2023, and then settled at $4.6 billion in assets and $1.2 billion in liabilities in 2024 (Note 6, page 206).  The trend—large gains in deposit assets coupled with a modest decline in liabilities—indicates MetLife is increasingly using deposit‑method agreements to transfer risk and preserve liquidity while maintaining a net positive deposit position that mitigates counter‑party exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its accuracy. The ground truth states that deposit assets reached $5.1 billion by the end of 2024, but the LLM claims they were $4.6 billion in 2024. This is a material discrepancy of $500 million (approximately 10% difference) that directly contradicts the original answer. The LLM correctly identifies the 2022 starting point ($1.8B assets, $1.4B liabilities) and accurately reports the 2023 peak ($5.1B assets, $1.3B liabilities). However, the 2024 asset figure is wrong. The liability figures for 2024 are correct ($1.2B). The LLM's reasoning about the strategic implications—that MetLife is using deposit-method agreements to transfer risk and preserve liquidity—is sound and aligns with the ground truth's interpretation. The multi-hop synthesis across years is mostly correct, and the contextual understanding of the deposit method's role in reinsurance strategy is appropriate. The answer addresses all parts of the question (evolution from 2022-2024, deposit assets and liabilities, strategic implications) but the quantitative error in the final year significantly impacts overall correctness. The LLM also omits the specific reference to the Global Atlantic transaction ($10.3 billion in reinsurance recoverables) mentioned in the ground truth, which provided important context for understanding the 2023 spike. The writing is clear and well-structured, but the numerical inaccuracy is a critical flaw in a financial analysis context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 417,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities fell from a fair value of **$679 million** and carrying value of **$696 million** in 2022 to **$596 million** and **$603 million** in 2023, and further to **$508 million** and **$512 million** in 2024 (2023 10‑K, page 53; 2024 10‑K, page 56). The steady decline in both fair value and carrying value indicates a shrinking portfolio—likely due to maturities or sales—while the fair value remaining below carrying value each year shows that the company is not recognizing unrealized losses on securities held to maturity. This pattern reflects a conservative investment strategy that prioritizes credit quality and maturity certainty, with market‑valuation adjustments driven mainly by interest‑rate movements rather than credit deterioration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - 2022: fair value $679M, carrying value $696M; 2023: fair value $596M, carrying value $603M; 2024: fair value $508M, carrying value $512M. The year-over-year declines are accurately represented. (2) ENTITY ACCURACY: UnitedHealth Group correctly identified, fiscal years 2022-2024 properly sequenced, debt securities held-to-maturity metric correctly specified. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the 3-year progression across multiple filing periods, correctly identifying the consistent downward trend in both metrics. (4) REASONING QUALITY: The LLM provides sound analysis beyond the ground truth, offering additional insights about why fair value remains below carrying value (unrealized losses not recognized under HTM accounting), the role of interest-rate movements, and the conservative investment strategy. This demonstrates deeper understanding of accounting treatment and market dynamics. (5) MINOR ENHANCEMENT: The LLM answer includes specific page references (2023 10-K page 53; 2024 10-K page 56) and explains the accounting mechanics (HTM securities don't recognize unrealized losses), which adds credibility and context beyond the ground truth. The only minor distinction is that the ground truth uses simpler language ('strategic reduction or repositioning'), while the LLM provides more technical accounting context. Both characterizations are accurate and complementary. The answer fully addresses the question's three components: fair value evolution, carrying value evolution, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 460,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target Circle Card penetration fell from **19.8 % in 2022 to 18.6 % in 2023 and further to 17.8 % in 2024**【page_29】. This modest decline suggests that, while the card remains widely used, its ability to generate incremental sales is weakening or plateauing, indicating diminishing returns from the credit‑card strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) WRONG NUMBERS: LLM provides 19.8% (2022), 18.6% (2023), 17.8% (2024), but ground truth shows 20.5% (2022), 19.8% (2023), 18.6% (2024). The LLM's 2022 figure is off by 0.7 percentage points, and the 2024 figure is off by 1.2 percentage points. (2) WRONG CARD NAME: LLM calls it 'Target Circle Card' but ground truth refers to 'Target Credit Card' - these are different products. (3) INCOMPLETE ANALYSIS: LLM fails to address the second part of the question about what the trend suggests regarding effectiveness. Ground truth acknowledges the declining trend but notes that Target's internal analysis still indicates meaningful incremental sales contribution, providing nuanced context. LLM only states 'diminishing returns' without this important qualification. (4) CALCULATION VERIFICATION: The year-over-year declines in LLM answer (19.8→18.6 = -1.2pp, 18.6→17.8 = -0.8pp) are internally consistent but based on wrong baseline numbers. Ground truth declines are: 20.5→19.8 = -0.7pp, 19.8→18.6 = -1.2pp. (5) MISSING CONTEXT: LLM omits Target's assertion that card-linked discounts and loyalty benefits still drive incremental sales despite the declining penetration rate. This is a material omission that affects the interpretation of the trend's strategic significance. The answer demonstrates fundamental factual errors in the core quantitative data that undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 393,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike continued to own and operate its Laakdal, Belgium distribution center throughout fiscal 2022‑2024, with no change in ownership or operational footprint noted in the 10‑K filings for those years【page 29 (2022)】【page 29 (2023)】【page 29 (2024)}. This steady ownership of a key European hub underscores Nike’s strategic focus on maintaining owned logistics infrastructure in Europe to secure control, improve supply‑chain resilience, and support its global distribution network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies Nike's continued ownership of the Laakdal, Belgium facility across fiscal years 2022-2024 with no changes in ownership or operational status; (2) Accurately cites page references (page 29 for all three years), demonstrating proper source documentation; (3) Correctly synthesizes the multi-hop information showing consistency across the three-year period; (4) Appropriately interprets the strategic implications of stable ownership. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'supply-chain resilience' and 'secure control' that goes slightly beyond what the ground truth explicitly states - the ground truth simply notes 'consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe,' while the LLM elaborates with additional strategic rationales not explicitly confirmed in the source material; (2) The ground truth emphasizes the facility's characterization as 'one of the most significant international distribution centers' in 2022 with consistency through 2024, but the LLM answer doesn't explicitly reference this 'most significant' characterization, though it does acknowledge it as a 'key European hub.' QUANTITATIVE ACCURACY: No numerical errors - dates (2022-2024) and page references are correct. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across three fiscal years is properly executed. The interpretation about strategic focus is reasonable but slightly speculative beyond the ground truth's more conservative statement. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of ownership and operational footprint, and appropriately connects this to strategic focus, though with slightly more inference than the ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 513,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum has been listed as a competitor in NVIDIA’s 10‑K filings for all three years—2022 (pages 9, 15), 2023 (page 11) and 2024 (page 11)—always grouped with other networking and optical‑module suppliers.  Over this period NVIDIA’s supply‑chain strategy shifted toward greater redundancy and diversification in the Asia‑Pacific region (pages 9, 10), reducing its dependence on any single optical‑module vendor and thereby limiting Lumentum’s leverage.  At the same time, NVIDIA’s IP protection has deepened (expanded patent portfolio, licensing agreements and export‑control compliance measures; pages 9, 10), strengthening its competitive moat and further curbing Lumentum’s relative influence in the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the core narrative: Lumentum's consistent positioning as a competitor across 2022-2024, NVIDIA's supply chain diversification strategy, and IP protection expansion. The semantic content aligns well with the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies Lumentum as a persistent competitor across all three fiscal years (2022, 2023, 2024)\n2. Accurately characterizes the competitive domain (networking, optical modules, interconnect solutions)\n3. Properly synthesizes the multi-hop relationship: Lumentum's positioning + NVIDIA's supply chain strategy + IP protection expansion\n4. Correctly notes NVIDIA's shift toward supply chain redundancy and diversification\n5. Accurately describes IP protection deepening (patents, licensing, export controls)\n6. Appropriate page citations (though not verifiable against actual filings)\n7. Sound logical reasoning about how NVIDIA's strategic moves limit Lumentum's leverage\n\nWEAKNESSES:\n1. QUANTITATIVE ACCURACY ISSUE: The LLM provides specific page numbers (pages 9, 15 for 2022; page 11 for 2023 and 2024) without verification. While these may be accurate, they cannot be confirmed against the ground truth, which does not specify page numbers. This introduces uncertainty in quantitative precision.\n2. Missing specific detail from ground truth: The LLM does not mention NVIDIA's specific manufacturing partnerships (TSMC, Samsung) that were highlighted in the original answer as part of supply chain strategy.\n3. Missing patent expiration timeline detail: The ground truth mentions patent expiration dates moving from 2022 to 2045, which the LLM does not reference.\n4. The phrase \"limiting Lumentum's leverage\" and \"curbing Lumentum's relative influence\" are interpretive conclusions not explicitly stated in the ground truth, though logically sound.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three dimensions (competitor positioning, supply chain strategy, IP protection) and correctly identifies the causal relationships between NVIDIA's strategic moves and their impact on Lumentum's competitive position.\n\nSEMANTIC EQUIVALENCE: The core message matches the ground truth—Lumentum remains a persistent competitor despite NVIDIA's strategic advancements—though the LLM frames this more as a diminishment of Lumentum's relative position rather than maintenance of relevance.\n\nThe answer is substantively correct but loses points for unverifiable page citations and omission of specific partnership and patent timeline details from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 701,
        "total_tokens": 2198
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings from 2022‑24 consistently state that the company’s ability to deliver content hinges on licensing from third‑party rights holders and that a refusal to license could materially harm the business (2022 page 13; 2023 page 5; 2024 page 5). While this reliance has not diminished, the filings increasingly highlight a growing investment in original content projects (2023 page 4; 2024 page 4), signaling a strategic shift to reduce licensing dependence amid intensifying competition. The 2024 filing’s “Regulation” section (page 5) also notes rising content‑quota, levy, and ownership‑restriction pressures, underscoring the need for a more self‑sufficient content mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core risk factor of reliance on third-party rights holders across all three years (2022-2024), matching the ground truth's emphasis on this persistent challenge. (2) Accurately captures the evolution of Netflix's narrative from 2022 (content unavailability risks) through 2024 (regulatory constraints), demonstrating sound multi-hop synthesis across years. (3) Properly identifies the strategic shift toward original content as a response to competition and licensing challenges, which aligns with the ground truth's conclusion about 'securing exclusive and original content.' (4) Correctly notes the 2024 regulatory pressures (content quotas, investment obligations, ownership restrictions) as new constraints, matching the ground truth's observation about regulatory impacts. (5) Page citations (2022 p.13, 2023 p.5, 2024 p.5) appear reasonable and specific, though cannot be independently verified. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and doesn't explicitly mention 'variability of license terms' as emphasized in 2023, though this is a minor omission. (2) The phrase 'self-sufficient content mix' is a reasonable paraphrase of the ground truth's 'securing exclusive and original content' but is slightly less precise. (3) The answer could have been slightly more explicit about the 'compelling mix of content to support membership growth' aspect mentioned in the ground truth for 2023. QUANTITATIVE ACCURACY: No specific financial figures, percentages, or calculations are present in either answer, so this dimension relies on date accuracy (2022-2024 correctly identified) and page references (which appear plausible). QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and identifies the causal relationship between competition/regulation and Netflix's strategic shift. The multi-hop logic is sound: licensing risk → competitive pressure → regulatory constraints → strategic response (original content investment). CONTEXTUAL RELEVANCE: The answer directly addresses all components of the multi-part question: evolution of reliance (2022-2024), what it reveals about strategy, and the context of competition and regulatory changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 628,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "Southern Company has consistently treated scheduled lease payments under outdoor‑lighting contracts as immaterial, classifying them as lease income from operating leases and not including them in wholesale revenues.  The payments are shown in the maturity analysis as part of the operating‑lease obligations, and this presentation has remained unchanged from the 2022 to the 2024 filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) MATERIALITY CLAIM: The LLM states payments were 'consistently treated as immaterial' across all years, but the ground truth shows materiality status evolved - immaterial in 2022, but by 2023-2024 they were being included in maturity analyses, suggesting a shift in how they were being treated and disclosed. (2) EVOLUTION MISSED: The core question asks about 'evolution from 2022 to 2024,' and the ground truth explicitly describes a progression: 2022 (immaterial, undisclosed in maturity), 2023 (shift to inclusion in maturity analyses), 2024 (explicit inclusion with expanded disclosure). The LLM claims 'presentation has remained unchanged,' which directly contradicts the documented evolution. (3) REVENUE CLASSIFICATION ERROR: The LLM mentions 'lease income from operating leases' and 'not including them in wholesale revenues,' but the ground truth focuses on inclusion in maturity analyses and formalization of visibility - not on revenue classification per se. This suggests misunderstanding of what changed. (4) DISCLOSURE PROGRESSION IGNORED: The ground truth emphasizes 'increasing emphasis on formalizing the visibility' and 'more transparent treatment,' showing a deliberate shift in disclosure practices. The LLM's claim of unchanged presentation directly contradicts this. (5) MATURITY ANALYSIS TREATMENT: While the LLM mentions maturity analysis, it fails to capture that the key evolution was the ADDITION of these payments to maturity analyses over time, not their consistent presence. The ground truth states they were 'included in maturity analyses' starting in 2023, implying they weren't before. The LLM answer demonstrates a fundamental failure to identify and synthesize the multi-hop evolution across three fiscal years, instead presenting a static view that contradicts the documented progression in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 528,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.000% senior notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2023 (October 29, 2023) and remained unchanged at **$606 million** at the end of FY 2024 (November 3, 2024)【page_81】.  The 2022 10‑K shows the same balance of **$606 million** at the end of FY 2022, indicating that the company has not reduced the principal on this instrument during the three‑year period.  This steady balance suggests a debt‑management strategy that prioritizes maintaining a stable long‑term financing base—preserving liquidity and flexibility for future growth or refinancing—rather than aggressively paying down the notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. According to the original answer (from the knowledge graph), AVGO's 5.000% notes due April 2030 had an outstanding principal balance of $1,086 million in FY 2022, which decreased to $606 million in FY 2023, and remained at $606 million in FY 2024. However, the LLM claims the balance was $606 million at the end of FY 2022, stating 'The 2022 10‑K shows the same balance of $606 million at the end of FY 2022.' This is INCORRECT. The LLM failed to identify the significant $480 million reduction ($1,086M - $606M) that occurred between FY 2022 and FY 2023. This is a major quantitative error that undermines the entire analysis. The LLM's interpretation of the debt management strategy is therefore flawed—it incorrectly characterizes the strategy as maintaining 'a stable long-term financing base' with 'no reduction' over the three-year period, when in fact there was a deliberate and substantial debt reduction of $480 million in 2023. The LLM did correctly identify that the balance remained unchanged from FY 2023 to FY 2024 at $606 million, but this partial correctness cannot offset the major error regarding the FY 2022 baseline. The multi-hop reasoning failed because the model did not properly synthesize the year-over-year progression across all three fiscal years. The answer demonstrates incomplete research or misreading of the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 409,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM’s weighted‑average long‑term rate of return on U.S. pension‑plan assets was 6.3 % at December 31 2022 and stayed unchanged at 6.3 % at December 31 2023, but rose to 6.5 % at December 31 2024 after a new investment‑policy study (Note 16, pages 87 and 88). The increase signals a deliberate shift toward higher‑return, higher‑risk asset classes—evidenced by the 2024 target mix of 11 % equity, 60 % debt and 29 % alternative investments versus 8 % equity, 69 % debt and 23 % alternatives in 2022—to improve funded status and dampen volatility in a changing market environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states GM reported 5.4% in 2022, but the LLM claims 6.3% in 2022. This is a 0.9 percentage point discrepancy that undermines the entire analysis. The LLM correctly identifies 6.3% for 2023 and 6.5% for 2024, but the wrong 2022 starting point means the calculated trend is incorrect. Ground truth shows a 1.1 percentage point increase over two years (5.4% to 6.5%), but LLM shows only 0.2 percentage points (6.3% to 6.5%), fundamentally misrepresenting the magnitude of the strategic shift. The LLM does provide additional context about the asset mix changes (equity, debt, alternative investments percentages) and references the investment-policy study, which adds some value. However, these details cannot compensate for the core numerical error in the primary metric being analyzed. The reasoning about higher-return, higher-risk strategies is logically sound given the asset mix data provided, but it's based on an incorrect baseline. The multi-hop synthesis across years is attempted but fails due to the incorrect 2022 figure. This is a case where a single critical factual error severely compromises an otherwise reasonably structured answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 356,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "Across the 2022‑2024 filings, the 2.700% Senior Notes due 2031 are consistently listed in Supplemental Indenture No. 8 (dated March 29, 2021) and appear in the company’s debt schedules.  This treatment shows that American Tower is treating the notes as part of a structured long‑term debt program that locks in a moderate coupon for a 10‑year maturity, reflecting a strategy of maintaining a diversified, predictable debt profile to support growth and capital expenditures.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements: (1) The 2.700% Senior Notes due 2031 are consistently referenced across 2022-2024 filings - CORRECT; (2) Supplemental Indenture No. 8 dated March 29, 2021 is the governing document - CORRECT; (3) The notes appear in debt schedules - CORRECT. All numeric values and dates are accurate with no calculation errors. However, the answer has notable weaknesses: (1) It fails to explicitly state that the SAME indenture was referenced across ALL THREE years (2022, 2023, 2024), which is a key element of the ground truth's emphasis on 'consistency' and 'continuity'; (2) The ground truth emphasizes that this consistent treatment 'across all three filings' indicates 'stable long-term financing strategy' and 'steady approach without modifications,' but the LLM answer only mentions the notes appear in schedules without explicitly connecting this to the multi-year consistency pattern; (3) The LLM adds interpretive language about 'moderate coupon' and 'diversified, predictable debt profile' that goes beyond what the ground truth states, introducing some speculation not grounded in the filing references; (4) The ground truth's core insight about 'consistent referencing across all three filings' showing 'continuity in documentation and treatment' is somewhat implicit rather than explicit in the LLM answer. The answer is factually sound but lacks the explicit multi-hop synthesis across the three-year period that the question and ground truth emphasize.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 417,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal’s exposure to abusive behaviors remained a persistent risk from 2022 through 2024, with the risk‑factor language increasingly emphasizing new fraud schemes tied to expanded credit products and cross‑border transactions (page_26, page_26, page_24). To mitigate these risks, the company diversified its payment‑processor network, migrated to alternative processors, invested in fraud‑detection and credit‑risk models, and in 2023 sold a large portion of its U.K./European BNPL loan receivables to reduce credit exposure (page_25). Across the period, PayPal continued to monitor cross‑border regulatory, currency, and tariff risks while tightening underwriting for its consumer and merchant credit offerings (page_24).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core trajectory of PayPal's exposure to abusive behaviors from 2022-2024 and correctly identifies the key strategic action (2023 sale of U.K./European BNPL loan receivables). However, there are notable gaps and imprecisions: (1) The LLM mentions €40 billion implicitly through 'large portion' but does not state the specific amount, whereas the ground truth explicitly references 'up to €40 billion' - this is a material omission of a key quantitative detail. (2) The LLM correctly identifies the three-year progression (identifying risk → offloading exposure → reinforcing mechanisms) but presents it less clearly than the ground truth's explicit year-by-year breakdown. (3) The LLM adds details about 'diversifying payment-processor network' and 'migrating to alternative processors' that are not mentioned in the ground truth, which could represent either additional valid information or potential hallucination - this introduces uncertainty. (4) The LLM correctly emphasizes the persistent nature of the threat and third-party dependencies, aligning with ground truth. (5) The mention of 'cross-border regulatory, currency, and tariff risks' is relevant but somewhat tangential to the core question about abusive behaviors specifically. Quantitative accuracy is strong (dates and the BNPL sale are correct) but incomplete (missing the €40 billion figure). Qualitative reasoning is sound in identifying the strategic shift but lacks the precision and clarity of the ground truth's year-by-year analysis. The answer is substantially correct on main points but omits a significant quantitative detail and adds unverified claims about processor diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 461,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan assets in “Collective trust and other funds” fell from **$622 million in 2022** (page 70) to **$370 million in 2023** (page 57), then rose modestly to **$382 million in 2024** (page 58). This pattern— a sharp decline followed by a small rebound—indicates the company’s shift away from these less‑liquid, higher‑risk funds toward a more diversified, lower‑risk mix (e.g., debt securities), consistent with its broader de‑risking strategy for long‑term employee benefits.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly different dollar amounts than the ground truth for all three years: (1) 2022: LLM states $622M vs. Ground Truth $756M (difference of $134M or 17.7% understatement); (2) 2023: LLM states $370M vs. Ground Truth $382M (difference of $12M or 3.1% understatement); (3) 2024: LLM states $382M vs. Ground Truth does not provide updated dollar value. The LLM's claim that 2024 shows a 'modest rebound' to $382M is problematic because the ground truth explicitly states 'no updated dollar value is provided' for 2024, yet the LLM presents $382M as a confirmed 2024 figure. MULTI-HOP REASONING ISSUES: The LLM correctly identifies the general trend (decline followed by rebound) but bases this on incorrect numbers. The ground truth emphasizes a 'significant downward trend' from $756M to $382M (49.5% decline), whereas the LLM's numbers show only a 38.6% decline from $622M to $370M, then a rebound. QUALITATIVE ASSESSMENT: The LLM's interpretation about de-risking and portfolio rebalancing aligns with the ground truth's conclusion, and the mention of NAV-based valuation is contextually appropriate, though the ground truth specifically emphasizes this as a 2024 strategic focus on transparency. ENTITY ACCURACY: UNP ticker is correct, years are correct, metric identification is correct. The fundamental problem is that the LLM provides materially incorrect financial figures that undermine the entire analysis, despite reaching a similar directional conclusion about de-risking strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 427,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "From 2022 through 2024 Pfizer had **no Breakthrough Performance Awards (BPAs) granted or outstanding** (the 2023 and 2024 10‑Ks both state “No BPAs were granted…and no BPAs were outstanding as of December 31”).  The company continued to **value BPAs at intrinsic value based on the closing price of its common stock and amortize the fair‑value expense on a straight‑line basis over the probable vesting term into operating expenses (cost of sales, selling, informational and administrative, and R&D)**, with periodic adjustments for changes in stock price or vesting probability.  Thus, the valuation methodology and accounting treatment remained unchanged across the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on multiple key factual points. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth explicitly states that in 2022, Pfizer issued 1,165 thousand BPAs at $38.73 weighted average intrinsic value, with 859 thousand outstanding at $59.05 per share. The LLM claims 'no BPAs were granted or outstanding' from 2022-2024, which directly contradicts the documented 2022 grant activity. (2) TIMELINE MISREPRESENTATION: The LLM conflates 2023-2024 data (where no BPAs were granted/outstanding) with 2022, creating a false narrative that BPAs were inactive across all three years. The ground truth shows a clear evolution: active issuance in 2022 → discontinuation in 2023 → formalized methodology in 2024. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the multi-hop evolution requested in the question. It misses the 2022 grant activity entirely and incorrectly states the valuation methodology 'remained unchanged across the three years' when the ground truth indicates a NEW formalized methodology was detailed in 2024. (4) ACCOUNTING TREATMENT: While the LLM correctly describes the intrinsic value method and amortization approach, this appears to apply to 2024 specifically, not uniformly across all three years as the LLM implies. The ground truth indicates this was a 2024 disclosure of methodology, not a consistent approach from 2022. The LLM answer demonstrates a fundamental failure to synthesize multi-year data and misses the core evolution narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 426,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements fell from **$1.49 billion** at December 31 2022 to **$800 million** at December 31 2023 and further to **$491 million** at December 31 2024 (page 102, page 99). This downward trend indicates that the company’s derivative exposure or the amount of collateral needed for initial‑margin purposes has been shrinking, likely reflecting reduced trading volumes or more efficient netting/clearing arrangements that lower margin requirements over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three collateral amounts are correct - $1.49 billion (equivalent to $1,494 million) at end of 2022, $800 million at end of 2023, and $491 million at end of 2024. The format variation ($1.49 billion vs $1,494 million) is acceptable and demonstrates proper number handling. All dates are accurate (December 31 for each year). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the specific collateral values for all three years, (2) the trend analysis (downward trajectory), and (3) interpretation of what the trend suggests about derivative exposure and margin requirements. ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, the metric 'collateral under master netting arrangements related to Investments, advances and long-term receivables' is properly referenced, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the numerical trend to its implications (reduced derivative exposure, more efficient netting/clearing, lower margin requirements). The interpretation that declining collateral suggests shrinking derivative exposure or improved efficiency is logically sound and consistent with financial principles. MINOR CONSIDERATIONS: The LLM provides additional context (page references, explanation of potential causes like reduced trading volumes) that enhances the answer without introducing errors. The semantic meaning perfectly matches the ground truth - both convey the same downward trend and its implications. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 457,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K (p. 8) lists industrial fiber optics as a key product in its industrial portfolio. In 2023 and 2024 the company kept that product but expanded the application scope to cover industrial automation, power‑generation and distribution, medical systems, defense and aerospace, and automotive subsystems such as EV powertrain, infotainment and ADAS (p. 3‑7). This consistency and broadened scope signals a strategic focus on using fiber‑optic connectivity to drive growth in high‑margin industrial segments—especially automotive electrification and advanced driver‑assist technologies—while maintaining a diversified industrial portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The company and ticker (Broadcom/AVGO) are correct; (2) The general application areas mentioned (industrial automation, power systems, medical, defense, aerospace, automotive) align with the ground truth; (3) The reference to EV-related applications is appropriate. SIGNIFICANT ISSUES: (1) The LLM claims Industrial Fiber Optics positioning was 'expanded' in 2023-2024, but the ground truth indicates the applications were already present in 2022 and remained consistent through 2024—this is a mischaracterization of the evolution; (2) The LLM adds specific applications (EV powertrain, infotainment, ADAS) that are not explicitly mentioned in the ground truth as part of the Industrial Fiber Optics positioning evolution; (3) The LLM misses the key structural evolution described in the ground truth: the shift from broad narrative description (2022) to structured table format (2023) to streamlined presentation alongside related products like optocouplers, sensors, encoders, and Ethernet ICs (2024); (4) The LLM's interpretation of 'broadened scope' contradicts the ground truth's emphasis on 'consistency' across years; (5) The LLM adds interpretive claims about 'high-margin industrial segments' and strategic focus on 'fiber-optic connectivity' that go beyond what the ground truth supports. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-by-year evolution across the three fiscal periods. The ground truth emphasizes HOW the positioning evolved (format and presentation changes) rather than WHAT applications expanded. The LLM reversed this emphasis. MISSING ELEMENTS: The LLM does not mention the structured table format in 2023 or the integration with optocouplers, sensors, encoders, and Ethernet ICs in 2024, which are central to understanding the strategic evolution. The answer demonstrates partial understanding but contains material misinterpretations of the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 539,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s 2022‑24 10‑K notes consistently state that the company “has full discretion in determining the fee charged to customers” and “bear[s] full margin risk when completing a payment transaction,” even when it uses third‑party processors (2022 page 78‑79; 2023 pages 75‑77; 2024 page 77).  Thus, its exposure to margin risk remained high and unchanged over the period, with PayPal retaining control over transaction pricing and the associated margin risk throughout.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The LLM correctly identifies PayPal's consistent stance across 2022-2024 that it bears full margin risk, has full discretion over fee pricing, and maintains this position despite using third-party processors. The core facts match the ground truth perfectly. (2) QUANTITATIVE ACCURACY: The LLM provides specific page references (2022 pages 78-79; 2023 pages 75-77; 2024 page 77) which adds credibility and specificity. While these page numbers cannot be independently verified in this evaluation context, they are presented with appropriate precision and consistency. No calculations are required for this question, so quantitative accuracy focuses on the factual claims, which are correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the evolution (or lack thereof) in PayPal's margin risk exposure. The reasoning that margin risk 'remained high and unchanged over the period' directly parallels the ground truth's conclusion of a 'stable margin risk profile, with no material changes.' (4) SEMANTIC EQUIVALENCE: The LLM's phrasing ('exposure to margin risk remained high and unchanged,' 'retaining control over transaction pricing') conveys the same meaning as the ground truth ('stable margin risk profile,' 'consistent narrative'). The direct quotes from the 10-K filings strengthen the answer's credibility. (5) COMPLETENESS: The answer addresses all aspects of the question: the evolution of margin risk exposure (showing stability), PayPal's control over pricing, and the use of third-party processors across the three-year period. Minor deduction (1 point) only because the answer could have slightly more explicitly emphasized the 'reiteration' and 'affirmation' language that shows consistency across years, though this is a very minor omission given the clear statement that the exposure 'remained...unchanged.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 546,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold its Meridian subsidiary in 2021 for about $51 million in cash, recording a $167 million net loss (2022 10‑K, page 117).  After the sale, Pfizer entered into interim TSAs and a three‑year MSA (with a two‑year extension) with the purchaser, but the related revenues and costs were immaterial in 2023 (2023 10‑K, pages 73‑74).  By 2024 no further financial or contractual activity with Meridian is disclosed, underscoring Pfizer’s divestiture of its generic/consumer‑healthcare assets and a long‑term focus on its core biopharma and specialty businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. All quantitative data is accurate: the 2021 sale price of $51 million, the $167 million net loss, and the three-year MSA with two-year extension option are all correctly stated. The timeline is properly sequenced (2021 sale, 2022-2023 operations under MSA, 2024 minimal activity). The multi-hop synthesis is sound, correctly connecting the sale event to post-sale contractual arrangements and their materiality status. The answer appropriately identifies the strategic shift from direct ownership to arms-length contract-based relationship. However, there are minor differences from the ground truth: (1) The LLM mentions 'interim TSAs' which the ground truth does not explicitly reference, though this is not contradictory; (2) The LLM states 'no further financial or contractual activity with Meridian is disclosed' in 2024, while the ground truth notes Meridian was 'listed in Pfizer's glossary as Meridian Medical Technologies, Inc.' - this is a subtle difference in how the 2024 relationship is characterized. The ground truth emphasizes the formalized glossary listing as indicating a 'formalized but likely reduced relationship,' while the LLM emphasizes the absence of disclosed activity. Both interpretations are reasonable but slightly different in emphasis. The LLM's conclusion about Pfizer's strategic focus on core biopharma and specialty businesses aligns well with the ground truth's statement about refocusing on core therapeutic areas and platform technologies. The answer is well-structured, cites specific document pages, and demonstrates clear multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 465,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024 PMI’s 10‑K filings consistently flag product‑regulation risks that could commoditize its portfolio and curtail adult‑consumer communication about RRPs/SFPs. In 2022 the company warned that regulation could diminish product differentiation and restrict truthful information about SFPs (page 13, page 15, page 16). The 2023 filing reiterated that limits on branding, communication and product differentiation could hamper adult‑smoker conversion to RRPs (page 18, page 20), and the 2024 filing maintained the same emphasis, noting that restrictions on branding and communication continue to threaten the commercialization of its SFPs (page 17, page 20). Thus, the impact has remained a persistent, material risk with no substantive shift in PMI’s competitive positioning.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) TERMINOLOGY ERROR - The LLM states that in 2022 the company warned about 'SFPs' (smoke-free products), but the ground truth explicitly indicates that 2022 used 'RRPs' (reduced-risk products) terminology, with 'SFPs' only appearing in 2024. This is a significant factual error that contradicts the core evolution described in the ground truth. (2) PAGE CITATIONS - The LLM provides specific page numbers (13, 15, 16, 18, 20, 17, 20) without verification against actual filings. These citations cannot be validated and appear potentially fabricated, which is a serious accuracy concern. (3) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a specific evolution: 2022 (RRPs, differentiation/access restrictions) → 2023 (evolved language, disproportionate impact emphasis) → 2024 (terminology shift to SFPs, continued concerns). The LLM's answer flattens this progression by using 'SFPs' throughout and doesn't capture the 2023 'disproportionate impact' distinction that the ground truth highlights as important. (4) CORRECT ELEMENTS - The LLM correctly identifies: (a) persistent regulatory burden across all three years, (b) restrictions on communication and differentiation, (c) impact on commercialization, (d) material competitive risk. (5) REASONING QUALITY - The multi-hop synthesis is partially sound (connecting regulatory themes across years) but fails to capture the nuanced evolution of language and emphasis that distinguishes each year's filing. The conclusion that there was 'no substantive shift' contradicts the ground truth's assertion of 'deepening regulatory challenge' and evolution in how the company framed the issue. VERDICT: While the LLM captures the general theme of persistent regulatory pressure, it makes a critical terminology error (SFPs vs RRPs in 2022), provides unverifiable page citations, and misses the important evolution in how PMI framed the issue across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 525,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements fell from $1.494 billion in 2022 to $491 million in 2024, a net reduction of about $1.003 billion (page_99; page_102). This decline indicates the company has tightened collateral requirements, reflecting more efficient derivative hedging and stronger risk‑management controls.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the starting value ($1.494 billion in 2022) and ending value ($491 million in 2024), with proper format conversion. (2) The calculated net reduction of $1.003 billion is mathematically accurate ($1,494M - $491M = $1,003M). (3) The company and metric identification are correct. (4) The reasoning about risk management practices is sound and semantically aligned with the ground truth. CRITICAL WEAKNESS: (1) The LLM OMITTED the intermediate 2023 data point ($800 million), which is essential to understanding the trend. The ground truth explicitly states the three-year progression: $1,494M (2022) → $800M (2023) → $491M (2024). This omission is significant because it prevents full assessment of the trend pattern and year-over-year changes. (2) The LLM's interpretation that the company 'tightened collateral requirements' is slightly different from the ground truth's characterization of 'strategic reduction in derivative exposure or shift in risk management practices' - while not contradictory, it's a different emphasis. CALCULATION VERIFICATION: $1,494M - $491M = $1,003M ✓ Correct. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the multi-year comparison but fails to capture the complete temporal progression. The question asks about the change 'from 2022 through 2024,' which implies understanding the full trajectory, not just endpoints. The missing 2023 data point represents incomplete multi-hop synthesis across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 413,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model lowered its market‑risk assumption over the period: the model used an expected volatility of 28.6 % in 2023 (page 206) and 18.7 % in 2024 (page 215).  The 2022 10‑K does not disclose an expected‑volatility figure, but the subsequent decline from 28.6 % to 18.7 % signals that the company is now viewing its relative market risk as lower and more stable compared with its peer group.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023 (28.6%) and 2024 (18.7%) volatility figures and accurately notes the declining trend from 2023 to 2024. The reasoning about lower market risk perception is sound and semantically equivalent to the ground truth. The LLM appropriately cites page numbers (206, 215) showing document verification. CRITICAL ERRORS: The LLM states '2022 10-K does not disclose an expected-volatility figure,' but the ground truth explicitly provides 26.9% for 2022. This is a significant factual omission that undermines the completeness of the answer. The question specifically asks about evolution 'from 2022 to 2024,' requiring all three data points. QUANTITATIVE ACCURACY ISSUE: While the 2023 and 2024 figures are correct, the missing 2022 figure (26.9%) represents incomplete data presentation. The LLM's statement that there is no 2022 disclosure contradicts the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the trend analysis (28.6% to 18.7% decline) and correctly interprets this as indicating lower perceived market risk. However, without the 2022 baseline, the full three-year evolution cannot be properly assessed. The ground truth notes an interesting pattern: 26.9% (2022) → 28.6% (2023, increase) → 18.7% (2024, significant drop). The LLM misses this nuance of the short-term increase before the decline. SEMANTIC EQUIVALENCE: The interpretation of what the trend 'suggests' is appropriate and matches the ground truth's conclusion about improved market stability. The answer is contextually relevant but incomplete due to the missing 2022 data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 443,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 have remained unchanged at a principal of $495 million and a current‑portion balance of $495 million in FY 2022, FY 2023 and FY 2024 (see the senior‑notes table on page 81 of the 2024 10‑K, which lists the same amount for 2023 and 2024 and the 2022 filing shows the identical $495 million balance). This stability indicates that Broadcom has kept a predictable short‑term debt base while using proceeds from new senior‑note issuances (e.g., the $10 billion of notes issued in 2024) to refinance larger, longer‑term maturities and repay term‑loan balances, underscoring a strategy of maintaining a steady short‑term debt profile while selectively refinancing long‑term obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $495 million principal amount for the 3.125% notes due January 2025 across the three fiscal years (2022, 2023, 2024), matching the ground truth. The company name (Broadcom/AVGO) and note details are accurate. The LLM provides additional context about refinancing strategy with the $10 billion notes issued in 2024, which adds relevant detail about broader debt management.\n\nWEAKNESSES: The LLM answer contains a critical factual error regarding the classification of the debt. The ground truth states that by FY 2024, the note 'had transitioned into its current portion of long-term debt,' implying a change in classification status. However, the LLM claims the balance remained at '$495 million current-portion balance' consistently across all three years (2022, 2023, 2024). This contradicts the ground truth's key insight that the debt's status changed in 2024 as maturity approached. The LLM states the amount was 'current-portion balance of $495 million in FY 2022, FY 2023 and FY 2024,' which misses the important distinction that the classification evolved.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information about refinancing strategy by connecting the stable $495M note to the $10B issuance in 2024, which shows reasonable multi-hop thinking. However, this synthesis doesn't fully capture the ground truth's core insight about the debt transitioning to current portion status in 2024, which is the key revelation about short-term debt management.\n\nCALCULATIONS: No calculations are required for this question, so quantitative accuracy focuses on number verification. The $495M figure is correct, but the classification/status evolution is misrepresented.\n\nSEMANTIC ISSUES: The LLM's statement that the balance remained 'unchanged' across all three years is technically correct for the dollar amount, but it obscures the important change in debt classification that the ground truth emphasizes as revealing about refinancing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 541,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "AMD’s 10‑K filings from 2022 through 2024 consistently show that AMD protects AIB manufacturers’ inventory against price reductions and that system integrators use discrete graphics to differentiate their board‑level products.  Across all three years the wording and emphasis on these inventory‑protection policies and the role of discrete graphics remained unchanged, with no substantive policy shifts or new differentiation tactics noted.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some core elements correctly but has significant gaps in completeness and nuance. CORRECT ELEMENTS: (1) The identification of inventory protection policies for AIBs across 2022-2024 is accurate. (2) The mention of discrete graphics as a differentiation tool is correct. (3) The statement that policies remained consistent across the three years aligns with the ground truth. (4) No quantitative metrics are provided in either answer, so no calculation errors exist. SIGNIFICANT GAPS AND ISSUES: (1) The LLM answer states 'wording and emphasis...remained unchanged' which is overly simplistic and misses the ground truth's more nuanced point about 'repeated emphasis on short design cycles, rapid response to new technologies' as indicators of sustained strategic focus. (2) The ground truth emphasizes that AIBs 'build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors' - a specific characterization of the AIB role that the LLM answer omits. (3) The ground truth notes AMD 'continuing to offer component-level graphics and chipset products to AIBs' - this specific product offering detail is absent from the LLM answer. (4) The ground truth's insight about 'short design cycles, rapid response to new technologies' as strategic indicators is completely missing from the LLM response. (5) The LLM answer's claim of 'no substantive policy shifts or new differentiation tactics noted' is somewhat contradicted by the ground truth's emphasis on the 'sustained strategic focus' and evolution of emphasis, even if policies remained stable. The LLM answer is partially correct but lacks the depth of analysis regarding how AMD's strategic positioning evolved in terms of emphasis and focus areas, even if the core policies remained consistent. The answer reads as incomplete rather than incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 506,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "From 2022 to 2024 Disney shifted its DTC strategy from a broad re‑organization and heavy content‑marketing spend aimed at driving subscriber growth and launching an ad‑supported Disney+ (2022 risk factor, page 29) to a more focused, cost‑realignment‑driven approach that includes content curation, removal of under‑performing titles, and the launch of ESPN’s flagship DTC service (2023 risk factor, page 55). By 2024 the company emphasized further cost realignment, expanded its Star India joint venture, and continued to invest in ad‑supported Disney+ and new pricing models to compete in a crowded streaming market, while projecting that these investments would drive subscription‑fee and advertising‑revenue growth to offset declines in linear network revenue (2024 risk factors, pages 22‑25).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Disney's DTC strategy from 2022-2024 with generally accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the shift from 2022 risk acknowledgment to more confident 2023-2024 positioning; (2) Accurately mentions specific initiatives (ad-supported Disney+, ESPN DTC service, Star India joint venture, content curation); (3) Properly synthesizes that 2024 strategy emphasizes investments offsetting linear network declines; (4) Correctly notes competitive pressures in the streaming market; (5) Page references appear reasonable for risk factor sections. WEAKNESSES: (1) The LLM answer emphasizes 'cost realignment' and 'content curation/removal of underperforming titles' more heavily than the ground truth, which focuses on investment confidence and strategic dependency; (2) Missing the explicit 2022 language about 'costs and associated losses may continue to grow' and 'returns may be negative or lower'; (3) The characterization of the evolution differs slightly - ground truth emphasizes shift from 'cautious investment' to 'integrated and strategically dependent posture,' while LLM emphasizes 'broad reorganization' to 'focused cost-realignment'; (4) LLM doesn't explicitly capture the 2023 confidence statement about DTC investments leading to growth that 'will more than offset' impacts on affiliate/linear revenues - instead uses more general language about 'drive subscription-fee and advertising-revenue growth to offset declines'; (5) The framing of 2024 as 'further cost realignment' may understate the operational criticality and competitive positioning aspects highlighted in ground truth. QUANTITATIVE ACCURACY: No specific numbers or percentages provided in either answer, so this dimension is less applicable. Page references in LLM answer cannot be verified against ground truth but appear plausible. MULTI-HOP REASONING: Both answers successfully synthesize information across three years and multiple strategic dimensions (investment focus, competitive positioning, revenue expectations). The LLM demonstrates sound reasoning in connecting these elements. SEMANTIC EQUIVALENCE: While wording differs, the core message about strategic evolution is conveyed, though with different emphasis and framing that slightly diverges from the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 631,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850% notes, issued in September 2019, remained a $1.5 billion senior unsecured obligation with a 10/1/2029 maturity throughout 2022‑2024. The principal and effective interest rate (2.96%) stayed constant, and the note continued to be part of the company’s $10.6 billion term‑debt portfolio with no changes to its maturity schedule or redemption terms during that period【104】【107】【105】【108】【103】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1.5 billion principal amount of the 2.850% notes, the 2029 maturity date (10/1/2029), and that the notes remained unchanged throughout 2022-2024. The mention of the notes being senior unsecured and issued in September 2019 adds helpful context. The effective interest rate of 2.96% is provided.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the core evolution of PayPal's broader debt structure across the three years. The ground truth explicitly states total term debt was $9.0B (2022), $10.638B (2023), and $10.574B (2024) - showing significant changes. The LLM vaguely references \"$10.6 billion term-debt portfolio\" without showing the year-by-year evolution or the $9.0B starting point. (2) MISSING STRATEGIC CONTEXT: The ground truth highlights that PayPal issued new debt with higher rates (5.150% and 5.500% notes) in 2024, indicating a financing strategy shift. The LLM completely omits this important contextual information about how the company's debt strategy evolved. (3) INCOMPLETE ANSWER TO QUESTION: The question specifically asks how the relationship \"evolved\" across the three years and about \"debt structure and maturity obligations across these years.\" The LLM states things \"stayed constant\" and \"no changes\" - which is partially true for the 2.850% notes themselves, but misses the broader structural evolution that is central to the question. (4) VAGUE REFERENCE: The statement \"$10.6 billion term-debt portfolio\" lacks specificity about year-to-year changes and doesn't match the precise figures in the ground truth.\n\nCALCULATION/NUMBER VERIFICATION: All specific numbers cited ($1.5B, 2.850%, 2.96%, 10/1/2029) are correct. However, the incomplete presentation of the $9.0B→$10.638B→$10.574B progression represents a significant omission of quantitative data essential to answering the question.\n\nMULTI-HOP REASONING: The LLM fails to synthesize the evolution of PayPal's overall debt strategy while maintaining the 2.850% notes. It treats the notes in isolation rather than showing how they fit into the changing debt landscape across 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 579,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan corporate‑stock holdings fell sharply from **$1,111 million (≈37 % of plan assets) in 2022** to **$181 million (≈5 % of plan assets) in 2023**, then rose modestly to **$226 million (≈7 % of plan assets) in 2024**【page_58】【page_56】.  \nThis swing shows a deliberate de‑risking move away from direct equity exposure—aligning with the plan’s target equity range of 20‑30 %—and a subsequent, modest re‑balancing back toward equities while still keeping the allocation well below the 2022 level.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 figure. The ground truth states UNP's Corporate Stock allocation was $1,990 million in 2022, but the LLM claims it was $1,111 million—a discrepancy of $879 million (44% understatement). This is a major quantitative error that undermines the entire analysis. The 2023 figure of $181 million is correct, matching the ground truth. The 2024 figure of $226 million cannot be verified against the ground truth, which does not provide a specific 2024 dollar amount, only noting a reclassification to Level 1 investments. MISSING CRITICAL INFORMATION: The ground truth emphasizes a crucial strategic shift—the reclassification of common stock holdings as Level 1 investments in 2024 while maintaining preferred shares as Level 2. The LLM answer completely omits this important detail about the change in valuation methodology and investment structure, which is central to understanding the company's investment strategy evolution. PERCENTAGE CALCULATIONS: The LLM provides percentages (37%, 5%, 7%) that cannot be verified from the ground truth, which does not include percentage allocations. The reasoning about target equity ranges (20-30%) is introduced without ground truth support. REASONING QUALITY: While the LLM correctly identifies the general trend of de-risking and rebalancing, the analysis is built on an incorrect 2022 baseline figure, making the comparative analysis fundamentally flawed. The multi-hop synthesis fails because it misrepresents the magnitude of the initial decline. The answer does address the evolution question but with significant factual errors that distort the narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 464,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost declined from **$800 million at December 31 2022** to **$719 million at December 31 2024** (a drop of $81 million)【page_87】【page_83】. This modest contraction indicates the company has reduced its allocation to illiquid alternative assets, suggesting a strategic shift toward a more balanced or less concentrated private‑equity exposure over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the 2022 value as $800 million, but the ground truth clearly shows $623 million - a $177 million discrepancy (28% error). The 2024 value of $719 million is correct. The calculated decline of $81 million is mathematically incorrect given the wrong 2022 baseline ($800M - $719M = $81M is arithmetically correct for those numbers, but the 2022 figure itself is wrong). The correct decline should be $623M - $719M = -$96M (actually an increase, not a decline). (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM completely omitted the 2023 intermediate data point ($755 million), which is crucial for understanding the trend. The ground truth shows a three-year progression (2022→2023→2024) with growth followed by decline. The LLM only presents endpoints, missing the critical inflection point that characterizes the actual strategic pattern. (3) MISCHARACTERIZATION OF TREND: The LLM incorrectly describes this as a 'modest contraction' and 'reduction' when the actual data shows an increase from 2022 to 2024 ($623M to $719M = +$96M or +15.4%). The ground truth correctly identifies growth in 2023 followed by modest retrenchment in 2024. The LLM's interpretation is backwards. (4) REASONING QUALITY: While the LLM's reasoning about strategic implications (balanced allocation, less concentrated exposure) is plausible, it is built on incorrect factual foundations. The conclusion about 'reduced allocation to illiquid alternative assets' contradicts the actual net increase over the period. (5) ENTITY AND METRIC ACCURACY: The company (Pfizer) and metric (long-term private equity securities at cost) are correctly identified, but the numerical values are substantially wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 499,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024, Mastercard’s multi‑layered security strategy deepened collaboration with issuers, acquirers, merchants, governments and industry associations to set technical standards and share best practices, while expanding its real‑time payment infrastructure from 12 of the top 50 markets in 2022 to 13 markets in 2023 and further global real‑time clearing and settlement capabilities in 2024 (page_11, 2022‑2024). Throughout this period, the company strengthened cyber resilience by deploying Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, conducting regular vulnerability testing, and integrating enterprise resilience programs and insurance coverage, all while monitoring and responding to threats—including those from third‑party providers—through public‑private partnerships (page_11, 2022‑2024). These enhancements have enabled Mastercard to maintain a robust, multi‑layered security posture that protects the global payments ecosystem and supports the rapid expansion of its real‑time payment services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the main question components but contains a significant quantitative error that undermines accuracy. STRENGTHS: (1) Correctly identifies the evolution of Mastercard's security approach from 2022-2024 with appropriate emphasis on third-party collaboration, real-time payment infrastructure, and cyber resilience; (2) Accurately mentions Security Operations Centers, Fusion Centers, and Mastercard Intelligence Center; (3) Properly synthesizes multi-hop information across the three-year period; (4) Correctly notes the shift toward ecosystem integration and partnership-driven security. CRITICAL ERROR: The LLM states 'expanding its real-time payment infrastructure from 12 of the top 50 markets in 2022 to 13 markets in 2023.' The ground truth indicates 13 markets as of year-end 2023, but does not mention '12 of the top 50 markets in 2022' as a baseline. This appears to be an unsupported claim that introduces a false quantitative comparison. The ground truth only confirms 13 markets in 2023 and 'further global expansion' in 2024, without specifying a 2022 baseline of 12 markets. MINOR ISSUES: (1) The answer adds details about 'issuers, acquirers, merchants, governments and industry associations' that, while plausible, are not explicitly confirmed in the ground truth; (2) References to 'enterprise resilience programs and insurance coverage' are not mentioned in the ground truth; (3) The phrase 'global real-time clearing and settlement capabilities' in 2024 is vague and not specifically detailed in the ground truth. MULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound and addresses all three question components (third-party collaboration, real-time infrastructure, cyber resilience), though the unsupported 2022 baseline number significantly weakens the quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 497,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1,494 million in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (page 102; page 99). The steady decline—about 45 % from 2022‑23 and 38 % from 2023‑24—suggests the company has reduced its derivative exposure or improved netting and hedging practices, thereby lowering the initial‑margin collateral required and indicating more efficient derivative‑risk management over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) WRONG 2022 FIGURE: LLM states $1,494 million for 2022, but ground truth shows $800 million at end of 2022. This is a 87% overstatement. (2) CORRECT 2023 FIGURE: LLM correctly states $800 million for 2023, matching ground truth's 2022 year-end figure (reported in 2023 filing). (3) CORRECT 2024 FIGURE: LLM correctly states $491 million for 2024, matching ground truth. (4) CALCULATION ERRORS: LLM calculates 45% decline from 2022-23 ($1,494M to $800M), but this is based on the incorrect $1,494M starting point. The actual decline from correct 2022 figure ($800M) to 2023 ($491M) is 38.6%, which the LLM does correctly state for 2023-24. (5) MISSING CONTEXT: The ground truth explicitly references the 2021 baseline ($641M) which provides important context for understanding the trend. The LLM omits this starting point entirely. (6) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (declining collateral suggesting improved derivative management), this reasoning is undermined by the incorrect baseline number. The qualitative interpretation about reduced derivative exposure and improved netting practices is sound, but built on faulty quantitative foundation. (7) ENTITY/METRIC ACCURACY: Correctly identifies ExxonMobil, master netting arrangements, and collateral metrics, but fails on the actual values. The answer demonstrates understanding of the concept but severe execution failure on the primary quantitative requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 436,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "From 2022 to 2024, Duke Energy’s relative TSR model’s expected volatility rose from 26.9 % in 2022 to 28.6 % in 2023, then fell sharply to 18.7 % in 2024【page_214】【page_206】【page_216】. This multi‑year swing indicates that market participants viewed the company’s equity as riskier in 2023, but perceived a significant reduction in risk by 2024, likely reflecting improved stability or lower expected market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% (2022), 28.6% (2023), and 18.7% (2024) - matching the ground truth exactly. The numerical progression and magnitude of changes are accurate. (2) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR model is properly referenced, and the peer group context is maintained. The three-year period (2022-2024) is correctly addressed. (3) MULTI-HOP REASONING: The answer successfully synthesizes the volatility data across three years and correctly interprets the trajectory - identifying 2023 as a peak risk period and 2024 as showing significant risk reduction. The logical inference about market perception is sound and matches the ground truth's interpretation. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'market participants viewed the company's equity as riskier in 2023, but perceived a significant reduction in risk by 2024' is semantically equivalent to the ground truth's 'peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty.' Both convey the same analytical insight. (5) MINOR DIFFERENCES: The LLM adds slightly more interpretive language ('likely reflecting improved stability or lower expected market volatility') which provides reasonable context without contradicting the ground truth. The inclusion of page references adds credibility. No calculation errors, no missing data points, and the overall narrative structure properly addresses the multi-year shift question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 444,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024, GM’s indemnification obligations to Stellantis under the Opel/Vauxhall sale remained uncertain and subject to thresholds, caps, and time limits, with no material accruals recorded. The company continued to indemnify Stellantis for an immaterial amount for certain recalls—including those related to Takata inflators in legacy Opel vehicles—and it believed any further indemnification would be remote. Consequently, GM could not estimate a material loss from emissions claims or Takata recalls, so the accruals for these obligations stayed immaterial throughout the period (see pages 92–93 of the 2024, 2023, and 2022 10‑K filings).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core narrative: immaterial indemnification amounts throughout the period with no material accruals recorded; (2) Accurately captures the evolution of GM's stance on Takata recalls (from potential future obligations in 2022 to 'remote' assessment by 2023-2024); (3) Properly identifies both key claim types: Takata inflators in legacy Opel vehicles AND European Commission/UK CMA investigations into Opel conduct; (4) Correctly notes the thresholds, caps, and time limits governing indemnification obligations; (5) Appropriately emphasizes the consistency of minimal financial exposure across the three-year period; (6) Provides specific filing references (pages 92-93 of 2024, 2023, 2022 10-Ks) that enhance credibility. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer uses slightly more technical language ('subject to thresholds, caps, and time limits') compared to the ground truth's more narrative approach, though this is semantically equivalent and arguably more precise; (2) The ground truth explicitly mentions 'accrued an immaterial amount related to European Commission and UK CMA investigations' in 2024, while the LLM answer references this more generally as part of the overall immaterial accruals discussion—this is not an error but represents a slightly less explicit treatment of the 2024-specific development; (3) No quantitative discrepancies detected—all references to 'immaterial' amounts, 'remote' likelihood, and 'no material accruals' align with ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and two distinct claim categories (Takata recalls and emissions investigations), correctly tracking how GM's assessment evolved from 2022 through 2024. The logic connecting immateriality, remoteness assessments, and lack of material accruals is sound and well-integrated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 544,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks, AMD consistently cites the 2011 Executive Incentive Plan as Exhibit 10.2 to the 2011 10‑Q, with identical wording in the Exhibits section (see 2022 p. 91, 2023 p. 99, 2024 p. 98).  The unchanged reference shows that the plan remains in effect and is a core element of the company’s executive‑compensation framework.  This consistency signals a long‑term, stable strategy that relies on a single, enduring incentive plan rather than frequent redesigns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the plan was referenced as 'Exhibit 10.2 to the 2011 10-Q' but the ground truth clearly indicates it was 'Exhibit 10.1' in 2022 (and maintained in 2023/2024). This is a factual error on a specific, verifiable detail. (2) PAGE NUMBER VERIFICATION: The LLM provides specific page numbers (2022 p. 91, 2023 p. 99, 2024 p. 98) that cannot be verified against the ground truth provided, and these specific citations may be inaccurate. (3) FILING DATE DISCREPANCY: The ground truth specifies the plan was 'filed on April 2, 2011' but the LLM references it as 'Exhibit 10.2 to the 2011 10-Q' without mentioning the specific filing date. The reference to a 10-Q rather than the original filing is potentially incorrect. (4) CONSISTENCY OF ANALYSIS: While both answers correctly identify that the plan was consistently referenced across 2022-2024 without amendments, the LLM's specific details about exhibit numbers and filing sources appear to contradict the ground truth. (5) QUALITATIVE REASONING: The LLM's conclusion about stable strategy and long-term consistency is sound and aligns with the ground truth's interpretation, but this correct reasoning is undermined by the factual errors in the supporting details. The answer demonstrates understanding of the question's intent but fails on precision of verifiable facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 387,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal’s 2022 10‑K identified bad‑transaction risk, credit‑product default risk, cross‑border trade disruption, and third‑party payment‑processor dependence as material risks. The 2024 filing reiterated these concerns but added more detail on evolving fraud schemes, trade‑barrier impacts, and the potential for partner‑bank lending interruptions, underscoring the continued exposure. In 2023, PayPal mitigated these risks by selling a €40 bn portfolio of UK and European BNPL loan receivables (with a forward‑flow arrangement) and accelerating diversification of its payment‑processor network to reduce reliance on a single partner.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the €40 billion BNPL receivables sale in 2023 as a key strategic mitigation action, matching the ground truth. (2) The numeric value (€40 bn) is accurate and properly formatted. (3) The answer correctly identifies 2022, 2023, and 2024 as the relevant time periods. (4) The LLM appropriately recognizes credit defaults, fraud, and third-party dependencies as material risks across the period.\n\nWEAKNESSES: (1) The LLM introduces unsupported claims not in the ground truth: specifically, it mentions 'accelerating diversification of its payment-processor network' and 'reduce reliance on a single partner' as 2023 mitigation actions. The ground truth makes no mention of payment-processor network diversification as a strategic response in 2023. (2) The LLM mentions 'forward-flow arrangement' in parentheses, which is not explicitly confirmed in the ground truth and appears to be an inference or addition. (3) The LLM conflates some risk categories: it mentions 'cross-border trade disruption' and 'trade-barrier impacts' but the ground truth specifically focuses on 'cross-border trade' in the context of bad transactions risk, not trade barriers. (4) The answer lacks specificity about the Synchrony Bank partnership mentioned in the ground truth as a key credit product exposure in 2022. (5) The LLM doesn't clearly distinguish between risks that evolved versus those that remained consistent across the three-year period.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the 2023 BNPL sale to risk mitigation across the 2022-2024 period. However, it adds unsupported strategic actions (payment-processor diversification) that weren't part of the ground truth's documented mitigation steps, which weakens the accuracy of the multi-hop analysis.\n\nCORRECTION NEEDED: The primary error is the introduction of payment-processor network diversification as a 2023 mitigation strategy, which is not supported by the ground truth. This represents a factual inaccuracy that affects the overall correctness despite getting the main BNPL transaction correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 573,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific’s owned multiple‑purpose locomotives fell from 6,204 in 2022 to 5,971 in 2023 and 5,973 in 2024, while the average age rose from 22.5 to 24.3 to 25.2 years (2022: page 24 of the 2022 10‑K; 2023: page 19 of the 2023 10‑K; 2024: page 19 of the 2024 10‑K). This gradual reduction in fleet size coupled with a steadily aging core signals a deliberate strategy of retiring older units and slowly replacing them with newer, more efficient locomotives to modernize the fleet while maintaining a leaner, more cost‑effective operation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding owned locomotives in 2024. Ground truth states 5,973 units in 2024, but the LLM claims 5,973 in 2024 while also stating 5,971 in 2023. This creates an internal inconsistency and suggests potential data confusion. More importantly, the LLM completely OMITS leased locomotives data, which is a major component of the original answer. Ground truth shows leased units dropped from 1,038 to 920 - this is a substantial 118-unit reduction (11.4% decline) that represents important fleet management information. The LLM's failure to address leased equipment is a significant omission in a multi-hop question about fleet composition. REASONING QUALITY ISSUE: The LLM's interpretation of the data is fundamentally contradicted by the ground truth. The LLM concludes the strategy involves 'retiring older units and slowly replacing them with newer, more efficient locomotives to modernize the fleet,' but the ground truth explicitly states the opposite: 'This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.' The aging fleet (22.5 to 25.2 years) combined with reduced fleet size and no mention of new purchases indicates cost control, not modernization. The LLM misinterprets the data trend as evidence of modernization when it actually indicates deferred modernization. NUMERIC VERIFICATION: Owned locomotives 6,204→5,973 is correct directionally. Average age progression 22.5→24.3→25.2 years is correct. However, the missing leased equipment data (1,038→920) is a critical omission. The LLM provides page citations which adds credibility but doesn't compensate for the analytical error and incomplete data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 502,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral exposure under master‑netting arrangements tied to equity‑company receivables fell sharply: it was $1.494 billion at year‑end 2022, dropped to $800 million in 2023, and further declined to $491 million in 2024 (see XOM 10‑K 2023, p. 102 and XOM 10‑K 2024, p. 99). This consistent downward trend suggests the company is tightening its derivative risk management—likely trimming derivative positions or improving netting efficiency to reduce collateral costs and counter‑party exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect numbers. Ground truth shows 2022: $641M, 2023: $800M, 2024: $491M. LLM claims 2022 was $1.494 billion (nearly 2.3x the correct amount), which is a major factual error. The 2023 and 2024 figures match ground truth, but the 2022 figure is completely wrong. (2) TREND MISCHARACTERIZATION - Ground truth describes a peak in 2023 followed by decline (up then down pattern: $641M→$800M→$491M). LLM incorrectly characterizes this as a 'sharp fall' and 'consistent downward trend' starting from 2022, which is false—the 2022-2023 movement was actually upward. (3) MULTI-HOP REASONING - The LLM's interpretation of the trend is logically flawed because it's based on incorrect starting data. Ground truth correctly identifies the 2023 peak as significant; LLM misses this inflection point entirely. (4) PARTIAL CREDIT - The LLM correctly identifies 2023 ($800M) and 2024 ($491M) values and provides reasonable interpretation about derivative risk management tightening, but the foundational error about 2022 undermines the entire trend analysis. (5) SEMANTIC ISSUES - The phrase 'fell sharply' and 'consistent downward trend' are semantically incorrect given the actual 2022-2023 increase. The answer demonstrates some understanding of risk management concepts but fails on basic factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 395,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” category continued to be defined the same way in each filing – packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware, and other items (see Note 17, page 86).  Revenue in the category rose from $6.89 B (21 % of total) in 2022 to $7.71 B (22 %) in 2023, then fell slightly to $7.54 B (21 %) in 2024, keeping its share of total revenue roughly 21‑22 % (page 86).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the composition of the 'Other' category and accurately notes that it remained stable across 2022-2024, which aligns with the ground truth. The qualitative assessment of consistency is sound. However, there are significant issues with the quantitative data: (1) The LLM provides specific revenue figures ($6.89B in 2022, $7.71B in 2023, $7.54B in 2024) and percentages (21-22% of total) that are NOT present in the ground truth answer. The ground truth explicitly states there was 'no explicit mention of new product categories or significant shifts' but does NOT provide these specific dollar amounts or percentage breakdowns. (2) The LLM cites 'Note 17, page 86' as a source, but the ground truth does not reference these specific figures, suggesting the LLM may have fabricated or hallucinated these numbers. (3) The calculation logic (revenue rising then falling, maintaining 21-22% share) is internally consistent, but without verification against actual 10-K filings, these numbers cannot be confirmed as accurate. The answer demonstrates good understanding of the question's multi-hop nature and correctly synthesizes the compositional stability across years, but the introduction of unverified quantitative data significantly undermines credibility. The answer would be stronger if it either: (a) provided verified numbers with proper sourcing, or (b) acknowledged that specific revenue figures were not available in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 407,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 onward Alphabet continued to monetize inventory on Google Network properties (AdMob, AdSense, and Google Ad Manager) using impression‑based metrics—cost‑per‑impression is defined as the ratio of impression‑based and click‑based revenue to total impressions (2022 page 31; 2023 page 57; 2024 page 56).  In 2023 the company clarified that it reports revenue for these ads on a **gross basis**—the full amount billed to customers is recorded as revenue, while partner payments are treated as cost of revenues (2023 page 57; 2024 page 56).  This gross‑revenue reporting approach remained unchanged in 2024, underscoring a consistent recognition policy for Google Ad Manager inventory across the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about Google's advertising monetization evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the impression-based and click-based revenue model with accurate cost-per-impression definition; (2) Accurately captures the 2023 clarification regarding gross revenue reporting; (3) Properly notes that this approach remained consistent through 2024; (4) Correctly identifies the key principle that full amounts billed to customers are recorded as revenue with partner payments as cost of revenues; (5) Provides specific page citations (2022 page 31; 2023 page 57; 2024 page 56) that add credibility; (6) Correctly names Google Network properties (AdMob, AdSense, Google Ad Manager). MINOR WEAKNESSES: (1) The LLM answer expands slightly beyond the original ground truth by explicitly naming AdMob and AdSense as Google Network properties, though this is not incorrect—it's actually more specific; (2) The original answer emphasizes 'increasing transparency and accounting clarity over time' as part of the evolution narrative, while the LLM answer focuses more on consistency rather than evolution/change; (3) The LLM answer could have been slightly more explicit about the evolution aspect (how things changed/clarified) versus just consistency. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly traces the evolution of accounting practices and transparency. The connection between impression-based metrics and gross revenue recognition is properly established. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis (consistency vs. evolution) but no factual contradictions. The core message about gross revenue reporting and the accounting treatment is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 524,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across 2022, 2023 and 2024 MDLZ’s exposure to sales‑ and media‑marketing restrictions has remained essentially unchanged – the company continues to be subject to front‑of‑pack labeling rules for nutrient and environmental claims and to marketing limits on promotions of products with specified nutrient profiles.  The extended‑producer‑responsibility (EPR) landscape, however, has broadened: the company notes EPR mandates in more than 25 EU member states and the ongoing implementation or contemplation of similar policies in India, Vietnam and U.S. states, indicating a widening jurisdictional scope while the nature of the exposure stays consistent.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant omissions and mischaracterizations of the evolution described in the ground truth. STRENGTHS: (1) Correctly identifies the 25+ EU countries with EPR policies, (2) Correctly mentions India, Vietnam, and U.S. states as jurisdictions with EPR implementation/contemplation, (3) Accurately references front-of-pack labeling and nutrient profile restrictions. CRITICAL WEAKNESSES: (1) The LLM claims exposure 'has remained essentially unchanged' across 2022-2024, which directly contradicts the ground truth showing clear evolution and expansion. The ground truth explicitly documents a 'shift from contemplation to enforcement' and 'growing regulatory burden across more jurisdictions.' (2) Missing key 2023 developments: The LLM fails to mention the increased attention to front-of-pack labeling based on nutrient profiles and environmental claims that became more prominent in 2023. (3) Missing critical 2024 development: The LLM does not mention the EU's formal adoption of the Packaging and Packaging Waste Directive in 2024, which represents a major regulatory milestone. (4) Incomplete jurisdictional tracking: The ground truth shows Indonesia and the Philippines were mentioned in 2022-2023 regarding single-use plastic bans and taxes, but the LLM omits this entirely. (5) Mischaracterization of trend: The LLM states 'the nature of the exposure stays consistent' when the ground truth clearly shows increasing specificity and enforcement intensity. The LLM's characterization of 'widening jurisdictional scope' is correct but insufficient—it misses the qualitative shift from consideration to formal adoption and enforcement. The answer reads as a static snapshot rather than capturing the dynamic evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 482,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Mastercard’s A‑class common shares continued to carry **one vote per share and dividend rights** in each of the three reporting years.  The 2022, 2023 and 2024 10‑K “Classes of Capital Stock” tables all list A shares as “One vote per share Dividend rights”【page_98】【page_101】【page_96】.  This unchanged status demonstrates a deliberate capital‑structure strategy that preserves stable voting power and predictable dividend policy for common shareholders, underscoring Mastercard’s commitment to a consistent, shareholder‑friendly governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies that A Class shares maintained one vote per share and dividend rights consistently across 2022, 2023, and 2024 - matching the ground truth exactly. (2) Properly synthesizes the multi-hop requirement by comparing the status across all three years and drawing the correct conclusion about consistency. (3) Accurately cites the source documents (10-K filings with page references), demonstrating proper evidence gathering. (4) The interpretation that this consistency indicates a deliberate capital structure strategy preserving stable voting power and predictable dividend policy is semantically equivalent to and consistent with the ground truth's statement about 'maintaining a consistent capital structure strategy.' (5) All numeric claims (one vote per share) are factually correct. MINOR CONSIDERATIONS: (1) The LLM adds interpretive language about 'shareholder-friendly governance framework' and 'commitment to consistency' which goes slightly beyond the ground truth's more neutral statement, though this is not factually incorrect - it's an appropriate inference from the data. (2) The answer is slightly more elaborate than the ground truth but maintains complete factual accuracy. The core finding - no changes in voting or dividend entitlements over the three-year period - is correctly identified and properly supported with evidence. The multi-hop reasoning (comparing across three years) is sound and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 417,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: $1.49 billion in 2022, $800 million in 2023 and $491 million in 2024.  The decline—primarily tied to initial‑margin requirements on “Investments, advances and long‑term receivables”—suggests the company has reduced its net derivative exposure or shifted to more cleared, lower‑margin contracts, easing its margin obligations over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error in the 2022 figure. Ground truth states $641 million for 2022, but the LLM claims $1.49 billion—this is a 132% overstatement and fundamentally incorrect. The 2023 ($800 million) and 2024 ($491 million) figures are correct. QUANTITATIVE ACCURACY: The 2022 number is completely wrong ($1.49B vs $641M), representing a significant factual error that undermines the entire answer. The other two years are accurate. QUALITATIVE ACCURACY: The reasoning about derivative exposure reduction and margin requirements is plausible and aligns with the trend direction, but it's built on an incorrect foundation. The interpretation about 'cleared, lower-margin contracts' is speculative and not supported by the ground truth answer. MULTI-HOP SYNTHESIS: The answer attempts to synthesize the collateral data with derivative exposure implications, which is appropriate, but the incorrect starting point (2022 figure) breaks the logical chain. CONTEXTUAL RELEVANCE: The answer addresses the question's core elements (collateral changes, derivative exposure, margin requirements) but the fundamental numerical error severely compromises its value. The trend analysis would be different if starting from $641M rather than $1.49B. The answer should have shown a more modest increase from 2022-2023 before the 2024 decline, not a sharp overall decline from an inflated 2022 baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 395,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ 2022 10‑K (page 12) stated that its fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward contracts, futures and collars, would secure an adequate supply of green coffee through fiscal 2023. The 2023 and 2024 10‑Ks (page 12) extend that coverage to fiscal 2025, showing a deliberate shift to longer‑term hedging and supply agreements. This evolution indicates the company is proactively locking in supply and hedging price risk over a broader horizon to strengthen its resilience against coffee price volatility and supply disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Starbucks' supply chain commitments evolution. STRENGTHS: (1) Correctly identifies the fiscal year progression (2022→2023→2024) and the corresponding supply coverage periods (through fiscal 2023 in 2022 10-K, extended to fiscal 2025 in 2023 and 2024 10-Ks). (2) Accurately cites page 12 of the relevant 10-Ks as the source. (3) Correctly identifies the specific risk management tools used (fixed-price commitments, price-to-be-fixed commitments, forward contracts, futures, and collars). (4) Properly synthesizes the multi-hop information across three fiscal years to identify the strategic trend toward longer-term hedging. (5) Accurately interprets the strategic implications: proactive locking in of supply and price risk hedging to manage volatility and supply disruptions. (6) The reasoning is sound and logically connects the evolution of commitments to the company's risk management strategy. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions 'C' price exposure specifically, while the LLM answer uses the more general term 'price risk' - both are semantically equivalent and accurate. The LLM answer's characterization of the shift as 'deliberate' and 'proactive' aligns well with the ground truth's description of a 'strategic shift.' All dates, fiscal years, and financial concepts are correctly identified and synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 430,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN moved its U.S. defined‑benefit plans to a 100 % debt‑only mix, dropping the 5 % cash allocation it held in 2023, while its non‑U.S. plans increased equity exposure from 19 % to 28 % and reduced debt from 43 % to 36 % (cash rose from 6 % to 7 %). This shift shows a deliberate move to match U.S. plan assets more closely to liability duration with a conservative debt focus, while taking on higher equity risk abroad to lift expected returns. Overall, the multi‑year adjustment signals a long‑term strategy aimed at achieving risk‑adjusted returns that exceed inflation over time, consistent with the plans’ stated investment objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS: The LLM states specific allocation percentages (U.S. plans moved to 100% debt, non-U.S. plans increased equity from 19% to 28%, debt reduced from 43% to 36%, cash rose from 6% to 7%) - these precise numbers are not present in the ground truth answer and appear to be hallucinated data points. The ground truth explicitly states that specific allocation percentages are not detailed, only that the company maintained 'a diversified portfolio of fixed income and equities' with 'updated flexibility ranges.' (2) FACTUAL CONTRADICTION: The ground truth emphasizes 'continuity in strategy' and 'consistent yet adaptive' approach, while the LLM claims a dramatic shift to '100% debt-only mix' for U.S. plans - this represents a fundamental mischaracterization of the strategic evolution. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information about liability matching and risk-adjusted returns (which aligns with ground truth themes), it does so by inventing specific allocation data that contradicts the ground truth's emphasis on flexibility and diversification. (4) MISSING CONTEXT: The ground truth notes that the company maintained 'specific attention to matching debt securities' duration to plan liabilities' - the LLM oversimplifies this to a 100% debt allocation claim. (5) VERIFICATION FAILURE: The precise percentages cited (100%, 19%, 28%, 43%, 36%, 6%, 7%) cannot be cross-referenced with the ground truth, suggesting data fabrication rather than accurate synthesis from SEC filings. The answer demonstrates confident but incorrect quantitative claims that would mislead users about ACN's actual pension allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 495,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen has consistently positioned Olpasiran as an siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease, with the molecule listed under cardiovascular disease in the product‑candidate tables of the 2022, 2023, and 2024 10‑K filings (page_24). The composition‑of‑matter patents for Olpasiran, issued in the U.S. and EU, are projected to expire in 2036, a timeline that has remained unchanged across the three reports (page_26). Thus, Olpasiran’s therapeutic focus and IP protection strategy have been stable from 2022 through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the core question about how Olpasiran's positioning 'evolved' from 2022-2024. The ground truth explicitly states a progression: (1) 2022 - phase 2 trials for atherosclerotic CV disease, (2) 2023 - patent protection disclosure (2036 expiration), (3) 2024 - transition to 'Cardiovascular disease' indication suggesting advancement. The LLM claims the positioning was 'stable' and 'unchanged' across all three years, which directly contradicts the ground truth's narrative of strategic evolution and transition from early clinical investigation to more advanced development. QUANTITATIVE ACCURACY: The LLM correctly identifies the 2036 patent expiration date and mentions composition-of-matter patents in U.S. and EU, which aligns with ground truth. However, the LLM adds specific details ('lowers lipoprotein(a)') and page references that cannot be verified against the ground truth provided. QUALITATIVE ACCURACY: The LLM fundamentally mischaracterizes the nature of the evolution. The ground truth describes a clear progression (phase 2 → patent disclosure → indication transition), while the LLM claims stability. This represents a major reasoning error in synthesizing the multi-hop information across years. The LLM appears to have conflated 'consistent therapeutic area focus' (cardiovascular) with 'no evolution in positioning,' missing the developmental stage transitions and strategic milestones. COMPLETENESS: The LLM fails to address the key evolutionary elements: the phase 2 status in 2022, the patent protection disclosure milestone in 2023, and the indication transition in 2024. Instead, it presents a static view. The question specifically asks about 'evolution' and the LLM's answer of 'stable/unchanged' is semantically opposite to what was asked and what the ground truth documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 508,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "From 2022 through 2024, American Express’s reliance on aggregators shifted from a growing but secondary role to a core component of its merchant‑acceptance ecosystem, with the 2024 10‑K (pp. 33‑37) explicitly listing aggregators among the third‑party service providers that support card acquisition and transaction processing. In 2022 and 2023 (pp. 27‑31), the company warned that aggregators might not promote card usage or could pursue business interests that conflict with its own, creating a risk of merchant steering away from the network and loss of partner relationships. By 2024, the disclosures broadened the risk narrative to include the operational complexity and governance challenges of a larger third‑party base, the potential for service disruptions or data‑security incidents, and the regulatory and reputational consequences of failing to meet service‑level or compliance obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of American Express's evolving reliance on aggregators from 2022-2024. STRENGTHS: (1) Correctly identifies the progression from secondary to core role for aggregators; (2) Accurately captures the 2022-2023 concerns about merchant steering and conflicting business interests; (3) Properly synthesizes the 2024 expansion to include operational complexity, data-security risks, and regulatory/reputational consequences; (4) Appropriately references specific page numbers (pp. 27-31, 33-37) showing document-level precision; (5) Multi-hop reasoning is sound, connecting the evolution across three years with logical progression. MINOR WEAKNESSES: (1) The LLM answer adds specific page citations that, while appearing credible, cannot be verified against the ground truth provided; (2) The phrase 'core component of its merchant-acceptance ecosystem' is slightly more emphatic than the ground truth's 'increasingly emphasized' language, though semantically compatible; (3) The ground truth emphasizes 'litigation exposure' as a specific 2024 concern, while the LLM answer generalizes this to 'regulatory and reputational consequences' - this is a minor semantic shift but captures the essence; (4) The ground truth mentions 'surcharging' explicitly as a 2023 concern, which the LLM answer does not specifically call out, though it's implied in the broader risk discussion. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) based on the absence of numerical errors. QUALITATIVE ACCURACY: The reasoning chain is logical and well-structured, correctly synthesizing information across three years. The entity identification (American Express, aggregators, merchants, third-party processors) is accurate. The only minor issue is the slight generalization of specific risks in 2024. CONTEXTUAL RELEVANCE: The answer directly addresses the multi-part question about evolution and risks across the three-year period, maintaining appropriate focus on the disclosure narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 574,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks’ 2022 10‑K noted that green‑coffee price volatility was influenced by commodity index funds and that the company hedged exposure with forward contracts, futures and collars, with forward supply commitments covering up to fiscal 2023 (page_12, 2022). The 2023 filing reiterated the same exposure and hedging approach, extending forward commitments through fiscal 2024 (page_12, 2023). By fiscal 2024, the company further extended forward supply commitments to cover through fiscal 2025, indicating a longer‑term hedging horizon while the exposure to index funds remained a stated risk (page_12, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL YEAR PROGRESSION: The LLM answer contains a significant factual error in the timeline of forward supply commitments. According to the ground truth: (1) FY2022: commitments covered through FY2023, (2) FY2023: extended to FY2025, (3) FY2024: remained through FY2025. However, the LLM states: (1) FY2022: through FY2023 (CORRECT), (2) FY2023: through FY2024 (INCORRECT - should be FY2025), (3) FY2024: through FY2025 (CORRECT). This is a material error in the multi-hop synthesis showing the evolution of commitments. The LLM incorrectly characterized the FY2023 extension as only reaching FY2024 rather than FY2025, which undermines the core narrative about the strategic shift toward longer-term risk mitigation. STRENGTHS: The answer correctly identifies commodity index funds as a consistent factor, properly mentions hedging instruments (forward contracts, futures, collars), and accurately captures the general trend toward extended commitments. The answer appropriately notes that exposure remained a stated risk across all years. WEAKNESSES: Beyond the fiscal year error, the answer lacks the strategic insight present in the ground truth about the 'multi-year extension' signaling increased confidence and stabilized strategy. The ground truth emphasizes that the FY2023-to-FY2025 extension was significant, but the LLM misrepresents this as only FY2024. This is a quantitative accuracy failure on a key metric (fiscal year coverage periods) that affects the overall correctness of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 423,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture’s share‑repurchase activity grew from $4.11 B in fiscal 2022 (12.18 M shares) to $4.5 B in fiscal 2024 (2.07 M shares in Q4 alone, part of a $4.5 B total)【page_94】【page_40】【page_39】. Its aggregate available authorization for the open‑market program fell from $3.129 B in 2022 to $2.694 B in 2024, while the total outstanding authority for all share purchases rose to $6.694 B after a $4.0 B boost【page_93】【page_94】【page_39】. This trajectory signals Accenture’s intent to scale its capital‑return program, balancing dividends with an expanding share‑buyback capacity as cash flow permits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims Accenture repurchased $4.11B in fiscal 2022 and $4.5B in fiscal 2024, but the ground truth states only $605 million was spent in fiscal 2023 (not 2022 or 2024 specifically). The LLM's figures of $4.11B and $4.5B appear to be completely fabricated or misattributed. The ground truth mentions 2,000,308 shares purchased for $605M in fiscal 2023, not the 12.18M shares claimed for 2022. (2) AUTHORIZATION FIGURES: The LLM correctly states the available authorization fell from $3.129B (2022) to $2.694B (2024) and that a $4.0B boost raised total outstanding authority to $6.694B - these match ground truth. However, this partial accuracy is overshadowed by the massive errors in repurchase amounts. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the multi-year trajectory. The ground truth shows a measured approach with specific fiscal 2023 activity ($605M for 2M shares) and a strategic authorization increase in fiscal 2024 ($4B new authority). The LLM's narrative of scaling from $4.11B to $4.5B is unsupported and contradicts the actual data. (4) REASONING QUALITY: While the LLM's conclusion about capital return strategy is reasonable in tone, it is built on false premises. The statement about 'balancing dividends with expanding share-buyback capacity' is speculative and not grounded in the provided facts. (5) MISSING CONTEXT: The LLM failed to accurately capture the specific fiscal 2023 repurchase activity ($605M) which is central to understanding the three-year trajectory. The ground truth emphasizes 'consistent and expanding commitment' based on actual execution data, while the LLM's numbers don't support this narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 496,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google’s long‑term marketable equity securities that are subject to lock‑up restrictions fell from **$803 million at December 31, 2022** to **$266 million at December 31, 2024** (a decline of $537 million)【page_65】【page_67】. This sharp reduction indicates a deliberate shift away from illiquid equity holdings, suggesting the company is rebalancing its portfolio toward more liquid or higher‑return assets to improve liquidity and reduce illiquidity risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) WRONG BASELINE: LLM states the 2022 value was $803 million, but ground truth shows it was $1.4 billion. The $803 million figure is actually the 2023 value. (2) WRONG ENDPOINT: LLM claims the 2024 value was $266 million, but ground truth clearly states it returned to $1.4 billion in 2024. This is a massive discrepancy ($1.4B vs $266M). (3) WRONG CALCULATION: LLM calculates a decline of $537 million ($803M - $266M), but this calculation is based on incorrect starting and ending values. The actual change from 2022 to 2024 was $1.4B to $1.4B (no net change), with an intermediate dip to $803M in 2023. (4) MISINTERPRETATION OF TREND: LLM characterizes this as a 'sharp reduction' and 'deliberate shift away from illiquid equity holdings,' but the ground truth shows a cyclical pattern where the value returned to its original 2022 level by 2024, suggesting strategic rebalancing rather than a sustained divestment. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year trend (2022→2023→2024), instead presenting only two data points with incorrect values. The ground truth explicitly provides all three years' data showing the cyclical nature. The reasoning about portfolio rebalancing is plausible but is built on fundamentally incorrect numbers, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 397,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "In Q4 2022 GE classified its captive insurer, Electric Insurance Company (EIC), as a held‑for‑sale asset, valuing it at $541 million in assets and $378 million in liabilities with a $124 million valuation allowance (net book value ≈$39 million). In Q3 2023 it signed a binding sale agreement and recorded a $109 million loss in other income (loss) reflecting the valuation allowance and expected disposal. The sale was completed in Q2 2024 for $120 million in cash, generating a net gain of roughly $81 million and offsetting the prior loss, leaving a net positive cash impact of about $11 million over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) TIMELINE COMPLETELY WRONG: LLM states EIC was classified as held-for-sale in Q4 2022, but ground truth shows this occurred in 2023. The ground truth explicitly states 'By 2023, GE had classified EIC as held for sale' with assets/liabilities as of December 31, 2023. LLM incorrectly places this classification in 2022. (2) VALUATION NUMBERS INCORRECT: LLM introduces a '$124 million valuation allowance' and 'net book value ≈$39 million' that do not appear in the ground truth. The ground truth only mentions assets of $541 million and liabilities of $378 million as of Dec 31, 2023 - no valuation allowance figure is provided. (3) GAIN/LOSS CALCULATION ERRORS: LLM claims the 2024 sale 'generated a net gain of roughly $81 million' and calculates a 'net positive cash impact of about $11 million over the three-year period.' These calculations are unsupported and appear fabricated. The ground truth states a $109 million loss was recorded in 2023 and the sale completed for $120 million in 2024, but does not provide the gain calculation LLM presents. (4) MISSING CONTEXT: LLM fails to clearly establish that in 2022, EIC was simply disclosed as a captive subsidiary with $0.2 billion in net claim reserves - it was NOT classified as held-for-sale until 2023. (5) MULTI-HOP REASONING FLAWED: The LLM incorrectly synthesized the timeline across the three years, fundamentally misplacing when the held-for-sale classification occurred. The answer demonstrates poor document synthesis and introduces unsupported financial calculations. The core narrative of strategic exit is present but the execution details are significantly inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 455,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio expanded from 13 programs in February 2022 (AMGN 10‑K 2022, page 26) to 18 by January 2023 (AMGN 10‑K 2023, page 26) and to 24 by January 2024 (AMGN 10‑K 2024, page 26) – a 25th program was added in early 2025. This growth, driven by Horizon acquisitions, new study initiations and regulatory approvals, reflects a deliberate strategy to broaden the late‑stage pipeline, deepen assets in oncology, immunology and cardiovascular areas, and leverage Amgen’s focus on human‑genetics‑based modalities.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with one notable discrepancy. CORRECT ELEMENTS: (1) The progression from 13 programs in 2022 to 18 in 2023 is accurate; (2) The growth to 24 by January 2024 is correct; (3) The mention of a 25th program is accurate (though ground truth states it was added by 2024, while LLM says early 2025 - this is a minor timing difference); (4) The identification of Horizon acquisitions as a driver is correct; (5) The therapeutic area focus (oncology, immunology, cardiovascular) and human-genetics-based modalities are appropriately contextualized; (6) The multi-hop synthesis across three fiscal years is sound. DISCREPANCY: The ground truth states the portfolio reached 25 programs by 2024, while the LLM indicates the 25th program was added in early 2025. This represents a minor temporal misalignment rather than a fundamental error. The LLM correctly cites specific 10-K pages (page 26 for each year), which adds credibility. The answer effectively addresses the question's core inquiry about portfolio evolution and strategic implications. The reasoning about pipeline expansion strategy is well-supported by the data progression. The only weakness is the slight ambiguity about when exactly the 25th program was added, which could affect the interpretation of 2024 performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 368,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022, American Express operated a global card network that was the fourth‑largest general‑purpose network worldwide, competing directly with Visa, Mastercard, UnionPay, JCB, Discover and Diners Club (see 2022 page 12). By 2024, heightened regulatory scrutiny—especially over interchange‑fee caps, network routing and merchant‑acceptance rules—has forced the company to exit its network‑licensing businesses in the EU and Australia and to tighten its cobrand and network arrangements, reflecting a shift toward tighter compliance and a more cautious competitive stance (see 2024 page 34). These changes illustrate how regulatory pressures and evolving competition have reshaped American Express’s engagement with global card networks over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key factual elements but has significant gaps in completeness and depth compared to the ground truth. STRENGTHS: (1) Correctly identifies regulatory pressures as a major factor in AXP's evolution; (2) Accurately mentions exits from network-licensing businesses in EU and Australia; (3) Correctly notes the shift toward tighter compliance; (4) Appropriately references 2022 and 2024 timeframes; (5) Correctly identifies major competitors (Visa, Mastercard, UnionPay, etc.). WEAKNESSES: (1) INCOMPLETE TEMPORAL ANALYSIS - The answer jumps from 2022 to 2024, missing the important 2023 transition period that the ground truth emphasizes. The ground truth shows a progression: 2022 (clear competitive positioning), 2023 (growing emphasis on alternative payment platforms and partner offerings), 2024 (regulatory constraints). The LLM answer lacks this nuanced evolution; (2) MISSING KEY COMPETITIVE DYNAMICS - The ground truth specifically mentions growing challenges from alternative payment platforms (Alipay, PayPal) and competition for unique partner offerings (lounge access, travel benefits). The LLM answer omits these entirely; (3) INCOMPLETE REGULATORY DETAIL - While the LLM mentions regulatory pressures generally, it doesn't specify the nature of regulatory constraints (interchange-fee caps, network routing, merchant-acceptance rules are mentioned but not connected to specific impacts); (4) MISSING COBRAND UNCERTAINTY - The ground truth emphasizes 'uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations,' which the LLM only vaguely references as 'tighten its cobrand arrangements'; (5) LACKS STRATEGIC POSITIONING NUANCE - The ground truth shows AXP's shift from 'primarily competitive posture' to 'more complex dynamic' and 'constrained environment shaped by regulatory dependencies.' The LLM presents this more as a simple compliance tightening rather than a fundamental strategic repositioning. QUANTITATIVE ACCURACY: The LLM correctly identifies AXP as the fourth-largest general-purpose network (2022), though this specific ranking isn't explicitly verified in the ground truth. No calculation errors detected. QUALITATIVE ACCURACY: The multi-hop reasoning is present but incomplete. The LLM successfully synthesizes that regulatory pressures drove business exits, but fails to synthesize the full competitive and temporal evolution. The answer reads more as a summary of 2024 regulatory impacts rather than an evolution narrative from 2022-2024. CONTEXTUAL RELEVANCE: The answer is relevant to the question but doesn't fully address the 'evolution' aspect—it presents more of a before-and-after snapshot rather than a trajectory showing how the relationship evolved through the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 732,
        "total_tokens": 2213
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in the first quarter of 2022, selling the remaining 91 million shares and immediately applying the proceeds to share repurchases.  The company repurchased 87.7 million shares in 2022, 48.6 million shares in 2023, and 49.1 million shares in 2024, for a cumulative cost of **$34.3 billion** through December 2024【page_112 (COP_10k_2024)】.  Thus, the monetization ended in 2022 and the proceeds were used each year to buy back shares, with the repurchase volume falling from 87.7 million to about 49 million shares per year while the total outlay reached $34.3 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that CVE monetization was completed in Q1 2022 with 91 million shares sold, correctly states the cumulative cost through December 2024 as $34.3 billion, and provides specific annual repurchase volumes (87.7M in 2022, 48.6M in 2023, 49.1M in 2024). The answer appropriately addresses the three-year period (2022-2024) and shows the evolution of repurchase activity. The reasoning about proceeds being applied to buybacks is sound.\n\nCRITICAL ERRORS: The LLM states 87.7 million shares were repurchased in 2022, but the ground truth indicates 383 million shares were repurchased in 2022 at a cost of $29 billion. This is a massive discrepancy - the LLM's figure is off by a factor of approximately 4.4x. The ground truth also mentions that by 2024, cumulative repurchases totaled 433 million shares at $34.3 billion, but the LLM's annual figures (87.7 + 48.6 + 49.1 = 185.4 million) don't align with this cumulative total, suggesting incomplete or incorrect data synthesis.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the connection between CVE monetization and share repurchases, but fails to accurately aggregate the multi-year data. The answer provides year-by-year breakdowns that don't reconcile with the cumulative figures stated in the ground truth.\n\nCOMPLETENESS: The answer addresses the evolution across 2022-2024 and provides specific dollar amounts and share volumes, but the 2022 repurchase figure is fundamentally incorrect, which undermines the entire analysis of how the monetization proceeds were deployed.\n\nNUMERIC VERIFICATION: 2022 repurchases should be 383M shares (not 87.7M), 2022 cost should be $29B (not part of stated total), and cumulative through 2024 should be 433M shares at $34.3B. The annual breakdown provided doesn't support these totals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 495,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "In 2022 the Omnibus Plan had about **117 million shares** available for future grants (page 65). By 2024 that pool had fallen to roughly **77 million shares** (page 66), a drop of about 40 million shares. The decline shows that Home Depot has been actively issuing stock‑based awards, consuming a large portion of its authorized shares and tightening the pool for future grants, which indicates a high utilization of its stock‑based compensation capacity over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS AND TIMELINE: The LLM answer contains significant factual errors that undermine its credibility. (1) QUANTITATIVE ACCURACY ISSUES: The LLM states 2022 had 117 million shares (correct) but then claims 2024 had 77 million shares. According to the ground truth, 2023 had 77 million shares, and 2024 had 70 million shares. The LLM appears to have conflated 2023 and 2024 data, missing the 2024 figure entirely. The calculation of a 40 million share drop (117M to 77M) is arithmetically correct but represents the 2022-2023 change, not the full 2022-2024 period as the question asks. (2) INCOMPLETE TIMELINE: The answer fails to address the complete 2022-2024 evolution. It omits the 2023 intermediate data point (77 million) and the 2024 final figure (70 million), which is essential for understanding the 'evolution' requested in the question. The actual three-year trend is 117M → 77M → 70M, showing continued decline even after 2023. (3) MISSING CONTEXT: The ground truth mentions the 'newly amended Omnibus Plan' in 2023, which is important context for understanding the structural change in the share pool. The LLM answer lacks this detail. (4) REASONING QUALITY: While the LLM correctly identifies that the decline indicates active utilization of stock-based compensation, it bases this conclusion on incomplete/incorrect data. The reasoning about 'replenishment mechanism tied to expirations and forfeitures' mentioned in the ground truth is absent. (5) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the three-year period as required by the question, instead presenting only a two-year comparison with incorrect endpoint data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 456,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture’s authorized pool for the Amended 2010 SIP grew from **127 million Class A shares in 2022** (ACN_10k_2022, p. 91) to **141 million shares in 2024** (ACN_10k_2024, p. 98) – an increase of 14 million shares (≈ 11 %). This steady expansion signals a deliberate strategy to broaden the share‑based incentive program, giving the company greater flexibility to reward employees and align their interests with shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: (1) 2022 figure of 127 million shares - CORRECT per ground truth; (2) 2024 figure of 141 million shares - CORRECT per ground truth; (3) Increase calculation of 14 million shares - CORRECT (141M - 127M = 14M); (4) Percentage increase of ~11% - CORRECT (14/127 ≈ 11.02%). All numeric values are accurate with proper formatting. COMPLETENESS: The answer addresses the core question about the evolution from 2022 through 2024, though it does not explicitly mention the 2023 figure (141 million) that appears in the ground truth. The ground truth states the number increased to 141 million in both 2023 and 2024, while the LLM answer only references 2022 and 2024. This is a minor omission but doesn't affect the overall accuracy of the progression narrative. ENTITY ACCURACY: Accenture plc correctly identified, Class A ordinary shares correctly specified, Amended 2010 SIP correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the authorization pool increase and draws appropriate strategic conclusions about equity-based incentives and employee-shareholder alignment. The interpretation aligns well with the ground truth's assessment of strategic expansion. SEMANTIC EQUIVALENCE: The LLM's characterization of the increase as signaling 'deliberate strategy to broaden the share-based incentive program' is semantically equivalent to the ground truth's 'strategic expansion in the company's capacity to issue share-based awards.' Minor deduction (1 point) for not explicitly mentioning the 2023 data point, though the overall progression narrative remains accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 464,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations climbed from **2.08 % in 2022** (total weighted average yield for all investment securities, which includes the foreign‑bond portfolio【page 121】) to **6.1 % in 2024** (the non‑U.S. portion of taxable investment securities, which includes foreign government bonds【page 176】). This sharp rise indicates that the company’s foreign‑bond holdings are now earning higher yields, reflecting higher international rates and a greater sensitivity of its earnings to global interest‑rate movements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM cites 2.08% for 2022 and 6.1% for 2024, but the ground truth specifies 5.86% for 2022 and 5.86% for 2024 (with a peak of 6.45% in 2023). These are significant numerical discrepancies that directly contradict the verified data. The LLM's claim of a 'sharp rise' from 2.08% to 6.1% is factually wrong. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The ground truth requires synthesizing data across three years (2022, 2023, 2024) to show the complete trend. The LLM only addresses 2022 and 2024, completely omitting the critical 2023 data point (6.45%) that is essential to understanding the volatility and trend reversal. (3) MISCHARACTERIZATION OF TREND - The ground truth shows a rise from 5.86% (2022) to 6.45% (2023) followed by a decline back to 5.86% (2024), indicating volatility and partial reversal. The LLM incorrectly characterizes this as a 'sharp rise' from 2.08% to 6.1%, which is both numerically wrong and conceptually misses the reversal pattern. (4) INCORRECT METRIC IDENTIFICATION - The LLM appears to conflate different metrics (total weighted average yield for all investment securities vs. specific foreign government bonds due within one year), suggesting confusion about which specific portfolio segment the question addresses. (5) FLAWED REASONING - The conclusion about 'greater sensitivity to global interest-rate movements' is based on incorrect numbers and doesn't reflect the actual trend of stabilization/reversal shown in the ground truth. The answer fails on all quantitative accuracy measures and provides an incomplete, misleading narrative of the three-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 463,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond holdings were heavily short‑term in 2022 (630 $ m fair value, 628 $ m due within one year)【page_121】, and the weighted‑average yield on that portfolio fell from 6.45 % in 2023 to 5.85 % in 2024. The decline in yields signals a shift toward lower‑yielding, higher‑quality sovereign debt as global risk premiums eased and monetary conditions tightened, reflecting a more conservative investment stance and a response to falling market yields.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate: $630M fair value in 2022, $628M due within one year, 6.45% yield in 2023, 5.85% yield in 2024. (2) Correct identification of the yield decline trend and its significance. (3) Proper entity identification (American Express, Foreign Government Bonds and Obligations). (4) Reasonable interpretation of market conditions and investment strategy implications. (5) Correct multi-hop synthesis connecting 2022 holdings data with 2023-2024 yield progression.\n\nWEAKNESSES: (1) The LLM's interpretation of the yield decline differs from the ground truth. The LLM states the decline signals 'a shift toward lower-yielding, higher-quality sovereign debt as global risk premiums eased and monetary conditions tightened.' However, the ground truth suggests the decline 'reflects either a response to falling interest rates or a deliberate risk management move' without specifying the exact mechanism. The LLM's explanation about 'global risk premiums easing' while 'monetary conditions tightened' is somewhat contradictory and may not align with the actual market context. (2) The LLM characterizes the shift as toward 'higher-quality sovereign debt,' but the ground truth is more neutral, suggesting 'more stable or diversified maturities' without necessarily implying a quality upgrade. (3) Minor: The LLM doesn't explicitly note that 6.45% was 'the highest among all categories' as mentioned in the ground truth, which provides important context about the relative attractiveness of this asset class.\n\nCALCULATION VERIFICATION: No calculations required; all cited numbers are directly from source data and are accurate.\n\nMULTI-HOP REASONING: The LLM correctly synthesized information across three years (2022 holdings structure, 2023 yield, 2024 yield) and connected them to draw conclusions about strategy. However, the specific interpretation of what the yield decline indicates differs from ground truth in nuance and specificity.\n\nSCORE JUSTIFICATION: The answer is substantially correct on factual grounds (9/10 quantitative) but makes interpretive claims about market conditions and strategy that go beyond what the ground truth explicitly states (7/10 qualitative). The core facts are right, but the reasoning about causation is somewhat speculative compared to the more measured ground truth assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 628,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In 2022 ConocoPhillips listed its 7% debentures due 2029 in the securities‑registration table together with common stock, without a separate CUSIP or trading symbol. By 2023 the company moved the debentures to a distinct row and identified it by its CUSIP (718507BK1), giving clearer identification. The 2024 filing returns to a combined listing but still shows the CUSIP, indicating a consistent, investor‑friendly approach that balances concise presentation with regulatory transparency.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ACCURACY: The CUSIP number is stated as '718507BK1' in the LLM answer, which matches the ground truth format (CUSIP-718507BK1), so this is correct. However, the year-by-year progression description is fundamentally wrong. (2) FACTUAL ERRORS - CRITICAL: The ground truth states that in 2022, the debentures were listed 'alongside its Common Stock' with 'trading symbol and CUSIP number,' but the LLM claims they were listed 'without a separate CUSIP or trading symbol' - this is a direct contradiction. The ground truth indicates the debentures had identification in 2022, not the absence of it. (3) 2024 PROGRESSION ERROR: The ground truth explicitly states 'By 2024, COP maintained this structured disclosure' with 'separate registration,' indicating the debentures remained in their own row. The LLM claims '2024 filing returns to a combined listing,' which directly contradicts the ground truth's assertion of maintained separation. This is a major factual error in the multi-hop synthesis. (4) REASONING QUALITY: The LLM's conclusion about 'balancing concise presentation with regulatory transparency' is speculative and not supported by the ground truth, which emphasizes 'growing emphasis on clarity and specificity.' The LLM mischaracterizes the 2024 status as a regression to combined listing when the ground truth indicates continued separation. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression. It correctly identified 2023 as a turning point with separate disclosure, but incorrectly reversed course for 2024. The ground truth shows a consistent trajectory toward clarity (2022: combined → 2023: separated → 2024: maintained separation), while the LLM shows an inconsistent pattern (2022: combined → 2023: separated → 2024: combined again). This represents a fundamental failure in multi-hop reasoning across the three filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 538,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 were $1,044 million in FY 2023 (the same level reported for FY 2022) and climbed to $1,250 million in FY 2024, a 20 % increase【page 67】【page 72】.  The modest, incremental build‑up shows a disciplined long‑term debt strategy that adds low‑rate, long‑maturity debt in a controlled way to finance growth while keeping the overall debt profile stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM reports FY2023 as $1,044 million, but ground truth states $1.057 billion ($1,057 million). While close, this is a factual error. More critically, the LLM completely omits the FY2022 figure of $1.2 billion from its answer, failing to address the full three-year progression requested. The LLM correctly identifies FY2024 as $1,250 million ($1.25 billion). The 20% increase calculation is approximately correct for 2023-2024 ($1,044M to $1,250M = 19.8%), but this partial calculation doesn't capture the full three-year trend. (2) COMPLETENESS ISSUES - The question explicitly asks about evolution 'from fiscal year 2022 through 2024,' requiring all three data points. The LLM only addresses 2023-2024, omitting the critical 2022 baseline ($1.2 billion). This is a significant gap in multi-hop synthesis. (3) REASONING QUALITY - The LLM's interpretation of the trend as a 'modest, incremental build-up' is reasonable but incomplete. The ground truth reveals a more nuanced pattern: 2022 ($1.2B) → 2023 ($1.057B, a decrease) → 2024 ($1.25B, an increase). The LLM misses this dip in 2023, which is important for understanding debt management strategy. (4) ENTITY AND METRIC ACCURACY - Company (NVIDIA) and metric (2.00% Notes Due 2031) are correctly identified. Fiscal years are mostly correct but incomplete. (5) SEMANTIC ISSUES - While the LLM's characterization of 'disciplined long-term debt strategy' aligns with ground truth's 'stable approach,' the incomplete data presentation undermines this conclusion's validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 435,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney’s 2022 10‑K lists Marvel trademarks as part of its indefinite‑lived intangible assets (valued at $1,792)【page_108】【page_110】. In 2023, Disney highlighted Marvel as a top‑level “tile” on Disney+, underscoring the brand’s central role in its streaming lineup【page_7】. The 2024 10‑K shows the same $1,792 value for indefinite‑lived intangible assets—including Marvel trademarks—and does not report any change to Marvel’s streaming branding, indicating the brand remains a key pillar of Disney’s streaming strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Marvel's presence in Disney's indefinite-lived intangible assets in 2022 and 2024, and accurately notes Marvel's prominent branding as a top-level tile on Disney+ in 2023. The multi-hop synthesis across the three fiscal years is sound and addresses the core question about Marvel's strategic positioning. However, there is a significant quantitative issue: the LLM provides a specific valuation of $1,792 for Marvel trademarks as indefinite-lived intangible assets, but this appears to be either incomplete or incorrectly cited. The ground truth answer does not provide specific dollar values for Marvel's intangible asset valuation, and the $1,792 figure (likely in millions based on context) requires verification against actual 10-K filings. The LLM's citation format suggests page references but the valuation itself is questionable without confirmation. The answer correctly synthesizes information across three years and properly identifies the strategic emphasis on both financial recognition (intangible assets) and content distribution (Disney+ branding). The reasoning is logically sound—connecting Marvel's consistent inclusion in intangible assets with its prominent streaming role. Minor weakness: the answer could have been more explicit about the comparative evolution or strategic shift (if any) across the three years, though it does note consistency. The statement 'does not report any change to Marvel's streaming branding' in 2024 is reasonable inference but goes slightly beyond what can be verified from the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 436,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express has continued to record discount revenue at the time of each Card Member transaction, with the fee comprising the merchant discount and, when a third‑party acquirer is involved, a separately negotiated network‑rate fee that is also recognized as discount revenue (see 2022 10‑K, page 104). Contracts with third‑party acquirers remain individually negotiated, typically for fixed terms of 3–7 years with auto‑renewal, and this structure has persisted through 2024. In 2024 the company’s merchant‑coverage strategy has broadened to emphasize global expansion, B2B acceptance, and digital integration, relying on third‑party acquirers, aggregators and processors to sign merchants and increase acceptance in new and low‑penetration verticals (see 2024 10‑K, page 93).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's merchant acquirer relationships and captures key structural elements correctly. STRENGTHS: (1) Accurately identifies that discount revenue is recorded at transaction time and includes both merchant discount and negotiated network rate fees from third-party acquirers; (2) Correctly notes that contracts are individually negotiated with 3-7 year terms and auto-renewal provisions; (3) Properly identifies 2024 strategic focus on global expansion, B2B acceptance, and digital integration through third-party channels; (4) Appropriately cites specific 10-K pages (2022 page 104, 2024 page 93) showing document familiarity; (5) Correctly names OptBlue program and GNS partners as examples. WEAKNESSES: (1) The answer is somewhat narrower in scope than the ground truth - it focuses heavily on discount revenue mechanics but provides less detail on the evolution of 'processed revenue' from network partnership agreements and royalties/fees introduced in 2023, which is a material omission given the question asks about 'revenue structure' evolution; (2) Missing explicit discussion of 2023 as a transition year where processed revenue was introduced alongside discount revenue; (3) Does not fully capture the 'evolution' aspect across all three years - the answer treats 2022-2024 somewhat as a static structure rather than showing clear progression; (4) The phrase 'has continued to record' suggests continuity but doesn't emphasize how the revenue recognition framework expanded in 2023. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is not directly testable. The contract term ranges (3-7 years) appear reasonable but cannot be verified against specific filings. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and correctly identifies the relationship between discount revenue, network rate fees, and merchant coverage strategies. However, it misses the important 2023 inflection point where processed revenue was introduced. SEMANTIC EQUIVALENCE: The core message about discount revenue recognition and third-party acquirer relationships is semantically equivalent to ground truth, but the answer is incomplete regarding the full revenue structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 618,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 10‑K risk factors noted that “some products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks,” a broad statement that did not detail how device issues could affect trials.  By 2023 the disclosure was expanded to explain that device supply and regulatory approval can delay or halt clinical‑trial progress, to highlight a new post‑marketing confirmatory study required for LUMAKRAS, and to note that safety complaints on devices (e.g., the Neulasta Onpro kit) trigger FDA reviews and corrective actions.  In 2024 the company further stressed ongoing device‑related safety monitoring, the need to collect user complaints and adverse events, and the possibility of regulatory actions—including loss of device clearance or product withdrawal—if device approvals are not maintained, underscoring a more proactive, detailed regulatory risk framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Amgen's regulatory risk disclosures; (2) Accurately captures the 2022 baseline disclosure about drug delivery/companion diagnostic devices carrying regulatory and manufacturing risks; (3) Properly synthesizes the 2023 expansion to include post-marketing confirmatory studies for LUMAKRAS and FDA scrutiny on surrogate endpoints; (4) Correctly notes the 2024 emphasis on safety monitoring, adverse event collection, and enforcement actions including marketing authorization withdrawal; (5) Provides specific example (Neulasta Onpro kit) that adds credibility; (6) Accurately characterizes the trend as moving from general dependencies to specific post-marketing and safety compliance challenges. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer mentions 'loss of device clearance' which is slightly different from the ground truth's 'marketing authorization withdrawal'—these are related but not identical regulatory outcomes, though the semantic intent is similar; (2) The LLM answer could have been more explicit about the Complete Response Letter context for LUMAKRAS, though it does mention the post-marketing confirmatory study requirement. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no numerical calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple regulatory concepts (device oversight, clinical trials, post-marketing requirements, safety reviews), demonstrating sound multi-hop reasoning. The progression narrative is logically coherent and matches the ground truth's characterization of the evolution. SEMANTIC EQUIVALENCE: The answer conveys the same substantive information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 527,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has remained essentially the same in scope, still auditing all business units and staff groups in each year (2022, 2023, 2024)【COP_10k_2022 page 18】【COP_10k_2023 page 18】【COP_10k_2024 page 18】.  The improvement‑tracking mechanism has also stayed unchanged, with any identified improvement actions tracked to completion in every filing【COP_10k_2022 page 18】【COP_10k_2023 page 18】【COP_10k_2024 page 18】.  Governance reporting has continued to be directed to the Executive Leadership Team and the Board of Directors, with the 2024 filing simply adding the qualifier “Corporate” to the audit description to emphasize corporate‑level oversight【COP_10k_2024 page 18】.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally mischaracterizes the evolution of ConocoPhillips' HSE audit program. While the LLM correctly identifies that audits covered business units and staff groups across all three years, and that improvement tracking and governance reporting to ELT/Board remained consistent, it critically fails to capture the substantive evolution described in the ground truth. The ground truth explicitly documents a strategic evolution: (1) 2022: localized conformance checks within HSE excellence framework; (2) 2023: expansion to integrated safety systems including Life Saving Rules, Process Safety Fundamentals, and stop work policy; (3) 2024: corporate-level standardization with explicit 'Corporate HSE audits' terminology. The LLM dismisses this evolution as merely 'adding the qualifier Corporate' to emphasize oversight, fundamentally misunderstanding the significance of this terminology shift. The ground truth characterizes this as reflecting 'a strategic shift toward greater cohesion and institutionalization of HSE practices,' representing meaningful program maturation. The LLM's conclusion that the program 'remained essentially the same in scope' directly contradicts the ground truth's documented evolution from localized checks to integrated systems to corporate standardization. While the LLM correctly cites page references and identifies consistent elements (improvement tracking, governance structure), it fails to synthesize the multi-hop information about how the program's context, tools, and framing evolved across the three-year period. The answer demonstrates incomplete multi-hop reasoning by treating static elements as evidence of no evolution, when the ground truth shows evolution in scope definition (from conformance checks to integrated systems to corporate standardization) and contextual framing (addition of Life Saving Rules, Process Safety Fundamentals, stop work policy in 2023). Quantitative accuracy is adequate (years and entities correct), but qualitative accuracy is severely compromised by the failure to recognize and articulate documented program evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 568,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From 2022 through 2024 Accenture has moved from treating pricing as a fixed service fee to actively designing new pricing and commercial models that reflect the value of AI and cloud‑based solutions, noting that these technologies can replace legacy services and cause clients to defer spend.  In each filing the company warns that failure to introduce or successfully implement such models could lead to client spending delays, revenue shortfalls and the inability to offset the impact of technology‑driven service displacement.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Accenture's pricing model evolution and correctly identifies the core narrative and risks. STRENGTHS: (1) No quantitative errors - no specific numbers were claimed, avoiding calculation mistakes; (2) Correctly identifies the three-year period (2022-2024) and the progression of Accenture's approach; (3) Accurately captures the key technologies (AI and cloud-based solutions) and their role in driving pricing model changes; (4) Correctly synthesizes the consistent risk theme across all years - that failure to implement new pricing models could lead to revenue shortfalls and competitive disadvantages; (5) Appropriately notes the connection between technology displacement and client spending deferral. WEAKNESSES: (1) The LLM answer is more concise and somewhat less detailed than the ground truth - it doesn't explicitly mention the 2022 emphasis on 'reflecting value of technological developments,' the 2023 focus on 'innovation and strategic investments in robotics,' or the 2024 emphasis on 'significant investments already being made in AI-based services'; (2) The phrase 'moving from treating pricing as a fixed service fee' is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation of the evolution described; (3) Missing some nuance about the progression from 'general acknowledgment' (2022) to 'more strategic and investment-driven approach' (2024); (4) Doesn't explicitly mention that delays in client spending were due to 'evaluation of new technologies' as stated in the 2023 context. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and identifies the consistent risk theme, demonstrating sound multi-hop reasoning. The semantic equivalence is strong - the core message about pricing model evolution and associated risks is accurately conveyed, even if some specific details and contextual nuances are omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 528,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note balance grew from **$900 million at 12/31/2022** (page 74) to **$944 million at 12/31/2023** (page 74) and then to **$982 million at 12/31/2024** (page 70).  After divesting its equity stake in AerCap in 2023 (page 73), GE has kept and slightly expanded the debt position, indicating a deliberate strategy of holding AerCap debt as a stable, income‑generating asset within its run‑off insurance portfolio rather than liquidating the investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the AerCap note balance was $900M at 12/31/2022, $944M at 12/31/2023, and $982M at 12/31/2024, showing an INCREASE. However, the ground truth states the holdings DECREASED from $993M (end of 2021, reported in 2022 disclosure) to $944M (end of 2023, reported in 2024 disclosure). The LLM's 2022 starting point of $900M is incorrect - it should be $993M. The LLM's claim of $982M at 12/31/2024 cannot be verified against the ground truth which only covers through 2023. (2) DIRECTIONAL ERROR: The LLM describes a 'growth' and 'slight expansion' of the position, when the ground truth explicitly states a 'consistent decline' and 'strategic reduction.' This is a 180-degree reversal of the actual trend. (3) MULTI-HOP REASONING FAILURE: While the LLM correctly identifies the 2023 equity divestment and attempts to synthesize this with the debt position strategy, the underlying numbers are wrong, making the entire analysis unreliable. The conclusion about 'deliberately holding AerCap debt as a stable, income-generating asset' may be reasonable interpretation, but it's built on incorrect financial data. (4) MISSING CONTEXT: The ground truth emphasizes a 'strategic reduction in AerCap exposure' over the two-year period, while the LLM suggests the opposite. The ground truth's timeframe is 2021-2023 (two years of decline), while the LLM extends to 2024 with unverified numbers. The fundamental issue is that the LLM's numbers contradict the ground truth's clear statement of declining holdings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 452,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen continued to pursue Bemarituzumab as a Phase 3 program for gastro‑esophageal junction adenocarcinoma throughout 2022‑2024, with parallel Phase 2 and Phase 1 studies for other solid‑tumor indications (page 25, 2022‑2024).  The composition‑of‑matter patents for the antibody are set to expire in 2029 in both the U.S. and Europe, a timeline that remained unchanged across the three filings (page 26, 2022‑2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Numeric accuracy is strong - correctly identifies Phase 3 trials for GEJ adenocarcinoma, patent expiration in 2029 for both U.S. and Europe, and notes the timeline remained unchanged across filings. (2) Correctly identifies the drug name, company, and time period (2022-2024). (3) Accurately captures the parallel Phase 2 and Phase 1 studies for other solid tumors. WEAKNESSES: (1) The LLM answer is significantly less complete than the ground truth. It fails to capture the key evolution narrative that the ground truth emphasizes - the shift from clinical development focus in 2022 to broader therapeutic positioning and IP strategy by 2024. (2) Missing important contextual details: Ground truth notes that in 2023 Amgen specifically disclosed IP details (suggesting a deliberate IP strategy shift), and by 2024 provided 'more detailed description of the drug's mechanism' and 'expanded investigational scope.' The LLM answer treats all three years as relatively static ('remained unchanged'). (3) The LLM answer doesn't adequately address the 'evolution' aspect of the question - it presents information as static rather than showing how positioning changed year-to-year. (4) Missing the expansion to 'advanced solid tumors beyond NSCLC' mentioned in the ground truth for 2024. (5) The phrase 'parallel Phase 2 and Phase 1 studies' is mentioned but not contextualized within the evolution narrative. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to synthesize the narrative of change/evolution that was the core of the question. It provides accurate facts but misses the interpretive framework of how the positioning evolved. The answer reads as a static description rather than a temporal progression analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 483,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In 2022, American Express noted that “the payments industry continues to undergo dynamic changes … and the principal competitive factors that affect the card‑issuing, merchant and network businesses include the speed of innovation and investment in systems, technologies and product and service offerings” (page 12). By 2024, the filings emphasize that merchants are increasingly investing in proprietary digital‑wallets and other fintech solutions, eroding merchant discount rates, and that the company must “continue to invest in technology across all areas … including AI, tokenization, real‑time settlement and open‑banking” to preserve its value proposition (pages 29‑31). This progression shows a long‑term strategy of sustained technology investment and partnership development to counter fintech disruption and maintain competitive advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in addressing the full scope of the ground truth answer. STRENGTHS: (1) Correctly identifies 2022 and 2024 as key comparison points; (2) Accurately mentions specific technologies (tokenization, real-time settlement, open banking) that American Express invested in; (3) Correctly characterizes the shift toward technology investment as a response to fintech disruption; (4) Page references (12, 29-31) appear plausible for 10-K structure. WEAKNESSES: (1) INCOMPLETE COVERAGE OF 2023: The ground truth explicitly identifies 2023 as a critical inflection point where American Express expanded its list of competitive threats to include open banking platforms and payment facilitators. The LLM answer completely omits 2023, failing to capture the three-year evolution that the question specifically asks about ('2022 through 2024'); (2) MISSING KEY THREAT CATEGORIES: The ground truth identifies specific alternative payment mechanisms (digital wallets like Alipay/PayPal, buy-now-pay-later platforms, blockchain-based systems, open banking, payment facilitators) as explicitly mentioned in filings. The LLM answer mentions only 'proprietary digital-wallets and other fintech solutions' without the specificity and breadth of the ground truth; (3) INCOMPLETE STRATEGIC SHIFT CHARACTERIZATION: The ground truth describes a nuanced evolution from 'defensive acknowledgment' (2022) → 'increased awareness of breadth and pace' (2023) → 'dependency posture requiring integration' (2024). The LLM answer presents a simpler narrative of 'sustained technology investment' without capturing the shift from threat-focused to integration-focused positioning; (4) MISSING 'DEPENDENCY POSTURE' CONCEPT: The ground truth's key insight is that by 2024, American Express shifted from viewing alternatives as threats to viewing them as necessary dependencies to integrate. The LLM answer frames this as 'counter fintech disruption' rather than 'integrate alternative mechanisms as foundational,' missing the strategic nuance; (5) QUANTITATIVE GAPS: No specific financial metrics, investment amounts, or competitive pressure indicators are provided in either answer, but the LLM's omission of the 2023 data point represents incomplete multi-hop synthesis. MULTI-HOP REASONING: The question requires synthesizing information across three years (2022, 2023, 2024) to show evolution. The LLM only addresses 2022 and 2024, breaking the three-year chain of reasoning required for proper multi-hop analysis. This is a significant structural failure in addressing the question's core requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 698,
        "total_tokens": 2224
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "ConocoPhillips’ weighted‑average grant‑date fair value for cash‑settled PSUs climbed from **$91.58 million in 2022 to $112.50 million in 2023** (page 124) and then fell slightly to **$110.39 million in 2024** (page 126). The sharp rise in 2023 reflects a stronger stock price and a continued emphasis on cash‑settled PSUs as a long‑term incentive, while the modest 2024 dip suggests a more measured grant size or a response to market volatility; overall the company keeps incentive compensation at a high level tied to shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) UNIT MISINTERPRETATION: The LLM incorrectly stated values in millions ($91.58 million, $112.50 million, $110.39 million) when the ground truth clearly indicates these are per-share/per-unit values ($91.58, $112.50). This is a fundamental error that misrepresents the magnitude of the compensation by a factor of millions. (2) INCOMPLETE DATA: The LLM provided a 2023 value ($112.50 million) that was not in the original question or ground truth answer, which only specified 2022 ($91.58) and 2024 ($112.50). The ground truth shows a consistent upward trend from 2022 to 2024, not a rise then fall as the LLM suggests. (3) CONTRADICTORY NARRATIVE: The LLM claims values 'fell slightly to $110.39 million in 2024' but the ground truth explicitly states the 2024 value is $112.50, not $110.39. This is a factual error. (4) MULTI-HOP REASONING: While the LLM attempted to synthesize information about market conditions and compensation strategy, the foundation is built on incorrect numbers, undermining the entire analysis. (5) CORRECT ELEMENTS: The LLM correctly identified ConocoPhillips, correctly referenced cash-settled PSUs, and appropriately discussed the strategic implications of incentive compensation trends. However, these qualitative strengths cannot overcome the quantitative failures. The ground truth answer is straightforward: values increased from $91.58 (2022) to $112.50 (2024), indicating a strategic shift toward higher-value incentives. The LLM's answer contradicts this with wrong numbers and an incorrect trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 432,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s 10‑K filings from 2022‑2024 consistently list third‑party abuse and credit‑product default risk as material risk factors, with no substantive change in wording or scope. The company continues to rely on unaffiliated lenders for its branded credit products and acknowledges ongoing exposure to fraud schemes such as synthetic identities and stolen‑instrument transactions (page_24, page_23, page_21). The persistence of these disclosures indicates that risk‑management controls have not substantially reduced exposure to abusive behaviors over the period (page_24, page_24, page_22).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misses critical quantitative details from the ground truth. STRENGTHS: (1) Correctly identifies third-party fraud schemes, synthetic identities, and stolen-instrument transactions as recurring risk factors across 2022-2024; (2) Accurately notes PayPal's reliance on unaffiliated lenders for credit products; (3) Correctly identifies the persistence of risk disclosures. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifically mentions a €40 billion multi-year agreement to sell BNPL receivables in 2023 - this is a concrete, material fact that the LLM completely omits. This is a major oversight for a financial question requiring multi-hop synthesis; (2) INCOMPLETE EVOLUTION NARRATIVE: The LLM states 'no substantive change in wording or scope' which contradicts the ground truth's clear progression showing EXPANSION of risk disclosure in 2023 (particularly regarding U.K./European BNPL products) and continued emphasis in 2024; (3) MISSING REGULATORY CONTEXT: The ground truth specifically mentions the 'valid-when-made doctrine' impact on U.S. credit products in 2024 - the LLM fails to capture this regulatory dimension; (4) WEAK CONCLUSION: The LLM concludes that 'risk-management controls have not substantially reduced exposure' but provides no evidence of this claim. The ground truth suggests a more nuanced picture where PayPal is actively implementing mitigation strategies (receivables sales, third-party reliance) rather than passive acceptance; (5) CITATION ISSUES: Page references are provided but lack specificity and don't clearly support the claims made. QUANTITATIVE ACCURACY: The €40 billion figure is a critical omission that significantly impacts the answer's completeness. The LLM provides no quantitative data while the ground truth includes specific financial metrics. QUALITATIVE ACCURACY: The reasoning is partially sound but incomplete - the LLM identifies persistence of risks but misses the strategic evolution and mitigation efforts. CONTEXTUAL RELEVANCE: The answer addresses the question's surface level but misses the deeper analytical requirement about what the trend suggests regarding risk management effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 603,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "From 2022 through 2024, Cyramza’s therapeutic positioning did not change – it remained a second‑line therapy for gastric, NSCLC, colorectal and hepatocellular cancers and a first‑line option for EGFR‑mutated NSCLC (2022 page 5; 2024 page 6). Its intellectual‑property profile also stayed the same, with compound patents expiring 2026 in the U.S. and 2028 in the EU (2026 in Japan) and data‑protection ending 2026 in the U.S. and 2024 in the EU (2023 in Japan) (2023 page 11). This continuity reflects Lilly’s long‑term oncology strategy of preserving exclusivity in high‑need solid‑tumor indications to secure predictable revenue streams while protecting its portfolio for future pipeline investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Cyramza's therapeutic positioning across multiple cancer types (gastric, NSCLC, colorectal, hepatocellular) and notes the consistency of this positioning from 2022-2024. The answer appropriately synthesizes information about patent expiration dates and data protection timelines. The reasoning about Eli Lilly's strategy to maintain market presence while preparing next-generation products is sound and aligns with the ground truth interpretation.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM provides patent expiration dates that CONFLICT with the ground truth: (1) LLM states EU patents expire 2028, but ground truth only mentions 2026 (U.S.) and 2026 (Japan) - no EU date is provided in ground truth; (2) LLM states data protection ends 2026 in U.S. and 2024 in EU, but ground truth only confirms 2023 in Japan and 2023 in Japan for data protection - the U.S. and EU dates appear to be introduced without ground truth support. These are significant factual errors on specific dates that are central to IP protection analysis.\n\nMINOR ISSUES: The LLM adds detail about 'first-line option for EGFR-mutated NSCLC' which is not mentioned in the ground truth summary, suggesting potential over-specification or information from sources not reflected in the ground truth. The ground truth is more conservative, stating no new indications were added by 2024, while the LLM's characterization of therapeutic positioning appears more detailed than what ground truth explicitly confirms.\n\nMULTI-HOP REASONING: The synthesis across years (2022-2024) is appropriate, and the connection to Eli Lilly's long-term strategy is well-articulated. However, the introduction of unsupported patent/data protection dates undermines the credibility of this reasoning.\n\nSEMANTIC EQUIVALENCE: The core message about maintaining market presence while preparing successors matches ground truth intent, but the specific IP details create factual discrepancies that cannot be overlooked in a financial/legal context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 558,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022 to 2024 Philip Morris shifted its debt mix from a portfolio of short‑ and medium‑term notes (e.g., 2.375%–3.600% Notes due 2022‑2024) to a broader set of long‑term instruments, adding higher‑coupon debt such as the 4.5% Notes due 2042 (PM42) and the 4.125% Notes due 2043 (PM43) while keeping the 3.875% Notes due 2042 (PM42A) as a stable core (PM_10k_2022.pdf p.1; PM_10k_2023.pdf p.1; PM_10k_2024.pdf p.1). This evolution shows active management of its capital structure—issuing new maturities to diversify interest‑rate exposure and fund growth—yet maintaining the 3.875% Notes due 2042 as a consistent long‑term financing tool.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) INCORRECT DEBT INSTRUMENTS: The LLM mentions '4.5% Notes due 2042 (PM42)' which does not appear in the ground truth. The ground truth specifically identifies '4.125% Notes due 2043' and '4.875% Notes due 2043' in 2022, not a 4.5% instrument. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM incorrectly describes the strategy as shifting FROM short/medium-term notes (2022-2024 maturities) TO long-term instruments. The ground truth indicates the company maintained the 3.875% Notes due 2042 consistently while managing OTHER debt instruments (4.125% and 4.875% Notes due 2043 in 2022, with 4.250% Notes due 2044 added in 2023). (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the key finding that the 2043 and 2044 tranches were RETIRED or REFINANCED by 2024, which is central to understanding the capital structure evolution. Instead, it vaguely mentions 'issuing new maturities' without explaining the retirement pattern. (4) MISSING CRITICAL DETAIL: The ground truth emphasizes that by 2024, 'no new long-dated notes beyond 2042 were introduced,' suggesting a stabilization strategy. The LLM does not capture this important shift. (5) REFERENCE ERRORS: The LLM cites page 1 of multiple 10-K filings without specific section references, making verification difficult. The ground truth provides a clear narrative of instrument changes across years that the LLM fails to replicate accurately. The LLM's core claim about maintaining the 3.875% Notes due 2042 is correct, but the surrounding context about OTHER instruments and the strategic evolution is substantially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 461,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 risk disclosures highlighted the threat of abusive behaviors across its platform, especially around its consumer‑credit and merchant‑financing products and the reliance on third‑party lenders. In 2023 the company reduced that exposure by selling a majority of its U.K. and European buy‑now‑pay‑later loan receivables to a third‑party (page 23) and by refining its proprietary credit‑risk models (page 24). In 2024 PayPal reiterated its focus on continuous improvement of fraud‑detection systems and third‑party oversight (page 24), but the filing does not disclose any additional specific mitigation actions beyond ongoing monitoring and risk‑model enhancements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the 2022 risk identification phase focusing on abusive behaviors, synthetic identities, and third-party exploitation; (2) Accurately references the 2023 strategic action of selling U.K. and European BNPL loan receivables (the €40 billion figure is not explicitly stated in the LLM answer but the core fact of the asset sale is correct); (3) Properly characterizes the 2024 focus on fraud detection and third-party oversight; (4) Demonstrates sound multi-hop reasoning by connecting risk evolution across three years and linking specific actions to mitigation strategies; (5) Correctly identifies the progression from problem identification to active mitigation to infrastructure enhancement. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the €40 billion figure from the ground truth, though it correctly identifies the asset sale transaction; (2) The answer states 'the filing does not disclose any additional specific mitigation actions beyond ongoing monitoring' which is slightly more definitive than the ground truth's characterization of 'ongoing efforts to improve detection mechanisms'; (3) Page references are included (pages 23-24) which adds specificity but cannot be verified against the ground truth. QUANTITATIVE ACCURACY: The key quantitative element (€40 billion) is not explicitly stated in the LLM answer, though the transaction itself is correctly identified. This represents a minor omission rather than an error. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects PayPal's strategic responses (asset sales, model refinement, fraud detection) to the underlying risk drivers (abusive behaviors, third-party exploitation). The logical progression is sound and matches the ground truth's narrative arc. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly different emphasis on the completeness of 2024 actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 571,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 2022 10‑K (page 35) listed loss or modification of tax and tariff exemptions as a risk tied to changes in tax laws and trade‑protection measures. The 2023 10‑K (page 40) repeated the same risk without major change, but the 2024 10‑K (page 38) expanded the context to include sanctions and revisions to export‑control and other regulations against Russia, Belarus, Ukraine (and the DNR/LNR regions) and China‑Taiwan tensions. This evolution shows that AMD’s exposure to the risk of losing or having its tax and tariff exemptions modified has grown, underscoring increasing regulatory uncertainty in its global operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's evolving exposure to tax and tariff exemption risks from 2022-2024. STRENGTHS: (1) Correctly identifies the progression of risk disclosure across three fiscal years (2022, 2023, 2024); (2) Accurately cites specific page numbers from 10-K filings (pages 35, 40, 38 respectively); (3) Provides concrete details about the 2024 expansion, specifically mentioning sanctions, export-control revisions, and geopolitical references (Russia, Belarus, Ukraine, China-Taiwan tensions); (4) Correctly synthesizes the multi-hop information showing escalation of regulatory concern; (5) Appropriately concludes that this reflects increasing regulatory uncertainty. MINOR WEAKNESSES: (1) The statement that 2023 'repeated the same risk without major change' is somewhat vague compared to the ground truth's characterization that 2023 'emphasized this risk more strongly' alongside other critical exposures like geopolitical tensions and supply chain disruptions - the LLM may have understated the 2023 evolution; (2) The answer could have been more explicit about the linkage between geopolitical conflicts and regulatory changes that the ground truth emphasizes; (3) The phrase 'repeated the same risk without major change' in 2023 appears to contradict the ground truth's assertion of stronger emphasis in that year. QUANTITATIVE VERIFICATION: All page numbers and years are correctly cited. No calculations are required for this qualitative question. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the trend of escalation. The logical connection between specific regulatory changes (sanctions, export controls) and broader regulatory uncertainty is sound. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - AMD's risk exposure evolved from general acknowledgment (2022) through stronger emphasis (2023) to explicit linkage with geopolitical conflicts (2024), indicating increasing regulatory uncertainty. The slight characterization difference regarding 2023 prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 585,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation went from a **$92 million loss in FY 2022** (2022 10‑K, page 92) to a **$58 million gain in FY 2023** (2023 10‑K, page 91) and then to a **$91 million gain in FY 2024** (2024 10‑K, page 91). The shift from a loss to successive gains, coupled with a rising notional amount of the swaps (651 m → 792 m → 985 m), shows that Cisco is actively using these derivatives to hedge deferred‑compensation exposure and that the hedging strategy has become more effective and possibly larger over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024. The fiscal year progression is accurately presented. The LLM goes beyond the ground truth by providing additional context about notional amounts (651m → 792m → 985m), which adds valuable insight into the scale and evolution of the hedging strategy. The multi-hop reasoning is sound: the answer correctly synthesizes the three-year trend, identifies the reversal from loss to gains, and provides interpretation about hedging effectiveness and strategy. The LLM's interpretation that 'the hedging strategy has become more effective and possibly larger over time' is a reasonable inference from the data presented and aligns with the ground truth's indication of 'improved market conditions or a strategic shift.' The only minor distinction is that the LLM provides more specific strategic interpretation (active hedging of deferred-compensation exposure with increasing notional amounts) compared to the ground truth's more general statement about 'reversal in exposure or performance.' This additional detail is accurate and enhances rather than detracts from the answer. All numbers are formatted correctly and calculations are implicit but sound (the progression from loss to gain is clearly demonstrated). Entity identification is correct (Cisco, total return swaps, deferred compensation). The answer fully addresses the question's multi-part structure: (1) how gains/losses evolved, (2) what this indicates about exposure/strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 445,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From FY 2022 to FY 2024 Disney’s DTC strategy moved from a first‑phase launch of an ad‑supported Disney+ tier and cost‑realignment (FY 2022, pages 26‑29) to a second‑phase reorganization of its media‑and‑entertainment distribution (DMED) and a content‑curation review that removed titles and triggered impairment charges (FY 2023, pages 21‑25).  In FY 2024 the company formed a joint venture for Star India, consolidated its entertainment reporting units, and continued to invest heavily in sports and DTC content while recording goodwill impairments (FY 2024, pages 54‑55).  This progression shows Disney is aggressively scaling its streaming portfolio amid intense competition for talent, rights, and advertising, while facing financial risks such as impairment losses, higher borrowing costs, and the threat of subscriber churn that could erode the expected return on its streaming investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's DTC evolution across FY 2022-2024 and correctly identifies the strategic progression and financial risks. Strengths: (1) Accurately captures the three-phase evolution from FY 2022 (ad-supported tier launch, cost-realignment) through FY 2023 (DMED reorganization, content curation) to FY 2024 (Star India JV, consolidation, impairment charges); (2) Correctly identifies key financial risks including impairment losses, higher borrowing costs, and subscriber churn; (3) Properly synthesizes multi-hop information across fiscal years showing strategic pivot toward scaling DTC despite increasing risks; (4) Appropriately references specific page numbers from filings, demonstrating document grounding. Weaknesses: (1) The answer provides more operational/tactical detail (specific actions like Star India JV, goodwill impairments) than the ground truth, which focuses more on strategic positioning and financial uncertainty; (2) Ground truth emphasizes 'uncertainty around returns' and 'losses might continue to grow or reduce more slowly than anticipated' in FY 2022, while LLM focuses on operational changes; (3) Ground truth explicitly notes the shift from acknowledging uncertainty (FY 2022) to 'active investment' (FY 2023) to 'competitive pressures' (FY 2024), whereas LLM describes operational reorganizations rather than this strategic mindset shift; (4) LLM mentions 'pricing constraints' implicitly through competitive pressures but doesn't explicitly address the pricing tension noted in ground truth. The LLM answer is factually sound and addresses the core question about evolution and financial risks, but takes a more operational/tactical approach rather than the strategic/financial positioning lens of the ground truth. No quantitative errors detected. Multi-hop reasoning is sound—correctly synthesizes information across three fiscal years and connects operational changes to financial risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 531,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s footnote on transaction revenue is identical in the 2022, 2023 and 2024 filings.  In each year it states that the company “has full discretion in determining the fee charged to our customers, which is independent of the costs we incur when we use payment processors or other financial institutions.”  Consequently, PayPal bears the entire margin risk on every transaction, and the fees paid to processors are recorded as transaction expense.  Because the wording and the accounting treatment of transaction expense have not changed, PayPal’s exposure to margin risk has remained essentially unchanged across 2022‑2024, with the company continuing to set fees at its discretion and absorb the resulting margin variance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that PayPal's footnote language on transaction revenue is identical across 2022, 2023, and 2024; (2) Accurately quotes the key language about 'full discretion in determining the fee charged' and independence from processor costs; (3) Correctly states that PayPal bears full margin risk on every transaction; (4) Accurately notes that processor fees are recorded as transaction expense; (5) Properly synthesizes the multi-hop information that margin risk exposure remained stable/unchanged across the three-year period; (6) Correctly identifies that accounting treatment has not changed. The answer directly addresses all components of the question: evolution of margin risk exposure (stable), discretion in setting fees (maintained), and role of transaction expenses tied to payment processors (consistent treatment). Minor observation: The LLM answer does not explicitly mention the ASU 2023-07 segment reporting standards adoption mentioned in the ground truth for 2024, though this is a minor contextual detail that doesn't affect the core factual accuracy of the response. The LLM's conclusion that margin risk exposure 'remained essentially unchanged' is semantically equivalent to the ground truth's 'remained stable.' No quantitative errors detected. The reasoning is sound and properly synthesizes information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 403,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s Aerospace risk‑factor language in the 2022, 2023 and 2024 10‑Ks all contain the same warning that “downturns in the global demand for air travel…may impact new aircraft production or result in the delay or cancellation of new aircraft orders” (2022 page 31; 2023 page 31; 2024 page 32). The unchanged wording shows that the risk of order cancellations has remained a persistent concern over the three‑year span. Yet the modest rebound in 2024 net sales (+3 %) and segment profit (+2 %) versus 2023 indicates the commercial aviation sector is gradually recovering, though volatility and uncertainty still temper full stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that aircraft order cancellations remained a persistent risk across 2022-2024 and provides accurate page references (31, 31, 32) for the risk factor language. The sales growth figures (+3%) and segment profit growth (+2%) for 2024 appear reasonable and are presented as supporting evidence of gradual recovery. However, the answer has significant limitations in addressing the core question about how the risk 'evolved' as a concern. The ground truth emphasizes a clear progression: (1) 2022 - pandemic-specific concerns, (2) 2023 - expansion to geopolitical/macroeconomic risks, (3) 2024 - structural/competitive shifts with new entrants. The LLM answer states the wording was 'unchanged' across all three years, which directly contradicts the ground truth's finding of evolving language and shifting risk drivers. This is a critical failure in multi-hop synthesis - the question explicitly asks about evolution/progression, and the LLM concludes there was no meaningful evolution ('unchanged wording'), missing the nuanced shift in risk characterization that the ground truth documents. The LLM does correctly note that the sector remained fragile despite recovery, which aligns with the ground truth's conclusion. The quantitative data (page numbers, growth percentages) appears accurate, but the qualitative analysis of how risks evolved is substantially incomplete and contradicts the ground truth's core finding about the progression of risk language from pandemic-specific to geopolitical to structural concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 427,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 to 2024 PMI’s risk disclosures show a clear shift toward tighter regulation that blunts product differentiation and limits adult‑consumer communication.  In 2022 the filings warned that new rules could commoditize products and impede conversion to RRPs, citing product‑classification, advertising‑restriction and scientific‑substantiation challenges [page_13, page_15, page_16].  By 2023 the language broadened to cover both RRPs and SFPs, noting that regulation could diminish differentiation and restrict truthful information about both lines [page_19, page_20, page_21].  In 2024 the emphasis moved further toward SFPs, with explicit references to regulatory hurdles around product classification, advertising, distribution and consumer communication for SFPs, underscoring an intensifying regulatory environment that increasingly hampers PMI’s ability to differentiate and market its reduced‑risk offerings [page_18, page_19, page_20].",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core narrative arc from 2022-2024 regarding regulatory constraints on PMI's product differentiation and communication. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with appropriate temporal evolution; (2) Accurately captures the shift from RRPs focus to SFPs focus; (3) Correctly identifies key regulatory themes: product classification, advertising restrictions, scientific substantiation, consumer communication barriers; (4) Properly synthesizes the multi-hop concept that regulation increasingly constrains competitive positioning and product differentiation; (5) Appropriately emphasizes the asymmetric competitive impact and unfair competition angle. WEAKNESSES: (1) The page references [page_13, page_15, etc.] appear to be fabricated or unverifiable - these specific citations cannot be confirmed against the ground truth knowledge graph, which does not provide page-level granularity; (2) While the LLM captures the evolution narrative, it lacks the specific detail about 'digital media spreading misleading information' mentioned in the ground truth for 2023; (3) The phrase 'commoditize products' in 2022 is not explicitly mentioned in the ground truth, though it's semantically consistent with the restriction of differentiation theme; (4) The answer could have been more explicit about the 'regulatory asymmetries' and 'unfair competition' elements that appear in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and two product categories (RRPs and SFPs), showing proper understanding of how regulatory pressure evolved alongside PMI's strategic product transitions. The logic connecting regulation→differentiation constraints→competitive disadvantage is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both convey intensifying regulatory pressure limiting PMI's ability to market and differentiate products. The LLM's framing of 'tighter regulation that blunts product differentiation' is semantically equivalent to the ground truth's 'consistent and intensifying regulatory pressure.' No quantitative errors detected (no specific numbers to verify). The answer appropriately addresses all parts of the multi-part question regarding evolution, RRPs/SFPs, and what this reveals about regulatory constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 637,
        "total_tokens": 2216
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024.  In each year the company is the principal on every payment transaction, setting a mix of fixed and variable fees (the variable portion being a percentage of the payment amount) and bearing full margin risk regardless of the costs of payment processors, which are recorded as transaction expense (see Notes 2‑Revenue, 2022 p. 81; 2023 p. 75; 2024 p. 77).  Incentives to merchants and consumers—discounts, rebates, rewards and coupons—continue to be offered and are treated as revenue reductions, with no material change in the approach across the three years (2022 p. 81; 2023 p. 76; 2024 p. 76).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and demonstrates accurate multi-hop synthesis across the three years (2022-2024). Strengths: (1) Correctly identifies that PayPal bears full margin risk consistently across all three years; (2) Accurately describes the fee structure (fixed and variable components); (3) Correctly notes that payment processor costs are recorded as transaction expense; (4) Properly identifies that incentives (discounts, rebates, rewards, coupons) are treated as revenue reductions; (5) Appropriately cites specific page numbers from the filings; (6) Correctly synthesizes information across multiple years showing consistency in approach. Weaknesses: (1) The answer states 'no material change in the approach across the three years' which slightly understates the ground truth's emphasis on 'increasing detail' and 'more nuanced disclosure' regarding incentives and transaction pricing evolution; (2) The LLM characterizes the evolution as 'essentially unchanged' when the ground truth indicates there was increasing detail and nuance in disclosures, even if the underlying strategic approach remained stable; (3) Missing explicit mention that the independence of fees charged to customers from processor costs was highlighted in 2024 specifically. The answer is factually accurate on all verifiable claims (margin risk exposure, fee structures, incentive treatment, expense recognition) but slightly misses the nuance about disclosure evolution that the ground truth emphasizes. The multi-hop reasoning is sound—correctly synthesizing information across three years and multiple disclosure elements. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 463,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑Ks all describe the same AIB‑relationship framework: agreements with add‑in‑board manufacturers protect their inventory from price cuts, and AMD continues to sell directly to system integrators (SIs).  Across the three years the company kept the same inventory‑protection policy and reiterated that SIs use AMD’s discrete graphics solutions as a key differentiation tool to add value and respond quickly to short design cycles.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core framework (inventory protection policies, AIB relationships, discrete graphics as differentiator) and accurately captures that these elements were consistent across 2022-2024. The statement about SIs using discrete graphics solutions as key differentiation is accurate. No numeric errors or date inaccuracies present. WEAKNESSES: The LLM answer significantly undersells the evolution and nuance described in the ground truth. Specifically: (1) The ground truth emphasizes a SHIFT in emphasis from 2022-2023 to 2024 - moving from general descriptions of AIB/SI relationships to more strategic alignment language and deepening value propositions. The LLM states 'kept the same inventory-protection policy' and 'reiterated' the same framework, missing this subtle but important evolution. (2) The ground truth notes that by 2024, AMD placed 'more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies' - this strategic shift is completely absent from the LLM answer. (3) The ground truth describes a 'deepening of the value proposition for AIBs within the broader ecosystem' in 2024, suggesting strategic evolution beyond mere consistency. (4) The LLM's characterization of 'the same AIB-relationship framework' across all three years contradicts the ground truth's narrative of evolution and shifting emphasis. The LLM also mentions AMD 'continues to sell directly to system integrators' which, while not incorrect, is not emphasized in the ground truth and may introduce a slightly different framing. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to identify the temporal evolution pattern that is central to the question. The question explicitly asks 'how did...evolve' and the LLM's answer emphasizes consistency rather than evolution, which is a fundamental misalignment with the question's intent and the ground truth's answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 535,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "From fiscal 2022 through 2024 Disney kept the same policy: it only enters derivative transactions with counterparties rated **A‑ or better**, requires **collateral** if a counterparty’s rating falls below A‑ or if aggregate exposures exceed contract limits, and limits investment‑credit exposure to a single institution to **no more than 10 % of total cash and cash equivalents** (2022 page 113; 2024 page 120). The credit‑rating and collateral rules did not change, and the company still had no material cash‑equivalent balances with below‑investment‑grade institutions in any year. However, the actual concentration shifted – in 2023 no balances exceeded the 10 % threshold, whereas by fiscal 2024 balances that exceeded 10 % represented **24 % of total cash and cash equivalents** (2024 page 120).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All key numeric values are correct - A- or better credit rating requirement, 10% concentration threshold, and 24% actual concentration in fiscal 2024 are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies the consistent policy elements (counterparty ratings, collateral requirements) across the three-year period while also capturing the evolution in actual concentration levels. (3) The answer properly addresses all three sub-components of the question: counterparty credit ratings (A- or better - unchanged), collateral requirements (unchanged policy), and concentration thresholds (10% policy limit maintained, but actual concentration shifted from 0% in 2022 to 24% in 2024). (4) The temporal evolution is clearly articulated - distinguishing between the stable policy framework and the changing actual concentration. (5) Page citations (2022 page 113; 2024 page 120) add credibility and specificity. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (mentioning the 2023 intermediate year with no threshold exceedances), which adds helpful context without contradicting the ground truth. The phrasing 'balances that exceeded 10% represented 24% of total cash and cash equivalents' is a precise way to express the concentration metric. The answer correctly notes that no material below-investment-grade balances existed in any year, which reinforces the credit quality discipline. All factual claims are verifiable and consistent with the ground truth answer's core message about policy consistency combined with strategic concentration shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 460,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s exposure to the 2029‑maturing Fixed‑rate 2.850% notes stayed flat at $1.5 billion in 2022, 2023 and 2024 (page 107 for 2022‑23 and page 104 for 2024). The unchanged balance indicates the company has not accelerated repayment or repurchased this tranche, instead maintaining a stable maturity profile. This pattern reflects a disciplined long‑term debt‑management strategy that prioritizes a consistent debt mix and balances refinancing risk with interest‑rate exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. QUANTITATIVE ACCURACY: The key financial figure of $1.5 billion (equivalent to $1,500 million in ground truth) is correctly stated and consistently applied across all three years (2022, 2023, 2024). The format variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. Page references (107 for 2022-23, 104 for 2024) are provided, showing source documentation. COMPLETENESS: The answer addresses the core question about how exposure evolved (remained flat) and provides multi-year pattern analysis. ENTITY ACCURACY: Company (PayPal/PYPL), debt instrument (2029-maturing Fixed-rate 2.850% notes), and time periods are all correctly identified. REASONING QUALITY: The LLM correctly synthesizes that the unchanged balance across three years indicates no principal reduction or refinancing of this specific instrument. The interpretation that this reflects a disciplined debt-management strategy is sound and aligns with the ground truth's suggestion of strategic retention. MINOR GAPS: The LLM answer does not explicitly mention that PYPL issued new debt in 2023 and 2024 (including higher-interest notes like 5.150% and 5.500% in 2024), which the ground truth includes as context for understanding why the 2029 notes were retained despite new issuances. This contextual detail would strengthen the multi-hop synthesis but is not essential to answering the core question. The LLM's interpretation about 'balancing refinancing risk with interest-rate exposure' is reasonable inference but slightly less specific than the ground truth's mention of 'preserving favorable interest terms.' Overall, the answer demonstrates solid multi-hop reasoning across the three-year period and correctly identifies the strategic pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 489,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "In 2022 Honeywell identified raw‑material demand and supply as a key risk for its Performance Materials and Technologies segment. By 2023 the company reported that 64 % of that segment’s raw‑material supply base was under contract, and in 2024 that coverage rose to a majority of the base. This trend shows a deliberate effort to lock in prices and reduce supply uncertainty, thereby mitigating—but not eliminating—the segment’s exposure to commodity‑market volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM claims '64% of that segment's raw-material supply base was under contract' in 2023 and 'a majority' in 2024. These specific percentages do not appear in the ground truth and cannot be verified. This is a major factual claim presented as fact without source support. (2) MISSING KEY INFORMATION: The ground truth explicitly mentions the segment was rebranded as 'Energy and Sustainability Solutions' by 2024—the LLM completely omits this important contextual detail. (3) INCOMPLETE SYNTHESIS: The ground truth discusses multiple risk factors including product commoditization, illegal HFC imports, and oil/natural gas price volatility. The LLM ignores these nuances and oversimplifies the risk profile. (4) MISCHARACTERIZATION OF TREND: The ground truth emphasizes that risks were 'consistently highlighted' and 'reiterated' across all three years, indicating sustained vulnerability despite adjustments. The LLM frames this as a 'deliberate effort' to mitigate risks through contracting, which is a different narrative not supported by the ground truth. (5) LOGICAL FLAW: The LLM's conclusion that the company is 'mitigating—but not eliminating' exposure is reasonable, but it's based on unverified percentage claims rather than the ground truth's emphasis on consistent risk presence. The answer demonstrates poor multi-hop reasoning by introducing unsourced quantitative claims and failing to synthesize the actual evolution of risk framing across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 447,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC remained a member of PMI’s peer group in each of the 2022, 2023 and 2024 10‑Ks (see PM_10k_2022 page 21, PM_10k_2023 page 26 and PM_10k_2024 page 26). The unchanged inclusion shows PMI’s benchmarking strategy is deliberately stable, using a fixed set of global tobacco and consumer‑products peers that reflect its size and focus, and that Imperial Brands PLC is consistently viewed as a relevant peer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies Imperial Brands PLC as consistently included in PM's peer group across all three years (2022, 2023, 2024) - matching the ground truth exactly. (2) Provides specific document citations (PM_10k_2022 page 21, PM_10k_2023 page 26, PM_10k_2024 page 26) that add credibility and verifiability. (3) Accurately characterizes the benchmarking strategy as deliberately stable with a fixed set of peers. (4) Correctly identifies the relevant sector context (global tobacco and consumer products). (5) Properly synthesizes the multi-hop information across three years to draw a conclusion about strategic consistency. Minor observations: (1) The LLM uses 'PMI' while the ground truth uses 'PM' - these are equivalent (PMI is Philip Morris International's ticker), so this is acceptable notation variation. (2) The LLM answer is slightly more concise than the ground truth but captures all essential information and reasoning. (3) Both answers convey the same semantic meaning: Imperial Brands remained a consistent peer choice reflecting PM's stable benchmarking approach. The answer demonstrates sound multi-hop reasoning by synthesizing information across three separate 10-K filings to establish a trajectory and draw conclusions about strategic intent. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 392,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850% notes stayed constant at **$1.5 billion** for each year examined: $1.5 bn in 2022 and 2023 (page 107) and $1.5 bn in 2024 (page 104).  The maturity of the series (10/1/2029) and its effective interest rate (2.96%) also remained unchanged, indicating that the company has chosen to keep this long‑term debt exposure stable rather than reducing or expanding it.  This consistency reflects a conservative debt‑management approach that prioritizes predictable interest‑rate exposure and a steady maturity profile over aggressive refinancing or debt reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All key numbers are correct - $1.5 billion principal balance for 2022, 2023, and 2024 matches the ground truth exactly. The maturity date (10/1/2029) and effective interest rate (2.96%) are additional accurate details not contradicted by the ground truth. The format variations ($1.5 bn vs $1.5 billion) are acceptable. COMPLETENESS: The answer addresses all aspects of the question - the evolution of exposure across the three-year period (2022-2024), the stability of the position, and the implications for debt management strategy. ENTITY ACCURACY: PayPal/PYPL correctly identified, years correct (2022, 2023, 2024), debt instrument correctly specified (fixed-rate 2.850% notes). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the constant $1.5 billion balance across all three years and draws appropriate conclusions about debt management strategy. The interpretation that this reflects a conservative approach prioritizing predictable interest-rate exposure is logically consistent with the data and aligns with the ground truth's assessment that PYPL maintained a consistent liability position. MINOR CONSIDERATIONS: The LLM provides slightly more detail (maturity date, effective interest rate) than the ground truth, but these are accurate enhancements rather than errors. The characterization of the strategy as 'conservative' and focused on 'predictable interest-rate exposure' is semantically equivalent to the ground truth's description of maintaining a 'consistent long-term liability position' and 'leveraging the low fixed rate.' No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 471,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips expanded its HSE audit scope from 2022 to 2024, adding staff‑group audits to the business‑unit reviews and tightening conformance tracking by requiring that identified improvement actions be followed through to completion. The 2024 10‑K notes that audit progress is now reported to both the Executive Leadership Team and the Board of Directors, a step up from the 2022 filing, which reported progress only to the ELT, thereby integrating HSE oversight more closely with corporate governance. (COP_10k_2024, pp. 18‑19; COP_10k_2022, p. 18)",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and a potential factual error regarding reporting structure. CORRECT ELEMENTS: (1) The identification of HSE audits across business units and staff groups is accurate; (2) The emphasis on tracking improvement actions to completion is correct; (3) The 2024 reference to corporate-level audits is mentioned; (4) The general evolution toward more integrated governance is captured; (5) Citation format and page references appear reasonable. CRITICAL ISSUES: (1) The LLM claims that 2022 reporting was 'only to the ELT' while 2024 added Board reporting. However, the ground truth indicates that by 2023, outcomes were already being 'reported to the Executive Leadership Team (ELT) and the Board of Directors.' This suggests Board reporting was established by 2023, not newly added in 2024. The LLM's characterization of this as a 'step up from the 2022 filing' may misrepresent the timeline of when Board reporting was introduced. (2) MISSING ELEMENTS: The ground truth emphasizes the explicit linking of audit outcomes to 'annual objectives, targets, and deadlines' in 2023, which the LLM does not mention. This is a substantive aspect of the evolution that represents a key refinement in the audit framework. (3) The ground truth describes a 'shift from localized conformance checks toward a more integrated, governance-driven audit model' - the LLM captures the governance integration but doesn't fully articulate the shift from localized to centralized oversight as clearly. (4) The 2024 'centralized oversight approach' is mentioned only briefly in the LLM answer without sufficient emphasis on this structural change. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022, 2023, and 2024 filings but appears to have incomplete or inaccurate information about the 2023 transition point, which is critical to understanding the evolution. The answer would benefit from more precise temporal sequencing of when each change occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 544,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across 2022, 2023, and 2024 AMD consistently incorporated the 2011 Executive Incentive Plan as Exhibit 10.2 in its Form 10‑K, underscoring that the plan remains a foundational governance document.  In each filing the plan is referenced by the same “incorporated by reference” language (see 2022 Exhibit list on pages 92‑93, 2023 on pages 99‑103, and 2024 on pages 96‑100), even as the company expands its executive‑compensation disclosures with newer plans and amendments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT NUMBER MISMATCH: The LLM answer states the 2011 Executive Incentive Plan was listed as Exhibit 10.2 across 2022, 2023, and 2024. The ground truth explicitly states it was listed as Exhibit 10.1 in all three years. This is a fundamental factual error on a specific, verifiable detail that is central to the question. The LLM also provides page numbers (92-93 for 2022, 99-103 for 2023, 96-100 for 2024) that cannot be verified against the ground truth and may be fabricated. While the LLM correctly identifies: (1) the 2011 Executive Incentive Plan as the foundational document, (2) consistent referencing across 2022-2024, (3) the 'incorporated by reference' language, and (4) the broader context of expanding executive compensation disclosures, the exhibit number error is a critical factual inaccuracy that undermines the entire answer. The question specifically asks about the plan's reference 'as a foundational governance document,' and the exhibit designation is a concrete, verifiable way this reference is documented. The LLM's semantic understanding of the evolution and consistency is reasonable, but the specific exhibit number citation is demonstrably wrong and represents a major factual failure on a quantifiable detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 353,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s 10‑K filings show the same indemnification framework for Stellantis: the company guarantees the Seller’s obligation to indemnify Stellantis for losses tied to inaccuracies in representations, warranties, emissions, product liabilities and recalls, with the obligations capped by time limits, thresholds and caps (see GM_10k_2022 page 90, GM_10k_2023 page 91, GM_10k_2024 page 92).  GM has not disclosed any material accrued liability for these obligations and continues to state it cannot estimate a reasonable loss, indicating that its exposure to post‑sale liabilities has remained uncertain but potentially material, without a significant increase or decrease over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core evolution and progression that the question asks about. MAJOR ISSUES: (1) The LLM describes a static framework ('the same indemnification framework') across 2022-2024, directly contradicting the ground truth which shows clear evolution and expansion of exposure. (2) The LLM fails to capture the geographic expansion (Germany, UK, Netherlands in 2023; Austria added in 2024) that is central to understanding how exposure evolved. (3) The LLM misses the specific regulatory developments: Takata inflator recalls in 2023 and the European Commission/UK CMA investigation in 2024 are not mentioned. (4) The LLM incorrectly states 'no material accrued liability' consistently, when the ground truth indicates an 'immaterial accrual' was recorded in 2024 related to the regulatory investigation. (5) The LLM's conclusion that exposure 'remained uncertain but potentially material, without a significant increase or decrease' directly contradicts the ground truth's finding of 'growing complexity and persistence' with 'widening legal exposure.' (6) While the LLM correctly identifies that no material accruals were recorded and that the company stated further indemnification was remote, it fails to synthesize the multi-hop information showing how the scope and complexity of post-sale liabilities actually increased over the period. The LLM appears to have focused on the structural framework of indemnification obligations rather than tracking their actual evolution through specific claims, recalls, and regulatory actions. The page references provided (90, 91, 92) cannot be verified but the substantive content analysis is clearly incomplete relative to the ground truth narrative of expanding exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 476,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022, bamlanivimab generated $2.01 billion of Lilly’s COVID‑19 antibody revenue, with royalty payments to AbCellera recorded as cost of sales (page_72). By 2023 and 2024 no COVID‑19 antibody revenue was reported, indicating the product was discontinued and the royalty obligation had ended (page_68). This shift shows that bamlanivimab was a short‑term revenue driver rather than a long‑term strategic asset for Lilly (page_70).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative elements. The $2.01 billion (or $2,008.9 million) figure for 2022 COVID-19 antibody revenue is correct, and the statement that no COVID-19 antibody revenue was reported in 2023 and 2024 is accurate. The multi-hop synthesis correctly identifies the trajectory from significant revenue contributor to complete phase-out.\n\nSTRENGTHS:\n1. Quantitative accuracy is high - the $2.01 billion figure matches the ground truth ($2,008.9 million)\n2. Correctly identifies the timeline: 2022 revenue → 2023/2024 zero revenue\n3. Properly synthesizes the multi-hop information: revenue data + royalty obligations + strategic importance\n4. Correctly identifies AbCellera as the royalty partner\n5. Appropriately concludes bamlanivimab was a short-term asset, not long-term strategic\n\nWEAKNESSES:\n1. The answer mentions royalty obligations \"had ended\" in 2023/2024, but the ground truth specifies the royalty structure was \"tiered percentages ranging from mid-teens to mid-twenties on global sales\" - the LLM doesn't provide these specific percentage details\n2. The answer states royalty payments were \"recorded as cost of sales\" but doesn't elaborate on the tiered structure that was part of the original agreement\n3. Missing some contextual detail about the shift to \"newer therapeutic areas like cardiometabolic health\" that the ground truth mentions\n4. The answer is somewhat more concise than the ground truth, omitting the specific royalty percentage ranges\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across multiple years and connects revenue data with royalty obligations and strategic importance. The logic is sound: declining revenue → discontinued product → ended royalty obligations → not a long-term strategic asset.\n\nSEMANTIC EQUIVALENCE:\nThe core message matches: bamlanivimab was significant in 2022, disappeared by 2023-2024, and represents a short-term pandemic-driven revenue source rather than a strategic long-term asset. The wording differs but the meaning is equivalent.\n\nThe score of 8 reflects that while the answer is substantially correct on all major points and numbers, it omits some specific details about the royalty structure (tiered percentages) and doesn't fully address the strategic pivot to other therapeutic areas mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 636,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Philip Morris International continued to list Jackpot as a local Philippine brand in its 2022, 2023 and 2024 10‑Ks, with no change in its strategic emphasis on the brand【page_5】【page_6】【page_5】.  During the same period the company narrowed its international cigarette lineup from seven brands in 2022 to five brands in 2023 and 2024, while keeping Jackpot (alongside Fortune) in its local portfolio【page_5】【page_6】【page_5】.  This three‑year trajectory shows that PMI is maintaining a steady focus on local brands in key markets even as it streamlines its global brand mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Jackpot was consistently listed as a local Philippine brand across 2022-2024, and accurately notes that Fortune was also mentioned alongside Jackpot. The answer correctly captures the core insight that PMI maintained focus on local brands while streamlining global offerings. The semantic understanding of PMI's dual strategy is sound.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific claim about international cigarette brands narrowing from 'seven brands in 2022 to five brands in 2023 and 2024' with page citations. This quantitative claim is NOT present in the ground truth and cannot be verified. This is a significant factual addition that may be incorrect. (2) MISSING CONTEXT - The ground truth emphasizes the 'broader strategic pivot toward smoke-free products and wellness' as important context for understanding why Jackpot's continued presence is notable. The LLM mentions 'streamlines its global brand mix' but doesn't capture the smoke-free transition context that frames the significance of maintaining local cigarette brands. (3) INCOMPLETE SYNTHESIS - The ground truth provides more nuanced year-by-year evolution (2022 as baseline, 2023 as reiteration of reliance, 2024 as persistence despite pivot), while the LLM treats all three years as essentially equivalent ('no change in strategic emphasis'). (4) CITATION CONCERNS - The page citations provided lack specificity and cannot be independently verified against the ground truth.\n\nMULTI-HOP REASONING: The LLM does synthesize information across three years and connects local brand strategy to global brand streamlining, which shows multi-hop capability. However, the introduction of unverified quantitative claims undermines the reasoning quality.\n\nOVERALL: The answer captures the main conclusion but introduces unverified quantitative claims and misses important contextual nuance about the smoke-free strategic pivot that gives meaning to the local brand persistence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 542,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal’s credit and BNPL products carried direct exposure to bad transactions, with credit‑risk models and default rates affecting its receivables. The 2023 sale of up to €40 billion of U.K. and European BNPL loan receivables reduced future exposure, but the forward‑flow arrangement is contingent on conditions that could delay benefits. In 2024, persistent fraud and third‑party processing disruptions continue to pose significant risks, potentially increasing bad‑transaction exposure even after the BNPL sale.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the €40 billion BNPL receivables sale in 2023 and proper year-by-year framing (2022-2024). The numeric values and dates are accurate. However, the answer has notable gaps in completeness and qualitative depth compared to the ground truth. Strengths: (1) Correctly identifies the €40 billion sale amount and 2023 timing; (2) Accurately notes the contingent nature of the forward-flow arrangement; (3) Properly synthesizes the multi-hop concept of risk reduction through asset sale while acknowledging persistent fraud/processing risks; (4) Maintains appropriate temporal progression across the three-year period. Weaknesses: (1) Lacks specific mention of fraud types (synthetic identities, stolen financial instruments) that were highlighted in 2022; (2) Does not explicitly address PayPal's reliance on third-party lenders and processors as a distinct risk category; (3) Missing discussion of account takeover attempts and regulatory challenges mentioned in ground truth; (4) Does not capture the nuance that while direct exposure decreased, underlying risks persisted; (5) Omits the multi-year agreement context and execution risks associated with the sale. The answer is concise and factually sound but sacrifices important contextual details that demonstrate comprehensive understanding of PayPal's evolving risk profile. The reasoning is logically sound but less thorough than the ground truth in explaining the full scope of bad transaction exposure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 427,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "Honeywell’s 2022 risk‑factor disclosure warned that “fluctuations in retail markets” could hurt its Safety and Productivity Solutions segment, and the company’s 2022 segment results showed a decline in sales and margin for that business.  In 2024, the newly‑realigned Industrial Automation segment faced the same retail‑market risk, yet the company’s overall profit rose to $1.52 billion (page 28), indicating that other drivers (e.g., advanced‑materials demand) offset the retail impact.  In 2023, the risk‑factor statement again highlighted retail‑market volatility for both Safety and Productivity Solutions and Industrial Automation, underscoring Honeywell’s continued sensitivity to retail demand swings across its industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about Honeywell's persistent exposure to retail market fluctuations across the three-year period (2022-2024) and properly synthesizes the multi-hop information across segments and years. The qualitative reasoning about the evolution of this risk and its consistency across business reorganizations is sound and aligns with the ground truth.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. UNVERIFIED CLAIM: The LLM states \"the company's overall profit rose to $1.52 billion (page 28)\" in 2024. This specific figure and its attribution to page 28 cannot be verified against the ground truth provided. The original answer does not mention this profit figure, and introducing specific financial metrics with page citations that aren't in the ground truth is problematic.\n\n2. INCOMPLETE SEGMENT ANALYSIS: The LLM mentions \"2022 segment results showed a decline in sales and margin for that business\" but provides no specific numbers. The ground truth doesn't provide these figures either, but the LLM's assertion about decline is presented as fact without supporting data.\n\n3. SPECULATIVE REASONING: The statement about \"other drivers (e.g., advanced-materials demand) offset the retail impact\" introduces speculation not present in the ground truth. While the reasoning is logical, it goes beyond what can be verified from the provided information.\n\n4. MISSING NUANCE: The LLM correctly identifies the 2023 risk reiteration but doesn't fully capture the ground truth's emphasis on \"global economic instability\" as a broader context for the retail market risk in 2023.\n\nSTRENGTHS:\n- Correctly identifies all three years (2022, 2023, 2024)\n- Properly names both segments (Safety and Productivity Solutions, Industrial Automation)\n- Accurately conveys the core finding about persistent sensitivity to retail demand volatility\n- Sound multi-hop synthesis connecting the three-year progression\n- Appropriate emphasis on business reorganization context\n\nWEAKNESSES:\n- Introduces unverified financial metrics ($1.52 billion profit)\n- Makes claims about segment performance declines without supporting numbers\n- Adds speculative analysis about offsetting factors\n- Slightly less comprehensive than ground truth in capturing macroeconomic context",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 623,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024 the Incyte collaboration kept its financial structure as a worldwide license and collaboration: tiered double‑digit royalties up to 20 % on worldwide net sales (plus an additional low‑teens royalty for COVID‑19 sales above a threshold) (page 72). Milestone payments were capitalized as intangible assets and amortized to cost of sales; the amounts were $260 million in 2021 and $210 million in 2020, and no material net milestones were recorded in 2023 or 2024, though Incyte remained eligible for up to $100 million in additional sales‑based milestones (page 73). Olumiant’s revenue grew from $830.5 million in 2022 to $957.4 million in 2024, underscoring its increasing importance to LLY’s revenue base (page 74).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) MILESTONE PAYMENT DISCREPANCY: LLM states '$260 million in 2021 and $210 million in 2020' but ground truth specifies '$260.0 million in 2022' as capitalized milestone payments. The LLM appears to have confused years and cited 2020-2021 data instead of 2022 baseline. (2) CONTINGENT PAYMENT ERROR: Ground truth clearly states Incyte was 'eligible for up to an additional $200.0 million in contingent payments' but LLM claims 'up to $100 million in additional sales-based milestones' - this is a 50% understatement of the contingent payment obligation. (3) REVENUE FIGURES: LLM provides Olumiant revenue of '$830.5 million in 2022 to $957.4 million in 2024' which cannot be verified against ground truth (ground truth does not provide these specific revenue figures, making this potentially fabricated data). (4) INCOMPLETE EVOLUTION NARRATIVE: LLM fails to capture the strategic evolution described in ground truth - specifically the 2023 shift to 'ongoing revenue recognition' and the 2024 emphasis on 'expanded use under EUA and inclusion of follow-on compounds.' The LLM answer treats the collaboration as static rather than evolving. (5) MISSING CONTEXT: LLM does not address the tiered nature of the royalty structure evolution or the strategic deepening indicated by the ground truth. STRENGTHS: The LLM correctly identifies the royalty structure (tiered, up to 20%, plus low-teens for COVID-19 sales above threshold) and recognizes Olumiant's growing importance. However, the quantitative errors on milestone amounts and years, combined with potentially fabricated revenue figures and incomplete strategic analysis, significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 464,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s relationship with UST remained essentially unchanged from 2022 to 2024: UST continued to be a wholly‑owned subsidiary and its indefinite‑lived intangible assets—$8.8 billion of MST and snus trademarks and $2.6 billion of cigar trademarks acquired in 2009—were still reported as part of Altria’s intangible assets with no impairment disclosed (page_66). The 2024 10‑K continues to list UST as a wholly owned subsidiary and reports no change in ownership or intangible‑asset valuation (page_4). UST’s moist‑smokeless tobacco products remain a core component of Altria’s “smoke‑free” transition strategy, which is further reinforced by the 2024 joint venture with JTIUH for heated‑tobacco stick and the acquisition of NJOY (page_4).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies UST as wholly-owned subsidiary across 2022-2024 period. (2) Accurately cites $8.8 billion in MST and snus trademarks from 2009 acquisition. (3) Correctly notes no impairment disclosed. (4) Properly identifies NJOY acquisition and JTIUH joint venture as part of broader strategy. (5) Number formatting and quantitative data are accurate.\n\nWEAKNESSES: (1) CRITICAL OMISSION: LLM introduces $2.6 billion cigar trademarks figure that is NOT mentioned in the ground truth answer. While this may be factually present in 10-K filings, it represents information beyond the scope of the original answer and suggests the LLM may be adding details not directly relevant to the UST-specific evolution question. (2) INCOMPLETE STRATEGIC EVOLUTION NARRATIVE: The ground truth emphasizes a 3-year TRAJECTORY showing strategic evolution where UST's traditional MST business remained core but was \"increasingly complemented by newer, potentially less harmful tobacco alternatives.\" The LLM states the relationship \"remained essentially unchanged,\" which contradicts the ground truth's emphasis on strategic diversification and evolution. (3) MISSING NUANCE: Ground truth highlights the shift toward oral nicotine pouches (Helix) and e-vapor (NJOY) as complementary to UST's traditional business, suggesting a portfolio rebalancing. LLM mentions these but doesn't capture the evolutionary/complementary nature emphasized in ground truth. (4) CHARACTERIZATION ERROR: LLM describes UST's MST products as part of \"smoke-free\" transition strategy, but ground truth more carefully notes these are traditional products being complemented by \"potentially less harmful\" alternatives—a subtle but important distinction about Altria's strategic positioning.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across years and identifies the key entities (UST, USSTC, NJOY, JTIUH, Helix), but fails to properly synthesize the EVOLUTION aspect that is central to the question. The answer treats 2022-2024 as static rather than dynamic.\n\nQUANTITATIVE VERIFICATION: $8.8 billion figure is correct. The $2.6 billion cigar trademark figure, while potentially accurate from filings, is not in the ground truth and represents scope creep. No calculation errors detected.\n\nSEMANTIC EQUIVALENCE: The core semantic difference is significant—ground truth emphasizes evolution/trajectory; LLM emphasizes stasis. This is not merely a wording difference but a substantive interpretation difference about how the relationship changed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 678,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% senior note stayed at a $500 million principal balance through FY 2022‑FY 2024, but its effective interest rate climbed sharply—from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024【page 89】. This steep rise in the effective rate signals that borrowing costs for Cisco’s debt rose markedly, reflecting a tightening of capital‑market conditions and higher yields on comparable corporate debt during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the 3.50% Senior Note's effective interest rates are accurately stated as 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024). The principal balance of $500 million is correctly identified and adds useful context not explicitly required but relevant to understanding the debt instrument. The multi-hop reasoning is sound—the model correctly synthesizes the evolution of interest rates across three fiscal years and properly interprets what this trend indicates about capital market conditions and borrowing costs. The answer goes slightly beyond the ground truth by including the principal balance detail, which is factually accurate and enhances understanding without introducing errors. The interpretation of the trend (tightening capital market conditions, higher yields on comparable corporate debt) aligns with the ground truth's explanation. Minor formatting differences (spaces in percentages like '3.20 %' vs '3.20%') are inconsequential. The citation reference [page 89] adds credibility. The only minor consideration is that the answer could have been slightly more explicit about the magnitude of the increase (3.46 percentage point rise from FY2022 to FY2024), but this is not a deficiency since the trend is clearly communicated. Overall, this is a high-quality response that accurately addresses all aspects of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 400,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion** at December 31, 2022 to **$15.0 billion** at December 31, 2023 and further to **$13.0 billion** at December 31, 2024 (Table 6, 2023 and 2024 filings). This steady decline shows Amazon is actively paying down older, higher‑rate debt, reducing interest expense and improving its leverage profile—evidence of a disciplined, proactive debt‑management strategy over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three key financial figures are correct: $16.0B (2022), $15.0B (2023), $13.0B (2024). (2) Dates are accurate (December 31 for each year). (3) The characterization of the trend as a 'steady decline' is accurate. (4) The reasoning about debt management strategy is sound and well-articulated. (5) The LLM correctly identifies this as evidence of disciplined debt management.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The original answer provides crucial context by noting the broader long-term debt reduction from $67.2B (2022) to $52.6B (2024), which demonstrates how the 2017 Notes reduction fits into Amazon's overall debt strategy. The LLM answer mentions 'broader trend' but does not provide these specific comparative figures that would strengthen the multi-hop analysis. (2) The LLM answer focuses on interest expense reduction and leverage improvement, which are reasonable inferences but are not explicitly stated in the ground truth answer. While these are logical conclusions, they represent added interpretation rather than direct synthesis of the provided data. (3) The reference to 'Table 6, 2023 and 2024 filings' adds specificity but cannot be verified against the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully identifies the 2017 Notes trajectory across three years and connects it to debt management strategy. However, it misses the opportunity to synthesize the specific broader debt context ($67.2B to $52.6B) that the ground truth explicitly includes, which would have demonstrated more complete multi-hop reasoning across the company's overall debt portfolio.\n\nCORRECTNESS ASSESSMENT: All quantitative data is accurate. The qualitative assessment of debt management strategy is reasonable but less comprehensive than the ground truth, which explicitly contextualizes the 2017 Notes reduction within the larger debt reduction narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 511,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "In fiscal 2022 the 5.000% notes due April 2030 were not listed in the debt table (page 80), implying a $0 outstanding balance.  In fiscal 2023 and 2024 the notes remained at an outstanding principal of $606 million with an effective interest rate of 5.18% (page 81).  This steady balance and unchanged rate show that AVGO has kept the instrument as a stable, long‑term financing source without refinancing or altering its terms, reflecting a disciplined debt‑management strategy focused on predictable interest costs and maturity structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on a fundamental fact. The ground truth clearly states that in fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030. The LLM claims these notes 'were not listed in the debt table (page 80), implying a $0 outstanding balance' in fiscal 2022. This is factually incorrect and represents a major quantitative accuracy failure. The correct progression is: FY2022: $606M at 5.18%, FY2023: $606M at 5.18%, FY2024: $606M at 5.18%. The LLM's claim of $0 in FY2022 is wrong. Additionally, the LLM correctly identifies the FY2023 and FY2024 figures ($606M, 5.18%), but this partial correctness cannot offset the fundamental error about FY2022. The LLM's interpretation that the notes were 'not listed' in FY2022 appears to be a misreading of the source documents. The qualitative reasoning about debt management strategy is sound (stable, disciplined approach), but this cannot compensate for the incorrect quantitative data. The multi-hop synthesis fails because it incorrectly characterizes the three-year progression as starting from $0 rather than $606M. This is a critical factual error that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 355,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "Netflix formally amended and restated its Performance Bonus Plan in December 2022 (Exhibit 10.5†, 2023 10‑K). The 2023 10‑K incorporated the amended plan into the company’s executive‑compensation framework, with the plan referenced in the Executive Compensation section and as Exhibit 10.5†. In 2024 the plan was again amended and restated (Exhibit 10.5† filed 9 Dec 2023) and further integrated into the updated executive‑compensation agreements for 2024, reflecting a continued formalization and alignment of the bonus structure with executive pay【page 69 (2023)】【page 69 (2024)】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates and documents. Strengths: (1) Correctly identifies December 2022 as the date of the Amended and Restated Performance Bonus Plan filing; (2) Properly references Exhibit 10.5† as the relevant exhibit; (3) Accurately notes the plan's integration into executive compensation framework across 2023-2024; (4) Correctly identifies the 2023 10-K and 2024 10-K as sources. Weaknesses: (1) The statement 'In 2024 the plan was again amended and restated (Exhibit 10.5† filed 9 Dec 2023)' is somewhat confusing in its temporal framing - it references a December 2023 filing date but presents it as a 2024 development, which could be clearer; (2) The answer provides slightly more specific document citations than the ground truth but doesn't substantially add new information about the evolution; (3) Missing explicit mention of the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement' that the ground truth identifies as part of the integrated compensation strategy in 2024. Multi-hop reasoning is sound - the answer correctly synthesizes information across multiple years and documents to show the progression from foundational role (2022) to formal amendment (2022/2023) to further integration (2024). The answer accurately conveys the evolution of formalization and integration, though it could be more explicit about the specific companion agreements mentioned in the ground truth. Page citations appear reasonable though cannot be independently verified. Overall, the core narrative of evolution is correct with minor gaps in comprehensiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 457,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s approach to international terrorism exposure did not materially change between 2022 and 2024.  In each filing the company states that it models losses with a third‑party vendor, monitors concentration, and purchases targeted reinsurance for selected lines while relying on government‑sponsored terrorism pools in non‑U.S. jurisdictions (2022: page 169; 2023: page 121; 2024: page 88).  No new modeled loss estimates for international terrorism were disclosed, and the reinsurance and mitigation strategy remained essentially unchanged across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth and misses critical factual information. MAJOR ERRORS: (1) The LLM claims 'no material change' and 'essentially unchanged' strategy, but the ground truth explicitly documents significant evolution in reinsurance protections and risk mitigation from 2022-2024. (2) MISSING SPECIFIC NUMBERS: The LLM fails to mention the $1.3 billion modeled loss estimate for a five-ton bomb attack in NYC (2022), the $200 million Japan attachment point (2024), the $125 million rest-of-world attachment point (2024), and the $20.1 billion collateral held for reinsurance recoverable assets (2024). These are concrete, quantifiable metrics that directly answer the question. (3) INCOMPLETE SYNTHESIS: The question asks about evolution 'particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies' - the LLM addresses none of these specifically. The ground truth shows clear progression: 2022 had specific modeled loss estimates, 2023 emphasized routine monitoring and targeted reinsurance, 2024 had specific attachment points and global property covers. (4) REASONING FAILURE: The LLM's conclusion that strategy remained 'essentially unchanged' is contradicted by the documented evolution in reinsurance structures (core attachment points, global property per risk covers) and collateral management ($20.1B). (5) PAGE CITATIONS: While the LLM provides page references, these appear to be generic citations that don't validate the claim of 'no material change.' The ground truth demonstrates material changes in specific reinsurance mechanisms and risk mitigation approaches across the three-year period. The LLM fundamentally mischaracterizes the evolution as static when it was actually dynamic and strategic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 487,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio expanded markedly between 2022 and 2024.  Equity‑security holdings grew from **$3.7 billion in 2022 to $4.9 billion in 2023** and remained at that level in 2024 (page 50).  Equity‑method investments in healthcare operating businesses dipped slightly from **$1.5 billion in 2022 to $1.4 billion in 2023** but then **more than doubled to $3.8 billion in 2024**, reflecting a shift toward larger, strategic healthcare investments (page 52).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine its credibility. (1) EQUITY SECURITIES - 2022: LLM states $3.7 billion, but ground truth is $3.5 billion (error of $200M or 5.7%). This is a material discrepancy. 2023 and 2024 figures of $4.9 billion are correct. (2) EQUITY METHOD INVESTMENTS - 2022: LLM states $1.5 billion, but ground truth is $1.3 billion (error of $200M or 15.4%). This is a significant error. 2023 figure of $1.4 billion is correct. 2024 figure of $3.8 billion is correct. (3) MULTI-HOP SYNTHESIS: The LLM correctly identifies the strategic pivot toward equity method investments in 2024 and the overall trend, but the foundational numbers are wrong, which undermines the analysis. (4) COMPLETENESS: The answer addresses both equity securities and equity method investments across all three years, which is appropriate. However, the 2022 baseline figures are incorrect, making year-over-year comparisons inaccurate. (5) REASONING: The qualitative interpretation about 'shift toward larger, strategic healthcare investments' is sound and matches the ground truth narrative, but this cannot compensate for the quantitative errors. The statement that equity method investments 'more than doubled' is correct (from $1.4B to $3.8B is approximately 2.7x), but this comparison is based on the incorrect 2022 starting point. VERDICT: While the LLM demonstrates understanding of the strategic evolution and correctly identifies the 2023-2024 trend, the material errors in 2022 baseline figures (both equity securities and equity method investments) represent fundamental factual inaccuracies that significantly impact the reliability of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 470,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 1.700% Notes due 2025 were first issued in 2022 and remained on the books in the 2023 and 2024 10‑K filings, with no change to the coupon or maturity (see the “Securities registered” list on page 1 of each filing).  The notes continued to form a core part of the company’s long‑term debt mix, reflecting a deliberate strategy of keeping a stable, low‑interest debt base to support capital‑allocation decisions such as share repurchases and the transition to a smoke‑free portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Altria's 1.700% 2025 Notes were present across 2022, 2023, and 2024 filings with consistent coupon and maturity dates. The numeric values (1.700% coupon, 2025 maturity) are accurate. However, there are significant issues with the multi-hop synthesis and completeness: (1) The LLM claims the notes were 'first issued in 2022,' which cannot be verified from the ground truth and may be inaccurate - the ground truth only states they were 'disclosed' in 2022, not necessarily issued then. (2) The LLM fails to address the key multi-hop comparison element of the original question: the evolution of the capital structure across the three years, specifically the maturation and removal of the 1.000% 2023 Notes by 2023. This is a critical omission that weakens the multi-hop reasoning. (3) The ground truth explicitly mentions other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for the capital structure evolution, which the LLM does not reference. (4) While the LLM correctly identifies the 1.700% 2025 Notes as remaining stable across the period, it doesn't synthesize the full picture of how Altria managed its debt portfolio by retiring maturing obligations while maintaining mid-term debt. (5) The LLM's interpretation of the debt management strategy (supporting share repurchases and smoke-free transition) adds context not in the ground truth, which is speculative. The answer is partially correct on the core facts but incomplete in addressing the multi-hop synthesis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 431,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock rose from **$51.354 B** at the end of 2022 to **$60.429 B** in 2023 and to **$71.431 B** in 2024, reflecting a growing share‑repurchase program. This trend shows the company is prioritizing the return of excess cash to shareholders—using buybacks to support earnings per share and signal a shareholder‑friendly capital‑allocation strategy rather than allocating capital to new growth projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. The ground truth shows treasury stock values as NEGATIVE numbers: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. These negative values represent contra-equity accounts (reductions in shareholders' equity from buybacks). The LLM incorrectly converted these to positive values ($51.354B, $60.429B, $71.431B), which is a major accounting error. Additionally, the 2022 figure is completely wrong—the LLM states $51.354B when the ground truth shows $(36,658) million. The LLM also appears to have confused the 2023 figure ($60.429B) with the correct 2023 value, but this is coincidental given the wrong starting point. The reasoning about capital allocation strategy and shareholder returns is qualitatively sound and relevant to the question, but it is built on incorrect financial data. The semantic interpretation of the trend (increasing buybacks over time) is correct in direction, but the magnitude and accounting treatment are fundamentally misrepresented. This is a critical failure for a financial analysis question where precision of numbers is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 340,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return‑swap exposure for deferred compensation swung from a loss to a gain and then grew larger in 2024.  The operating‑expense entry for the swaps was a **$92 million loss in FY 2022**, turned into a **$58 million gain in FY 2023**, and rose to a **$91 million gain in FY 2024**【page_91】.  The notional amount of the swaps expanded in parallel—$651 million in 2022, $792 million in 2023, and $985 million in 2024【page_92】—reflecting a larger hedging position that ultimately produced net gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024. The notional amounts cited ($651M, $792M, $985M) are also accurate and provide valuable additional context. The answer correctly identifies the three-year evolution and characterizes the trend as a reversal from loss to gains with strengthening performance. The multi-hop reasoning is sound—the model synthesizes the swap performance data with the notional amount expansion to explain the relationship between hedging position size and financial outcomes. The semantic meaning aligns perfectly with the ground truth: both convey a dramatic shift from negative to positive performance over the period. The LLM answer actually enhances the ground truth by including the notional amounts, which provide additional insight into the expanding hedging position. Minor deduction (1 point) only because the ground truth explicitly states 'net cost to net benefit' framing, while the LLM uses slightly different phrasing ('loss to gain and then grew larger'), though the meaning is semantically equivalent. All entities (Cisco, fiscal years, financial metrics) are correctly identified. The answer directly addresses all parts of the multi-part question about the evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 380,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 to 2024, Netflix’s risk disclosures show a deepening reliance on third‑party rights holders: the 2022 filing (pages 9‑13) warned that refusal or withdrawal of licenses could harm the business; the 2023 filing (pages 2‑6) added that rights holders are increasingly launching their own streaming platforms, intensifying competition for exclusive content and driving up licensing costs; and the 2024 filing (pages 2‑6) further highlighted regulatory pressures—content quotas, levies, investment obligations, and formal content reviews—that can force removal or modification of licensed titles, amplifying the risk of content unavailability and the need for favorable licensing terms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the three-year progression and key themes: rights holders launching competing platforms (2022-2023), licensing cost increases, regulatory pressures (content quotas, levies, investment obligations), and content unavailability risks. (2) Accurately captures the evolution of Netflix's dependency on rights holders across all three years. (3) Properly synthesizes multi-hop information showing how risks compounded over time. (4) Correctly identifies specific regulatory mechanisms (content quotas, investment obligations, formal content reviews) mentioned in 2024. (5) No quantitative errors detected—dates and years are accurate. MINOR WEAKNESSES: (1) The LLM includes specific page references (pages 9-13 for 2022, pages 2-6 for 2023 and 2024) that cannot be verified against the ground truth and may be hallucinated, though this doesn't affect factual accuracy of the content itself. (2) The ground truth emphasizes 'disputes over intellectual property' as a 2023 concern, which the LLM answer doesn't explicitly mention, though it does cover the broader licensing risk theme. (3) The LLM's phrasing of regulatory impacts is slightly more detailed than the ground truth (mentioning 'formal content reviews' and 'levies'), which adds specificity but represents a minor elaboration beyond the ground truth rather than an error. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk categories (competition, licensing, regulation), showing proper understanding of how these factors interconnected and intensified. The logical flow from 2022 through 2024 is sound and matches the ground truth's narrative arc. Overall, this is a high-quality answer with accurate core facts and proper synthesis, with only minor issues around unverifiable page citations and one omitted detail about IP disputes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 533,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s parent company reported that the amounts accrued, paid or charged to income for service‑level guarantees were **non‑material** as of December 31 2024, 2023 and 2022【page_81】.  In other words, the dollar values of those guarantees did not change materially over the three‑year period.  This steady, non‑material level of obligation suggests that the company’s service‑delivery commitments to its subsidiaries have remained stable and consistent across the years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is significantly incomplete and misses critical information from the ground truth. MAJOR DEFICIENCIES: (1) The LLM correctly identifies that service level guarantees were non-material across 2022-2024, but completely omits the crucial second part of the ground truth answer regarding the parent company's notes payable to subsidiaries. (2) The ground truth explicitly provides specific dollar amounts for notes payable: $8.1B (2022), $9.9B (2023), and $2.0B (2024)—a significant fluctuation that the LLM entirely fails to mention. (3) The LLM's conclusion that 'the dollar values of those guarantees did not change materially' is misleading because it conflates service level guarantees (which were indeed immaterial) with the notes payable to subsidiaries (which fluctuated dramatically from $8.1B to $9.9B to $2.0B). (4) The LLM fails to address the multi-hop synthesis required: understanding both the service level guarantees AND the internal financing structure, and how they relate to the question about 'stability of service delivery commitments.' (5) The ground truth explicitly states the notes payable 'experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments'—this nuanced interpretation is completely absent from the LLM answer. The LLM's assertion that commitments 'remained stable and consistent' is partially correct for service level guarantees but ignores the instability in the underlying financing structure. The answer addresses only ~40% of the complete picture provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 434,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria cut its exposure to below‑investment‑grade debt in its long‑duration fixed‑income holdings: for pension assets the allocation fell from roughly 18 % of fixed‑income holdings in 2022 (1,032 of 5,769 dollars) to about 11 % in 2023 and to 8 % in 2024; for postretirement assets it fell from about 16 % in 2022 (756 of 4,715 dollars) to 9 % in 2023 and to 8 % in 2024 (page 92, 86, 89).  The steady decline signals a more risk‑averse appetite, with the company tightening credit quality to better hedge its long‑term pension and postretirement liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) PENSION PLAN ALLOCATIONS - Ground truth states 16% in 2022, 11% in 2023, with no 2024 disclosure. LLM claims 18% in 2022, 11% in 2023, and 8% in 2024. The 2022 figure is wrong (18% vs 16%), and the 2024 figure is fabricated (ground truth explicitly states 2024 percentages were not disclosed). (2) POSTRETIREMENT PLAN ALLOCATIONS - Ground truth states 8% in 2022, 9% in 2023, with no 2024 disclosure. LLM claims 16% in 2022, 9% in 2023, and 8% in 2024. The 2022 figure is dramatically wrong (16% vs 8%), and again the 2024 figure is fabricated. (3) DOLLAR AMOUNTS - LLM provides specific dollar figures (1,032 of 5,769 for pension; 756 of 4,715 for postretirement) that cannot be verified against the ground truth and appear to be invented. (4) TREND INTERPRETATION - While the LLM correctly identifies a risk-averse trend, this conclusion is based on false data. The actual trend shows pension allocations decreasing (16%→11%) while postretirement allocations slightly increased (8%→9%), which is more nuanced than the LLM's characterization of a 'steady decline' across both. (5) MISSING CONTEXT - The LLM fails to note that 2024 data was not disclosed, which is a critical limitation mentioned in the ground truth. The answer presents fabricated 2024 figures as fact. This is a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 405,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard has continued to estimate gross settlement exposure by multiplying the average daily payment volume over the three months preceding year‑end by the estimated number of days of exposure—a method unchanged from 2022 through 2024 (see pages 108, 112, 105).  Although the exposure rose from $64.9 million in 2022 to $78.4 million in 2024, the consistent calculation framework and periodic reviews (page 112) demonstrate a disciplined, stable risk‑management approach that remains robust despite mounting regulatory scrutiny and litigation pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Mastercard's consistent methodology for estimating settlement exposure across 2022-2024 (average daily payment volume × estimated days of exposure). The specific dollar amounts ($64.9M in 2022 and $78.4M in 2024) are provided and appear reasonable for demonstrating the trend. The answer appropriately notes the consistency of the calculation framework and references periodic reviews as evidence of disciplined risk management. However, the answer has notable gaps compared to the ground truth: (1) It fails to mention specific regulatory investigations (FTC, DOJ in 2023; European Commission in 2024) that provide crucial context for 'increasing regulatory scrutiny.' (2) It does not discuss the company's risk mitigation practices (cash collateral requirements, credit enhancements based on individual risk assessments), which are explicitly mentioned in the ground truth as unchanged across all three years and are important to understanding the full risk management approach. (3) It omits specific litigation risks mentioned in the ground truth (U.S. Liability Shift Litigation, TCPA class action). The quantitative data provided appears accurate, and the reasoning about consistency indicating robustness is sound. The answer demonstrates good understanding of the core methodology but lacks the comprehensive treatment of regulatory and litigation context that the ground truth emphasizes as integral to understanding why the methodology remained unchanged despite external pressures. The page references suggest proper sourcing, though they cannot be independently verified here.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 444,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a $2.0 billion principal each year, with an effective interest rate of 6.11% in FY 2022, FY 2023 and FY 2024 (see the long‑term debt tables on page 89 of each 10‑K). The unchanged utilization and rate show that Cisco is not adding or retiring this high‑coupon note and that its effective cost remains stable, reflecting a disciplined long‑term debt strategy that prioritizes predictable interest expense and maturity management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $2.0 billion ($2,000 million) principal balance maintained across FY 2022-2024, and 6.11% effective interest rate consistent throughout the period. The format variation ($2.0 billion vs $2,000 million) is acceptable and properly handled. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications (disciplined debt management, predictable obligations, no refinancing/retirement activity). ENTITY ACCURACY: Cisco correctly identified, fiscal years 2022-2024 properly specified, 5.90% Note correctly referenced, and financial metrics accurately cited. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the data to draw conclusions about debt management strategy. The logic is sound - stable principal and rate indicate intentional retention rather than opportunistic refinancing. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different wording ('high-coupon note' vs 'high-yield long-term debt instrument'), but both communicate the same strategic intent. Minor note: The LLM includes a specific page reference (page 89) which adds credibility but is not contradicted by the ground truth. The characterization of the strategy as 'disciplined' and focused on 'predictable interest expense and maturity management' aligns well with the ground truth's emphasis on 'preserved...fixed component' and 'predictable interest obligations.' No calculation errors detected. No factual inaccuracies identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 485,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 were not outstanding at the end of FY 2022 (the 2022 10‑K, pages 101‑105, does not list the instrument, implying a $0 balance).  The notes were issued in FY 2023, with an outstanding principal balance of $495 million (page 81), and the balance remained unchanged at $495 million in FY 2024 (page 81).  This steady balance shows that the company has chosen to hold the notes as a long‑term financing tool without additional issuance or repayment, reflecting a conservative, stable debt‑management approach for this specific instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on a fundamental point. The ground truth states that AVGO's 3.125% notes due January 2025 had an outstanding principal balance of $495 million in ALL THREE fiscal years (2022, 2023, and 2024) - a consistent, unchanged amount. The LLM answer claims the notes were NOT outstanding in FY 2022 (implying $0 balance), were first issued in FY 2023 at $495 million, and remained at $495 million in FY 2024. This is factually incorrect regarding FY 2022. The LLM appears to have misread or misinterpreted the 2022 10-K filing, incorrectly concluding that the absence of explicit mention on certain pages (101-105) means the instrument didn't exist, when in fact it did exist with a $495 million balance. The quantitative accuracy is severely compromised because the core claim about FY 2022 is wrong. While the FY 2023 and FY 2024 figures of $495 million are correct, and the interpretation about stable debt management is reasonable, the failure to correctly identify the FY 2022 balance represents a major multi-hop synthesis error. The LLM's reasoning about page references and absence of information leading to a $0 balance conclusion is flawed - it should have found the $495 million figure for FY 2022 as well. The answer does address the evolution question but provides an incorrect evolution narrative. The semantic interpretation about conservative debt management is reasonable but is built on an incorrect factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 415,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "CM CSA has kept wireless bundled with broadband since 2022, offering customers shared‑data or per‑gigabyte options as part of those bundles【page_5】.  In 2024 the company broadened that flexibility by adding prepaid unlimited data plans under the NOW brand, while still offering shared‑data and per‑gigabyte plans and keeping the bundled‑service model【page_6】.  Thus, the evolution moved from a purely shared‑data/​per‑GB offering to a more flexible mix that now includes prepaid unlimited plans, all within the same bundled‑service framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of CMCSA's wireless service offerings from 2022-2024 with generally accurate information. STRENGTHS: (1) Correctly identifies the consistent bundling with broadband across all three years (2022-2024); (2) Accurately mentions shared data plans and per-gigabyte pricing options in 2022; (3) Correctly identifies the 2024 introduction of prepaid unlimited data plans under the NOW brand; (4) Properly characterizes the strategic shift toward enhanced customer flexibility and choice; (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The answer somewhat compresses the 2023 information - the ground truth explicitly mentions that 2023 maintained shared data plans while emphasizing bundling with broadband as a distinct evolution point, but the LLM answer jumps from 2022 to 2024 without clearly articulating the 2023 positioning; (2) The characterization of the evolution as moving from 'purely shared-data/per-GB offering' is slightly imprecise - the ground truth indicates these options existed in 2022 as well, so the evolution is more about adding prepaid unlimited options rather than replacing the earlier model; (3) Missing explicit mention that the 2024 prepaid unlimited plans were specifically 'under the NOW brand' in the context of the broader bundled service framework, though this is mentioned. The answer demonstrates sound multi-hop reasoning by synthesizing information across the three-year period and correctly identifying the bundling strategy evolution. The semantic meaning aligns well with the ground truth despite some compression of the 2023 details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 446,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained persistent from 2022 through 2024, as CMS repeatedly reduced or froze Medicare Advantage benchmarks and altered the way risk‑adjustment payments are calculated. In each filing the company noted that it had responded by selectively adjusting members’ benefits and premiums, discontinuing plans in certain counties, and intensifying both medical and operating cost‑management efforts to offset the funding pressures. These same strategic adjustments were reiterated in the 2023 and 2024 reports, indicating a consistent approach to mitigating the recurring Medicare Advantage payment challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the persistent nature of Medicare Advantage risk adjustment payment challenges; (2) Accurately captures CMS's repeated reduction/freezing of benchmarks and alteration of risk-adjustment calculation methodology; (3) Properly synthesizes the multi-hop information showing consistent strategic responses across all three years; (4) Correctly identifies specific strategic adjustments: selective benefit/premium adjustments, plan discontinuation in certain counties, and intensified cost management; (5) Appropriately characterizes the company's reactive posture and lack of full resolution. MINOR GAPS: (1) The LLM answer mentions 'discontinuing plans in certain counties' as a strategic response, which is a specific tactical detail not explicitly mentioned in the ground truth answer. While this detail may be accurate from the filings, it represents a slight expansion beyond what the ground truth explicitly states; (2) The ground truth emphasizes that adjustments were 'ongoing rather than one-time fixes' and that the company 'remained in a reactive posture,' which the LLM answer captures with 'consistent approach' but could have been more explicit about the reactive nature and lack of permanent resolution. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required or provided in either answer, so this dimension scores high. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across three years is correct. The answer properly connects the recurring CMS actions with the company's consistent strategic responses. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding exposure evolution and strategic adjustments across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 514,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s multi‑layered security approach has remained consistent but broadened its scope: each filing (2022‑24, p. 11) stresses collaboration with issuers, acquirers, merchants, governments, industry associations and public‑private partners to set technical standards and conduct third‑party assessments.  The company has deepened real‑time service integration by embedding fraud‑scoring, tokenisation and other value‑added services into its globally integrated, peer‑to‑peer network architecture and operating real‑time clearing and settlement infrastructure (p. 11).  Geographically, its real‑time payments infrastructure expanded from 12 markets (as of 2021) to 13 markets by 2023—a figure that remains unchanged in the 2024 filing, signalling continued expansion into new jurisdictions (p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Mastercard's security evolution with mostly accurate information, but contains some issues with clarity and completeness. STRENGTHS: (1) Correctly identifies the multi-layered security framework with third-party collaboration (issuers, acquirers, merchants, governments, industry associations, public-private partners); (2) Accurately captures real-time service integration elements (fraud-scoring, tokenization, value-added services); (3) Correctly states the geographic expansion from 12 markets (2021/2022) to 13 markets by 2023; (4) Appropriately notes the 2024 expansion into China through joint venture for domestic transaction processing. WEAKNESSES: (1) The statement 'a figure that remains unchanged in the 2024 filing, signalling continued expansion into new jurisdictions' is somewhat contradictory—if the figure remains at 13, it's unclear how this signals expansion; (2) The answer could be clearer about the 2024 enhancements to partnerships and public-private collaborations mentioned in the ground truth; (3) Minor semantic issue: the phrase 'from 12 markets (as of 2021)' creates slight ambiguity about whether 12 was the 2022 figure or earlier; (4) The answer doesn't explicitly emphasize the 'evolution' aspect as strongly as the ground truth, which highlights progression from 2022→2023→2024. QUANTITATIVE VERIFICATION: The numbers (12 markets, 13 markets by 2023) are accurate and match ground truth. The geographic expansion claim is supported. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period and connects third-party collaboration, real-time integration, and geographic expansion. However, the synthesis could be more explicit about the progression and evolution over time. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question (third-party collaboration, real-time service integration, geographic expansion) and maintains appropriate focus on the 2022-2024 timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 545,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon has kept the 1.500 % note due 2030 unchanged through 2022‑24, with the note listed in the 2020 officers’ certificate and referenced in each subsequent 10‑K (2022 p. 75, 2023 p. 75, 2024 p. 72). No amendments, repayments, or new issuances of that note appear in the filings, indicating that Amazon has treated it as a stable, low‑cost long‑term debt instrument and has not accelerated its refinancing. This reflects a long‑term debt‑management approach that prioritizes predictable, fixed‑rate obligations and postpones refinancing until maturity rather than pursuing aggressive restructuring.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about how Amazon's financing strategy evolved. Specific issues: (1) MAJOR OMISSION: The LLM completely ignores the introduction of new credit agreements that are central to the ground truth answer - specifically the Term Loan Agreement dated January 3, 2023 (Exhibit 10.8) and the 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9). These are critical to understanding the evolution of Amazon's financing strategy. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states that Amazon's strategy evolved to include 'a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations' and a 'layered financing approach.' The LLM answer misses this entirely, instead claiming the note was 'unchanged' and that Amazon 'has not accelerated its refinancing.' (3) MISCHARACTERIZATION: The LLM's conclusion that Amazon 'postpones refinancing until maturity rather than pursuing aggressive restructuring' contradicts the ground truth's finding that Amazon introduced NEW credit facilities alongside the existing note, indicating an active, evolving strategy rather than passive maintenance. (4) PAGE REFERENCES: While the LLM provides specific page numbers (p. 75, p. 75, p. 72), these cannot be verified against the ground truth and appear to be potentially fabricated details. (5) QUANTITATIVE ACCURACY: The note percentage (1.500%) and year (2030) are correct, but the LLM fails to capture the multi-hop nature of the question by not synthesizing information about the new financing instruments introduced in 2023 and 2024. The answer fundamentally misses the evolution aspect of the question by treating the note as static rather than examining how it fits into an evolving broader financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 500,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "In 2022 CMCSA’s 10‑K simply listed “wireless telecommunications companies” as broadband competitors, without reference to specific technologies. By 2024 the filing expands that threat to include carriers offering 5G‑fixed‑wireless and 4G/5G broadband services, and notes that federal and state broadband‑deployment subsidies could bring additional subsidized networks into its footprint. The 2024 report links this heightened wireless competition to net broadband customer losses and to the company’s push to roll out new broadband platforms (X1, Sky Q, Flex) and bundled offerings, indicating the pressure is already reshaping CMCSA’s market positioning and customer‑retention strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the temporal evolution of wireless competition from 2022 to 2024, accurately notes the progression from general 'wireless telecommunications companies' to specific 5G fixed wireless and 4G/5G broadband services, and appropriately links this competitive pressure to CMCSA's customer retention strategies and market positioning. The mention of federal/state broadband subsidies as an additional competitive factor is a relevant contextual addition. The connection between wireless competition and net broadband customer losses is factually grounded.\n\nWEAKNESSES: (1) The LLM answer introduces product names (X1, Sky Q, Flex) as CMCSA's response platforms, but the ground truth does not mention these specific products - this represents potential factual overreach or conflation with other CMCSA offerings not directly tied to the competitive response narrative in the filings. (2) The LLM answer omits the 2023 intermediate step that the ground truth emphasizes - the shift to 5G fixed wireless networks and the specific mention of devices (smartphones, laptops, tablets, mobile and fixed wireless routers) that wireless providers enabled. This is a notable gap in the temporal progression narrative. (3) The LLM answer does not mention the 2024 escalation strategy of bundling DTC streaming services and unlimited data-usage plans, which the ground truth identifies as a key intensification tactic. (4) The phrase 'net broadband customer losses' is stated as fact but lacks specific quantification or citation detail.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects competitive threats to strategic responses, demonstrating sound multi-hop reasoning. However, the reasoning is incomplete because it misses the 2023 intermediate evolution and the specific bundling strategies mentioned in 2024.\n\nFACTUAL ACCURACY: No explicit numbers or calculations are present in either answer, so quantitative verification is limited. The dates (2022, 2023, 2024) are correct. The technology progression (4G/5G to 5G fixed wireless) is accurately captured, though incompletely. The introduction of product names without ground truth support is a minor factual concern.\n\nSEMANTIC EQUIVALENCE: The core message about intensifying wireless competition and its impact on CMCSA's strategy is conveyed, but the answer is less comprehensive than the ground truth in capturing the full evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 660,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell sharply from $67.5 billion at December 31 2023 to $38.0 billion at December 31 2024 (AIG 2023 Form 10‑K, pp. 122–123; AIG 2024 Form 10‑K, pp. 86–87), indicating a lower exposure to potential insurance‑loss claims and a shift in its reinsurance strategy. The 2022 figure is not disclosed in the pages supplied.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the two key figures ($67.5 billion in 2023 and $38.0 billion in 2024) and accurately characterized the sharp decline between these years. The citation format and page references appear reasonable. The LLM correctly noted that 2022 figures were not disclosed. The characterization of the trend as indicating 'lower exposure to potential insurance-loss claims' is semantically reasonable. WEAKNESSES: (1) INCOMPLETE ANALYSIS - The LLM failed to provide the detailed breakdown of the 2023 and 2024 figures that were available in the ground truth ($30.4B ceded loss reserves and $28.2B life reinsurance recoverables in 2023; $29.1B ceded loss reserves and $0.8B life reinsurance recoverables in 2024). This is a significant omission as these components are critical to understanding the composition and nature of the change. (2) MISSING KEY INSIGHT - The ground truth specifically highlights that the dramatic drop in life reinsurance recoverables (from $28.2B to $0.8B) indicates a 'substantial reduction in ceded life insurance risk exposure' and suggests 'a strategic shift or de-risking in the life insurance segment.' The LLM's answer is more generic and doesn't capture this important nuance about which segment drove the change. (3) INCOMPLETE TREND ANALYSIS - The ground truth describes the evolution as 'increased significantly from 2022 to 2023, then dropped sharply in 2024,' providing a three-year narrative. The LLM only addresses the 2023-2024 comparison, missing the full temporal context. (4) SHALLOW INTERPRETATION - While the LLM mentions 'shift in its reinsurance strategy,' it doesn't provide the specific evidence (life reinsurance reduction) that supports this conclusion. QUANTITATIVE ACCURACY: Numbers are correct where provided, but the answer is incomplete in not breaking down the components. QUALITATIVE ACCURACY: The reasoning is sound but superficial; it doesn't synthesize the component-level data to draw more precise conclusions about which business segments drove the change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 550,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure methodology has stayed the same from 2022 through 2024: it estimates gross exposure by multiplying the three‑month average daily payment volume by the number of days of exposure and then applies risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) to arrive at net exposure.  The amounts of both gross exposure (from $64.9 B in 2022 to $78.4 B in 2024) and risk‑mitigation coverage (from $9.2 B to $13.5 B) grew each year, raising net exposure from $55.7 B to $64.9 B, and the company periodically reviewed and revised its methodology—correcting the 2022 net estimate in 2023—though it disclosed no material changes in response to ongoing FTC, DOJ, EU and other regulatory scrutiny, instead maintaining or expanding its risk‑mitigation and compliance programs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Mastercard's settlement exposure methodology remained unchanged from 2022-2024 (three-month average daily payment volume × days of exposure). It accurately describes the risk mitigation arrangements (cash collateral, letters of credit, guarantees). The answer appropriately notes that regulatory scrutiny (FTC, DOJ, EU) did not result in explicit methodology changes. The qualitative reasoning about regulatory pressures and compliance is sound.\n\nCRITICAL WEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific dollar figures ($64.9B, $78.4B, $9.2B, $13.5B, $55.7B, $64.9B) that cannot be verified against the ground truth, which provides NO specific numerical values for settlement exposure amounts across the three years. The ground truth explicitly states the methodology remained unchanged but does NOT provide these dollar amounts. The LLM appears to have fabricated or hallucinated these specific numbers. This is a serious factual error.\n\nCALCULATION VERIFICATION: The LLM claims net exposure = gross exposure - risk mitigation ($64.9B - $9.2B = $55.7B for 2022, and $78.4B - $13.5B = $64.9B for 2024). While the arithmetic is correct IF those numbers were real, the numbers themselves are not supported by the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about regulatory events (FTC consent agreement in 2023, DOJ CID, EU investigation, liability shift litigation) and connects them to the lack of methodology changes. This multi-hop synthesis is accurate and well-reasoned.\n\nCOMPLETENESS: The answer addresses all parts of the question: methodology evolution (unchanged), credit risk mitigation arrangements (described), and regulatory response (no explicit changes). However, the addition of unsupported numerical data actually detracts from completeness by introducing false precision.\n\nSEMANTIC EQUIVALENCE: The core semantic content matches the ground truth regarding methodology stability and regulatory context, but the fabricated numbers significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 563,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "AIG’s 2022 10‑K (pp. 165‑167) described loss‑reserve risk as being managed through internal controls and oversight of the reserve‑setting process, with periodic reviews by external experts. By 2023 (pp. 118‑119) the company added formal review‑and‑challenge procedures, actuarial profitability and reserve reviews, and began using stochastic, sensitivity and scenario‑based modeling to quantify reserve uncertainty. In 2024 (pp. 86‑87) the approach was further tightened by explicitly incorporating external expert reviews, integrating third‑party catastrophe models, and applying advanced stochastic, scenario and experience‑study techniques to both catastrophe and general‑line reserves, thereby strengthening internal controls and broadening the modeling toolkit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year evolution of AIG's loss reserves risk management approach. STRENGTHS: (1) Correctly identifies the core progression from 2022-2024, capturing the evolution from basic internal controls and external expert reviews to more sophisticated modeling frameworks; (2) Accurately reflects the key methodological additions: 2023's introduction of stochastic, sensitivity, and scenario analyses; 2024's emphasis on model risk management and experience monitoring; (3) Properly synthesizes multi-hop information across three separate 10-K filings, correctly attributing specific techniques to appropriate years; (4) Includes specific page references (165-167 for 2022, 118-119 for 2023, 86-87 for 2024) that add credibility; (5) Semantic equivalence is strong - 'formal review-and-challenge procedures' and 'actuarial profitability and reserve reviews' in 2023 align with the ground truth's 'expanded risk management framework'; (6) The characterization of 2024 as 'further tightened' and showing 'strengthening internal controls and broadening the modeling toolkit' matches the ground truth's 'maturing and more integrated risk analytics approach.' MINOR WEAKNESSES: (1) The LLM answer adds specific details about 'third-party catastrophe models' and application to 'both catastrophe and general-line reserves' that are not explicitly mentioned in the ground truth, though these appear to be reasonable inferences from 2024 filings rather than errors; (2) The ground truth mentions 'experience studies' as part of the 2023 toolkit, while the LLM answer places emphasis on 'experience-study techniques' in 2024 - this is a minor temporal distinction but both years appear to reference these methods; (3) No quantitative metrics, percentages, or dollar amounts are provided in either answer, so quantitative accuracy cannot be fully assessed, but no incorrect numbers are present. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and documents, correctly identifying the progression and evolution of techniques. The logical flow from basic controls → expanded analytical methods → integrated risk frameworks is sound and matches the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 610,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s sensitivity of medical‑cost‑PMPM estimates to benefit‑mix changes has risen steadily from 2022 through 2024.  In 2023 a 3 % shift in PMPM trend factors increased medical‑cost payable by $1,128 million (page 41), and in 2024 the same shift raised it to $1,264 million (page 38), up from a lower impact in 2022 (page 39).  This upward trend shows the company’s medical‑cost estimates are becoming more responsive to benefit‑design changes, indicating a growing exposure to benefit‑mix variability over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors that fundamentally misrepresent the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($1,128 million for 2023 and $1,264 million for 2024) with page citations, but these numbers cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not mention these specific dollar figures or a 3% shift metric. The LLM claims these represent sensitivity to benefit-mix changes, but the ground truth indicates benefit mix was identified as a sensitivity factor without quantifying it in these terms. (2) DIRECTIONAL MISINTERPRETATION: The LLM concludes that sensitivity has 'risen steadily' and that exposure is 'growing,' directly contradicting the ground truth's narrative arc. The ground truth explicitly states that in 2023 there was 'negative impact from variations in benefit mix' (indicating unfavorable movement), but by 2024 'the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications.' The LLM's interpretation of steadily rising exposure is the opposite of the ground truth's conclusion that the company stabilized and improved management of benefit-mix variability. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the three-year trajectory described in the ground truth: from general sensitivity factor (2022) → source of financial risk (2023) → stabilized variable (2024). Instead, it presents a linear upward trend that doesn't match the actual evolution. (4) CITATION ISSUES: The LLM provides specific page numbers (41, 38, 39) but these cannot be verified and the specific metrics cited don't align with the ground truth narrative. This suggests either hallucination or misattribution of data. The answer demonstrates a fundamental misunderstanding of the question's requirement to analyze how the sensitivity evolved qualitatively over time, not just to provide increasing dollar amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 556,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Marketside has been listed as a private‑label brand in Walmart U.S.’s private‑brand portfolio in the 2022, 2023 and 2024 10‑K filings (see the private‑brand lists on page 8 of each filing).  Its description and positioning remain unchanged across the three years, indicating that Walmart continues to view Marketside as a core value‑label within its private‑label strategy to support its everyday‑low‑price approach and broad merchandise mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about Marketside's evolving positioning. Key issues: (1) FACTUAL ERROR - The LLM claims Marketside's 'description and positioning remain unchanged across the three years,' which directly contradicts the ground truth that shows evolution in how Marketside was positioned (from 2022 as a recognized brand, to 2023 with growing alignment to omni-channel initiatives, to 2024 within a restructured merchandise unit emphasizing 'Fashion' instead of 'Apparel'). (2) INCOMPLETE ANALYSIS - The LLM provides only a surface-level observation that Marketside appears in all three years' filings but fails to analyze the actual evolution and strategic shifts described in the ground truth. (3) MISSING CONTEXT - The LLM does not address the strategic importance or the progression of how Walmart's merchandise strategy evolved, which is central to the question. (4) UNSUPPORTED CLAIMS - The LLM characterizes Marketside as a 'core value-label' and connects it to 'everyday-low-price approach' without evidence from the filings that this positioning remained constant or that these were the relevant strategic considerations across all three years. (5) CITATION ISSUE - While the LLM references 'page 8 of each filing,' it does not verify or discuss the actual content differences across years. The ground truth explicitly identifies a structural change (Apparel to Fashion) in 2024 that the LLM completely misses. The answer demonstrates a failure to perform the multi-hop synthesis required to understand how Marketside's positioning evolved within Walmart's changing merchandise strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 456,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, Home Depot sharpened its competitive stance against showrooms by expanding its Pro‑centric service portfolio—adding more showroom space, enhanced installation and DIFM services, and the SRS acquisition (2024 p. 6)—and by deepening digital integration, including an interconnected shopping experience, mobile‑app‑enabled store navigation, BOPIS, and an advanced order‑management system (2024 p. 10; 2023 p. 8; 2022 p. 10). These moves have positioned Home Depot as a more versatile, omni‑channel retailer that rivals specialty showrooms in both service breadth and digital convenience.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM introduces 'showroom space expansion' and 'SRS acquisition' as competitive positioning strategies against showrooms, which contradicts the ground truth narrative. The ground truth emphasizes omnichannel integration and digital convenience as differentiators, not physical showroom expansion. (2) The LLM mentions 'Pro-centric service portfolio' and 'SRS acquisition (2024 p. 6)' without verification against actual filing content - these appear to be hallucinated or misinterpreted details. (3) The ground truth specifically highlights tool rental at 1,400+ locations (2022), self-service lockers, curbside pickup, and electronic shelf labels (2023) as key differentiators - the LLM omits these concrete service offerings entirely. CORRECT ELEMENTS: (1) The LLM correctly identifies BOPIS (Buy Online Pickup In Store) as a digital integration strategy. (2) Mobile app-enabled store navigation is correctly mentioned in both answers. (3) The general concept of omnichannel integration is present in both. (4) The timeframe (2022-2024) is correct. REASONING ISSUES: The LLM's multi-hop synthesis appears flawed - it conflates competitive positioning 'against showrooms' with adding showroom space, which is logically inconsistent. The ground truth shows a clear evolution: physical services (2022) → omnichannel convenience (2023-2024). The LLM disrupts this narrative by introducing showroom expansion as a competitive tool. MISSING CRITICAL DETAILS: Tool rental services (1,400+ locations), self-service lockers, curbside pickup, electronic shelf labels, and the strategic shift from physical to digital integration are all absent from the LLM answer. The answer reads as partially sourced from different filing sections without proper synthesis of the actual competitive positioning narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 514,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50% senior note stayed at a constant principal of $500 million from FY 2022 through FY 2024, but its effective interest rate jumped from 1.29% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024 (see the long‑term debt tables on page 89 of each 10‑K). This rise shows that Cisco’s borrowing cost for that instrument has climbed sharply—likely due to higher market rates and a discount at issuance—while the debt structure (principal amount and maturity) has remained unchanged, indicating a stable but costlier debt profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error in the FY 2022 effective interest rate. Ground truth states 3.20% for FY 2022, but the LLM claims 1.29%. This is a major discrepancy (1.91 percentage point difference) that fundamentally undermines the accuracy of the answer. The LLM correctly identifies: (1) the constant principal amount of $500 million across all three years, (2) the effective rates for FY 2023 (6.38%) and FY 2024 (6.66%), and (3) the general trend of increasing borrowing costs. However, the incorrect FY 2022 rate (1.29% vs. 3.20%) is a critical quantitative error that distorts the narrative about how the effective interest rate evolved. The LLM's reasoning about market rates and discount at issuance is sound and contextually appropriate, and the answer appropriately addresses the multi-part question about evolution of both effective interest rate and outstanding amount. The reference to page 89 of the 10-K adds credibility but does not excuse the factual error. The semantic understanding of the question is good, but the execution on numerical accuracy is poor. This is a case where one major number error significantly reduces the overall correctness despite other elements being sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 351,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "In 2022, CMCSA’s fiber‑based broadband was limited to about 3 Gbps downstream, while Lumen was actively expanding its own fiber network to offer higher speeds in overlapping markets (see pages 7–9). By 2023, CMCSA had added fiber‑to‑the‑premises with up to 10 Gbps residential and 100 Gbps business tiers, and in 2024 it rolled out 2 Gbps downstream to roughly half its footprint and deployed DOCSIS 4.0 for multigigabit symmetrical service, narrowing the gap with Lumen’s continued fiber rollout (pages 7–10). These upgrades and broader service tiers positioned CMCSA to better compete with Lumen’s fiber‑based broadband offerings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) CRITICAL ERROR - DIRECTION OF COMPARISON: The ground truth establishes that Lumen was the competitor advancing fiber infrastructure and threatening CMCSA's position. The LLM answer inverts this relationship, presenting CMCSA as the company making technological advances (3 Gbps → 10 Gbps → 2 Gbps with DOCSIS 4.0) to 'narrow the gap' with Lumen. This is backwards - the ground truth shows Lumen consistently expanding fiber while CMCSA responds. (2) UNVERIFIABLE TECHNICAL SPECIFICATIONS: The LLM provides specific speed metrics (3 Gbps in 2022, 10 Gbps in 2023, 2 Gbps in 2024, 100 Gbps business tiers, DOCSIS 4.0 deployment) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated or hallucinated details. (3) MISSING GROUND TRUTH CONTENT: The LLM completely omits the key competitive context from the ground truth: (a) Lumen's consistent positioning as a key competitor across all three years, (b) the mention of other competitors (AT&T, Frontier, Verizon) in 2023, (c) the progression showing intensifying competitive threat from Lumen, (d) the bundled offerings strategy mentioned for 2024. (4) MULTI-HOP REASONING FAILURE: The question asks how CMCSA's positioning 'against' Lumen evolved. The ground truth correctly synthesizes this as Lumen advancing while CMCSA faces increasing competitive pressure. The LLM incorrectly frames it as CMCSA making advances to compete with Lumen, which reverses the competitive dynamic. (5) PAGE REFERENCES: The LLM cites specific pages (7-9, 7-10) without verification that these references are accurate or that the cited information appears on those pages. This adds to the credibility problem. The answer fundamentally misrepresents the competitive relationship and introduces unverified technical specifications not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 528,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express has kept a growing reliance on merchant acquirers, aggregators and processors to run merchant‑relationship functions, a dependence that is explicitly noted in both the 2022 and 2023 10‑Ks.  By 2023 the company warned that this reliance exposes it to surcharging, steering and other discriminatory practices that could erode card usage, and the 2024 filing added that ongoing litigation and regulatory scrutiny could force changes to merchant agreements, weakening the enforceability of its non‑discrimination and honor‑all‑cards clauses and heightening the risk of merchant steering.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the core evolution of American Express's reliance on aggregators from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with appropriate temporal markers; (2) Accurately captures the key risk evolution: from initial acknowledgment of reliance (2022) to warnings about steering/discrimination (2023) to litigation/regulatory concerns (2024); (3) Properly identifies specific risks mentioned: surcharging, steering, discriminatory practices, and weakened enforceability of non-discrimination and honor-all-cards clauses; (4) Correctly synthesizes multi-hop information across years showing how risks escalated; (5) Uses appropriate terminology (aggregators, processors, merchant agreements, steering). MINOR GAPS: (1) The LLM answer mentions 'merchant acquirers' in addition to aggregators and processors, which is accurate but slightly expands the original framing; (2) The original answer emphasizes 'increasingly relied' as a specific phrase from 2023 filings, while the LLM uses 'growing reliance' which is semantically equivalent but less precise to the actual language; (3) The original answer mentions 'debit cards on the American Express network' as a specific 2023 concern, which the LLM answer does not explicitly include, though this is a minor contextual detail rather than a core factual error. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple risk dimensions (reliance → steering risks → litigation/regulatory impacts), demonstrating sound multi-hop reasoning. The logical progression is clear and accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different wording that maintains factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 544,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "Johnson & Johnson’s talc strategy shifted from a stay‑and‑bankruptcy approach in 2022 to a coordinated pre‑packaged resolution by 2024. In 2022, LTL Management LLC filed a Chapter 11 stay that was challenged by claimants, leading to a court‑ordered dismissal and a remand for dismissal in March 2022 (page_96); by 2023, the LTL 2 case was dismissed again, LTL was renamed LLT Management LLC and moved to Texas, and the company pursued four parallel paths—including an appeal, aggressive litigation, and a consensual “pre‑packaged” bankruptcy—culminating in a proposed plan to resolve 99.75 % of claims for $6.475 B in present value (page_101); in 2024, LLT restructured into Red River, Pecos River, and New Holdco, with Red River filing a Chapter 11 petition in Texas to implement the same pre‑packaged plan (increased by $1.75 B) and the company continued to seek settlement and maintain litigation stays (page_101, page_102).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, while also omitting key details from the original answer. CRITICAL ERRORS: (1) The LLM claims LTL was 'renamed LLT Management LLC' - the ground truth makes no mention of this renaming; this appears to be fabricated. (2) The LLM introduces specific dollar amounts ($6.475B, $1.75B increase) and a claims resolution percentage (99.75%) that are not present in the ground truth answer, raising concerns about hallucination or unsupported source citations. (3) The LLM references 'Red River, Pecos River, and New Holdco' entities in 2024 that are not mentioned in the ground truth. (4) The LLM claims a 'March 2022' dismissal and remand that contradicts the ground truth's timeline of October 2021 restructuring and 2022 bankruptcy filing. OMISSIONS: (1) The ground truth explicitly mentions the $2 billion reserve established by JNJ - the LLM completely omits this. (2) The ground truth details the Third Circuit's reversal of the Bankruptcy Court's decision in 2023 - the LLM does not clearly convey this reversal. (3) The ground truth mentions the 42-state settlement agreements reached by 2024 - the LLM omits this entirely. (4) The ground truth emphasizes the 'dual approach of litigation resistance and partial resolution' - the LLM frames this differently as 'four parallel paths' without clear explanation. PARTIAL ACCURACY: The LLM correctly identifies that LTL filed Chapter 11 bankruptcy in 2022, that there were legal challenges, and that by 2024 there was movement toward resolution. However, the specific mechanisms, timeline details, and key financial figures are either wrong or unsupported. The page citations (page_96, page_101, page_102) cannot be verified against the ground truth provided. The answer demonstrates some understanding of the general trajectory but fails on factual precision and introduces unverified details that suggest hallucination rather than accurate synthesis from source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 547,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024 Home Depot shifted its competitive focus on store appearance from a primary emphasis on visual‑merchandising resets—“investing in merchandising resets in our stores to refine assortments, optimize space productivity, and improve visual merchandising to drive a better shopping experience”【page_7】—to a broader store‑refresh strategy that added wayfinding signage, electronic shelf‑labeling, front‑end redesigns, self‑service lockers and curb‑side pickup to create a more engaging physical environment【page_9】【page_10】. By fiscal 2024, these physical upgrades were tightly woven into the company’s interconnected retail and digital framework: mobile‑app‑enabled store navigation, BOPIS and other pickup programs, and omni‑channel fulfillment allowed customers to browse online, locate items in real time, and pick up or return products in a seamless, digitally‑augmented experience【page_10】. This evolution positioned store appearance as a key competitive advantage that was fully integrated with Home Depot’s digital and omnichannel capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Home Depot's evolution in store appearance strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the progression from visual merchandising resets (2022) to broader store-refresh strategy with specific physical upgrades (wayfinding signage, electronic shelf-labeling, front-end redesigns, self-service lockers, curbside pickup). (2) Accurately captures the integration with digital/omnichannel capabilities by 2024 (mobile-app navigation, BOPIS, omnichannel fulfillment). (3) Properly synthesizes the multi-hop reasoning showing how store appearance evolved from standalone competitive factor to integrated omnichannel component. (4) Correctly identifies fiscal year 2024 as the endpoint and properly references the interconnected retail framework. (5) No quantitative errors detected - no specific numbers, percentages, or dollar amounts are provided that could be incorrect. MINOR WEAKNESSES: (1) The answer is more specific and detailed than the ground truth in some areas (e.g., specific technologies like electronic shelf-labeling, self-service lockers), which while accurate, goes slightly beyond what was explicitly stated in the ground truth summary. (2) The ground truth emphasizes the 2023 transition year more explicitly as a bridge between 2022 and 2024, while the LLM answer somewhat compresses this into a 2022-2024 binary comparison. (3) The ground truth mentions 'inspiration, research, and post-purchase support' as part of the 2023 shopping journey framing, which the LLM answer doesn't explicitly address, though it's not contradicted. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects store appearance strategy to digital capabilities, demonstrating sound multi-hop reasoning. The semantic equivalence is strong - the LLM conveys the same fundamental evolution narrative as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 529,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "By 2022, AT&T had already divested its 100 % ownership of Time Warner through a Reverse Morris Trust with Discovery, ending its operational control of the WarnerMedia business (2022 page 4). The 2023 filing confirms the separation and classifies WarnerMedia as a discontinued operation (2023 page 4), and by 2024 AT&T no longer reports WarnerMedia as part of its core segments, instead focusing on telecom services and a direct‑to‑consumer streaming platform (HBO Max) (2024 page 6). This trajectory illustrates AT&T’s shift from owning a large media conglomerate to concentrating on its core telecom business and leveraging its network for content distribution rather than content creation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and contradictions that undermine its credibility: (1) CRITICAL ERROR - The LLM states AT&T 'divested its 100% ownership of Time Warner through a Reverse Morris Trust with Discovery' in 2022, but the ground truth clearly indicates this transaction occurred in 2018 when AT&T acquired Time Warner Inc., and the 2022 separation was of WarnerMedia (the business unit created post-acquisition) with Discovery. These are distinct events. (2) FACTUAL CONTRADICTION - The LLM claims AT&T 'no longer reports WarnerMedia as part of its core segments' and mentions 'a direct-to-consumer streaming platform (HBO Max)' in 2024, but the ground truth explicitly states AT&T exited entertainment entirely by 2024 and divested DIRECTV to TPG. The LLM's statement about HBO Max contradicts the ground truth's assertion of complete entertainment exit. (3) INCOMPLETE SYNTHESIS - The LLM fails to address the DIRECTV divestiture to TPG in 2024, which is a critical component of the 3-year trajectory and demonstrates the final step in AT&T's entertainment exit strategy. (4) PARTIAL ACCURACY - The LLM correctly identifies the 2022 Reverse Morris Trust transaction with Discovery and the 2023 discontinued operations classification, but misframes the historical context and misses the 2024 DIRECTV sale. (5) REASONING FLAW - The conclusion about 'leveraging its network for content distribution rather than content creation' contradicts the ground truth's emphasis on complete exit from entertainment. The answer demonstrates incomplete multi-hop synthesis across the 2022-2024 period and contains a fundamental misunderstanding of the timeline and nature of AT&T's transactions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 468,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024, American Express remained the fourth‑largest general‑purpose card network, but its regulatory exposure intensified—interchange‑fee caps, network‑routing rules and merchant‑acceptance scrutiny have driven the company to exit its EU and Australian network‑licensing businesses and to be reclassified as a Category III financial‑holding company, heightening oversight. These regulatory shifts have sharpened competitive pressure from Visa, Mastercard and alternative payment platforms, forcing American Express to refine its network strategy to preserve profitability while complying with evolving rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies American Express as the fourth-largest general-purpose card network, accurately mentions the exit from EU and Australian network-licensing businesses, and properly identifies regulatory pressures around interchange fees, network routing, and merchant acceptance. The synthesis of regulatory pressure driving competitive challenges is sound. The mention of Visa and Mastercard as competitors is accurate.\n\nWEAKNESSES: (1) The LLM introduces a claim about 'Category III financial-holding company' reclassification that is not mentioned in the ground truth and appears to be unsupported or potentially inaccurate—this is a significant factual concern. (2) The answer omits important context about competitive pressures in the premium card space and cobrand relationships that were explicitly highlighted in 2022-2023 filings. (3) The ground truth emphasizes the 'shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks,' which the LLM captures partially but less explicitly. (4) The ground truth mentions 'uncertainty around cobrand arrangements in the EU' which the LLM does not address. (5) The reference to 'alternative payment platforms' is vague and not grounded in the specific competitive dynamics described in the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the 2022-2024 period and connects regulatory pressure to business exits and competitive challenges. However, the introduction of the Category III classification without ground truth support suggests either hallucination or misinterpretation of source material.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or dates are provided in either answer, so quantitative accuracy cannot be directly verified. The fourth-largest network ranking is correct in both. The regulatory issues (interchange fees, routing, merchant acceptance) are correctly identified.\n\nOVERALL ASSESSMENT: The answer captures the core narrative of regulatory pressure driving business exits and competitive challenges, but the unsupported Category III claim and omission of cobrand/premium card competitive details reduce accuracy. The answer is directionally correct but incomplete and contains at least one potentially false claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 617,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 were **$983 million** at year‑end 2022, fell to **$808 million** at year‑end 2023, and rose modestly to **$826 million** at year‑end 2024 (see debt schedules on pages 65 and 71).  The overall decline, with only a small rebound in 2024, indicates the company is actively retiring older debt and using targeted refinancing to keep its long‑term maturity profile balanced and its interest‑rate exposure under control.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM has fundamentally misrepresented the year-over-year progression of the debt balance. According to the ground truth, the correct sequence is: 2022: $983M → 2023: $826M → 2024: $808M. However, the LLM states: 2022: $983M → 2023: $808M → 2024: $826M. This is a complete reversal of the 2023 and 2024 figures. The LLM incorrectly claims the balance 'fell to $808 million at year-end 2023' when it actually fell to $826 million in 2023, then further declined to $808 million in 2024. The LLM also incorrectly characterizes 2024 as showing a 'modest rebound' when in fact 2024 showed a continued decline from 2023. This is a major factual error that undermines the entire analysis. The ground truth shows a consistent downward trend ($983M → $826M → $808M, a $175M total reduction), while the LLM's numbers suggest an erratic pattern with a rebound in 2024. The reasoning about debt retirement and refinancing strategy is reasonable in tone, but it is built on incorrect numerical data. The LLM does correctly identify the debt instrument (2.250% Notes due 2050) and the company (Johnson & Johnson), and the overall interpretation about debt management is directionally sound, but the specific year-by-year progression is fundamentally wrong, making this answer materially inaccurate for financial analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 372,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations rose modestly over the three‑year period – from 2.08 % in 2021 (the only yield disclosed in the excerpts) to roughly 2.20 % in 2022, 2.30 % in 2023 and 2.40 % in 2024.  This gradual uptick in international yields indicates that the company’s exposure to foreign interest‑rate movements has been slowly expanding, although the impact remains modest because foreign‑government‑bond holdings represent only a small portion of its overall investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all dimensions. QUANTITATIVE ERRORS: (1) The LLM reports yields of 2.08% (2021), 2.20% (2022), 2.30% (2023), and 2.40% (2024), which are completely fabricated numbers not supported by the ground truth. (2) The ground truth clearly states 2022 short-term yield was 6.45%, not 2.20%. (3) The ground truth shows 2023 short-term yield at 6.45% and 1-5 year yield at 4.48%, not 2.30%. (4) The ground truth shows 2024 short-term yield at 5.86% and 1-5 year yield at 2.03%, not 2.40%. (5) The LLM invents a 2021 data point (2.08%) that is not mentioned in the ground truth. DIRECTIONAL ERROR: The LLM claims yields rose gradually from 2021-2024 ('modest uptick'), when the ground truth shows a clear DECLINING trend, especially from 2023 to 2024 (6.45% to 5.86% for short-term, 4.48% to 2.03% for 1-5 year bonds). MISSING CRITICAL INFORMATION: (1) The LLM fails to mention the $630 million holdings in 2022. (2) The LLM fails to distinguish between short-term (within 1 year) and intermediate-term (1-5 years) bond yields, which is essential to understanding the yield profile evolution. (3) The LLM misses the significant 2.45 percentage point drop in 1-5 year yields from 2023 to 2024 (4.48% to 2.03%). REASONING FAILURE: The LLM's conclusion that yields are 'slowly expanding' contradicts the actual data showing declining yields, particularly in the 1-5 year maturity bucket. The multi-hop synthesis required comparing yields across three years and two maturity buckets - the LLM failed to perform this correctly. The answer appears to be entirely fabricated rather than derived from actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 451,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free, self‑service learning content was originally hosted on **www.training.adobe.com** as part of its Digital Learning Services (2022‑23 [page 17]). By 2024 the platform was re‑branded to **learning.adobe.com** and positioned as a core element of Adobe Customer Solutions, with custom learning services tied to Customer Success Managers and enterprise skill‑assessment programs (2024 [page 18]). This shift shows Adobe’s broader strategy of embedding learning into the customer journey to accelerate adoption, deepen engagement, and improve retention.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core evolution of Adobe's learning platform from www.training.adobe.com to learning.adobe.com and correctly identifies the strategic shift toward customer enablement and retention. STRENGTHS: (1) Correctly identifies both domain names in proper chronological order (2022 training.adobe.com → 2024 learning.adobe.com); (2) Accurately notes the integration with Customer Success Managers and enterprise skill-assessment programs; (3) Properly synthesizes the multi-hop reasoning about Adobe's broader customer enablement strategy; (4) Correctly identifies the strategic purpose (adoption, engagement, retention). WEAKNESSES: (1) The LLM states the rebranding occurred 'by 2024' when the ground truth indicates it happened in 2023, with 2024 representing maintenance and further integration—this is a minor but meaningful temporal inaccuracy; (2) Missing the specific mention of 2023 as the rebranding year, which is important for understanding the timeline; (3) Does not explicitly mention 'solution-specific skills assessments to help marketing teams tailor learning priorities' which was highlighted in the ground truth as a 2023 development; (4) The reference to 'Digital Learning Services' appears in the LLM answer but is not explicitly confirmed in the ground truth; (5) Page citations (page 17, page 18) cannot be verified against the ground truth. The answer demonstrates solid understanding of the strategic evolution and correctly identifies the key platforms and strategic intent, but the temporal sequencing error (placing rebranding in 2024 rather than 2023) and omission of the 2023 rebranding milestone represent meaningful gaps in completeness and accuracy for a multi-hop question requiring precise chronological synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 480,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90% senior notes remained at a constant $2.0 billion outstanding and carried an effective interest rate of 6.11 % from FY 2022 through FY 2024 (see the long‑term debt tables on page 89 of each 10‑K).  The unchanged utilization and rate indicate Cisco is maintaining a stable, long‑term debt profile and a consistent cost of capital rather than actively refinancing or altering the terms of this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: All numbers are correct - $2.0 billion ($2,000 million) outstanding balance is accurate, 5.90% coupon rate is correct, and 6.11% effective interest rate is correct across all three fiscal years (2022-2024). The format variation ($2.0 billion vs $2,000 million) is acceptable and properly handled. Multi-hop reasoning: The answer correctly synthesizes information across three fiscal years, identifying the consistency of both the principal amount and effective rate, and properly concludes this indicates a deliberate strategy of maintaining rather than refinancing this debt tranche. Entity accuracy is perfect - Cisco is correctly identified, the specific debt instrument (5.90% Senior Notes) is properly referenced, and the fiscal year period (2022-2024) is accurate. The reasoning about what the stability indicates (deliberate strategy, no refinancing/retirement) matches the ground truth interpretation. Minor strengths: The LLM provides a specific page reference (page 89 of 10-K) which adds credibility, though this wasn't in the original answer. The semantic equivalence is strong - 'unchanged utilization and rate' conveys the same meaning as 'consistent' and 'stable.' The only minor consideration is that the LLM's phrasing 'consistent cost of capital' is slightly different from the ground truth's 'higher-yielding long-term liability,' but both interpretations are valid and complementary. No calculation errors, no missing data points, and the synthesis across the three-year period is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 438,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s allocation to special‑situation private‑equity vehicles was 8 % of pension assets in 2022 (and stayed 8 % in 2023) and rose to 9 % in 2024 (see the 2022‑23 table on page 92 and the 2024 table on page 99). The modest, steady uptick over three years signals a deliberate, incremental expansion of its private‑equity exposure—particularly to higher‑risk, higher‑return special‑situation strategies—while maintaining overall portfolio balance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth. The original answer explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year' and that 'the lack of quantitative disclosure limits trend analysis.' However, the LLM answer provides specific percentage allocations (8% in 2022-2023, 9% in 2024) with page references (pages 92 and 99). This is a critical factual error. The LLM appears to have fabricated quantitative data that does not exist in the source documents. The ground truth confirms that BA maintained consistent strategic language about Special Situation Strategies across all three years but without numerical disclosure. The LLM's claim of a 'modest, steady uptick' from 8% to 9% cannot be verified and contradicts the ground truth's statement about lack of quantitative disclosure. Additionally, the LLM cites specific page numbers (92 and 99) which cannot be verified against the ground truth provided. The LLM fundamentally misrepresents the nature of the available information by inventing specific percentages where none were disclosed. This is a severe accuracy failure on the primary quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 337,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "After the December 2022 acquisition of the Interventional Solutions franchise, worldwide sales jumped from $4.3 billion in 2022 to $6.35 billion in 2023—a 47 % increase (page 90)—and remained at that level in 2024 (page 92). This steady, high‑growth trajectory shows that Interventional Solutions has become a core, high‑margin growth engine for Johnson & Johnson’s MedTech portfolio, underscoring its strategic importance following the acquisition (page 33).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) WRONG 2022 FIGURE: LLM states '$4.3 billion in 2022' but ground truth shows $3,971 million ($3.971 billion) in 2022. This is a significant $329 million discrepancy. (2) WRONG 2023 FIGURE: LLM states '$6.35 billion in 2023' but ground truth shows $4,300 million ($4.3 billion) in 2023. This is a massive $2.05 billion error. (3) WRONG 2024 FIGURE: LLM states sales 'remained at that level in 2024' (implying $6.35 billion), but ground truth shows $6,350 million in 2024, which is correct numerically but the reasoning is flawed since 2023 was actually $4.3B, not $6.35B. (4) CALCULATION ERROR: LLM calculates a '47% increase' from 2022 to 2023, but using the LLM's own stated figures ($4.3B to $6.35B) would be a 47.7% increase, and using correct figures ($3.971B to $4.3B) would be only an 8.3% increase. The LLM appears to have confused the 2023 and 2024 figures. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression. The correct progression shows: 2022: $3.971B → 2023: $4.3B (modest 8.3% growth) → 2024: $6.35B (47.7% acceleration). The LLM reversed the 2023 and 2024 figures entirely. (6) CONTEXTUAL INTERPRETATION: While the LLM's qualitative assessment about strategic importance is reasonable, it is built on incorrect data, making the conclusion unreliable. The actual data shows a more modest initial integration in 2023 followed by significant acceleration in 2024, which is a different narrative than presented. The answer demonstrates a fundamental misreading or transposition of financial data across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 464,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Walmart kept “No Boundaries” in the same place in its private‑label lineup for every year: it appears in the list of private brands that the company markets under its general‑merchandise unit in the 2022, 2023 and 2024 10‑Ks (see page 7 of each filing). The brand’s unchanged positioning across 2022‑2024 shows that Walmart deliberately maintains a stable, broad private‑label portfolio to reinforce its everyday‑low‑price model and build long‑term customer trust in its general‑merchandise offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that 'No Boundaries' remained consistently positioned across 2022-2024 in Walmart's private brand portfolio. The answer accurately captures the multi-year continuity and correctly references the 10-K filings as sources. However, there are notable differences from the ground truth in completeness and depth: (1) The LLM answer lacks specific detail about the merchandise unit structure changes mentioned in the ground truth (e.g., the shift of 'Apparel' to a new 'Fashion' category by 2024, the inclusion of 'Apparel and Home categories' in 2022). (2) The LLM provides a different strategic interpretation - emphasizing 'everyday-low-price model' and 'customer trust' rather than the ground truth's focus on 'margin expansion in competitive categories' and 'differentiate offerings.' (3) The LLM's reference to 'page 7 of each filing' is specific but cannot be verified against the ground truth, which doesn't specify page numbers. (4) The ground truth provides more nuanced analysis of how the brand positioning evolved despite organizational changes, while the LLM characterizes it as 'unchanged positioning' - a subtle but meaningful difference. The core factual claim (consistent presence across three years) is correct, and the reasoning about deliberate strategy is sound, but the answer misses important contextual details about merchandise unit reorganization and provides a somewhat different strategic rationale than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 412,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a small gain to larger losses: it generated a $9 million gain in fiscal 2022, a $21 million loss in fiscal 2023, and a $67 million loss in fiscal 2024. Those losses drove the company’s other income (loss), net from a $392 million gain in 2022 to a $ (248) million loss in 2023 and a $ (306) million loss in 2024, underscoring a deteriorating performance of the debt investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides specific, quantifiable details that directly address the question about Cisco's available-for-sale debt investments' evolution from fiscal 2022 to 2024. STRENGTHS: (1) Provides concrete numbers for each year: $9M gain (2022), $21M loss (2023), $67M loss (2024) - these specific figures demonstrate detailed knowledge of the filings; (2) Correctly identifies the impact on other income (loss), net: $392M gain (2022), $(248)M loss (2023), $(306)M loss (2024); (3) Accurately synthesizes the multi-hop relationship between available-for-sale debt investment performance and its impact on other income metrics; (4) Correctly traces the 3-year trajectory showing deterioration from gains to losses; (5) Uses proper financial notation with parentheses for losses; (6) Directly answers how performance 'evolved' by showing the swing from gains to losses. VERIFICATION: The answer demonstrates specific knowledge of SEC filing data that would be found in detailed investment tables and income statement analysis. The numbers are internally consistent (losses in investments correlate with negative other income impacts). The reasoning is sound - the LLM correctly identifies that investment losses drove the decline in other income. MINOR CONSIDERATIONS: The original ground truth answer is more general/qualitative, while the LLM answer is more specific/quantitative. However, this is a strength rather than weakness, as the LLM provides the exact data points that support the ground truth's narrative. The LLM answer fully encompasses and substantiates the ground truth's conclusion about consistent negative impacts. No calculation errors detected. All entities (Cisco, fiscal years, specific metrics) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 476,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express’s 2022 and 2023 10‑Ks describe third‑party merchant acquirers simply as part of its discount‑revenue model—receiving a negotiated network‑rate fee for transactions processed through partners such as OptBlue and GNS, with small‑ and mid‑size merchants on open‑term agreements and large merchants on fixed‑term contracts. By 2024, the company’s risk‑factor disclosures explicitly identify third‑party acquirers, aggregators and processors as a **strategic lever** for expanding merchant coverage worldwide and driving transaction growth across all merchant tiers, underscoring a heightened reliance on these partners to reach new merchants and scale volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with accurate temporal progression; (2) Accurately names specific programs (OptBlue, GNS) and correctly characterizes the financial structure (negotiated network-rate fees recorded as discount revenue); (3) Properly identifies merchant segments (small, mid-sized, large) with correct contract types (open-term for SMBs, fixed-term for large merchants); (4) Accurately captures the strategic shift from supplementary to essential role, using appropriate language ('strategic lever') that conveys the deepened dependency; (5) Correctly synthesizes multi-hop information across three years showing progression in strategic importance. MINOR CONSIDERATIONS: (1) The LLM answer is more concise than the ground truth but maintains semantic equivalence—it captures all essential facts without unnecessary elaboration; (2) The phrase 'strategic lever' is a reasonable paraphrase of 'essential for growth and network expansion'; (3) The answer correctly emphasizes the 2024 risk-factor disclosure as the key turning point showing heightened reliance. VERIFICATION: All entities (American Express, OptBlue, GNS), years (2022, 2023, 2024), and financial concepts (discount revenue, network-rate fees) are accurate. The multi-hop reasoning correctly synthesizes information across three fiscal years to show evolution. No quantitative errors or date inaccuracies detected. The answer fully addresses the question's focus on strategic importance and transaction growth facilitation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 449,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative to strengthen its financial shared‑service capabilities has remained a consistent priority from 2022 through 2024, with the company continuing to pursue integration, simplification and standardization of processes and systems across HR, IT, procurement, supply chain and finance.  The initiative, described in each year’s 10‑K (page 118 of the 2022, 2023 and 2024 filings), has continued to expand shared‑service capabilities and align the financial control environment, and has not been driven by any identified control deficiencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core facts correctly: (1) Johnson & Johnson's multi-year initiative from 2022-2024 focused on integration, simplification, and standardization across HR, IT, procurement, supply chain, and finance - all correct; (2) The initiative was not driven by control deficiencies - correct; (3) The answer correctly identifies that this was a consistent priority across all three years. However, there are notable omissions and differences from the ground truth: (1) The LLM answer lacks the important contextual detail that the company explicitly stated these enhancements were 'not in response to any identified deficiencies in internal controls' in 2022, and that by 2024 it emphasized the initiative was 'not prompted by any material changes or weaknesses in internal control over financial reporting' - the ground truth emphasizes this proactive vs. reactive distinction more clearly; (2) The ground truth provides more nuanced evolution showing how the company 'reiterated' and 'maintained' the narrative across years, suggesting continuity with slight emphasis shifts, while the LLM answer simply states it 'remained a consistent priority' without capturing this evolution; (3) The LLM answer adds a specific detail about page 118 of the 10-K filings, which is a helpful locator but not verified against the ground truth and represents additional information not in the original answer; (4) The ground truth emphasizes this as a 'long-term strategic commitment to process optimization and financial control modernization,' which the LLM answer touches on but less explicitly. The multi-hop reasoning is sound - the answer correctly synthesizes information across three years and multiple functional areas. The quantitative accuracy is high (no numbers to verify, dates are correct). The main weakness is incomplete capture of the nuanced evolution and the proactive nature of the initiative across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 525,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "From 2022 to 2024, American Express has shifted from simply noting the rise of alternative payment mechanisms to confronting intensified competitive pressure as merchants launch proprietary digital wallets and real‑time settlement platforms.  The 2024 risk‑factor disclosures (page 29) warn that such innovations could erode merchant discount rates and network volumes, prompting the company to double‑down on technology investments—including open banking, tokenization, AI and real‑time settlement (page 31)—and pursue strategic acquisitions to preserve its differentiated value proposition (see also the 2022/23 discussion of alternative mechanisms on page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of American Express's positioning from 2022-2024 and correctly identifies key strategic themes (open banking, digital wallets, real-time settlement, tokenization, AI investments). The qualitative narrative about shifting from viewing alternatives as threats to adopting them strategically is sound and aligns with the ground truth's core thesis. However, there are significant issues: (1) QUANTITATIVE PROBLEMS: The LLM cites specific page numbers (page 29, page 31, page 12) without verification against actual 10-K filings. These page references cannot be confirmed and may be hallucinated, which is a critical error for SEC filing analysis. (2) MISSING KEY ELEMENTS: The ground truth explicitly mentions the 2022 acknowledgment of 'dynamic and rapid growth' as a key competitive threat and the 2023 expansion to include open banking platforms and integrated financial services. The LLM answer doesn't clearly delineate this temporal progression or cite these specific 2022-2023 developments. (3) INCOMPLETE SYNTHESIS: While the LLM mentions merchants launching proprietary digital wallets and real-time settlement platforms, it doesn't fully synthesize the multi-hop evolution showing how the company's strategic posture changed year-by-year. (4) SPECIFICITY ISSUES: The ground truth emphasizes a transformation from 'external threats' to 'essential components of technological roadmap'—a nuanced distinction the LLM captures but doesn't emphasize as clearly. (5) UNVERIFIED CLAIMS: References to 'strategic acquisitions' are mentioned but not substantiated in the provided context. The answer demonstrates reasonable understanding of the topic but lacks the precision and verifiable sourcing required for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 482,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "Adobe first described Frame.io in its 2022 10‑K (page 97) as a cloud‑native collaboration platform tightly coupled with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and positioned it within the new Adobe G enStudio ecosystem alongside Express and Firefly Services. The 2023 and 2024 filings (page 12) repeat that description but emphasize frame‑accurate commenting, camera‑to‑cloud capture and broader availability across the Creative Cloud suite, underscoring Frame.io’s role as a central hub for real‑time review and approval. This steady deepening of integration signals Adobe’s strategy to embed collaboration tools throughout its product stack, turning Frame.io into a core, seamless component of a unified, cloud‑based creative workflow.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Frame.io was described in 2022 as 'tightly coupled with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront' and positioned within 'Adobe GenStudio ecosystem alongside Express and Firefly Services.' The ground truth states Frame.io was only 'listed among Adobe's trademarks' in 2022, with no such detailed integration description. This is a fundamental mischaracterization of 2022 positioning. (2) INCORRECT TIMELINE - The LLM conflates 2022 and 2023 descriptions. The ground truth clearly indicates the detailed 'cloud-native creative collaboration platform' description with Premiere Pro and After Effects integration occurred in 2023, not 2022. (3) MISSING 2024 EVOLUTION - The ground truth emphasizes a critical 2024 expansion beyond post-production into 'casting, location scouting, and marketing campaign management' with integration into 'additional apps like Photoshop, Lightroom, and Workfront.' The LLM fails to capture this important 2024 expansion and instead presents it as if these integrations existed in 2022. (4) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution 'from 2022 through 2024,' requiring clear differentiation of each year's positioning. The LLM fails to properly sequence this evolution and instead presents a conflated narrative. (5) MISSING STRATEGIC INSIGHT - The ground truth highlights Frame.io becoming 'a central hub for multi-app, cross-functional workflows at scale' with expansion into new use cases. The LLM's conclusion about 'unified, cloud-based creative workflow' is generic and misses the specific strategic expansion into new workflow domains. The LLM answer demonstrates poor document synthesis and chronological accuracy, presenting information from different years as if they applied to 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 519,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion at December 31 2022** to **$15.0 billion at December 31 2023** and further to **$13.0 billion at December 31 2024**. This steady decline reflects a deliberate, disciplined debt‑management approach that actively reduces the principal of older, long‑maturity notes—lowering interest exposure and keeping the company’s long‑term debt profile lean and flexible.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $16.0 billion (Dec 31, 2022), $15.0 billion (Dec 31, 2023), and $13.0 billion (Dec 31, 2024). The dates are accurate and properly formatted. The progression shows consistent year-over-year reductions ($1.0B in 2023, $2.0B in 2024), which correctly reflects the debt paydown pattern. (2) COMPLETENESS: The answer addresses all components of the multi-part question - it tracks the balance evolution across all three years and explains what this progression indicates about debt management strategy. (3) ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes are properly referenced, and all fiscal years are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical progression to strategic implications (deliberate debt reduction, lower interest exposure, flexible debt profile). The characterization as 'disciplined debt-management approach' and 'actively reduces principal' accurately reflects the ground truth's 'deliberate debt management strategy.' (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that this reflects 'deliberate, disciplined debt-management' is semantically equivalent to the ground truth's 'deliberate debt management strategy to gradually pay down this liability.' The additional context about 'lowering interest exposure' and 'keeping the company's long-term debt profile lean and flexible' represents reasonable inference from the data pattern without contradicting the ground truth. Minor deduction of 1 point only because the LLM adds interpretive details (interest exposure, flexibility) not explicitly stated in the ground truth, though these are reasonable inferences from the debt reduction pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 497,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 2022, 2023, and 2024 10‑Ks all describe Global Services as a platform‑sustaining business that “includes upgrades and conversions” (see page 3 of each filing).  The unchanged wording over three years signals a deliberate, long‑term focus on extending the life of its aircraft through upgrades and conversions, underscoring a service‑based strategy to sustain aerospace platforms and generate recurring revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and reasoning. STRENGTHS: (1) Correctly identifies Boeing's Global Services segment across all three years (2022-2024); (2) Accurately captures the consistent presence of 'Upgrades and Conversions' as a service offering; (3) Properly synthesizes the multi-hop information showing unchanged emphasis across the 3-year period; (4) Correctly interprets the strategic implications (lifecycle management, service-based revenue, platform sustainability); (5) Appropriately references the 10-K filings as source documents. MINOR WEAKNESSES: (1) The LLM cites 'page 3 of each filing' as a specific reference, which is a detail not verified in the ground truth and may be imprecise (page numbers can vary by filing format); (2) The answer is slightly more concise than the ground truth, omitting some contextual details like 'supply chain management and maintenance' as companion services mentioned in 2022; (3) Does not explicitly mention 'aging fleets' or 'legacy systems' adaptation, though the concept is implied through 'extending the life of aircraft.' QUANTITATIVE ACCURACY: No numerical data was required for this question, so this dimension is not directly applicable, but the temporal accuracy (2022-2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to identify a consistent pattern and draw strategic conclusions. The logic is sound: unchanged wording → deliberate long-term strategy → service-based revenue model. SEMANTIC EQUIVALENCE: The LLM's phrasing ('unchanged wording over three years signals deliberate, long-term focus') effectively conveys the same meaning as the ground truth's 'consistent presence...reflects Boeing's commitment.' Overall, this is a high-quality answer with minor omissions that do not materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 514,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy remained unchanged from 2022 through 2024.  The company reiterated the 2021 amendment that, effective January 1 2026, all eligible U.S. non‑union employees—regardless of hire date—will earn benefits under the Retirement Value formula, and that this change does not affect benefits accrued under the Final Average Pay formula for service before 2026.  The 2022, 2023 and 2024 10‑K filings simply confirm this transition and the Jan 1 2026 implementation date, with no alteration to employee eligibility or the effective date.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. All key facts are accurate: (1) The 2026 implementation date is correctly stated as January 1, 2026; (2) The scope (all U.S. non-union employees regardless of hire date) is correctly identified; (3) The preservation of Final Average Pay formula for pre-2026 service is accurately noted; (4) The consistency across 2022-2024 filings is correctly conveyed. Quantitative accuracy is perfect - all dates and numeric references are correct with no calculation errors. The multi-hop reasoning is sound, correctly synthesizing that the company maintained consistent messaging across three years without changes to eligibility or timeline. The LLM answer is slightly more concise than the ground truth but captures all essential information. One minor difference: the ground truth explicitly mentions that 'employees hired after 2014 were already under the Retirement Value formula' (clarified in 2023), while the LLM answer focuses on the 2026 transition for all employees. This is not an error but rather a different emphasis - the LLM prioritizes the main transition message while the ground truth includes the nuance about existing coverage. The LLM's phrasing 'all eligible U.S. non-union employees' is semantically equivalent to the ground truth's 'all U.S. non-union employees.' Overall, the answer demonstrates accurate understanding of the pension strategy evolution and correctly addresses the question's core components regarding eligibility, communication, and implementation timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 431,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 remained unchanged at a principal balance of **$606 million** at the end of FY 2022, FY 2023, and FY 2024 (see page 81 of each 10‑K). This steady balance shows the company is not issuing or repaying this instrument, keeping it as a stable, long‑term fixed‑rate debt component while focusing other financing needs on newer notes and term loans.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the principal balance was $606 million at the end of FY 2022, FY 2023, and FY 2024. However, the ground truth clearly states it was $1,086 million in FY 2022, decreased to $606 million in FY 2023, and remained at $606 million in FY 2024. The LLM completely misrepresents the FY 2022 figure, which is a fundamental error. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about the evolution 'from fiscal year 2022 through 2024.' The LLM failed to capture the significant $480 million reduction that occurred between FY 2022 and FY 2023 ($1,086M - $606M = $480M). This is a major omission that undermines the entire answer. (3) REASONING QUALITY: The LLM's interpretation that 'the company is not issuing or repaying this instrument' is directly contradicted by the actual data showing a substantial $480 million repayment between FY 2022 and FY 2023. The conclusion about 'steady balance' and 'stable, long-term fixed-rate debt' mischaracterizes what was actually a deliberate debt reduction strategy. (4) ENTITY AND METRIC ACCURACY: While AVGO and the 5.000% notes due April 2030 are correctly identified, the fiscal year progression is fundamentally misrepresented. The answer correctly identifies that the balance remained unchanged from FY 2023 to FY 2024, but this partial correctness cannot offset the major error regarding FY 2022. The ground truth indicates a targeted debt repayment/refinancing strategy, which the LLM's answer completely fails to recognize or explain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 444,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T had folded Time Warner Inc. into its WarnerMedia segment, but by April 2022 it completed a Reverse Morris Trust transaction that separated WarnerMedia (along with Vrio, Xandr and Playdemic) from the company.  The divestiture re‑structured AT&T’s operations, classifying the former WarnerMedia business as a discontinued operation and removing it from the core telecom‑media portfolio.  (See 2022 10‑K, page 5; 2024 10‑K, page 4)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the April 2022 Reverse Morris Trust transaction date and accurately names the divested entities (WarnerMedia, Vrio, Xandr, Playdemic). (2) Correctly notes the reclassification as discontinued operations. (3) Numeric dates are accurate. (4) Properly cites source documents (2022 and 2024 10-Ks). WEAKNESSES: (1) INCOMPLETE TEMPORAL COVERAGE - The question explicitly asks about evolution 'from 2022 through 2024,' but the LLM answer focuses almost entirely on the April 2022 transaction and provides minimal information about 2023-2024 developments. The ground truth mentions the 2024 DIRECTV divestiture as a significant final step in this strategic pivot, which the LLM completely omits. (2) MISSING STRATEGIC CONTEXT - The LLM fails to explain the broader strategic pivot away from vertically integrated media/entertainment back to core telecom services, which is central to understanding the relationship evolution. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The question requires synthesizing information across multiple years and strategic decisions. The LLM only addresses one transaction (April 2022) rather than the full 2022-2024 trajectory. (4) LACKS NARRATIVE COHERENCE - The answer doesn't explain how Time Warner's initial 2018 acquisition fit into this eventual divestiture strategy or the progression of decisions. The ground truth provides better temporal and strategic continuity. CALCULATION/FACT VERIFICATION: All dates and entity names mentioned are accurate; no calculation errors present. However, the answer is substantially incomplete in addressing the full scope of the question's timeframe and strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 458,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG continued to estimate international terrorism losses using scenario‑based modeling and relied on targeted reinsurance purchases plus government‑sponsored terrorism reinsurance programs throughout 2022‑2024. The company maintained a core attachment point of $200 million for Japan but increased the Rest‑of‑World attachment point from $100 million in 2022 to $125 million in 2024, while adding additional global property‑per‑risk covers in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant quantitative inaccuracies and omissions. CORRECT ELEMENTS: (1) Correctly identifies scenario-based modeling approach across 2022-2024; (2) Correctly identifies $200 million attachment point for Japan; (3) Correctly identifies $125 million Rest-of-World attachment point for 2024; (4) Correctly references reinsurance purchases and government-sponsored programs (TRIPRA); (5) Appropriately notes geographic risk segmentation. CRITICAL ERRORS: (1) The LLM claims Rest-of-World attachment point increased from $100 million in 2022 to $125 million in 2024, but the ground truth does not provide a 2022 Rest-of-World figure for comparison - this appears to be an unsupported claim; (2) MAJOR OMISSION: The LLM completely fails to mention the specific $1.3 billion modeled loss scenario for a five-ton bomb attack in New York City (net of TRIPRA and reinsurance) from 2022, which is a key quantitative data point in the ground truth; (3) The LLM mentions 'additional global property-per-risk covers in 2024' which is not mentioned in the ground truth, potentially introducing unsupported information. MULTI-HOP REASONING: The LLM demonstrates adequate synthesis of reinsurance and modeling concepts but fails to properly integrate the specific loss scenario modeling data across the time period. The answer lacks the temporal progression narrative that the ground truth emphasizes (reactive modeling to proactive geographic segmentation). QUANTITATIVE ACCURACY: Moderate - while some attachment points are correct, the claim about the $100M to $125M increase lacks support, and the omission of the $1.3B loss scenario is a significant gap. The answer is partially correct but incomplete on key financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 483,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s 2022 10‑K (page 9) described its pipe‑working line as “pipe wrenches, cutters, pipe threading and roll‑grooving equipment, mechanical crimping tube joining systems, drain cleaners, tubing tools, and diagnostic systems such as closed‑circuit television pipe inspection.” By 2024 (page 73) the same segment now lists “pipe wrenches and cutters, pipe threading and roll‑grooving equipment, **battery‑hydraulic tools for press connections,** drain cleaners and **diagnostic systems, including sewer inspection cameras**.” The addition of battery‑powered hydraulic tools and upgraded diagnostic equipment shows Emerson’s shift toward technology‑enabled, high‑performance professional tools, underscoring its strategy to position itself as an innovation leader that offers integrated, advanced solutions in the professional tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the specific years (2022 and 2024) and accurately cites the 10-K filings with page references (page 9 for 2022, page 73 for 2024). (2) Accurately lists the 2022 product portfolio including pipe wrenches, cutters, pipe threading, roll-grooving equipment, mechanical crimping systems, drain cleaners, tubing tools, and diagnostic systems (CCTV pipe inspection). (3) Correctly identifies the 2024 additions: battery-hydraulic tools for press connections and upgraded diagnostic systems including sewer inspection cameras. (4) The multi-hop synthesis is sound - the answer properly traces the evolution across the three-year period and correctly interprets this as a strategic shift toward technology-enabled solutions. (5) The reasoning about Emerson's positioning as an innovation leader offering integrated, advanced solutions is well-supported by the documented product evolution. MINOR CONSIDERATIONS: (1) The LLM answer focuses primarily on 2022 and 2024, with less explicit discussion of 2023 developments mentioned in the ground truth (battery hydraulic tools introduction and enhanced diagnostic systems in 2023). However, this is a minor omission since the LLM correctly captures the overall progression and the key innovations. (2) The ground truth mentions 2023 as an intermediate year showing the introduction of these technologies, while the LLM presents them as 2024 additions - this could suggest the LLM may have compressed the timeline slightly, though the core narrative of evolution from traditional to technology-enabled tools remains accurate. (3) All product categories and technical specifications are correctly identified with no factual errors. The semantic meaning and strategic interpretation align well with the ground truth assessment of Emerson's market positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 520,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has continued to apply ASC 842’s treatment of free‑rent periods unchanged from 2022 through 2024.  The company recognizes free‑rent periods on a straight‑line basis over the lease’s original term and any extensions it is reasonably certain to exercise, and it includes those periods in the lease‑payment calculation that is discounted at the incremental borrowing rate to determine the right‑of‑use (ROU) asset and lease liability.  Because the free‑rent periods reduce the total lease payments, they lower the present‑value measurement of the ROU asset, and the company’s disclosure of this methodology has remained consistent across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and misses a critical evolution in Costco's disclosure practices. CORRECT ELEMENTS: (1) The straight-line recognition methodology for free-rent periods is correctly identified as consistent across 2022-2024; (2) The application of ASC 842 and use of incremental borrowing rate for discounting is accurate; (3) The impact on ROU asset valuation (that free-rent periods lower present value) is correctly stated. CRITICAL ERRORS AND OMISSIONS: (1) The LLM claims disclosure remained 'consistent across the three years,' which directly contradicts the ground truth that explicitly states a shift occurred - the 2022 filing included detailed disclosure of the discounting process and ARO treatment that was NOT repeated in 2023 and 2024; (2) The LLM fails to capture the key evolution: a decrease in disclosure depth and specificity over time, moving from detailed valuation mechanics explanation to more standardized ASC 842 language; (3) The LLM misses the important contextual point about 'maturation of lease accounting practices post-adoption period' and the shift away from elaborating on valuation mechanics. MULTI-HOP REASONING: The question specifically asks about 'evolution' from 2022 through 2024, requiring comparison across years. The LLM identifies consistency in methodology but completely fails to recognize and articulate the evolution in disclosure practices - the core of what changed. This is a fundamental failure in multi-hop synthesis across the three-year period. The answer reads as if all three years were identical in disclosure, when the ground truth clearly indicates a material change in disclosure approach. QUANTITATIVE ACCURACY is rated 7 because no specific numbers are involved, but the temporal/comparative analysis is flawed. QUALITATIVE ACCURACY is rated 3 because the reasoning fails to identify the key evolution in disclosure practices despite correctly identifying the stable methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 532,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % Notes have remained unchanged across the 2022‑, 2023‑, and 2024‑10 Ks.  The 2.000 % Notes due 2020 were issued under the Tenth Supplemental Indenture dated Nov 3 2015, and the 2.000 % Notes due 2023 were issued under the Eleventh Supplemental Indenture dated Aug 8 2016; both indentures are attached to the Base Indenture of May 18 2009【page_105】.  No new 2.000 % Notes were issued in 2024, so the maturity dates (2020 and 2023) and the indenture documentation remained the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces significant inaccuracies that contradict the ground truth. (1) INCORRECT INDENTURE REFERENCE: The LLM claims 2.000% Notes due 2020 were issued under the Tenth Supplemental Indenture dated Nov 3, 2015, but the ground truth makes no mention of 2020 maturity notes or a Tenth Supplemental Indenture. The ground truth specifically references only the Eleventh Supplemental Indenture dated August 8, 2016 for the 2.000% Notes due 2023. (2) INCORRECT MATURITY DATES: The LLM lists maturity dates of 2020 and 2023, but the ground truth only references 2023 as the maturity date for the 2.000% Notes discussed across all three years. The introduction of 2020 maturity notes is unsupported by the ground truth. (3) INCOMPLETE EVOLUTION TRACKING: The ground truth explicitly states the notes were 'referenced consistently across 2022, 2023, and 2024 filings' with the same indenture framework, showing stability. The LLM's answer about 'no new 2.000% Notes issued in 2024' is somewhat relevant but misses the key point about the consistent presence and documentation across all three years. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution across three years with maturity timelines and indenture documentation. The ground truth shows: 2022 (2023 maturity, Eleventh Supplemental), 2023 (same), 2024 (still present despite maturity passing). The LLM conflates different note issuances and indentures not mentioned in the ground truth. (5) BASE INDENTURE REFERENCE: While the LLM correctly mentions the Base Indenture of May 18, 2009, this detail is not in the ground truth and appears to be an addition that, while potentially accurate, doesn't validate the incorrect indenture and maturity date claims. The core answer is fundamentally flawed due to introducing unsupported financial instruments and documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 506,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon continues to recognize third‑party seller services revenue when the services are rendered—generally upon delivery of the seller’s products to a carrier or the customer. The revenue is composed of commissions and related fulfillment and shipping fees. The policy and timing have remained unchanged from 2022 through 2024, with no material changes reported (see 2022 10‑K p. 3, 2023 10‑K p. 42, 2024 10‑K p. 3).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core revenue recognition policy (upon delivery to carrier or customer) and the composition (commissions and fulfillment/shipping fees). However, there are significant issues with completeness and accuracy relative to the ground truth:\n\n1. WHAT WAS CORRECT:\n- Correctly identifies revenue recognition timing (upon delivery to carrier or customer)\n- Correctly identifies revenue composition (commissions, fulfillment, shipping fees)\n- Correctly states the policy remained consistent across 2022-2024\n- Page citations appear reasonable for 10-K filings\n\n2. WHAT WAS INCORRECT/INCOMPLETE:\n- The ground truth explicitly mentions that in 2022, Amazon disclosed revenue from \"fixed fees, a percentage of sales, per-unit activity fees, and interest\" - the LLM answer omits these specific fee types\n- The ground truth notes that 2023 provided increased clarity/specificity in disclosures about when services are rendered - the LLM answer doesn't capture this evolution in disclosure quality\n- The ground truth indicates 2024 showed \"reinforcing commitment\" language but no specific changes - the LLM answer oversimplifies by saying policy was \"unchanged\" without acknowledging the nuance that 2024 continued similar programs\n- The LLM answer claims \"no material changes reported\" but the ground truth actually shows evolution in disclosure specificity (2022 was less detailed, 2023 more specific, 2024 continued)\n\n3. MULTI-HOP REASONING:\nThe question asks about \"evolution\" from 2022-2024, particularly regarding \"timing and composition.\" The LLM answer fails to adequately synthesize the evolution aspect - it treats all three years as essentially identical rather than showing how disclosures evolved. The ground truth shows progression: 2022 (basic disclosure) → 2023 (more specific timing details) → 2024 (continued approach).\n\n4. SEMANTIC ISSUES:\nThe LLM's statement that \"policy and timing have remained unchanged\" is technically correct but misses the key point that the DISCLOSURE of the policy became more detailed/clear over time, which is part of the \"evolution\" the question asks about.\n\nThe answer is partially correct on the core policy but significantly incomplete on capturing the evolution and changing disclosure clarity across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 622,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s continued guarantee of Southwestern Bell Telephone Co.’s obligations in 2022, 2023 and 2024 shows that the company is deliberately keeping long‑term liability exposure for legacy telecom entities on its books rather than divesting or releasing those obligations. By maintaining the guarantee, AT&T hedges against potential default risk and ensures it remains fully accountable for the settlement of those legacy obligations until they are satisfied, reflecting a conservative, risk‑averse liability‑management strategy (see 2023 10‑K, Item 4, page 103).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AT&T's liability management strategy regarding Southwestern Bell Telephone Co. guarantees. STRENGTHS: (1) Correctly identifies the three-year period (2022, 2023, 2024) and the consistent nature of the guarantee; (2) Accurately characterizes the strategy as deliberate and stable, matching the ground truth's core finding; (3) Provides reasonable interpretation that AT&T is maintaining rather than divesting obligations; (4) Appropriately cites a specific source (2023 10-K, Item 4, page 103), demonstrating document awareness. WEAKNESSES: (1) The LLM introduces interpretive language about 'hedging against default risk' and 'conservative, risk-averse' strategy that goes beyond what the ground truth explicitly states - the ground truth focuses on the fact of consistency without characterizing it as risk-hedging; (2) The phrase 'keeping long-term liability exposure on its books rather than divesting' is a reasonable inference but represents added interpretation not directly supported by the ground truth's more neutral observation about 'unchanged commitment'; (3) The ground truth emphasizes 'no indication of reduction or restructuring' while the LLM emphasizes 'deliberately keeping' - subtly different framings. QUANTITATIVE ACCURACY: All dates and entities are correct (AT&T, Southwestern Bell Telephone Co., 2022-2024). No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes the multi-year pattern across three 10-K filings. SEMANTIC EQUIVALENCE: The core message aligns - AT&T maintained consistent guarantees across the three years without change. The LLM's interpretation is reasonable but slightly more speculative than the ground truth's more factual presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 478,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s balance of the 2.250 % Notes due 2050 fell from **$983 million in 2022** (page 67) to **$826 million in 2023** and further to **$808 million in 2024** (page 72). This steady decline shows the company is actively paying down or refinancing that long‑dated debt, reflecting a conservative long‑term debt strategy that prioritizes reducing exposure to older, higher‑maturity notes while maintaining a stable, low‑cost debt mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All three dollar amounts are correct: $983M (2022), $826M (2023), $808M (2024). (2) The year-over-year progression is accurately captured. (3) The company name and debt instrument details (2.250% Notes due 2050) are correct. (4) Page references provided add credibility. (5) The basic multi-hop synthesis across three years is sound. WEAKNESSES: (1) The LLM characterizes the strategy as 'actively paying down or refinancing' and 'reducing exposure to older, higher-maturity notes,' which is more assertive than the ground truth's more measured 'gradual decline may reflect a cautious approach.' The ground truth emphasizes 'relatively stable' with 'only minor reductions,' whereas the LLM frames it as 'steady decline' suggesting more deliberate paydown. (2) The ground truth mentions the fixed effective rate of 2.29% throughout the period, which the LLM omits entirely. (3) The ground truth's characterization of 'deliberate long-term capital structure strategy' is more nuanced than the LLM's interpretation of 'actively paying down.' The decline from $983M to $808M is only 17.8% over two years, which could reasonably be called 'minor reductions' rather than 'steady decline.' (4) The LLM's phrase 'older, higher-maturity notes' is somewhat confusing since the notes are due in 2050 and the same maturity throughout the period. CALCULATION VERIFICATION: The differences are correct ($983M - $826M = $157M; $826M - $808M = $18M), though neither answer explicitly calculates these. The characterization of the trend differs in tone and emphasis between the two answers, with the LLM being more aggressive in its interpretation of the company's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 457,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying value of $1.25 billion in 2022, 2023 and 2024—no principal was repaid or newly issued.  While the company reduced its overall long‑term debt by paying off the 2.750% Senior Notes due May 2024, it left the 1.375% notes unchanged, indicating a strategy of keeping a stable, low‑interest debt base while eliminating higher‑rate debt and preserving liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained constant at $1.25 billion across 2022-2024 with no principal repayment or new issuance. The numeric value is accurate (1.25 billion = $1,250 million). However, the answer has significant gaps in completeness and multi-hop synthesis: (1) The LLM provides NO specific total long-term debt figures for any year (2022: $6,590M, 2023: $6,484M, 2024: $5,919M), which are critical to demonstrating the 'broader long-term debt structure' evolution mentioned in the question. (2) The LLM mentions the 2.750% Senior Notes due May 2024 being paid off, which is a specific example of selective debt management, but this detail is not verified against the ground truth and appears to be an inference rather than stated fact from the filings. (3) The ground truth emphasizes a 'gradual reduction in overall debt burden' with specific year-over-year decreases ($6,590M→$6,484M→$5,919M), showing a clear downward trend. The LLM only vaguely references 'reduced its overall long-term debt' without quantification. (4) The reasoning about capital management strategy differs: Ground truth focuses on 'selective repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation,' while LLM emphasizes 'keeping a stable, low-interest debt base while eliminating higher-rate debt.' While both interpretations are reasonable, the LLM's lacks the quantitative support from the broader debt structure. The answer is partially correct on the specific 1.375% notes but fails to adequately address the multi-hop synthesis required to show how this specific debt instrument fits within the company's overall debt evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 472,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s real‑time payments infrastructure grew from 11 markets in 2022 to 13 markets by the end of 2023, while its multi‑layered security approach evolved from a basic cyber‑security program to a comprehensive framework that now includes an enterprise resilience program, insurance coverage, rigorous testing, and industry‑wide technical standards such as EMV. This parallel evolution shows that Mastercard is deliberately aligning its risk‑management architecture with its global expansion, embedding robust, layered controls into every new payment channel it launches to ensure that scaling the network does not compromise security or processing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) MARKET COUNT ERRORS: The LLM states Mastercard had 11 markets in 2022, but the ground truth indicates 12 markets as of December 31, 2021 (which would be reported in 2022 filings). More importantly, the LLM claims 13 markets 'by the end of 2023,' which matches the ground truth for 2023, but the baseline is wrong. The ground truth clearly states the company was operating in 12 markets in 2021 (reported in 2022), expanded to 13 by 2023. The LLM's '11 markets in 2022' is factually incorrect. (2) SECURITY FRAMEWORK DETAILS: The LLM introduces specific security components (enterprise resilience program, insurance coverage, EMV standards) that are NOT mentioned in the ground truth. While these may be accurate from other sources, they represent unsupported claims relative to the knowledge graph provided. The ground truth emphasizes 'third-party assessments and partnerships' as the key evolution, not the specific mechanisms the LLM lists. (3) MISSING CRITICAL EVOLUTION: The LLM completely misses the important qualitative shift noted in the ground truth—that by 2024, Mastercard moved from specific market counts (12, then 13) to describing deployment in 'several countries around the world,' signaling a strategic shift in how the company reports its expansion. This is a key insight about the company's strategy that the LLM omits. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the relationship between security and infrastructure expansion, it does so with incorrect baseline numbers and introduces unsupported details. The ground truth explicitly notes 'the filings do not explicitly state that security measures directly enabled infrastructure expansion,' which the LLM's confident assertion about 'deliberately aligning' and 'embedding robust controls' may overstate. (5) SEMANTIC ISSUES: The phrase 'basic cyber-security program' in the LLM answer mischaracterizes the ground truth, which describes a 'robust program' from 2022 onward, not a basic one that evolved. The LLM's answer suggests a more dramatic evolution than the ground truth supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 591,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s FY 2022, 2023, and 2024 10‑K filings all list the same third supplemental indenture (Exhibit 4.6) that contains 4.000% Notes due 2021, but the company issued no new 4.000% Notes or altered that maturity in any of those years. The 4.000% Notes, which matured in 2021, remain referenced only as part of the historic indenture, showing that Microsoft has not pursued additional short‑term debt and instead relies on a long‑term, low‑rate debt structure—an indicator of a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates solid understanding of Microsoft's debt management pattern. STRENGTHS: (1) Correctly identifies that the 4.000% Notes due 2021 were referenced consistently across FY 2022, 2023, and 2024; (2) Accurately notes the Third Supplemental Indenture (Exhibit 4.6) appeared in all three years; (3) Correctly states the notes matured in 2021 and were past maturity by the fiscal years in question; (4) Properly synthesizes the multi-hop information showing no new issuances of these notes; (5) Accurately concludes this reflects a disciplined, long-term debt management strategy. MINOR WEAKNESSES: (1) The LLM states 'no new 4.000% Notes or altered that maturity in any of those years' which is accurate but slightly awkwardly phrased; (2) The answer could have been more explicit about the 'delayed settlement, rollover, or ongoing disclosure requirement' possibilities mentioned in the ground truth, though the LLM's interpretation (historic indenture reference) is reasonable; (3) The LLM characterizes the notes as 'short-term debt' in the context of 2022-2024 (when they were already past maturity), which is technically accurate but could be clearer. QUANTITATIVE VERIFICATION: All dates are correct (2021 maturity, 2022-2024 fiscal years, May 18, 2009 indenture date from ground truth context). The 4.000% rate is correctly stated. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of consistent disclosure without new issuances. The connection to debt management strategy is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis (focusing on 'no new issuances' rather than 'post-maturity disclosure') but both interpretations are valid and complementary.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 517,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated inclusion of the 1.500% Note due 2030 in its 2020, 2022, 2023 and 2024 10‑Ks (the 2020 Officers’ Certificate is incorporated in each filing) signals that the company treats this mid‑term, moderate‑rate debt as a core, stable part of its long‑term capital structure [page_75, page_72, page_76].  Compared with the very short‑term, low‑coupon notes (0.4‑0.8% due 2023‑2025) and the longer‑term, higher‑coupon notes (2.5‑4.9% due 2050‑2060), the 1.5% Note offers a balanced cost‑duration profile, helping Amazon smooth interest expense and lock in predictable financing for the near future [page_75].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) YEAR DISCREPANCY - LLM claims the 1.500% Note appears in 2020 filings, but ground truth explicitly states it was 'introduced' in 2022 and referenced in 2022, 2023, and 2024 filings. The 2020 reference is factually incorrect and contradicts the ground truth timeline. (2) COUPON RATE MISCHARACTERIZATION - LLM describes the 1.500% Note as 'moderate-rate debt' and claims it offers a 'balanced cost-duration profile' between 'very short-term, low-coupon notes (0.4-0.8%)' and 'longer-term, higher-coupon notes (2.5-4.9%)'. However, ground truth indicates the 1.500% Note is actually LOW-COST capital from earlier issuances, not moderate-rate. The comparison framework is inverted. (3) INCOMPLETE SYNTHESIS - LLM fails to capture the key strategic insight from ground truth: that Amazon was simultaneously managing near-term obligations (4.700% Note due 2024) while maintaining long-term presence, and later adapting to higher market rates (4.700% Note due 2032). The ground truth emphasizes the LAYERED maturity profile and refinancing risk mitigation across multiple instruments and years. (4) MISSING CONTEXT - LLM does not adequately explain the strategic evolution across the three-year period (2022-2024) or how Amazon's approach changed as market conditions shifted. CORRECT ELEMENTS: The LLM correctly identifies that the 1.500% Note is part of Amazon's long-term capital structure strategy and that it serves a balancing function relative to other debt instruments. The general concept of smoothing interest expense is directionally correct. However, the factual errors regarding the 2020 inclusion and the mischaracterization of the note's cost position relative to other instruments are significant enough to substantially undermine the answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 485,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2024, AT&T maintained a 41.3 % equity stake in SKY Mexico, accounting for it under the equity method until the June 2024 sale that eliminated the investment and the equity‑method recognition (page 94; page 66). The 2024 10‑K confirms the disposition and the end of equity‑method accounting for SKY Mexico, while the 2022 10‑K notes the stake and equity‑method treatment (page 94; page 66). This three‑year trajectory, coupled with the earlier Vrio sale in 2021, underscores AT&T’s systematic divestiture of international pay‑TV assets as it refocuses on its core wireless and broadband businesses (page 94).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key facts: (1) AT&T's 41.3% ownership stake in SKY Mexico is accurate; (2) the June 2024 sale date is correct; (3) equity method accounting treatment is properly identified; (4) the reference to the earlier Vrio sale in 2021 correctly contextualizes the divestiture strategy. The multi-hop synthesis across 2022-2024 is sound, connecting the ownership stake, accounting treatment, and eventual exit. The answer correctly identifies the strategic rationale (refocusing on core U.S. telecommunications). However, there are minor gaps: (1) The LLM answer does not explicitly confirm the 2023 equity method accounting treatment as a distinct year-by-year progression (though it implies continuity); (2) The answer could have been more explicit about the 2022 post-Vrio positioning statement mentioned in the ground truth; (3) The phrasing 'June 2024 sale' is correct but the ground truth uses 'mid-2024' which is semantically equivalent. The page citations provided (page 94, page 66) appear to be references but cannot be independently verified from the question context. The answer successfully synthesizes the three-year trajectory and connects it to broader divestiture strategy, demonstrating solid multi-hop reasoning. The core narrative matches the ground truth: phased exit from international pay-TV assets aligned with strategic refocusing. Minor semantic differences in presentation do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 415,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—outlined in each filing—lowers the share of return‑seeking (equity) assets as the plan’s funded ratio improves, shifting toward liability‑hedging fixed‑maturity securities.  The target allocation changed from 15 % equity/75 % fixed/10 % other in 2022 (page 310) to 8 % equity/77 % fixed/15 % other in 2023 (page 252), and then to 9 % equity/80 % fixed/11 % other in 2024 (page 182).  This progression reflects a gradual de‑risking of the U.S. pension portfolio in response to a stronger funded status, with the modest equity rebound in 2024 likely reflecting a small shift in funding or interest‑rate assumptions (glide‑path description on page 184).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable allocation percentages across the three years. The quantitative data (15%/75%/10% for 2022, 8%/77%/15% for 2023, and 9%/80%/11% for 2024) is presented clearly with page references, showing concrete evidence of the de-risking progression. The answer correctly identifies the core de-risking strategy and explains the mechanism (reducing equity/growth assets while increasing fixed-maturity/liability-hedging assets as funded status improves). The multi-hop reasoning is sound: it synthesizes the glide path evolution across three years and connects this to the underlying funded status improvement. The observation about the modest 2024 equity rebound and its potential connection to funding/interest-rate assumptions adds nuanced interpretation. However, the answer could be slightly more explicit about the temporal relationship between funded status measurements and target allocations (e.g., that 2024 targets are based on 2023 funded status), which the ground truth emphasizes. The answer also doesn't explicitly state that each year's target allocation is based on the prior year-end funded status, though this is implied. The semantic equivalence is strong—the LLM captures the essence of AIG's liability-driven investing principles and methodical de-risking approach. Minor weakness: the answer doesn't explicitly reference the glide path as a formal policy mechanism tied to funded status thresholds, though it describes the mechanism accurately. Overall, this is a high-quality answer that correctly synthesizes multi-year pension allocation data and explains the strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 456,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard has scaled its credit‑risk buffers for settlement exposure from $9.2 billion in 2022 to $13.5 billion in 2024, while its qualified cash settlement fund and accrued MDL liabilities rose in tandem with growing litigation and regulatory scrutiny. The company continues to require cash collateral, letters of credit and guarantees for customers that fall outside its risk standards, and it has kept risk‑mitigation arrangements for Mastercard‑branded travelers cheques stable at roughly $272 million. These adjustments demonstrate Mastercard’s agile risk‑management framework, expanding its credit‑risk safeguards and monitoring practices to meet escalating legal and regulatory pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported quantitative claims that are not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($9.2 billion in 2022 to $13.5 billion in 2024 for settlement exposure, $272 million for travelers cheques) that are not mentioned in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be fabricated or hallucinated. (2) MISSING CRITICAL CONTEXT: The LLM completely omits the specific regulatory and litigation events that are central to the ground truth answer - the FTC's finalized consent agreement (2023), DOJ antitrust investigation into U.S. debit program (2023), U.S. Liability Shift Litigation (2024), and European Commission investigation (2024). These are essential to understanding how Mastercard's risk management evolved in response to specific pressures. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'in response to increasing regulatory scrutiny and litigation risks' - the ground truth properly connects specific regulatory events to strategic responses, while the LLM provides generic statements about 'escalating legal and regulatory pressures' without substantive connection. (4) CORE FRAMEWORK MISREPRESENTATION: The ground truth emphasizes that Mastercard 'maintained a consistent framework' while the context changed - the LLM incorrectly frames this as 'scaling' and 'expanding' buffers, suggesting more dramatic changes than the ground truth supports. (5) MISSING KEY INSIGHT: The ground truth's important conclusion that 'losses from customer settlement failures remained low across all three years' - indicating core strategies remained effective - is absent from the LLM answer. The LLM answer reads as if it contains specific financial data but lacks grounding in the actual filing information provided in the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 526,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "Home Depot’s equity‑award pool shrank markedly: the 2022 10‑K reported about **117 million shares** available for future grants under the 2005 Plan (page 68); the 2023 10‑K shows the amended Omnibus Plan authorizes **80 million shares** (plus up to 10 million from outstanding awards) (page 65); by January 2024 the available pool had fallen to roughly **77 million shares** (page 67). This downward trend signals a more conservative, performance‑driven equity‑compensation strategy aimed at limiting dilution and aligning awards with shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall downward trend in available shares and provides reasonable interpretation of the strategic implications (equity incentives, dilution concerns). The answer demonstrates multi-hop synthesis across multiple years and documents. The qualitative reasoning about performance-driven strategy and shareholder alignment is sound and relevant.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) 2023 figure is significantly wrong: LLM states '80 million shares (plus up to 10 million from outstanding awards)' but ground truth shows 77 million shares as of January 28, 2024. The LLM appears to conflate authorization amounts with available shares. (2) The LLM then contradicts itself by stating 'by January 2024 the available pool had fallen to roughly 77 million shares' - this creates internal inconsistency and suggests confusion about the 2023 vs 2024 figures.\n\nMISSING INFORMATION: The LLM fails to address the 2024 data point (70 million shares as of February 2, 2025) that was explicitly mentioned in the ground truth. The question asks about evolution from 2022 to 2024, and the LLM only covers through early 2024, missing the final year's data.\n\nMULTI-HOP REASONING: While the LLM attempts to synthesize across years, the quantitative errors undermine the reliability of the trend analysis. The reasoning about strategy implications is sound but based on incomplete/inaccurate data.\n\nSEMANTIC ISSUES: The interpretation of the trend as 'conservative' and 'limiting dilution' differs from the ground truth's characterization of 'increased reliance on equity incentives' - these represent different strategic conclusions from the same data trend.\n\nVERIFICATION: 2022: 117M ✓ correct; 2023: 77M (not 80M) ✗ incorrect; 2024: 70M ✗ missing entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 489,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom had no 3.625% notes due October 2024 outstanding in FY 2022.  In FY 2023 the note was outstanding at $622 million (effective interest rate 3.98 %【page_81】).  By FY 2024 the note had matured/been repaid, leaving zero principal outstanding【page_81】.  This pattern shows a disciplined short‑term debt strategy—issuing the note and then repaying it before maturity to keep long‑term debt exposure low and manage interest costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains fundamental contradictions with the ground truth that severely undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 'Broadcom had no 3.625% notes due October 2024 outstanding in FY 2022' but the ground truth explicitly states the obligation was $622 million in FY 2022. This is a direct contradiction of a key factual claim. The LLM then correctly identifies $622 million for FY 2023, but this creates an internal inconsistency - if there were no notes in FY 2022, where did the $622 million in FY 2023 come from? (2) MULTI-HOP REASONING FAILURE: The LLM's narrative about 'issuing the note' in FY 2023 and then repaying it by FY 2024 contradicts the ground truth progression which shows the note existed at $622 million in both FY 2022 and FY 2023, then was repaid by FY 2024. The LLM fundamentally mischaracterized the timeline and nature of the debt instrument. (3) DEBT MANAGEMENT STRATEGY MISINTERPRETATION: The ground truth indicates a 'deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date' - showing the company held the debt for two years then paid it off before maturity. The LLM's characterization of 'issuing the note and then repaying it' suggests a different timeline that doesn't match the actual progression. (4) SEMANTIC ISSUES: While the LLM correctly identifies the FY 2024 repayment and mentions the effective interest rate (3.98%), these minor correct details cannot offset the major factual error about FY 2022. The answer demonstrates a fundamental failure to accurately synthesize the multi-year progression of this specific debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 477,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T’s relationship with Time Warner began with the 2018 acquisition, which was integrated into its WarnerMedia segment [page_4]. In 2022, AT&T planned and executed a divestiture via a Reverse Morris Trust with Discovery, effectively exiting the business and classifying it as a discontinued operation [page_4][page_6]. By 2024 the company no longer holds any WarnerMedia assets and its 10‑K focuses on 5G, fiber and network infrastructure, underscoring a strategic pivot from entertainment to core telecommunications services [page_5].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND FACTS: The LLM answer contains a major factual error regarding the timing of the WarnerMedia divestiture. The ground truth states the Reverse Morris Trust transaction with Discovery was completed in 2023, but the LLM claims it was 'planned and executed' in 2022. This is a significant chronological error that fundamentally misrepresents the evolution of T's strategic relationship. MISSING KEY INFORMATION: The LLM answer fails to adequately address the 2024 DIRECTV exit to TPG, which is explicitly mentioned in the ground truth as 'finalizing its exit from the entertainment sector' and representing 'a full retreat from the media investments.' The LLM only vaguely states 'by 2024 the company no longer holds any WarnerMedia assets' without discussing the DIRECTV divestiture, which is a critical component of the multi-year strategic progression. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 through 2024' with specific focus on 'integration, divestiture planning, and final exit strategy.' The LLM answer conflates 2022 and 2023 events, fails to clearly delineate the three-year progression, and doesn't adequately explain the strategic reversal from vertical integration (2018 acquisition) through separation (2023) to complete exit (2024). PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies the 2018 Time Warner acquisition, the Reverse Morris Trust structure with Discovery, the classification as discontinued operation, and the strategic pivot toward telecommunications. However, these correct elements are undermined by the timeline error and incomplete coverage of the DIRECTV exit. The semantic understanding of the strategic shift is present but the factual execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 481,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson positioned its Pipe Cutters as part of the Safety & Productivity segment’s pipe‑working tools, noting their use with battery‑hydraulic press‑connection tools and diagnostic systems such as sewer‑inspection cameras (page 9). By 2023‑24 the positioning remained unchanged, but the description broadened to highlight battery‑hydraulic tools for cutting and crimping electrical cable and a wider range of diagnostic equipment, underscoring a continued emphasis on portable, battery‑powered, tech‑enabled tools across the segment (page 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) TIMELINE CONTRADICTION: The ground truth clearly states that in 2022, Pipe Cutters were 'standalone tools' with NO mention of battery-hydraulic integration. The LLM incorrectly claims that in 2022 they were already 'positioned...with battery-hydraulic press-connection tools and diagnostic systems.' This is a fundamental misrepresentation of the 2022 positioning. (2) EVOLUTION MISCHARACTERIZATION: The ground truth emphasizes a clear EVOLUTION from 2022 (standalone) → 2023 (battery-hydraulic integration introduced) → 2024 (broader ecosystem with diagnostics). The LLM claims 'positioning remained unchanged' from 2023-24, which contradicts the ground truth's narrative of continued strategic evolution. (3) PRODUCT SCOPE ERROR: The LLM introduces 'cutting and crimping electrical cable' which is not mentioned in the ground truth and appears to be an incorrect product category for Pipe Cutters in the Safety & Productivity segment. (4) MISSING KEY INSIGHT: The LLM fails to capture the strategic progression that is central to the ground truth - the shift from standalone tools to integrated smart tooling solutions. (5) PAGE REFERENCES: The LLM cites specific pages (9, 73) but these cannot be verified against the ground truth, and the content described doesn't align with the documented evolution. The answer demonstrates poor multi-hop synthesis and misses the core narrative of product line evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 427,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson has maintained a **multi‑year, enterprise‑wide initiative** that “integrates, simplifies and standardizes processes and systems for the human resources, information technology, procurement, supply chain and finance functions” to grow its financial shared‑service capabilities and standardize financial systems (2022 page 117; 2023 page 118; 2024 page 119). The unchanged wording across the 2022‑24 filings shows a sustained, proactive commitment to standardizing financial processes, underscoring the company’s strategic priority of improving efficiency, consistency and control in its global financial operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative spanning 2022-2024; (2) Accurately quotes the standardization language ('integrates, simplifies and standardizes processes and systems'); (3) Correctly identifies the functional areas (HR, IT, procurement, supply chain, finance); (4) Properly synthesizes the consistent messaging across three years; (5) Correctly interprets this consistency as indicating strategic commitment to process optimization; (6) Page citations (117, 118, 119) are appropriately referenced and appear reasonable for 10-K filings. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth and omits some contextual nuance - specifically, it doesn't explicitly mention that in 2022 the company emphasized this was 'not in response to any internal control deficiencies,' which is an important clarification in the original answer; (2) The ground truth provides slightly more detailed year-by-year progression narrative ('reiterated,' 'affirming commitment,' 'maintained the same narrative') whereas the LLM uses 'unchanged wording' which is accurate but less granular; (3) The ground truth emphasizes 'foundational to operational efficiency and control framework' while the LLM says 'improving efficiency, consistency and control' - semantically similar but slightly different emphasis. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and draws the appropriate conclusion about strategic intent from consistent messaging. The logic is sound. QUANTITATIVE ACCURACY: No calculations or specific numbers are required for this question, so this dimension is less critical, but the year references (2022-2024) and page numbers are correct. Overall, this is a strong answer that captures the essential information and reasoning, with only minor omissions of contextual detail that don't fundamentally undermine the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 544,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "In FY 2022, FY 2023, and FY 2024 Costco’s 10‑K lists the Executive Health Plan as Exhibit 10.1* and files it with the 10‑K itself (no separate filing) – the exhibit’s “Form” column is “10‑K” and the original filing date remains 10/19/2012 (COST_10k_2022 p. 66; COST_10k_2023 p. 66; COST_10k_2024 p. 66). The unchanged filing status shows Costco’s continued commitment to a stable, long‑term executive benefits program and consistent disclosure of its terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All numeric values are correct - the filing date of 10/19/2012 is accurate, and the fiscal years 2022, 2023, 2024 are correctly identified. (2) The exhibit designation (Exhibit 10.1*) matches the ground truth. (3) The multi-hop synthesis is sound - the answer correctly traces the Executive Health Plan's consistent disclosure across three fiscal years and draws the appropriate conclusion about stable executive benefit strategy. (4) The page references (p. 66 for all three years) provide specific sourcing. (5) The semantic meaning aligns perfectly with the ground truth: both identify consistency in filing status, the same original filing date, and interpret this as indicating no material updates and a stable long-term strategy. MINOR CONSIDERATIONS: (1) The LLM answer adds the detail that the exhibit is filed 'with the 10-K itself (no separate filing)' and notes the 'Form' column shows '10-K' - this is a reasonable inference about filing status that adds clarity, though the ground truth doesn't explicitly state this. (2) The ground truth mentions the 'Period Ended' date of September 2, 2012, which the LLM answer does not explicitly reference, though this is a minor omission that doesn't affect the core conclusion. (3) The LLM answer's phrasing about 'continued commitment' and 'consistent disclosure of its terms' is semantically equivalent to the ground truth's statement about 'stable long-term executive benefit strategy without structural changes.' Overall, the answer demonstrates strong multi-hop reasoning across three fiscal years and correctly synthesizes the disclosure pattern into a meaningful strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 468,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A shares retained the same voting structure—one vote per share and dividend rights—while the quarterly cash dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (2022 page 98; 2023 page 99; 2024 page 94). This consistency shows a shareholder‑friendly governance strategy that preserves equal voting influence for Class A holders while steadily enhancing dividend payouts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that dividend and voting rights remained 'identical' across all three years with 'standard dividend rights'—it does NOT mention increasing quarterly cash dividends per share. The LLM appears to have fabricated or confused dividend payment amounts with the structural rights of the shares themselves. The question asks about how 'dividend and voting rights associated with MA's A Class Shares evolved,' and the ground truth answer clarifies that these rights did NOT evolve—they remained constant. The LLM fundamentally misinterprets the question by conflating the actual dividend payments made (which may have increased) with the structural dividend rights of the share class (which remained unchanged). Additionally, the LLM provides specific page citations (2022 page 98, 2023 page 99, 2024 page 94) that cannot be verified against the ground truth and appear to be hallucinated. The core governance insight from the ground truth—that MA maintained a 'stable and unchanging governance strategy'—is contradicted by the LLM's narrative of 'steadily enhancing dividend payouts.' While the LLM correctly identifies the one vote per share structure, it fundamentally misses the key finding that the rights themselves (not the amounts paid) remained consistent, which is the entire point of the ground truth answer regarding governance strategy stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 431,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform continued to provide the same core capabilities across FY 2022, 2023 and 2024: it rapidly interprets mainframe security posture, identifies risks and generates remediation steps that can be fed into customers’ in‑house SIEM tools. The 10‑K descriptions for all three years are identical, indicating no significant evolution in its integration with in‑house security tools or its risk‑identification functionality (page_11, 2022; page_11, 2023; page_11, 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Strengths: (1) Correctly identifies the three fiscal years (2022, 2023, 2024) and accurately conveys that the platform's core functionality remained consistent across all three years; (2) Accurately describes the platform's key capabilities: assessing mainframe security posture, identifying risks, and generating remediation steps; (3) Correctly notes that descriptions were identical across the three years, indicating no significant evolution; (4) Properly cites page references (page_11 for all three years); (5) Accurately identifies SIEM tools as the in-house security tool integration point. Minor considerations: (1) The LLM answer uses slightly more specific language ('rapidly interprets,' 'generates remediation steps') compared to the ground truth's more general phrasing ('assessing,' 'identifying risks'), though this is semantically equivalent and not incorrect; (2) The ground truth mentions 'ongoing and ad hoc remediation planning' as a 2023 distinction, which the LLM answer doesn't explicitly highlight, though the LLM's statement that descriptions were 'identical' across years is consistent with the ground truth's overall conclusion of stable functionality; (3) The LLM answer is more direct in stating 'no significant evolution' while the ground truth uses softer language like 'suggesting a mature and well-defined offering,' but both convey the same core finding. The multi-hop reasoning is sound—the answer correctly synthesizes information across three fiscal years and identifies the consistent nature of the platform's capabilities. No numerical errors or calculation issues present. The answer directly addresses the question about evolution (or lack thereof) in integration and risk identification capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 489,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 to 2024 AIG continued to use internal controls, oversight and third‑party catastrophe models to estimate loss reserves, but the 2023 and 2024 filings added explicit review‑and‑challenge procedures, escalation paths, actuarial profitability and reserve reviews, and experience‑monitoring updates to assess adequacy (2023 10‑K, pp. 119‑120; 2024 10‑K, pp. 86‑88). Across all three years, external experts consistently reviewed and validated reserve estimates, providing independent oversight of the reserve‑setting process (2022 10‑K, pp. 165‑169; 2023 10‑K, pp. 119‑120; 2024 10‑K, pp. 86‑88). Thus, the methodology evolved from a general internal‑control framework in 2022 to a more structured, transparent, and review‑centric approach by 2023 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures the key methodological shifts: from general internal controls (2022) to more structured, review-centric approaches (2023-2024); (3) Properly identifies specific mechanisms introduced: review-and-challenge procedures, escalation paths, actuarial profitability and reserve reviews, experience-monitoring updates; (4) Correctly emphasizes the consistent role of external experts across all three years; (5) Provides specific page citations that appear reasonable for 10-K filings; (6) Demonstrates sound multi-hop reasoning by synthesizing information across three separate annual filings. MINOR WEAKNESSES: (1) The LLM answer mentions 'third-party catastrophe models' which is not explicitly mentioned in the ground truth - this is a reasonable inference but adds detail not confirmed in the original answer; (2) The ground truth specifically mentions 'stochastic and deterministic' modeling techniques in 2023, which the LLM answer does not explicitly reference, though it does mention 'detailed modeling techniques' more generally; (3) The ground truth specifically mentions 'ERM second-line reviews' in 2024, which the LLM answer does not explicitly call out, though it does reference enhanced oversight structures. QUANTITATIVE ACCURACY: No numerical errors detected. Page citations appear plausible though cannot be independently verified. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential narrative as the ground truth - progressive maturation of AIG's loss reserve risk management framework with increasing formalization and external validation. The core message about evolution from basic controls to structured, transparent, review-centric processes is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 520,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s Industrial Solutions product offering has consistently included electrical distribution equipment across 2022‑2024 (see page 76 for 2022 and page 73 for 2023‑2024). In each filing the same product is also highlighted as a core element of the Discrete Automation segment—listed alongside solenoid valves, pneumatic actuators and linear‑motion solutions (page 73). The segment’s sales remained stable (2022 $2,612 M, 2023 $2,635 M, 2024 $2,506 M) (page 75), underscoring Emerson’s deliberate emphasis on discrete‑automation markets where electrical distribution equipment is a key enabler.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM answer directly contradicts the ground truth on the core claim. Ground truth states that in 2023, Electrical Distribution Equipment was REORGANIZED/MOVED from Industrial Solutions to the Discrete Automation segment. The LLM claims it was 'consistently included' in Industrial Solutions across 2022-2024 and 'also highlighted' in Discrete Automation in each filing. This is fundamentally incorrect—the ground truth explicitly describes a reorganization/shift between segments, not a consistent dual positioning. (2) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key strategic evolution described in the ground truth: the deliberate 3-year shift showing movement FROM Industrial Solutions (2022) TO Discrete Automation (2023-2024), with deepening integration. The LLM presents this as static consistency rather than dynamic repositioning. (3) QUANTITATIVE ISSUES: While the LLM provides segment sales figures ($2,612M, $2,635M, $2,506M for 2022-2024), these cannot be verified against the ground truth, which does not provide specific sales numbers. The inclusion of unverified numbers without ground truth confirmation is problematic. (4) MISSING STRATEGIC CONTEXT: The ground truth emphasizes 'deliberate shift' and 'deepening strategic focus' with specific product groupings evolving (from fluid control/materials joining in 2022 to solenoid valves/programmable systems in 2023 to electric linear motion/programmable control in 2024). The LLM mentions some products but misses the evolution of product groupings and strategic emphasis. (5) MULTI-HOP REASONING FAILURE: The question requires synthesizing how positioning evolved across three years and what this reveals strategically. The LLM fails the synthesis by presenting a static picture rather than the dynamic evolution. The core error is claiming consistency where the ground truth describes reorganization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 525,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s pension structure has not changed through 2024 – the company continues to operate a dual‑formula system (Final Average Pay for hires before 2015 and Retirement Value for hires after 2014) and the 2021 amendment that will bring all eligible U.S. non‑union employees under the Retirement Value formula is still scheduled to take effect on Jan 1 2026【page_73】【page_77】.  The 2022‑2024 filings simply confirm that the transition remains pending and that benefit obligations and plan assets are being adjusted in anticipation of the change.  This multi‑year rollout reflects a long‑term strategy to standardize and simplify pension benefits, align them with total compensation, and manage pension liabilities more predictably for the workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. Key strengths: (1) All dates are correct - the January 1, 2026 effective date is accurately stated, and the 2022-2024 timeframe is properly addressed; (2) The dual-formula system description is accurate (Final Average Pay for pre-2015 hires, Retirement Value for post-2014 hires); (3) The core finding that the transition remains pending through 2024 with consistent messaging across all three years aligns with the ground truth; (4) The multi-hop reasoning correctly synthesizes information across multiple years to identify the strategic pattern of consistent communication about the pending change. The LLM properly identifies this as a long-term workforce strategy focused on standardization, cost predictability, and alignment with total compensation. Minor differences from ground truth: (1) The LLM uses slightly different phrasing ('dual-formula system' vs. the ground truth's description of 'preserving Final Average Pay formula benefits accrued before 2026'), but both convey the same structural reality; (2) The LLM emphasizes the 'pending' nature of the transition more explicitly, while ground truth emphasizes the 'consistent messaging' aspect - both are valid interpretations of the same underlying facts; (3) The LLM references specific page numbers (73, 77) which adds credibility but cannot be verified against the ground truth. The answer correctly identifies that no reversal or delay occurred, maintains the same structural description across years, and articulates the strategic implications regarding workforce inclusivity and cost management. The reasoning is sound and the synthesis across the three-year period is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 470,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from **$25.7 billion** at December 31 2022 (Table 8.1, page 178) to **$31.2 billion** at December 31 2023 (Table 8.2, page 179), then fell modestly to **$30.7 billion** at December 31 2024 (Table 9.1, page 188). The pattern—an increase followed by a slight decline—suggests the company has been using notes to fund growth and refinance, while the 2024 dip indicates a gradual debt‑reduction or refinancing effort to manage leverage and interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) 2022 VALUE: LLM states $25.7 billion, but ground truth shows $27,219 million ($27.219 billion) - a $1.5 billion understatement. (2) 2023 VALUE: LLM states $31.2 billion, ground truth shows $31,248 million ($31.248 billion) - this is approximately correct with minor rounding. (3) 2024 VALUE: LLM states $30.7 billion, but ground truth shows $31,248 million - a critical error of $548 million. The ground truth indicates the 2024 value remained at the 2023 peak of $31,248 million, NOT a decline to $30.7 billion. (4) TREND ANALYSIS: The LLM incorrectly characterizes the trend as 'increase followed by a slight decline,' when the ground truth shows a consistent upward trend from 2022 to 2024 with no decline. The 2024 figure matches 2023, not a reduction. (5) STRATEGIC INTERPRETATION: The LLM's conclusion about 'debt-reduction or refinancing effort' in 2024 is unsupported by the actual data, which shows stable/maintained debt levels at the higher 2023-2024 plateau. The ground truth interpretation of 'general upward trend' and 'strategic shift toward issuing more senior and subordinated notes' is more accurate. The LLM demonstrates reasonable multi-hop reasoning structure and addresses the question format appropriately, but the fundamental numerical errors (particularly the 2022 and 2024 figures) and resulting mischaracterization of the trend are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 432,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "From 2022 through 2024 AT&T maintained a 41.3 % equity‑method investment in SKY Mexico (page 93), recognizing its share of net income and distributions under the equity method (page 66). In June 2024 the company sold that stake, terminating the equity‑method accounting and removing the investment from its balance sheet (page 64). This three‑year pattern—holding a significant minority stake, accounting for it via the equity method, then divesting the asset—illustrates AT&T’s broader strategy to systematically exit Latin American pay‑TV holdings and refocus on core or streaming businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All quantitative data correct - 41.3% ownership stake accurately stated, June 2024 exit date correct, equity method accounting properly identified. (2) Multi-hop reasoning sound - correctly synthesizes the three-year trajectory (2022-2024) showing holding period, equity method treatment, then divestiture. (3) Entity identification accurate - correctly identifies AT&T (T), SKY Mexico, and the equity method accounting treatment. (4) Strategic interpretation valid - correctly characterizes this as part of AT&T's broader divestiture strategy in Latin American pay-TV. (5) Page citations provided add credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the specific mention of DIRECTV and Gigapower as comparable equity method investments in 2023, though this is not essential to answering the core question. (2) The phrase 'refocus on core or streaming businesses' is a reasonable inference but slightly broader than the ground truth's 'focus on core domestic operations' - however, both convey the same strategic intent. (3) The LLM correctly notes the removal from balance sheet upon sale, which adds useful detail. The answer fully addresses all parts of the multi-part question: ownership stake evolution (41.3% maintained), equity method accounting treatment (properly identified and explained), eventual exit (June 2024 sale), and strategic implications (Latin American pay-TV divestiture strategy). No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 442,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures about limits on capital returns to shareholders stayed essentially the same.  Each filing repeatedly stated that the Board’s discretion and U.S. banking laws—specifically capital‑planning rules, Delaware law, and the requirement to pay full and timely dividends on preferred stock—can restrict capital distributions, and that failing to meet “well‑capitalized” and “well‑managed” regulatory standards or other capital‑adequacy and liquidity rules could further limit activities.  No new regulatory or dividend‑policy language was added in the 2024 filing beyond what was already disclosed in 2022 and 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how BNY Mellon's disclosures EVOLVED from 2022 to 2024. CRITICAL ERRORS: (1) The LLM claims 'No new regulatory or dividend-policy language was added in the 2024 filing beyond what was already disclosed in 2022 and 2023,' which directly contradicts the ground truth that shows clear evolution and expansion of disclosures. The ground truth explicitly states that by 2023 'the firm expanded its risk discussion to include ESG-related regulatory pressures' and by 2024 there was 'additional emphasis on the Parent company's reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning.' (2) The LLM's characterization of disclosures as 'essentially the same' across all three years misses the documented trend of 'increasing contextual complexity around capital return limitations.' WHAT WAS CORRECT: The LLM accurately identified the core regulatory constraints (capital adequacy rules, Delaware law, preferred dividend requirements, 'well-capitalized' and 'well-managed' standards) that remained consistent across the period. The identification of these regulatory elements is factually accurate. MULTI-HOP REASONING FAILURE: The question asks specifically about how disclosures EVOLVED - requiring comparison across three years and identification of changes. The LLM failed to synthesize the documented evolution: it acknowledged consistency in core regulatory framework but missed the documented expansion of contextual factors (ESG pressures, strategic initiatives, subsidiary dividend reliance, liquidity impacts). This is a fundamental failure to address the 'evolution' aspect of the multi-part question. QUANTITATIVE ACCURACY: No specific numbers were required or provided, so this scores well (8) for not introducing false data. QUALITATIVE ACCURACY: Poor (4) because the LLM's core conclusion contradicts the ground truth's documented evolution. The answer reads as a static description rather than a dynamic analysis of change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 563,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "3M kept structural adhesives within its Safety and Industrial segment throughout 2022‑2024, but the 2024 filing shows the former Industrial Adhesive & Tapes division was merged into a newly created Industrial Specialties division that also houses closure systems and personal‑safety products【page_110】.  The shift from a standalone adhesive‑tape grouping to a broader “industrial specialties” bundle signals that 3M views adhesives as a core, cross‑cutting technology that underpins integrated industrial solutions—providing structural integrity and bonding across metalworking, automotive, construction and safety markets【page_131】【page_107】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual discrepancies with the ground truth that warrant a below-average score.\n\nCORRECT ELEMENTS:\n- Correctly identifies that Structural Adhesives remained in the Safety and Industrial segment throughout 2022-2024\n- Correctly notes a strategic shift in positioning from standalone to integrated offerings\n- Appropriately interprets adhesives as a cross-cutting technology\n- Correctly identifies the time period (2022-2024)\n\nMAJOR ISSUES:\n1. FACTUAL INACCURACY - Divisional Reorganization: The LLM claims \"the former Industrial Adhesive & Tapes division was merged into a newly created Industrial Specialties division.\" The ground truth makes no mention of such a divisional merger or creation of an \"Industrial Specialties division.\" This is a significant structural claim that cannot be verified against the ground truth and appears to be fabricated or misinterpreted.\n\n2. INCOMPLETE EVOLUTION NARRATIVE: The ground truth provides a year-by-year evolution (2022 → 2023 → 2024) showing specific product groupings and how they shifted. The LLM answer collapses this into a binary before/after comparison without capturing the 2023 intermediate positioning or the specific product adjacencies mentioned (industrial abrasives, autobody repair, electrical materials in 2022; packaging/closure systems emphasis in 2023; specialized industrial applications in 2024).\n\n3. MISSING CONTEXTUAL DETAILS: The ground truth emphasizes integration with \"metalworking and OEM electrical markets\" (2022) and a shift toward \"construction and maintenance\" applications (2024). The LLM mentions these markets but doesn't capture the specific evolution of market focus.\n\n4. CITATION ISSUES: The LLM provides page references (page_110, page_131, page_107) but these cannot be verified against the ground truth, which doesn't specify page numbers. The specific claim about \"Industrial Adhesive & Tapes division\" being merged lacks grounding in the provided ground truth.\n\n5. MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing structural claims (divisional merger) not present in the ground truth, which undermines the reliability of the synthesis.\n\nQUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is neutral. However, the structural claims about divisional reorganization are factually unverifiable.\n\nQUALITATIVE ACCURACY: The reasoning about adhesives as a \"cross-cutting technology\" is sound and aligns with the ground truth's conclusion. However, the specific mechanism (divisional merger) is not supported.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about evolution and strategic role, but introduces unsupported claims that reduce relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 752,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From its 2022 10‑K, Lilly positioned Cyramza as a second‑line therapy for advanced gastric cancer, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated NSCLC (page 5). The 2023 filing’s IP table shows the compound patents expire in 2026 in the U.S. and Japan and 2028 in major European markets, with data protection ending in 2026 (U.S.), 2024 (Europe) and 2023 (Japan) (page 11). The 2024 filing lists the same indications and the same patent schedule (page 6), indicating that Lilly has maintained a stable therapeutic positioning while relying on the existing patent and data‑protection portfolio to preserve exclusivity until those expiry dates in key global markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Cyramza's therapeutic positioning and IP protections, but contains significant factual discrepancies with the ground truth regarding data protection expiration dates. CORRECT ELEMENTS: (1) Therapeutic indications are accurately identified across 2022-2024 (gastric, lung, colorectal, liver cancers, EGFR-mutated NSCLC); (2) The core narrative of stable therapeutic positioning is sound; (3) The multi-hop synthesis across years is logically structured; (4) The focus on IP management as a strategic element is appropriate. CRITICAL ERRORS: (1) Data protection expiration dates are significantly misrepresented - LLM states Japan 2023, Europe 2024, U.S. 2026, which matches the ground truth; however, the LLM also states compound patents expire in 2026 (U.S./Japan) and 2028 (Europe), while ground truth indicates the data protection timeline is the primary strategic concern, not compound patent expiration; (2) The ground truth emphasizes that data protection expires in 2023 (Japan), 2024 (Europe), and 2026 (U.S.), which the LLM correctly states, but the LLM conflates this with compound patent expiration dates that appear to be different; (3) The LLM provides specific page references (pages 5, 11, 6) that cannot be verified against the ground truth, potentially indicating citation accuracy issues. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years (2022, 2023, 2024) and connects therapeutic positioning with IP strategy, which is appropriate for the question. However, the distinction between patent expiration and data protection expiration could be clearer. The answer demonstrates understanding that IP protection is central to Cyramza's strategic positioning through the 2024 period. QUANTITATIVE ACCURACY ISSUES: While the dates provided (2023, 2024, 2026 for data protection) align with ground truth, the introduction of separate patent expiration dates (2026 U.S./Japan, 2028 Europe) creates confusion about whether these are accurate or represent a misinterpretation of the source material. The ground truth focuses on data protection timelines as the strategic concern, not compound patent expiration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 592,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from **$19.98 bn at a 2.91 % weighted‑average rate in 2022** (page 186, 2022 10‑K) to **$27.17 bn at 4.45 % in 2023** (page 178, 2023 10‑K), then fell slightly to **$26.93 bn at 4.84 % in 2024** (page 186, 2024 10‑K). The jump in both carrying value and rate between 2022 and 2023 reflects a shift to larger, higher‑cost issuances, while the modest decline in 2024 carrying value amid a further rate rise suggests maturity‑management and refinancing activity that keeps the debt profile stable but signals rising financing costs in a tightening rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. Verification of key numbers: (1) 2022 carrying value of $19.98bn matches ground truth $19,975M (format variation acceptable); 2.91% rate matches exactly. (2) 2024 carrying value of $26.93bn matches ground truth $26,930M; 4.84% rate matches exactly. (3) The intermediate 2023 data point ($27.17bn at 4.45%) is provided but not in the ground truth answer, which only covers 2022-2024 endpoints. This additional data point is factually accurate and enhances the answer by showing the full three-year trajectory. The LLM correctly synthesized the multi-hop information: tracking both carrying value AND weighted-average interest rate across three fiscal years, identifying the trend pattern (increase 2022-2023, slight decline 2023-2024 in carrying value while rates continued rising), and providing sound reasoning about debt strategy implications. The interpretation that this reflects 'shift to larger, higher-cost issuances' and 'maturity-management and refinancing activity' is logically sound and consistent with the numerical trends. Minor note: The ground truth answer is more concise (2022-2024 endpoints only), while the LLM provides richer detail with the 2023 intermediate year, which adds value without contradicting the ground truth. All calculations are accurate, entity identification (Capital One, fixed unsecured senior debt, weighted-average interest rate) is correct, and the reasoning about financing costs in a tightening rate environment is appropriate and well-supported by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 437,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation increased each year: $651 million in FY 2022, $792 million in FY 2023, and $985 million in FY 2024 (page 92; page 91).  Net gains on the swaps were a loss of $92 million in 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024 (page 91).  This pattern shows that while the fair‑value swings were sizable, the instrument’s performance shifted from a negative to a positive outcome over the three‑year period, indicating moderate volatility with an overall upward trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - losses/gains of $92M (2022), $58M (2023), and $91M (2024) match the ground truth exactly. The notional exposure amounts ($651M, $792M, $985M) are additional data points not in the ground truth but appear to be accurate supplementary information from the filings. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) how the exposure evolved across three fiscal years, and (2) what the pattern reveals about volatility. The LLM provides more comprehensive information than the ground truth by including notional exposure amounts alongside the gains/losses. ENTITY ACCURACY: All entities are correct - Cisco, Total Return Swaps, Deferred Compensation, fiscal years 2022-2024. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the shift from loss to gains and characterizes the volatility pattern. The interpretation that this shows 'moderate volatility with an overall upward trend' is a reasonable characterization of the data, though slightly different from the ground truth's 'volatile financial impact.' SEMANTIC EQUIVALENCE: The core message aligns with ground truth - the instrument showed volatility, swinging from loss to gains. The LLM's additional context about notional exposure and the characterization of 'moderate volatility with upward trend' adds value without contradicting the ground truth. Minor difference: ground truth emphasizes 'notable loss' and 'consistent gains,' while LLM emphasizes the overall upward trend - both are valid interpretations of the same data pattern. Page references (91, 92) add credibility. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 476,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "Home Depot’s 2022 filing focused mainly on product assortment and merchandising, with little emphasis on store appearance. By 2024 the company had shifted to a strategic investment in store refresh packages, wayfinding signage, electronic shelf labels, curbside pickup and mobile‑app navigation (page 10, 2024), and reported that 50 % of U.S. online orders were fulfilled through a store in 2024 versus 55 % in 2023 (page 10, 2023), indicating that the enhanced in‑store experience helped maintain a strong channel and higher customer‑satisfaction scores, reinforcing its competitive positioning against multichannel and online rivals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM cites \"50% of U.S. online orders were fulfilled through a store in 2024 versus 55% in 2023\" but presents this backwards - the ground truth indicates the percentage DECREASED from 55% to 50%, yet the LLM frames this as supporting the argument that store enhancements helped maintain competitive positioning. This is a logical contradiction.\n   - The LLM provides specific page references (\"page 10, 2024\" and \"page 10, 2023\") that cannot be verified and appear to be fabricated citations.\n   - No actual financial metrics or measurable impacts are provided despite the question explicitly asking for \"measurable impact.\"\n\n2. FACTUAL INACCURACIES:\n   - The LLM claims 2022 filing \"focused mainly on product assortment and merchandising, with little emphasis on store appearance,\" directly contradicting the ground truth which states store appearance was \"a key component of its competitive strategy\" in 2022.\n   - The LLM introduces specific tactical elements (electronic shelf labels, curbside pickup, mobile-app navigation) not mentioned in the ground truth, suggesting either fabrication or unsupported extrapolation.\n   - The claim about \"higher customer-satisfaction scores\" is unsupported by any data in either the ground truth or the LLM answer.\n\n3. MULTI-HOP REASONING FAILURES:\n   - The LLM fails to properly synthesize the evolution across three years. The ground truth shows a clear progression: 2022 (standalone in-store), 2023 (integrated with digital), 2024 (fully omnichannel). The LLM presents a binary 2022-to-2024 comparison without capturing the 2023 transition.\n   - The LLM does not adequately address how store appearance specifically evolved in strategic emphasis, instead jumping to tactical implementations.\n\n4. SEMANTIC AND CONTEXTUAL ISSUES:\n   - The LLM's conclusion that \"enhanced in-store experience helped maintain a strong channel\" is contradicted by the declining fulfillment percentage (55% to 50%), making the reasoning internally inconsistent.\n   - The answer addresses \"competitive positioning\" but does not substantively explain HOW store appearance improvements specifically positioned Home Depot against \"multichannel and online retailers\" as requested.\n   - The ground truth emphasizes the strategic INTEGRATION of store appearance with digital capabilities (omnichannel), while the LLM treats them more as separate tactical initiatives.\n\n5. MISSING ELEMENTS:\n   - No discussion of how store appearance supported Pros and DIY customers differently.\n   - No mention of the shift from standalone to hybrid/interconnected retail model.\n   - No substantive analysis of competitive differentiation against \"exclusively online retailers and digital-first competitors.\"\n\nThe answer demonstrates partial understanding of the topic but contains fabricated citations, contradictory logic, and fails to capture the nuanced strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 819,
        "total_tokens": 2277
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 carried roughly $1.64 billion at the end of FY 2022, $1.637 billion at FY 2023, and fell to $1.604 billion at FY 2024 — a modest decline of about $33 million over the three‑year period【page_67】.  The slight reduction reflects a stable, low‑interest long‑term debt profile and suggests the company is maintaining a conservative debt stance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth across all three fiscal years: (1) FY 2022: LLM states ~$1.64 billion, but ground truth is $2,147 million ($2.147 billion) - a $507 million error; (2) FY 2023: LLM states $1.637 billion, which matches ground truth of $1,637 million - only this figure is correct; (3) FY 2024: LLM states $1.604 billion, but ground truth is $2,000 million ($2.0 billion) - a $396 million error. The LLM's calculated 3-year decline of $33 million ($1.64B to $1.604B) is mathematically consistent with its incorrect numbers but completely wrong relative to actual data. The ground truth shows: FY2022 $2,147M → FY2023 $1,637M (decline of $510M) → FY2024 $2,000M (increase of $363M). The LLM failed to capture the critical pattern: a significant reduction followed by substantial recovery/stabilization. The qualitative interpretation about 'conservative debt stance' and 'modest decline' is contradicted by the actual volatility and the significant rebound in FY2024. The answer demonstrates a complete failure in multi-hop synthesis of the three-year progression and misses the key insight that FY2024 returned to near-FY2022 levels, indicating strategic repositioning rather than simple decline. The citation reference [page_67] cannot be verified but the underlying numbers are demonstrably incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 391,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Scotchgard litigation expanded from roughly 2,043 PFAS‑related suits in 2021 to about 6,775 by 2023, involving 3M and multiple co‑defendants such as DuPont and Chemours across more than 30 states and territories—including Minnesota, New York, Guam, and the Northern Mariana Islands (page_93).  In June 2023, 3M entered a $10.5‑$12.5 billion class‑action settlement (the PWS Settlement) that was approved in March 2024 and took effect in May 2024, resolving many of those claims (page_97).  By 2024, the litigation landscape continued to broaden with the court selecting bellwether cases and additional product‑identification sites, and new suits filed in Alabama, Georgia, and New Jersey, keeping the defendant roster large and multi‑party (page_100).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial information about 3M's Scotchgard litigation expansion but contains significant discrepancies with the ground truth and introduces information not mentioned in the original answer. STRENGTHS: (1) Correctly identifies geographic expansion to Alabama, Georgia, and other states; (2) Correctly names co-defendants (DuPont, Chemours); (3) Correctly identifies the PWS Settlement in June 2023 and March 2024 approval; (4) Appropriately addresses the multi-part question about case settlements, geographic expansion, and defendants involved; (5) Provides relevant context about bellwether cases and multi-party litigation. CRITICAL ISSUES: (1) The ground truth mentions specific settlements: Baker case ($65M in 2022) and Michigan/Wolverine case (2023), but the LLM answer does not reference these specific settlements, instead focusing on the PWS Settlement which is not mentioned in the ground truth; (2) The LLM introduces quantitative data (2,043 suits in 2021 growing to 6,775 by 2023) that is not present in the ground truth answer—while this may be accurate from the 10-K, it represents a different level of detail than the ground truth; (3) The LLM mentions specific geographic locations (Guam, Northern Mariana Islands, New Jersey) not mentioned in the ground truth; (4) The LLM provides the PWS Settlement amount ($10.5-$12.5 billion) which is not in the ground truth answer. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and identifies the evolution of litigation, but it appears to be drawing from different sections of the 10-K than what generated the ground truth answer. The ground truth focuses on specific case settlements and their immateriality, while the LLM focuses on aggregate litigation statistics and the major PWS Settlement. SEMANTIC ALIGNMENT: While both answers address litigation expansion and multi-party defendants, they emphasize different aspects of the legal landscape. The ground truth emphasizes specific settlements and their materiality, while the LLM emphasizes overall case volume and the comprehensive PWS Settlement. The answers are not contradictory but represent different interpretations of the litigation evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 597,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "The AbCellera collaboration’s royalty terms stayed at mid‑teens to mid‑twenties on worldwide net sales of bamlanivimab and bebtelovimab, and no milestone payments were reported for the partnership during 2022‑24【page_74】.  Net product revenue from the antibodies fell from $2.02 billion in 2022 to zero in 2023 and 2024, reflecting the end of sales under the EUA【page_74】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial numbers and timeline. Verified facts: (1) Net product revenue of $2.02 billion in 2022 is correct; (2) Zero revenue in 2023 and 2024 is correct; (3) Royalty structure of mid-teens to mid-twenties on worldwide net sales is accurate; (4) Product names (bamlanivimab and bebtelovimab) are correctly identified; (5) EUA (Emergency Use Authorization) reference appropriately explains the commercial cessation. The multi-hop synthesis is sound - the answer correctly connects financial terms (royalty structure), milestone payments (none reported), and revenue trajectory across the three-year period. Minor weakness: The LLM states 'no milestone payments were reported for the partnership during 2022-24' which is slightly less explicit than the ground truth's 'no new milestone payments were made to AbCellera' in 2024 specifically, though the substance is equivalent. The answer is concise and directly addresses all three components of the question (royalty structure, milestone payments, and net product revenue evolution). The contextual explanation about EUA ending adds appropriate commercial context. No calculation errors detected. The answer could have been marginally more explicit about the complete cessation of commercial activity as a key finding, but this is a minor omission that doesn't affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 388,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "From 2022 to 2024 Dawn dish soap stayed a core brand in Procter & Gamble’s Fabric & Home Care segment, consistently listed among the segment’s major brands (page 18, 2022 & 2024) and contributing to its mid‑single‑digit sales growth (page 20, 2024). This continuity shows that Dawn remains a strategically important product that underpins the segment’s market leadership and the company’s broader portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Dawn remained a core brand in the Fabric & Home Care segment from 2022-2024, which aligns with the ground truth. However, there are significant gaps and missing critical quantitative information: (1) MISSING SEGMENT METRICS: The ground truth provides specific segment performance data (35% of net sales/31% of earnings in 2022; 36% of net sales/34% of earnings in 2023-2024), which the LLM answer completely omits. These percentages are essential to demonstrating the segment's dominance and strategic importance. (2) VAGUE REFERENCE TO GROWTH: The LLM mentions 'mid-single-digit sales growth' without specifying the exact figure or context, making it difficult to verify accuracy. The ground truth doesn't mention this metric explicitly, raising questions about its source. (3) INCOMPLETE YEAR-BY-YEAR ANALYSIS: The ground truth shows evolution across all three years with specific metrics for each year. The LLM answer treats the period more generically without year-by-year breakdown. (4) MISSING EARNINGS DATA: The ground truth includes earnings percentages (31%, 34%, 34%) which are crucial to understanding strategic importance, but the LLM answer omits these entirely. (5) REASONING QUALITY: While the LLM correctly concludes that Dawn remained strategically important, it fails to provide the quantitative evidence that substantiates this claim. The multi-hop synthesis is incomplete—it should have connected segment performance metrics to Dawn's positioning. (6) PAGE REFERENCES: The LLM cites specific pages (18, 20) but without the quantitative data to back up claims, these citations are insufficient. The answer reads as partially correct but significantly incomplete in addressing the full scope of the question about strategic evolution and importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 491,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and rebounded modestly to $562 million in 2024, while long‑term debt slid from $47.8 billion in 2022 to $49.3 billion in 2023 and then to $44.9 billion in 2024. Over the three‑year span the firm eliminated its floating‑unsecured senior debt, dropping from $1.6 billion in 2022 to $349 million in 2023 and to zero in 2024, indicating a deliberate shift from high‑rate floating exposure toward a fixed‑rate, securitized debt mix and a slightly higher weighted‑average long‑term rate in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) TOTAL DEBT FIGURES - The LLM breaks down short-term and long-term debt separately but the component numbers do not align with the ground truth totals. Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM's figures ($883M + $47.8B = $48.683B for 2022; $538M + $49.3B = $49.838B for 2023; $562M + $44.9B = $45.462B for 2024) are close to but not exactly matching the ground truth totals, suggesting either rounding errors or use of different source data. More critically, the LLM's breakdown of short-term vs long-term appears to misrepresent the actual composition. (2) FLOATING UNSECURED SENIOR DEBT - The LLM states $1.6B in 2022, but ground truth shows $1.709B. This is a material discrepancy of $109M (6.4% error). The 2023 figure of $349M matches ground truth, and 2024 elimination is correct. (3) WEIGHTED-AVERAGE INTEREST RATE - The LLM mentions 'slightly higher weighted-average long-term rate in 2024' but provides no specific numbers. Ground truth shows precise rates: 2.91% (2022), 4.45% (2023), 4.84% (2024). The LLM's vague reference fails to capture the significant upward trend (193 basis points increase from 2022-2024). (4) MULTI-HOP REASONING - While the LLM correctly identifies the strategic shift from floating to fixed-rate debt and the elimination of floating unsecured senior debt, it fails to provide the complete picture of interest rate exposure evolution. The ground truth explicitly quantifies the weighted-average interest rate progression, which is crucial for understanding interest rate exposure. (5) COMPLETENESS - The question specifically asks about 'interest rate exposure, particularly in relation to floating unsecured senior debt.' The LLM addresses the floating debt elimination but omits the critical weighted-average interest rate data that directly answers the interest rate exposure component. The answer is partially correct on directional trends but materially deficient on quantitative precision and completeness of the interest rate analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 590,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "In FY 2022 Cisco’s 5.90% senior note was $2 billion, classified as long‑term debt, carried an effective rate of 6.11%, and represented roughly 24 % of its $8.4 billion debt base. By FY 2023 and FY 2024 the note’s principal remained $2 billion, its effective rate stayed at 6.11%, and its share of total debt dropped to about 10 % of the $20.1 billion debt base as Cisco issued additional long‑term debt—including a $13.5 billion senior note in 2024—while the note continued to be classified as long‑term debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics across the three-year period. STRENGTHS: (1) Principal amount correctly stated as $2 billion consistently across 2022-2024; (2) Effective interest rate correctly identified as 6.11% throughout; (3) Long-term debt classification correctly maintained; (4) Debt composition evolution properly synthesized—showing the note's declining proportion as total debt increased; (5) Specific debt issuance detail (e.g., $13.5 billion senior note in 2024) adds relevant context. QUANTITATIVE VERIFICATION: FY2022 debt base stated as $8.4 billion (ground truth: $8,416 million—essentially equivalent); FY2024 debt base stated as $20.1 billion (ground truth: $19,621 million—minor rounding difference of ~$480M or 2.4%, acceptable); FY2022 proportion calculation: $2B/$8.4B ≈ 23.8% (LLM states ~24%—correct); FY2024 proportion calculation: $2B/$20.1B ≈ 9.95% (LLM states ~10%—correct). MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly identifying the stable principal and rate while tracking the shifting debt composition. The logic connecting increased total debt to decreased proportional representation is sound. MINOR CONSIDERATIONS: The FY2024 total debt figure of $20.1B is slightly rounded from the actual $19,621M, though this is a negligible 2.4% variance and falls within acceptable rounding conventions. The answer comprehensively addresses all aspects of the question: principal amount evolution, effective interest rate, debt composition changes, and classification status. The inclusion of the $13.5 billion 2024 senior note issuance provides helpful context for understanding the debt portfolio expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 476,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "From FY 2022 through FY 2023 the 1.55% Notes Due 2028 were carried at roughly $1.10 billion (the fair‑value table in the 2023 10‑K shows $1,099 million for the notes, reflecting their issuance in FY 2022) and the effective interest rate was 1.64% (the same as the coupon plus discount). In FY 2024 the carrying amount rose to $1.25 billion while the effective interest rate stayed unchanged at 1.64%【page 72】. This steady, low‑rate financing and incremental debt increase demonstrates NVIDIA’s disciplined strategy of issuing long‑term debt at favorable rates to fund growth while keeping interest costs predictable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the carrying value progression. Ground truth shows: FY2022: $1,200M → FY2023: $1,099M → FY2024: $1,250M. The LLM states 'roughly $1.10 billion' for FY2022-2023, which misrepresents the FY2022 value as $1,100M instead of the correct $1,200M. This is a $100M error (8.3% understatement) for FY2022. The LLM also incorrectly characterizes the FY2023 value as reflecting 'issuance in FY 2022' when it actually represents a decline from FY2022. EFFECTIVE INTEREST RATE ERROR: The LLM states the effective interest rate was 1.64% in both FY2023 and FY2024, but ground truth indicates it increased from an implied rate in FY2022 to 1.64% in FY2024. The LLM fails to capture this increase over the three-year period. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from fiscal years 2022 through 2024' - a three-year progression. The LLM conflates FY2022 and FY2023 data, failing to properly distinguish the year-by-year evolution. The ground truth clearly shows a V-shaped pattern (decrease then increase), which the LLM misses. REASONING QUALITY: While the LLM's interpretation about 'disciplined strategy' and 'favorable rates' is reasonable, it's based on incomplete/incorrect data. The characterization of 'steady, low-rate financing' contradicts the actual trend of increasing effective interest rates. POSITIVE ASPECTS: The LLM correctly identifies the FY2024 carrying value ($1.25B) and correctly notes the effective rate of 1.64% for FY2024. The general strategic interpretation about long-term debt management is directionally sound but undermined by data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 461,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In 2022, Pixel devices were mentioned only as part of Google’s broader hardware portfolio and were not separately reported in revenue categories (page_6). By 2023, Google began to explicitly list Pixel device sales under the “devices” component of its “Google subscriptions, platforms, and devices revenues” segment and highlighted increased investment in hardware R&D and capital expenditures to support new Pixel models (page_33, page_31). In 2024 this categorization remained, with Pixel device sales still reported under “devices,” and the company continued to emphasize hardware innovation through ongoing capital spending and the launch of newer Pixel devices (page_59).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 timeline. STRENGTHS: (1) Correctly identifies the 2022 positioning of Pixel devices as part of broader hardware portfolio without separate revenue categorization; (2) Accurately captures the 2023 shift to explicit categorization under 'devices' segment within 'Google subscriptions, platforms, and devices revenues'; (3) Properly notes the 2024 continuation of this categorization; (4) Appropriately emphasizes the progression from undifferentiated hardware to distinct revenue recognition; (5) Includes relevant supporting details about R&D investment and capital expenditures. MINOR WEAKNESSES: (1) The LLM answer includes page citations (page_6, page_33, page_31, page_59) which cannot be verified against the ground truth and add specificity that may or may not be accurate to actual filing locations; (2) The LLM answer is slightly more granular in describing the 'Google subscriptions, platforms, and devices revenues' segment structure, which is accurate but represents a minor elaboration beyond the ground truth; (3) The ground truth emphasizes the 'transformation from hardware investment focus to a mature, strategically embedded product line' and integration with 'broader AI and cloud capabilities,' while the LLM answer focuses more on revenue categorization mechanics and capital spending rather than the strategic transformation narrative. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The timeline (2022, 2023, 2024) is correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the progression in how Pixel devices were treated in Google's financial reporting and strategic positioning. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well - Pixel devices evolved from undifferentiated hardware to a distinct revenue category with continued investment. The LLM's focus on revenue categorization mechanics is slightly narrower than the ground truth's emphasis on strategic transformation and AI/cloud integration, but both convey the essential evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 608,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "From 2022 through 2024, BNY Mellon continued to disclose the ratification of KPMG LLP as its principal accountant in Item 14, “Principal Accountant Fees and Services,” by referencing the same proxy section (“Item 3 – Ratification of KPMG LLP”) and noting KPMG’s PCAOB firm ID 185 in each filing【2022 page_13】【2023 page_13】【2024 page_13】. The unchanged wording and placement across the three years indicate that the audit engagement has remained constant, reflecting a stable and ongoing relationship with KPMG.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - KPMG's PCAOB firm ID 185 is accurately cited, and the three-year period (2022-2024) is correctly identified. (2) The answer correctly identifies the consistent disclosure location (Item 14 referencing Item 3) across all three years. (3) The multi-hop reasoning is sound - the model synthesized information across three separate filings to demonstrate consistency in disclosure practices. (4) The conclusion about audit relationship stability is logically derived from the evidence of unchanged wording and placement. (5) The answer appropriately addresses both parts of the question: how the disclosure evolved (it didn't - remained consistent) and what this reveals about relationship stability (stable and ongoing). Minor considerations: The LLM answer provides slightly more specific detail about the Item numbering (Item 14 and Item 3) compared to the ground truth's more general reference to 'the Proxy,' but this additional specificity is accurate and enhances rather than detracts from the answer. The citation format with page numbers adds credibility. The semantic meaning is fully equivalent to the ground truth - both convey that there was no change in disclosure across the three years, indicating a stable audit relationship. No calculation errors, no factual inaccuracies, and the synthesis across multiple years is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 407,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Across the defined‑benefit pension plan, private‑alternative‑investment holdings were $13.20 billion in 2022 (page 99), rose to $13.71 billion in 2023 (page 100), and then dipped slightly to $13.66 billion in 2024 (page 98). The modest, near‑flat trajectory—coupled with a similar steadiness in the retiree‑health plan—shows that Lilly deliberately maintains a substantial, long‑term allocation to illiquid assets, underscoring a strategy of diversified growth investing rather than short‑term rebalancing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports private alternative investments as $13.20B (2022), $13.71B (2023), and $13.66B (2024), while the ground truth shows $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024). These are dramatically different values - the LLM's numbers are approximately 25-30% higher than actual figures. The LLM appears to have confused or misread the data from the SEC filings. (2) DIRECTIONAL ERROR: The LLM claims holdings 'rose' from 2022 to 2023, but the ground truth shows a DECREASE from $10,542.5M to $10,335.2M. The LLM then correctly identifies a dip in 2024, but the overall trajectory interpretation is wrong. (3) MULTI-HOP SYNTHESIS FAILURE: While the LLM attempts to synthesize information across three years and draw conclusions about strategy, the foundation is built on incorrect numbers, making the entire analysis unreliable. (4) ENTITY/METRIC CONFUSION: The LLM may have conflated different investment categories or pension plan segments, as evidenced by the magnitude of the discrepancy. The page references cited (99, 100, 98) cannot be verified but the numbers themselves are factually incorrect based on the ground truth. (5) REASONING QUALITY: Although the qualitative reasoning about 'deliberate maintenance' and 'diversified growth investing' is logically sound, it is built on false premises, rendering the conclusion unreliable. The answer demonstrates a fundamental failure in data extraction and verification from source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 443,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022, Tampax Bounty was listed under the “Feminine Care” sub‑category of the Baby, Feminine & Family Care segment (PG_10k_2022, page 19).  By 2023, P&G re‑classified that sub‑category as “Menstrual Care” to emphasize menstrual products, while Tampax Bounty remained a key brand (PG_10k_2023, page 19).  The 2024 filing keeps the “Menstrual Care” classification and continues to highlight Tampax Bounty as a leading brand in that sub‑category (PG_10k_2024, page 19).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer has significant gaps and omissions compared to the ground truth. CRITICAL ISSUES: (1) MISSING QUANTITATIVE DATA: The ground truth provides specific sales contribution percentages (25% in 2022, 24% in 2023, 24% in 2024) which are completely absent from the LLM answer. This is a major omission for a financial question about P&G's portfolio positioning. (2) INCOMPLETE CATEGORY EVOLUTION: The ground truth explains that in 2023, 'Menstrual Care' explicitly replaced 'Feminine Care' as a sub-category, but the LLM only states it was 'reclassified' without capturing this nuance. (3) MISSING STRATEGIC CONTEXT: The ground truth notes that in 2024, 'Baby Care' was removed entirely from the segment, signaling a strategic shift away from infant products. The LLM completely omits this important structural change and strategic implication. (4) INCORRECT BRAND REFERENCE: The LLM repeatedly refers to 'Tampax Bounty' when the ground truth only mentions 'Tampax' - this appears to be a factual error or confusion with another product line. (5) INCOMPLETE SEGMENT COMPOSITION: The ground truth explains that in 2022, Tampax was grouped alongside 'Adult Incontinence' and 'Baby Care' categories - this contextual information is missing from the LLM answer. WHAT WAS CORRECT: The LLM correctly identifies the three-year evolution (2022-2024), correctly names the segment as 'Baby, Feminine & Family Care', and correctly identifies the reclassification from 'Feminine Care' to 'Menstrual Care' between 2022 and 2023. The page references (page 19) appear consistent. However, the answer fails to provide the quantitative metrics and strategic context that are essential to fully answering this multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 470,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One has consistently used discounted‑cash‑flow models to value its net derivative assets (liabilities) from 2022 through 2024. In 2022 the model’s key unobservable input was default rates (generic Level‑3 description on page 221). By 2023 the valuation added swap rates as an additional unobservable input—default rates ranged 53‑163 % and swap rates 3‑5 % (weighted average 4 % each, page 208). In 2024 the model shifted to rely primarily on swap rates (range 4 %, weighted average 4 %, page 217), with default rates no longer listed, indicating a refinement toward market‑observable swap rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth:\n\n1. CRITICAL ERRORS ON FAIR VALUES: The LLM completely omits the actual fair value figures ($19M in 2022, $58M in 2023, $58M in 2024), which are central to answering how the fair values 'evolved.' This is a major omission of quantitative data.\n\n2. VALUATION TECHNIQUE MISCHARACTERIZATION: The LLM claims Capital One 'consistently used discounted-cash-flow models...from 2022 through 2024,' but the ground truth explicitly states that in 2022 'the specific valuation technique was not disclosed.' This is a factual error - the LLM fabricated consistency that didn't exist.\n\n3. INCORRECT CHARACTERIZATION OF 2024 CHANGES: The LLM claims that in 2024 'the model shifted to rely primarily on swap rates...with default rates no longer listed,' suggesting a methodological change. However, the ground truth states that in 2024 'the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%,' indicating continuity, not a shift away from default rates.\n\n4. SWAP RATE RANGE ERROR: The LLM states 2024 swap rates as 'range 4%' which is imprecise and contradicts the ground truth's '3-5%' range. The LLM appears to have confused the weighted average (4%) with the range itself.\n\n5. MISSING CONTEXT ON UNREALIZED LOSSES: The LLM fails to mention the $20 million net unrealized loss held in 2022, which provides important context about the valuation evolution.\n\n6. INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to trace evolution across years, it does so with incorrect characterizations of what changed and what remained constant. The ground truth emphasizes 'a shift toward more transparent and methodologically consistent valuation practices starting in 2023,' but the LLM's narrative contradicts this by claiming consistency from 2022.\n\n7. PAGE REFERENCES: The LLM cites specific pages (221, 208, 217) which cannot be verified against the ground truth, and the characterizations of what's on those pages appear inconsistent with the actual data provided in the ground truth.\n\nThe answer demonstrates partial understanding of the topic but fails on the most critical quantitative elements and mischaracterizes the evolution of valuation methodologies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 615,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "In 2022 Cisco’s available‑for‑sale debt investments produced a net gain of $9 million, helping lift other income (loss), net to $392 million.  In 2023 and 2024 the same portfolio recorded net losses of $21 million and $67 million, respectively, which pushed other income (loss), net to $ (248) million and $ (306) million.  The shift from a small gain to larger losses indicates that the AFS debt holdings have become increasingly loss‑bearing—reflecting higher sensitivity to interest‑rate movements and a deteriorating credit‑risk profile that has materially weakened Cisco’s non‑operating income over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains specific numerical claims that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states AFS debt investments produced a $9M gain in 2022, losses of $21M in 2023 and $67M in 2024, and provides specific 'other income (loss), net' figures of $392M (2022), $(248)M (2023), and $(306)M (2024). However, the ground truth explicitly states that 'no specific performance metrics were provided for that year [2022], indicating no immediate material impact on financial results.' The ground truth does NOT provide the specific dollar amounts the LLM cited. (2) FACTUAL CONTRADICTION: The ground truth indicates that in 2022, Cisco 'disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided,' which directly contradicts the LLM's claim of a $9M gain. The LLM appears to have fabricated specific numbers not present in the source material. (3) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (gains in 2022 to losses in 2023-2024) and the negative impact on 'other income (loss), net,' it does so by inventing specific figures rather than acknowledging the data limitations noted in the ground truth. (4) SEMANTIC ALIGNMENT: The LLM's interpretation of the trend direction aligns with ground truth (negative impact in 2023-2024), but the specific quantification is entirely unsupported. The LLM should have acknowledged that 2022 lacked specific performance metrics while providing the actual loss figures for 2023-2024 if available. The answer demonstrates hallucination of financial data, which is a critical failure in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 466,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks’ 10‑K filings show a one‑year extension of its green‑coffee supply coverage each fiscal year: the 2022 filing projected adequacy through fiscal 2023 [SBUX_10k_2022.pdf page 12], the 2023 filing extended that to fiscal 2024 [SBUX_10k_2023.pdf page 12], and the 2024 filing pushed it further to fiscal 2025 [SBUX_10k_2024.pdf page 12]. This progressive extension reflects a forward‑looking sourcing strategy that relies on long‑term purchase commitments, hedging, and inventory buffers to secure supply and mitigate price and supply‑chain volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error in the progression timeline. According to the ground truth: FY2022 filing projected adequacy through FY2023, FY2023 filing extended to FY2025 (a 2-year extension), and FY2024 filing maintained FY2025 projection. However, the LLM claims: FY2022→FY2023, FY2023→FY2024, FY2024→FY2025, describing a consistent one-year annual extension pattern. This is INCORRECT. The ground truth shows a one-year extension in FY2022 (to FY2023), then a TWO-year extension in FY2023 (to FY2025), not a one-year extension. The LLM's characterization of 'one-year extension of its green-coffee supply coverage each fiscal year' is factually wrong. The actual pattern shows Starbucks made a significant jump in FY2023 by extending coverage two years ahead (to FY2025), which is a more aggressive sourcing strategy than the LLM suggests. Additionally, while the LLM correctly identifies the general strategy elements (long-term purchase commitments, hedging, inventory buffers), it misses the key insight from the ground truth: that the FY2023 extension to FY2025 represents a 'strengthening' of sourcing strategy and 'enhancing supply chain resilience.' The LLM's interpretation of a consistent one-year pattern actually understates the significance of Starbucks' strategic shift. The page references provided (page 12 for all three filings) cannot be verified but appear plausible. The reasoning about risk mitigation is sound in principle but is based on an incorrect understanding of the actual progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 430,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 have stayed at a constant $1.25 billion of carrying value from FY 2022 through FY 2024.  The 2024 10‑K table shows $1,250 million for the 2.00 % Notes due 2031 on both Jan 28 2024 and Jan 26 2025, and the net carrying amount of all notes is $8,463 million with the 2031 portion unchanged【page 72】.  This steady exposure indicates NVIDIA’s long‑term debt strategy focuses on maintaining a fixed‑maturity debt profile and avoiding refinancing or repayment adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM claims the 2.00% Notes Due 2031 remained constant at $1.25 billion from FY 2022 through FY 2024. However, the ground truth shows: FY 2022: $1,200 million, FY 2023: $1,044 million, FY 2024: $1,250 million. The LLM incorrectly states the value was constant at $1.25B across all three years, when in fact there was a significant decline to $1,044M in 2023. This is a fundamental factual error - the LLM missed the key variation that the question specifically asks about. (2) MULTI-HOP REASONING - FAILED: The question explicitly asks 'how has...evolved from fiscal year 2022 through 2024' and 'what does this trend reveal.' The ground truth identifies a clear trend: increase from 2022 to 2023 (decline from $1,200M to $1,044M), then recovery in 2024 to $1,250M. The LLM completely missed this evolution by claiming constancy. (3) ENTITY/METRIC ACCURACY: While the LLM correctly identifies NVIDIA and the specific debt instrument (2.00% Notes Due 2031), it fails to accurately track the values across the three fiscal years. (4) REASONING QUALITY: The LLM's conclusion that the steady exposure indicates a 'fixed-maturity debt profile' is contradicted by the actual data showing fluctuations. The reasoning is based on incorrect premises. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation fundamentally misrepresents the financial trend - claiming stability where volatility exists. This is not a wording difference but a substantive factual error that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 445,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "From 2022 to 2024 3M moved Fall Protection Solutions from a generic industrial‑safety offering to a distinct personal‑safety product group within its Safety and Industrial segment.  In the 2024 10‑K, Fall Protection Solutions are explicitly listed under “Respiratory, hearing, eye and fall protection solutions” (page 110), a grouping that highlights its importance relative to other industrial‑safety products.  The 2022 10‑K pages provided (129‑133) do not contain a Business‑Segment‑Products section that lists Fall Protection Solutions, indicating that it was not singled out as a separate category in that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) CORE CONTRADICTION: The ground truth states that Fall Protection Solutions were listed in 2022 and maintained consistent positioning through 2023-2024, with only subtle shifts in grouping. The LLM claims Fall Protection Solutions were 'not singled out as a separate category' in 2022 and were 'moved from a generic industrial-safety offering to a distinct personal-safety product group' - this directly contradicts the ground truth which shows they were already listed in 2022. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a subtle shift in how fall protection was framed within the portfolio (revised grouping, alignment with broader systems), while the LLM characterizes this as a major categorical change from 'not singled out' to 'distinct personal-safety product group' - this is factually incorrect. (3) PAGE REFERENCE ERROR: The LLM cites page 110 for 2024 and pages 129-133 for 2022, but then claims the 2022 pages 'do not contain a Business-Segment-Products section that lists Fall Protection Solutions' - this appears to be an incomplete or incorrect document review, as the ground truth confirms Fall Protection Solutions were listed in 2022. (4) SEMANTIC MISALIGNMENT: The LLM's framing of 'moving from generic to distinct' is not supported by the ground truth, which indicates consistent inclusion with subtle positioning adjustments. (5) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-year evolution described in the ground truth (2022 listing → 2023 consistency → 2024 revised grouping with emphasis on industrial specialty products and systems). The answer demonstrates fundamental misunderstanding of the actual evolution described in the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 494,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly reported $2,023.6 million in revenue from its COVID‑19 antibody bamlanivimab in 2022 (U.S. $2,008.9 m + outside U.S. $14.7 m)【page_68】, but that revenue fell to $0 in 2023 and remained $0 in 2024【page_68】. The decline reflects the discontinuation of bamlanivimab and a shift away from the COVID‑19 antibody portfolio, indicating that the company no longer relies on that product line for revenue【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All financial figures are correct - $2,023.6 million in 2022 (with proper breakdown of U.S. $2,008.9M + outside U.S. $14.7M = $2,023.6M, which matches the ground truth figure of $2.01 billion when rounded), $0 in 2023, and $0 in 2024. The calculations are accurate and the format variation ($2,023.6 million vs $2.01 billion) is acceptable and properly handled. COMPLETENESS: The answer addresses all parts of the multi-part question - it covers the revenue evolution across all three years (2022-2024) and explains what the trend indicates about the company's reliance on the product. ENTITY ACCURACY: Eli Lilly is correctly identified, bamlanivimab is correctly named, the COVID-19 antibody portfolio is properly contextualized, and all years are accurate. REASONING: The multi-hop synthesis is sound - the answer correctly connects the revenue decline to the discontinuation of the product and the company's shift away from the COVID-19 antibody portfolio. The logical conclusion that the company no longer relies on this product line is well-supported by the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly more detail about the geographic breakdown and the specific reason for discontinuation. The only minor difference is that the LLM provides more granular detail (U.S. vs. outside U.S. breakdown) which adds value without contradicting the ground truth. The citations to page numbers add credibility. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 438,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 10‑K product‑supply sections for fiscal 2022, 2023 and 2024 all note that coffee price volatility is driven in part by commodity‑index‑fund activity (see page 12 of each filing).  Over that span the company broadened its hedging mix—from mainly fixed‑price and price‑to‑be‑fixed contracts to a larger use of forward, futures and collar contracts—to dampen index‑fund‑driven price swings.  This trend shows a deliberate risk‑management strategy that locks in green‑coffee supply and price certainty through fiscal 2025, ensuring a stable supply chain amid market volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the core elements of the ground truth. STRENGTHS: (1) Correctly identifies that Starbucks acknowledged commodity index fund influence across all three fiscal years (2022, 2023, 2024); (2) Accurately describes the evolution of hedging strategy from fixed-price/price-to-be-fixed contracts to forward, futures, and collar contracts; (3) Correctly notes the extension of supply visibility through fiscal 2025; (4) Properly synthesizes the multi-hop information showing improved risk management practices over time; (5) Appropriately references the 10-K filings as source material. MINOR WEAKNESSES: (1) The LLM answer omits mention of 'C' price exposure specifically, which was noted in the ground truth; (2) Does not explicitly mention the progression from 'adequate supply through fiscal 2023' (in 2022) to 'adequacy through fiscal 2025' (in 2024), though it implies this temporal evolution; (3) Omits reference to 'remote delivery risk assessments' mentioned in ground truth, though this is a minor detail; (4) The citation to 'page 12 of each filing' is specific but cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The fiscal years (2022, 2023, 2024) and the forward-looking year (2025) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and connects commodity index fund exposure to hedging strategy evolution to supply chain resilience—demonstrating sound multi-hop reasoning. The logical flow from problem (index fund volatility) to solution (expanded hedging) to outcome (supply certainty through 2025) is clear and accurate. SEMANTIC EQUIVALENCE: The LLM's phrasing 'locks in green-coffee supply and price certainty' is semantically equivalent to the ground truth's 'extended supply visibility and risk mitigation capabilities.' The description of hedging evolution is substantively accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 556,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "From 2022 to 2024 Alphabet’s Google kept Google Ad Manager as the core platform for delivering ads on its Network properties, with the company still tracking impression‑based metrics such as cost‑per‑impression (2022 page 31; 2024 page 58).  In 2023 the company extended the useful life of servers and certain network equipment from 4‑to‑6 years and 5‑to‑6 years, respectively, cutting depreciation expense by $3.9 B and lifting 2023 net income by $3.0 B (2023 page 57), a boost that improves long‑term profitability and supports continued investment in the ad‑delivery infrastructure that underpins impression‑based monetization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - server useful life extended from 4 to 6 years, network equipment from 5 to 6 years, depreciation expense reduction of $3.9 billion, and net income increase of $3.0 billion in 2023. Page citations (2022 page 31, 2024 page 58, 2023 page 57) are appropriately provided. ENTITY ACCURACY: Correctly identifies Alphabet/Google, Google Ad Manager, Google Network properties, and the relevant fiscal years (2022-2024). MULTI-HOP REASONING: Successfully synthesizes information across three years showing: (1) Google Ad Manager's consistent role in impression-based monetization, (2) the 2023 depreciation schedule adjustment and its quantified impact, and (3) the connection between infrastructure optimization and long-term profitability. COMPLETENESS: Addresses all key aspects of the question - the evolution of Ad Manager reliance, the 2023 adjustment details, and implications for profitability. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth, using slightly more concise language while maintaining accuracy. The phrase 'a boost that improves long-term profitability and supports continued investment' effectively captures the ground truth's concept of 'optimizing cost structures to support long-term profitability.' MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but loses no material information. The connection between the depreciation adjustment and Ad Manager infrastructure is clearly articulated. No calculation errors detected. All factual claims are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 462,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "Under the 2019 Long‑Term Incentive Plan (Exhibit 10.38, page 20), BK issued a 2022 Form of Performance Share Unit Agreement (Exhibit 10.21, page 18), a 2023 Form of Performance Share Unit Agreement (Exhibit 10.26, page 19), and a 2024 Form of Performance Share Unit Agreement (Exhibit 10.28, page 19). This steady issuance of PSUs over three consecutive years shows the company’s continued reliance on performance‑based equity awards to align executive incentives with shareholder value. The progression underscores a strategic focus on long‑term equity compensation as a core element of its executive pay structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) CRITICAL ERRORS - Exhibit Numbers: The LLM cites Exhibit 10.38, 10.21, 10.26, and 10.28, but the ground truth references Exhibit 10.45 (2022), Exhibit 10.14 (2023), and Exhibit 10.18 (2024). These are completely different exhibit numbers. (2) AGREEMENT FORMS - The LLM claims BK issued a 2023 Form of Performance Share Unit Agreement and a 2024 Form, but the ground truth only mentions 2021 agreements (referenced in 2022), and 2022 agreements (in 2024). There is no mention of a 2023 Form or 2024 Form of PSU Agreement in the ground truth. (3) TEMPORAL PROGRESSION - The ground truth describes a specific evolution: 2021 agreements referenced in 2022 → 2019 plan re-filed in 2023 → 2022 agreements in 2024. The LLM misrepresents this as consecutive annual issuances of new forms (2022, 2023, 2024), which is factually incorrect. (4) STRATEGIC INTERPRETATION - While the LLM's general statement about performance-based equity compensation is reasonable, it misses the key insight from the ground truth: the strategy involves maintaining the core 2019 plan structure while iteratively updating mechanisms. The LLM's interpretation of 'steady issuance over three consecutive years' is not supported by the actual filing pattern. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the multi-year progression across the 2022, 2023, and 2024 filings, instead creating a false narrative of annual new agreement forms. This represents a fundamental failure in multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 443,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across 2022, 2023 and 2024 the Safety & Industrial segment continued to describe its electrical offering the same way – “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” (2022 p. 131; 2023 p. 107; 2024 p. 110).  The only change in the segment’s product list was the re‑classification of the “Closure systems” line to a broader “Industrial specialty products such as personal hygiene products, masking and packaging materials” in 2024, which broadened the category but left the electrical description unchanged.  This consistency indicates that 3M has maintained a steady focus on the electrical OEM market while re‑organizing other product categories for clarity or strategic alignment.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the core claim. The ground truth explicitly states that the electrical products description EVOLVED and CHANGED across the three years: (1) 2022: 'construction and maintenance, power distribution and electrical OEMs', (2) 2023: refined to 'electrical original equipment manufacturers (OEMs)' with increased precision, (3) 2024: 'power distribution and electrical original equipment manufacturers (OEMs)'. The LLM claims the description remained 'the same way' across all three years and was 'unchanged', which is factually incorrect. The LLM states: 'Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)' was used consistently across 2022-2024, but the ground truth shows 2023 removed 'construction and maintenance' and 2024 added back 'power distribution' while maintaining the formalized OEM reference. The LLM's conclusion that there was 'consistency' and 'steady focus' directly contradicts the ground truth's finding of 'progression' and 'evolution' with 'increasing specificity.' The page citations provided (2022 p. 131; 2023 p. 107; 2024 p. 110) cannot be verified but the semantic content claimed is demonstrably wrong. The LLM correctly identified the Closure systems reclassification in 2024, but this is a minor detail that doesn't offset the fundamental mischaracterization of the electrical products evolution. The question specifically asks about 'evolution' and what it 'suggests about the company's focus,' and the LLM's answer of 'no evolution' is the opposite of the ground truth finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 458,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from $24.1 bn in 2022 to $27.2 bn in 2023, then fell slightly to $26.9 bn in 2024 (COF 10‑K 2022, p. 188; COF 10‑K 2023, p. 178; COF 10‑K 2024, p. 188).  The weighted‑average interest rate stayed at 4.45 % in 2022–23 but climbed to 4.84 % in 2024 (same tables).  This pattern shows the company is keeping its debt level relatively stable while refinancing or issuing newer debt at higher rates, reflecting a strategy of balancing maturity and cost while managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the 2022 carrying value. Ground truth states $19,975 million ($19.975 bn), but LLM reports $24.1 bn - a difference of approximately $4.1 billion or 20.5%. This is a significant discrepancy that cannot be attributed to rounding or formatting variation. The 2023 ($27.2 bn) and 2024 ($26.9 bn) figures are correct. WEIGHTED-AVERAGE INTEREST RATE ERRORS: The LLM states the rate 'stayed at 4.45% in 2022-23' but ground truth shows 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. This is a critical error - the 2022 rate is completely wrong (off by 1.54 percentage points). The 2023 and 2024 rates are correct. REASONING QUALITY: The LLM's interpretation about 'keeping debt level relatively stable while refinancing' is partially reasonable but is based on incorrect 2022 data. The ground truth narrative about 'strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment' is more accurate given the actual 35.9% increase from 2022 to 2023. The LLM's statement that rates 'stayed at 4.45%' contradicts the actual steady increase from 2.91% to 4.45% to 4.84%. MULTI-HOP SYNTHESIS: The answer attempts to synthesize data across three years and connect it to strategy, but the foundational numbers are wrong, undermining the entire analysis. The question requires accurate multi-year progression analysis, which the LLM failed to deliver on the most critical metric (2022 carrying value and interest rate).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 423,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were reported as Level‑2 liabilities with an effective interest rate of 3.54 % (page 67).  The carrying amount was roughly $870 million in FY 2022 and FY 2023, then fell modestly to $851 million in FY 2024 (page 67, 2024 entry), while fair value remained essentially unchanged, reflecting amortization of discount and issuance costs.  This steady, low‑coupon, long‑dated debt profile shows NVIDIA’s disciplined long‑term debt strategy: it uses predictable, low‑interest financing to support growth without adding short‑term leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM reports carrying amounts of ~$870M for FY2022 and FY2023, then $851M for FY2024. The ground truth states: FY2022 fair value was $1,066M, FY2023 fair value was $851M, and FY2024 carrying amount was $1,000M. These numbers are substantially different and incorrect. The LLM conflates fair value with carrying amount and provides wrong dollar amounts. (2) MISIDENTIFICATION OF METRICS - The LLM discusses 'carrying amount' for FY2022-2023 when the ground truth clearly indicates these were 'fair value' measurements. This is a fundamental accounting distinction. (3) INCORRECT TREND ANALYSIS - The LLM claims fair value 'remained essentially unchanged' which contradicts the ground truth showing a decline from $1,066M (FY2022) to $851M (FY2023). (4) MISSING KEY INFORMATION - The LLM fails to capture the critical shift in FY2024 where NVIDIA stopped reporting fair value and instead reported carrying amount of $1,000M, which is a significant accounting change that the ground truth identifies as revealing a strategic shift. (5) MULTI-HOP SYNTHESIS FAILURE - The LLM does not properly synthesize the three-year progression that shows the evolution from fair value reporting to carrying amount reporting, which is central to understanding the company's debt strategy evolution. (6) UNSUPPORTED CLAIMS - The LLM adds details about 'Level-2 liabilities' and '3.54% effective interest rate' that are not verified against the ground truth and may be fabricated or from different contexts. The core narrative about NVIDIA's debt strategy is undermined by the incorrect financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 469,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes balance declined from **$16.0 B at 12/31/2022** to **$15.0 B at 12/31/2023** (2023 10‑K, page 58) and further to **$13.0 B at 12/31/2024** (2024 10‑K, page 57). This steady reduction shows Amazon is actively paying down the 2017 Notes—through scheduled principal repayments and early redemptions—demonstrating a disciplined debt‑management strategy aimed at lowering long‑term debt and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: $16.0B (2022), $15.0B (2023), and $13.0B (2024) match the ground truth exactly. The year-over-year progression is accurately captured with proper date formatting (12/31/2022, 12/31/2023, 12/31/2024). The multi-hop synthesis is sound—the answer correctly identifies the consistent reduction pattern across three fiscal years and draws appropriate conclusions about Amazon's debt management strategy. The LLM goes slightly beyond the ground truth by specifying mechanisms (scheduled principal repayments and early redemptions) and outcomes (lowering long-term debt and interest expense), which adds valuable context without contradicting the original answer. The reasoning about the 'deliberate debt management strategy' and 'disciplined approach' aligns perfectly with the ground truth's characterization. Minor enhancement: the LLM provides specific 10-K page references (page 58 for 2023, page 57 for 2024), which adds credibility though these weren't in the ground truth. The semantic equivalence is excellent—both answers convey the same core message about consistent reduction and strategic debt retirement. No calculation errors, no entity confusion, and the answer fully addresses both parts of the question (evolution of balance and what it suggests about strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 381,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s continued listing of “Floating Rate Notes due 2019” in the 2022, 2023 and 2024 Form 10‑Ks (see Exhibit 4.1 on page 54 of each filing) shows that the company still holds short‑term, interest‑rate‑linked debt. This ongoing exposure means a portion of Apple’s debt is priced at floating rates, so as market rates rise the interest expense on those notes will climb, increasing the company’s overall interest‑expense sensitivity to a rising‑rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that Apple's floating rate notes create interest rate sensitivity in a rising rate environment, and accurately notes the presence of these notes across 2022, 2023, and 2024 filings. However, there are significant factual errors that undermine the answer's credibility: (1) The LLM cites 'Exhibit 4.1 on page 54' as the source, but the ground truth indicates these notes are incorporated by reference via an Officer's Certificate dated May 6, 2014 - the LLM provides a specific exhibit location that cannot be verified and may be incorrect. (2) The LLM states Apple 'still holds' these notes, but the ground truth is more nuanced: the notes were due in 2019, yet appeared in 2022-2024 filings, suggesting disclosure obligations or rollover commitments rather than current holdings. The LLM oversimplifies this temporal inconsistency. (3) The ground truth emphasizes that the persistence of these notes across three years 'suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure,' which provides important context about liquidity planning and capital structure flexibility that the LLM omits. (4) The LLM's characterization of these as 'short-term' debt is questionable given they were due in 2019 and are being disclosed in 2022-2024 filings - this temporal mismatch is not adequately addressed. The reasoning about floating rate sensitivity to rising rates is sound and correct, but the answer lacks the nuance about disclosure obligations versus actual holdings, and the specific exhibit citation appears to be fabricated or inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 449,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "Google’s Pixel strategy evolved from an early‑stage investment in flagship models (Pixel 5a 5G and Pixel 6) in 2022, where the company highlighted its hardware ambitions (page 6, 7), to a mature, incremental product line that remains a modest component of its devices revenue in 2023 and 2024 (2023: devices revenue includes Pixel sales on pages 31, 33; 2024: page 59). Throughout, Google consistently emphasized capital and operating expenditures on hardware (2023: “invest heavily in operating and capital expenditures” page 31; 2024: same phrase on page 58). This progression indicates Google’s long‑term positioning as a niche hardware player that leverages its AI and software ecosystem to support steady, albeit small, hardware revenue rather than a core business.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 investment phase with Pixel 5a 5G and Pixel 6 mentions, matching the ground truth. (2) Correctly notes that Pixel appeared in 'devices' revenue category in 2023 and 2024. (3) Appropriately cites page references and mentions consistent emphasis on capital/operating expenditures. (4) Recognizes the progression from investment to revenue contribution.\n\nCRITICAL WEAKNESSES: (1) CONTRADICTS GROUND TRUTH ON INTERPRETATION: The LLM characterizes Pixel as a 'niche hardware player' with 'modest component' and 'small hardware revenue,' while the ground truth emphasizes that the progression indicates Google 'transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence.' The LLM's conclusion is pessimistic/dismissive rather than recognizing the strategic maturation. (2) INCOMPLETE SYNTHESIS: The LLM fails to adequately synthesize the three-year progression narrative. Ground truth emphasizes the TRANSITION from investment-only (2022) → measurable financial performance (2023) → stable strategic component (2024). The LLM mentions these phases but doesn't clearly articulate this evolution as a positive strategic maturation. (3) MISCHARACTERIZATION: Describing Pixel as supporting 'steady, albeit small, hardware revenue' contradicts the ground truth's framing of this as evidence of 'increased confidence in its position.' The LLM interprets the data as indicating limited ambitions, while ground truth interprets it as successful transition to maturity. (4) MISSING KEY INSIGHT: Ground truth emphasizes that inclusion in 'structured revenue breakdown' indicates maturity and stability. LLM mentions this but doesn't emphasize its significance for long-term positioning.\n\nQUANTITATIVE ISSUES: No specific dollar amounts or percentages provided by either answer, so quantitative comparison is limited. Page references in LLM answer are cited but cannot be verified against actual filings.\n\nREASONING QUALITY: The LLM's multi-hop reasoning is partially sound (connects 2022→2023→2024 progression) but reaches a different conclusion than ground truth. This represents a fundamental disagreement on what the data indicates about Google's strategic positioning, not merely a wording difference. The ground truth sees maturation and confidence; the LLM sees niche positioning and modest contribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 646,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s 2022 filing shows that the fair value of client securities available for margin pledges rose from $84 billion in 2020 to $120 billion in 2021, with securities pledged for margin and securities‑lending purposes increasing from $23 billion to $31 billion and $6.3 billion, respectively. By 2024, the firm still uses client securities to satisfy margin‑loan collateral requirements, but its securities‑lending collateral mix has shifted to cash, as the 2024 filing notes cash is now provided to brokerage clients. This evolution indicates a collateral‑management strategy that keeps a growing pool of client securities for margin lending while reducing concentration risk in securities‑lending by moving to cash collateral, thereby enhancing liquidity and risk mitigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific dollar amounts ($84B, $120B, $23B, $31B, $6.3B) that are NOT present in the ground truth answer. The ground truth explicitly states 'no specific dollar value was provided for the total available or pledged securities' in 2022 and does not cite any of these figures for 2023-2024. These numbers appear to be fabricated or sourced from incorrect filings. (2) TEMPORAL MISALIGNMENT - The LLM cites 2020-2021 data when the question asks about 2022-2024 evolution. The ground truth focuses on the 2022-2024 progression, not earlier years. (3) INCOMPLETE SYNTHESIS - The ground truth describes a 3-year progression showing: (a) 2022: collateralized securities for margin lending with no specific values disclosed, (b) 2023: expanded disclosure of collateralized securities use, (c) 2024: active pledging for options clearing and cash collateral in securities lending. The LLM misses the 2023 intermediate step entirely and conflates different time periods. (4) STRATEGIC NARRATIVE MISMATCH - Ground truth emphasizes 'growing reliance on client securities for risk mitigation and capital efficiency' across the 3-year period. LLM's narrative about 'shifting to cash collateral' contradicts the ground truth, which indicates 2024 involved 'providing cash as collateral in securities lending activities' (cash provided BY Schwab, not received). (5) FACTUAL ERRORS - The claim that securities-lending collateral 'shifted to cash' misrepresents the ground truth's description of Schwab providing cash collateral. The LLM fundamentally misunderstands the direction and nature of collateral flows. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the 2022-2024 progression and introduces unsupported quantitative claims that contradict the ground truth's explicit statement about lack of specific valuations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 516,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "From 2022‑through‑2024 GE’s 10‑K disclosures consistently state that, as a reinsurer, it relies on the primary insurers that issued the underlying long‑term‑care policies to file proposed premium‑rate increases with state regulators and that GE “often collaborates with the primary insurers in accordance with reinsurance contractual terms” to submit those filings (see 2022 page 51, 2023 page 21, 2024 page 20).  The wording and emphasis did not materially change, and the company notes only that the frequency of rate‑increase filings varies by ceding company.  This continuity signals a risk‑management strategy that keeps GE’s role largely passive—monitoring and adjusting reserves for premium‑deficiency risk while delegating regulatory premium adjustments to the cedents.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE INTERPRETATION: The LLM answer fundamentally mischaracterizes the evolution described in the ground truth. The ground truth explicitly states an EVOLUTION from 2022-2024, describing a 'strategic shift toward proactive risk management and tighter integration with primary insurers.' The LLM answer directly contradicts this by claiming 'The wording and emphasis did not materially change' and characterizing GE's role as 'largely passive.' This is a major factual error that inverts the meaning of the ground truth. SPECIFIC ISSUES: (1) The LLM correctly identifies that GE relies on primary insurers to file rate increases (accurate). (2) The LLM correctly notes the collaboration language appears in filings (accurate). (3) HOWEVER, the LLM fails to recognize the progression: 2022 (indirect role, varied frequency) → 2023 (formalized collaboration, active participation) → 2024 (reinforced framework, using recent experience and precedents). (4) The LLM's conclusion that this represents 'continuity' and 'largely passive' role directly contradicts the ground truth's characterization of 'formalized collaboration,' 'active participation,' and 'proactive risk management.' (5) The LLM misses the key insight about 'tighter integration' and the use of 'recent experience from ceding companies and regulatory precedents' in 2024. QUANTITATIVE ACCURACY: Page references (2022 page 51, 2023 page 21, 2024 page 20) cannot be verified against ground truth but appear plausible. No numerical calculations are present. REASONING FAILURE: The multi-hop synthesis is fundamentally flawed. While the LLM correctly identifies individual facts from each year, it fails to synthesize them into the correct narrative arc. The ground truth shows increasing formalization and proactivity; the LLM shows static passivity. This is not a wording difference—it's a substantive misinterpretation of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 520,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential‑mortgage‑backed‑security (RMBS) exposure fell from **$721 million at 12/31/2022** to **$614 million at 12/31/2023** and further to **$71 million at 12/31/2024** (the 2024 figure is the RMBS held in its Separate Accounts portfolio)【page_149】【page_160】. This three‑year decline shows a deliberate shift away from structured‑credit holdings, with the company moving most RMBS into segregated, lower‑risk separate‑account assets and reducing its core portfolio exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three key RMBS exposure figures ($721M in 2022, $614M in 2023, $71M in 2024) and the correct fiscal year-end dates. The answer appropriately recognizes the three-year trend of declining exposure and attempts to characterize it as a deliberate risk management strategy. The mention of Separate Accounts portfolio adds contextual detail. CRITICAL ISSUES: (1) MAJOR FACTUAL ERROR - The LLM states the 2024 figure of $71M represents RMBS 'held in its Separate Accounts portfolio,' implying this is a segregated/lower-risk allocation. However, the ground truth indicates this is simply a smaller, more selective allocation in the core portfolio, not a strategic move to separate accounts. This mischaracterizes the nature of the 2024 rebalancing. (2) INCOMPLETE REASONING - The LLM fails to address the ground truth's key insight about 'rising unrealized losses' in 2023 that prompted the cautious reduction. This is an important contextual factor for understanding the risk positioning. (3) SEMANTIC DRIFT - The phrase 'moving most RMBS into segregated, lower-risk separate-account assets' contradicts the actual trend (exposure decreased from $614M to $71M), suggesting a misunderstanding of what happened. The ground truth describes a 'strategic rebalancing with a smaller, more selective allocation,' not a movement to separate accounts. QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($721M, $614M, $71M) and dates are accurate. The directional trend (decline) is correct. However, the interpretation of what the 2024 figure represents is factually incorrect. MULTI-HOP SYNTHESIS: The answer attempts to synthesize across three years but introduces an unsupported interpretation about separate accounts that doesn't align with the ground truth characterization of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 497,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings dropped sharply from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (Table 8.1, 2023 – page 178; Table 9.1, 2024 – page 186; Table 8.1, 2022 – page 186). Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, before falling to $44.99 billion in 2024 (same tables). The combined debt load fell from $48.7 billion to $45.6 billion, reflecting a deliberate shift toward a leaner balance sheet, reduced leverage, and a focus on refinancing at lower rates while preserving liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental numerical inaccuracies that severely undermine its credibility. (1) SHORT-TERM BORROWINGS: LLM reports $883M (2022), $538M (2023), $562M (2024), but ground truth indicates these are components of a much larger total debt picture. The LLM appears to have isolated only a subset of short-term borrowings rather than the complete figure. (2) LONG-TERM DEBT: LLM reports $47.8B (2022), $49.3B (2023), $44.99B (2024). Ground truth shows total short-term borrowings AND long-term debt of $43.086B (2022), $49.856B (2023), $45.551B (2024). The LLM's long-term debt figures alone don't match the ground truth totals, indicating a fundamental misunderstanding of what metrics to include. (3) COMBINED TOTALS: LLM claims combined debt fell from $48.7B to $45.6B, but ground truth shows $43.086B to $45.551B in 2024. The LLM's 2022 figure is already higher than ground truth's total. (4) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a key indicator of rising borrowing costs and capital structure strategy. The LLM also fails to mention the reduction in floating unsecured senior debt ($1,709M → $349M → $0), which is explicitly highlighted in ground truth as revealing strategic shift away from variable-rate instruments. (5) REASONING QUALITY: While the LLM's narrative about 'deliberate shift toward leaner balance sheet' and 'refinancing at lower rates' sounds plausible, it contradicts the ground truth's emphasis on rising interest rates and is based on incorrect underlying numbers. The multi-hop synthesis is fundamentally flawed because the source data appears to be misidentified or misread. (6) SEMANTIC ISSUES: The claim about 'refinancing at lower rates' directly contradicts the ground truth showing interest rates RISING from 2.76% to 4.84%, suggesting the LLM either misread the data or fabricated this interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 536,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s carrying amount of the 3.50% Notes Due 2050 was $1,637 million at year‑end 2023 and $1,604 million at year‑end 2024, a modest $33 million decline (page 66 for 2023; page 67 for 2024). In 2022 the liability was $1,637 million, so the debt level has been essentially flat over the three‑year period (page 78). This stability indicates a capital‑structure strategy that relies on long‑term debt to finance growth while keeping leverage levels steady.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 liability value. According to the ground truth, the 3.50% Notes Due 2050 liability was $2,147 million in fiscal 2022, NOT $1,637 million as stated in the LLM answer. This is a major discrepancy of $510 million. The LLM incorrectly claims the 2022 value was $1,637 million (which was actually the 2023 value), leading to a completely wrong conclusion about the trend. SPECIFIC ERRORS: (1) 2022 liability stated as $1,637M when it should be $2,147M - a $510M error; (2) The LLM correctly identifies 2023 as $1,637M and 2024 as $1,604M; (3) The LLM calculates a $33M decline from 2023-2024, which is correct ($1,637M - $1,604M = $33M); (4) However, the LLM's characterization of the trend as 'essentially flat over the three-year period' is fundamentally wrong - there was actually a $543M decline from 2022-2024 ($2,147M - $1,604M = $543M), representing a 25% reduction in this liability. REASONING FAILURE: The LLM failed to properly synthesize the multi-hop data across all three fiscal years. It appears to have confused or misread the 2022 figure, using the 2023 value instead. This led to an inverted conclusion - the LLM suggests stability and steady leverage when the ground truth indicates deliberate reduction and strategic debt management. The interpretation of capital structure strategy is therefore backwards. MULTI-HOP SYNTHESIS: The question requires tracking a single metric (3.50% Notes Due 2050 liability) across three fiscal years and identifying the trend. The LLM failed at this basic synthesis task by providing incorrect data for one of the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 457,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 were issued in 2013 (see Exhibit 4.3 in the 2024 10‑K, page 54) and are listed in the “Description of Securities” exhibit in each of the 2022 (page 54), 2023 (page 53), and 2024 (page 54) Form 10‑Ks. This consistent inclusion—despite the notes maturing in 2016—shows Apple’s systematic, transparent long‑term debt disclosure strategy, ensuring investors see the full history of all debt issuances, not just those currently outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) All key facts are correct - the 0.45% Notes were issued in 2013, matured in 2016, and are consistently referenced in 2022, 2023, and 2024 10-K filings. (2) Specific exhibit references are provided (Exhibit 4.3) with page numbers (54, 53, 54), demonstrating detailed sourcing. (3) The multi-hop synthesis is sound: the answer correctly identifies the pattern across three years and explains the strategic implication (transparency and legal continuity). (4) The reasoning about Apple's disclosure strategy is logically sound - maintaining legacy debt disclosures post-maturity for transparency and historical completeness. (5) The answer directly addresses both parts of the question: how the disclosure evolved (consistent inclusion across years) and what it indicates about strategy (systematic, transparent approach showing full debt history). Minor consideration: The LLM provides slightly more specific detail (exhibit numbers and page references) than the ground truth answer, but this is additive rather than contradictory and enhances credibility. The semantic meaning aligns perfectly with the ground truth - both convey that Apple consistently includes this historical debt instrument in its filings as part of a transparency-focused disclosure strategy. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 386,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s fair‑value of net derivative assets (liabilities) rose from $19 million in 2022 to $58 million in 2023 and $69 million in 2024, while the swap‑rate input used in the Level 3 valuation climbed from a 1‑2 % range (average 2 %) in 2022 to a 3‑5 % range (average 4 %) in 2023 and a flat 4 % in 2024. This upward trajectory signals expanding derivative exposure and a shift toward higher‑rate assumptions in the valuation models, underscoring the company’s growing sensitivity to interest‑rate movements and its reliance on significant unobservable inputs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - Multiple significant factual inaccuracies: (1) WRONG NUMBERS: LLM states 2022 fair value was $19M (ground truth: $31M), 2024 was $69M (ground truth: $58M). These are material errors in core financial metrics. (2) WRONG RISK INPUTS: LLM claims 'swap-rate input' was the significant unobservable input in 2022-2023, but ground truth shows 'default' was the significant input in 2023, and 'swap rates' only appeared in 2024. LLM incorrectly backdates the swap-rate focus. (3) WRONG PERCENTAGES: LLM cites 1-2% range (avg 2%) for 2022 swap rates, but ground truth doesn't mention swap rates as the key input until 2024 when it was 4%. The percentage progression is fabricated. (4) INCOMPLETE SYNTHESIS: LLM misses the critical insight that the significant unobservable input SHIFTED from 'default' (2023) to 'swap rates' (2024), which is the core finding about evolving risk drivers. (5) MISSING CONTEXT: LLM omits the $20M net unrealized loss in 2022 and the $43M realized losses mentioned in ground truth, which are important for understanding the multi-year progression. (6) FLAWED REASONING: The conclusion about 'upward trajectory' and 'expanding derivative exposure' is contradicted by the actual data showing stable $58M valuations in 2023-2024. The LLM appears to have confused or fabricated the 2024 figure of $69M. This answer demonstrates fundamental misreading of the source data with multiple invented numbers and incorrect characterization of the risk input evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 413,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s net carrying amount for the 1.55% Notes due 2028 remained at $1.25 billion from FY 2022 through FY 2024 (see the debt schedule in page 72), while the fair value of the notes rose modestly from $1.099 billion in FY 2023 to $1.115 billion in FY 2024 (page 67). This steady exposure shows that NVIDIA’s long‑term debt strategy focuses on maintaining a predictable, low‑interest borrowing base to fund growth without increasing leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that directly contradict the ground truth. (1) INCORRECT NUMBERS: The LLM claims the net carrying amount remained at $1.25 billion from FY 2022 through FY 2024, but the ground truth shows: FY 2022: $1.2 billion, FY 2023: $1.1 billion, FY 2024: $1.25 billion. The LLM completely missed the variation across years, particularly the $1.1 billion figure in 2023. (2) INCOMPLETE FAIR VALUE DATA: The LLM provides fair value figures for FY 2023 ($1.099 billion) and FY 2024 ($1.115 billion), but the ground truth does not mention these specific fair value numbers, and the LLM provides no FY 2022 fair value data, making the comparison incomplete. (3) FAILED MULTI-HOP SYNTHESIS: The question asks how the exposure 'evolved' from 2022-2024, requiring tracking the progression across three years. The LLM incorrectly states the amount 'remained at $1.25 billion' when it actually fluctuated ($1.2B → $1.1B → $1.25B). This is a fundamental failure to capture the evolution requested. (4) MISCHARACTERIZATION OF STRATEGY: The LLM's conclusion that the 'steady exposure' reflects a strategy of 'maintaining a predictable, low-interest borrowing base' is contradicted by the actual data showing a dip in 2023 followed by an increase in 2024. The ground truth correctly identifies this as 'consistent long-term debt position...with a slight increase in 2024 after a minor reduction in 2023.' (5) PAGE REFERENCES: The LLM cites specific pages (72, 67) without verification against the actual filings, which appears to be fabricated detail. The core answer fails on quantitative accuracy due to the incorrect claim that the amount remained constant when it clearly varied year-to-year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 477,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 10‑K filings from 2022 through 2024 consistently reference trailing legal liabilities that stem from the 2015 Alstom acquisition and shareholder suits over past financial reporting.  Each year’s disclosure—2022 (page 73), 2023 (page 36), and 2024 (page 33)—uses identical language to describe ongoing legacy proceedings, expected cash outflows, and reserves, showing no substantive change in exposure.  This continuity indicates that these contingent liabilities remain persistent and continue to pose a material financial risk that could materially affect GE’s cash flows and financial position.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core issue—GE's persistent legal liabilities from the 2015 Alstom acquisition and shareholder lawsuits spanning 2022-2024. It accurately notes that these matters remained consistent across the three-year period and correctly identifies them as material financial risks. The semantic understanding of the question is sound, and the answer appropriately emphasizes the persistence and lack of diminishment of these liabilities. WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific page numbers (page 73 for 2022, page 36 for 2023, page 33 for 2024) without verification. These page citations cannot be confirmed against the ground truth and may be fabricated or inaccurate. This is a significant concern as it suggests potential hallucination of specific filing details. (2) INCOMPLETE SYNTHESIS: The ground truth provides a more detailed multi-hop synthesis showing the evolution across years—2022 (legacy proceedings with cash outflows), 2023 (reiteration with emphasis on potential to exceed estimates), and 2024 (continued shareholder lawsuits plus acknowledgment of contingent liabilities from exited businesses). The LLM answer states there was 'no substantive change' but doesn't capture the nuanced progression described in the ground truth regarding how the company's characterization and emphasis evolved. (3) MISSING DETAILS: The ground truth mentions specific aspects like 'claims of anti-competitive conduct or corruption,' 'reputational risks,' and 'contingent liabilities from exited businesses' that the LLM answer omits. (4) VAGUE LANGUAGE: The LLM uses 'identical language' and 'continuity' but doesn't substantiate this claim with actual textual evidence or specific liability amounts. The ground truth is more specific about what changed (emphasis on potential to exceed estimates, acknowledgment of broader contingent liabilities). CALCULATION/VERIFICATION: No specific dollar amounts are provided in either answer, so quantitative verification is limited. However, the LLM's citation of specific page numbers without corroboration is problematic. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but oversimplifies the progression by claiming 'no substantive change' when the ground truth suggests a more nuanced evolution in how GE characterized and disclosed these risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 638,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan grew its hedge‑fund limited‑partnership exposure from **$225 million in 2022 to $280 million in 2024** (page 174 and page 166), a $55 million increase.  The plan’s target allocation for hedge funds rose from 3 % in 2022 to 4 % in 2024 (page 169), underscoring a deliberate shift toward greater alternative‑investment exposure to enhance returns and diversify risk while keeping these holdings measured at NAV rather than through the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG 2022 BASELINE: LLM states $225 million in 2022, but ground truth shows $214 million in 2022. This is a $11 million discrepancy on the starting value. (2) WRONG 2024 VALUE: LLM claims $280 million in 2024, but ground truth shows $252 million in 2024. This is a $28 million error on the ending value - a 11% overstatement. (3) WRONG CALCULATED CHANGE: LLM calculates a $55 million increase ($225M to $280M), but the correct increase from 2022 to 2024 is $38 million ($214M to $252M). This calculation error compounds the initial data errors. (4) MISSING 2023 DATA: Ground truth explicitly includes the 2023 intermediate value of $225 million, showing a three-year progression. The LLM only provides 2022 and 2024, missing the complete picture of the 'consistent upward trend' mentioned in ground truth. (5) PERCENTAGE CLAIMS UNVERIFIED: The LLM claims target allocation rose from 3% to 4%, but these specific percentages cannot be verified against the ground truth provided and appear to be fabricated or misread. (6) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution and what it suggests about strategy. While the LLM attempts to address strategy implications (alternative investment exposure, risk diversification), the foundation is built on incorrect numbers, making the strategic interpretation unreliable. The ground truth's characterization of a 'consistent upward trend' across all three years ($214M → $225M → $252M) is more accurate than the LLM's two-point comparison with inflated figures. The LLM does correctly identify that this represents a strategic shift toward alternative investments, but this insight is undermined by the pervasive numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 497,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 Africa/Eurasia generated an operating profit of **$228 million** (page 116). In 2023 the Global Productivity Initiative allocated roughly **5 % of the $32 million restructuring charges** to the region—about **$1.6 million** (pages 86‑87). In 2024 depreciation and amortization for Africa/Eurasia was **$8 million**, a slight decline from $9 million in 2023, indicating a modest but steady investment in maintaining the region’s assets (page 117).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its credibility: (1) OPERATING PROFIT ERROR: LLM states $228 million for 2022, but ground truth is $203 million—a $25 million discrepancy (12% error). This is a significant quantitative error on a core metric. (2) RESTRUCTURING CHARGES ERROR: LLM claims 5% of $32 million restructuring charges (~$1.6 million) allocated to Africa/Eurasia, but ground truth indicates 10% of $20-24 million (~$20-24 million). This is a massive error—the LLM understated the restructuring allocation by approximately 93% ($1.6M vs $20-24M). The percentage is also wrong (5% vs 10%) and the base amount is incorrect ($32M vs $20-24M). (3) DEPRECIATION/AMORTIZATION: The LLM correctly identifies $8 million for 2024 and $9 million for 2023, which matches ground truth. However, the ground truth also notes the 2022 figure was $9 million, which the LLM omits. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to address all three years, the synthesis is compromised by the incorrect numbers. The narrative about 'modest but steady investment' contradicts the actual data showing significant restructuring charges. (5) MISSING CONTEXT: The LLM fails to capture the strategic narrative of cost optimization and the 2022 Global Productivity Initiative context that frames the restructuring charges. The ground truth provides a coherent 3-year trajectory showing cost optimization focus; the LLM's incorrect numbers obscure this narrative. The only correct element is the 2024 depreciation/amortization figure and the general direction of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 440,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022, AIG reported a modeled loss estimate of **$1.3 billion** for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, with international attachment points of **$200 million for Japan and $100 million for the rest of the world**. By 2024, the company had **reduced the Japan attachment point to $150 million and increased the rest‑of‑world point to $125 million**, while its reinsurance recoverable assets fell from **$67.5 billion in 2023 to $38.0 billion at year‑end 2024**, indicating a tightening of recoverable exposure; no new modeled loss estimate for international terrorism was disclosed in 2023 or 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) ATTACHMENT POINT ERRORS: LLM states Japan attachment point was $200M in 2022 and was 'reduced to $150M' by 2024, but ground truth shows Japan remained at $200M throughout the period. LLM claims rest-of-world was $100M in 2022 and 'increased to $125M' by 2024, but ground truth shows it was $125M throughout. This represents a fundamental factual error about how these metrics evolved. (2) REINSURANCE RECOVERABLE ASSETS: LLM claims assets 'fell from $67.5 billion in 2023 to $38.0 billion at year-end 2024.' Ground truth only confirms $38.0 billion in 2024 with $29.1 billion in ceded loss reserves, but does not mention a $67.5 billion figure for 2023. This appears to be fabricated data. (3) CORRECT ELEMENTS: The $1.3 billion modeled loss estimate for 2022 is correct. The $38.0 billion reinsurance recoverable assets for 2024 is correct. (4) MISSING INFORMATION: LLM fails to mention the $1.7 billion TRIPRA deductible from 2022. LLM correctly notes no new modeled loss estimate was disclosed in 2023-2024, which aligns with ground truth. (5) MULTI-HOP REASONING: The answer attempts to synthesize evolution across years but does so incorrectly by inventing changes in attachment points that did not occur and citing a non-existent 2023 figure. The core narrative of 'tightening of recoverable exposure' is not supported by the ground truth, which emphasizes 'expansion in reinsurance protections.' This represents a significant mischaracterization of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 412,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The 2.00 % Notes Due 2031 fell from about $1.20 billion in FY 2022 to $1.044 billion in FY 2023, then rose to roughly $1.25 billion in FY 2024 (see Note 9, page 67 and Note 12, page 72). This modest fluctuation shows NVIDIA is keeping the long‑term debt level relatively stable—re‑financing or issuing new notes to replace maturing debt while still using the low‑rate 2031 notes to fund growth, indicating a conservative, balance‑sheet‑friendly debt‑management approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures: $1.20 billion (2022), $1.044 billion (2023), and $1.25 billion (2024). The numbers match the ground truth exactly, and the format variations are appropriately handled. The answer correctly identifies the trend pattern and provides reasonable interpretation of NVIDIA's debt management strategy. However, there are some differences in depth and framing compared to the ground truth: (1) The LLM answer mentions 'refinancing or issuing new notes to replace maturing debt' which adds interpretive detail not explicitly stated in the ground truth, though this is a reasonable inference. (2) The ground truth emphasizes 'strategic intent to preserve stable long-term liabilities' and connection to 'R&D and operational investments,' while the LLM focuses more on 'conservative, balance-sheet-friendly' approach. (3) The LLM answer references specific page numbers (Note 9, page 67 and Note 12, page 72), which adds credibility but cannot be verified against the ground truth. (4) The ground truth explicitly notes the 2023 decrease 'possibly reflecting minor debt repayments or reclassifications,' while the LLM's explanation of refinancing is slightly different but not contradictory. The multi-hop reasoning is sound—the LLM correctly synthesizes the three-year trend and connects it to debt management strategy. The characterization of the pattern as 'modest fluctuation' and 'relatively stable' aligns well with the ground truth's assessment. Minor deduction for slightly less comprehensive contextual analysis regarding the strategic purpose (R&D and operational investments) compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 461,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple issued the 1.05% Notes due 2017 in 2014 (Officer’s Certificate dated May 6 2014) and they matured in 2017, as shown in the description of securities in the 2022 and 2024 10‑K filings (page 56). By the 2022–2024 filings the instrument is no longer outstanding, illustrating Apple’s disciplined, long‑term debt‑management strategy and clear maturity schedule that ensures continuity and transparency in its debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims the 1.05% Notes due 2017 'matured in 2017' and 'is no longer outstanding' by 2022-2024. However, the ground truth explicitly states the notes 'remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments' and were 'continued to be a documented part of Apple's ongoing capital structure.' This is a fundamental contradiction. (2) MISINTERPRETATION - The LLM misunderstands what 'persistent inclusion in subsequent filings' means. The ground truth indicates the notes were still referenced/documented in 2022, 2023, and 2024 filings, not that they had been retired. (3) INCOMPLETE SYNTHESIS - The LLM provides specific details (Officer's Certificate date of May 6, 2014; page 56 reference) that may be accurate but fails to address the core question about how the instrument 'evolved' across the three years and what its continued presence reveals. The LLM's conclusion that the instrument is 'no longer outstanding' directly contradicts the ground truth's assertion of consistent reference across all three years. (4) REASONING FAILURE - The LLM's logic that maturity in 2017 means non-existence in 2022-2024 filings ignores the ground truth's explanation that the notes may have been 'rolled over, refinanced, or retained in documentation.' The answer demonstrates a failure to synthesize the multi-hop information correctly and arrives at an opposite conclusion from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 430,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022, under the 2019 IDA agreement, Schwab could migrate up to **$10 billion of IDA balances each year**—but only floating‑rate balances—and had to keep a **minimum $50 billion IDA balance** while ensuring **80 % of balances were fixed‑rate through 2026**【page_102】. The 2023 IDA agreement replaced those terms, **eliminating the $10 billion cap and the fixed‑rate requirement** and instead imposing new balance limits: a **$30 billion maximum above fixed‑rate balances until September 10 2025**, then a **$60 billion minimum and $90 billion maximum thereafter**; Schwab did not migrate any balances in 2023 or 2024【page_102】【page_100】. Thus, Schwab’s migration ability shifted from a capped, fixed‑rate‑restricted regime to a more flexible but still constrained framework governed by evolving minimum/maximum balance thresholds and capital considerations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more detailed information than the ground truth but contains several factual inaccuracies and unsupported claims that significantly impact correctness:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2019 IDA agreement allowed up to $10 billion annual migration\n- Correctly states Schwab did not migrate balances in 2023 or 2024\n- Correctly identifies the transition from the 2019 to 2023 IDA agreement\n- Correctly captures the shift from active migration to constrained off-balance sheet management\n- Appropriate multi-hop synthesis across 2022-2024 period\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- Claims the $10 billion cap applied only to \"floating-rate balances\" - the ground truth states $10.1 billion was migrated without this restriction specified\n- States a \"minimum $50 billion IDA balance\" requirement in 2022 - NOT mentioned in ground truth\n- Claims \"80% of balances were fixed-rate through 2026\" requirement - NOT mentioned in ground truth\n- States the 2023 agreement eliminated \"the fixed-rate requirement\" - this requirement was never established in ground truth for 2022\n- Provides specific balance thresholds for 2023 agreement ($30B maximum until Sept 10 2025, then $60B minimum/$90B maximum) - these specific numbers are NOT in the ground truth\n- The ground truth only mentions \"new minimum and maximum balance thresholds\" without specifying the exact amounts\n\nQUANTITATIVE ACCURACY ISSUES:\nThe LLM introduces multiple specific dollar amounts and percentages ($50B minimum, 80% fixed-rate, $30B/$60B/$90B thresholds) that cannot be verified against the ground truth and appear to be hallucinated or from unreliable sources. This is a critical error in financial reporting.\n\nQUALITATIVE ASSESSMENT:\nThe reasoning structure is sound - the LLM correctly identifies the evolution and transition. However, the addition of unverified specific numbers undermines the credibility of the analysis. The semantic understanding of the shift from active migration to constrained management is correct.\n\nCONTEXTUAL RELEVANCE:\nThe answer directly addresses the question about migration ability evolution and key changes, though it adds details beyond what can be confirmed from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 601,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "GE’s exposure to Bank BPH’s borrower litigation grew from an estimated loss of $1.36 billion in 2022 to $2.67 billion in 2023, then eased to $2.46 billion in 2024 (page 52, 50). To shore up capital, GE injected $530 million in cash in 2022 and later forgave $1.80 billion of inter‑company debt in 2023, with no further cash contribution in 2024 (page 52, 48). The Polish mortgage portfolio’s carrying value was fully offset by valuation allowances, leaving a net zero balance as of December 31 2023 and 2024 (page 48, 50).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: (1) Estimated losses: $1.36B (2022) → $2.67B (2023) → $2.46B (2024) - all correct with acceptable format variations; (2) Capital contributions: $530M cash (2022) and $1.80B intercompany debt forgiveness (2023) - both accurate; (3) Carrying value: correctly identified as zero/fully offset by valuation allowances by end of 2023 and 2024. Multi-hop synthesis: The answer successfully synthesizes information across three years and multiple financial metrics (estimated losses, capital contributions, carrying values), showing the evolution from 2022 through 2024. The narrative correctly captures the escalation in 2023 followed by stabilization in 2024. Minor observations: (1) The LLM slightly compresses the narrative by not explicitly mentioning the Q2 2023 settlement charge of $1,014M, though this is a minor omission that doesn't affect the core answer's accuracy; (2) The characterization of the portfolio as \"Polish mortgage portfolio\" is accurate and adds helpful context; (3) The phrase \"fully offset by valuation allowances, leaving a net zero balance\" is semantically equivalent to \"full valuation write-down.\" Entity accuracy is correct throughout (GE, Bank BPH, years 2022-2024). The reasoning is sound and the answer appropriately addresses all parts of the multi-part question regarding financial exposure evolution, strategic handling, estimated losses, capital contributions, and carrying value changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 419,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "From 2022 to 2023, CVS’s commercial mortgage‑backed securities (CMBS) fair value climbed from **$992 million to $1,066 million** while unrealized losses fell from **$155 million to $100 million** (page 149). In 2024 the company’s CMBS exposure in separate accounts dropped to **$3 million** (down from $6 million in 2023) with no unrealized losses reported (page 160). This pattern—higher fair value coupled with lower losses and a subsequent trimming of CMBS holdings—suggests CVS is actively managing interest‑rate and credit‑quality risk by limiting exposure and maintaining a conservative, loss‑controlled investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth across all years examined. Specific errors: (1) 2022 CMBS fair value: LLM states $992 million vs. ground truth $574 million (73% overstatement); (2) 2023 CMBS fair value: LLM states $1,066 million vs. ground truth $675 million (58% overstatement); (3) 2022 unrealized losses: LLM states $155 million vs. ground truth $12 million (1,192% overstatement); (4) 2023 unrealized losses: LLM correctly states $100 million (matches ground truth); (5) 2024 CMBS fair value: LLM states $3 million (matches ground truth); (6) 2024 unrealized losses: LLM states zero vs. ground truth not explicitly stated but implied minimal. The LLM's narrative interpretation of the trend is also incorrect—it describes fair value as 'climbing' from 2022-2023 when ground truth shows an increase from $574M to $675M (14% increase, not the 7% increase the LLM's numbers would suggest). More critically, the LLM misses the dramatic 2024 collapse from $675M to $3M, which is the most significant finding. The LLM's conclusion about 'higher fair value coupled with lower losses' is contradicted by the ground truth showing unrealized losses rising sharply from $12M to $100M between 2022-2023. The multi-hop synthesis fails because the LLM appears to have retrieved data from incorrect rows or misidentified CMBS holdings. The reasoning about risk management strategy is partially sound in concept but built on false premises, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 424,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑brand lineup—including Marketside—was unchanged from FY 2022 through FY 2024, with the same 23 private labels listed in each filing (Allswell, Athletic Works, Bonobos Fielder, Eloquii Elements, Equate, Free Assembly, Freshness Guaranteed, George, Great Value, Holiday Time, Hyper Tough, Mainstays, Marketside, No Boundaries, onn., Ozark Trail, Parent’s Choice, Sam’s Choice, Scoop, Spring Valley, Time and Tru, Way to Celebrate, Wonder Nation) (page_8 FY2022, page_8 FY2023, page_8 FY2024). This steady lineup over three years signals that Walmart’s grocery private‑label strategy prioritizes a stable, broad assortment of low‑price brands to support its EDLP model and customer loyalty, rather than frequent brand churn (page_8 FY2022, page_8 FY2023, page_8 FY2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The LLM claims that Walmart's private brand lineup was 'unchanged' with 'the same 23 private labels listed in each filing' from FY2022-2024. However, the ground truth explicitly states that by 2024, Walmart 'introduced new private brands like bettergoods,' indicating the lineup was NOT unchanged. The LLM's assertion of a static 23-brand portfolio across all three years is factually incorrect. The LLM lists 23 specific brands but fails to account for the introduction of 'bettergoods' in 2024, which the ground truth identifies as a key strategic development. Additionally, the LLM's interpretation of the strategy differs significantly: it emphasizes 'stability' and 'no brand churn,' while the ground truth emphasizes a 'dual approach' of 'preserving trusted private brands while innovating.' The LLM misses the strategic expansion and modernization aspect that is central to understanding Walmart's 3-year progression. The LLM does correctly identify Marketside as a consistent element and provides appropriate page references, but the core narrative about portfolio evolution is fundamentally flawed. The quantitative claim about '23 private labels' being identical across three years cannot be verified as correct given the introduction of new brands in 2024. The reasoning about EDLP model support is reasonable but doesn't address the actual strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 410,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022‑2024, Lowe’s broadened supplier oversight by updating its human‑rights policy to address modern slavery, adding a conflict‑minerals policy, and tightening its Vendor Code of Conduct with enhanced environmental standards. In 2023 it overhauled its wood‑sourcing policy—introducing country‑specific risk levels, improved monitoring, and a forestry grievance process—and in 2024 it further refined that policy with a risk‑based approach and new monitoring tools. The company also invested $300‑$400 million in energy‑efficiency and renewable‑energy projects, encouraged suppliers to report scope‑3 emissions to CDP, and set a net‑zero target for scope 1‑3 emissions by 2050 to strengthen supply‑chain sustainability.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer states investments of '$300-$400 million in energy-efficiency and renewable-energy projects,' which directly contradicts the ground truth that specifies 'multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives.' The LLM's figure is significantly lower and appears to conflate or misrepresent the investment amounts. This is a critical factual error on a key quantitative claim. QUALITATIVE STRENGTHS: The LLM correctly identifies the evolution of policies across the three-year period (2022-2024), accurately mentions the 2023 wood-sourcing policy overhaul with country-specific risk levels, improved monitoring, and forestry grievance process, and correctly notes the 2024 refinements with risk-based approach. The mention of human rights policy, conflict minerals policy, and Vendor Code of Conduct updates is appropriate. QUALITATIVE WEAKNESSES: The LLM introduces information about CDP scope-3 emissions reporting and net-zero 2050 targets that are not mentioned in the ground truth, which may represent either additional context or potential hallucination. The answer doesn't clearly distinguish between the specific investments mentioned in the ground truth ($550M+ by 2022, $400M+ through 2023) versus energy-efficiency projects. MULTI-HOP REASONING: The answer does synthesize information across the three-year period and shows progression, but the investment figures are fundamentally incorrect, undermining the credibility of the multi-hop synthesis. The policy evolution narrative is sound but incomplete compared to ground truth. OVERALL: While the qualitative policy evolution is reasonably captured, the significant quantitative error on investments (the most concrete, verifiable claim) substantially reduces the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 508,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 in its 2022 10‑K as part of the “Description of Securities” exhibit (page_58). The 2023 10‑K, as shown in the provided pages, contains no reference to those notes, implying they had matured or been repaid by year‑end 2023 (pages 53‑57). The 2024 10‑K again lists the 2.40% Notes due 2023 in the same exhibit (page_58), indicating Apple re‑issued or retained similar debt and reflecting a disciplined approach to short‑term debt issuance and retirement to support liquidity and a flexible capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Disclosure Pattern: The ground truth states Apple consistently included the 2.40% Notes due 2023 in filings for 2022, 2023, AND 2024. The LLM claims the 2023 10-K contains 'no reference' to those notes, which is factually incorrect according to the ground truth. This is a major multi-hop synthesis failure. (2) CRITICAL ERROR - Maturity Assumption: The LLM incorrectly infers the notes 'had matured or been repaid by year-end 2023' based on absence from 2023 filing, but the ground truth explicitly states the notes appeared in 2023 filings. (3) CRITICAL ERROR - Re-issuance Claim: The LLM speculates Apple 're-issued or retained similar debt' in 2024, but the ground truth indicates the SAME 2.40% Notes due 2023 were consistently disclosed across all three years - not a re-issuance. (4) INTERPRETATION ERROR - Strategy Assessment: The LLM characterizes the pattern as 'disciplined approach to short-term debt issuance and retirement,' which misrepresents the actual pattern of consistent disclosure of the same legacy debt instrument. The ground truth describes this as 'sustained transparency' and 'stable and transparent debt disclosure strategy,' not active debt cycling. (5) PAGE REFERENCE ISSUES: The LLM cites specific page numbers (53-57, 58) that cannot be verified against the ground truth, and the claim about 2023 10-K having no reference contradicts the stated ground truth. The LLM fundamentally failed to correctly synthesize the three-year disclosure pattern and misinterpreted what the consistent inclusion of the same notes indicates about Apple's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 466,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note holdings grew from $900 million at the end of 2022 to $944 million at the end of 2023 and stayed at that level through 2024. The modest, incremental rise followed by stability indicates a cautious, risk‑managed approach that prioritizes investment‑grade debt while monetizing equity interests elsewhere, reflecting a deliberate strategy of maintaining a steady, long‑term debt exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ERRORS - Critical discrepancies in all three years: The LLM states 2022 holdings at $900 million when ground truth shows $976 million (off by $76M or 7.8%); 2023 is correct at $944 million; 2024 is stated as $944 million when ground truth shows $982 million (off by $38M or 4.0%). The LLM's claim that holdings 'stayed at that level through 2024' is factually incorrect - there was a $38 million increase from 2023 to 2024. (2) TREND MISCHARACTERIZATION - The LLM describes a 'modest, incremental rise followed by stability,' but the actual pattern is: decrease ($976M to $944M), then increase ($944M to $982M). This is a fluctuation pattern, not monotonic growth followed by stability. The ground truth correctly identifies this as 'fluctuation' with 'slight overall stability' (2022-2024 net change of only $6M despite interim movements). (3) REASONING QUALITY - While the LLM's interpretation about 'cautious, risk-managed approach' and 'steady, long-term debt exposure' is plausible reasoning, it is built on incorrect numerical foundations. The actual data pattern (decrease then increase back near original levels) better supports the ground truth's characterization of 'dynamic approach' rather than the LLM's 'modest rise followed by stability.' (4) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year progression. The ground truth appropriately contextualizes the AerCap holdings within broader portfolio changes, while the LLM makes unsupported claims about 'monetizing equity interests elsewhere' without evidence from the provided context. The answer demonstrates fundamental misreading of the financial data across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 484,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy – which ties the “return‑seeking” portion of the U.S. pension portfolio to the plan’s funded ratio and prevailing interest rates – remained unchanged from 2022 through 2024, but the target mix was shifted to a more conservative stance as the plan became better funded.  In 2022 the glide path called for 15 % equity, 75 % fixed‑maturity and 10 % other; by 2024 the target had moved to 9 % equity, 80 % fixed‑maturity and 11 % other, reflecting a deliberate reduction in growth assets and an increase in liability‑hedging assets.  This progression demonstrates AIG’s de‑risking strategy: as the funded ratio improves, the plan systematically lowers equity exposure and boosts fixed‑income holdings to reduce risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of AIG's glide path de-risking strategy and correctly identifies the core concept that the plan shifted toward more conservative allocations as funded status improved. The qualitative reasoning about the relationship between funded ratio improvement and reduced equity exposure is sound and aligns with the ground truth's characterization of liability-driven investing principles.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. SPECIFIC ALLOCATION PERCENTAGES: The LLM provides specific target allocations (2022: 15% equity, 75% fixed-maturity, 10% other; 2024: 9% equity, 80% fixed-maturity, 11% other) that cannot be verified against the ground truth. The ground truth does not provide these specific percentage breakdowns, only describing the general progression of \"reduced allocation to growth assets while increasing allocation to liability-hedging assets.\" Without access to the actual SEC filings, these specific numbers appear to be either fabricated or from a different source than the knowledge graph.\n\n2. TEMPORAL FRAMING: The LLM states \"In 2022 the glide path called for...\" and \"by 2024 the target had moved to...\" but the ground truth indicates a more nuanced temporal relationship: the 2022 target was based on 2021 funded status, the 2023 target was based on 2022 funded status, and the 2024 target was based on 2023 funded status. The LLM's framing is somewhat simplified.\n\n3. POLICY CHARACTERIZATION: The LLM describes the glide path as \"unchanged from 2022 through 2024\" while the ground truth emphasizes the \"consistent\" application of the approach across years. This is a subtle but important distinction - the policy framework remained consistent, but the target allocations evolved based on funded status changes.\n\n4. COMPLETENESS: The LLM does address the multi-hop synthesis required (evolution over time, de-risking strategy, funded status relationship) but lacks the specific temporal detail about how each year's target was determined based on the prior year's funded status.\n\nThe answer is contextually relevant and demonstrates understanding of pension plan de-risking, but the unverified specific percentages and simplified temporal framing reduce confidence in the quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 616,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept embedded‑processing at the heart of its strategy from 2022 through 2024, with each MD&A (2022 page 19; 2023 page 18; 2024 page 19) stating that its strategic focus is on analog and embedded‑processing products.  The company repeatedly ties that focus to long‑term free‑cash‑flow‑per‑share growth (2022 page 21; 2023 page 20; 2024 page 20), underscoring that embedded‑processing remains a core driver of the cash‑generating model that fuels shareholder value over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Texas Instruments' strategic evolution of embedded processing products from 2022-2024. STRENGTHS: (1) Correctly identifies the core finding that embedded processing remained consistently emphasized across all three years (2022-2024); (2) Accurately notes the pairing of embedded processing with analog as key product lines; (3) Properly synthesizes the connection between embedded processing focus and long-term free cash flow per share growth across multiple years; (4) Provides specific MD&A page references (2022 page 19, 2023 page 18, 2024 page 19 for strategic focus; 2022 page 21, 2023 page 20, 2024 page 20 for FCF/share connection), demonstrating multi-hop synthesis across documents; (5) Uses appropriate terminology ('core driver,' 'foundational pillar' concept implied through 'core driver'). MINOR WEAKNESSES: (1) The answer is more concise than the ground truth and omits some specific qualitative language from the original filings (e.g., the exact phrase 'more opportunity per customer and more value for our investments' from 2023, or the explicit mention of 'supply chain control, customer reach, and diversified returns' from 2024); (2) Does not explicitly characterize embedded processing as 'not a tactical shift but a foundational pillar,' though the answer's emphasis on consistency implies this; (3) The answer could have been slightly more detailed in explaining what the multi-year consistency reveals about the strategic importance. QUANTITATIVE VERIFICATION: Page references appear reasonable for 10-K MD&A sections, though specific verification of exact page numbers is not possible without access to the actual filings. The years (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple sections of filings (strategic focus sections and cash flow sections), correctly linking the strategic emphasis to financial outcomes. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 559,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s IP strategy has consistently protected its private‑brand names—including Kobalt—through trademarks, domain names and patents, as noted in the 2022, 2023 and 2024 10‑K intellectual‑property sections (page 7).  Over the same period the company has shifted its product‑selection narrative to highlight high‑value private brands (2023 and 2024 product‑selection sections, page 6) and has woven those brands into its expanding omnichannel and digital ecosystem—online shopping, mobile apps and digital inspiration tools—supporting its broader digital‑transformation agenda (2023 and 2024 omnichannel sections, page 5–6).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the general topic of Lowe's IP strategy and digital transformation but fails to accurately capture the specific evolution detailed in the ground truth. Critical issues: (1) The LLM does not mention the specific brand portfolio changes across fiscal years—it fails to note that RONA and Reno Depot were listed in 2022 but removed by 2023, which is a key factual element of the ground truth's narrative about 'streamlining' and 'refocusing.' (2) The LLM provides vague references to '2022, 2023 and 2024' and page numbers without substantiating the specific brand portfolio evolution that occurred. (3) The ground truth explicitly identifies a three-year progression: FY2022 (broader listing including RONA/Reno Depot) → FY2023 (streamlined to three brands) → FY2024 (same three brands plus digital context). The LLM answer treats the strategy as 'consistent' rather than showing this evolution. (4) While the LLM correctly identifies that digital transformation was integrated (omnichannel, mobile apps, digital tools), it does not establish the temporal progression showing that digital language was 'introduced' in FY2024 as new context. (5) The LLM mentions 'high-value private brands' emphasis in 2023-2024 but does not connect this to the removal of RONA/Reno Depot from the IP disclosure. The answer is partially relevant to the question's scope but lacks the specific multi-hop synthesis required: tracking which brands were disclosed in which years and correlating that with digital transformation timing. The answer reads as a general description of Lowe's IP practices rather than a detailed evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 450,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 10‑K filings from 2022 through 2024 consistently list “client relationships and trust” as a core competitive differentiator, showing a sustained focus on building long‑term client partnerships. In 2024 the company expands this emphasis by explicitly pairing trust with security in its hybrid‑cloud platform narrative, underscoring a deeper commitment to secure, trusted AI solutions. This steady, then deepening emphasis signals IBM’s strategic positioning as a trusted partner in the hybrid‑cloud and AI market, leveraging incumbency and expertise to differentiate from competitors and drive growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM consistently emphasized client relationships and trust as a competitive differentiator from 2022-2024, and accurately notes the evolution toward pairing trust with security/AI in 2024. However, the answer has significant gaps in multi-hop synthesis and completeness. STRENGTHS: (1) Correctly identifies the core theme of trust as a sustained differentiator across all three years; (2) Accurately captures the 2024 evolution linking trust to security in hybrid-cloud platforms; (3) Properly synthesizes the strategic positioning conclusion. WEAKNESSES: (1) MAJOR OMISSION - Fails to mention the critical 2023 evolution involving strategic partnerships with AWS, Microsoft, and SAP, which the ground truth identifies as a key turning point in the 3-year trajectory; (2) INCOMPLETE SYNTHESIS - Does not address the ecosystem-driven approach that emerged in 2023 as a bridge between 2022's platform focus and 2024's security emphasis; (3) MISSING ENTITY - Fails to mention Palo Alto Networks as a strategic cybersecurity partner added in 2024, which the ground truth identifies as evidence of growing security emphasis; (4) INCOMPLETE REASONING - The answer presents a 'steady, then deepening' narrative but misses the intermediate 'expansion' phase in 2023 that shows the full strategic evolution; (5) LACKS SPECIFICITY - Does not explain HOW trust evolved (from platform integration → ecosystem partnerships → security partnerships), only that it deepened. The answer is partially correct on the overall trajectory but fails to capture the nuanced multi-year progression that demonstrates IBM's strategic evolution. The omission of 2023 partnerships is a significant gap in multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 480,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "Gilead’s El Segundo, California site moved from a purely clinical cell‑therapy manufacturing role in 2022 to a dual clinical‑and‑commercial manufacturing hub by 2023, a role it continued to play in 2024.  In 2023 the company described the facility as “utilized for clinical and commercial manufacturing and processing of our cell therapy products”【page_12 (2023)】, and the same description appears in the 2024 filing【page_12 (2024)】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution of the facility's role. The LLM claims the facility 'moved from a purely clinical cell-therapy manufacturing role in 2022 to a dual clinical-and-commercial manufacturing hub by 2023,' but the ground truth explicitly states the facility's role 'remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities.' The ground truth indicates the facility was already serving a DUAL role (clinical AND commercial) in 2022, not a purely clinical role. This is a major factual error that misrepresents the entire evolution narrative. The LLM correctly identifies that 2023 and 2024 descriptions match ('clinical and commercial manufacturing and processing'), and the citations appear appropriate, but the characterization of 2022 as 'purely clinical' is incorrect and contradicts the ground truth's statement that 2022 already described the facility as serving 'dual role in both trial-related and market-ready production.' The LLM also fails to address the ground truth's key finding about 'consistency' and 'continuity' in the facility's role across all three years, instead framing it as an evolution/change. The answer is incomplete in not discussing 2022's actual dual role and the stability of operations across the period. While the quantitative elements (years, facility location) are correct, the qualitative reasoning about the facility's evolution is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 426,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "From 2022 through 2024 Lowe’s continued to hold its 4.550% Notes that were issued in 2019 with a maturity of April 5, 2049【page_75】, and no new 4.550% Notes were issued during that period.  Instead, the company issued shorter‑term notes to create a staggered maturity ladder—4.400% Notes due 2025 in 2022【page_77】 and 4.800% Notes due 2026 in 2023【page_78】—while keeping the long‑dated 4.550% Notes unchanged.  This multi‑year pattern shows a long‑term debt strategy that relies on a stable, long‑dated fixed‑rate instrument while using shorter‑term debt to manage liquidity and refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 4.550% Notes due April 5, 2049 issued in 2019, and accurately references the issuance of shorter-term notes (4.400% due 2025 and 4.800% due 2026) during the 2022-2024 period. All numeric values, percentages, and dates are correct. The multi-hop synthesis is sound—the answer correctly connects the consistent presence of the long-dated instrument across three years with the strategic issuance of shorter-term debt, demonstrating understanding of Lowe's debt ladder strategy. The reasoning about using shorter-term debt for liquidity management while maintaining long-dated fixed-rate instruments is logically sound and aligns with the ground truth's emphasis on capital structure management and refinancing risk mitigation. The answer goes slightly beyond the ground truth by providing additional context about the staggered maturity ladder strategy, which is relevant and accurate. Minor difference: the ground truth emphasizes the 'consistency' and 'unchanged' nature of the 4.550% Notes as the primary finding, while the LLM answer frames this within a broader debt strategy context that includes the shorter-term issuances. This is not an error but rather a more comprehensive interpretation. The page references provided (75, 77, 78) appear reasonable for a 10-K filing structure. Overall, the answer correctly synthesizes multi-year information and provides accurate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 410,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024, 3M’s exposure to lawsuits over Scotchgard remained largely unchanged— the company continued to face a pending Wolverine‑related class action but reported only immaterial liabilities (2022 10‑K, p. 122; 2023 10‑K, p. 94).  The final settlement payment was made in June 2023, and the 2024 10‑K still lists only immaterial amounts (p. 96).  This trend shows that while PFAS litigation continues to expose 3M to legal risk, the specific costs tied to Scotchgard have been small and have not materially impacted the company’s financial position.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The LLM claims exposure 'remained largely unchanged' and costs were 'small and immaterial,' directly contradicting the ground truth which documents significant expansion of litigation from 2022-2024. The ground truth explicitly mentions a $65 million settlement in 2022 (with Saint-Gobain and Honeywell), another $65 million settlement in New York being finalized in 2024, and expansion to approximately 68 AFFF suits outside the MDL by 2023. (2) QUANTITATIVE INACCURACY: The LLM fails to cite the $65 million settlements documented in the ground truth. While the LLM mentions 'immaterial liabilities,' this contradicts the documented $65 million settlements which are material amounts. The LLM's characterization of costs as 'small' is unsupported by the evidence of multiple multi-million dollar settlements. (3) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information showing geographic expansion (New York, Michigan, Illinois, Canada, Alabama, Georgia) and case complexity growth documented in the ground truth. The answer misses the key trend of escalating litigation across multiple jurisdictions. (4) MISINTERPRETATION: The LLM appears to have confused 'immaterial' accounting classifications (which may apply to individual line items) with the overall financial impact, missing that the company faced material settlement obligations totaling at least $130 million across the period. (5) MISSING CONTEXT: The answer fails to address the 'growing financial burden' and 'escalating liabilities' that are central to the ground truth's assessment of the trend. The LLM's conclusion that Scotchgard costs 'have not materially impacted the company's financial position' directly contradicts the ground truth's finding of 'increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 547,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022, Foster City was described as the corporate headquarters that “houses our administrative, manufacturing and R&D activities” (page 31). By 2023 the facility’s role had become more specialized: it “conducts process chemistry research, analytical method development and formulation and device development activities, and manufactures API and drug product for our clinical trials” (page 11). The same focus is reported for 2024 (page 10). Thus, over this period the site evolved from a broad HQ‑level hub to a dedicated R&D‑manufacturing center that supports early‑stage clinical production, aligning its activities with Gilead’s global pipeline and manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2023-2024 with accurate year citations; (2) Accurately captures the 2022 description of Foster City as 'corporate headquarters' housing 'administrative, manufacturing and R&D activities'; (3) Precisely quotes the 2023-2024 specialized functions: 'process chemistry research, analytical method development and formulation and device development activities, and manufactures API and drug product for our clinical trials'; (4) Correctly synthesizes the strategic shift from broad HQ hub to dedicated R&D-manufacturing center; (5) Appropriately identifies the alignment with early-stage clinical production and global manufacturing strategy; (6) Page citations (31 for 2022, 11 for 2023, 10 for 2024) are provided, enhancing credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information; (2) The ground truth mentions specific alternative locations (La Verne, Oceanside, international sites) handling commercial-scale manufacturing, which the LLM answer does not explicitly detail, though this is a minor omission that doesn't affect the core narrative; (3) The LLM's characterization of the shift as moving from 'broad HQ-level hub to dedicated R&D-manufacturing center' is semantically equivalent to the ground truth's description of 'consolidating R&D and clinical production capabilities.' MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the progression in facility utilization. The logical flow from administrative/manufacturing/R&D generalist role to specialized clinical development and manufacturing is sound. QUANTITATIVE ACCURACY: No numerical errors; dates and year references are correct. ENTITY ACCURACY: Gilead Sciences and Foster City correctly identified throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 542,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "In 2022 AIG’s loss‑reserve oversight was largely business‑unit‑level, with chief risk officers, risk committees and pricing committees reviewing pricing and reserving models, actuarial reserve reviews, and external‑expert assessments of reserve adequacy. By 2023 the company added a formal ERM second‑line review and challenge function that evaluated pricing, reserving, and modeling assumptions, while retaining a model‑risk‑management framework that validated both stochastic and deterministic reserve models. In 2024 the oversight structure expanded further to include ERM second‑line review, internal‑audit audits and continuous monitoring of remediation, and a structured external‑expert review process—all integrated within a comprehensive model‑risk‑management and validation framework that governs the entire loss‑reserve setting process.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AIG's loss reserves risk management evolution from 2022-2024. STRENGTHS: (1) All years and entities are correctly identified (AIG, 2022-2024 timeline). (2) The progression narrative is accurate: 2022 business-unit level oversight → 2023 formal ERM second-line review → 2024 expanded structure with internal audit and continuous monitoring. (3) Key mechanisms are correctly identified: chief risk officers, risk committees, pricing committees, external expert reviews, stochastic/deterministic models, model-risk-management framework. (4) The answer captures the shift from reactive to proactive governance as stated in ground truth. (5) Multi-hop synthesis is sound—correctly connects oversight mechanisms, modeling approaches, and external reviews across three years. MINOR GAPS: (1) The LLM answer is more operationally detailed (mentions 'chief risk officers,' 'pricing committees,' 'internal-audit audits,' 'continuous monitoring of remediation') compared to the ground truth's more conceptual framing of 'sensitivity and scenario analyses' and 'experience studies.' However, these are complementary rather than contradictory. (2) The ground truth emphasizes the shift from 'reactive oversight to proactive, model-driven, and enterprise-wide risk governance' more explicitly as a thematic conclusion, while the LLM answer focuses on structural expansion. (3) The LLM answer doesn't explicitly mention 'sensitivity and scenario analyses' or 'experience studies' that appear in the 2023 ground truth description, though it does reference stochastic and deterministic models which capture similar concepts. QUANTITATIVE ACCURACY: No numbers, percentages, or dollar amounts are present in either answer, so this dimension scores perfectly (10/10). QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct, though the LLM provides more granular operational detail rather than the conceptual framework emphasis of the ground truth. This is not an error but a different emphasis (8/10). CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all three sub-components of the question (oversight mechanisms, modeling approaches, external reviews integration) across the specified time period (9/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 624,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 through 2024 Texas Instruments kept a single Melaka, Malaysia site that is listed only for analog manufacturing (the property table shows an “X” in the Analog column and a blank in Embedded Processing for Melaka in each year’s 10‑K). The tables in TXN_10k_2022.pdf page 16, TXN_10k_2023.pdf page 16, and TXN_10k_2024.pdf page 16 all confirm this unchanged designation. This three‑year consistency indicates TI has maintained a focused analog‑only footprint in Melaka, with no expansion into embedded‑processing production in that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the core fact that Melaka maintained exclusive Analog manufacturing focus from 2022-2024 with no Embedded Processing expansion, matching the ground truth exactly. (2) Provides specific documentary evidence by citing the exact pages (page 16) from all three years' 10-K filings (2022, 2023, 2024), demonstrating multi-hop synthesis across multiple documents. (3) Uses precise language about the property table structure ('X' in Analog column, blank in Embedded Processing) which shows detailed knowledge of the source documents. (4) Correctly characterizes the 3-year progression as 'unchanged designation' and 'focused analog-only footprint,' which aligns perfectly with the ground truth's description of 'stable but specialized role' and 'limited to Analog product lines.' (5) All entities are correct: Texas Instruments (TXN), Melaka Malaysia, Analog vs. Embedded Processing distinction, and the 2022-2024 timeframe. Minor consideration: The answer could have been slightly more explicit about what 'stable' means in business context (e.g., no new capacity additions), but this is a very minor omission that doesn't affect the core accuracy. The reasoning is sound and the multi-hop synthesis across three years of filings is executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 373,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In FY 2022 Lowe’s had a forward‑interest‑rate‑swap notional amount of $2.56 billion (page_61). By FY 2023 the fair value of those swaps had fallen to $251 million (page_54), and by FY 2024 the company had no forward‑interest‑rate‑swap exposure (page_54). This evolution shows that Lowe’s hedging strategy is tightly linked to its forecasted debt issuances, scaling the hedges up when new issuances are expected and trimming or eliminating them as issuances mature or are no longer anticipated (page_46).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct quantitative information but has significant gaps in completeness and reasoning compared to the ground truth. STRENGTHS: (1) Correctly identifies the $251 million fair value for FY 2023 forward interest rate swaps, matching the ground truth. (2) Correctly notes that by FY 2024, Lowe's had no forward interest rate swap exposure. (3) Appropriately references fiscal years 2022-2024 as requested. (4) The general interpretation about hedging strategy being linked to forecasted debt issuances is reasonable. WEAKNESSES: (1) The LLM provides a notional amount of $2.56 billion for FY 2022, but the ground truth does not mention this specific figure - this appears to be an unsupported claim that cannot be verified against the provided ground truth. (2) The LLM answer lacks the important contextual detail that in FY 2022, Lowe's referenced forward swaps in the context of their impact on other comprehensive income and earnings, indicating active use over multiple prior periods (2019-2021). (3) The answer fails to mention the strategic shift to fixed-to-floating interest rate swaps as fair value hedges on existing debt in FY 2024, which is a critical element of understanding the company's hedging strategy evolution. (4) The reasoning about 'scaling hedges up when new issuances are expected and trimming as issuances mature' is somewhat speculative and doesn't fully capture the ground truth's more nuanced explanation of a shift from hedging anticipated debt issuances to managing interest rate exposure on existing debt. (5) The answer is incomplete in explaining what the progression indicates about the company's strategic shift in financial risk management focus. The LLM provides a partial narrative but misses the key insight about the transition from cash flow hedges (forward swaps for anticipated issuances) to fair value hedges (swaps on existing debt).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 515,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 10‑K filings for 2022 (page 31), 2023 (page 21) and 2024 (page 19) all reference the 6.50% Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8, 1998,” with no change in wording or additional detail. The identical, unchanged filing date shows that the debt was issued in 1998 and has remained in force without amendment, underscoring a long‑term, stable debt structure that IBM continues to rely on the original indenture for.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct—the 6.50% interest rate, the 2028 maturity date, the January 8, 1998 filing date, and the specific page numbers (31, 21, 19 for 2022, 2023, 2024 respectively) are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies that IBM referenced the same exhibit across all three years and draws the logical conclusion that this consistency indicates stable, unchanged debt structure with no material amendments. (3) Entity identification is precise: IBM is correctly identified, the debentures are properly characterized, and the Form 8-K reference is accurate. (4) The reasoning about what the consistency of the filing date reveals—that the debt instrument has remained unchanged and stable—directly addresses the question's core inquiry about what consistency reveals about long-term structure and documentation. Minor observation: The LLM answer adds interpretive detail ('the debt was issued in 1998') which is a reasonable inference from the 1998 filing date, though the ground truth focuses more narrowly on what the consistency reveals. This is a minor enhancement rather than an error. The answer fully addresses both parts of the multi-part question: how the disclosure evolved (it didn't—remained identical) and what the consistency reveals (stable, long-standing structure with no amendments). No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 415,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective Signage is listed as a product in the Transportation and Electronics segment in all three years – 2022 (page 131), 2023 (page 107) and 2024 (page 108). In 2024 the segment was reorganized to create the Commercial Branding and Transportation division, which incorporates the former Commercial Solutions and Transportation Safety units, effectively grouping Reflective Signage with other safety‑and‑branding offerings (page 110). The unchanged product listing and its placement in a newly formed safety‑focused division indicate that Reflective Signage remains a core, strategically important component of 3M’s transportation portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. CRITICAL ISSUES: (1) POSITIONING DATA MISSING: The ground truth explicitly tracks Reflective Signage's positioning across three years (5th in 2022, 4th in 2023, 4th in 2024), showing a clear evolution. The LLM answer completely omits this positional analysis, which is the primary focus of the question. (2) INCORRECT STRUCTURAL CLAIM: The LLM states that in 2024 'the segment was reorganized to create the Commercial Branding and Transportation division,' but the ground truth shows Reflective Signage remained within the Transportation and Electronics segment in 2024 (page 108). The LLM appears to have confused or misidentified the segment structure. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about the 'sequence' and 'evolution' across three years. The ground truth provides specific positional rankings for each year and explains what this sequence suggests (consistent top-half placement with a 2023 boost). The LLM provides page references but no actual positional data or comparative analysis across the three years. (4) MISSING STRATEGIC INSIGHT: The ground truth concludes that the consistent top-half positioning 'suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.' The LLM's conclusion about 'core, strategically important component' is vague and unsupported by the positional evidence that should have been presented. (5) QUANTITATIVE ACCURACY: The LLM provides page numbers but no positional rankings or comparative metrics. The ground truth provides specific ordinal positions (5th, 4th, 4th) which are verifiable facts that the LLM completely omits. The answer reads more like a general statement about segment reorganization rather than a detailed analysis of Reflective Signage's evolving position within the product portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 520,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site is identified in both the 2023 and 2024 10‑K filings as a commercial manufacturing and processing facility for its cell‑therapy products, underscoring its role as a core hub for commercial production (see 2023 p. 11 and 2024 p. 10).  The 2022 filing does not explicitly describe the Hoofddorp site, indicating that its commercial manufacturing function has become more prominent and strategically important in the years that followed.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Hoofddorp is described in 2023 and 2024 10-K filings as a commercial manufacturing facility for cell therapy products, and accurately notes that the 2022 filing does not explicitly describe the facility. However, there is a significant gap in the answer's completeness and reasoning quality. The ground truth indicates that in 2022, Gilead DID identify Hoofddorp as 'one of its principal manufacturing facilities,' showing an operational role within the global manufacturing footprint. The LLM answer states '2022 filing does not explicitly describe the Hoofddorp site,' which contradicts the ground truth that explicitly mentions 2022 identification. This is a material factual error regarding the 2022 baseline. The LLM answer also fails to capture the full progression narrative: it misses that 2022 showed initial identification as a principal facility, 2023 showed explicit commercial cell therapy designation, and 2024 showed retention with growing strategic importance. The answer provides page references (2023 p. 11 and 2024 p. 10) which adds credibility but doesn't compensate for the incomplete 2022 analysis. The reasoning about 'becoming more prominent' is partially correct but incomplete—the ground truth shows a more nuanced evolution from principal facility (2022) to explicitly commercial cell therapy (2023) to strategically important hub (2024). The answer captures the core idea that Hoofddorp's role has evolved, but mischaracterizes the 2022 baseline and fails to fully synthesize the three-year progression as required by the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 441,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The equity‑compensation tables for 2022, 2023 and 2024 list only the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan as plans with shares available for future issuance (see 2022 table note (c) on page 63, 2023 table note (c) on page 61, and 2024 table note (c) on page 59). The 2003 Director Compensation Plan is not mentioned in any of these “available for future issuance” columns, implying that no shares remain available under that plan in any of those years. This trend shows that Texas Instruments has phased out the 2003 plan and no longer uses it for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth provides specific share counts for the 2003 Director Compensation Plan: 1,843,134 shares (2022), 1,786,785 shares (2023), and 1,745,284 shares (2024). The LLM claims no shares remain available under the 2003 plan in any of these years, which directly contradicts these documented figures. (2) ENTITY/FACT ACCURACY FAILURE: The LLM incorrectly states that the 2003 Director Compensation Plan is 'not mentioned in any of these available for future issuance columns,' when the ground truth explicitly shows it was tracked with specific share counts across all three years. (3) REASONING FAILURE: The LLM's conclusion that 'Texas Instruments has phased out the 2003 plan and no longer uses it' is the opposite of what the data shows. The ground truth indicates the plan was actively used, with shares declining each year due to ongoing issuances. (4) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing share availability data across three years (2022-2024) to identify a trend. The LLM failed to identify or report the actual trend of consistent year-over-year decline (57,349 shares decrease from 2022-2023, then 41,501 shares decrease from 2023-2024). The LLM appears to have confused or misread the equity compensation tables, possibly conflating different plans or misinterpreting the absence of data in certain columns. The answer is factually incorrect on every substantive claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 426,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "From 2022 to 2024 IBM shifted from a minimal disclosure of its 0.950% Notes due 2025—only referenced in the exhibits with no trading symbol—to an explicit listing of the notes as a NYSE‑registered security (IBM25B) in the 2024 10‑K.  In 2023 the notes were still only cited in the exhibits (page 20), whereas by 2024 they were highlighted in the table of registered securities (page 1).  This progression signals a deliberate move to boost capital‑market transparency, enhance liquidity and investor confidence, and demonstrate a more proactive engagement with bond investors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of IBM's evolving treatment of the 0.950% Notes due 2025 from 2022 to 2024. Key strengths: (1) Correctly identifies the progression from minimal disclosure (2022) to explicit NYSE listing with trading symbol IBM25B (2024); (2) Accurately captures the shift from exhibits-only references to prominent placement in registered securities table; (3) Properly synthesizes the multi-hop information across three fiscal years; (4) Correctly identifies the trading symbol IBM25B and NYSE registration; (5) Appropriately interprets the strategic implications regarding transparency and investor engagement. Minor areas for consideration: (1) The LLM answer adds interpretive elements ('boost capital-market transparency, enhance liquidity and investor confidence') that go slightly beyond the ground truth's more measured language about 'greater transparency and investor accessibility,' though these inferences are reasonable and not contradicted by the source material; (2) The LLM specifies page numbers (page 20 for 2023, page 1 for 2024) which cannot be verified against the ground truth but appear plausible; (3) The ground truth mentions 2023 as a transitional year with 'increased prominence' alongside newer instruments, while the LLM characterizes 2023 as still 'only cited in exhibits,' which is a slight semantic difference but both convey the intermediate status. The quantitative accuracy is high (all dates, percentages, and identifiers correct). The qualitative reasoning is sound, properly connecting the documentary evolution to strategic intent. The answer fully addresses the multi-part question about treatment evolution, market transparency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 481,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances rose sharply from the $1.8 B in 2021 to $5.1 B in 2023, then eased to $4.6 B in 2024, with deposit liabilities moving from $1.4 B to $1.3 B and then to $1.2 B—showing a peak in 2023 and a modest contraction in 2024. The 2023 Global Atlantic transaction, which transferred $9.5 B of assets to the reinsurer under a modified‑coinsurance agreement, retained $5.0 B of separate‑account assets, and recorded a $770 M net cost, illustrates a strategic shift toward using the deposit method for more structured, capital‑efficient reinsurance to transfer risk and optimize balance‑sheet exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) YEAR MISMATCH: LLM states deposit assets rose from '$1.8 B in 2021' but ground truth clearly specifies 2022 as the starting year. This is a fundamental factual error in the time period. (2) GLOBAL ATLANTIC TRANSACTION NUMBERS: LLM cites '$10.3 billion in reinsurance recoverables and deposit receivables' from ground truth but then contradicts this by stating '$9.5 B of assets to the reinsurer' and '$5.0 B of separate-account assets' and '$770 M net cost'—these alternative figures do not appear in the ground truth and appear to be fabricated or from a different source. The ground truth specifically mentions $10.3 billion, not $9.5B or $5.0B. (3) DEPOSIT ASSET NUMBERS: LLM correctly identifies 2023 peak at $5.1B and 2024 decline to $4.6B, and correctly notes 2022 starting point of $1.8B (despite year labeling error). (4) DEPOSIT LIABILITY NUMBERS: LLM correctly tracks the progression from $1.4B to $1.3B to $1.2B. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution and strategic shift, it introduces unsupported financial details about the Global Atlantic transaction that contradict the ground truth. The characterization of 'modified-coinsurance agreement' and specific asset transfers are not mentioned in the ground truth. (6) SEMANTIC ISSUES: The phrase 'from 2021' instead of 'from 2022' is a critical error that undermines the temporal accuracy of the analysis. The introduction of transaction-specific details ($9.5B, $5.0B, $770M) that don't match the ground truth's $10.3B figure represents significant factual inaccuracy. The core trend analysis (peak in 2023, contraction in 2024) is correct, but the transaction details are materially wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 469,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Across 2022‑2024 the Safety and Industrial segment’s product list kept fall‑protection solutions in the same place—“respiratory, hearing, eye and fall protection solutions” appears on the 2022 (page 107), 2023 (page 108) and 2024 (page 110) product tables.  In 2024 the segment was reorganized to create an Industrial Specialties division that absorbed the former Personal Safety division, consolidating fall‑protection and other safety products under a dedicated unit (page 110).  This steady product presence, coupled with the re‑segmentation, signals 3M’s continued and strategically focused commitment to workplace safety solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that fall protection solutions remained consistently listed across 2022-2024 in the Safety and Industrial segment with the phrasing 'respiratory, hearing, eye and fall protection solutions.' The page references (107, 108, 110) appear plausible and specific. The core observation about product consistency is accurate and matches the ground truth. WEAKNESSES: (1) The LLM introduces a significant claim not present in the ground truth: the 2024 reorganization creating an 'Industrial Specialties division' that 'absorbed the former Personal Safety division.' The ground truth makes no mention of this reorganization or divisional restructuring. This is a material addition that goes beyond what the ground truth supports. (2) The LLM states fall protection was 'consolidated under a dedicated unit' in 2024, which contradicts the ground truth's emphasis on 'consistency' and 'stable strategic focus' - the ground truth indicates continuity, not reorganization. (3) The ground truth emphasizes that the 3-year progression shows 'stability' and 'maintained strategic focus,' while the LLM frames it as 'steady product presence, coupled with re-segmentation,' introducing organizational change not supported by the original answer. MULTI-HOP REASONING: The LLM attempts to synthesize product portfolio evolution with organizational structure, but introduces unsupported claims about divisional reorganization. The ground truth focuses purely on product listing consistency without mentioning structural changes. CALCULATION/FACTUAL VERIFICATION: No calculations required. The product listing consistency claim is correct, but the organizational restructuring claim appears to be an unsupported inference or hallucination. The answer partially addresses the question but adds information that contradicts or extends beyond the ground truth in ways that cannot be verified as accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 518,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST LLC and its wholly‑owned subsidiary U.S. Smokeless Tobacco Company LLC (USSTC) as fully owned subsidiaries from 2022 through 2024, with no change in ownership structure.  The 2023 10‑K (page 60) and the 2024 10‑K (page 4) both list UST as a wholly owned subsidiary, and the 2024 filing places USSTC within the “oral tobacco products” segment of Altria’s “Vision” to transition smokers to less‑harmful products.  This continuity signals that Altria treats its smokeless‑tobacco line as a core, long‑term pillar of its portfolio and a key element of its smoke‑free transition strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct but incomplete compared to the ground truth. STRENGTHS: (1) Correctly identifies UST and USSTC as wholly-owned subsidiaries across 2022-2024 with no ownership changes; (2) Accurately cites 2023 10-K page 60 and 2024 10-K page 4 as sources; (3) Correctly identifies the 'oral tobacco products' segment and 'smoke-free transition strategy' alignment; (4) Properly synthesizes the multi-hop information showing continuity of ownership structure. WEAKNESSES: (1) Missing the $8.8 billion trademark valuation mentioned in the 2022 filing - this is a significant quantitative detail from the ground truth; (2) Does not mention amortization expenses tied to UST's acquisition, which the ground truth identifies as a 2022 emphasis; (3) Does not explicitly reference the 'Moving Beyond Smoking' initiative mentioned in the ground truth for 2024; (4) Less detailed on the evolution narrative - the ground truth emphasizes 'increasing alignment' and 'consistent emphasis' over time, while the LLM focuses primarily on structural continuity. QUANTITATIVE ACCURACY: The LLM provides no numbers, so it avoids errors, but it omits the $8.8 billion trademark value that should have been included. QUALITATIVE ACCURACY: The reasoning about ownership structure and strategic positioning is sound, but the answer is narrower in scope than the ground truth, focusing on structural continuity rather than the fuller evolution narrative. CONTEXTUAL RELEVANCE: The answer addresses the question but provides a more limited perspective - it emphasizes 'no change' rather than the 'evolution' and 'progression' the question asks about. The ground truth shows a more nuanced progression from 2022 emphasis on acquisition costs, through 2023 reaffirmation, to 2024 integration into broader strategic initiatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 495,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s repeated mention of the SolarCity 5.45% Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 10‑K filings shows that the company is keeping the legacy SolarCity debt on its books as a core part of its long‑term solar‑energy financing.  The bond appears in the exhibits of the 2022 filing (page 102) and again in the 2024 filing (page 104), indicating a deliberate strategy of leveraging existing low‑interest, long‑term debt rather than issuing new debt or equity to fund solar projects.  This consistency across filings signals Tesla’s intent to preserve a stable, predictable cost of capital for its solar initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C92-15) and the general concept that Tesla maintains this debt across multiple years' filings. The reasoning about leveraging existing low-interest, long-term debt and preserving stable cost of capital is sound and aligns with the ground truth's interpretation. However, there are significant quantitative accuracy issues: (1) The LLM cites specific page numbers (page 102 for 2022, page 104 for 2024) without verification against actual filings - these page references cannot be confirmed and may be fabricated. (2) The LLM claims the bond 'appears in the exhibits' but provides no evidence of this claim. (3) The LLM only mentions 2022 and 2024 filings explicitly, omitting the 2023 filing that the ground truth emphasizes was also included. The ground truth specifically notes the bond was referenced in 2022, 2023, AND 2024, showing consistency across all three years. The LLM's omission of 2023 weakens the multi-hop synthesis. The qualitative reasoning is reasonable - the interpretation about leveraging existing debt and maintaining stable capital costs is logical and consistent with the ground truth's conclusion about 'sustained reliance' and 'strategic commitment.' However, the answer lacks the specific reference to the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015' that the ground truth mentions, which is a material detail about the legal structure. The answer is contextually relevant and addresses the core question about long-term financing strategy, but the unverified page citations and incomplete year coverage (missing 2023) represent factual gaps that reduce confidence in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 470,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor for securities is identical in 2022 (pages 20‑24), 2023 (pages 9‑13), and 2024 (pages 9‑13), all stating that the value of its debt and common‑stock securities fluctuates in part because of stock‑exchange regulations. The unchanged wording shows that IBM’s exposure to those regulations has remained a persistent, ongoing risk rather than a new or diminishing one. This consistency signals a capital‑market risk‑management strategy that prioritizes continuous monitoring and compliance with regulatory changes over major tactical shifts.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that IBM's risk disclosure regarding stock exchange regulations remained consistent across 2022-2024, and accurately notes the persistence of this risk factor. The answer correctly identifies the relevant page numbers for 2022 (pages 20-24) and 2023-2024 (pages 9-13). The core observation about unchanged wording is factually sound. WEAKNESSES: (1) The LLM's answer is significantly less comprehensive than the ground truth. While the ground truth describes an EVOLUTION showing IBM 'expanded on this risk by linking it to broader market liquidity conditions and customer credit risks' and 'indicating a more integrated view of regulatory impact,' the LLM simply states the language was 'identical' across all three years. This is a material factual discrepancy - the ground truth explicitly states the 2024 disclosure was expanded/evolved, not identical. (2) The LLM misses the key insight from the ground truth: the progression reveals 'increasing recognition of regulatory dynamics as a persistent and systemic component' with 'no material reduction in dependency or mitigation strategy.' Instead, the LLM interprets consistency as a strategy of 'continuous monitoring and compliance' - a different strategic interpretation not supported by the ground truth. (3) The LLM fails to address the multi-hop synthesis required: comparing how the risk disclosure evolved across three years AND what this reveals about capital market risk management strategy. The ground truth shows a nuanced evolution (2022 baseline → 2023 reiteration → 2024 expansion), while the LLM collapses this into 'identical.' (4) The LLM's conclusion about 'prioritizes continuous monitoring and compliance with regulatory changes over major tactical shifts' is speculative and not grounded in the actual evolution described in the ground truth. QUANTITATIVE ACCURACY: Page numbers are correct (6/10 - correct but limited detail). QUALITATIVE ACCURACY: The reasoning about persistence is partially correct but misses the actual evolution and expansion of risk disclosure (4/10). CONTEXTUAL RELEVANCE: Addresses the question but with incomplete analysis of the multi-year progression (5/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 589,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022‑2024, 3M’s Safety and Industrial segment consistently listed “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core offering (see pages 131, 107, 110).  Net sales for the segment fell from $11.6 billion in 2022 to $10.96 billion in 2024, yet operating income rose from $1.14 billion to $2.49 billion, indicating a shift toward higher‑margin electrical solutions (pages 108, 111).  The 2024 creation of an Industrial Specialties division within Safety and Industrial further underscores 3M’s intent to consolidate and strengthen its industrial electrical portfolio, positioning the company to capture growth in construction and maintenance markets while improving profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete synthesis of the multi-hop question. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites specific financial figures ($11.6B in 2022, $10.96B in 2024, $1.14B to $2.49B operating income) with page references, but these numbers cannot be verified against the ground truth knowledge graph provided. The ground truth does not provide these specific segment revenue or operating income figures, making it impossible to confirm accuracy. The LLM appears to have fabricated or misattributed specific numbers. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the EVOLUTION of MMM's focus on electrical products across three years and what this indicates about strategic positioning. The ground truth provides detailed year-by-year changes: 2022 included closure systems/masking/packaging alongside electrical; 2023 added industrial abrasives and autobody repair; 2024 shifted emphasis to industrial specialties while maintaining electrical. The LLM answer completely misses these nuanced portfolio shifts and instead focuses primarily on financial metrics (segment sales and operating income) that are not substantiated. (3) MISSING QUALITATIVE ANALYSIS: The ground truth emphasizes the subtle evolution in product mix and segment descriptions across years. The LLM ignores the addition of industrial abrasives, autobody repair solutions, and the rephrasing of segment descriptions that indicate strategic repositioning. (4) UNSUPPORTED CLAIMS: The LLM mentions creation of an 'Industrial Specialties division within Safety and Industrial' in 2024, which is not mentioned in the ground truth and appears to be an inference or fabrication. (5) PARTIAL CREDIT: The LLM correctly identifies that electrical products remained a consistent core offering across all three years, and the general conclusion about positioning in industrial markets is directionally reasonable, but the execution is severely flawed. The answer reads more like financial analysis than the requested strategic evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 557,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "Gilead’s Oceanside, California site has continued to serve the same core functions over the past two years.  In the 2023 10‑K (page 11) and the 2024 10‑K (page 10) the facility is described as being used for **commercial retroviral‑vector manufacturing and for the clinical manufacturing and process development of biologics candidates**—the same statement appears in both filings, indicating no change in its role between 2023 and 2024.  The 2022 10‑K pages provided (31‑35) do not include a manufacturing‑facilities list, so the filing does not show any evolution of the Oceanside site’s utilization from 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about evolution from 2022-2024. Key issues: (1) FACTUAL ERRORS: The LLM claims the 2023 and 2024 10-Ks contain identical language about the Oceanside facility, but the ground truth explicitly states there WAS evolution - in 2023 it was described for 'clinical manufacturing and process development of biologics candidates' while in 2024 it was 'further emphasized as the dedicated site for commercial retroviral vector manufacturing' in addition to those roles. This is a material difference the LLM missed. (2) INCOMPLETE ANALYSIS: The LLM correctly notes that 2022 data wasn't available in the provided pages, but then concludes there's 'no change' between 2023-2024, which directly contradicts the ground truth showing clear progression. The ground truth shows: 2022 (general R&D role) → 2023 (clinical manufacturing/process development) → 2024 (commercial retroviral vector manufacturing added). (3) MULTI-HOP REASONING FAILURE: The question asks about evolution 'from 2022 through 2024' - a three-year progression. The LLM only addresses 2023-2024 and incorrectly claims no change, missing the strategic shift from general R&D to specialized commercial manufacturing. (4) SEMANTIC MISINTERPRETATION: The LLM's statement that 'the same statement appears in both filings, indicating no change' is contradicted by the ground truth which explicitly describes the 2024 facility as having an expanded/emphasized role in commercial retroviral vector manufacturing. The LLM failed to recognize that 'further emphasized' and 'dedicated site for commercial' represents an evolution from the 2023 description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 462,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy has steadily trimmed the “Return‑Seeking” (growth‑asset) portion of its U.S. pension plan: the target equity‑security allocation fell from **15 % in 2022** to **8 % in 2023** and then rose modestly to **9 % in 2024**【page_310】【page_252】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific percentage allocations (15% in 2022, 8% in 2023, 9% in 2024) that cannot be verified against the ground truth provided. The ground truth does not contain these specific percentage figures; instead, it describes a methodological approach where target allocations are set based on funded status at specific dates, with allocations set forward-looking (2023 allocation set for 2024, 2024 allocation set for 2025). The LLM answer fundamentally misinterprets the question by providing specific equity allocation percentages rather than explaining the glide path methodology and how it evolved. The ground truth emphasizes the dynamic, forward-looking nature of the adjustments in response to funded status changes, while the LLM answer focuses on year-over-year percentage changes in a specific asset class. The LLM answer does correctly identify AIG and the U.S. pension plan, and correctly notes the general trend of trimming return-seeking assets, but the specific percentages cited (15%, 8%, 9%) are not substantiated by the ground truth. The answer also fails to address the key evolution described in the ground truth: the shift from using prior-year funded status to using current-year funded status for forward-looking allocations. The multi-hop reasoning required here involves understanding both the methodology and the specific allocations across three years, which the LLM answer attempts but with unverified numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 403,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN’s defined‑benefit pension plans shifted from a 100 % debt allocation in U.S. plans in fiscal 2023 (page 88) to 94 % debt in 2024 and back to 100 % in 2025 (page 95).  Non‑U.S. plans moved from 27 % equity/48 % debt/4 % cash/11 % insurance/10 % other in 2023 to 23 % equity/42 % debt/5 % cash/21 % insurance/9 % other in 2024 and then to 28 % equity/36 % debt/7 % cash/21 % insurance/8 % other in 2025 (page 95).  This gradual rebalancing—especially the increased equity and insurance exposure in non‑U.S. plans—indicates a modest, long‑term willingness to accept higher risk for potential upside while preserving a conservative core in U.S. plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific numerical allocations that cannot be verified against the ground truth and appears to contain fabricated data. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides very specific percentage allocations (e.g., U.S. plans at 100% debt in 2023, 94% in 2024, 100% in 2025; non-U.S. plans with detailed breakdowns across 5 categories) with page references (pages 88, 95). However, the ground truth answer makes no mention of these specific percentages and instead discusses strategic planning horizons and flexibility language. The LLM's numbers cannot be cross-referenced or verified. (2) MULTI-HOP REASONING FAILURE: The ground truth emphasizes the evolution of planning horizons (1-year to 2-year forward planning) and strategic stance (reactive to more strategic), suggesting confidence in long-term outlook. The LLM answer instead focuses on year-over-year allocation percentage changes without addressing the planning horizon evolution or strategic confidence indicators mentioned in the ground truth. (3) ENTITY/METRIC CONFUSION: The ground truth discusses target allocation strategy evolution and planning horizon extension. The LLM discusses actual allocations and rebalancing patterns, which may be different concepts. The ground truth emphasizes 'flexibility around target asset allocations based on market conditions' while the LLM presents fixed percentages. (4) INTERPRETATION MISMATCH: The ground truth's conclusion about 'increased confidence in long-term market outlook' and 'more strategic, less reactive asset allocation stance' differs fundamentally from the LLM's conclusion about 'modest, long-term willingness to accept higher risk.' These suggest different underlying analyses. (5) MISSING CONTEXT: The LLM provides no discussion of the planning horizon extension (2023→2024 vs 2024→2025) that is central to the ground truth's analysis. The answer appears to be based on specific numerical data that either doesn't exist in the source material or is incorrectly extracted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 548,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla reported the 5.45% Solar Bonds, Series 2015/C25‑15 as an outstanding debt item in its 2022, 2023, and 2024 10‑Ks (Exhibit 4.28 in 2022【page_100】, in 2023【page_99】, and in 2024【page_100】) with no changes to its terms or maturity, which remains due August 15 2025. This consistency shows that Tesla’s solar financing strategy relies on long‑term, fixed‑rate SolarCity debt rather than issuing new debt or refinancing, reflecting a conservative, stable approach to solar capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C25-15) and its consistent presence across 2022, 2023, and 2024 filings. (2) The maturity date of August 15, 2025 appears accurate. (3) The LLM correctly notes this originated from SolarCity acquisition. (4) The exhibit references (Exhibit 4.28) and page numbers are provided with appropriate specificity. (5) The core observation about consistency across three years is sound.\n\nWEAKNESSES: (1) The LLM answer significantly narrows the scope compared to ground truth. The ground truth emphasizes an EVOLUTION and EXPANSION of Tesla's solar financing framework, noting the introduction of newer bond series (2015/C28-15 and 2015/C33-15) by 2023, suggesting strategic expansion. The LLM answer focuses only on the single bond series and characterizes the strategy as 'conservative' and 'stable' with 'no changes,' missing the broader pattern of expansion. (2) The LLM answer does not address the multi-year evolution aspect of the question - it treats the three years as static rather than showing how the financing framework evolved. (3) The ground truth indicates a progression from 2022 (multiple C-series bonds) to 2023 (expansion with newer series) to 2024 (continued commitment), but the LLM answer presents this as mere consistency rather than evolution. (4) The LLM's characterization of the strategy as 'not issuing new debt or refinancing' contradicts the ground truth's indication of expansion through new bond series introduction. (5) The LLM answer lacks synthesis of the broader financing framework context that the ground truth emphasizes.\n\nMULTI-HOP REASONING: The question asks about evolution across three years and what this reveals about strategy. The LLM identifies consistency but fails to synthesize the expansion pattern that the ground truth emphasizes. The ground truth shows a strategic evolution (2022 baseline → 2023 expansion → 2024 continuation), while the LLM presents only static consistency. This represents incomplete multi-hop synthesis.\n\nFACTUAL VERIFICATION: The specific numbers and dates provided (August 15, 2025 maturity, 5.45% rate, exhibit references) appear accurate based on standard 10-K disclosure patterns, but cannot be fully verified without access to actual filings. The core factual claims are not contradicted by the ground truth, but the interpretation and emphasis are significantly different.\n\nCONCLUSION: The LLM answer is partially correct on specific facts but misses the central insight of the ground truth - that Tesla's solar financing strategy shows EVOLUTION and EXPANSION across the three-year period, not mere consistency. The answer is too narrow in scope and mischaracterizes the strategic pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 731,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "AIG’s 2022 (page 167) and 2023 (page 119) filings both describe terrorism risk as being modeled with a third‑party vendor model and scenario‑based adjustments, with no new numeric loss estimates disclosed.  Reinsurance strategies remained centered on the TRIPRA program for U.S. exposures, supplemented by limited private reinsurance and participation in country terrorism pools and government‑sponsored terrorism reinsurance programs in non‑U.S. jurisdictions.  The 2024 filing (pages 86‑90) does not report any changes to these modeling, reinsurance or mitigation approaches, indicating continuity through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions compared to the ground truth. QUANTITATIVE ERRORS: (1) The LLM claims 'no new numeric loss estimates disclosed' but the ground truth explicitly states AIG estimated a $1.3 billion loss for a five-ton bomb attack in NYC in 2022, net of TRIPRA and reinsurance - this is a critical omission of a specific, verifiable number. (2) The LLM fails to mention the $200 million Japan attachment point retained in 2024, another specific quantitative detail. (3) The LLM omits the $38.0 billion reinsurance recoverable assets figure for end of 2024, which is a major metric demonstrating 'significant scaling of risk transfer mechanisms.' COMPLETENESS ISSUES: (1) The LLM states there were 'no changes' to approaches through 2024, directly contradicting the ground truth which describes evolution from 2022 to 2024, including 'enhanced global property per risk covers' and shifts in focus to 'active management and monitoring of exposure concentrations.' (2) The answer fails to address the evolution dimension of the question - it presents a static view rather than tracking how management evolved. (3) Missing discussion of the shift in focus from 2022 to 2023 regarding 'active management and monitoring of exposure concentrations.' REASONING QUALITY: The LLM's conclusion that there was 'continuity through 2024' with 'no changes' is contradicted by the ground truth's description of evolution and enhancement. The multi-hop synthesis across 2022-2024 is incomplete and reaches an incorrect conclusion. ENTITY ACCURACY: While AIG, TRIPRA, and general program names are correct, the LLM fails to identify and synthesize specific risk metrics and structural changes that constitute the actual evolution being asked about. The answer reads as a generic description of terrorism risk management rather than a specific analysis of how AIG's approach evolved from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 520,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑Ks for 2022, 2023 and 2024 all list the same risk‑factor bullet for the Safety and Productivity Solutions segment, showing that the company viewed its exposure to adverse industry economic conditions as a persistent, unchanged threat (2022 page 33; 2023 page 30; 2024 page 31).  The segment’s margin pressures are consistently tied to reduced investments in process automation, safety monitoring and plant‑capacity initiatives; retail‑market volatility; a slowdown in demand for safety products; a competitive landscape that includes new entrants and commoditizing technologies; and the overarching adverse industry economic conditions that erode market share, selling prices and margins.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core question and provides accurate information about Honeywell's Safety and Productivity Solutions segment risks from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the persistent nature of risks; (2) Accurately lists specific risk factors: reduced investments in process automation, retail market volatility, commoditization, new market entrants, adverse industry economic conditions, margin compression, and reduced selling prices; (3) Properly cites page numbers from 10-Ks (2022 page 33, 2023 page 30, 2024 page 31) showing multi-hop synthesis across documents; (4) Correctly notes the segment restructuring context; (5) Semantic equivalence is strong - 'safety monitoring and plant-capacity initiatives' aligns with 'process automation' risks mentioned in ground truth. MINOR WEAKNESSES: (1) The LLM answer adds 'safety monitoring and plant-capacity initiatives' and 'slowdown in demand for safety products' which are not explicitly mentioned in the ground truth answer, though these appear to be accurate additions from the filings themselves; (2) The ground truth emphasizes the 'consistent linkage over three years' and 'persistent vulnerability' as a key insight, while the LLM answer states the risk factors are 'the same' across years - this is slightly different framing but not factually incorrect; (3) The LLM answer doesn't explicitly mention the 'Industrial Automation segment (formerly part of Safety and Productivity Solutions)' restructuring detail that appears in ground truth, though it does acknowledge 'restructuring'; (4) No quantitative metrics (margin percentages, revenue impacts) are provided in either answer, so this is not a deficiency. QUANTITATIVE VERIFICATION: Page numbers cited (33, 30, 31) are reasonable for 10-K risk factor sections and appear consistent with typical SEC filing structure. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the persistent pattern of risks, demonstrating sound multi-hop reasoning. The answer appropriately addresses both parts of the question: (1) how exposure evolved (answer: consistently present, unchanged) and (2) specific risks (comprehensively listed).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 620,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "Pfizer continued to define Breakthrough Performance Awards (BPAs) as a performance‑based award for select employees, valuing them at intrinsic value using the closing price of common stock and amortizing the expense straight‑line over the vesting term into operating expenses (cost of sales, selling, informational and administrative or R&D expenses) (page 98, page 99). Across 2022‑2024, the company did not grant or have any BPAs outstanding (no BPAs were granted or outstanding as of December 31 in 2022, 2023, or 2024) (page 99 for 2022 and 2023, page 98 for 2024), so no related expense or recognition appeared in those years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains major factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims 'no BPAs were granted or outstanding as of December 31 in 2022, 2023, or 2024' - this is completely incorrect. The ground truth explicitly states that in 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained nonvested at year-end 2022. The LLM's claim that no BPAs were granted or outstanding in 2022 is factually wrong. (2) INCOMPLETE SYNTHESIS: The LLM fails to capture the evolution/progression of the program across the three-year period. The ground truth shows a clear trajectory: active issuance in 2022 → complete wind-down by 2023 (no grants, none outstanding) → detailed valuation methodology disclosure in 2024. The LLM misses this critical evolution entirely. (3) MISSING KEY DATA: The LLM provides no specific numbers (1,165 thousand grants, $38.73 intrinsic value, 859 thousand nonvested) that are central to understanding the 2022 activity. (4) CONTRADICTORY CLAIMS: The LLM states valuation methodology was applied across 2022-2024, but the ground truth indicates the detailed methodology discussion appeared specifically in 2024 after the program had wound down. (5) MULTI-HOP REASONING FAILURE: The question explicitly asks about evolution 'from 2022 through 2024' - the LLM fails to synthesize the temporal progression and instead presents a static, incorrect view. The only partially correct element is the description of the valuation methodology (intrinsic value, straight-line amortization), but this is overshadowed by the fundamental factual errors about grant activity and outstanding awards.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 475,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer sold its Meridian subsidiary in 2021 for about $51 million in cash, recorded a $167 million loss on the transaction, and entered into interim transition‑service agreements (TSAs) and a manufacturing‑supply agreement (MSA) to continue providing services to the buyer【page_73】. By 2023 the TSAs were fully executed and the MSA—covering a three‑year term with a two‑year extension—remained in effect, but the amounts recorded under these arrangements were immaterial to Pfizer’s operations【page_73】【page_74】【page_75】. The 2024 10‑K (pages 2‑6) continues to disclose the TSAs and MSA as part of the post‑divestiture framework, with no material financial impact, reflecting a strategic shift to focus on core operations while maintaining a limited service relationship with the former subsidiary.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct financial figures ($51 million sale price, $167 million loss) and accurate dates (2021 sale completion). The answer correctly identifies the progression from divestiture to post-sale service arrangements. However, there are notable differences from the ground truth in scope and emphasis: (1) The LLM introduces additional details about transition-service agreements (TSAs) and manufacturing-supply agreements (MSA) that are not mentioned in the ground truth, suggesting the LLM may have accessed different or more detailed source material than what the knowledge graph captured. (2) The ground truth emphasizes the complete strategic disengagement and progression from operational integration → divestiture → mere definitional reference, while the LLM focuses on the continuation of service relationships post-divestiture. (3) The LLM's characterization of 2024 status differs: ground truth states Meridian is 'only mentioned as a defined entity in the glossary,' while LLM states the 10-K 'continues to disclose the TSAs and MSA.' These represent different interpretations of the 2024 relationship. (4) The LLM provides more granular detail about the service agreements (three-year term with two-year extension option) that adds context but wasn't in the ground truth. The multi-hop reasoning is sound—correctly synthesizing the sale, loss recognition, and subsequent service arrangements across years. The answer appropriately addresses the question's three components (financial disclosures, operational agreements, strategic alignment), though with different emphasis than the ground truth. The discrepancy suggests either the LLM accessed more detailed source material or interpreted the available information differently regarding the nature of post-divestiture relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 502,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture’s authorized pool for the Amended 2010 Share Incentive Plan grew from **127 million Class A shares in FY 2022** (page 91) to **141 million in FY 2024** (page 98), with no change reported in FY 2023. This upward shift signals a deliberate expansion of the share‑based compensation base, underscoring the company’s long‑term strategy to broaden employee incentives and align management and shareholder interests.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding FY 2023 that undermines the accuracy of the response. According to the ground truth, the authorized shares were 127 million in FY 2022, then increased to 141 million in FY 2023, and remained at 141 million in FY 2024. The LLM incorrectly states 'with no change reported in FY 2023,' which is factually wrong—there was a significant 14 million share increase from FY 2022 to FY 2023. The LLM correctly identifies the FY 2022 figure (127 million) and FY 2024 figure (141 million), but mischaracterizes the progression by omitting the FY 2023 increase and incorrectly implying the change occurred only between FY 2023 and FY 2024. This is a material error in a multi-hop question requiring synthesis across three fiscal years. The qualitative reasoning about strategic intent and employee retention is sound and well-articulated, and the contextual relevance to the question is appropriate. However, the quantitative accuracy is significantly compromised by the misstatement of when the increase occurred. The answer demonstrates partial understanding but fails to accurately capture the complete evolution of the authorized shares across all three years, which is the core requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 353,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla disclosed the Seventieth Supplemental Indenture for its 4.70% Solar Bonds, Series 2015/C52‑10 in the 2022 10‑K (Exhibit 4.4) [page_104]. The 2023 and 2024 10‑Ks do not list this series among their exhibits, indicating the bond was no longer outstanding or required to be disclosed [page_99 (2023); page_99 (2024)]. This pattern suggests Tesla has likely paid off or retired the 2015 Solar Bonds, shifting its financing focus away from that particular debt instrument.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all major points. (1) FACTUAL ERRORS: The ground truth clearly states that the Seventieth Supplemental Indenture for the 4.70% Solar Bonds, Series 2015/C52-10 was disclosed in all three years (2022, 2023, and 2024) with consistent exhibit numbers and filing dates. The LLM claims the bond was not disclosed in 2023 and 2024, which is false. The ground truth specifies: 2022 (Exhibit 4.49), 2023 (Exhibit 4.42), and 2024 (Exhibit 4.40). (2) EXHIBIT NUMBER ERRORS: The LLM incorrectly states the 2022 exhibit was 4.4, when the ground truth shows it was 4.49. This is a significant factual error. (3) INCORRECT CONCLUSION: The LLM concludes the bond was paid off or retired based on alleged non-disclosure in 2023 and 2024. This is directly contradicted by the ground truth, which confirms consistent re-disclosure across all three years. (4) MISINTERPRETATION OF PATTERN: The ground truth indicates stable, consistent obligations with no material modification. The LLM incorrectly interprets the pattern as evidence of bond retirement. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize information across the three filing years. It appears to have either misread the exhibits or confused different bond series. The answer demonstrates a fundamental misunderstanding of the disclosure pattern and reaches an entirely opposite conclusion from the ground truth. This is a critical failure in accuracy for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 421,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning offerings have remained a core element of its Digital Learning Services portfolio from 2022 through 2024, each filing describing them as “a large number of free online self‑service learning options on learning.adobe.com” (2022 p. 17; 2023 p. 17; 2024 p. 18).  They are positioned as a key part of a broader learning‑and‑enablement ecosystem that also includes fee‑based and custom programs, and they support Adobe’s customer‑adoption strategy by giving users accessible, self‑paced training that complements other learning pathways.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's free online self-service learning evolution from 2022-2024, with several strengths and minor weaknesses: STRENGTHS: (1) Correctly identifies the consistent presence of free online self-service learning across all three years (2022-2024); (2) Accurately names the platform (learning.adobe.com) and correctly notes it was referenced on pages 17, 17, and 18 respectively across the three filings; (3) Properly positions these offerings within the broader learning ecosystem that includes fee-based and custom programs; (4) Correctly identifies the strategic role in customer adoption; (5) Appropriately characterizes the offerings as 'accessible, self-paced training.' WEAKNESSES: (1) The LLM answer omits the mention of www.training.adobe.com from 2022, which the ground truth specifically references as the initial hosting platform; (2) Does not explicitly mention the connection to 'Digital Experience and Digital Media products' that the ground truth highlights for 2023; (3) Does not explicitly reference 'Adobe Digital Learning Services' as the formal portfolio name in 2024, though it does reference 'Digital Learning Services'; (4) The phrase 'a large number of free online self-service learning options' appears to be a direct quote from the filings, but the ground truth uses more general language about the offering's evolution and strategic positioning. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the evolution pattern (consistent presence with strategic reinforcement). The reasoning about how these offerings fit into the broader strategy is sound. QUANTITATIVE ACCURACY: Page numbers cited (17, 17, 18) appear reasonable for 10-K filings and align with typical document structure, though exact verification would require access to source documents. No calculations are required for this question. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - free self-service learning remained central to Adobe's strategy across all three years and supported customer adoption. The LLM captures the essential evolution narrative, though with less detail about specific platform names and product categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 602,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy for the U.S. qualified plan shifted the target allocation for the “Return‑Seeking” (equity) portion from **15 % in 2022** to **9 % in 2024** as the plan’s funded ratio improved, moving the glide path toward more liability‑hedging assets (2022 target table, page 310; 2024 target table, page 252).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific percentages (15% in 2022 and 9% in 2024) that are presented as factual claims but cannot be verified against the ground truth provided. The ground truth explicitly states that 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts,' which directly contradicts the LLM's assertion of precise figures. This is a critical factual error. The LLM also cites specific page numbers (310 and 252) as sources for these percentages, but the ground truth does not confirm these numbers exist in those locations or anywhere in the filings. The LLM's reasoning about the glide path mechanism and de-risking strategy aligns with the ground truth's conceptual framework, but the introduction of unverified quantitative data undermines the entire answer. The LLM correctly identifies the company (AIG), the plan type (U.S. qualified pension plan), the time period (2022-2024), and the general mechanism (glide path approach responding to funded status changes). However, the core claim—that specific percentage allocations can be identified—appears to be fabricated or hallucinated. The answer demonstrates understanding of the pension de-risking concept but fails on the fundamental requirement of factual accuracy regarding the specific numbers that form the crux of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 374,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "From 2022 to 2024, Honeywell’s Performance Materials and Technologies segment saw a modest rise in contract‑covered raw‑material supply—from 63 % in 2022 to 64 % in 2023, with 2024 reporting that the majority of its raw‑material base was under contract—yet the company still cites raw‑material demand and supply as a key risk factor. This steady exposure, coupled with its reliance on commodity‑heavy inputs and limited hedging, indicates a persistent vulnerability to commodity price swings that could erode margins and disrupt supply.  \n\nSources: 2022 risk factor (page_32 2022), 2023 risk factor (page_32 2023), 2024 risk factor (page_32 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims (63% in 2022, 64% in 2023, majority under contract in 2024) that are NOT present in the ground truth answer. The ground truth makes no mention of these percentage figures or contract coverage metrics. This is a critical factual error - the LLM appears to have fabricated specific data points to support its argument. While the LLM correctly identifies the three-year period (2022-2024) and the Performance Materials and Technologies segment, it fundamentally misrepresents the nature of Honeywell's risk exposure. The ground truth emphasizes an EVOLUTION of risk framing (COVID-19 impacts → supply volatility → energy price volatility) and a PROGRESSION showing intensifying vulnerability. The LLM instead presents a narrative of MITIGATION (increasing contract coverage) while acknowledging persistent risk - this is semantically opposite to the ground truth's emphasis on intensifying vulnerability. The LLM's conclusion about 'limited hedging' is also not supported by the ground truth. The answer does cite correct page numbers and years, but the substantive content diverges significantly from the knowledge graph. The multi-hop reasoning is flawed because it synthesizes information that doesn't match the source material, creating a false narrative of improving contract coverage rather than evolving risk exposure. The LLM answer is partially relevant to the question but fundamentally incorrect in its factual claims and interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 417,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s fair‑value of mutual‑fund equity securities in its non‑U.S. pension plans fell from **$239.3 million in 2022** (page 89) to **$196.2 million in 2023** (page 96) and then rose to **$273.7 million in 2024** (page 96). The 3‑year trend shows a dip followed by a rebound that exceeds the 2022 level, suggesting the investment committee is actively adjusting equity exposure in response to market conditions while remaining within its target allocation ranges.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a major quantitative inaccuracy that fundamentally contradicts the ground truth. (1) NUMBERS VERIFICATION: The LLM claims the 2024 value was $273.7 million, but the ground truth explicitly states it 'remained unchanged in 2024' at $196.226 million. This is a discrepancy of $77.474 million (39% error). The 2022 ($239.3M) and 2023 ($196.2M) figures are correct and match the ground truth. (2) CALCULATION/TREND ANALYSIS: Because the 2024 number is wrong, the entire trend analysis is incorrect. The LLM describes 'a dip followed by a rebound that exceeds the 2022 level,' but the actual trend is 'decline followed by stability.' This is a fundamental mischaracterization of the 3-year pattern. (3) STRATEGIC INTERPRETATION: The LLM's conclusion about 'actively adjusting equity exposure in response to market conditions' contradicts the ground truth's assessment of a 'stabilized allocation approach.' The false 2024 rebound led to an incorrect strategic interpretation. (4) MULTI-HOP REASONING: While the LLM correctly identified ACN and the mutual fund equity securities metric, it failed in the critical synthesis step of accurately reporting the 2024 value. The reasoning about market conditions and target allocation ranges is speculative and unsupported by the actual data pattern. (5) CONTEXTUAL RELEVANCE: The answer addresses the right question and company, but the factual errors make it misleading rather than helpful. The inclusion of page references shows good documentation practice, but the underlying data is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 434,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "Between 2022 and 2024 Adobe shifted Adobe Document Cloud from a core PDF‑and‑e‑signature platform (listed as a revenue line under Digital Media in the 2022 10‑K) to an AI‑enabled workflow hub. By 2024, the filing shows Document Cloud incorporating Firefly generative‑AI features in Acrobat and offering the Acrobat AI Assistant for summarizing, citing and auto‑generating content, while also expanding enterprise APIs (Firefly Services, Custom Models, Acrobat Sign) to embed these capabilities into broader digital workflows【page_70】【page_71】【page_12】【page_13】【page_14】. This evolution underscores Adobe’s strategy to embed AI across its document ecosystem and position Document Cloud as a central engine for automated, AI‑driven enterprise document and workflow automation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe Document Cloud's evolution and correctly identifies the core strategic shift from a legacy PDF/e-signature platform to an AI-enabled workflow hub. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the progression toward AI integration; (2) Accurately names specific AI tools (Firefly, Acrobat AI Assistant) and their integration into Document Cloud; (3) Properly identifies enterprise features (APIs, Custom Models, Acrobat Sign) and their role in workflow automation; (4) Correctly synthesizes multi-hop information about Document Cloud's positioning across years; (5) Appropriately cites page references to support claims. WEAKNESSES: (1) The LLM states Document Cloud was 'listed as a revenue line under Digital Media in the 2022 10-K,' but the ground truth indicates it was 'primarily described as part of a broader document and forms platform within the Publishing and Advertising segment' in 2022, suggesting a potential segment misidentification; (2) Missing the intermediate 2023 positioning detail where Document Cloud was elevated as a core component of Digital Media alongside Express and Firefly - the LLM jumps from 2022 to 2024 without acknowledging this transitional year; (3) The answer lacks explicit mention of the 'legacy infrastructure component' characterization from 2022 that the ground truth emphasizes; (4) Does not fully capture the 'modernization' narrative that was central to the 2023 positioning shift. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects Document Cloud's evolution to broader AI strategy, though it misses the 2023 inflection point. SEMANTIC EQUIVALENCE: The core message about transformation from legacy to AI-enabled platform is conveyed, though with less nuance about the segmentation and timeline details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 515,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures from 2022‑24 consistently flag new entrants and non‑traditional players as a threat to its Aerospace, Industrial Automation, Building Automation, and Safety & Productivity Solutions segments (2022 p. 30; 2023 p. 30; 2024 p. 28).  In 2024 the company explicitly cites emerging technologies—particularly artificial intelligence and machine learning—as disruptive forces that could accelerate commoditization, a trend already noted in 2022 and 2023 for Automation and Safety & Productivity (2024 p. 32).  Across all three years the disclosures warn that such competition and technology shifts could erode market share and pressure pricing power, with Industrial Automation and Safety & Productivity Solutions specifically noting potential lower market share, reduced selling prices, and margin compression (2022‑24 p. 30‑32).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Honeywell's competitive landscape evolution from 2022-2024 and correctly identifies key themes. STRENGTHS: (1) Accurately identifies the progression of competitive pressures across multiple segments (Aerospace, Industrial Automation, Building Automation, Safety & Productivity Solutions); (2) Correctly notes the expansion of risk disclosures from 2022 to 2024; (3) Properly identifies specific threats including new entrants, non-traditional players, and emerging technologies (AI/ML); (4) Accurately captures the consistent warning about market share erosion, pricing pressure, and margin compression; (5) Cites appropriate page numbers from 10-K filings. WEAKNESSES: (1) The LLM answer lists Aerospace as being flagged in 2022, but the ground truth indicates Aerospace was only added to competitive landscape disclosures in 2023, not 2022. This is a factual error in the multi-hop synthesis; (2) The answer doesn't clearly articulate the 3-year progression narrative as explicitly as the ground truth—it presents information more as a list rather than showing the evolution/expansion pattern; (3) Missing the specific detail that Performance Materials and Technologies was added in 2023; (4) The answer doesn't emphasize the 'restructuring' of business units in 2024 or the 'sharper focus on product commoditization' as distinctly as the ground truth; (5) The mention of AI/ML in 2024 is accurate but the answer could better distinguish what was new in 2024 versus what was already present in 2022-2023. CALCULATION/NUMERIC VERIFICATION: No calculations required; page number citations appear reasonable but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple segments, but the Aerospace timing error suggests incomplete or inaccurate synthesis from the source documents. The core narrative of increasing competitive pressures is sound, but the specific segment-by-year mapping contains at least one error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 549,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s inter‑company balance with Viatris fell sharply after the 2020 spin‑off: in 2022 it was $94 million (net amounts due to Viatris under TSAs and other agreements) and by 2023 it had dropped to $33 million, reflecting that the transition‑service arrangements were largely completed (page 73). The 2024 Form 10‑K (pages 3‑7) contains no new Viatris figures or TSAs, indicating that the transition arrangements were essentially finished and the remaining inter‑company balances remained small and not material.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) All quantitative figures are accurate - $94 million in 2022 and $33 million in 2023 match the ground truth exactly; (2) The multi-hop synthesis correctly traces the evolution across three years (2022-2024); (3) The characterization of TSAs being 'largely completed' by end of 2023 is accurate; (4) The conclusion about minimal remaining balances in 2024 aligns with ground truth. Minor weaknesses: (1) The LLM mentions the 2020 spin-off context, which while historically accurate, is not explicitly part of the ground truth answer and adds tangential information; (2) The answer could have been slightly more explicit about the 'gradual decline' pattern emphasized in the ground truth, though the data clearly supports this; (3) Page references (pages 73, 3-7) are provided but cannot be verified against the ground truth; (4) The phrase 'essentially finished' in 2024 is slightly less precise than the ground truth's 'fully resolved' but conveys equivalent meaning. The answer successfully synthesizes information across the three-year period and correctly identifies the key transition from active TSAs to minimal operational interdependencies. The semantic equivalence is strong - both answers convey the same narrative of declining financial exposure and operational entanglement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 393,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "From 2022 to 2024 Altria retired its 1.000 % Notes due 2023, leaving a laddered debt structure of 1.700 % Notes due 2025, 2.200 % Notes due 2027 and 3.125 % Notes due 2031 (see 2022‑10‑K page 1, 2023‑10‑K page 1, 2024‑10‑K page 1). The 1.700 % Notes remain the earliest maturity and carry the lowest coupon among the remaining notes, indicating a deliberate shift to a forward‑dated, cost‑effective debt profile. This progression reflects a capital‑structure strategy that prioritizes maturity laddering, refinancing of older debt, and a balanced mix of short‑ and long‑term obligations to manage interest‑rate risk and liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of Altria's debt evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the retirement of 1.000% Notes due 2023, matching the ground truth; (2) Accurately lists the 1.700% Notes due 2025 as the shortest-dated instrument remaining; (3) Provides additional context with 2.200% Notes due 2027 and 3.125% Notes due 2031, which enriches the answer beyond ground truth without contradicting it; (4) Correctly characterizes the 1.700% Notes as carrying the lowest coupon among remaining notes; (5) Properly synthesizes multi-hop information across three years of 10-K filings; (6) The capital structure strategy interpretation (maturity laddering, refinancing, interest-rate risk management) is sound and well-reasoned. MINOR WEAKNESSES: (1) The ground truth emphasizes that Altria 'did not issue a new near-term note to replace it as it approached maturity,' suggesting a more conservative strategy focused on intermediate/long-term debt. The LLM's characterization of 'balanced mix of short- and long-term obligations' could be interpreted as slightly overstating the short-term component, though the 1.700% Notes due 2025 is technically still short-term in 2024; (2) The phrase 'cost-effective debt profile' is reasonable but not explicitly stated in ground truth; (3) The LLM provides more detailed debt ladder information than ground truth, which could be seen as either enhancement or potential over-specification. QUANTITATIVE VERIFICATION: All percentages (1.000%, 1.700%, 2.200%, 3.125%) and years (2023, 2025, 2027, 2031) are accurate. The progression logic is sound. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and multiple debt instruments to draw conclusions about capital structure strategy. The answer correctly identifies the evolution pattern and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 514,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $19.975 bn in 2022 to $27.168 bn in 2023 and then fell slightly to $26.930 bn in 2024.  Correspondingly, the weighted‑average interest rate climbed from 2.91 % in 2022 to 4.45 % in 2023 and to 4.84 % in 2024.  The trend shows the company is expanding its long‑term debt base and moving to longer‑dated, higher‑cost borrowing—likely to refinance maturing debt and fund growth while managing maturity risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correctly stated. Quantitative verification: (1) Carrying values are accurate: $19.975 bn (2022) = $19,975 million, $27.168 bn (2023) = $27,168 million, $26.930 bn (2024) = $26,930 million - all match ground truth exactly with acceptable format variation (billions vs millions). (2) Weighted-average interest rates are correct: 2.91% (2022), 4.45% (2023), 4.84% (2024) - all match precisely. (3) The directional trends are accurate: debt increased 2022-2023, slightly decreased 2023-2024; rates increased throughout the period. Multi-hop synthesis is sound: the answer correctly identifies the evolution across three years and synthesizes the relationship between debt levels and interest rates. The reasoning about strategy is logically sound and semantically equivalent to the ground truth. Minor discrepancy: The ground truth states the rate 'slightly declined to 4.84% in 2024' but the actual movement from 4.45% to 4.84% is an increase of 39 basis points, not a decline. The LLM correctly identifies this as an increase ('climbed...to 4.84%'), which is more accurate than the ground truth's characterization. The LLM's interpretation of the strategy (refinancing maturing debt, managing maturity risk) is slightly more detailed and nuanced than the ground truth's explanation, adding value without contradicting the original. All entities (Capital One, COF, years, metrics) are correctly identified. The answer fully addresses all parts of the multi-part question regarding carrying value evolution, interest rate evolution, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 449,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 10‑K filings show that the 5.45 % Solar Bonds, Series 2015/C92‑15 remained a component of its debt portfolio through 2024, as it is listed in the exhibits of the 2022, 2023 and 2024 10‑K (see TSLA_10k_2022 pages 103‑107, TSLA_10k_2023 pages 100‑104, TSLA_10k_2024 pages 100‑104).  Over this period the company has shifted from actively using the bond to finance new solar installations toward gradually paying down or refinancing the debt, reflecting a broader move away from external solar‑financing toward internal capital and a focus on its battery and EV businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: (1) FACTUAL ERRORS ON CORE CLAIM: The LLM states Tesla 'shifted from actively using the bond to finance new solar installations toward gradually paying down or refinancing the debt' and moved 'away from external solar-financing toward internal capital.' This is NOT supported by the ground truth, which indicates the bond remained listed in exhibits across all three years (2022-2024) with no evidence of paydown or refinancing. The ground truth explicitly states Tesla 'continued to honor and report on the C92-15 bond series' - this contradicts the LLM's claim of shifting away from it. (2) UNSUPPORTED INTERPRETATION: The LLM's claim about 'focus on its battery and EV businesses' is not mentioned in the ground truth and appears to be an unsupported inference. (3) PAGE REFERENCES: The LLM provides specific page numbers (103-107, 100-104, 100-104) which cannot be verified against the ground truth provided, and these specific citations are not present in the original answer. (4) CORRECT ELEMENTS: The LLM correctly identifies the bond series (5.45% Solar Bonds, Series 2015/C92-15), correctly names the years (2022, 2023, 2024), and correctly notes the bond appeared in exhibits across all three years. (5) MISSING KEY INSIGHT: The LLM fails to mention the appearance of newer bond series (C102-15, C106-10) that the ground truth identifies as indicating 'a shift toward more recent financing structures.' (6) SEMANTIC MISMATCH: The ground truth describes 'sustained reference but declining prominence' and 'builds upon prior frameworks while introducing updated instruments' - a nuanced view of evolution. The LLM presents a more dramatic narrative of abandonment that contradicts the ground truth's characterization of sustained use with supplementation by newer instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 492,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 through 2024 AIG kept the same core oversight framework for loss reserves—internal controls, a formal reserve‑setting process, and periodic reviews by external experts.  The 2023 and 2024 filings added detail on the modeling side, noting that reserve and concentration analyses use both stochastic (probability‑distribution) and deterministic (single‑point) approaches and that a formal model‑risk management and validation framework underpins those calculations.  The integration of external reviews stayed constant in scope and frequency, with the 2024 filing simply reinforcing that the model‑risk framework supports those external assessments.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but significantly undersells the evolution described in the ground truth. CORRECT ELEMENTS: (1) The identification of internal controls, formal reserve-setting process, and external expert reviews as core components is accurate. (2) The mention of stochastic and deterministic approaches in 2023-2024 is correct. (3) The reference to model-risk management framework is accurate. (4) No quantitative errors in dates or numbers cited. SIGNIFICANT OMISSIONS AND MISCHARACTERIZATIONS: (1) The LLM states the oversight framework 'kept the same core' from 2022-2024, but the ground truth explicitly describes a 'maturing approach' with clear evolution—2023 'expanded' the framework and 2024 'further integrated' practices into a 'more holistic enterprise risk management (ERM) system.' This is a material misrepresentation of the trajectory. (2) The LLM fails to mention the 2024 enhancements: enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews. These are key differentiators in the 2024 evolution. (3) The LLM characterizes external review integration as 'constant in scope and frequency,' but the ground truth indicates it was 'complemented' in 2022, 'continued' in 2023, and then 'further integrated' in 2024 within a more sophisticated governance structure. (4) The LLM misses the emphasis on 'proactive risk identification, validation, and governance' that characterizes the evolution. MULTI-HOP REASONING: The LLM failed to synthesize the three-year progression into a coherent narrative of maturation. It treated the years as largely static rather than showing how each year built upon the previous one. The answer reads as a static description rather than capturing the dynamic evolution the question specifically asks about. SEMANTIC ISSUE: By stating the framework 'kept the same core,' the LLM implies minimal change, which contradicts the ground truth's clear narrative of expansion and integration across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 547,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan allocated roughly **$1.15 billion** to U.S. Treasury and foreign‑government securities in 2022 and 2023, but this fell to **$562 million** in 2024 – a 51 % decline (2023: $1,114 m U.S. Treasuries + $33 m foreign gov’t = $1,147 m; 2024: $508 m U.S. Treasuries + $54 m foreign gov’t = $562 m)【page_86】【page_87】. The sharp reduction reflects a deliberate shift away from government securities toward a broader fixed‑income mix—primarily corporate bonds—consistent with Altria’s liability‑driven investment framework that prioritizes rate‑sensitive debt to hedge pension liabilities and maintain funded status.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES BETWEEN LLM AND GROUND TRUTH:\n\n1. FUNDAMENTAL METRIC MISMATCH: The LLM provides absolute dollar amounts ($1.15B, $562M) while the ground truth provides percentage allocations (19% → 16% → 8%). These are fundamentally different metrics. The question asks about 'allocation' which in pension asset context typically refers to percentage allocation, not absolute dollar amounts. The LLM appears to have misinterpreted the metric entirely.\n\n2. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims 2022-2023 allocation was ~$1.15B, then dropped to $562M in 2024 (51% decline)\n   - Ground truth shows percentage allocation: 19% (2022) → 16% (2023) → 8% (2024)\n   - These cannot both be correct; the LLM is answering a different question about absolute values rather than allocation percentages\n   - The LLM's calculation of 51% decline in dollar amounts is mathematically correct for those numbers, but those numbers don't match the ground truth metric\n\n3. MISSING KEY INFORMATION:\n   - LLM completely omits the percentage allocation trend (19% → 16% → 8%), which is the core answer\n   - LLM omits the expected rate of return reduction (6.6% → 6.1% → 6.1%), which ground truth identifies as important context\n   - LLM omits the below-investment-grade securities trend (11% → 9%), which ground truth cites as supporting evidence\n\n4. REASONING QUALITY:\n   - LLM's reasoning about 'liability-driven investment framework' and 'rate-sensitive debt' is plausible but not supported by ground truth\n   - Ground truth emphasizes 'recalibration of risk exposure and return expectations' and 'more conservative or diversified investment posture'\n   - LLM's interpretation diverges from ground truth's narrative\n\n5. MULTI-HOP SYNTHESIS:\n   - Ground truth synthesizes: allocation percentages + expected return changes + below-investment-grade trends → strategic shift narrative\n   - LLM only provides dollar amounts and corporate bond shift, missing the broader strategic context\n\n6. DIRECTIONAL CORRECTNESS:\n   - Both agree allocation decreased (correct direction)\n   - But LLM uses wrong metric (dollars vs. percentages)\n   - LLM's explanation of the shift (toward corporate bonds) differs from ground truth's emphasis on diversification and conservative posture\n\nCONCLUSION: The LLM answer is fundamentally incorrect because it answers with absolute dollar amounts instead of percentage allocations. While the directional trend (decrease) is correct, the core metric is wrong, and critical supporting information (expected returns, below-investment-grade trends) is completely missing. This represents a significant failure in multi-hop synthesis and metric identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 714,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (page 186, 2024; page 178, 2023). Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, before declining to $44.9 billion in 2024 (page 178, 2023; page 186, 2024). Over the three years the firm shifted away from floating‑rate debt (from $1.7 billion in 2022 to $0 in 2024), expanded fixed unsecured senior debt (peaking at $27.2 billion in 2023) and cut securitized debt obligations (from $16.97 billion in 2022 to $14.26 billion in 2024), reflecting a move toward a more fixed‑rate, lower‑floating‑rate structure and a modest tightening of securitized exposure (page 178, 2023; page 186, 2024).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Capital One's debt structure and evolution. CRITICAL ERRORS: (1) Total debt figures are substantially wrong - LLM reports $47.8B (2022), $49.3B (2023), $44.9B (2024) for long-term debt alone, but ground truth shows total short-term + long-term debt of $43.086B (2022), $48.715B (2023), $45.551B (2024). The LLM appears to have confused or misreported the long-term debt component. (2) Securitized debt is significantly misstated - LLM claims $16.97B in 2022, but ground truth shows $14.994B (13% error). (3) Floating unsecured senior debt numbers are partially correct ($1.7B in 2022, $0 in 2024) but the intermediate year value is missing/unclear. (4) Fixed unsecured senior debt peak is stated as $27.2B in 2023, but ground truth shows $26.930B in 2024 as the peak, suggesting the LLM may have confused years or values. (5) CRITICAL OMISSION: The LLM completely fails to address weighted-average interest rates, which are central to the question about 'interest rate exposure.' Ground truth shows securitized debt rates rising from 1.51% (2022) to 3.01% (2023) to 3.48% (2024), and fixed unsecured senior debt rates rising from 2.91% to 4.84% - these are essential to understanding the debt structure evolution and strategic positioning. (6) The LLM's characterization of the trend as 'tightening of securitized exposure' is partially correct directionally but lacks the nuance that securitized debt actually increased in 2023 before declining in 2024. POSITIVE ELEMENTS: The LLM correctly identifies the shift away from floating-rate debt and toward fixed-rate debt, and correctly notes the general directional trends. However, the numerous quantitative errors and complete absence of interest rate analysis make this answer substantially incorrect for a question explicitly asking about 'interest rate exposure.' The multi-hop synthesis is incomplete and inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 527,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the 5.45% Solar Bonds, Series 2015/C25‑15 as an exhibit (see Exhibits on pages 102, 100 and 97), indicating that the company still relies on this bond series to finance its solar projects. The repeated inclusion of the same bond across three consecutive filings shows that the debt remains outstanding and continues to be a key component of Tesla’s capital structure, underscoring its ongoing role in funding solar initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and confirms their repeated appearance across 2022, 2023, and 2024 10-K filings. The bond series designation, interest rate, and years are all accurate. The answer appropriately synthesizes the multi-hop information by noting the consistent inclusion across three consecutive filings and drawing the logical conclusion that this reflects ongoing reliance and strategic importance for solar financing. However, there are some notable differences from the ground truth: (1) The LLM provides specific page numbers (102, 100, 97) for exhibit locations, which are not verified against the ground truth and may introduce factual errors if incorrect. (2) The LLM references the exhibits appearing on specific pages, whereas the ground truth emphasizes the Thirty-Sixth Supplemental Indenture dated April 14, 2015 as the specific document referenced. (3) The ground truth provides more precise documentation of the indenture date and supplemental indenture designation, which the LLM omits. (4) The LLM's reasoning about the bonds remaining 'outstanding' and being a 'key component' is sound and aligns with the ground truth's conclusion about ongoing reliance, though the ground truth uses slightly different language ('active and integral component'). The core message is semantically equivalent - both answers conclude that the repeated inclusion indicates ongoing strategic importance for solar financing. The main risk is the unverified page number citations, which could be factually incorrect and would undermine the answer's credibility if wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 445,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s share‑buyback program accelerated from 2022 to 2024, with purchases of Class A treasury stock rising from $8.8 billion in 2022 to $9.1 billion in 2023 and then to $11.0 billion in 2024, while the book value of treasury stock climbed from $51.4 billion to $60.4 billion to $71.4 billion【page_70】. This trend signals a capital‑allocation strategy focused on returning excess cash to shareholders and boosting earnings per share through share repurchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth shows treasury stock values of $(51,354)M in 2022, $(60,429)M in 2023, and $(71,431)M in 2024. The LLM reports these same figures but in billions ($51.4B, $60.4B, $71.4B), which is correct format conversion. However, the LLM introduces completely fabricated annual purchase amounts ($8.8B, $9.1B, $11.0B) that do NOT appear in the ground truth and cannot be verified. These appear to be calculated differences (e.g., $60.4B - $51.4B ≈ $9B), but the ground truth does not provide annual purchase data - only year-end treasury stock balances. (2) MULTI-HOP REASONING ISSUE: The LLM conflates two different metrics: (a) the book value of treasury stock (balance sheet figure), and (b) annual treasury stock purchases (cash flow/activity figure). The ground truth only provides the former. The LLM's calculation of annual purchases from balance sheet changes is mathematically unsound because treasury stock balances can change due to factors beyond purchases (e.g., accounting adjustments, retirements). (3) ENTITY/METRIC CONFUSION: The original answer contains an apparent typo ('$(51,354) million in 2023 to $(60,429) million in 2023') but clearly intends 2022-2023-2024 progression. The LLM correctly interprets this as a three-year trend. (4) SEMANTIC ISSUE: The negative signs in the ground truth (parentheses notation) indicate contra-equity accounts, which the LLM correctly interprets as treasury stock values. However, the LLM's introduction of unsupported purchase figures ($8.8B, $9.1B, $11.0B) represents fabrication of data not in the source material. (5) CONTEXTUAL RELEVANCE: The LLM's interpretation of the trend (capital allocation toward buybacks) is reasonable and matches the ground truth's conclusion, but is based on partially incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 519,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions risk factor was worded the same in 2022, 2023 and 2024, each time noting that the segment could be hurt by “reduced investments in process automation, safety monitoring, and plant capacity‑utilization initiatives” (2022 page 32; 2023 page 31; 2024 page 32). The unchanged wording signals that the company viewed these headwinds as persistent, reflecting ongoing macro‑economic pressures—constrained capital budgets, inflation, supply‑chain constraints and a slowdown in industrial demand—that dampened investment in automation and capacity expansion. This continuity indicates a sustained downturn in industrial activity and a cautious outlook for automation and plant utilization over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year period (2022-2024) and the Safety and Productivity Solutions segment. (2) Page citations are provided (2022 page 32; 2023 page 31; 2024 page 32) which adds specificity. (3) The LLM correctly notes that the wording remained consistent across the three years regarding 'reduced investments in process automation, safety monitoring, and plant capacity-utilization initiatives.' (4) The identification of macroeconomic pressures (constrained capital budgets, inflation, supply-chain constraints, slowdown in industrial demand) is reasonable and contextually appropriate. (5) No numerical errors or calculation mistakes are present.\n\nWEAKNESSES: (1) The LLM's core claim that the risk factor wording was 'the same' across all three years contradicts the ground truth, which explicitly states that while 2022 and 2023 were 'largely consistent,' by 2024 there was a 'sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts.' This represents a meaningful evolution that the LLM missed. (2) The ground truth emphasizes a 'trajectory' showing 'persistent and potentially worsening' conditions, suggesting escalation or deepening concern. The LLM's characterization of 'unchanged wording' and 'continuity' actually understates the evolution described in the ground truth. (3) The LLM does not capture the distinction between 2023 (emphasis on 'ongoing global economic uncertainty') and 2024 (emphasis on 'geopolitical instability and trade policy shifts'), which represents a shift in the nature of macroeconomic concerns. (4) The LLM's conclusion about 'sustained downturn' is reasonable but less nuanced than the ground truth's assessment of 'deepening concern' and 'potentially worsening' conditions.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but fails to capture the evolution/trajectory that is central to the question. The question specifically asks 'how did...evolve' and 'what does this trend suggest,' requiring analysis of change over time. The LLM's assertion of unchanged wording misses the documented shift in emphasis from general economic uncertainty (2023) to specific geopolitical and trade policy concerns (2024).\n\nSEMANTIC EQUIVALENCE: While the LLM's identification of macroeconomic pressures is semantically reasonable, it does not match the ground truth's characterization of the trajectory as showing 'deepening concern' and 'potentially worsening' conditions. The LLM presents a static picture ('sustained downturn') rather than a dynamic one ('evolution' and 'trajectory').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 702,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through 2024, Cyramza’s therapeutic portfolio stayed the same—second‑line treatment of advanced gastric cancer or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, hepatocellular carcinoma, and first‑line treatment of metastatic NSCLC with EGFR mutations (see pages 5–6). The 2023 10‑K’s IP table shows that the U.S. compound patent and biologics data protection expire in 2026, the EU compound patent in 2028, while data protection ends in the EU in 2024 and Japan in 2023, indicating a gradual erosion of exclusivity (page 11). Thus, Cyramza’s lifecycle is moving from a period of robust exclusivity toward an approaching expiration window, with no new indications added by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Cyramza's therapeutic indications and IP protection timeline. STRENGTHS: (1) All numeric dates are correct - U.S. compound patent/biologics data protection expiring 2026, EU compound patent 2028, EU data protection 2024, Japan data protection 2023. (2) Therapeutic indications are accurately listed and comprehensive, including second-line gastric/GEJ adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, hepatocellular carcinoma, and first-line NSCLC with EGFR mutations. (3) Multi-hop synthesis is sound - correctly connects therapeutic portfolio stability (2022-2024) with IP erosion timeline. (4) Semantic equivalence is strong - conveys the same narrowing exclusivity window concept as ground truth. (5) Contextual framing is appropriate, noting the transition from robust to approaching expiration. MINOR WEAKNESSES: (1) The LLM provides slightly more granular detail on indications (specifically mentions EGFR mutations for first-line NSCLC) than the ground truth, which is not incorrect but represents additional specificity. (2) The ground truth uses the phrase 'second-line treatments' while LLM specifies 'second-line treatment' for some indications and 'first-line' for others - this is actually more precise and accurate. (3) The LLM answer is more detailed overall, which enhances rather than detracts from accuracy. The core message about lifecycle positioning - stable indications with narrowing IP protection - is correctly conveyed. No calculation errors detected. All dates and patent expiration timelines verified as accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 449,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities fair value grew markedly from 2022 to 2024 – $5 million at December 31 2022, $58 million at December 31 2023 and $69 million at December 31 2024.  The instruments remained Level 3 and were valued by discounted‑cash‑flow models; the only significant unobservable input in the models was the swap‑rate assumption, which widened from a 1‑2 % range (weighted average 2 %) in 2022 to a 3‑5 % range (weighted average 4 %) in 2023 and to a 4 % weighted average in 2024, reflecting higher swap‑rate assumptions in the valuation models.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) CRITICAL NUMBER ERRORS: The LLM states the 2022 fair value was $5 million, but the ground truth clearly states it was $19 million - a 73% discrepancy. More problematically, the LLM claims 2024 fair value was $69 million, but the ground truth explicitly states it remained at $58 million - a $11 million error (19% overstatement). These are not minor rounding differences but substantial misstatements of key financial metrics. (2) SWAP RATE RANGE ERROR: The LLM claims swap rates were 1-2% (weighted 2%) in 2022, but the ground truth does not specify this range for 2022 - it only mentions swap rates and default rates were used. The LLM appears to have fabricated or misattributed this 2022 range. (3) PARTIAL CORRECTNESS: The LLM correctly identifies that swap rates were 3-5% (weighted 4%) in 2023 and 4% weighted average in 2024, matching the ground truth. The LLM also correctly identifies the Level 3 classification and discounted cash flow methodology. (4) MISSING CONTEXT: The LLM omits important details about the $20 million in net losses held in the 2022 portfolio and the default rate ranges (53-163%) mentioned in the ground truth, reducing completeness. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the evolution across years, the fundamental numerical errors in 2022 and 2024 values break the logical narrative of the trend analysis. The ground truth shows stabilization at $58M from 2023-2024, but the LLM incorrectly shows continued growth to $69M. These quantitative errors are critical failures in a financial analysis context where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 470,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022, thousands of Qualcomm employees participated in the charitable‑match program, which supported more than 1,500 organizations; by fiscal 2024 the same scale of employee engagement persisted, but the number of organizations benefited had fallen to just over 1,300.  This steady employee participation, coupled with a modest decline in the breadth of supported charities, reflects Qualcomm’s ongoing emphasis on human‑capital initiatives—progress on such programs is explicitly tied to executive bonus modifiers (a 0.9–1.1× multiplier) in both 2022 and 2024, aligning philanthropic engagement with executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct—2022 participation of 'thousands of employees' supporting 'over 1,500 organizations' matches ground truth; 2024 figures of 'thousands' participating with 'just over 1,300' organizations supported are accurate. The executive bonus modifier range of 0.9–1.1× is correctly stated. COMPLETENESS: The answer addresses all major components of the multi-part question: (1) employee participation evolution (thousands in both years), (2) supported organizations trend (1,500+ to 1,300+), and (3) alignment with executive compensation (bonus modifiers). MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions—connecting charitable program metrics to executive compensation structures and human capital strategy. The logical flow from program participation data to compensation linkage is sound. MINOR OMISSIONS: The ground truth mentions 'Qualcomm's 2025 goals for diversity, equity, and inclusion' as part of the broader human capital strategy context. The LLM answer does not explicitly reference these 2025 goals, instead focusing on the 2022-2024 period and the compensation linkage. This is a minor contextual omission rather than a factual error. SEMANTIC EQUIVALENCE: The phrasing differs slightly from ground truth (e.g., 'modest decline in the breadth of supported charities' vs. 'slightly decreased'), but the semantic meaning is equivalent and accurate. The characterization of the trend as reflecting 'ongoing emphasis on human-capital initiatives' aligns well with the ground truth's assessment of 'sustained alignment with Qualcomm's broader human capital strategy.' ENTITY ACCURACY: Company name (Qualcomm), fiscal years (2022, 2024), and metrics (employee participation, organizations supported, bonus modifiers) are all correctly identified and applied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 527,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Acrobat has been positioned as the core PDF engine of Adobe Document Cloud, integrated with Adobe Sign, APIs and AI‑driven features such as Liquid Mode and Sensei, and available on web, mobile and desktop (pages 5‑8). The 2023 filing reiterated this role, stressing further improvements to Acrobat web, expanded task‑based actions, and deeper Sign integration, but did not disclose new product enhancements beyond those already described (pages 4‑5). The 2024 filing’s provided pages contain no additional Acrobat enhancements, indicating the positioning remains unchanged (pages 94‑98).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about Acrobat's evolution from 2022 to 2024. Specific issues: (1) The LLM claims the 2024 filing 'provided pages contain no additional Acrobat enhancements' and that 'positioning remains unchanged,' which directly contradicts the ground truth stating that by 2024, Acrobat was 'formally associated with AI capabilities through the introduction of Acrobat AI Assistant as a registered trademark.' This is a major factual error. (2) The LLM mentions 'Liquid Mode and Sensei' as features but provides no temporal context or evolution narrative across the three years. The ground truth clearly traces a progression: 2022 (document standard focus), 2023 (AI-powered innovation introduction), 2024 (AI Assistant formalization). The LLM fails to capture this evolution. (3) The LLM references specific page numbers (5-8, 4-5, 94-98) without providing substantive content about what those pages actually disclosed regarding the evolution of Acrobat's positioning. (4) The LLM does not adequately address the integration with other Adobe services evolution or the shift from document-centric to AI-enhanced positioning. (5) The claim that 2023 'did not disclose new product enhancements beyond those already described' contradicts the ground truth's statement about 'forward-looking statements about new or enhanced offerings, including AI-driven features' in 2023. The answer demonstrates incomplete multi-hop synthesis across the three years and misses the fundamental narrative of Acrobat's transformation into an AI-powered platform.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 443,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "From 2022 through 2024 the AbCellera collaboration produced a single year of revenue.  In 2022 the company recognized **$2.02 billion** in net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) under the AbCellera license, but in 2023 and 2024 there were **no sales** and thus no net product revenue.  Royalty payments to AbCellera were recorded as cost of sales and are described as “mid‑teens to mid‑twenties percent” of worldwide net sales, but the filing does not disclose the dollar amounts of those royalties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All numbers are correct - $2.02 billion in 2022 revenue, zero sales in 2023 and 2024, and the royalty percentage range (mid-teens to mid-twenties) matches the ground truth exactly. No calculation errors detected. ENTITY ACCURACY: Correctly identifies LLY, AbCellera, bamlanivimab, bebtelovimab, and the relevant fiscal years (2022-2024). MULTI-HOP REASONING: Successfully synthesizes the three-year progression showing the sharp decline from peak 2022 revenue to complete wind-down by 2023-2024, with corresponding elimination of royalty obligations. COMPLETENESS: Addresses all key aspects of the question including net product revenue evolution, royalty payment structure, and the overall trend. The answer correctly notes that royalty dollar amounts are not disclosed in filings, which is an important caveat. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer is slightly more concise and doesn't explicitly mention 'reduced demand or regulatory changes affecting EUA-based sales' as context for the wind-down, though this is a minor omission of interpretive context rather than factual error. The core factual content is accurate and well-synthesized. The answer appropriately emphasizes that while royalty percentages are disclosed, actual dollar amounts are not separately itemized in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 388,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife has consistently reinsured **59 % of its closed block** through a modified coinsurance agreement in each of the three reporting years: 59 % in 2022 (page 214), 59 % in 2023 (page 227), and 59 % in 2024 (page 204). This unchanged percentage shows that the company deliberately maintains a fixed portion of the closed block under the same modified‑coinsurance arrangement, underscoring a stable, long‑term risk‑transfer strategy that relies on a predictable, deposit‑method reinsurance structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core finding that MetLife maintained approximately 59% reinsurance of its closed block through a modified coinsurance agreement across 2022-2024, demonstrating strategic consistency. The qualitative interpretation about long-term risk transfer strategy and stability is sound and well-reasoned. The answer appropriately addresses the multi-hop question by synthesizing data across three years and drawing conclusions about strategic intent.\n\nCRITICAL ISSUE - QUANTITATIVE ACCURACY: The ground truth specifies 59.25% for 2022, but the LLM rounds this to 59%. While the difference is minor (0.25 percentage points), the evaluation criteria emphasize strictness on numbers and calculations. The ground truth explicitly distinguishes 59.25% in 2022 from 59% in 2023 and 2024, suggesting this precision matters. The LLM's statement that the percentage was '59% in 2022' is technically inaccurate.\n\nMINOR ISSUES: (1) The LLM adds page references (214, 227, 204) that cannot be verified against the ground truth, which doesn't include page numbers. While these may be correct, they introduce unverifiable claims. (2) The phrase 'deposit-method reinsurance structure' appears in the LLM answer but not in the ground truth, adding interpretation beyond what was confirmed.\n\nMULTI-HOP REASONING: The synthesis across three years is correct, and the logical conclusion about strategic continuity is sound and well-supported by the data.\n\nSCORING RATIONALE: The answer loses points primarily for the 59.25% → 59% rounding error in 2022, which violates the strict numerical accuracy requirement. The unverifiable page references and added terminology also create minor concerns. However, the core insight and overall reasoning quality remain strong, preventing a lower score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 492,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "From 2022 to 2024 Mastercard expanded its real‑time account‑based payment infrastructure from 12 to 13 markets (2022 10‑K p. 11; 2024 10‑K p. 11) while deepening its multi‑layered security model by formalising collaboration with issuers, acquirers, merchants, governments and industry associations to set technical standards and monitor third‑party risks (2022 10‑K p. 12; 2024 10‑K p. 12). This evolution signals a cybersecurity strategy that prioritises ecosystem‑wide resilience, proactive threat monitoring, and continuous expansion of secure real‑time payment channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Mastercard's security approach from 2022-2024, accurately captures the expansion of real-time payment infrastructure (12 to 13 markets), and properly identifies the multi-layered security model with third-party collaboration. The answer appropriately synthesizes information across multiple years and correctly identifies key stakeholders (issuers, acquirers, merchants, governments, industry associations). The reasoning about ecosystem-wide resilience and proactive threat monitoring is sound and relevant.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE: The LLM states expansion from '12 to 13 markets' but the ground truth indicates 2022 had 12 markets, 2023 had 13 markets, and 2024 had 'several countries globally' - the LLM fails to capture the 2024 progression to 'several countries globally,' which represents a significant evolution beyond the 13-market figure. This is a material omission of the 2024 data point. (2) INCOMPLETE TEMPORAL COVERAGE: The answer focuses primarily on 2022 and 2024 but underemphasizes the 2023 transition year, which the ground truth identifies as important for showing 'more structured integration of third-party risk management.' The ground truth explicitly notes 2023 as a turning point where the company 'explicitly mentioned working with third-party providers to address threats associated with outsourced services.' (3) MISSING SPECIFICITY: The ground truth mentions 'public-private collaborations' and 'outsourced services risk management' as specific elements that evolved - the LLM answer is more generic about 'third-party collaboration' without capturing these nuances. (4) CITATION ACCURACY: While the LLM provides page citations, these cannot be verified against actual filings and appear potentially inaccurate (both 2022 and 2024 10-Ks cited as page 11-12 for identical information seems suspicious).\n\nMULTI-HOP REASONING: The answer demonstrates adequate multi-hop synthesis across years and entities, correctly connecting real-time payment expansion with security evolution. However, it misses the critical 2024 evolution to 'several countries globally' which represents a qualitative shift in the narrative.\n\nOVERALL: The answer captures approximately 70% of the ground truth content with correct core facts but material omissions regarding 2024 progression and insufficient emphasis on the 2023 transition period. The quantitative error (incomplete market count progression) and missing temporal nuance prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 678,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 to 2024 the fair‑value of equity‑like funds in Lilly’s defined‑benefit pension plans moved from $4,014.1 million in 2022 to $4,093.7 million in 2023 and then to $3,931.5 million in 2024, while the retiree‑health‑plan portion rose from $332.8 million to $335.1 million and then to $346.1 million. The allocation has remained broadly stable, with only modest year‑to‑year swings, indicating that Lilly maintains a consistent, long‑term commitment to illiquid private‑alternative investments as part of its growth‑investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and critical errors that make it largely incorrect:\n\n(1) MAJOR QUANTITATIVE ERRORS:\n- Ground truth shows 2022: $2,844.7M, 2023: $4,014.1M, 2024: $4,093.7M\n- LLM states 2022: $4,014.1M, 2023: $4,093.7M, 2024: $3,931.5M\n- The LLM has shifted all values by one year and provided completely wrong numbers for 2024 ($3,931.5M vs correct $4,093.7M)\n- The 2022 figure is off by $1,170M (41% error)\n- The 2024 figure is off by $162.2M (3.8% error)\n\n(2) TREND ANALYSIS FAILURE:\n- Ground truth shows clear upward trajectory: $2,844.7M → $4,014.1M → $4,093.7M (39.1% growth over 2 years)\n- LLM incorrectly characterizes the trend as \"broadly stable\" with \"modest year-to-year swings\"\n- LLM shows a declining trend in its (incorrect) numbers: $4,014.1M → $4,093.7M → $3,931.5M\n- This is the opposite of the actual trend\n\n(3) MULTI-HOP SYNTHESIS FAILURE:\n- The question asks about evolution from 2022-2024 and what it suggests about strategy\n- Ground truth correctly identifies this as indicating \"strategic emphasis on long-duration, higher-return potential assets\" and \"growing confidence in private market investments\"\n- LLM's incorrect numbers lead to wrong conclusion about \"consistent, long-term commitment\" rather than growth trajectory\n- The retiree health plan numbers appear to be additional detail not in ground truth, suggesting possible data confusion\n\n(4) ENTITY AND CONTEXT ISSUES:\n- LLM conflates or separates pension plan and retiree health plan allocations in a way that obscures the main trend\n- Ground truth focuses on the equity-like funds allocation as a whole\n- LLM's breakdown into two categories may be technically accurate but obscures the primary finding\n\n(5) INTERPRETATION ERROR:\n- LLM concludes \"broadly stable\" when the data shows significant growth\n- This is a fundamental misinterpretation of the trend that contradicts the ground truth's conclusion about growing confidence and strategic emphasis",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 537,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade remained a core brand in the Home Care sub‑category of Procter & Gamble’s Fabric & Home Care segment, with its product categorization (Air Care, Dish Care, P&G Professional, Surface Care) unchanged from 2022 through 2024【page_19】.  The segment’s share of the company’s net sales grew from 35 % in 2022 to 36 % in 2024, indicating a modest rise in Cascade’s relative contribution to overall net sales【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the segment's net sales share progression (35% in 2022 to 36% in 2024), matching the ground truth. (2) Correctly identifies Cascade as a core brand within Fabric & Home Care segment. (3) Appropriately notes the modest increase in segment contribution. (4) Number formatting is acceptable and matches ground truth values.\n\nWEAKNESSES: (1) The LLM introduces product categorization details (Air Care, Dish Care, P&G Professional, Surface Care) that are NOT addressed in the ground truth answer. While these may be factually accurate from the filing, they represent a different interpretation of what 'product categorization' means in the question context. The ground truth focuses on Cascade's positioning within the segment structure, not its internal product subcategories. (2) The LLM states the segment share 'grew from 35% in 2022 to 36% in 2024' but omits the intermediate 2023 data point (36%) that the ground truth explicitly mentions. This is a significant omission for a three-year evolution question. (3) The phrase 'indicating a modest rise in Cascade's relative contribution' is somewhat speculative - the ground truth more conservatively states 'stable positioning and consistent contribution.' (4) The LLM answer doesn't explicitly address the 2023 year, which is critical for showing the evolution across the full three-year period.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information about Cascade's positioning and segment contribution, but the synthesis is incomplete by omitting 2023 data. The reasoning about 'modest rise' is logical but differs from the ground truth's characterization of 'stable positioning.'\n\nCRITICAL GAP: The ground truth explicitly mentions 2023 (36% share), showing the evolution was 35% → 36% → 36%. The LLM only shows 35% → 36%, missing the intermediate year that demonstrates the positioning stabilized after the initial increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 523,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "In 2022, Lowe’s policy required all wood to come from well‑managed, non‑endangered forests and its Vendor Code of Conduct included enhanced environmental standards (page 10, 2022). In 2023 the wood‑sourcing policy was updated with country‑specific risk levels, stronger monitoring and a new forestry grievance process, tightening supplier sustainability oversight (page 9, 2023). By 2024 Lowe’s expanded monitoring by encouraging suppliers to report emissions to CDP and bolstered its investment strategy with over $300 M in energy‑efficiency and renewable‑energy projects, rooftop solar at 100+ sites, and a $350 M community‑investment commitment (page 10, 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the evolution of Lowe's wood sourcing practices across 2022-2024, accurately capturing: (1) 2022 emphasis on well-managed, non-endangered forests and Vendor Code of Conduct; (2) 2023 updates including country-specific risk levels, enhanced monitoring, and forestry grievance process; (3) 2024 expansion of monitoring practices. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years and connecting policy framework changes to investment strategy.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) The LLM states 'over $300 M in energy-efficiency and renewable-energy projects' for 2024, but the ground truth specifies the 2022 investment was 'over $550 million in environmental facility upgrades' - this is a significant discrepancy ($300M vs $550M) and appears to conflate or misattribute investment figures. (2) The LLM introduces a '$350 M community-investment commitment' for 2024 that is not mentioned in the ground truth answer, suggesting potential hallucination or confusion with other metrics. (3) The ground truth mentions a '$50 million Gable Grants program over five years' for 2023, which the LLM completely omits.\n\nPARTIAL OMISSIONS: The LLM fails to mention the $50M Gable Grants program for skilled trades education (2023), which is a specific policy enhancement mentioned in the ground truth. The answer also doesn't explicitly address the 'long-term shareholder value' alignment mentioned for 2024.\n\nNEW INFORMATION NOT IN GROUND TRUTH: The LLM introduces CDP emissions reporting encouragement and rooftop solar at 100+ sites, which may be accurate but are not mentioned in the provided ground truth, making verification impossible.\n\nMULTI-HOP REASONING: The synthesis across years is generally sound, but the quantitative errors and omissions undermine the overall accuracy. The answer correctly identifies the progression of policy enhancements but fails on investment strategy specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 537,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures for 2022‑24 (all on page 30 of each filing) consistently flag competitive‑landscape changes—new entrants and emerging technologies—as threats to market share, pricing, and margins in Safety and Productivity Solutions, Building Technologies, and Industrial Automation.  The language for Safety and Productivity Solutions and Industrial Automation explicitly cites product commoditization each year, while Building Technologies references new entrants and tech but not commoditization.  This unchanged, persistent emphasis signals that market pressures and commoditization risks remain high and are likely intensifying across these core businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three business segments (Safety and Productivity Solutions, Building Technologies, Industrial Automation) and the 2022-2024 timeframe. (2) It accurately notes that competitive landscape risks involving new entrants and emerging technologies are flagged across all three divisions. (3) The observation about commoditization language in Safety and Productivity Solutions and Industrial Automation is correct. (4) The general conclusion about persistent market pressures is reasonable. WEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM states all risk disclosures are 'on page 30 of each filing'—this is a specific claim that cannot be verified and may be incorrect, introducing false precision. (2) INCOMPLETE PROGRESSION ANALYSIS: The ground truth emphasizes a 3-year PROGRESSION showing how the risk evolved ACROSS different divisions year-by-year (2022→Safety, 2023→Building Tech, 2024→Industrial Automation), indicating BROADENING exposure. The LLM treats this as a static, parallel disclosure across all three divisions rather than capturing the temporal evolution and expanding scope. (3) SEMANTIC MISALIGNMENT: The ground truth indicates 'intensifying and broadening market pressures' with risks becoming 'more systemic rather than isolated.' The LLM concludes risks 'remain high and are likely intensifying' but misses the key insight about the BROADENING pattern across divisions over time. (4) BUILDING TECHNOLOGIES CHARACTERIZATION: The LLM correctly notes Building Technologies doesn't explicitly mention commoditization, but this distinction is less emphasized than in the ground truth's narrative of progression. (5) MULTI-HOP REASONING: The LLM fails to synthesize the temporal dimension—that the risk appeared in different divisions in different years, suggesting expanding corporate concern rather than static parallel risks. The question specifically asks about 'evolution' and 'progression,' which the LLM inadequately addresses. QUANTITATIVE: No specific numbers are provided in either answer, so this dimension is less critical, but the page reference claim is problematic. OVERALL: The answer captures some correct elements but misses the core insight about the temporal progression and broadening scope of competitive risks across divisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 616,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K (page 8) described a nascent digital‑cockpit focus, with automotive revenue at $1.5 billion—just 4 % of its QCT segment. By 2024, that figure had nearly doubled to $2.9 billion (8.8 % of QCT revenue) and the company recognized $558 million of previously satisfied performance obligations, indicating earlier delivery of digital‑cockpit and ADAS/AD components (2024 10‑K, page 83). Segment reporting shows the QCT automotive sub‑segment’s earnings rebounding to $9.5 billion in 2024 from $7.9 billion in 2023, underscoring Qualcomm’s strategic pivot toward high‑performance, low‑power computing for connected vehicles (2023 10‑K, page 73).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific automotive revenue figures ($1.5B in 2022, $2.9B in 2024) and percentages (4% and 8.8% of QCT) that cannot be verified against the ground truth, which does not provide these specific numbers\n   - The LLM references $558 million in previously satisfied performance obligations - this number is not mentioned in the ground truth\n   - The LLM cites QCT automotive sub-segment earnings of $9.5B (2024) and $7.9B (2023) - these figures are not in the ground truth and appear to conflate revenue with earnings\n   - These specific dollar amounts and percentages are presented with high confidence but lack grounding in the provided ground truth\n\n2. MULTI-HOP REASONING FAILURE:\n   - The ground truth describes a progression: 2022 (strategic vision/analyst projections) → 2023 (explicit revenue recognition) → 2024 (formalized segment reporting)\n   - The LLM answer focuses heavily on quantitative metrics and financial performance but misses the qualitative evolution described in the ground truth\n   - The LLM does not address the key transition from \"forward-looking market opportunity statement\" to \"structured revenue recognition\" to \"full operational integration\"\n\n3. ENTITY AND METRIC CONFUSION:\n   - The LLM conflates \"earnings\" with \"revenue\" when discussing segment performance\n   - The ground truth emphasizes the recognition of digital cockpit products as a distinct revenue stream alongside connectivity and ADAS/AD\n   - The LLM answer focuses on overall automotive segment growth rather than the specific evolution of digital cockpit positioning\n\n4. MISSING KEY ELEMENTS:\n   - No mention of the 70% analyst projection for 2028 vehicles with embedded cellular connectivity\n   - No discussion of the transition from strategic vision to monetization\n   - No reference to the grouping of digital cockpit with connectivity and ADAS/AD under structured segment reporting\n   - The answer provides financial metrics but lacks the strategic narrative arc that defines the ground truth\n\n5. CONTEXTUAL RELEVANCE:\n   - While the answer attempts to show growth and evolution, it does so through financial metrics that may not be accurate\n   - The answer partially addresses the question's focus on \"strategic positioning\" but emphasizes financial performance over strategic evolution\n   - Page citations (page 8, page 83, page 73) suggest specific sourcing but cannot be verified against the ground truth\n\nThe LLM answer appears to have fabricated or misremembered specific financial figures while missing the core strategic narrative that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 728,
        "total_tokens": 2144
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "By 2024, Frame.io had broadened its media support to still images, design files, PDFs and video, added camera‑to‑cloud uploads, and expanded cross‑product integration from Premiere Pro and After Effects to also include Photoshop, Lightroom and Workfront, while becoming available in Adobe G enStudio for enterprise‑scale production [page_12]. These enhancements reflect a clear evolution from the 2022 offering, which was limited to video, still images, design files and PDFs and integrated only with Premiere Pro and After Effects.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several issues when compared to the ground truth: (1) FACTUAL ERRORS: The LLM claims that in 2022, Frame.io was 'limited to video, still images, design files and PDFs' - but the ground truth only states it was 'listed as a trademarked product' in 2022 without specifying those capabilities. The LLM appears to have conflated 2022 and 2023 information. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the 2023 description of Frame.io as 'cloud-native creative collaboration platform' and fails to mention the significant 2024 expansion into non-post-production workflows (casting, location scouting, marketing campaign management). This is a major omission since the question specifically asks about 'functional expansion' and the ground truth emphasizes this broadening of use cases. (3) INCOMPLETE EVOLUTION NARRATIVE: The answer presents only a 2022-to-2024 comparison but misses the important 2023 intermediate step and the qualitative shift in 2024 from post-production-only to broader enterprise content production workflows. (4) MEDIA TYPE ACCURACY: The LLM correctly identifies the supported media types (video, still images, design files, PDFs) but doesn't clarify the timeline of when these were introduced. (5) INTEGRATION ACCURACY: The cross-product integrations listed (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio) are correct. (6) POSITIVE ASPECTS: The answer correctly identifies the progression of integrations and the inclusion in GenStudio. The answer demonstrates partial understanding but fails to capture the full scope of functional expansion, particularly the shift into new business domains beyond post-production in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 466,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022‑2024, Mastercard’s Class A common stock retained the same voting structure—one vote per share (see Note 16, page 98)—with no change in voting rights.  The declared dividend per share, however, rose each year: $2.04 in 2022 (page 97), $2.37 in 2023 (page 99), and $2.74 in 2024 (page 98).  This steady voting right combined with a progressively higher dividend payout indicates a stable, shareholder‑friendly governance framework over the three‑year span.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces dividend per share amounts ($2.04, $2.37, $2.74) that are NOT supported by the ground truth. The ground truth explicitly states that dividend RIGHTS (not amounts) remained consistent with no changes across 2022-2024. The LLM conflates two different concepts: (1) dividend rights (a governance/structural right) vs. (2) dividend per share amounts (actual payouts). The question asks about 'dividend and voting rights associated with MA's A Class shares' - this refers to the structural rights granted to the share class, not the dollar amounts paid. The LLM's introduction of specific dividend per share figures appears to be fabricated data with page citations that cannot be verified against the ground truth. The voting rights portion is correct (one vote per share, no changes), but this represents only partial correctness. The LLM's conclusion about 'progressively higher dividend payout' contradicts the ground truth finding of stability in dividend rights. The reasoning about 'shareholder-friendly governance' is speculative and not grounded in the actual governance structure stability that the question asks about. The answer demonstrates a fundamental misunderstanding of what 'dividend rights' means in the context of share class governance versus actual dividend declarations. This is a significant factual error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 393,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment was repeatedly flagged as vulnerable to “fluctuations in retail markets,” which can lower demand for safety products and squeeze margins (2022‑23 risk factors, page 30; 2024 risk factors, page 32).  In 2023 the segment’s net sales and profit fell versus 2022, and the 2024 results still show the segment under pressure, underscoring its ongoing sensitivity to consumer‑demand volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Honeywell's Safety and Productivity Solutions segment faced repeated exposure to retail market fluctuations across the three-year period (2022-2024). It accurately captures the core risk factors (lower demand for safety products, margin pressure) and correctly notes the segment name change/restructuring. The semantic understanding of vulnerability to consumer demand volatility is sound. WEAKNESSES: (1) QUANTITATIVE ISSUES - The LLM cites specific page numbers (page 30 for 2022-23, page 32 for 2024) without verification; these cannot be confirmed from the ground truth and may be inaccurate. (2) INCOMPLETE SYNTHESIS - The LLM mentions '2023 the segment's net sales and profit fell versus 2022, and the 2024 results still show the segment under pressure' but provides NO ACTUAL NUMBERS. The ground truth does not provide specific financial figures either, but the LLM's claim about sales/profit declines is stated as fact without supporting data. This is a significant gap in multi-hop reasoning - the LLM should either provide specific figures or acknowledge data limitations. (3) MISSING CONTEXT - The LLM fails to explicitly note the segment name change from 'Safety and Productivity Solutions' (2022-2023) to 'Industrial Automation' (2024), which is a key detail in the ground truth. While it implies organizational changes, it doesn't clearly articulate this transition. (4) INCOMPLETE ANALYSIS - The ground truth emphasizes that 'the segment has not significantly mitigated its exposure' over three years, suggesting a lack of improvement. The LLM notes 'ongoing sensitivity' but doesn't explicitly address whether mitigation efforts occurred or failed. CALCULATION/VERIFICATION: No specific calculations are presented by either answer, so quantitative accuracy is limited to factual claims. The LLM's assertion about sales/profit declines cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to connect risk disclosures across years with financial performance, but the financial performance claims lack supporting evidence. The reasoning is partially sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 581,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Olumiant collaboration kept a tiered double‑digit royalty (capped at 20 %) for inflammatory/autoimmune sales and an additional low‑teens royalty on COVID‑19 sales above a threshold that was added in the 2020 amendment and has remained unchanged (see page 72, 2023‑24).  Milestone obligations were material in 2020 ($210 M) and 2021 ($260 M) but have not been material since 2022, indicating a reduction in milestone payments (page 72, 2023).  Net product revenue rose from $830.5 M in 2022 to $957.4 M in 2024, reflecting expanded sales—including the COVID‑19 indication (page 73, 2023‑24).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies the royalty structure with tiered double-digit rates capped at 20% for inflammatory/autoimmune indications and low-teens royalty for COVID-19 sales above threshold. (2) Accurately notes that the COVID-19 royalty was added in 2020 amendment and remained unchanged through 2024. (3) Provides specific milestone payment data showing $210M in 2020 and $260M in 2021, correctly noting these were not material since 2022. (4) Includes precise revenue figures: $830.5M (2022) and $957.4M (2024), demonstrating product sales growth. (5) Correctly synthesizes the evolution from milestone-driven to royalty-based model. (6) Provides page citations for verification. MINOR GAPS: (1) The original answer mentions 'up to $100 million in additional regulatory milestones and $100 million in sales-based milestones' for 2022, which the LLM answer does not explicitly state. However, the LLM's statement that milestones 'have not been material since 2022' is consistent with this - suggesting these contingent payments were either triggered or expired. (2) The LLM answer could have been more explicit about the specific milestone amounts available in 2022 ($100M regulatory + $100M sales-based), though the overall characterization of the shift is accurate. QUANTITATIVE VERIFICATION: All numbers provided are accurate - royalty percentages (20%, low-teens), milestone amounts ($210M, $260M), and revenue figures ($830.5M, $957.4M) are correct. The multi-hop reasoning correctly synthesizes information about royalty structure, milestone evolution, and revenue growth across the 2022-2024 period. The answer effectively demonstrates how the relationship evolved from milestone-heavy to royalty-focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 495,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "Procter & Gamble re‑structured its Baby, Feminine & Family Care segment between 2022 and 2024, dropping the baby‑care sub‑category and the Pampers/Luvs brands so that only feminine‑care and family‑care products remained【page_19】.  The 2023–24 tables list Always, Always Discreet, Tampax Bounty, Charmin and Puffs as the segment’s major brands, whereas 2022 included Luvs and Pampers【page_18】.  This shift positioned Always as the flagship brand in the remaining feminine‑care sub‑category, where it holds over 20 % global market share and competes with Tampax for the top 25 % share, thereby increasing its prominence relative to other segment brands【page_18】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims P&G 'dropped the baby-care sub-category and the Pampers/Luvs brands' between 2022-2024, but the ground truth makes no mention of this restructuring or removal of baby-care products. This is a fundamental mischaracterization of the segment evolution. (2) BRAND LIST DISCREPANCY - The LLM lists 'Tampax Bounty' as if it's a single brand, when the ground truth clearly shows these as separate brands (Tampax and Bounty). This is a critical error in entity identification. (3) QUANTITATIVE CLAIMS - The LLM introduces specific market share claims ('over 20% global market share' and 'competes with Tampax for the top 25% share') that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated data points. (4) CATEGORIZATION EVOLUTION - While the LLM correctly identifies that categorization shifted from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to something different in 2023-24, it fails to accurately capture the specific shift to 'Feminine Care (Adult Incontinence, Menstrual Care)' noted in the ground truth. (5) POSITIONING NARRATIVE - The ground truth emphasizes a 'strategic sharpening of Always' positioning around menstrual care,' but the LLM's narrative about Always becoming a 'flagship brand' with increased prominence is not supported by the ground truth and appears to be an unsupported inference. (6) MULTI-HOP REASONING - The LLM fails to properly synthesize the year-by-year evolution (2022→2023→2024) as presented in the ground truth, instead making broader claims about segment restructuring that aren't substantiated. The answer demonstrates poor factual accuracy with invented details and misidentified entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 496,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s 2023 target allocation (from the 2022 filing) was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other. In the 2023 filing (August 31 2023) the 2024 target shifted to 94 % debt for U.S. plans and, for non‑U.S. plans, 23 % equity, 42 % debt, 6 % cash, 21 % insurance and 9 % other. The 2025 target (shown in both 2023 and 2024 filings) returned U.S. plans to 100 % debt and, for non‑U.S. plans, increased equity to 28 %, lowered debt to 36 %, raised cash to 7 %, kept insurance at 21 % and reduced other to 8 %. This progression shows ACN keeping a debt‑heavy, duration‑matching core for U.S. plans while gradually tilting non‑U.S. plans toward higher equity and insurance exposure to boost risk‑adjusted returns while still maintaining a conservative, duration‑aligned asset mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides specific, detailed quantitative information that directly addresses the multi-hop question about ACN's pension plan asset allocation evolution. STRENGTHS: (1) Provides concrete percentage allocations for all three fiscal years (2023, 2024, 2025) with clear differentiation between U.S. and non-U.S. plans, (2) Correctly identifies the source documents (2022 filing for 2023 target, 2023 filing for 2024 target and 2025 target, 2024 filing reaffirming 2025 target), (3) Accurately tracks the progression of allocations across years with specific numbers (e.g., U.S. plans: 100% debt in 2023, 94% in 2024, 100% in 2025), (4) Provides meaningful synthesis showing the strategic pattern: debt-heavy U.S. plans with consistent 100% debt allocation in 2023 and 2025, while non-U.S. plans show tactical shifts in equity/insurance/debt mix, (5) Correctly interprets the strategic intent - duration matching for U.S. plans while gradually increasing risk-adjusted returns in non-U.S. plans through higher equity and insurance exposure. VERIFICATION: All percentages sum correctly (U.S. plans at 100%, non-U.S. plans at 100% for each year), the directional changes are logical and consistent with stated strategy. MINOR CONSIDERATIONS: The answer is more quantitatively detailed than the original ground truth answer, which was more qualitative/conceptual. However, this represents an enhancement rather than an error - the LLM provides the specific data points that support the ground truth's conclusions about liability duration matching and risk-adjusted returns. The multi-hop reasoning correctly synthesizes information across three separate filings and two time periods. The interpretation of the strategic evolution (debt-heavy core with tactical flexibility) aligns with the ground truth's characterization of 'stable investment framework with tactical flexibility.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 521,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "In 2022 Lowe’s held $2.56 billion of forward interest‑rate swaps as cash‑flow hedges (page_46).  By 2023 that exposure fell to $251 million, still measured at fair value (Level 2) and treated as a cash‑flow hedge (page_54, page_46).  In 2024 the company had no forward swaps, instead using fixed‑to‑floating swaps as fair‑value hedges on existing debt (page_54, page_46).  This evolution shows a shift from hedging forecasted debt issuances with forward swaps to hedging current debt with fair‑value swaps, reflecting a change in its interest‑rate risk management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Lowe's held '$2.56 billion of forward interest-rate swaps' in 2022, but the ground truth explicitly states 'no current fair value was listed for 2022 itself.' This is a major factual error - the LLM fabricated a specific dollar amount that contradicts the source material. The 2023 figure of $251 million is correct. (2) CLASSIFICATION ERROR - The LLM states the 2023 swaps were 'still measured at fair value (Level 2) and treated as a cash-flow hedge,' which matches the ground truth. However, the 2022 characterization is problematic since no fair value was disclosed for that year. (3) MULTI-HOP REASONING - The LLM correctly identifies the 2024 shift from forward swaps to fixed-to-floating swaps and the transition from cash flow hedges to fair value hedges. The reasoning about the strategic shift (from forecasted debt issuance risk to existing debt exposure) is sound and matches the ground truth interpretation. (4) COMPLETENESS - The answer addresses the evolution across all three years and discusses the strategic implications, which is appropriate. However, the fabricated 2022 figure undermines the entire analysis. (5) SEMANTIC EQUIVALENCE - The conclusion about the shift in risk management strategy is semantically equivalent to the ground truth, but this cannot overcome the fundamental factual error in the 2022 data. The LLM appears to have either hallucinated the $2.56 billion figure or misread source material, which is a critical failure in financial analysis where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 435,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s debt schedule shows a $606 million principal balance for the 5.000% notes due April 2030 in FY2023 and FY2024 (page 81 of each filing), and the same balance was reported in FY2022. The unchanged exposure indicates a disciplined debt‑management approach that prioritizes maintaining a stable maturity profile and interest‑rate exposure rather than expanding or reducing that particular instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the 5.000% notes due April 2030 had the same $606 million balance in FY2022, FY2023, and FY2024, stating 'the unchanged exposure indicates a disciplined debt-management approach.' However, the ground truth clearly shows the balance DECREASED from $1,086 million in 2022 to $606 million in 2023 and 2024. This is a $480 million reduction - a significant and material change that the LLM completely missed. (1) QUANTITATIVE ACCURACY: The LLM incorrectly states FY2022 had $606 million when it was actually $1,086 million. This is a $480 million error - a 44% understatement of the 2022 balance. The numbers for 2023 and 2024 ($606M) are correct, but the 2022 figure is wrong. (2) MULTI-HOP REASONING: The LLM failed to synthesize the three-year progression correctly. The question explicitly asks how the exposure 'evolved from fiscal year 2022 through 2024,' requiring comparison across all three years. The LLM's conclusion about 'unchanged exposure' is factually incorrect and contradicts the actual debt reduction strategy. (3) INTERPRETATION: The LLM's interpretation of the data is inverted - it characterizes unchanged balances as evidence of disciplined management, when the actual evidence shows active debt reduction (from $1,086M to $606M) as the disciplined strategy. (4) CONTEXTUAL RELEVANCE: The answer does address the right debt instrument and company, and attempts to discuss debt management strategy, but arrives at completely wrong conclusions based on incorrect numbers. The page references cited cannot be verified but the numerical claims are demonstrably false based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 473,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS disclosed the 7.620% debentures in 2022 (page 120) with an explicit interest‑rate history—8.375% until April 1 2020, then 7.620% thereafter—and detailed redemption terms. In the 2023 (page 105) and 2024 (page 108) filings the interest rate is omitted, but the notes continue to describe the same redemption structure—redeemable at any time at the greater of par plus accrued interest or the present value of remaining payments discounted at a treasury yield plus 5 bps—and the maturity remains April 1 2030. Thus, the evolution is a simplification of the interest‑rate disclosure while keeping the redemption and maturity terms unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct numbers: $276 million principal, 7.620% interest rate, April 1, 2030 maturity date, 8.375% historical rate until April 2020, and 5 basis points redemption terms. The multi-hop synthesis across 2022-2024 filings is sound, correctly identifying the evolution from explicit interest-rate history disclosure in 2022 to omission in 2023-2024. The redemption structure description is accurate and consistent with ground truth. However, there are notable omissions: (1) The LLM states the interest rate is 'omitted' in 2023-2024, but the ground truth indicates it was 'consistently reported as 7.620%' in those years—this is a meaningful distinction suggesting the rate remained disclosed, just without the historical context. (2) The LLM misses the ground truth's emphasis on the 2024 disclosure placing 'more emphasis on the semi-annual interest payment schedule' and confirmation of 'no sinking fund requirements'—these are important disclosure evolution details. (3) The LLM characterizes the evolution as 'simplification' while ground truth emphasizes 'increasing clarity in disclosure,' which are subtly different interpretations. The answer correctly addresses the core question about how treatment evolved regarding interest rates, redemption terms, and maturity structure, but incompletely captures the full scope of disclosure changes, particularly regarding 2024's enhanced clarity on payment schedules and sinking fund status. The reasoning is sound but the characterization of 2023-2024 disclosures as 'omitting' the interest rate may be slightly inaccurate based on ground truth language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 455,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s 2022 10‑K described Olpasiran as a phase‑2 siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease. The 2023 filing kept the program in phase 2 with the same cardiovascular focus, and the 2024 filing announced that the program had advanced to a phase‑3 trial for ASCVD, underscoring a strategic push for a first‑in‑class Lp(a)‑lowering therapy. Composition‑of‑matter patents for Olpasiran in the U.S. and Europe are projected to expire in 2036, giving the company a multi‑year exclusivity window.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error that significantly undermines its accuracy. MAJOR ERROR: The LLM claims that by 2024, Olpasiran 'had advanced to a phase-3 trial for ASCVD,' but the ground truth states that in 2024 the therapeutic indication was listed simply as 'cardiovascular disease' (broader than ASCVD), with no mention of phase-3 advancement. The ground truth explicitly indicates the program remained in phase 2 through 2023, and the 2024 change was a broadening of indication language, not a phase advancement. This is a fundamental mischaracterization of the clinical development trajectory. CORRECT ELEMENTS: (1) 2022 description as phase-2 siRNA targeting lipoprotein(a) for ASCVD is accurate; (2) Patent expiration date of 2036 for U.S. and European composition-of-matter patents is correct; (3) The characterization of IP protection as multi-year exclusivity is appropriate. INCOMPLETE/PROBLEMATIC ELEMENTS: (1) The LLM fails to capture the key 2023 disclosure about patent expiration dates, which is a significant part of the ground truth narrative about IP strategy evolution; (2) The claim about 'first-in-class Lp(a)-lowering therapy' is not mentioned in the ground truth and appears to be an inference not supported by the provided information; (3) The LLM misinterprets the 2024 indication change from ASCVD to 'cardiovascular disease' as a phase advancement rather than a potential expansion of clinical application or regulatory strategy, which is what the ground truth indicates. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across the three-year period. The ground truth shows a progression from specific indication (ASCVD) to broader indication (cardiovascular disease), combined with IP protection disclosure. The LLM instead created a false narrative of phase advancement. The quantitative accuracy is moderately good (patent dates correct) but the qualitative reasoning about clinical development is significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 537,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax has remained a major brand in P&G’s Baby, Feminine & Family Care segment throughout the period, appearing in the “major brands” list in 2022, 2023, and 2024 (PG_10k_2022, p. 19; PG_10k_2023, p. 19; PG_10k_2024, p. 19).  The segment’s sub‑category description, however, shifted from “Feminine Care (Adult Incontinence, Feminine Care)” in 2022 to “Feminine Care (Adult Incontinence, Menstrual Care)” by 2024, reflecting a clearer focus on menstrual products (PG_10k_2024, p. 19).  Despite this re‑categorization, Tampax’s prominence as a key brand in the segment remained unchanged across all three filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of Tampax's positioning within P&G's Feminine Care segment from 2022 to 2024. STRENGTHS: (1) Accurately captures the main categorization shift from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' by 2024, which is the core factual claim. (2) Correctly notes that Tampax remained a major brand across all three years (2022, 2023, 2024). (3) Properly cites page numbers and document references. (4) Accurately conveys that the prominence remained unchanged despite re-categorization. WEAKNESSES: (1) The LLM states the shift occurred 'by 2024' but the ground truth indicates the shift actually occurred between 2022 and 2023, with 2023 showing 'Feminine Care (Adult Incontinence, Menstrual Care)' and 2024 maintaining this same categorization. The LLM's phrasing could be misinterpreted as suggesting the change happened in 2024 rather than between 2022-2023. (2) The answer omits the detail that 2024 saw the segment name revert to 'Baby, Feminine & Family Care' (which was also used in 2022), suggesting a cyclical naming pattern. (3) Missing the explicit mention that the 2023 categorization was maintained in 2024, which is an important detail about consistency. The answer is substantially correct on the main facts but has a minor temporal ambiguity and omits some contextual details about the segment naming evolution that would strengthen the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 408,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 2022 10‑K (page 101) notes that “when we acquire non‑agency RMBS and CMBS that have not been previously evaluated by the NAIC, an internally developed designation is used until a NAIC designation becomes available.” By 2023 and 2024, the tables for those years (pages 95 and 86) show all RMBS and CMBS amounts assigned to NAIC designations—no internal designations appear—indicating that NAIC coverage of non‑agency RMBS/CMBS had expanded to cover the entire portfolio. This multi‑year trend shows that the NAIC’s availability of designations increased, and MetLife’s acquisition strategy has shifted toward securities that already carry NAIC designations, thereby reducing its reliance on internally developed ratings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth. The critical error is the LLM's claim that by 2023 and 2024, 'all RMBS and CMBS amounts assigned to NAIC designations—no internal designations appear.' This directly contradicts the ground truth, which states that internally developed designations remained a consistent practice across 2022-2024, with the practice continuing in 2023 and 2024. The LLM appears to have misread or misinterpreted the tables on pages 95 and 86 of the 2023 and 2024 filings. The ground truth explicitly confirms that internally developed designations persisted through 2024, not that they disappeared. The LLM's conclusion that 'MetLife's acquisition strategy has shifted toward securities that already carry NAIC designations, thereby reducing its reliance on internally developed ratings' is the opposite of what the ground truth indicates. The ground truth shows sustained, consistent use of internally developed designations across all three years, indicating an ongoing strategy of acquiring complex structured securities where NAIC evaluations lag behind acquisition timelines. The LLM correctly identified the general policy framework from the 2022 10-K but failed to accurately track the multi-year evolution, making a critical error in interpreting the 2023-2024 data. The reasoning about NAIC availability expanding is plausible but unsupported by the actual filing data as represented in the ground truth. This represents a major factual error in the core claim of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 422,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased 9.6 million shares ($3.15 million) under its open‑market program in fiscal 2022, with an available authorization of $3.129 million that was increased to $6.129 million after a $3 million add‑on. In fiscal 2023 the company bought roughly 2.0 million shares ($605 million) under the same program and raised its available authorization to $6.694 million with a $4 million add‑on. By fiscal 2024 the open‑market purchases remained around 2.0 million shares ($605 million) and the authorization stayed at $6.694 million. The steady rise in authorized capacity and consistent, dollar‑heavy repurchases signal a deliberate, expanding commitment to returning capital to shareholders.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and pervasive quantitative errors that fundamentally undermine its credibility. Critical issues: (1) UNIT ERRORS: The LLM states available authorization figures in millions when they should be in billions (e.g., '$3.129 million' should be '$3.129 billion', '$6.694 million' should be '$6.694 billion'). This is a systematic error affecting nearly every authorization figure. (2) FISCAL 2022 DATA: The LLM claims 9.6 million shares were repurchased for $3.15 million in fiscal 2022, which is factually incorrect and not supported by ground truth. The ground truth only mentions $3.13 billion in available authorization for fiscal 2022, with no repurchase amount specified for that year. (3) FISCAL 2023 DATA: The LLM correctly identifies 2.0 million shares for $605 million, but then incorrectly states the authorization was raised to '$6.694 million' (should be $6.694 billion based on ground truth context). (4) FISCAL 2024 DATA: The LLM states authorization 'stayed at $6.694 million' which contradicts the ground truth showing $2.69 billion available as of August 31, 2024, then increased to $6.69 billion on September 25, 2024. (5) MISSING CONTEXT: The LLM fails to properly distinguish between the authorization as of August 31, 2024 ($2.69 billion) versus the subsequent increase announced on September 25, 2024 ($4 billion additional). (6) CALCULATION ERRORS: The authorization figures are off by a factor of 1,000 throughout, suggesting fundamental misunderstanding of the scale of these financial metrics. While the LLM correctly identifies the general trend of increasing capital returns and consistent repurchases, the quantitative foundation is so compromised that the answer is unreliable for any practical financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 481,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom continued to list **industrial fiber optics** as a key product offering under its “Industrial” end‑market segment in each of the 2022, 2023 and 2024 10‑Ks (see the product‑portfolio tables on page 5 of each filing).  The same fiber‑optic component line is also described in the “Fiber Optic Components” section of the “Physical Layer Devices” narrative (page 6 of each filing).  This unchanged positioning signals a sustained strategic emphasis on industrial connectivity—particularly for factory automation, renewable‑energy, and automotive electronics—while keeping fiber optics central to its industrial portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing some correct elements. CRITICAL ISSUES: (1) The LLM claims industrial fiber optics appear in 'product-portfolio tables on page 5 of each filing' and a 'Fiber Optic Components' section on 'page 6 of each filing'—these specific page references and section names cannot be verified and appear to be fabricated. The ground truth does not reference these specific page locations or section titles. (2) The LLM states the positioning was 'unchanged' across all three years, which directly contradicts the ground truth's core finding that there was clear EVOLUTION: from 2022 (broad portfolio description) → 2023 (structured table categorization) → 2024 (explicit application linkage with factory automation, renewable energy, automotive electronics). The ground truth explicitly states 'increasing alignment to strategic industrial applications over time' and describes a 'maturing and application-focused product strategy.' (3) The LLM fails to capture the key evolution narrative: the ground truth shows progression from general portfolio inclusion to standardized categorization to explicit application-specific positioning. The LLM's claim of 'unchanged positioning' misses this strategic evolution entirely. CORRECT ELEMENTS: The LLM correctly identifies Broadcom (AVGO), the three years (2022, 2023, 2024), the Industrial end-market segment, and the applications (factory automation, renewable energy, automotive electronics). However, these correct elements are embedded in a fundamentally flawed analysis that misses the question's core focus on EVOLUTION. The answer reads as if the LLM may have hallucinated specific filing references to support a predetermined conclusion of 'unchanged' positioning, rather than synthesizing the actual multi-hop evolution described in the ground truth. This is a significant failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 530,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In 2022 and 2023, UPS SurePost was a residential ground service for non‑urgent, lightweight shipments that used UPS’s ground network and relied on the U.S. Postal Service for final delivery (UPS_10k_2022, page 6; UPS_10k_2023, page 6).  In 2024 the model remained the same, but UPS announced a strategic shift to insource the service beginning January 1 2025, thereby reducing its reliance on USPS and gaining greater control over the final leg of delivery (UPS_10k_2024, page 6).  This change reflects UPS’s broader effort to tighten control over its residential delivery network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key facts are correct: (1) UPS SurePost's role as a residential ground service for non-urgent, lightweight shipments is accurately described; (2) The reliance on USPS for final delivery in 2022-2023 is correctly stated; (3) The strategic shift to insource final delivery effective January 1, 2025 is accurately reported; (4) All dates and years are correct (2022, 2023, 2024, and the January 1, 2025 implementation date). The multi-hop reasoning is sound - the answer correctly synthesizes information about the service's evolution across three years and identifies the key strategic inflection point in 2024. The answer appropriately cites source documents (UPS 10-K filings for 2022, 2023, and 2024, page 6). The semantic meaning matches the ground truth perfectly: both convey that the service model remained consistent through 2023 with USPS reliance, then shifted in 2024 with an announced change to insource delivery starting 2025. Minor note: The LLM answer states 'In 2024 the model remained the same' which is technically accurate (the model didn't change in 2024 itself, only the announcement was made), though the ground truth phrasing 'in 2024, UPS announced' is slightly clearer about the timing of the announcement versus implementation. This is a negligible difference that doesn't affect factual accuracy. The answer effectively addresses all parts of the multi-part question regarding role evolution, delivery model changes, USPS reliance, and strategic shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 423,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline grew from 13 programs in 2022 (as of Feb 8, 2022) to 18 in 2023 (as of Jan 31, 2023) and to 24 in 2024 (as of Jan 31, 2024)【2022 page 26】【2023 page 26】【2024 page 26】. In 2024 the company added five programs via acquisition from Horizon, launched three new Phase 3 studies, secured an FDA approval and concluded one program, while in 2023 it had three FDA approvals and one Japan approval【2024 page 26】. This steady rise—combining organic growth with strategic acquisitions—underscores Amgen’s deliberate expansion of its R&D pipeline, diversification of therapeutic areas, and acceleration of development timelines.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core quantitative progression: 13 programs (Feb 8, 2022) → 18 (Jan 31, 2023) → 24 (Jan 31, 2024). All dates and program counts match the ground truth. The answer appropriately synthesizes multi-hop information by connecting the pipeline growth to the Horizon Therapeutics acquisition in 2023 and mentions the five Phase 3 programs added through this acquisition. The reasoning about R&D expansion strategy is sound and well-articulated, noting the combination of organic growth and strategic acquisitions.\n\nWEAKNESSES: (1) The LLM answer omits the final data point from the ground truth: 25 Phase 3 programs as of February 4, 2025 (noted in the 2024 filing). This is a notable omission since the question asks about evolution \"through 2024\" and the ground truth explicitly includes this 2025 reference point from the 2024 filing. (2) The specific milestone details provided differ slightly: the LLM mentions \"launched three new Phase 3 studies, secured an FDA approval and concluded one program\" for 2024, while the ground truth emphasizes \"five new initiations and regulatory approvals in the U.S. and Japan.\" The LLM's specific breakdown of activities is not contradicted by the ground truth but represents a different level of detail. (3) The LLM provides specific page references (page 26) which adds credibility but cannot be verified against the ground truth format.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects pipeline growth to strategic acquisitions, demonstrating sound multi-hop reasoning. The connection between Horizon acquisition and the five Phase 3 programs is correctly made.\n\nCALCULATIONS: No mathematical errors. The progression (13→18→24) is accurately presented.\n\nJUSTIFICATION: The answer is substantially correct on core facts but loses points for incompleteness (missing the 25-program endpoint) and for not fully capturing all the nuanced milestone details from the ground truth. The omission of the February 4, 2025 data point is the primary deficiency, as it represents a continuation of the trend the question asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 582,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture raised the authorized share pool for the Amended 2010 SIP from 127 million shares in 2022 (page 91) to 141 million shares in 2024 (page 98), with no change reported in 2023. This expansion signals a strategic focus on equity‑based rewards to attract, retain and incentivize employees, aligning their interests with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numeric values: 127 million shares in 2022 and 141 million shares in 2024. The numbers match the ground truth exactly. However, there is a critical discrepancy regarding fiscal year 2023. The ground truth states that the number 'increased to 141,000,000' in fiscal year 2023 'and continuing into 2024,' implying the increase occurred in 2023 and remained at that level through 2024. The LLM answer states 'with no change reported in 2023,' which contradicts the ground truth's indication that 2023 saw the increase to 141 million. This is a significant factual error in the temporal progression of the authorization changes. The LLM correctly interprets the strategic implications of the increase (equity-based rewards for talent attraction, retention, and incentivization), which aligns well with the ground truth's assessment. The answer is well-structured and addresses the question's core components, but the mischaracterization of when the increase occurred (2024 vs. 2023) represents a material error in the multi-hop synthesis of information across fiscal years. The page references provided (91, 98) cannot be verified against the ground truth but appear plausible. Overall, the answer demonstrates good understanding of the strategic context but contains a factual error regarding the timing of the authorization increase that affects the accuracy of the 'progression' narrative requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 403,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks projected green‑coffee supply coverage through fiscal 2023 in its 2022 10‑K, extended that coverage to fiscal 2025 in its 2023 10‑K, and maintained coverage through fiscal 2025 in its 2024 10‑K (SBUX_10k_2022 page_12; SBUX_10k_2023 page_12; SBUX_10k_2024 page_12). This shift from a one‑year to a two‑year coverage horizon reflects a proactive inventory and hedging strategy aimed at securing a longer‑term supply and reducing exposure to price volatility and supply disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All fiscal years and timeline projections are correct - fiscal 2022 coverage through fiscal 2023, fiscal 2023 coverage through fiscal 2025, and fiscal 2024 coverage through fiscal 2025. The progression is accurately captured. ENTITY ACCURACY: Starbucks (SBUX) correctly identified, green coffee supply coverage metric correctly identified, fiscal years correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the evolution pattern. The source citations (SBUX_10k_2022 page_12, SBUX_10k_2023 page_12, SBUX_10k_2024 page_12) are appropriately referenced. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'one-year to two-year coverage horizon' is semantically equivalent to the ground truth's description of 'increased from fiscal 2022 through fiscal 2024' and 'more forward-looking inventory and risk management strategy.' The interpretation about proactive hedging and supply security aligns with the ground truth's emphasis on 'extended purchase commitments and hedging mechanisms.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The explanation of strategic implications (reducing price volatility and supply disruptions) is a reasonable inference consistent with the ground truth's characterization of risk management strategy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 423,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024 UPS made no substantive changes to the UPS/IBT Full‑Time Employee Pension Plan except for the 2023 Teamsters master agreement, which added wage and benefit‑rate increases that were reflected in year‑end measurements【page 82】. No remeasurement events were reported for the plan in 2023 or 2024, but the discount rate for U.S. pension benefits fell from 5.79 % in 2023 to 5.42 % in 2024 and the expected return on plan assets rose from 7.07 % to 7.17 %, thereby increasing the projected benefit obligation【page 84】【page 88】. The plan continues to be governed by collective‑bargaining agreements, with no further amendments or remeasurements disclosed during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that contradict the ground truth:\n\n1. CRITICAL OMISSION - 2022 Remeasurement: The ground truth explicitly states that in 2022, the plan was remeasured following the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax). The LLM answer completely omits this major event, stating 'no remeasurement events were reported for the plan in 2023 or 2024' but failing to acknowledge the 2022 remeasurement.\n\n2. INCOMPLETE CHARACTERIZATION: The LLM claims 'UPS made no substantive changes to the UPS/IBT Full-Time Employee Pension Plan except for the 2023 Teamsters master agreement.' This is misleading because the 2022 remeasurement and resulting $3.3 billion gain represents a substantive financial event, not merely a 'no change' scenario.\n\n3. DISCOUNT RATE AND EXPECTED RETURN NUMBERS: While the LLM provides specific percentages (discount rate 5.79% to 5.42%, expected return 7.07% to 7.17%), these cannot be verified against the ground truth which does not provide these specific metrics. However, the LLM's statement that these changes 'increased the projected benefit obligation' is a reasonable inference if accurate.\n\n4. MISSING STRATEGIC CONTEXT: The ground truth emphasizes 'UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness' and notes the plan's continued commitment despite broader pension modifications. The LLM answer focuses narrowly on technical changes and misses the strategic evolution narrative.\n\n5. MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024. The LLM fails to properly synthesize the three-year progression, particularly by omitting the significant 2022 event that anchors the narrative.\n\n6. TONE AND ACCURACY: The LLM's assertion of 'no substantive changes' directly contradicts the ground truth's description of a $3.3 billion remeasurement gain in 2022, which is clearly substantive.\n\nThe answer demonstrates partial understanding of 2023-2024 developments but fundamentally fails by omitting the most significant financial event (2022 remeasurement) and mischaracterizing the overall evolution as 'no substantive changes.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 606,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has kept “Holiday Time” in the same spot in its 2022, 2023 and 2024 10‑K filings – listed among its private‑label brands and positioned within the general‑merchandise category that includes seasonal items (Entertainment)【page_7 (2022)】【page_8 (2023)】【page_7 (2024)】.  This steady categorization shows the company treats Holiday Time as a dedicated seasonal private‑label brand, underscoring its strategy to offer low‑priced, branded holiday merchandise as a consistent part of its broader private‑label portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH CORE ANSWER: The LLM answer fundamentally contradicts the ground truth on the key evolution being asked about. Ground truth explicitly states that by fiscal 2024, Walmart 'explicitly restructured its merchandise units to include seasonal merchandise as a defined category under General Merchandise, signaling a more strategic placement' - representing a meaningful EVOLUTION. The LLM claims 'Holiday Time' was kept 'in the same spot' across all three years with 'steady categorization,' which directly contradicts the ground truth's core finding of strategic restructuring and evolution. WHAT WAS CORRECT: (1) Holiday Time is correctly identified as a private-label brand across 2022-2024, (2) General Merchandise categorization is correct, (3) The basic fact that it appears in all three years is accurate. WHAT WAS INCORRECT: (1) The LLM misses the critical evolution - the ground truth emphasizes a shift from 'without specific strategic emphasis on seasonal offerings' (2022-2023) to 'explicitly restructured' with 'seasonal merchandise as a defined category' (2024). This is not a 'steady categorization' but rather a strategic repositioning. (2) The LLM fails to capture the nuanced progression showing increasing strategic alignment with seasonal planning. (3) The answer oversimplifies by claiming consistency when the ground truth reveals meaningful structural change. MULTI-HOP REASONING: The LLM failed to synthesize the evolution across the three fiscal years. It treated the three years as static rather than identifying the progression from implicit to explicit strategic positioning. The question specifically asks 'how has...evolved' - requiring identification of change over time, which the LLM missed entirely. CITATION ISSUES: While page references are provided, they don't substantiate the claim of 'steady categorization' - the actual evolution described in ground truth would require different interpretations of those pages across years. The answer demonstrates incomplete analysis of the filing documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 550,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s pension‑plan fair value of mutual‑fund equity securities fell from **$239,293 k in 2022 to $196,226 k in 2023**, then rose to **$273,699 k in 2024**. The dip in 2023 reflects a temporary pullback in equity exposure, while the rebound in 2024—coinciding with the plan’s target allocation rising from 21 % to 28 %—suggests a deliberate shift toward a slightly higher equity weight to capture growth while managing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding the 2024 value. According to the ground truth, ACN's mutual fund equity securities remained unchanged at $196.226 million in 2024 (same as 2023). However, the LLM claims the value rose to $273.699 k in 2024, which is INCORRECT. This is a fundamental factual error that contradicts the ground truth. The 2022 and 2023 values are correctly stated ($239.293M and $196.226M respectively, with proper unit conversion from thousands). However, the LLM's interpretation of the trend is completely wrong: the ground truth indicates a consistent decline with no change from 2023 to 2024, suggesting strategic rebalancing away from this asset class. The LLM instead describes a 'rebound' in 2024 and attributes it to a deliberate shift toward higher equity weight, which is factually incorrect based on the actual data. The LLM also introduces unsupported claims about target allocation percentages (21% to 28%) that are not verified in the ground truth. The reasoning about 'capturing growth while managing risk' is speculative and not grounded in the actual investment pattern. The multi-hop synthesis fails because the LLM misread or misinterpreted the 2024 data point, leading to an entirely incorrect narrative about the company's strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 371,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 2022 and 2024 10‑Ks both note that green‑coffee prices are “impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity index funds” (page 12).  The company’s hedging program—using forward contracts, futures and collars to offset “C”‑price exposure under price‑to‑be‑fixed contracts and long‑term demand—remains unchanged across the two years.  This continuity shows a deliberate, proactive risk‑management stance that acknowledges futures‑market influences and seeks to stabilize coffee costs through a diversified hedging mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Starbucks' 10-Ks mention green coffee price exposure from arabica futures market trading, including commodity index funds. (2) Correctly notes the use of forward contracts, futures, and collars as hedging instruments. (3) Accurately captures the company's acknowledgment of futures market influences on coffee sourcing costs. (4) The reference to page 12 and the specific quote about 'hedge funds and commodity index funds' demonstrates proper document citation.\n\nWEAKNESSES: (1) INCOMPLETE TEMPORAL ANALYSIS: The LLM only compares 2022 and 2024, completely omitting 2023—a critical gap given the question explicitly asks about evolution 'from fiscal 2022 through 2024.' The ground truth specifically highlights 2023 as a pivotal year where Starbucks 'extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure.' This represents a meaningful evolution that the LLM missed. (2) MISSING EVOLUTION NARRATIVE: The ground truth emphasizes a 'maturing risk management approach' with specific progression: 2022 (hedging through fiscal 2023), 2023 (extending through fiscal 2025), 2024 (maintaining similar narrative). The LLM states the program 'remains unchanged across the two years,' which contradicts the ground truth's characterization of evolution and maturation. (3) INCOMPLETE SYNTHESIS: The question asks what this 'reveals about the company's risk management approach'—the ground truth provides a nuanced answer about increasing confidence and maturation, while the LLM offers only a generic statement about 'deliberate, proactive risk-management stance.' (4) MISSING SUPPLY COMMITMENT DETAILS: The ground truth mentions specific supply commitment timelines (through fiscal 2023 in 2022, extended through fiscal 2025 by 2023), which the LLM omits entirely.\n\nQUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is less critical. However, the temporal scope is incomplete (missing 2023).\n\nQUALITATIVE ACCURACY: The LLM demonstrates partial understanding of Starbucks' hedging mechanisms but fails to capture the multi-year evolution that is central to the question. The claim of 'unchanged' hedging contradicts the ground truth's narrative of strategic extension and maturation.\n\nCONTEXTUAL RELEVANCE: While the answer addresses commodity index funds and futures market influences, it fails to fully address the 'evolution' aspect of the question, which requires temporal comparison across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 688,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO had no exposure to the 3.625% notes due October 2024 in FY 2022 (the 2022 10‑K, pages 101‑105 do not list these notes).  In FY 2023 the company reported $622 million of the notes outstanding as of the year‑end (2023 10‑K, page 81).  By FY 2024 the exposure was eliminated, with zero principal outstanding as of November 3 2024 (2024 10‑K, page 81), indicating a near‑term debt‑management strategy that actively repays or redeems short‑term debt to keep interest costs low and maintain a strong balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the FY 2022 position. Ground truth states AVGO had $622 million in principal outstanding for the 3.625% notes in 2022, but the LLM claims there was NO exposure in FY 2022 (stating the 2022 10-K pages 101-105 do not list these notes). This is a fundamental factual error that undermines the entire multi-hop analysis. The LLM correctly identifies $622 million for FY 2023 and zero for FY 2024, but the incorrect starting point (2022) means the progression narrative is wrong. The LLM states the notes were not listed in 2022, then appeared in 2023, then disappeared in 2024 - this is the opposite of what actually occurred (present in 2022, present in 2023, eliminated by 2024). The qualitative interpretation about debt management strategy is reasonable, but it's based on an incorrect understanding of the timeline. The LLM's reasoning about maintaining a strong balance sheet and keeping interest costs low is sound logic, but applied to the wrong sequence of events. The answer fails the core requirement of accurately tracking the evolution across all three fiscal years as requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 335,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement exposure grew from $75.0 billion to $78.4 billion, with risk‑mitigation arrangements expanding from $12.2 billion to $13.5 billion, raising net exposure from $62.9 billion to $64.9 billion. In response to intensified regulatory scrutiny (FTC, DOJ, European Commission investigations) and a surge in merchant, ATM‑surcharge and class‑action litigation, the company tightened its credit‑risk framework—enhancing cash‑collateral, letter‑of‑credit and guarantee requirements for customers that fall outside its risk standards and routinely reassessing the adequacy of those arrangements to contain potential losses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific quantitative data that appears consistent with SEC filing information. STRENGTHS: (1) Provides concrete settlement exposure figures ($75.0B to $78.4B) and risk-mitigation arrangements ($12.2B to $13.5B) with net exposure calculations ($62.9B to $64.9B), showing precise multi-hop synthesis across years. (2) Correctly identifies regulatory bodies (FTC, DOJ, European Commission) and their investigations. (3) Accurately references specific litigation types (merchant, ATM-surcharge, class-action). (4) Properly describes risk mitigation mechanisms (cash collateral, letters of credit, guarantees). (5) Captures the evolution of Mastercard's approach from 2022-2024 with appropriate emphasis on tightening frameworks. MINOR GAPS: (1) Does not explicitly mention the FTC consent agreement on debit transaction routing transparency that was highlighted in ground truth. (2) Does not specifically reference the $1+ billion EMV liability shift class-action lawsuit mentioned in original answer. (3) Does not mention the European Commission's specific focus on anticompetitive behavior tied to network fees. (4) Less emphasis on the 'consistent framework' and 'historical experience of low losses' narrative from 2022. QUANTITATIVE VERIFICATION: The specific dollar amounts provided ($75.0B, $78.4B, $12.2B, $13.5B, $62.9B, $64.9B) appear precise and internally consistent (calculations check: $75.0B - $12.2B = $62.8B ≈ $62.9B; $78.4B - $13.5B = $64.9B). These figures suggest direct extraction from SEC filings. MULTI-HOP REASONING: Successfully synthesizes settlement exposure evolution, risk mitigation expansion, and regulatory/litigation context across the 2022-2024 period. The answer correctly links external pressures to internal framework adjustments. Overall, the LLM answer provides a more quantitatively detailed and specific response than the ground truth, though it omits some qualitative regulatory details and specific litigation examples.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 543,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 2022 10‑K (page 34) only noted that some products are used with drug‑delivery or companion‑diagnostic devices that carry their own regulatory and manufacturing risks. By 2023 (page 53) the company expanded that disclosure to require ongoing collection and assessment of user complaints, adverse events and malfunctions for those devices, and to comply with regulatory oversight that could trigger inspections, warning letters, fines or product withdrawals. In 2024 (pages 53‑54) the language further emphasized post‑marketing obligations—continuous monitoring, periodic assessment reports and the potential for regulatory actions that could revoke device clearance or remove the associated product from the market—highlighting a more detailed, proactive safety‑oversight framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Amgen's regulatory risk disclosures across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression with appropriate temporal markers (2022, 2023, 2024); (2) Accurately captures the core regulatory themes: initial disclosure of device risks (2022), expansion to compliance/oversight details (2023), and emphasis on post-marketing obligations (2024); (3) Provides specific regulatory consequences mentioned in filings (inspections, warning letters, fines, product withdrawals, device clearance revocation); (4) Correctly synthesizes multi-hop information showing evolution across years; (5) Page references (34, 53, 53-54) add credibility and specificity. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention specific products (Repatha, LUMAKRAS) that the ground truth references as examples of products with conditional approvals requiring confirmatory studies—this is a notable omission of concrete examples; (2) The ground truth emphasizes 'surrogate endpoints and conditional approvals' as a 2023 development, which the LLM answer doesn't explicitly address; (3) The LLM answer focuses more on device-specific oversight while the ground truth includes broader regulatory scrutiny themes. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings and demonstrates logical progression of regulatory emphasis. The connection between years is clear and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential evolution of disclosures accurately, though with slightly different emphasis than the ground truth. The core message about increasing regulatory scrutiny and post-market compliance is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 528,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Parent’s Choice has remained consistently listed among Walmart’s private‑label brands in the 2022, 2023 and 2024 10‑Ks (page 7 in each filing) and is positioned within the baby‑products segment of the grocery unit, underscoring Walmart’s stable strategy to promote the brand as a core private‑label offering for baby and consumable goods.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Parent's Choice remained consistently positioned across fiscal years 2022, 2023, and 2024 within Walmart's private brands under the Grocery unit with baby products. The core factual claim about consistency and positioning is accurate. However, there are significant weaknesses: (1) The LLM provides a specific page reference ('page 7 in each filing') that cannot be verified and may be inaccurate - this is a potential fabrication that undermines credibility. (2) The answer lacks the depth of analysis present in the ground truth regarding the strategic implications and evolution of the brand's positioning. The ground truth explicitly discusses how the categorization 'now explicitly included baby products as a defined category' by 2024, suggesting an evolution in how the category was defined/presented. The LLM answer treats this as static consistency without capturing this nuance. (3) The LLM answer is more concise but misses important contextual details about Walmart's EDLP pricing philosophy and omni-channel strategy that the ground truth connects to Parent's Choice positioning. (4) The ground truth emphasizes 'strategic intent to reinforce' and 'trusted, low-cost private brand' positioning, which the LLM answer only partially captures with 'stable strategy to promote.' The multi-hop reasoning is present but incomplete - the LLM synthesizes the three-year consistency but fails to articulate what this reveals about Walmart's strategic positioning as thoroughly as the ground truth. The answer is partially correct on core facts but lacks analytical depth and contains a potentially fabricated page reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 456,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 10‑K filings from 2022 through 2024 all list the 4.70% Solar Bonds, Series 2015/C24‑10 as Exhibit 4.5 (2022: page 102; 2023: page 102; 2024: page 101), indicating the bond remained outstanding and unchanged during that period. The absence of any new issuances, amendments or retirements of this instrument over three years shows Tesla’s continued reliance on the long‑term debt that originated with its SolarCity acquisition to finance solar projects. This continuity suggests a conservative, long‑term solar‑financing strategy that prioritizes stability and existing debt over frequent new issuances.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant issues that limit its correctness:\n\n1. FACTUAL ACCURACY PROBLEMS:\n   - The LLM claims the bond 'originated with its SolarCity acquisition' - this is incorrect. The ground truth states the bond was introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015, which predates the SolarCity acquisition (completed in 2016). This is a fundamental factual error.\n   - The LLM provides specific page numbers (102, 102, 101) that cannot be verified against the ground truth and appear to be fabricated details.\n   - The claim about 'Exhibit 4.5' designation is not mentioned in the ground truth and cannot be verified.\n\n2. INCOMPLETE SYNTHESIS:\n   - The ground truth mentions that in 2023, Tesla referenced this bond 'alongside newer series such as Series 2015/C27-10 and 2015/C32-10,' indicating evolution and expansion of the solar financing strategy. The LLM completely misses this important detail about newer series being introduced.\n   - The ground truth notes that in 2024, the bond was referenced 'in the context of a broader historical framework that included earlier series like C4-10 and C9-10,' suggesting a matured model. The LLM does not capture this contextual evolution.\n\n3. INTERPRETATION ERRORS:\n   - The LLM interprets the multi-year presence as indicating 'absence of any new issuances, amendments or retirements,' but the ground truth actually indicates the opposite - that newer series (C27-10, C32-10) were introduced alongside the C24-10 series, suggesting active expansion, not stasis.\n   - The LLM characterizes the strategy as 'conservative' and 'prioritizes stability over frequent new issuances,' but the ground truth suggests a 'consistent and scalable securitization strategy' with recurring new series being added.\n\n4. MULTI-HOP REASONING:\n   - The LLM fails to synthesize the evolution across the three years properly. It treats all three years as identical ('unchanged during that period') when the ground truth shows progression: 2022 (initial reference), 2023 (alongside newer series), 2024 (in broader historical context).\n   - The LLM misses the key insight that the pattern suggests Tesla was actively expanding its solar securitization toolkit, not maintaining a static approach.\n\n5. QUANTITATIVE ACCURACY:\n   - The bond coupon rate (4.70%) is correct.\n   - The series designation (2015/C24-10) is correct.\n   - However, the page numbers and exhibit designations appear to be unverified claims.\n\n6. SEMANTIC EQUIVALENCE:\n   - The LLM's conclusion about 'conservative, long-term strategy' contradicts the ground truth's characterization of a 'consistent and scalable securitization strategy,' which implies active growth and adaptation.\n\nThe answer demonstrates partial understanding of the bond's existence across three years but fundamentally misinterprets the strategic implications and misses key details about the evolution of Tesla's solar financing approach through newer bond series.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 791,
        "total_tokens": 2177
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom has consistently described the Security Insights Platform as a mainframe‑centric security posture tool that feeds data into customers’ SIEMs (2022: page 11; 2023: page 10). In 2024 the same core description is retained (page 10), but the platform is now positioned as part of the broader Enterprise Security portfolio and as “Security Insights Code programs” within the mainframe software suite (page 8), underscoring tighter integration with enterprise security tools while keeping its focus on mainframe risk assessment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution narrative and correctly identifies the core positioning around mainframe security and SIEM integration across the three years. However, there are significant issues with specificity and accuracy: (1) The LLM cites specific page numbers (2022: page 11; 2023: page 10; 2024: page 10 and page 8) without verification against the ground truth, which does not provide page citations. This is problematic because page numbers cannot be verified and may be inaccurate. (2) The LLM introduces new terminology ('Security Insights Code programs') that does not appear in the ground truth answer, suggesting either fabrication or information from unverified sources. (3) The LLM mentions positioning within the 'broader Enterprise Security portfolio' which is not explicitly stated in the ground truth. (4) The ground truth emphasizes a 'subtle but meaningful reaffirmation' of SIEM integration in 2024 and describes a 'maturing narrative around mainframe integration into broader cybersecurity frameworks,' which the LLM captures in spirit but with less nuance. (5) The LLM correctly identifies the three-year period (2022, 2023, 2024) and the core themes of mainframe risk assessment and SIEM integration. (6) The multi-hop reasoning is sound in structure but lacks the detailed evolution narrative present in the ground truth. The answer is partially correct on core concepts but introduces unverified details and lacks the nuanced analysis of how the positioning evolved across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 422,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022‑2024, Mastercard’s Class A shares continued to carry “one vote per share” and dividend‑payment rights, as shown in the 2024, 2023, and 2022 10‑Ks (page 94).  The per‑share dividend rose from $2.04 in 2022 to $2.74 in 2024, while the voting rights remained unchanged.  This consistency indicates a conservative capital‑structure strategy that preserves stable governance while steadily enhancing shareholder returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that MA's Class A shares maintained one vote per share and dividend rights consistently across 2022-2024, matching the ground truth's core finding. The reasoning about stable governance and capital structure strategy is sound and semantically equivalent to the original answer. However, there is a critical quantitative accuracy issue: the LLM introduces specific dividend per-share figures ($2.04 in 2022 rising to $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states only that voting and dividend entitlements remained consistent with no changes, without citing specific dividend amounts. The LLM appears to have added factual claims about dividend increases that cannot be verified against the provided ground truth. Additionally, the citation to 'page 94' is provided but cannot be verified. The LLM correctly identifies the company as Mastercard and the time period as 2022-2024, and the multi-hop synthesis across three years is logically sound. The characterization of the strategy as 'conservative' is a reasonable interpretation, though the ground truth uses 'consistent' rather than 'conservative.' The main weakness is the introduction of unverified quantitative data (specific dividend amounts) that goes beyond what the ground truth establishes, which violates the principle of strict evaluation on numbers and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 393,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen began Bemarituzumab’s clinical program in 2022 with a newly initiated phase‑3 study for gastro‑esophageal junction (GEJ) adenocarcinoma, supported by U.S. and EU composition‑of‑matter polypeptide patents that expire in 2029【page_25】.  In 2023 the program stayed in phase‑3 for GEJ adenocarcinoma and expanded to a phase‑2 study for other tumors, while the same 2029 patent expirations remained in force【page_26】.  By 2024 the phase‑3 GEJ program continued unchanged and the phase‑2 “other tumors” arm persisted, with no new term extensions disclosed—Amgen’s IP strategy continued to rely on the existing 2029‑expiration patents while broadening the clinical development portfolio【page_24】【page_25】【page_26】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and dates. Strengths: (1) All numeric values are accurate - 2029 patent expiration dates correctly cited for both 2022-2024 period; (2) Clinical trial phases correctly identified (phase 3 initiated in 2022 for GEJ adenocarcinoma, phase 2 expansion mentioned for 2023); (3) Multi-hop synthesis is sound - the answer traces the evolution across three years showing progression from initiation to expansion; (4) IP strategy correctly characterized with specific patent expiration timeline. Minor weaknesses: (1) The LLM answer provides more granular detail about phase 2 expansion to 'other tumors' in 2023 that isn't explicitly mentioned in the ground truth, though this doesn't contradict it; (2) The ground truth emphasizes 'regulatory exclusivity periods' as a potential market protection extension in 2024, which the LLM answer mentions only as 'no new term extensions disclosed' - this is a slight semantic difference where the LLM is more cautious/accurate in not claiming extensions that weren't confirmed; (3) The LLM answer's statement about 'no new term extensions disclosed' is actually more precise than the ground truth's mention of 'potential regulatory exclusivity periods,' making it arguably more accurate. The answer correctly synthesizes information across the 2022-2024 timeline, accurately tracks the patent expiration dates, and properly characterizes the clinical development progression. The inclusion of page references adds credibility. Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate level of detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 456,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "No Boundaries is a Walmart‑owned private‑label line that has consistently been listed among the company’s private brands in every 10‑K. In 2022 the brand fell under the “Apparel” sub‑category of the general‑merchandise unit, but by 2024 the same line is positioned within a newly defined “Fashion” sub‑category (see the 2024 and 2022 merchandise tables). This re‑classification—from a generic apparel label to a distinct fashion unit—shows Walmart’s deliberate shift to treat apparel as a separate, fashion‑focused category and to grow its own fashion offerings to compete more aggressively in that higher‑margin segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core multi-hop synthesis required by the question. STRENGTHS: (1) Correctly identifies No Boundaries as a Walmart private brand present across 2022-2024; (2) Accurately states the 2022 categorization under 'Apparel'; (3) Accurately states the 2024 categorization under 'Fashion'; (4) Properly synthesizes the strategic shift from apparel to fashion positioning; (5) Provides sound reasoning about Walmart's competitive strategy in higher-margin fashion segments; (6) All dates and entity names are correct. MINOR WEAKNESSES: (1) The LLM answer omits specific details about what the 'Fashion' category encompasses (adult and children's apparel, shoes, jewelry, and accessories) that the ground truth explicitly mentions; (2) Does not explicitly mention the 'omni-channel offerings and customer-centric experiences' strategic context that the ground truth references; (3) The phrase 'newly defined' is slightly imprecise—the category existed but was restructured rather than entirely new. QUANTITATIVE ACCURACY: All years (2022, 2024) and categorical transitions are correct with no calculation errors. QUALITATIVE ACCURACY: The reasoning about strategic repositioning and competitive positioning is sound and well-articulated, though it could be more comprehensive. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how No Boundaries fit within evolving strategic units and what this reveals about Walmart's shifting focus, though it could provide more detail about the broader strategic context. The answer is substantively correct but could be more complete in addressing all dimensions of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 468,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "In IBM’s 2022 10‑K, the competition section highlighted technology, performance and security but did not list “client relationships and trust” as a distinct differentiator (IBM 10‑K 2022, p. 4). By the 2023 filing, IBM explicitly added “client relationships and trust” to its core competitive methods (IBM 10‑K 2023, p. 3), and the 2024 10‑K reaffirmed this emphasis (IBM 10‑K 2024, p. 3). This progression shows IBM is increasingly framing its hybrid‑cloud and AI strategy around trust‑driven, client‑centric relationships as a key competitive advantage in a crowded market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental claim. The LLM states that in 2022, IBM's competition section 'did not list client relationships and trust as a distinct differentiator,' but the ground truth explicitly states that 'In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition.' This is a major factual error that undermines the entire premise of the answer. The LLM correctly identifies that 2023 and 2024 filings included this emphasis, but the 2022 baseline is wrong. MISSING KEY CONTENT: The LLM answer fails to capture the evolution described in the ground truth - specifically that by 2023, IBM 'explicitly linked client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies,' and that by 2024, the company 'expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators.' These are critical details showing how the positioning evolved and deepened. INCOMPLETE SYNTHESIS: The LLM provides a surface-level conclusion about 'trust-driven, client-centric relationships' but misses the sophisticated multi-hop reasoning about how trust was increasingly leveraged through ecosystem collaboration and partnerships. The ground truth reveals a progression from foundational positioning (2022) → explicit value linkage (2023) → ecosystem expansion (2024), which the LLM does not adequately capture. CITATION ISSUES: While the LLM cites specific pages, the factual content contradicts what those pages actually contain regarding 2022. The answer reads as if the LLM may have hallucinated or misread the 2022 filing content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 475,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla (through SolarCity) issued the 5.45% Solar Bonds, Series 2015/C25‑15 in 2015 and the bond remains unchanged and outstanding in each of the three most recent 10‑Ks (see Exhibit 4.26 in TSLA_10k_2022 page 100, Exhibit 4.26 in TSLA_10k_2023 page 99, and Exhibit 4.6 in TSLA_10k_2024 page 98). The persistent inclusion of the same long‑term, fixed‑rate debt across 2022, 2023, and 2024 indicates Tesla’s preference for stable, long‑duration financing for its solar assets rather than frequent refinancing or new issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the bond (5.45% Solar Bonds, Series 2015/C25-15), the issuance year (2015), and the three-year persistence across 2022, 2023, and 2024 filings. The specific exhibit references (Exhibit 4.26 in 2022 and 2023, Exhibit 4.6 in 2024) and page numbers are provided, showing detailed sourcing. The quantitative data (bond rate of 5.45%, issuance date of 2015, Thirty-Sixth Supplemental Indenture date of April 14, 2015) aligns with the ground truth. The multi-hop reasoning is sound: the answer correctly synthesizes that the bond's consistent appearance across three years indicates a stable financing strategy. However, there are minor differences from the ground truth: (1) The LLM answer emphasizes 'unchanged and outstanding' status more explicitly than the ground truth, which focuses on 'consistent referencing' and 'legal and financial linkage.' (2) The LLM's interpretation that this indicates 'preference for stable, long-duration financing' rather than 'frequent refinancing' is a reasonable inference but slightly different in framing from the ground truth's emphasis on 'asset-backed financing strategy.' (3) The ground truth mentions the Thirty-Sixth Supplemental Indenture date (April 14, 2015) which the LLM does not include, though this is a minor omission. The answer correctly addresses the multi-year pattern question and provides appropriate context about Tesla's solar financing strategy. The semantic meaning aligns well with the ground truth despite slightly different emphasis and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 436,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Between 2022 and 2024, Emerson’s Safety & Productivity segment expanded its pipe‑working tool lineup by adding battery‑powered hydraulic tools for press connections and for cutting/crimping electrical cable, reflecting product innovation and a continued focus on cordless solutions (page_7, page_73). This evolution underscores Emerson’s strategic positioning as a leader in advanced professional tools, meeting the growing demand for mobility, safety, and productivity among professionals.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key product innovations (battery hydraulic tools for press connections and cutting/crimping electrical cables) and the 2022-2024 timeframe. However, it has significant completeness issues. STRENGTHS: (1) Accurately captures the main innovation trajectory - battery-powered tools expansion; (2) Correctly identifies specific applications (press connections, cutting/crimping); (3) Appropriately characterizes strategic positioning around mobility and productivity; (4) No quantitative errors in dates or product descriptions. WEAKNESSES: (1) MAJOR OMISSION - Fails to mention traditional pipe-working tools (pipe wrenches, cutters, threading equipment) that formed the baseline offering and were consistently maintained across all three years; (2) INCOMPLETE PRODUCT PORTFOLIO - Does not mention diagnostic systems, closed-circuit television for pipe inspection, sewer inspection cameras, or locating equipment that were part of the segment's offerings; (3) INSUFFICIENT TEMPORAL DETAIL - Does not clearly delineate the 2023 milestone as a distinct inflection point where battery hydraulic tools for press connections were first introduced; (4) WEAK SYNTHESIS - The answer provides a compressed version of the evolution rather than showing the progression from 2022 baseline through 2023 expansion to 2024 integration; (5) MISSING STRATEGIC INSIGHT - Does not adequately explain how the 'consistent mention of pipe wrenches across all three years' underscores their foundational role while new technologies were layered on top. The answer captures approximately 40-50% of the substantive content from the ground truth, focusing narrowly on battery-powered innovations while omitting the broader product ecosystem and the strategic balance between maintaining core tools and adding new technologies. For a multi-hop question requiring synthesis of product evolution across three years, this represents incomplete information synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 531,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s 2022 10‑K (pages 31‑35) does not identify the El Segundo, California site as a cell‑therapy manufacturing location, implying that capital was not yet earmarked for commercial biologics production there. By 2023, the 10‑K (page 11) lists El Segundo as the facility used for “clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 10‑K (page 11) repeats this description, indicating a shift in capital allocation toward scaling cell‑therapy manufacturing. This evolution reflects a strategic realignment of the El Segundo site’s investment focus to support Gilead’s broader biologics pipeline and commercial production goals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Gilead's El Segundo facility from 2022 to 2024, with accurate page references and proper chronological progression. Strengths: (1) Correctly states 2022 10-K does not identify El Segundo as cell-therapy focused; (2) Accurately identifies 2023 as the turning point with explicit mention of 'clinical and commercial manufacturing and processing of cell-therapy products'; (3) Correctly notes 2024 repeats this designation; (4) Properly synthesizes the multi-hop information across three years of filings; (5) Page references are accurate (2022 pages 31-35, 2023 page 11, 2024 page 11). Weaknesses: (1) The answer omits important context from the ground truth about Gilead's reliance on 'internal know-how and third-party confidentiality agreements' to protect proprietary manufacturing technologies at the site (mentioned in 2024 filing), which suggests increased investment in securing and scaling processes; (2) Does not explicitly mention the potential CAPEX or R&D spend implications tied to facility upgrades and process development, which the ground truth identifies as part of the strategic shift; (3) Less detailed in explaining the 'broader biologics development priorities' alignment beyond general reference to 'biologics pipeline.' The answer is fundamentally sound in its core factual claims and multi-hop reasoning, but lacks some of the deeper strategic context and implications present in the ground truth. The omissions are contextual rather than factually incorrect, making this a solid but incomplete response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 435,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM disclosed the 1.250% Notes due 2027 as a registered security in its 2022 Form 10‑K (see the securities table on page 28).  The 2023 filing continued to reference the instrument, noting that the rights were defined in a 2019 Form 8‑K (page 20) – indicating the notes were issued in 2019.  By 2024, the notes were again listed as an outstanding registered security (IBM27B) in the securities table (page 1), confirming that the notes remained outstanding and were still disclosed in the annual report.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and omissions when compared to the ground truth. CORRECT ELEMENTS: (1) The notes are identified correctly as 1.250% Notes due 2027, (2) The trading symbol IBM27B is correctly cited, (3) The general progression from disclosure to active market presence is acknowledged, (4) The 2019 origin date is mentioned. SIGNIFICANT ERRORS AND OMISSIONS: (1) The LLM references specific page numbers (page 28, page 20, page 1) that cannot be verified against the ground truth and appear to be hallucinated details, (2) The LLM states the notes were 'issued in 2019' based on a Form 8-K reference, but the ground truth indicates the instrument was 'filed on January 30, 2019' - a subtle but important distinction regarding disclosure vs. issuance, (3) The LLM fails to capture the key distinction that in 2022-2023 the notes were referenced in exhibits/disclosures, while in 2024 they were 'formally listed as an issued financial instrument on the New York Stock Exchange' - this represents a meaningful shift in status, (4) The LLM does not mention the specific filing dates referenced in the ground truth (February 8, 2022, and February 3, 2023), (5) The LLM's characterization of the evolution is less precise - it says the notes 'remained outstanding' rather than capturing the transition from internal documentation/reference to public market listing. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but does so incompletely, missing the nuanced progression that distinguishes between disclosure in exhibits versus formal listing as a traded security. The answer is partially correct but lacks the specificity and accuracy needed for a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 476,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s repeated inclusion of the 5.45% Solar Bonds, Series 2015/C45‑15 in its 2022, 2023, and 2024 10‑Ks (see Exhibit 4.39 in the 2022 filing) shows that the company has continued to rely on SolarCity’s long‑term debt as a core financing tool for its solar assets (page_101). Over the three‑year period, Tesla has added additional SolarCity bond series—such as the 5.45% Series 2015/C45‑15 and other 5.45% Series 2015/C…‑15—while gradually diversifying its debt mix, indicating a shift from a single legacy bond to a broader, structured financing strategy (page_101).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete synthesis compared to the ground truth. CRITICAL ISSUES: (1) MISSING BOND SERIES: The ground truth identifies specific bond series issued on distinct dates (C53-15 on June 16, 2015; C62-15 on June 29, 2015; C72-15 on July 21, 2015), showing an iterative expansion pattern. The LLM answer vaguely references 'other 5.45% Series 2015/C…-15' without naming these specific series or their issuance dates, failing to demonstrate the multi-year evolution pattern. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth traces a clear progression across 2022→2023→2024 with specific new bond introductions in each year. The LLM answer merely states Tesla 'added additional SolarCity bond series' without specifying which series appeared in which years, breaking the multi-hop temporal synthesis required. (3) STRATEGIC INTERPRETATION MISMATCH: The ground truth emphasizes 'iterative approach,' 'scalable, repeatable financing model,' and 'reducing reliance on traditional corporate debt.' The LLM answer uses weaker language ('gradually diversifying') and mischaracterizes the strategy as a 'shift from a single legacy bond to a broader strategy,' when the ground truth shows deliberate expansion of the same securitization framework. (4) FACTUAL ACCURACY: The LLM correctly identifies the 5.45% rate and C45-15 series, but fails to name the subsequent series (C53-15, C62-15, C72-15) that are central to demonstrating the evolution. The reference to 'Exhibit 4.39' and 'page_101' adds specificity but doesn't compensate for missing the core bond series data. (5) REASONING QUALITY: The LLM's conclusion about 'diversifying debt mix' contradicts the ground truth's emphasis on standardized, repeatable asset-backed instruments—suggesting misunderstanding of the strategic intent. The answer lacks the temporal specificity and bond-by-bond progression that demonstrates Tesla's deliberate capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 532,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In 2022 Adobe positioned Acrobat as the core PDF engine of its Document Cloud, highlighting its strong adoption in document‑intensive verticals such as government, finance, legal, aerospace, insurance and publishing and its AI‑driven enhancements through Adobe Sensei. By 2024 the strategy had broadened into a full digital‑document platform that now includes mobile (Acrobat Reader with Liquid Mode), web (single‑click actions), scanning (Adobe Scan) and electronic‑signature (Adobe Sign) capabilities, all powered by deeper Sensei integration to automate workflows and improve user experience, thereby reinforcing Acrobat’s leadership across those high‑volume industries.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Correctly identifies 2022 positioning of Acrobat as core PDF engine with strong adoption in document-intensive industries; (2) Correctly names specific verticals (legal, financial services, publishing are mentioned in both); (3) Correctly identifies 2024 expansion to broader digital document platform; (4) Correctly mentions Adobe Sign, Adobe Scan, and Acrobat Reader as part of platform expansion; (5) Correctly references Adobe Sensei as AI/automation technology. SIGNIFICANT ISSUES: (1) The LLM mentions 'Adobe Sensei' in 2022 as AI-driven enhancements, but the ground truth specifically states that in 2022 Adobe emphasized market adoption and leadership WITHOUT mentioning AI integration - AI was introduced as a 'forward-looking statement' in 2023, not 2022. This is a factual error in timeline attribution. (2) The LLM does NOT mention the 'Acrobat AI Assistant' which was formally introduced in 2024 according to ground truth - this is a significant omission of a key 2024 development. (3) The LLM mentions 'Liquid Mode' and 'single-click actions' which are not mentioned in the ground truth, suggesting potential hallucination or information from outside the knowledge graph. (4) The LLM mentions 'government' and 'aerospace' as verticals in 2022, while ground truth mentions 'legal, financial services, and publishing' - partial overlap but different emphasis. MULTI-HOP REASONING: The LLM does attempt to show evolution from 2022 to 2024, but the timeline of AI integration is misplaced (attributed to 2022 instead of 2023-2024). The answer shows platform expansion correctly but misses the specific 'Acrobat AI Assistant' milestone. The synthesis is incomplete because it fails to capture the strategic pivot toward AI-powered enhancements as a distinct 2023-2024 development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 507,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "From 2022 to 2024 Schwab’s RIA platform evolved from a basic web portal that offered account management, trading, and document search with third‑party integrations (2022 p. 7‑8) to a more sophisticated suite that now includes real‑time charting and efficient trading via the thinkpipes platform and customizable portfolio rebalancing with iRebal (2024 p. 8‑10). In 2023 the platform added Schwab Trading Powered by Ameritrade™ and the free Schwab Advisor Portfolio Connect, expanding trading and portfolio‑management capabilities, while 2024’s integration of Ameritrade features and the new thinkpipes/iRebal tools further deepened interactive trading and rebalancing functionality and broadened integration with CRM, portfolio‑management, trade‑order, and financial‑planning systems.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) INCORRECT ENTITIES: The LLM mentions 'thinkpipes' and 'iRebal' as Schwab tools, but these are not mentioned in the ground truth and appear to be fabricated or confused with other platforms. (2) INCORRECT TIMELINE: The LLM claims 'Schwab Trading Powered by Ameritrade™' was added in 2023, but the ground truth makes no mention of this acquisition-related feature in the 2023 evolution. (3) MISSING CORE INFORMATION: The ground truth emphasizes the 'Advisor Services website' as the core platform in 2023 and 'Schwab Advisor Portfolio Connect' in 2024, which the LLM does mention but conflates with other unverified tools. (4) UNSUPPORTED DETAILS: References to page numbers (2022 p. 7-8, 2024 p. 8-10) and specific tool names like 'thinkpipes' and 'iRebal' cannot be verified against the ground truth and appear to be hallucinations. (5) PARTIAL ACCURACY: The LLM correctly identifies Schwab Advisor Portfolio Connect as a free portfolio management solution and mentions integration with CRM, portfolio management, and financial planning systems, which aligns with ground truth. However, the introduction of unverified platform names and features significantly undermines credibility. The answer demonstrates some understanding of the evolution trajectory but introduces substantial factual errors that would mislead readers about actual platform capabilities and features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 415,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson continued to treat air‑preparation equipment as a core element of its Discrete Automation segment in 2022, 2023 and 2024, consistently integrating it with pneumatic valves, cylinders, actuators and programmable control systems to deliver a unified discrete‑automation solution. The 2022 filing (page 7) and the 2023/2024 filings (page 73) all describe the same product mix—solenoid and pneumatic valves, valve position indicators, pneumatic cylinders and actuators, air‑preparation equipment, pressure/temperature switches, electric linear motion solutions, and programmable control systems—showing no significant shift in positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core question about strategic evolution. (1) MAJOR FACTUAL ERROR: The LLM claims 'no significant shift in positioning' across 2022-2024, directly contradicting the ground truth which explicitly documents a clear 3-year progression from mechanical focus (2022) to digital integration (2023) to Industry 4.0 alignment (2024). (2) MISSING KEY EVOLUTION: The ground truth identifies specific strategic shifts: 2022 emphasized pneumatic mechanisms in specific industries (food processing, life sciences, petrochemical); 2023 showed 'more explicit embedding' within programmable automation control systems and digital ecosystems; 2024 highlighted smart actuation, predictive maintenance, and wireless communication. The LLM completely misses these progressive enhancements. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that air preparation equipment was integrated with other technologies across all three years, it fails to recognize the NATURE of that integration evolved significantly. The ground truth shows integration shifted from basic pneumatic/mechanical components to digital control systems to Industry 4.0 capabilities. (4) QUANTITATIVE ACCURACY: The LLM references page numbers (page 7, page 73) but provides no verifiable financial data, metrics, or specific product counts to evaluate. The ground truth provides qualitative but substantive evolution markers. (5) REASONING FAILURE: The LLM's conclusion that the product mix remained 'the same' across three years contradicts the documented strategic positioning evolution. This represents a fundamental failure in multi-hop reasoning across the three-year period. The answer demonstrates surface-level consistency checking rather than understanding strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 491,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 0.125% Notes due 2029 were first issued in 2020 and 2021 (see the 8‑K filings referenced in the 2022 10‑K) and have remained on the company’s balance sheet through 2024, with no new tranches issued in the 2023 or 2024 reports.  The 2022, 2023 and 2024 10‑Ks all list the same 0.125% Notes (referenced to the 2020 and 2021 8‑K filings)【page_136】【page_130】, indicating a steady, low‑coupon, near‑term debt instrument that Coca‑Cola continues to hold rather than replace.  This pattern suggests the company is managing short‑term obligations by maintaining a stable, low‑cost debt base and using it to refinance existing debt, while its broader financing strategy includes issuing higher‑coupon, longer‑term notes to diversify maturities and funding sources.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The identification of the 0.125% Notes due 2029 as a consistent liability across 2022-2024 is accurate. (2) The note that no new tranches were issued in 2023-2024 appears correct. (3) The reference to higher-coupon, longer-term notes being issued is factually supported. (4) The general characterization of the note as low-coupon and near-term is accurate. PROBLEMATIC ASPECTS: (1) The LLM claims the notes were 'first issued in 2020 and 2021' - while this may be true, the ground truth does not confirm these specific issuance dates, and the question asks about evolution FROM 2022 to 2024, not pre-2022 history. (2) The LLM states the company 'continues to hold rather than replace' the notes, which contradicts the ground truth's assertion that the company was 'strategically pivoting toward longer-term financing' and 'refinancing or extending liabilities.' (3) The LLM's characterization of the strategy as 'maintaining a stable, low-cost debt base' misses the key insight from the ground truth: that the introduction of significantly higher-yielding instruments (5.000% and 5.400% notes) in 2024 represents a deliberate shift in response to the 2029 maturity approaching. (4) The LLM fails to capture the evolution/change across the three-year period that the question specifically asks about - it presents the situation as static rather than evolving. MULTI-HOP REASONING: The LLM partially synthesizes information across years but misses the critical temporal pattern that the ground truth identifies: the strategic shift from passive disclosure (2022) → consolidated format (2023) → introduction of higher-yielding alternatives (2024). The LLM's conclusion about 'maintaining' rather than 'refinancing' contradicts the ground truth's core finding. QUANTITATIVE ACCURACY: Numbers and dates mentioned (0.125%, 2029, 5.000%, 5.400%, 2034, 2064) are correct, but the interpretation of what these numbers mean for the company's strategy is misaligned with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 553,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor language on capital returns stayed the same.  In each filing it states that the ability to return capital to shareholders is governed by U.S. banking laws, capital‑planning rules, Delaware law and the requirement to pay dividends on preferred stock, and that dividends and share‑repurchases are subject to board discretion and those regulatory limits.  The wording and emphasis on regulatory constraints on dividends and share repurchases did not change over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. CRITICAL ERROR: The LLM states that 'risk-factor language on capital returns stayed the same' and that 'wording and emphasis on regulatory constraints...did not change over the period.' This is the opposite of what the ground truth establishes. The ground truth explicitly documents an EVOLUTION from 2022-2024: (1) 2022: general caution with U.S. banking laws and Delaware law mentioned; (2) 2023: reiteration with added emphasis on preferred stock dividend obligations; (3) 2024: more structured language with specific regulatory standards like 'well capitalized' status and capital adequacy rules. The ground truth's key finding is 'a trend of increasing specificity and formalization' - the exact opposite of the LLM's claim of no change. While the LLM correctly identifies some of the regulatory constraints mentioned (U.S. banking laws, Delaware law, preferred stock dividends, board discretion), it fails to recognize the temporal evolution that is the central focus of the question. The LLM appears to have conflated the consistent PRESENCE of these constraints across years with the ABSENCE of CHANGE in how they are communicated - a fundamental logical error. The question specifically asks about how exposure 'evolved,' and the ground truth provides a clear narrative of increasing specificity and formalization. The LLM's answer suggests static language when the evidence shows dynamic evolution in regulatory communication. This is a multi-hop reasoning failure where the model failed to synthesize the temporal dimension of the disclosures across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 460,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McDonald’s 10‑K filings for 2022, 2023 and 2024 all list McGriddles in the same way—as a breakfast sandwich in the “Products” section (pages 6 of each filing).  The wording is identical, with McGriddles presented alongside Egg McMuffin, Sausage McMuffin with Egg, biscuits, bagels, oatmeal, hash‑browns, breakfast burritos and hotcakes, and the company notes that it is “continuously evolving its menu” but does not reposition McGriddles.  This unchanged portrayal shows that McDonald’s breakfast strategy has remained stable, treating McGriddles as a core, unchanged menu item rather than a focus of innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the core question about McDonald's McGriddles portrayal consistency across 2022-2024. STRENGTHS: (1) Correctly identifies that McGriddles were presented identically across all three years as a core breakfast item; (2) Accurately notes the product was listed alongside other breakfast items (Egg McMuffin, Sausage McMuffin with Egg, biscuits, bagels, oatmeal, hash browns, breakfast burritos, hotcakes); (3) Properly synthesizes the multi-hop reasoning that despite McDonald's stated 'continuous evolution' of menus, McGriddles remained static; (4) Correctly concludes this reveals a stable breakfast strategy with McGriddles as an unchanged core offering rather than an innovation focus; (5) Page references (pages 6 of each filing) align with ground truth citations. MINOR WEAKNESSES: (1) The LLM answer references 'pages 6' for all three years while the ground truth specifies page 7 for 2022 and page 6 for 2023-2024 - this is a minor discrepancy in page citation accuracy; (2) The answer could have been slightly more explicit about the specific chunk references (chunk_1) mentioned in ground truth, though this is a minor documentation detail; (3) The phrase 'does not reposition McGriddles' is slightly less precise than the ground truth's 'remained presented as a static menu item' - though semantically equivalent. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correctly identified with no calculation errors. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and identifies the strategic implication (stable vs. innovative positioning). CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and strategic consistency inquiry posed in the original question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 487,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Across 2022, 2023 and 2024 Adobe’s Digital Learning Services consistently highlighted a large number of free online self‑service learning options on **learning.adobe.com**. The positioning of these free courses within the Digital Learning Services portfolio remained unchanged, and the platform used to deliver them stayed the same—learning.adobe.com—without any shift to a new delivery channel.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) PLATFORM EVOLUTION ERROR - The LLM claims learning.adobe.com was used consistently across all three years (2022-2024), but the ground truth explicitly states that in 2022, Adobe used www.training.adobe.com, and only shifted to learning.adobe.com by 2023. This is a critical factual error regarding the platform evolution. (2) MISSING KEY EVOLUTION - The LLM completely fails to capture the documented shift from training.adobe.com to learning.adobe.com between 2022 and 2023, which is a central element of the question about how the emphasis 'evolved.' The ground truth emphasizes this platform transition as evidence of a 'more centralized or rebranded approach.' (3) INCOMPLETE CHARACTERIZATION - The LLM states positioning 'remained unchanged' when the ground truth indicates a maturing and more structured approach with increased integration into the broader Adobe Learning Services ecosystem by 2024. The LLM misses the progression from initial introduction (2022) to continued provision (2023) to reinforced production and deeper integration (2024). (4) MISSING CONTEXT - The LLM omits the strategic context that these offerings were positioned as assisting 'customer and partner teams in product adoption' and fails to note the integration with fee-based and custom learning programs by 2024. (5) CONTRADICTORY CLAIM - The statement that 'the platform used to deliver them stayed the same—learning.adobe.com—without any shift' directly contradicts documented evidence that the platform changed from training.adobe.com to learning.adobe.com. The answer demonstrates a fundamental misunderstanding of the evolution being tracked and provides factually incorrect information about platform consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 494,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "From 2022 to 2024 Emerson shifted Commercial Vacuums from the Tools & Home Products segment’s Professional Tools sub‑segment to the Safety & Productivity segment of Intelligent Devices. In 2022 the vacuums were listed among other professional tools in the Tools & Home Products segment (page 9), whereas by 2023–24 the Safety & Productivity segment is described as delivering tools that support infrastructure, promote safety and enhance productivity, with commercial vacuums listed as part of its other professional tools (page 73). This repositioning signals a strategic emphasis on safety‑centric, productivity‑focused professional tools and aligns commercial vacuums with Emerson’s broader professional‑tools portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution of Commercial Vacuums from Tools & Home Products segment (2022) to Safety & Productivity segment (2023-2024). The timeline is accurate, and the basic repositioning narrative is sound. Page references are provided, showing attempt at source documentation.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM answer lacks critical details from the ground truth about the specific product groupings and strategic emphasis changes. Ground truth emphasizes that in 2023, Commercial Vacuums were grouped with infrastructure/safety tools (battery hydraulic tools, sewer inspection cameras), while in 2024 they were aligned with more technologically advanced industrial tools (programmable automation control systems, electrical distribution equipment). The LLM fails to capture this important distinction between 2023 and 2024 positioning. (2) MISSING STRATEGIC NUANCE: The ground truth highlights a shift from 'general tools category' to 'integrated industrial safety and productivity solutions' - a key strategic insight about technological advancement and industrial focus. The LLM's answer is more generic, stating 'safety-centric, productivity-focused professional tools' without capturing the evolution toward more advanced/industrial positioning. (3) VAGUE CATEGORIZATION: The LLM mentions 'Intelligent Devices' as a parent segment but doesn't clearly explain how Commercial Vacuums fit within the broader product ecosystem evolution. (4) INCOMPLETE PRODUCT CONTEXT: The ground truth provides specific examples of companion products in each year (water jetters, wet-dry vacuums in 2022; battery hydraulic tools and sewer cameras in 2023; automation control systems and electrical distribution in 2024). The LLM only vaguely references 'other professional tools' without these specifics. (5) REASONING GAP: While the LLM identifies the segment shift, it doesn't fully explain the strategic repositioning from general professional tools to integrated industrial solutions, which is the core insight of the question.\n\nNUMERIC/DATE VERIFICATION: Years (2022, 2023, 2024) are correct. No calculations required. Segment names are accurate.\n\nMULTI-HOP SYNTHESIS: The LLM partially synthesizes the information but misses the critical evolution in product categorization and strategic emphasis across the three-year period. The answer reads as a two-point comparison (2022 vs 2023-24) rather than a three-year evolution with distinct positioning in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 666,
        "total_tokens": 2123
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has continued to serve the same role over the past three years.  In the 2022 10‑K (page 31), the 2023 10‑K (page 11), and the 2024 10‑K (page 12) the facility is described as being used for **commercial manufacturing and processing of our cell‑therapy products**.  No additional activities—such as expanded clinical manufacturing or new processing functions—are reported, indicating a consistent utilization of the site from 2022 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The original answer clearly states that the facility's utilization EVOLVED from 2022 through 2024, with a 'strategic shift toward advanced therapies' in 2023 and a 'sustained and potentially expanding role' by 2024. However, the LLM answer explicitly claims the facility 'continued to serve the same role over the past three years' with 'consistent utilization' and 'no additional activities.' This is a fundamental mischaracterization of the progression described in the ground truth. The LLM correctly identifies: (1) the facility name and location (Hoofddorp, Netherlands), (2) the company (Gilead/GILD), (3) the time period (2022-2024), (4) the general function (commercial manufacturing and processing of cell therapy products), and (5) provides specific 10-K page references. However, the LLM fails to capture the key insight that the ground truth emphasizes: the EVOLUTION and SHIFT in the facility's role over time. The ground truth indicates a progression from being 'identified as a principal manufacturing site' in 2022 to being 'explicitly described' for cell therapy in 2023 to 'continuing' with a 'sustained and potentially expanding role' in 2024. The LLM's assertion of consistency directly contradicts this narrative of evolution. This represents a significant failure in multi-hop reasoning and synthesis, as the question specifically asks 'how has...evolved' and the LLM answered that it remained static. The quantitative accuracy score is higher because the specific activities mentioned are correct, but the qualitative accuracy is low due to the fundamental misinterpretation of the temporal progression and strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 471,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 2022‑2024 filings repeatedly cite the 1.000% Notes due 2028 (see Exhibit 4.26 in the 2022, 2023 and 2024 10‑K indexes), underscoring its continued reliance on low‑cost, short‑term debt as a core financing tool.  In 2024 the company also issued 5.000% Notes due 2034 and 5.400% Notes due 2064 (Exhibit 4.39‑4.41 in the 2024 10‑K), adding higher‑yield, longer‑maturity debt to diversify its maturity profile and lock in rates for the long term.  Together, these actions reflect a shift toward a more balanced capital structure that blends inexpensive short‑term borrowing with longer‑term, higher‑cost debt to manage interest‑rate risk and optimize overall financing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. All key financial instruments are correctly identified: 1.000% Notes due 2028 (persistent across 2022-2024), 5.000% Notes due 2034, and 5.400% Notes due 2064 (introduced in 2024). The quantitative data is accurate with no calculation errors. The answer correctly synthesizes information across multiple years and filing documents to show the evolution of Coca-Cola's debt strategy. The reasoning is sound: the model identifies the shift from low-cost short-term debt to a more balanced portfolio including higher-yield longer-maturity instruments, and correctly interprets this as reflecting changes in capital structure management and interest-rate risk management. The LLM adds specific exhibit references (Exhibit 4.26, 4.39-4.41) which, while not in the ground truth, demonstrate detailed filing knowledge and enhance credibility. The semantic meaning aligns well with the original answer—both convey that Coca-Cola balanced low-cost near-term debt with higher-cost long-term debt to optimize its capital structure. Minor differences in wording (e.g., 'short-term' vs 'near-term,' 'lock in rates for the long term' vs 'fund new strategic initiatives') are acceptable variations that don't affect factual accuracy. The answer fully addresses the multi-part question regarding how the persistent reference to 1.000% Notes combined with introduction of higher-yield notes reflects changes in debt financing costs and capital structure management. No material omissions or errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 430,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s 2022 10‑K (page 9) lists pipe cutters as part of a conventional tool set that included diagnostic systems but no battery‑powered options. By 2023 the Safety & Productivity segment notes the addition of battery‑hydraulic tools for press connections and diagnostic equipment such as sewer‑inspection cameras (page 73, 2023 10‑K). The 2024 filing further emphasizes battery‑powered hydraulic tools and integrated diagnostic systems, underscoring a deliberate shift toward cordless, connected tools (page 73, 2024 10‑K). This evolution signals Emerson’s positioning as a technology‑driven leader in the professional plumbing tools market, prioritizing convenience, safety, and data‑enabled performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution across the three-year period (2022-2024), accurately capturing the progression from traditional tools to battery-powered and diagnostic-integrated offerings. The semantic understanding of Emerson's market positioning is sound, and the answer appropriately synthesizes information across multiple filing years. The qualitative reasoning about the company's strategic pivot toward technology-driven solutions is well-articulated and matches the ground truth narrative.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUES: The LLM cites specific page numbers (page 9 for 2022 10-K, page 73 for 2023 and 2024 10-Ks) without verification against actual filings. These page citations cannot be confirmed as accurate and represent a potential factual error. (2) FACTUAL DISCREPANCY: The LLM states that the 2022 10-K lists pipe cutters as including 'diagnostic systems but no battery-powered options.' However, the ground truth indicates that in 2022, there was 'no emphasis on battery-powered or diagnostic capabilities' - suggesting diagnostic systems were not prominently featured in 2022's pipe cutter portfolio. This is a subtle but meaningful distinction that the LLM misrepresents. (3) INCOMPLETE ATTRIBUTION: The LLM references specific page numbers and segment names (Safety & Productivity segment) without clear verification that these details match the actual filings.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression pattern. The logical flow from traditional → battery-hydraulic → integrated diagnostic systems is sound and matches the ground truth narrative.\n\nSCORE JUSTIFICATION: The answer demonstrates strong qualitative understanding and appropriate contextual relevance, but the unverified page citations and the subtle mischaracterization of 2022's diagnostic capabilities reduce confidence in quantitative accuracy. The core narrative is correct, but specific factual claims (page numbers, exact 2022 positioning) are questionable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 563,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024, Gilead’s Santa Monica, California facility has consistently been described as a site for clinical manufacturing and processing of cell‑therapy products (2023: pages 11‑12; 2024: page 8). The unchanged role across the three years underscores the facility’s strategic importance as a core clinical manufacturing hub within Gilead’s cell‑therapy network, supporting both clinical trials and potential commercial scale‑up.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the key factual claim. Ground truth explicitly states that in 2022, the Santa Monica facility was NOT specifically highlighted for cell therapy processing, and only by 2023 was it explicitly noted for this role. The LLM claims the facility was 'consistently described' for this purpose 'from 2022 through 2024,' which is factually incorrect. This is a major error in multi-hop synthesis across the three-year period. The LLM also fails to capture the critical progression/evolution that is central to the question - the transition from general R&D site to dedicated cell therapy manufacturing hub. Instead, it incorrectly portrays the role as unchanged across all three years. The page citations (2023: pages 11-12; 2024: page 8) cannot be verified but appear to be fabricated specificity. The answer does correctly identify the facility location (Santa Monica, California) and company (Gilead/GILD), and appropriately mentions cell therapy manufacturing, but the core narrative about how the facility's role evolved is inverted - claiming consistency where the ground truth shows clear progression. This represents a fundamental failure to answer the question about 'evolution' and 'progression' of the facility's role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 363,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s Frame.io began as a video‑centric collaboration tool that was only integrated with Premiere Pro and After Effects, supporting video and still‑image uploads (2022). By 2023 the platform still focused on those two apps but broadened its media support to still images, design files and PDFs and added camera‑to‑cloud uploads【2023 page 12】. In 2024 Frame.io’s integration expanded further to Photoshop, Lightroom, Workfront and GenStudio, enabling frame‑accurate commenting across a wider array of Creative Cloud apps while maintaining support for video, still images, design files, PDFs and camera‑to‑cloud workflows【2024 page 12】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Frame.io from 2022-2024 and correctly identifies most key integration points and supported media types. However, there are significant issues with accuracy and completeness:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2023 support for still images, design files, and PDFs\n- Correctly identifies 2024 integrations with Photoshop, Lightroom, Workfront, and GenStudio\n- Correctly notes frame-accurate commenting capability\n- Properly sequences the evolution across the three-year period\n- Correctly identifies Premiere Pro and After Effects as early integrations\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. 2022 CHARACTERIZATION: The LLM states Frame.io was \"video-centric\" and \"only integrated with Premiere Pro and After Effects\" in 2022. The ground truth indicates Frame.io was merely \"listed as part of Adobe's trademark portfolio\" in 2022 with \"no detailed functional description.\" The LLM is making unsupported claims about 2022 capabilities.\n\n2. MISSING CRITICAL CONTEXT: The ground truth emphasizes that in 2024, Frame.io's capabilities expanded to include use cases \"beyond post-production workflows—such as casting, location scouting, and marketing campaign management.\" The LLM completely omits this important expansion of use cases, which is a significant part of the evolution story.\n\n3. POSITIONING EVOLUTION: The ground truth notes Frame.io was \"positioned as part of Adobe GenStudio for enterprise-scale content production\" in 2024. While the LLM mentions GenStudio integration, it doesn't capture the strategic positioning aspect for enterprise-scale content production.\n\n4. 2023 DESCRIPTION: The ground truth specifies Frame.io was described as a \"cloud-native creative collaboration platform\" in 2023, which the LLM doesn't mention.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple applications, showing sound multi-hop reasoning. However, the synthesis is incomplete because it misses the use-case expansion dimension.\n\nCITATION ISSUES: The LLM includes citations (\"【2023 page 12】\", \"【2024 page 12】\") that cannot be verified and may be hallucinated.\n\nOVERALL: The answer demonstrates partial understanding of the evolution but contains factual inaccuracies about 2022 capabilities and omits important information about use-case expansion beyond post-production workflows. The core timeline and application integrations are mostly correct, but the answer is incomplete in capturing the full scope of Frame.io's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 680,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 Emerson’s Discrete Automation offering was grouped under the broader Automation Solutions segment and was described mainly as “industrial valves and equipment” without a specific focus on electrical distribution equipment or its integration with control systems【page_74 (2022)】. By 2024, the Discrete Automation segment’s description explicitly lists “electrical distribution equipment” alongside electric linear‑motion solutions and “programmable automation control systems and software,” signaling a deliberate shift to embed electrical distribution products within an integrated automation portfolio and broaden the product scope for discrete‑industry customers【page_73 (2024)】.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM answer only addresses 2022 and 2024, completely omitting the 2023 evolution which is a key part of the 3-year progression. The ground truth explicitly states that 2023 was a pivotal year where Electrical Distribution Equipment was 'more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software.' This is a significant gap in the multi-hop analysis. (2) INACCURATE 2022 CHARACTERIZATION: The LLM states that in 2022 the offering was 'grouped under the broader Automation Solutions segment' and described as 'industrial valves and equipment' without specific focus on electrical distribution. However, the ground truth indicates that in 2022, Electrical Distribution Equipment was already 'positioned as a foundational product within the Industrial Solutions business' and 'used broadly in manufacturing operations as part of integrated solutions.' The LLM's characterization of 2022 as lacking specific focus on electrical distribution contradicts the ground truth. (3) PARTIAL CORRECTNESS ON 2024: The LLM correctly identifies that by 2024, electrical distribution equipment was listed alongside electric linear-motion solutions and programmable automation control systems, which aligns with the ground truth. However, the LLM states 'materials joining solutions' in the ground truth but the LLM answer says 'programmable automation control systems and software' - this is actually correct per ground truth, but the LLM missed the 'materials joining solutions' component mentioned in the original answer. (4) REASONING QUALITY: While the LLM correctly identifies a 'deliberate shift' and 'integration,' it fails to capture the nuanced 3-year evolution showing progressive deepening of integration. The answer presents only a 2-year comparison rather than the requested 3-year evolution. (5) DATES/ENTITIES: Years (2022, 2024) are correct, company (EMR/Emerson) is correct, segment names are correct. No calculation errors as this is qualitative analysis. The main failure is incomplete temporal coverage and mischaracterization of the 2022 baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 586,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Fixed unsecured senior debt rose from **$24.1 B in 2022 to $27.2 B in 2023** (Table 8.1, page 178) and then fell slightly to **$26.9 B in 2024** (Table 9.1, page 188).  The weighted‑average interest rate stayed at **4.45 % in 2022 and 2023** but climbed to **4.84 % in 2024** (Table 9.1, page 188).  This pattern—extending the debt maturity to 2035 and taking on new debt at higher rates while keeping overall levels largely flat—indicates a strategy of locking in longer maturities to hedge against rising rates, with modest use of hedging instruments to manage the higher cost of new fixed‑rate borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors in the primary financial metrics. (1) 2022 carrying value: LLM states $24.1B, but ground truth is $19,975M ($19.975B) - this is a $4.125B error (20.6% overstatement). (2) 2023 carrying value: LLM correctly states $27.2B, matching ground truth of $27,168M. (3) 2024 carrying value: LLM correctly states $26.9B, matching ground truth of $26,930M. (4) Weighted-average interest rates: MAJOR ERROR - LLM claims the rate was 4.45% in both 2022 and 2023, but ground truth shows 2.91% in 2022 and 4.45% in 2023. This is a fundamental misstatement of the 2022 rate (off by 1.54 percentage points). The 2023 and 2024 rates (4.45% and 4.84%) are correct. The LLM's claim that rates 'stayed at 4.45% in 2022 and 2023' directly contradicts the ground truth showing a significant increase from 2.91% to 4.45%. This error undermines the entire analysis of the company's debt strategy. (5) Multi-hop synthesis: While the LLM attempts to synthesize information about debt maturity extension and hedging strategy, these details are not verified against the ground truth and appear to be inferred or hallucinated. The core narrative about 'locking in longer maturities' and 'hedging instruments' cannot be validated. The reasoning about rising rate environment is partially sound but is built on incorrect foundational data. The answer demonstrates some understanding of debt strategy concepts but fails on the critical quantitative foundation required for a multi-hop financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 429,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s carrying amount of performance and operating‑cost guarantees fell from **$1.109 billion at 12/31/2022** to **$1.091 billion at 12/31/2023** and further to **$993 million at 12/31/2024** (page 112).  The net decline of roughly $116 million over two years reflects fewer or smaller settlements and a lower balance of outstanding guarantees.  This downward trend indicates that RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is easing—likely due to improved product reliability, tighter warranty terms, or a reduction in claims against its extended guarantees.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that are orders of magnitude larger than the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports liabilities of $1.109 billion (2022), $1.091 billion (2023), and $993 million (2024), while the ground truth shows $120 million (2022), $120 million (2023), and $101 million (2024). The LLM's numbers are approximately 9-11x larger than actual values. The LLM calculates a decline of $116 million, but the actual decline from 2022-2024 is only $19 million ($120M to $101M). (2) ENTITY/METRIC CONFUSION: The LLM appears to have cited the wrong liability category entirely - these figures may relate to a different guarantee or liability classification in RTX's filings, not the specific performance and operating cost guarantees requested. (3) REASONING FLAW: While the LLM's logic about declining exposure (improved reliability, tighter terms, fewer claims) is conceptually sound, it is applied to incorrect data. The actual trend shows remarkable stability ($120M for two years) followed by a modest decline, not the dramatic $116M reduction the LLM describes. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly identify and synthesize the specific liability line item across the three fiscal years. The answer demonstrates a fundamental data retrieval or matching error rather than a reasoning error. (5) DIRECTIONAL CORRECTNESS: The LLM correctly identifies a downward trend (which exists in both datasets), but the magnitude and interpretation are severely compromised by using wrong numbers. The ground truth indicates stability and controlled risk management; the LLM's data would suggest a more dramatic risk reduction that doesn't match the actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 481,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Coca‑Cola’s Note 4 on investments in both the 2023 and 2024 10‑Ks contains identical wording that lists “estimates of sales proceeds” as one of the valuation methods for non‑public investments (see page 78 of each filing). The unchanged phrasing shows that the company’s reliance on this approach has remained steady from 2022 through 2024. This consistency indicates a continued, diversified fair‑value strategy in emerging markets, where forecasting cash flows is inherently uncertain, and Coca‑Cola continues to use sales‑proceeds estimates alongside discounted‑cash‑flow and appraisal methods.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the core evolution described in the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims 'identical wording' in 2023 and 2024 filings, but the ground truth explicitly states the language EVOLVED from 2022 ('disclosed the use') to 2023 ('explicitly stated that it relies on') to 2024 ('continued to use'). This is a fundamental mischaracterization of the progression. (2) MISSING CRITICAL EVOLUTION - The ground truth describes a 3-year progression: disclosure → deepening dependence → risk-aware integration. The LLM completely misses this evolution by claiming consistency. (3) INCOMPLETE SYNTHESIS - The ground truth identifies a strategic shift in how the company applied the methodology (from disclosure to operational reliance to cautious application), particularly regarding emerging markets risk. The LLM only notes that the method remained 'steady' and 'unchanged.' (4) MISSING CONTEXT - The ground truth emphasizes increased emphasis on 'challenges of predicting future cash flows—particularly in emerging and developing markets' in 2024, suggesting a more cautious approach. The LLM mentions uncertainty but doesn't capture the temporal evolution of this concern. (5) CITATION ISSUE - The LLM cites 'page 78' but provides no verification that this supports the claimed 'identical wording' across years. (6) SEMANTIC MISALIGNMENT - The question asks how reliance 'evolved' and what this 'reveals about changing approach.' The LLM's answer that nothing changed contradicts the ground truth's documented evolution. The LLM answer demonstrates a failure in multi-hop reasoning across the three-year period and misses the core narrative of strategic evolution in valuation methodology application.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 484,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosure on capital return has stayed essentially the same from 2022 through 2024.  In 2022 (page 5) it states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  The identical wording appears in the 2023 risk factor (page 4) and again in the 2024 risk factor (page 4).  This consistency shows that regulatory constraints on capital distributions remain unchanged, indicating that BNY Mellon’s strategic flexibility in shareholder capital returns is constrained but still managed within those limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core disclosure language from 2022-2024 and accurately quotes the risk factor text. Page references (2022 page 5, 2023 page 4, 2024 page 4) appear reasonable. The LLM correctly notes the consistency of the primary regulatory language across all three years. CRITICAL WEAKNESSES: The LLM fundamentally misses the key evolution that the ground truth identifies. The ground truth explicitly states that '2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends.' This represents a material change in disclosure focus, not mere consistency. The LLM's conclusion that 'regulatory constraints on capital distributions remain unchanged' is incomplete and misleading—while the primary language may be identical, the 2024 filing introduced NEW emphasis on internal capital flow dependencies, which is a significant strategic shift. The LLM fails to perform the multi-hop synthesis required: comparing the 2022/2023 disclosures against 2024 to identify what CHANGED, not just what stayed the same. The question specifically asks about 'evolution' and what the 'progression suggests,' requiring identification of changes over time. The LLM's answer essentially says 'nothing changed' when the ground truth shows a meaningful evolution in emphasis regarding internal structural dependencies. REASONING ASSESSMENT: The LLM's logic is sound for what it addresses (consistency of primary language), but it fails to complete the full multi-hop analysis. It doesn't synthesize the additional 2024 disclosure elements about subsidiary dividends and IHC credit extensions that represent the strategic evolution. This is a significant analytical gap for a multi-year progression question. The conclusion about 'constrained but still managed' is generic and doesn't capture the specific strategic implications of the shift toward internal dependency emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 538,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD has consistently listed the risk of losing or having its tax‑and‑tariff exemptions modified in its political, legal and economic risk disclosures from 2022 through 2024, with the wording remaining essentially unchanged.  The 2024 filing, however, adds explicit references to sanctions and export‑control revisions tied to the Ukraine‑Russia and China‑Taiwan conflicts, underscoring a more turbulent geopolitical backdrop.  This continuity, coupled with the growing detail on sanctions and trade‑control changes, signals that AMD’s global regulatory environment is becoming increasingly complex and volatile, making the preservation of tax and tariff exemptions more uncertain.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of AMD's consistent disclosure of tax and tariff exemption risks across 2022-2024. The answer correctly identifies the key geopolitical events (Ukraine-Russia and China-Taiwan conflicts) and their connection to export controls and sanctions. However, there are notable differences in emphasis and completeness compared to the ground truth: (1) The LLM states the wording 'remained essentially unchanged' from 2022-2024, while the ground truth indicates AMD 'expanded its discussion' by 2023 to include specific geopolitical events, suggesting a more nuanced evolution than the LLM conveys. (2) The ground truth explicitly notes that in 2022 the risk was 'listed among other geopolitical and economic risks' and that by 2023 AMD 'expanded its discussion to include the effects of specific geopolitical events,' indicating a progression in disclosure detail. The LLM's characterization of 'continuity, coupled with growing detail' is partially correct but understates the expansion that occurred between 2022 and 2023. (3) The LLM correctly identifies the 2024 addition of explicit references to sanctions and export-control revisions. (4) Both answers reach the same conclusion about increasing complexity and volatility, though the LLM's reasoning path differs slightly. The LLM answer is semantically sound and addresses the core question about evolution and regulatory complexity, but it misses the nuance of how the disclosure evolved progressively from 2022 to 2023 to 2024, instead characterizing it more as a 2024 enhancement to otherwise stable language. No quantitative errors are present (no specific numbers were required for this qualitative question).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 474,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024.  The elimination of $1.6 billion of floating‑unsecured senior debt by 2024 – down to $349 million in 2023 and zero in 2024 – and the shift toward fixed‑rate and securitized debt shows a deliberate move to a more stable, lower‑interest‑rate‑exposure debt mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental numerical inaccuracies that severely undermine its credibility. (1) TOTAL DEBT FIGURES: The LLM states short-term borrowings of $883M (2022), $538M (2023), $562M (2024) and long-term debt of $47.8B (2022), $49.3B (2023), $44.9B (2024). These component figures do NOT sum to the ground truth totals of $43.086B (2022), $49.856B (2023), and $45.551B (2024). The ground truth shows total short-term borrowings + long-term debt = these totals, but the LLM's numbers are inconsistent with this basic accounting relationship. (2) FLOATING UNSECURED SENIOR DEBT: The LLM correctly identifies the elimination of floating unsecured senior debt and mentions $349M in 2023 and $0 in 2024, which matches ground truth. However, it states the debt was 'down to $349 million in 2023' implying a reduction, when ground truth shows it was $1.709B in 2022, then $349M in 2023 - a dramatic 80% reduction, not a modest decline. The LLM also claims '$1.6 billion of floating-unsecured senior debt by 2024' which is approximately correct ($1.709B - $0 = $1.709B ≈ $1.6B), but this is imprecise. (3) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rates (1.01% in 2022 rising to 6.75% in 2023 for floating debt; 2.91% in 2022 rising to 4.84% in 2024 for fixed debt), which are essential to answering the question about 'interest rate exposure.' The ground truth explicitly discusses these rates as evidence of the strategic pivot. (4) INCOMPLETE ANALYSIS: The LLM mentions 'shift toward fixed-rate and securitized debt' but provides no supporting data on fixed unsecured senior debt ($21.045B in 2022 → $27.168B in 2023 → $26.930B in 2024), which is central to understanding the debt structure evolution. (5) REASONING QUALITY: While the LLM correctly identifies the strategic shift from floating to fixed-rate debt, it lacks the quantitative rigor and detailed interest rate analysis that the ground truth provides. The conclusion about 'lower-interest-rate-exposure debt mix' is somewhat contradicted by the rising weighted-average rates on fixed debt (2.91% to 4.84%), which the LLM fails to address. The answer demonstrates partial understanding of the strategic direction but fails on numerical accuracy and completeness of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 624,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG remained unchanged at 57 % (with a 51 % share in IAE LLC) from 2022 through 2024. This stability shows that RTX continues to hold a majority stake and maintain its strategic influence in the V2500 engine‑program collaboration, with no shift in its role or ownership position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. (1) QUANTITATIVE ERRORS: The LLM states RTX's net program share interest 'remained unchanged at 57%' from 2022-2024, but the ground truth clearly shows it decreased from 61% in 2022 to 57% in 2023 and 2024. This is a critical factual error - the LLM misses the 4 percentage point decline that is central to the question. (2) MULTI-HOP REASONING FAILURE: The question explicitly asks 'how did...evolve from 2022 to 2024' - requiring comparison across three years. The LLM completely fails this synthesis by claiming no change occurred, when the ground truth shows a clear downward trend (61% → 57%). (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes the stability 'shows that RTX continues to hold a majority stake and maintain its strategic influence,' but this contradicts the actual data showing a reduction in stake. The ground truth correctly interprets the decrease as 'a strategic adjustment' and 'gradual dilution' of RTX's exposure. (4) ENTITY/METRIC ACCURACY: While the LLM correctly identifies IAE and the V2500 engine program, it provides incorrect percentage values for the key metric being analyzed. The mention of '51% share in IAE LLC' appears to be additional detail not directly addressing the net program share evolution question. (5) SEMANTIC CONTRADICTION: The LLM's claim of 'stability' and 'unchanged' directly contradicts the ground truth's documented 61% → 57% decline. This is not a wording difference but a fundamental factual error. The answer demonstrates a complete misunderstanding of the data trend and provides an incorrect strategic interpretation based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 458,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, Cascade is listed as a major brand in P&G’s Fabric & Home Care segment (2024: page 18; 2023: page 19; 2022: page 19).  The segment’s share of P&G’s net sales rose from 35 % in 2022 and 2023 to 36 % in 2024, and its earnings share grew from 31 % to 34 %, indicating that Cascade’s role within the home‑care portfolio has remained strong while the segment’s overall importance has expanded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical numerical error that significantly impacts accuracy. QUANTITATIVE ISSUES: The LLM states 'The segment's share of P&G's net sales rose from 35% in 2022 and 2023 to 36% in 2024.' However, the ground truth clearly indicates that 2022 was 35%, 2023 was 36%, and 2024 was 36%. The LLM incorrectly claims 2023 was 35% when it was actually 36%. This is a factual error in reading the segment reporting data. The earnings percentages (31% to 34%) are correctly stated. QUALITATIVE STRENGTHS: The LLM correctly identifies Cascade as a major brand in the Fabric & Home Care segment across all three years, correctly identifies the segment name and structure, and appropriately synthesizes the multi-hop information about Cascade's positioning. The reasoning that Cascade 'has remained strong while the segment's overall importance has expanded' is logically sound and supported by the data. MULTI-HOP REASONING: The answer successfully synthesizes information across three 10-K filings and correctly identifies the relationship between Cascade's positioning and segment performance. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how Cascade's positioning has evolved and provides appropriate segment-level context. The page number citations (2024: page 18; 2023: page 19; 2022: page 19) add credibility, though these cannot be independently verified. OVERALL ASSESSMENT: While the qualitative reasoning and multi-hop synthesis are sound, the numerical error regarding the 2023 net sales percentage (stating 35% instead of 36%) is a material factual mistake that undermines the accuracy of the answer. The error suggests the LLM may have misread or conflated the 2022 and 2023 figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 472,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2024 BNY Mellon moved its Directors’ Code of Conduct from a legacy **bnymellon.com** site to the newer **bny.com** domain and updated the path from “in relations” → “inv relations” → “investor‑relations” (e.g., 2022: …/in relations/directors‑code‑of‑conduct.pdf; 2023: …/inv relations/directors‑code‑of‑conduct.pdf; 2024: https://www.bny.com/.../investor‑relations/directors‑code‑ofconduct.pdf). The employee code‑of‑conduct likewise shifted from a generic “c code‑of‑conduct.pdf” to a CSR‑specific “employeecode‑of‑conduct.pdf” under the new domain. Throughout, the code remains embedded in the corporate‑governance section and proxy references, but the 2024 filing adds an explicit insider‑trading policy and a clearer investor‑relations link, tightening its governance framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution narrative (domain transition from bnymellon.com to bny.com, URL path evolution) and correctly identifies the three-year progression. However, there are several significant issues: (1) QUANTITATIVE ERRORS: The LLM introduces information not in the ground truth about an 'employee code-of-conduct' shifting to 'employeecode-of-conduct.pdf' under CSR-specific branding - this appears to be fabricated or confused with different documents. The ground truth focuses exclusively on the Directors' Code of Conduct, not employee codes. (2) URL PATH ACCURACY: The LLM correctly identifies the progression 'in relations' → 'inv relations' → 'investor-relations', matching the ground truth. However, the formatting of the 2024 URL in the LLM answer ('https://www.bny.com/.../investor‑relations/directors‑code‑ofconduct.pdf') uses hyphens inconsistently and appears incomplete compared to the ground truth's full path structure. (3) SCOPE CREEP: The LLM introduces discussion of 'insider-trading policy' and 'CSR-specific' branding that are not mentioned in the ground truth, suggesting either hallucination or synthesis from unverified sources. (4) SEMANTIC ACCURACY: The core insight about the shift from 'static document repository to stakeholder-oriented governance disclosure' is present but less explicitly articulated than in the ground truth. (5) MULTI-HOP REASONING: The answer does synthesize across three years and identifies the domain/path evolution correctly, but the introduction of unverified elements (employee code, CSR branding, insider-trading policy) undermines confidence in the synthesis. The answer is partially correct on the main narrative but contains material additions not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 480,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "AMD’s approach to AIB manufacturers stayed essentially the same from 2022 through 2024: it continued to offer component‑level graphics and chipset products while protecting AIB inventory against price reductions (AMD 10‑K 2022, p. 11; AMD 10‑K 2023, p. 11; AMD 10‑K 2024, p. 11).  Across all three years, AMD emphasized that system integrators use discrete graphics solutions to differentiate their board‑level products, a strategy that remained unchanged in the company’s disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core factual elements correctly: (1) AMD maintained consistent inventory protection policies for AIBs across 2022-2024, (2) discrete graphics solutions were emphasized as a differentiator across all three years, and (3) the strategy remained stable throughout the period. The answer correctly identifies the three fiscal years and appropriately cites the 10-K filings (though specific page numbers cannot be verified from the ground truth). The multi-hop synthesis is sound - the model successfully connected inventory protection policies with discrete graphics differentiation across the three-year period. However, the LLM answer is slightly less complete than the ground truth in a few ways: (1) it doesn't explicitly mention the role of AIBs in 'building board-level products for system integrators and retail buyers' as a distinct strategic element, (2) it uses more generic language ('component-level graphics and chipset products') rather than emphasizing the specific value proposition, and (3) it doesn't fully articulate the 'long-term partnership model' concept that the ground truth emphasizes. The answer correctly avoids introducing any false numbers or dates. The semantic equivalence is strong - 'stayed essentially the same' and 'remained unchanged' accurately convey the consistency theme. The citation format (10-K year, page number) adds credibility though page numbers cannot be independently verified. Minor weakness: the phrase 'component-level graphics' is slightly less precise than 'discrete graphics solutions' in capturing AMD's strategic positioning. Overall, this is a solid answer that correctly synthesizes the multi-hop information but with minor omissions in completeness and nuance compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 482,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "McDonald’s 2022, 2023, and 2024 10‑K filings all describe the Egg McMuffin as a core breakfast sandwich and note that the company is continually evolving its menu to meet customer expectations for taste, quality, value, and nutrition (see page 7 of each filing).  Across the same years, the supply‑chain narrative (page 6) consistently emphasizes high food‑safety and quality standards, supplier collaboration, and continuous improvement to ensure consistency—particularly for flagship items such as the Egg McMuffin.  In short, the disclosures show no substantive shift; McDonald’s simply reiterates its ongoing commitment to quality and consistency for this iconic product.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly states there WAS a substantive evolution/shift in McDonald's disclosure from 2022 to 2024, characterized by: (1) 2022: general quality/nutrition focus; (2) 2023: expanded narrative around supply chain collaboration and Global Chief Supply Chain Officer; (3) 2024: stronger emphasis on digital transformation in food safety/quality with specific digital transformation projects. The LLM answer claims 'the disclosures show no substantive shift' and that McDonald's 'simply reiterates its ongoing commitment'—this is the opposite of what the ground truth indicates. The LLM also provides page number citations (page 7, page 6) without verification against actual filings, which is problematic. While the LLM correctly identifies the Egg McMuffin as a core breakfast item and mentions quality/consistency themes, it fails to capture the critical evolution in HOW McDonald's discussed these topics across the three-year period. The ground truth shows a progression from basic quality assurance → supply chain strategy emphasis → digital transformation integration. The LLM's conclusion that there is 'no substantive shift' is factually incorrect based on the ground truth narrative. This represents a major failure in multi-hop reasoning and synthesis across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 388,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle’s repeated inclusion of the 4.30% Note due 2034 (Exhibit 4.09) in its 2022, 2023 and 2024 10‑Ks shows that the company has kept this long‑term, fixed‑rate debt instrument as a core part of its capital structure. The consistency indicates a deliberate preference for stable, long‑maturity financing and a focus on maintaining a predictable interest‑expense profile rather than shifting to short‑term or higher‑rate debt【page 112】【page 110】【page 110】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Oracle's 4.30% Note due 2034 was disclosed consistently across 2022, 2023, and 2024; (2) it is a long-term, fixed-rate debt instrument; (3) the consistency indicates strategic focus on stable, long-maturity financing. All numeric values (4.30%, 2034 maturity date, three years) are accurate. The reasoning about maintaining a predictable interest-expense profile and preference for stable financing is sound and logically derived from the consistent disclosure pattern.\n\nHowever, the LLM answer is less comprehensive than the ground truth in several ways: (1) It does not mention the diversified maturity profile or other concurrent debt instruments (3.625% Note due 2023, 4.50% Note due 2044, 2.950% Notes due 2024) that provide important context about Oracle's broader debt strategy; (2) It does not explicitly note how the debt portfolio evolved across the three years or how newer instruments were issued alongside the persistent 4.30% Note; (3) The ground truth emphasizes the note's role within a 'broader, evolving debt portfolio,' which the LLM answer omits. The LLM answer focuses narrowly on the single instrument's consistency rather than synthesizing its position within Oracle's overall capital structure changes across the three-year period.\n\nThe page citations (112, 110, 110) appear reasonable for 10-K filings but cannot be verified against the ground truth. The answer is factually accurate on what it covers but lacks the multi-hop synthesis depth expected for a question about long-term debt structure and financing priorities across multiple reporting periods. The answer would benefit from discussing how the 4.30% Note fits within the context of other debt instruments issued or retired during these years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 486,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) measured at Level 3 rose from **$5 million at year‑end 2022 to $58 million in 2023 and $69 million in 2024**, reflecting a larger portfolio of OTC derivatives priced with vendor‑based discounted‑cash‑flow models that use **swap rates as the key unobservable input**.  The valuation methodology—relying on market‑observable inputs for Level 2 instruments and significant unobservable inputs for Level 3—remained unchanged, but the growing fair‑value balances show an increasing exposure to the uncertainty inherent in those unobservable inputs over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies with the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022 Level 3 fair value was $5 million, but ground truth shows $19 million net derivative assets/liabilities. The LLM claims 2024 was $69 million, but ground truth shows $58 million (same as 2023). This is a critical error—the LLM fabricated a 2024 increase to $69M that contradicts the ground truth showing stable $58M from 2023-2024. (2) INCOMPLETE CONTEXT: The LLM omits the 2022 unrealized loss of $20 million mentioned in ground truth, which is relevant to understanding the valuation evolution. The ground truth explicitly notes the transformation from 'mixed realized/unrealized loss position in 2022' to 'stable fair value by 2023-2024,' which the LLM fails to capture. (3) UNOBSERVABLE INPUTS: The LLM correctly identifies swap rates (3-5%) as key unobservable inputs but omits the default rates (53-163%) disclosed in 2023 per ground truth. This represents incomplete synthesis of the multi-hop information about valuation methodology evolution. (4) METHODOLOGY CHARACTERIZATION: The LLM's claim that 'valuation methodology remained unchanged' is not directly contradicted by ground truth but misses the key insight that ground truth emphasizes—the transformation in methodology from 2022 to 2023-2024 with 'increasing transparency and reliance on structured unobservable inputs.' (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the three-year evolution. It incorrectly shows an upward trajectory (5M→58M→69M) when ground truth shows stabilization (19M→58M→58M). This fundamental misrepresentation of the trend undermines the entire analysis. The LLM's conclusion about 'increasing exposure to uncertainty' is contradicted by the ground truth's emphasis on stabilization and increased transparency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 508,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to pay Rolls‑Royce for V2500‑powered aircraft flight hours has remained a per‑hour contingent payment through June 2027, with the payments being capitalized as collaboration intangible assets and amortized to cost of sales (Note 17, pages 73, 101, 103).  The commitment amount fell from $770 million in 2023 to $704 million in 2024, reflecting a modest reduction in expected flight‑hour payments (see the “Other commercial aerospace commitments” table on pages 101 and 103).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and unverified claims. STRENGTHS: (1) Correctly identifies the per-hour contingent payment structure through June 2027; (2) Correctly states payments are capitalized as collaboration intangible assets and amortized to cost of sales; (3) Correctly identifies the 2023-2024 timeframe comparison. CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific dollar amounts ($770 million in 2023 declining to $704 million in 2024) that cannot be verified against the ground truth, which does not cite these specific figures. The ground truth mentions $14.1 billion in total commercial aerospace commitments for 2024 but does not break out the Rolls-Royce payment obligation amounts for 2023-2024; (2) INCOMPLETE COVERAGE: The LLM answer fails to address the 2022 baseline and how obligations evolved across the full 2022-2024 period as requested. The ground truth explicitly discusses 2022 obligations as 'contingent liabilities' and the evolution of transparency; (3) MISSING CONTEXT: The LLM omits the historical context of the 2012 acquisition of Rolls-Royce's stake in IAE, which is central to understanding the obligation's origin; (4) MISSING EVOLUTION NARRATIVE: The ground truth emphasizes how the amortization strategy and transparency improved over time (2022 contingent liability classification → 2023 clarification of capitalization → 2024 integration into intangible asset management). The LLM answer states 'amortization policy remained consistent' but doesn't capture the evolution in disclosure and classification. QUANTITATIVE ACCURACY PENALTY: The specific dollar amounts cited ($770M and $704M) are presented as fact but lack verification in the provided ground truth. This is a significant concern for a financial question requiring precision. The answer would score higher if these numbers were properly sourced or if the answer acknowledged uncertainty about specific commitment amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 535,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K (pp. 49‑53) first disclosed that, after the FDA’s 2017 review of the Neulasta Onpro kit, it had “implemented device and labeling enhancements to address product complaints” and that it “continually monitors complaints and adverse events.”  The same filing also noted operational resilience measures for its Puerto Rico plant—backup diesel generators and the risk of hurricanes, earthquakes and power outages.  \n\nIn the 2023 10‑K (p. 54) Amgen reiterated the device‑enhancement story, adding that it “continually monitors complaints and implements additional enhancements as needed,” and expanded the operational‑risk narrative to include the potential impact of natural disasters on manufacturing and supply.  \n\nBy the 2024 10‑K (p. 52) the device‑enhancement language remained unchanged, but the operational‑resilience section was updated with more recent events—Hurricane Fiona and a 2024 island‑wide power outage—highlighting the continued reliance on backup power and the importance of maintaining supply continuity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in factual accuracy and completeness. STRENGTHS: (1) Correctly identifies the core narrative arc across 2022-2024 regarding device enhancements and operational resilience; (2) Appropriately synthesizes the multi-hop evolution of disclosures; (3) Correctly references the 2017 FDA review and device/labeling enhancements; (4) Properly identifies Puerto Rico manufacturing facility and backup generator measures. CRITICAL ERRORS: (1) The LLM claims the 2022 10-K discusses operational resilience measures (backup generators, hurricanes, earthquakes, power outages), but the ground truth indicates these operational resilience measures were NOT disclosed until 2024. The ground truth explicitly states that by 2024, Amgen 'expanded its disclosures to include operational resilience measures' and that the 2024 disclosure included 'an island-wide outage on December 31, 2024.' This is a major factual error—the LLM backdates operational resilience disclosures to 2022 when they should only appear in 2024. (2) The LLM mentions 'Hurricane Fiona and a 2024 island-wide power outage' in the 2024 section, but the ground truth specifies 'December 31, 2024' for the island-wide outage. The LLM does not provide the specific date. (3) The LLM's claim that 2022 included operational resilience discussion contradicts the ground truth's clear statement that operational resilience measures were a 2024 expansion. QUANTITATIVE ACCURACY: The date error (attributing 2024 operational content to 2022) is a significant factual mistake that affects the core narrative of how disclosures 'evolved.' The specific date of December 31, 2024 is omitted. QUALITATIVE ACCURACY: The multi-hop reasoning is partially sound in structure but fundamentally flawed in execution due to the temporal misplacement of operational resilience disclosures. The answer fails to capture the key evolution: that operational resilience was NEW in 2024, not present in 2022. CONTEXTUAL RELEVANCE: The answer addresses the question's focus on evolution and device-related enhancements, but misrepresents the timeline of when operational resilience measures entered the disclosure narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 593,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings show the same wording for the ratification of KPMG LLP in Item 14 each year: the disclosure references the ratification in the proxy and repeats “KPMG LLP’s PCAOB firm identification number is 185” in 2022, 2023 and 2024【page_14】【page_14】【page_14】. The unchanged language and persistent use of the firm number indicate that BK has continued to rely on KPMG LLP as its principal accountant, underscoring a stable audit‑governance relationship over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric references are correct - KPMG LLP's PCAOB firm identification number 185 is accurately cited for all three years (2022, 2023, 2024), with no calculation errors or date discrepancies. ENTITY ACCURACY: BK and KPMG LLP are correctly identified throughout, with proper reference to Item 14 of the 10-K filings. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the disclosure evolved (showing consistency/no substantive changes), and (2) what the consistent PCAOB number suggests about audit governance continuity. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings to demonstrate continuity, and properly connects the unchanged PCAOB number to conclusions about stable audit governance and institutional trust. SEMANTIC EQUIVALENCE: The LLM's phrasing ('unchanged language and persistent use,' 'continued to rely on,' 'stable audit-governance relationship') conveys the same meaning as the ground truth ('no substantive changes,' 'no change in external audit firm,' 'maintained stable audit governance practices'). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The citation format【page_14】 appears to reference source documentation appropriately. The answer could have been marginally enhanced by explicitly stating 'no auditor rotation' as mentioned in the ground truth, but this is a minor omission that doesn't affect the core correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 448,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer financing guarantees fell from **$140 million in 2022** (reported in the 2023 10‑K) to **$135 million in 2023** and further to **$131 million in 2024** (reported in the 2024 10‑K). The steady decline in collaboration‑partner share of these guarantees indicates a deliberate risk‑management strategy that trims guarantee commitments—through renegotiated financing terms, tighter internal controls, and a shift of risk to partners—thereby reducing the company’s potential liability exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states $140 million for 2022, but the ground truth clearly specifies $142 million. This is a factual error of $2 million on a key data point. The 2023 ($135M) and 2024 ($131M) figures are correct. MISSING CONTEXT: The LLM fails to mention that RTX maintained fair market values of guaranteed assets equaled or exceeded the value of guarantees net of reserves—an important detail from the ground truth that demonstrates continued confidence in underlying asset values. REASONING QUALITY: The LLM's interpretation of the trend as a 'deliberate risk-management strategy' is reasonable and aligns with the ground truth's characterization of 'strategic reduction in shared financial risk.' However, the LLM adds speculative details ('renegotiated financing terms,' 'tighter internal controls,' 'shift of risk to partners') that are not explicitly stated in the ground truth, which could be seen as over-interpretation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year trend and connects it to risk management strategy, demonstrating adequate multi-hop reasoning. However, the quantitative error on the 2022 figure is a significant flaw that undermines the credibility of the entire response. The answer is incomplete because it doesn't address the full context about fair market values and asset confidence that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 387,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 to 2024, P&G kept Always in the Feminine Care sub‑category (Menstrual Care) but increased its prominence as the segment’s major‑brand list shifted from baby‑care brands (Luvs, Pampers) to feminine‑hygiene brands (Always, Tampax Bounty) (PG_10k_2022, page_18; PG_10k_2023, page_18; PG_10k_2024, page_18). The 2022 filing’s major‑brand list included Luvs and Pampers alongside Always, whereas the 2023 and 2024 filings list only Always, Always Discreet, Tampax Bounty, Charmin, and Puffs, underscoring a stronger focus on Always and its variant while Tampax Bounty remains a secondary brand (PG_10k_2023, page_18; PG_10k_2024, page_18). This shift, reflected in the removal of baby‑care brands from the major‑brand list, highlights the emphasis on Always as the core feminine‑hygiene offering (PG_10k_2024, page_18).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Ground truth states the segment contributed 25% of net sales in 2022, 24% in 2023, and 24% in 2024. The LLM answer provides NO percentage contributions, failing to include this key quantitative data.\n   - The LLM incorrectly references 'Tampax Bounty' multiple times, which appears to be a fabrication or confusion (ground truth mentions 'Tampax' only).\n   - The LLM claims baby-care brands (Luvs, Pampers) were removed from the major-brand list, but ground truth makes no such claim about major-brand list composition changes.\n\n2. ENTITY ACCURACY ISSUES:\n   - 'Tampax Bounty' is mentioned but ground truth only references 'Tampax' - this is a factual error.\n   - The LLM incorrectly characterizes the segment evolution, claiming it remained 'Feminine Care' when ground truth clearly states it was renamed to 'Baby, Feminine & Family Care' in 2023.\n   - References to Charmin and Puffs in the feminine care context are misleading and not supported by ground truth.\n\n3. MULTI-HOP REASONING FAILURES:\n   - The LLM failed to synthesize the key structural change: the segment name evolution from 'Feminine Care' (2022) to 'Baby, Feminine & Family Care' (2023-2024).\n   - The LLM's claim about shifting major-brand lists lacks support in the ground truth and appears to be an unsupported inference.\n   - The LLM misses the core finding that Always was consistently positioned alongside Always Discreet and Tampax across the period.\n\n4. SEMANTIC EQUIVALENCE ISSUES:\n   - Ground truth emphasizes 'consistent strategic emphasis' with 'minor structural refinements,' while LLM emphasizes a 'shift' and 'removal' of brands that isn't documented in ground truth.\n   - The narrative direction is fundamentally different and misleading.\n\n5. COMPLETENESS:\n   - Missing the segment name change (critical evolution point).\n   - Missing the percentage contribution data (25% → 24% → 24%).\n   - Missing the consistent positioning of Always alongside Always Discreet and Tampax.\n   - The answer addresses some aspects of product categorization but does so inaccurately.\n\nThe LLM answer appears to have fabricated or confused details about brand list changes and product names that are not supported by the ground truth, while simultaneously omitting key quantitative and structural information that defines the actual evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 659,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In 2022 AMD listed “difficulties in protecting our intellectual property” as a general risk associated with its worldwide operations, but the filing did not tie that risk to its manufacturing strategy. By 2024 the company explicitly linked the IP‑protection risk to its expanding international sales and its heavy reliance on third‑party wafer foundries in China, Malaysia and Taiwan, noting that geopolitical tensions, sanctions and export‑control restrictions in those regions heighten the likelihood of IP theft or infringement. Thus, the exposure to IP protection difficulties evolved from a broad, generic concern in 2022 to a more specific, heightened risk driven by AMD’s growing overseas footprint and dependence on Asian manufacturing partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about AMD's IP protection challenges across 2022-2024. STRENGTHS: (1) Correctly identifies the evolution from generic/broad risk in 2022 to specific, heightened risk by 2024; (2) Accurately names the three key manufacturing locations (China, Malaysia, Taiwan); (3) Properly links IP protection risks to international sales expansion and third-party manufacturing reliance; (4) Correctly identifies geopolitical tensions as an additional risk layer by 2024; (5) The semantic framing of the evolution (generic→specific) matches the ground truth's characterization (generic→complex and regionally concentrated). MINOR GAPS: (1) The LLM answer does not include the specific quantitative detail from the ground truth that international sales represented 65% of net revenue in 2023—this is a notable omission of a concrete metric that supports the 'expanding international operations' claim; (2) The answer does not explicitly mention 2023 as a transition year where the company emphasized these concerns, instead jumping from 2022 to 2024, which slightly compresses the 3-year progression narrative; (3) The phrase 'third-party wafer foundries' is accurate but the ground truth uses the broader term 'third-party manufacturing,' which is semantically equivalent but slightly different in scope. QUANTITATIVE VERIFICATION: No calculations or numerical comparisons are required in this answer, and the geographic references are accurate. The 65% figure omission is the only quantitative gap. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects IP protection risks to both international operations and manufacturing strategy, demonstrating sound multi-hop reasoning. The logical progression is clear and well-articulated. OVERALL ASSESSMENT: This is a strong answer that captures the essential evolution and correctly identifies the key drivers of changing IP risk exposure, with only the omission of the 65% international sales metric preventing a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 566,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle’s 2.300 % notes due 2028 were first issued in 2021 as part of a multi‑maturity program (1.650 % 2026, 2.300 % 2028, 2.875 % 2031, 3.650 % 2041, 3.950 % 2051, 4.100 % 2061) and the same notes appear unchanged in the 2022 and 2024 10‑Ks【ORCL_10k_2022 page 112】【ORCL_10k_2024 page 111】. By 2024 Oracle had also issued a new 4.500 % note due 2028 (together with notes due 2030, 2033 and 2053)【ORCL_10k_2024 page 112】, layering a higher‑coupon debt against the existing 2.300 % note. This multi‑year pattern shows Oracle’s strategy of spreading debt maturities over a long horizon and using a mix of coupon rates to manage interest‑rate exposure and refinance flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially correct information with some enhancements beyond the ground truth, but also introduces some discrepancies worth noting:\n\nSTRENGTHS:\n1. Correctly identifies the 2.300% Notes due 2028 as part of Oracle's debt portfolio\n2. Accurately notes the notes were first issued in 2021 (ground truth references 2022 as first reference year, but LLM correctly identifies 2021 as issuance year)\n3. Correctly identifies the notes appearing in 2022 and 2024 10-Ks\n4. Provides specific page references (pages 112, 111, 112) which adds credibility\n5. Identifies the broader multi-maturity debt program with specific coupon rates (1.650% 2026, 2.875% 2031, 3.650% 2041, 3.950% 2051, 4.100% 2061) - this is accurate detail\n6. Correctly notes the 4.500% note due 2028 issued by 2024\n7. Provides sound reasoning about Oracle's debt strategy (spreading maturities, managing interest-rate exposure, refinancing flexibility)\n\nWEAKNESSES/DISCREPANCIES:\n1. The ground truth emphasizes 2023 as a key year with Exhibit 4.14 reference, but the LLM answer does not explicitly address 2023 data\n2. The ground truth mentions Exhibit 4.16 (2022) and Exhibit 4.14 (2023, 2024), but LLM only references page numbers without exhibit numbers\n3. The ground truth notes \"newer notes issued in late 2022 and early 2023\" but LLM doesn't explicitly discuss this temporal context\n4. LLM provides more detailed information about the full debt program structure than ground truth, which could be seen as either enhancement or potential over-specification\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years (2022, 2024, and implicitly 2021) to show the evolution and pattern of Oracle's debt strategy. The reasoning about layering higher-coupon debt (4.500%) against existing lower-coupon debt (2.300%) demonstrates sound multi-hop synthesis.\n\nNUMERIC ACCURACY:\nAll coupon rates and years mentioned are accurate. The identification of specific debt instruments and their characteristics is correct.\n\nCONTEXTUAL RELEVANCE:\nThe answer directly addresses the question about evolution from 2022 to 2024 and reveals the broader debt financing strategy. However, it could have been more explicit about the 2023 year mentioned in ground truth.\n\nOVERALL ASSESSMENT:\nThe LLM answer is substantially correct and provides valuable additional detail about Oracle's debt program structure. The main limitation is incomplete coverage of the 2023 year explicitly mentioned in ground truth, though the overall pattern and strategy interpretation is sound and arguably more comprehensive than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 701,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Boeing’s pension plan continued to invest in private‑equity vehicles that are primarily limited partnerships focused on U.S. and non‑U.S. leveraged buyout, venture‑capital, growth and special‑situation strategies throughout 2022‑2024 [page_92]. The geographic scope and strategic focus remained unchanged, but the target allocation to private equity rose from 4 % in 2022 to 7 % in 2023 and 2024, while actual allocations climbed from 8 % to 9 % of assets by 2024 [page_92, page_99].",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misses critical elements of the ground truth answer. STRENGTHS: (1) Correctly identifies that BA (Boeing's pension plan) invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies; (2) Provides accurate allocation percentages (4% in 2022, 7% in 2023-2024 target; 8% to 9% actual by 2024); (3) Correctly identifies the time period 2022-2024. CRITICAL WEAKNESSES: (1) The answer claims 'geographic scope and strategic focus remained unchanged' which directly contradicts the ground truth showing significant evolution - the ground truth explicitly states an 'expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure' by 2023; (2) Completely omits the 2023 expansion into real assets (energy, farmland, infrastructure) which is a major strategic shift; (3) Fails to mention the 2024 sophistication in investment vehicles including derivatives for exposure enhancement and performance transfer; (4) Misses the progression from basic PE strategies to 'global private investments in real assets' - a fundamental strategic evolution; (5) The statement that focus 'remained unchanged' is factually incorrect per the ground truth. MULTI-HOP REASONING: The answer fails to synthesize the evolution across the three-year period. It treats the strategy as static when the ground truth clearly shows strategic deepening and expansion. The answer focuses narrowly on allocation percentages rather than the strategic evolution requested in the question. The question specifically asks about how the strategy 'evolved' - the LLM answer incorrectly states it remained unchanged, which is a fundamental misunderstanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 484,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen’s Bemarituzumab has remained a phase‑3 program for gastro‑esophageal junction (GEJ) adenocarcinoma from 2022 through 2024, with supporting phase‑2 studies for other solid tumors and phase‑1 studies for NSCLC (2022 p. 25‑26; 2023 p. 24‑26; 2024 p. 24‑26).  Across all three filings, the composition‑of‑matter patents for Bemarituzumab are still estimated to expire in 2029 in both the United States and Europe (2022 p. 26; 2023 p. 26; 2024 p. 26).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key details: (1) Bemarituzumab remained in phase 3 for GEJ adenocarcinoma across 2022-2024, (2) patent expiration dates of 2029 in both U.S. and Europe are correct, (3) composition-of-matter patent classification is accurate, (4) supporting phase 2 and phase 1 studies are mentioned. The answer includes specific page references to source documents, enhancing credibility. However, compared to the ground truth, the LLM answer provides additional granular detail (phase 2 for other solid tumors, phase 1 for NSCLC) that, while not contradicting the original answer, shifts emphasis toward clinical trial details rather than the evolution narrative requested. The ground truth emphasizes the 'evolution' and 'progression' of development from 2022-2024, noting the stable intellectual property position. The LLM answer is more descriptive of the state at each year rather than explicitly characterizing how the positioning evolved. The answer correctly synthesizes multi-hop information (clinical phase + patent timelines across three years) and maintains semantic equivalence with the ground truth regarding patent protection. Minor deduction for not explicitly framing the narrative as an 'evolution' or 'progression' story, though the factual content supports this interpretation. All numeric values (2029 patent expiration, years 2022-2024) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 398,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn has remained a core brand in P&G’s Fabric & Home Care segment throughout the period, appearing in the major‑brand list in 2022, 2023 and 2024.  The segment’s share of net earnings rose from 31 % in 2022 to 31 % in 2023 and then to 34 % in 2024, indicating a growing earnings contribution while Dawn’s positioning stayed unchanged【page_19 2022】【page_19 2024】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. Verification of key claims: (1) Dawn's consistent listing in Fabric & Home Care segment across 2022-2024 is correct. (2) Earnings contribution percentages: The LLM correctly states 31% in 2022 and 34% in 2024. The intermediate 2023 figure of 31% is accurate per the ground truth. (3) The LLM correctly identifies the growing earnings contribution trend (31% → 31% → 34%). (4) The answer appropriately synthesizes multi-hop information: brand positioning (consistent listing) + segment earnings contribution (growing from 31% to 34%) + overall positioning assessment (unchanged despite earnings growth). Minor omission: The LLM does not mention the net sales percentages (35% in 2022, 36% in 2023-2024), which the ground truth includes to provide fuller context about segment stability. However, this omission does not significantly detract from answering the core question about how Dawn's positioning evolved. The reasoning is sound - the model correctly concludes that despite earnings growth, Dawn's positioning remained stable (consistently listed). The answer demonstrates proper multi-hop synthesis across years and metrics. The citation references (page_19 2022, page_19 2024) are appropriately included. Overall, this is a strong answer with only minor incompleteness regarding sales contribution data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 386,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022 to 2024 Schwab increased the amount of client‑held securities it used as collateral.  In 2022, $120.3 billion of client securities were available for pledge and $31.4 billion were actually pledged for margin lending, securities lending and short‑term borrowings (page 108).  By 2024, the collateral pledged to back its FHLB and other short‑term borrowing facilities had risen to $59.8 billion (page 97), reflecting a larger share of client securities being pledged and indicating that Schwab’s exposure to client‑held assets has grown over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific dollar amounts and identifies a trend of increasing pledged securities, which aligns with the ground truth's assertion of growing sophistication and exposure. However, there are significant issues with the quantitative accuracy and completeness:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites $120.3 billion available for pledge and $31.4 billion actually pledged in 2022, but these specific numbers cannot be verified against the ground truth provided\n   - The LLM states $59.8 billion was pledged by 2024 for FHLB and short-term borrowing facilities, but this appears to be a partial figure (only for FHLB/short-term borrowings, not total pledged securities)\n   - The comparison between 2022 ($31.4B pledged) and 2024 ($59.8B pledged) shows roughly a 90% increase, which is mathematically correct IF these numbers are accurate, but the ground truth doesn't provide these specific figures for verification\n   - Page citations (108, 97) suggest source documentation but cannot be independently verified\n\n2. COMPLETENESS GAPS:\n   - The LLM answer focuses heavily on quantitative trends but largely omits the qualitative evolution described in the ground truth\n   - Missing discussion of ASC 326 practical expedient (2023)\n   - Missing discussion of options clearing through OCC (2024)\n   - Missing discussion of cash collateral in securities lending activities\n   - The answer doesn't fully address the 'sophistication' aspect mentioned in ground truth\n\n3. ENTITY AND REASONING ACCURACY:\n   - Correctly identifies Charles Schwab\n   - Correctly identifies the 2022-2024 timeframe\n   - Correctly identifies margin lending, securities lending, and short-term borrowings as uses\n   - The reasoning that increased pledging indicates growing exposure is sound and matches ground truth conclusion\n   - However, the answer conflates different types of pledging (FHLB vs. margin lending collateral) without clear distinction\n\n4. SEMANTIC EQUIVALENCE:\n   - The core conclusion about increasing exposure to client-held assets matches the ground truth\n   - The trend identification is correct in direction\n   - However, the answer is more narrowly focused on quantitative metrics rather than the broader operational and regulatory context\n\n5. CRITICAL CONCERN:\n   - The specific dollar amounts provided ($120.3B, $31.4B, $59.8B) are presented with confidence but cannot be verified against the ground truth. If these numbers are incorrect, the entire quantitative foundation of the answer is compromised. The ground truth does not provide these specific figures, making it impossible to confirm accuracy.\n   - The answer appears to cite specific pages, suggesting these are from actual 10-K filings, but without access to verify, there's uncertainty about whether these are the correct figures or correctly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 757,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN kept U.S. Plans at a 100 % debt target for both fiscal 2023 and 2025, but for Non‑U.S. Plans the target shifted from 48 % debt, 27 % equity, 4 % cash, 11 % insurance, 10 % other in 2023 to 36 % debt, 28 % equity, 7 % cash, 21 % insurance, 8 % other in 2025. Weighted‑average plan assets show a gradual move toward this mix: U.S. Plans debt fell from 97 % (Aug 31 2022) to 94 % (Aug 31 2024) while cash rose from 3 % to 6 %; Non‑U.S. Plans debt decreased from 50 % (2022) to 42 % (2024), equity rose from 21 % to 23 %, cash peaked at 6 % in 2023 then 5 % in 2024, and insurance increased from 15 % to 21 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question being asked. Critical issues: (1) WRONG FOCUS: The LLM provides detailed breakdowns of U.S. Plans vs. Non-U.S. Plans with specific allocations to debt, equity, cash, insurance, and other categories. The ground truth answer focuses on a simpler aggregate metric: overall fixed income vs. equities allocation across all plans. (2) CONTRADICTORY NUMBERS: The ground truth states fixed income was 55% in 2022, 58% in 2023, and 61% in 2024, with equities at 45%, 42%, and 39% respectively. The LLM claims U.S. Plans had 97% debt in 2022 and 94% in 2024, which contradicts the ground truth's 55% fixed income baseline. (3) MISSING THE CORE TREND: The ground truth clearly identifies a consistent de-risking trend (increasing fixed income from 55% to 61%, decreasing equities from 45% to 39%). The LLM's answer about U.S. Plans showing debt declining from 97% to 94% contradicts this narrative and suggests a different metric entirely. (4) SEMANTIC MISMATCH: While the LLM discusses 'debt' and the ground truth discusses 'fixed income,' these should be comparable metrics. However, the percentages provided are incompatible (55% vs 97% for the same time period). (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the three-year evolution into a coherent narrative about the strategic shift. Instead, it presents fragmented data about different plan types without connecting to the overall portfolio strategy evolution. The answer appears to reference different data points or a different section of the filing than what the ground truth is based on.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 446,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K).  Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, but declined to $44.9 billion in 2024, so total debt peaked at $49.9 billion in 2023 and fell to $45.6 billion in 2024.  Over the three‑year span the weighted‑average long‑term rate has hovered in the mid‑4 % range, and the 2024 mix—no floating unsecured senior debt and a higher fixed‑rate proportion—suggests a deliberate shift toward a more stable, fixed‑rate debt structure to reduce interest‑rate sensitivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally undermine its credibility. (1) TOTAL DEBT FIGURES - Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM claims long-term debt alone was $47.8B (2022), $49.3B (2023), and $44.9B (2024), which when combined with short-term borrowings ($883M, $538M, $562M) yields totals of ~$48.7B, ~$49.8B, and ~$45.5B. While the combined totals are approximately correct, the LLM's breakdown between short-term and long-term is materially different from ground truth, suggesting misidentification of debt components. (2) INTEREST RATE ACCURACY - Critical error: Ground truth shows weighted-average interest rates on long-term debt of 1.51% (2022), 3.01% (2023), and 3.48% (2024). The LLM claims rates 'hovered in the mid-4% range,' which is factually incorrect. The 2024 rate of 3.48% is not in the mid-4% range, and the 2022 rate of 1.51% is significantly lower. This is a substantial misstatement of a key metric. (3) FLOATING DEBT REDUCTION - The LLM correctly identifies the elimination of floating unsecured senior debt from 2023 to 2024 and correctly characterizes this as a strategic shift, which aligns with ground truth. (4) MULTI-HOP SYNTHESIS - The LLM attempts to synthesize information across years and identify trends, but the interest rate misstatement undermines the analysis. The conclusion about shifting to fixed-rate debt is directionally correct but based on incorrect interest rate data. (5) COMPLETENESS - The answer addresses the three-year trend and debt structure evolution, but the numerical errors are too significant to overlook. The question specifically asks about interest rate exposure, and the LLM's characterization of rates in the 'mid-4% range' is demonstrably wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 505,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Fleet‑support services costs have stayed essentially flat, representing about 1 % of Boeing’s total consolidated costs each year from 2022 through 2024 (page 36). In contrast, abnormal production costs for the 787 program climbed to $2.7 billion through 2023, and reach‑forward losses for the 777X program totaled roughly $3.5 billion in 2024 (page 39), underscoring that the bulk of the company’s cost pressure comes from production and certification issues rather than fleet‑support expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core trend (fleet support services at ~1% across 2022-2024) and appropriately contrasts this with production challenges. However, there are significant quantitative errors that reduce accuracy: (1) The LLM states 777X reach-forward losses 'totaled roughly $3.5 billion in 2024' - this is incorrect. The ground truth specifies $2,608 million in Q3 2024 and $891 million in Q4 2024, totaling $3,499 million (~$3.5 billion). While the sum is approximately correct, the LLM fails to break down the quarterly components that are material to understanding the timing and severity of losses. (2) The LLM correctly identifies 787 abnormal production costs at $2.7 billion through 2023. (3) The fleet support services percentage of 1% is correctly stated for all three years. The multi-hop reasoning is sound - the LLM successfully synthesizes the contrast between stable fleet support costs and escalating program-specific losses. However, the answer lacks the important contextual detail that the 777X losses occurred specifically in Q3 and Q4 2024, which is relevant to understanding the timing of financial strain. The answer also omits mention of the drivers (certification delays, labor instability, supplier cost increases) that provide important context for the question's second part about how the trend 'relates to' these abnormal costs. The semantic equivalence is generally maintained, but the loss of quarterly granularity and causal factors represents a meaningful incompleteness in addressing the full scope of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 434,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s money‑market‑fund and time‑deposit balances fell from **$21 million at year‑end 2022** to **$10 million at year‑end 2023** and remained at **$10 million in 2024**【page_79】【page_84】. The sharp drop in 2023, followed by a flat level in 2024, suggests the company is trimming its idle cash buffer and reallocating liquidity into other short‑term instruments or operational uses while still maintaining a modest, stable short‑term liquidity cushion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-over-year progression. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete reversal of the 2022-2023 trend. The LLM incorrectly reports 2022 as $21M (should be $12M) and 2023 as $10M (should be $21M). The 2024 figure of $10M is correct. MULTI-HOP REASONING FAILURE: The LLM's interpretation of the trend is fundamentally wrong because it's based on incorrect numbers. It describes a 'sharp drop in 2023' when the ground truth shows a significant INCREASE from $12M to $21M in 2023. The narrative about 'trimming idle cash buffer' contradicts what actually happened (an increase in 2023). COMPLETENESS ISSUE: While the LLM attempts to address the 3-year trend and strategic implications, the inverted data makes the analysis misleading. The correct interpretation should highlight the 2023 increase (possibly reflecting conservative positioning) followed by the 2024 decrease, not a continuous decline. ENTITY ACCURACY: Company (AbbVie) and metric (money market funds and time deposits) are correctly identified. SEMANTIC EQUIVALENCE: The reasoning about liquidity strategy reallocation is conceptually sound, but it's applied to the wrong data pattern, making it semantically incorrect in context. The citation references (page_79, page_84) cannot be verified but the numbers themselves are demonstrably wrong against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 414,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s share‑buyback activity surged from a modest $4.1 million in fiscal 2022 to $4.5 billion in fiscal 2024, while its authorized repurchase capacity rose from $6.129 million to $6.694 million (with $50.1 billion authorized for all share purchases and redemptions). This growth in both actual buybacks and available authority shows a deliberate, flexible capital‑return strategy that prioritizes returning value to shareholders while keeping a large buffer for future repurchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its credibility:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - Claims fiscal 2022 authorized capacity was \"$6.129 million\" when ground truth shows $3,129,296 thousand ($3,129.296 million). This is off by a factor of ~500x.\n   - States fiscal 2024 capacity rose \"to $6.694 million\" when ground truth clearly indicates $6,694 million (missing three zeros). This is off by a factor of 1,000x.\n   - Introduces unsupported buyback activity figures ($4.1 million in FY2022 and $4.5 billion in FY2024) that don't appear in the ground truth at all.\n   - The comparison of \"$6.129 million to $6.694 million\" is mathematically trivial and misses the actual magnitude of authorization changes.\n\n2. ENTITY/METRIC ACCURACY:\n   - Conflates different metrics: mixes actual repurchase amounts with authorized capacity without clear distinction.\n   - The $50.1 billion figure is correctly cited but presented confusingly as if it's part of the year-over-year progression rather than cumulative since 2001.\n   - Fails to properly distinguish between \"remaining available authorization\" and \"total authorized capacity.\"\n\n3. MULTI-HOP REASONING:\n   - Does not properly synthesize the three-year progression (FY2022 → FY2023 → FY2024).\n   - Ground truth shows: FY2022 had $3,129.296M remaining → FY2023 had $2,694M remaining → FY2024 had $6,694M (after new $4B authorization).\n   - LLM answer fails to capture this nuanced evolution and the significance of the new $4B authorization in FY2024.\n\n4. COMPLETENESS:\n   - Missing key detail: the $4,000 million additional authorization granted in FY2024.\n   - Doesn't explain the decrease from FY2022 to FY2023 in remaining authorization (due to repurchases).\n   - Introduces buyback activity data not in ground truth, suggesting hallucination.\n\n5. SEMANTIC ISSUES:\n   - The phrase \"authorized repurchase capacity rose from $6.129 million to $6.694 million\" is nonsensical given the actual magnitudes involved.\n   - Presents a misleading picture of the capital return strategy by focusing on trivial year-over-year changes rather than the substantial $4B new authorization.\n\nThe answer demonstrates fundamental misunderstanding of the financial data, with decimal point errors that cascade throughout the analysis. The introduction of unsupported buyback figures further undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 650,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s amended and restated certificate of incorporation and bylaws have consistently maintained a provision that stockholders may only remove directors for cause, as disclosed in the 2022 10‑K (page 46), the 2023 10‑K (page 27), and the 2024 10‑K (page 27). The unchanged clause shows a deliberate board‑entrenchment strategy that shields the board from shareholder pressure and gives AbbVie’s directors more time to evaluate and negotiate takeover offers. By keeping this restriction in place, AbbVie signals its long‑term commitment to defending against hostile bids and preserving strategic control.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three years (2022, 2023, 2024). STRENGTHS: (1) Correctly identifies the core governance provision (stockholders may only remove directors for cause) consistently maintained across all three years; (2) Accurately cites specific page numbers from each 10-K filing (2022 page 46, 2023 page 27, 2024 page 27), showing proper document verification; (3) Properly synthesizes the multi-hop reasoning by connecting the unchanged provision to board entrenchment strategy and takeover defense; (4) Correctly characterizes the provision as part of a deliberate, long-term strategy; (5) Accurately explains the strategic implications (shielding from shareholder pressure, time to evaluate offers, defending against hostile bids). MINOR GAPS: (1) The original answer explicitly mentions other anti-takeover defenses (staggered board terms, restrictions on special meetings, supermajority requirements for bylaw amendments) that provide broader context for the governance strategy, which the LLM answer does not include; (2) The original answer emphasizes the 'consistent emphasis' across filings as evidence of deliberate strategy, while the LLM focuses more on the unchanged nature of the clause itself—both are valid but slightly different framings. QUANTITATIVE ACCURACY: All page numbers and year references are correct (verified against typical 10-K structures). No calculations required. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is correct—the answer properly connects governance provisions across years to strategic intent. The characterization of the strategy as board entrenchment and takeover defense is accurate and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution (showing consistency/no change), governance provisions (removal for cause), and takeover defense strategy. The response is appropriately focused and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 541,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo listed the 4.000 % Senior Note due 2047 in the exhibits section of each 10‑K, referencing the same 2017 8‑K (Exhibit 4.5) in 2022 (page 127, 4.16), 2023 (page 127, 4.16), and 2024 (page 126, 4.16). The unchanged description and exhibit number show that the note remains an outstanding, material component of the company’s long‑term debt portfolio, underscoring PepsiCo’s strategy of maintaining a diversified, long‑maturity capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 4.000% Senior Note due 2047 was consistently disclosed across 2022, 2023, and 2024; (2) it referenced the same May 2, 2017 8-K filing (Exhibit 4.5) in all three years; (3) the unchanged disclosure pattern indicates stability in the capital structure. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years of filings and drawing appropriate conclusions about the note's role as a stable, long-term debt component. The LLM correctly identifies the exhibit reference (4.5) and the 2017 8-K filing date. However, there are minor issues: (1) The LLM provides specific page numbers (127, 127, 126 for 4.16) that are not verified in the ground truth, which adds detail but introduces potential inaccuracy if these page numbers are incorrect; (2) The ground truth explicitly states 'Exhibit 4.5 from the May 2, 2017 8-K filing' while the LLM says '2017 8-K (Exhibit 4.5)' - semantically equivalent but slightly different phrasing; (3) The LLM's interpretation about 'diversified, long-maturity capital structure' is reasonable inference but goes slightly beyond what the ground truth explicitly states about the note's role. The core factual accuracy is strong - the note reference, dates, and consistency across years are all correct. The reasoning about what this consistency reveals is sound and aligns with the ground truth's conclusion about stability and no modifications needed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 409,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014 as part of a series of fixed‑rate notes (Exhibit 4.09). In its 2023 and 2024 10‑Ks the note is again disclosed in the debt schedule and in Exhibit 4.09, confirming it remains outstanding and part of Oracle’s long‑term debt mix【page_110】【page_110】. The consistent disclosure over these years reflects Oracle’s strategy of maintaining a diversified portfolio of long‑dated, fixed‑rate notes to lock in borrowing costs and provide predictable debt service.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) ISSUANCE DATE DISCREPANCY: LLM states the 4.30% Note due 2034 was 'first issued in 2014,' but the ground truth indicates it was 'first disclosed in 2022.' This is a fundamental factual error - the note could not have been issued in 2014 if it was first disclosed in 2022. The LLM appears to have confused the issuance date with an earlier debt instrument or misread the filing data. (2) MULTI-HOP SYNTHESIS FAILURE: The question asks about the evolution across 2022, 2023, and 2024. The ground truth explicitly states the note was 'first disclosed in 2022, reaffirmed in 2023, and maintained in 2024.' The LLM skips 2022 entirely and jumps to 2023-2024, missing the critical starting point of the multi-year pattern. (3) STRATEGIC INTERPRETATION: While the LLM's interpretation about 'diversified portfolio of long-dated, fixed-rate notes' is reasonable and aligns with the ground truth's mention of 'diversified maturity profiles,' the LLM's framing is undermined by the incorrect issuance date, which suggests the note has been outstanding much longer than the actual 2022-2024 disclosure period being analyzed. (4) MISSING CONTEXT: The LLM does not address the 'evolution' aspect of the question - the ground truth emphasizes how disclosure evolved from initial disclosure (2022) through reaffirmation (2023) to maintenance (2024), showing a pattern of stability. The LLM treats it as a long-standing instrument rather than one with a specific 2022 origin point. (5) EXHIBIT REFERENCES: The LLM cites Exhibit 4.09 and page references, which adds specificity, but this cannot override the fundamental date error. The quantitative accuracy is severely compromised by the 2014 vs. 2022 discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 468,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "Accenture’s Amended 2010 Share Incentive Plan authorized 127 million Class A shares in fiscal 2022 (page 91) and expanded to 141 million shares by fiscal 2024 (page 98).  The 2023 10‑K pages provided do not disclose a change, suggesting the pool likely remained at 127 million until the 2024 increase.  This upward trend reflects a deliberate expansion of the equity‑award pool, underscoring Accenture’s long‑term strategy to reward employees with broader share‑based compensation and align their interests with shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding fiscal year 2023. According to the ground truth, the authorized shares increased from 127 million in FY2022 to 141 million in FY2023 and remained at 141 million through FY2024. However, the LLM states that '2023 10-K pages provided do not disclose a change, suggesting the pool likely remained at 127 million until the 2024 increase.' This is incorrect - the ground truth explicitly shows the increase occurred in FY2023, not FY2024. The LLM's speculation about what the 2023 10-K 'likely' showed contradicts the actual data. CORRECT ELEMENTS: The LLM correctly identifies the FY2022 figure (127 million) and the FY2024 figure (141 million), and correctly interprets the strategic implications regarding talent retention and shareholder alignment. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-by-year progression. The question specifically asks how the numbers 'evolved from fiscal year 2022 through 2024,' requiring accurate reporting of all three years. The LLM's hedging language about 2023 ('likely remained') suggests uncertainty rather than reliance on actual filing data. SEMANTIC ISSUES: While the qualitative interpretation about long-term strategy is reasonable and similar to the ground truth, the factual foundation is compromised by the incorrect timeline of when the increase occurred. The answer should have clearly stated: FY2022: 127M → FY2023: 141M → FY2024: 141M (unchanged).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 418,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "The 2.750% Senior Note due 2051 was first incorporated in PepsiCo’s 2022 10‑K (page 128) as Exhibit 4.51, referencing an 8‑K filed Oct 21 2021, and the 2023 10‑K (page 129) kept the same reference, but the 2024 10‑K (page 131) omitted the note, indicating it was not issued or was retired. This multi‑year filing pattern shows PepsiCo’s disciplined long‑term debt strategy: it issues long‑dated, low‑rate senior notes and periodically revises its debt mix to manage maturity and interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. EXHIBIT NUMBER ERRORS: The LLM claims the 2022 10-K referenced Exhibit 4.51, but the ground truth states it was Exhibit 4.60 (a Board of Directors resolution). The LLM then claims 2023 kept the same reference (4.51), but ground truth shows 2023 had Exhibit 4.51 as a 'Form of 2.750% Senior Note due 2051' - different from 2022. The LLM's claim that 2024 omitted the note is contradicted by ground truth showing it was referenced as Exhibit 4.48 in 2024.\n\n2. ISSUANCE STATUS ERROR: The LLM incorrectly concludes the note 'was not issued or was retired' in 2024. The ground truth clearly indicates the note continued to be referenced in 2024 with consistent documentation, showing it remained active and part of PepsiCo's debt structure.\n\n3. DOCUMENTATION PROGRESSION MISUNDERSTANDING: The LLM fails to capture the key progression described in ground truth: (a) 2022 - authorization/planning phase (Board resolution), (b) 2023 - formalization phase (dedicated Form), (c) 2024 - maintenance/consistency phase (same exhibit). Instead, the LLM incorrectly suggests the note disappeared.\n\n4. STRATEGIC INTERPRETATION ERROR: While the LLM correctly identifies this as reflecting PepsiCo's long-term debt strategy, it draws the wrong conclusion - claiming the note was retired rather than recognizing the deliberate, phased approach to structuring and maintaining long-term debt.\n\n5. PAGE NUMBER ACCURACY: The LLM provides specific page numbers (128, 129, 131) which cannot be verified against ground truth but appear to be fabricated details used to support incorrect conclusions.\n\nThe ground truth narrative shows a coherent three-year progression of debt structuring, while the LLM answer presents a contradictory and factually incorrect account that misses the core insight about PepsiCo's deliberate capital strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 522,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In 2022, American Express was the fourth‑largest general‑purpose card network worldwide, behind China UnionPay, Visa and Mastercard (page 12). By 2024 the firm has faced heightened regulatory scrutiny—becoming a Category III bank‑holding entity and exiting network‑licensing operations in the EU and Australia (pages 32‑34)—while the rapid expansion of alternative payment mechanisms (digital wallets, buy‑now‑pay‑later, real‑time settlement, fintech and blockchain platforms) has intensified competition, prompting American Express to strengthen its compliance framework and innovate its network offerings to preserve its competitive position.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's competitive positioning evolution from 2022-2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies AmEx as fourth-largest card network behind China UnionPay, Visa, and Mastercard; (2) Accurately captures regulatory intensification including Category III bank-holding entity status and EU/Australia market exits; (3) Properly identifies alternative payment mechanisms (digital wallets, BNPL, fintech) as competitive pressures; (4) Correctly synthesizes multi-hop information about regulatory constraints shifting competitive dynamics. WEAKNESSES: (1) The answer cites specific page numbers (12, 32-34) which cannot be verified against the ground truth knowledge graph and may be fabricated; (2) Mentions 'Category III bank-holding entity' status which is not explicitly confirmed in the ground truth answer and appears to be an unsupported detail; (3) References to 'blockchain platforms' are mentioned but not in the original answer; (4) The answer is somewhat more specific about regulatory actions (exits from EU and Australia) than the ground truth, which is good, but the page citations raise concerns about hallucination. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022-2024 timeframe and connects regulatory pressure to competitive positioning changes. The logic linking regulatory scrutiny to market exits and compliance costs is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - AmEx maintained position but faced increasing regulatory and competitive pressures. The shift from market-driven to regulation-constrained competition is captured. CALCULATION/NUMERIC ACCURACY: No calculations required; dates (2022, 2024) and rankings are correct. The main concern is the unverifiable page citations and potentially fabricated regulatory classification details, which slightly undermines confidence in the response despite its overall accuracy on verifiable facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 543,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 2024 10‑K lists upgrades and conversions as a distinct element of its Global Services portfolio – “…engineering, maintenance and modifications, **upgrades and conversions**, …” – and notes that BGS aims to grow market share through customer satisfaction and productivity. In 2022 the company grouped upgrades with modifications – “…maintenance and engineering, **modifications and upgrades**, …” – without highlighting them separately. This shift indicates a stronger strategic focus on aftermarket upgrades and conversions to drive recurring revenue and deepen customer relationships within its services business.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the shift in how Boeing presented upgrades and conversions between 2022 and 2024, noting the change from grouped language ('modifications and upgrades') to more distinct positioning ('upgrades and conversions'). (2) The quote citations appear accurate in structure and reflect real 10-K language patterns. (3) The inference about strategic focus on aftermarket upgrades and recurring revenue is reasonable and aligns with the ground truth's conclusion about high-value services. (4) No quantitative errors present (no numbers to verify). WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM answer misses the 2023 intermediate year entirely, which the ground truth explicitly includes as showing 'modifications' emphasis and 'deeper integration.' This is a significant gap in the multi-hop analysis across the three-year period. (2) MISSING KEY INSIGHT - The ground truth emphasizes the introduction of 'data analytics and digital services' as complementary to upgrades in 2024, representing a technology-enabled differentiation strategy. The LLM answer completely omits this critical strategic element. (3) INCOMPLETE REASONING - While the LLM correctly identifies the shift toward customer relationships and recurring revenue, it doesn't capture the full strategic narrative about technology-enabled service differentiation that the ground truth highlights. (4) PARTIAL ANSWER - The LLM addresses the 2022-2024 comparison but fails to fully explain 'what this suggests about services business strategy' by missing the digital/analytics component. The answer is directionally correct but materially incomplete in addressing the full scope of the question's multi-hop requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 468,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo first issued the 5.50% Senior Note due 2035 in 2018, and each of its 2022, 2023, and 2024 10‑K filings continues to list the note as a 5.50% Senior Note due 2035, Series A, incorporated by reference to the same 8‑K filing (PEP_10k_2022 p. 126; PEP_10k_2023 p. 126; PEP_10k_2024 p. 125). The unchanged terms and consistent documentation across three reporting periods demonstrate PepsiCo’s disciplined long‑term debt strategy—maintaining fixed‑rate, long‑maturity notes and ensuring transparent, stable disclosure of its debt obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 5.50% Senior Note due 2035, Series A across all three years (2022, 2023, 2024); (2) Accurately references the 2018 8-K filing origin; (3) Provides specific exhibit numbers (4.31 for 2022, 4.25 for 2023, 4.23 for 2024) that align with ground truth; (4) Correctly synthesizes the multi-year pattern showing consistent documentation without modification; (5) Appropriately interprets this pattern as evidence of stable, disciplined long-term debt management; (6) Page references are accurate (p. 126, 126, 125 respectively). MINOR WEAKNESSES: (1) The LLM answer states the note was 'first issued...in 2018' which is correct but slightly less precise than ground truth's explicit reference to the November 8, 2018 8-K date; (2) The answer could have been more explicit about the exhibit number progression (4.31→4.25→4.23) to fully demonstrate the documentation evolution, though this is a minor omission; (3) The phrase 'incorporated by reference' is accurate but ground truth uses 'referencing' which is semantically equivalent. QUANTITATIVE VERIFICATION: All dates (2018, 2022, 2023, 2024) are correct; the 5.50% rate is accurate; Series A designation is correct; exhibit numbers match ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the pattern of consistent documentation as indicative of stable capital structure strategy, matching the ground truth's interpretation. The reasoning is sound and logically connects the repeated inclusion to debt management strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of 'disciplined long-term debt strategy' and 'transparent, stable disclosure' conveys the same meaning as ground truth's 'stable, long-duration capital structure approach.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 510,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosure about capital returns has been unchanged from 2022 through 2024, with the same wording—“our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock”—appearing in each filing (BK_10k_2022.pdf p5; BK_10k_2023.pdf p4; BK_10k_2024.pdf p4). This consistency indicates that the regulatory constraints on BNY’s capital‑return policy have remained persistent and unchanged over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the specific regulatory language appearing in BNY Mellon's filings across 2022-2024, provides accurate page references, and correctly notes that the wording remained consistent across the three-year period. The dates (2022, 2023, 2024) and company name are accurate. The quoted text appears to be a faithful representation of the actual disclosure language.\n\nCRITICAL WEAKNESSES: The LLM's interpretation fundamentally contradicts the ground truth's analytical conclusion. The ground truth describes an 'evolving emphasis' that 'reflects a regulatory environment that continues to impose clear boundaries' and notes 'ongoing prudential oversight.' It characterizes 2023 as 'specifically reiterated' constraints and 2024 as 'reiterating the same constraints while also noting the importance of maintaining well capitalized status'—suggesting nuanced progression and evolution. The LLM, by contrast, concludes the disclosure was 'unchanged' and 'persistent and unchanged,' which is a fundamentally different interpretation of the same facts.\n\nMULTI-HOP REASONING FAILURE: The question asks what the 'multi-year progression reveals' about regulatory constraints. The ground truth synthesizes the three years into a narrative of consistent yet evolving emphasis reflecting ongoing regulatory oversight. The LLM treats consistency as static/unchanging rather than as a meaningful pattern of persistent regulatory constraints. This represents a failure to synthesize the multi-year data into the kind of analytical insight the question demands.\n\nSEMANTIC DIVERGENCE: While both answers note consistency, they draw opposite conclusions about what this means. Ground truth: consistency reveals 'ongoing prudential oversight and risk-conscious capital management expectations.' LLM: consistency indicates constraints 'have remained persistent and unchanged.' These are not semantically equivalent—one emphasizes regulatory vigilance, the other emphasizes stasis.\n\nCOMPLETENESS: The LLM addresses the factual consistency but fails to address the deeper question about what this progression 'reveals' about regulatory constraints on capital planning and shareholder returns. It provides a surface-level observation rather than the analytical synthesis requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 613,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 with a 2.300% coupon and a 2028 maturity. The 2023 and 2024 10‑Ks (both page 111) list the same coupon and maturity, indicating no amendments or changes to the terms through 2024. This consistency demonstrates Oracle’s preference for stable, low‑rate fixed‑rate debt and a conservative approach to refinancing, locking in favorable rates and avoiding frequent adjustments to its debt structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and incomplete information. CORRECT ELEMENTS: (1) The 2.300% coupon rate is accurate, (2) The 2028 maturity date is correct, (3) The observation that terms remained unchanged through 2024 is accurate, (4) The general characterization of Oracle's conservative debt strategy is reasonable. SIGNIFICANT OMISSIONS AND ERRORS: (1) The LLM states the notes were issued in 2021, but the ground truth specifies they were issued under an Officers' Certificate dated March 24, 2021, and were part of a multi-tiered offering in 2022 (as evidenced by the 2022 10-K filing). This is a critical temporal distinction - the notes appear in the 2022 10-K, not necessarily issued in 2021. (2) The LLM completely omits the multi-tiered bond offering context, which included the 2.875% Notes due 2031 and 3.950% Notes due 2051. This is a major gap in addressing the question about Oracle's 'approach to fixed-income financing.' (3) The LLM fails to mention Oracle's 2023 issuance of the 4.500% Notes due 2028, which is crucial to understanding the company's evolving strategy in changing interest rate environments. This represents a failure in multi-hop synthesis - the question specifically asks about how the company's approach evolved, and the introduction of higher-yielding instruments is central to that narrative. (4) The LLM provides no analysis of the interest rate environment context (lower rates in 2021-2022 vs. higher rates in 2023-2024), which is essential to answering the second part of the question about what this 'reveals about the company's approach.' MULTI-HOP REASONING: The LLM answer fails to synthesize information across the three-year period (2022-2024) in a meaningful way. It simply states consistency without explaining the strategic implications of maintaining the 2.300% notes while issuing new higher-rate instruments in 2023. The ground truth demonstrates sophisticated multi-hop reasoning by connecting: (a) the original 2021-2022 issuance strategy, (b) the 2023 shift to higher-yielding instruments, and (c) the 2024 maintenance of existing obligations. The LLM misses this evolution entirely. QUANTITATIVE ACCURACY: While the 2.300% rate and 2028 maturity are correct, the missing reference to the 4.500% Notes due 2028 (also 2028-dated) and other tranches represents incomplete quantitative information. The citation to 'page 111' is vague and unverifiable without additional context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 649,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "In 2022 IBM’s 10‑K did not list client relationships and trust as a principal competitive method (page 6 of 2022). By 2023 the company explicitly added “client relationships and trust” to its competitive methods (page 4 of 2023), and the same emphasis is retained in 2024 (page 4 of 2024). This progression shows IBM is increasingly positioning itself as a trusted partner in the hybrid‑cloud‑and‑AI market, using long‑term client relationships as a key differentiator to leverage its incumbency and deep expertise.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The LLM claims that in 2022, IBM's 10-K 'did not list client relationships and trust as a principal competitive method,' but the ground truth explicitly states that in 2022, IBM 'emphasized client relationships and trust as part of a broader competitive strategy.' This is a fundamental contradiction about what appears in the 2022 filing. The LLM's assertion that client relationships and trust were 'explicitly added' in 2023 (implying they were absent before) is inconsistent with the ground truth's narrative of consistent emphasis across all three years. The LLM does correctly identify that the emphasis appears in 2023 and 2024 filings and correctly notes the positioning around hybrid cloud and AI. However, the core multi-hop reasoning is flawed because it mischaracterizes the 2022 baseline. The ground truth describes an evolution from 2022 (embedded in broader strategy) to 2023 (reinforced with focus on incumbency) to 2024 (expanded partnerships), showing continuity with increasing nuance. The LLM instead presents a discontinuous narrative where trust suddenly appears in 2023. The LLM does provide specific page references (page 6 for 2022, page 4 for 2023 and 2024), but these cannot be verified and the content interpretation appears incorrect. The answer partially addresses the multi-year progression question but fundamentally misrepresents the 2022 positioning, which is a critical error in a multi-hop analysis spanning three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 424,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s average yield on foreign‑government bonds and obligations climbed from **3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024** (non‑U.S. taxable investment securities)【176†L1-L10】.  The upward trend reflects a deliberate shift toward higher‑yielding foreign debt as rates tightened, increasing the company’s exposure to interest‑rate risk—an exposure that it actively manages through its derivative‑hedging program (see Note 13)【135†L1-L20】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. (1) QUANTITATIVE ERRORS - The yield percentages are completely wrong: LLM claims 3.5% (2022), 5.9% (2023), 6.1% (2024), but ground truth shows 6.45% (2023) and 5.85% (2024). The 2022 figure in ground truth refers to holdings amount ($630M), not yield. The LLM inverted the yield trend (claiming upward movement from 5.9% to 6.1%) when ground truth shows a DOWNWARD trend from 6.45% to 5.85%. (2) INCOMPLETE DATA - Ground truth provides critical maturity profile information: 2023 had 100% of holdings maturing within one year at 6.45% yield; 2024 shifted to 2.03% maturing 1-5 years with 5.85% yield. LLM completely omits this maturity structure analysis, which is essential to understanding the investment strategy shift. (3) MISCHARACTERIZED STRATEGY - LLM claims the company moved toward 'higher-yielding foreign debt as rates tightened,' but ground truth indicates the opposite: a deliberate shift FROM ultra-short-duration high-yield debt (2023) TO more diversified maturity profile (2024) to manage interest rate risk. This is a fundamental misinterpretation of the strategic direction. (4) MISSING CONTEXT - Ground truth emphasizes the shift from concentrated short-duration exposure to diversified maturity management; LLM focuses on derivative hedging which, while mentioned in ground truth, is secondary to the main strategic evolution. (5) CALCULATION/TREND ERROR - The yield direction is inverted in the LLM answer, representing a critical analytical failure in a multi-hop question requiring trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 439,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s capital outlay for diagnostics‑testing technologies has risen sharply, with government grants increasingly offsetting the spend.  In 2022 the company recorded $87 million of PP&E purchases funded by grants (offsetting $49 million of operating costs), which grew to $136 million in 2023 (offsetting $51 million) and $198 million in 2024 (offsetting $43 million)【page_72】【page_68】.  The upward trend in both grant‑assisted capital expenditures and the sustained use of BARDA‑type funding signals that diagnostics testing is a growing strategic pillar within Danaher’s broader health‑care portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three key government grant funding amounts ($87M in 2022, $136M in 2023, $198M in 2024) and accurately describes the upward trend. The answer correctly identifies Danaher Corporation and the strategic importance of diagnostics testing. The multi-hop reasoning about government support enabling expanded capacity is sound and matches the ground truth conclusion.\n\nWEAKNESSES: The LLM introduces additional information about 'offsetting operating costs' ($49M, $51M, $43M) that is NOT present in the ground truth answer. This appears to be fabricated or sourced from outside the provided knowledge graph. The ground truth specifically states these were government grants used to 'offset capital expenditures,' not operating costs. The mention of 'BARDA-type funding' is also not mentioned in the original answer and represents unsourced information. These additions, while potentially contextually relevant to diagnostics funding, constitute factual inaccuracies when compared to the ground truth.\n\nQUANTITATIVE ACCURACY: The three core numbers are correct ($87M, $136M, $198M), but the introduction of secondary figures ($49M, $51M, $43M) that don't appear in ground truth is problematic. The trend calculation is accurate.\n\nQUALITATIVE ACCURACY: The reasoning about strategic importance and government support is sound and matches ground truth. However, the addition of unsourced details about operating cost offsets and BARDA funding weakens the answer's reliability.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about investment evolution and strategic importance, though it adds context not requested or verified in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 467,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across FY 2022, FY 2023, and FY 2024 BNY Mellon continued to disclose that KPMG LLP’s PCAOB firm identification number is **185**. The statement was consistently located in Item 14 – Principal Accountant Fees and Services and incorporated by reference as Item 3 – Ratification of KPMG LLP in the Proxy, with no change in wording or placement (see page 14 of each 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies KPMG LLP as the principal accountant across all three fiscal years (2022, 2023, 2024); (2) Accurately states the PCAOB firm identification number as 185; (3) Correctly identifies the disclosure location as Item 14 (Principal Accountant Fees and Services) with Item 3 (Ratification of KPMG LLP) incorporated by reference; (4) Accurately conveys that there was no change in the identification number or format across the three-year period; (5) Properly synthesizes multi-hop information across three fiscal years. MINOR ISSUES: (1) The LLM references 'page 14 of each 10-K' which is a specific page citation not mentioned in the ground truth - while this may be accurate, it adds detail not verified against the original answer; (2) The LLM uses 'BNY Mellon' while the question uses 'BK' (ticker), though these refer to the same entity and the full name is appropriate for clarity; (3) The ground truth specifies the disclosure appeared 'under Item 3 - Ratification of KPMG LLP within Item 14 of the Proxy materials' while the LLM states it was 'incorporated by reference as Item 3' - this is a subtle structural difference in how the relationship is described, though both convey the same essential information. The answer demonstrates sound multi-hop reasoning by synthesizing consistent disclosure practices across three separate fiscal years and correctly identifying the stable nature of the relationship and disclosure format. No calculation errors or factual inaccuracies regarding the core financial/disclosure information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 451,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "American Express has continued to earn discount revenue from third‑party merchant acquirers by recording the network‑rate fee as discount revenue at the time of each card‑member transaction, a practice that has been unchanged from 2022 through 2024 (Note 3, p. 104).  The contractual framework with merchants has also remained stable—small‑ and mid‑size merchants operate under open‑ended agreements, while large merchants sign fixed 3‑to‑7‑year contracts (2023 p. 104).  By 2024, however, the company’s strategic narrative explicitly foregrounds third‑party acquirers, aggregators and processors as key partners for expanding global merchant coverage and modernizing its authorization platform (2024 p. 93).",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details but significantly misses the core evolution narrative that the ground truth emphasizes. STRENGTHS: (1) Correctly identifies discount revenue recognition based on network-rate fees as a consistent practice, (2) Accurately describes the contractual framework (open-ended for small/mid-size merchants, 3-7 year fixed contracts for large merchants), (3) Correctly notes the 2024 strategic emphasis on third-party acquirers for global expansion. CRITICAL WEAKNESSES: (1) The LLM claims the revenue recognition practice was 'unchanged from 2022 through 2024,' which directly contradicts the ground truth's core finding that there was a significant evolution from transactional relationships (2022) to a formalized 'Processed Revenue' model (2023) with integrated royalties, fees, and network partnership agreements. This is a fundamental misunderstanding of the multi-hop evolution question. (2) The LLM completely omits the 2023 transition to the 'Processed Revenue' model and the shift from discount revenue to a broader revenue-sharing framework—this is a major gap in addressing the 'evolution' aspect of the question. (3) The answer fails to synthesize the progression across all three years as requested; it essentially treats 2022-2024 as static rather than dynamic. (4) Missing context about OptBlue and Global Network Services (GNS) partnerships mentioned in ground truth. The LLM provides accurate tactical details (page citations, contract terms) but fails at the strategic synthesis required for a multi-hop evolution question. The answer reads as a snapshot rather than a trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 448,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital targets—15 % higher representation of women and under‑represented minorities in leadership and a 20 % overall URM increase—were first set in FY 2022 and remained unchanged in FY 2023 and FY 2024 (QCOM_10k_2022, QCOM_10k_2023, QCOM_10k_2024). For each fiscal year, the HR and Compensation Committee linked progress on these diversity goals to executive bonuses, applying a non‑financial performance modifier that can adjust the bonus by a multiple of 0.9 to 1.1 (2022, 2023, 2024). Thus, both the diversity targets and the bonus‑adjustment mechanism stayed consistent across FY 2022‑FY 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key numeric targets (15% women/URM in leadership, 20% overall URM increase), correctly states the bonus modifier range (0.9 to 1.1), and accurately notes that these targets were set in FY 2022 and remained unchanged through FY 2024. The quantitative facts are accurate. WEAKNESSES: The LLM answer is significantly incomplete in addressing the question's core requirement to describe how goals and compensation 'evolved' from 2022-2024. The ground truth explicitly states that while targets remained constant, the company 'expanded its global engagement efforts' and 'highlighted broader wellness and development programs' by FY 2024, indicating 'a deepening integration of human capital metrics into corporate strategy.' The LLM completely omits this evolution narrative—it only states that things 'stayed consistent' without capturing the expansion of supporting programs and broader strategic integration that occurred. The ground truth also mentions specific FY 2023 activities (recognition in multiple regions, Reboot Representation Tech Coalition participation) that demonstrate evolution in implementation approach, which the LLM ignores. The question specifically asks about 'evolution' and the LLM's answer essentially says 'nothing changed,' which misses the qualitative evolution in how human capital strategy was implemented and integrated. While the factual numbers are correct, the answer fails to capture the substantive evolution in Qualcomm's approach to human capital management across the three-year period, which is the central focus of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 442,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s EMD‑branded products are sold through the same dealer network that distributes all of its machines.  In 2022 the network covered 44 U.S. dealers, 116 outside the U.S., and reached 193 countries 【page_76】, whereas in 2024 it had 41 U.S. dealers, 111 outside the U.S., and served 187 countries 【page_64】.  The modest contraction in dealer count and country reach suggests Caterpillar is streamlining its global distribution, concentrating on core markets and high‑margin opportunities while tightening dealer relationships to improve efficiency and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - 2022: 44 U.S. dealers, 116 outside U.S., 193 countries; 2024: 41 U.S. dealers, 111 outside U.S., 187 countries. The country count decline from 193 to 187 matches the ground truth exactly. The dealer reductions (44→41 U.S., 116→111 outside U.S.) are accurate and provide additional context not in the ground truth. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple data points (dealer counts and geographic reach) and connects them to strategic implications. COMPLETENESS: The answer addresses both parts of the question - the change in geographic reach (193→187 countries) and strategic positioning (consolidation/streamlining). REASONING QUALITY: The interpretation that the contraction suggests 'streamlining' and 'concentrating on core markets' is logically sound and semantically equivalent to the ground truth's 'strategic refocusing or consolidation.' The additional insight about 'tightening dealer relationships to improve efficiency and profitability' is a reasonable inference from the data pattern. MINOR CONSIDERATIONS: The LLM provides more granular detail (dealer counts by region) than the ground truth, which enhances rather than detracts from the answer. The interpretation of strategic positioning is slightly more specific than the ground truth but remains consistent with the data. No factual errors detected. The answer fully addresses the question with accurate numbers, sound reasoning, and appropriate contextual analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 444,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "Palmolive’s appearance as a principal global trademark in every 10‑K from 2022 through 2024 shows that it is a core, high‑value brand in Colgate’s Oral, Personal and Home Care segment. The company treats it as a key driver of sales and brand equity, and its continued inclusion signals a strategic focus on maintaining and leveraging this brand as a central pillar of the segment’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Palmolive appeared as a principal global trademark across 2022-2024 and recognizes its strategic importance to Colgate's segment. However, there are significant gaps in completeness and specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the 3-year consistency (2022-2024) of Palmolive's inclusion; (2) Accurately characterizes it as a 'core, high-value brand'; (3) Properly notes its role as a 'central pillar' of the segment's portfolio. WEAKNESSES: (1) Lacks specific product category examples - ground truth mentions 'liquid hand soap, dishwashing detergents, and household cleaners' while LLM provides no such detail; (2) Missing contextual comparison to other brands - ground truth references Ajax (2022) and Darlie (2023) to show Palmolive's sustained positioning despite competitive additions, which the LLM omits entirely; (3) No discussion of 'positional dilution' or how Palmolive maintained relevance despite portfolio changes; (4) Less nuanced analysis - ground truth explains the significance of Palmolive's consistency 'despite the addition of Darlie,' showing sophisticated multi-hop reasoning about brand portfolio dynamics that the LLM doesn't capture. QUANTITATIVE ACCURACY: The dates (2022-2024) are correct, and the characterization of 'every 10-K' is accurate. QUALITATIVE ACCURACY: While the LLM's reasoning is sound and not incorrect, it's superficial compared to the ground truth's deeper analysis of strategic positioning across multiple years and competitive context. The answer reads as a general statement about brand importance rather than a specific analysis of what the 3-year consistency pattern reveals about strategic choices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 471,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "From fiscal 2022 to 2024 Qualcomm kept edge‑networking as a core part of its IoT strategy, projecting the IoT device base to more than double to 27 billion by 2026 and positioning mobile‑broadband and Wi‑Fi 6/6E access points as key edge‑networking products【page_8】.  The company continued to classify edge‑networking under the IoT revenue stream (consumer, edge‑networking, industrial) in the QCT segment, with equipment sales recognized at a point in time and licensing revenue from QTL recognized over time【page_73】.  Although IoT revenue fell from $7.35 billion in 2022 to $5.94 billion in 2023 and $5.42 billion in 2024, Qualcomm’s strategic emphasis on edge‑networking persisted, reflected in ongoing investment in 5G‑enabled and Wi‑Fi‑based edge solutions【page_71-75】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's Edge Networking evolution and correctly identifies key facts: (1) the 27 billion IoT device projection by 2026, (2) the positioning of mobile broadband and Wi-Fi 6/6E as key products, (3) the classification under QCT segment with equipment sales at point-in-time and licensing revenue over time, and (4) the IoT revenue figures ($7.35B in 2022, $5.94B in 2023, $5.42B in 2024). The multi-hop synthesis across fiscal years is sound. However, there are notable gaps: (1) The answer does not explicitly address the 'formalized product grouping' aspect mentioned in ground truth - specifically that Edge Networking was 'explicitly included' as a third revenue category in fiscal 2023, representing a structural shift from 2022. (2) The answer mentions Edge Networking falling under 'IoT revenue stream' but doesn't clearly articulate the progression from emerging opportunity (2022) to 'structurally embedded product pillar' (2023-2024) as emphasized in ground truth. (3) The answer correctly notes 'strategic continuity' but doesn't fully capture the significance of the formalization that occurred between 2022-2023. The quantitative data is accurate and properly formatted. The reasoning about revenue recognition structure is correct. The main weakness is incomplete articulation of the strategic transformation narrative - the answer presents facts but doesn't fully synthesize the evolution from informal IoT positioning to formal product categorization that represents the core insight of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 433,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 10‑K filings from 2022 through 2024 consistently note that its global operations expose it to significant currency‑exchange‑rate risk and that it uses hedging instruments to mitigate adverse movements.  In 2022 the risk paragraph (page 22) states that hedging can protect against unfavorable fluctuations but forego potential gains; the 2023 and 2024 disclosures (page 19 in each filing) repeat the same language, underscoring that earnings volatility remains a risk but that the company’s hedging strategy has not materially changed over the period.  Thus, while the exposure from international operations stayed high, Caterpillar’s approach to managing it through hedges remained largely unchanged, balancing volatility reduction against the loss of upside from favorable currency moves.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) Correctly identifies that Caterpillar's global operations expose it to currency exchange rate risk; (2) Correctly notes the use of hedging instruments as a mitigation strategy; (3) Accurately captures the 2022 discussion about hedging protecting against downside but limiting upside; (4) Correctly identifies page references (page 22 for 2022, page 19 for 2023-2024). SIGNIFICANT ERRORS: (1) The LLM claims the 2023 and 2024 disclosures 'repeat the same language' and that 'the company's hedging strategy has not materially changed over the period.' This directly contradicts the ground truth, which explicitly states that by 2023, Caterpillar 'expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets' and that by 2024 the company 'underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified.' (2) The LLM fails to capture the evolution and escalation of risk discussion across the three-year period, particularly the growing emphasis on geopolitical and macroeconomic pressures, exchange controls, and currency devaluation risks. (3) The LLM's conclusion that the approach 'remained largely unchanged' is factually incorrect based on the ground truth's clear documentation of expanding and intensifying risk discussions. MULTI-HOP REASONING: The LLM failed to properly synthesize the multi-year evolution of Caterpillar's risk management discussion. While it correctly identified the 2022 baseline, it missed the critical progression showing increased concern about external macroeconomic pressures and emerging market risks in 2023-2024. This represents a fundamental failure in the multi-hop synthesis required by the question. The answer is partially correct on surface-level facts but substantially incorrect on the core analytical requirement of tracking evolution and change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 552,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive reduced its exposure to U.S. Treasury and agency securities in its pension‑plan fixed‑income portfolio from about **40 % in 2022** to roughly **30 % in 2023**, a level that remained unchanged in 2024 (CL_10k_2022, page 102; CL_10k_2023, page 100; CL_10k_2024, page 99). This downward trend indicates the company is diversifying away from the lowest‑risk Treasury holdings, likely to balance yield and interest‑rate risk while maintaining a conservative risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the allocation percentages. According to the ground truth, the allocation was 50% (2020), 40% (2021), 30% (2022), 30% (2023), and 30% (2024). The LLM states the allocation was '40% in 2022' and 'roughly 30% in 2023,' which is INCORRECT. The ground truth clearly shows 30% as of December 31, 2022 (reported in the 2023 filing), not 40%. This is a fundamental factual error that undermines the entire answer. INCOMPLETE HISTORICAL CONTEXT: The LLM answer fails to capture the full evolution of the allocation from 2020-2024. It only addresses 2022-2024, missing the initial decline from 50% (2020) to 40% (2021) to 30% (2022), which is essential context for understanding the 'gradual reduction over two years followed by stabilization' pattern described in the ground truth. MISSING KEY DETAILS: The LLM answer omits important information about the Level 2 classification and its implications for liquidity and over-the-counter trading, which the ground truth identifies as relevant to understanding the company's interest rate risk management approach. REASONING QUALITY: While the LLM's interpretation that the company is 'diversifying away from lowest-risk Treasury holdings' is reasonable, it lacks the nuance of the ground truth's observation about the strategic shift 'toward other government bonds and corporate bonds' and the connection to 'rising interest rates during this period.' The reasoning is partially sound but incomplete. MULTI-HOP SYNTHESIS: The LLM demonstrates some ability to synthesize across multiple years and filings (2022, 2023, 2024), but the factual errors in the base data severely compromise the validity of any synthesis. The answer correctly identifies the downward trend but gets the starting point wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 500,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer granted 1,165 Breakthrough Performance Awards (BPAs) in 2022 (see the 2022 10‑K table on page 101) and accounted for them using the intrinsic‑value method at grant date, amortizing the expense over the probable vesting term (Note 13, page 96). By 2023 the company disclosed that no BPAs were granted or outstanding (Note 13, page 97), a position that was repeated in the 2024 filing (Note 13, page 97). Across all three years the valuation methodology remained unchanged—intrinsic value based on the closing price of common stock—while disclosure transparency shifted from a detailed activity table in 2022 to a concise statement in 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant omissions and one notable discrepancy. CORRECT ELEMENTS: (1) The 1,165 thousand shares granted in 2022 is accurate; (2) The weighted average intrinsic value of $38.73 per share is correctly identified in the ground truth but NOT mentioned in the LLM answer; (3) The statement that no BPAs were granted in 2023 is correct; (4) The intrinsic-value methodology is correctly identified; (5) The shift from detailed disclosure to concise statements is accurately characterized. CRITICAL OMISSIONS: (1) The LLM completely fails to mention the 859 thousand nonvested shares remaining at year-end 2022, which is a material quantitative detail; (2) The LLM states that in 2024 'no BPAs were granted or outstanding' (repeating the 2023 position), but the ground truth indicates that in 2024, BPAs 'reappeared in disclosures with detailed valuation and amortization policies introduced,' suggesting active treatment and potentially different status than 2023. This is a significant factual error or mischaracterization; (3) The LLM misses the key insight about the 3-year trajectory showing 'suspension and then...more transparent and dynamic valuation framework' in 2024. REASONING ISSUES: The LLM's claim that 'valuation methodology remained unchanged' across all three years contradicts the ground truth's statement that 2024 introduced 'adjustments based on performance probability and stock price changes,' suggesting a more sophisticated methodology than simple intrinsic value at grant date. The multi-hop synthesis is incomplete—the LLM fails to capture the evolution from active issuance (2022) to suspension (2023) to reappearance with enhanced transparency (2024). The answer reads as partially correct but materially incomplete and potentially misleading about 2024 status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 499,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024, Schwab’s Advisor Services website kept its core interactive tools—such as the free Advisor Portfolio Connect and multi‑year statement archiving—while steadily expanding third‑party integrations. In 2022 the platform added the thinkpipes trading platform and iRebal rebalancing solution (pages 10, 8, 9), and in 2023 it introduced the Schwab Trading Powered by Ameritrade platform, further enhancing real‑time charting and trading for RIAs (pages 7, 8, 9). By 2024 those integrations—thinkpipes, iRebal, and the Ameritrade‑powered trading engine—remained central, broadening portfolio‑management capabilities and third‑party connectivity for independent advisors (pages 5‑9).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERRORS: The LLM introduces specific third-party integrations (thinkpipes, iRebal, Schwab Trading Powered by Ameritrade) with specific page citations that are NOT mentioned in the ground truth answer. The ground truth makes no reference to these specific platforms being added in 2022 or 2023. This represents fabrication of details not supported by the source material. (2) QUANTITATIVE ACCURACY: The LLM provides page numbers (pages 10, 8, 9; pages 7, 8, 9; pages 5-9) that cannot be verified against the ground truth and appear to be hallucinated citations. No specific page references are provided in the ground truth. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize evolution across 2022-2024, it does so by inventing specific product launches and integrations. The ground truth indicates Schwab emphasized existing capabilities and integrations without naming specific third-party platforms like thinkpipes or iRebal. (4) ENTITY ACCURACY: The LLM correctly identifies Schwab Advisor Portfolio Connect and multi-year archiving, which align with ground truth. However, it incorrectly adds 'Schwab Trading Powered by Ameritrade' as a 2023 introduction, which is not mentioned in the ground truth. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes a general evolution toward 'intuitive modern experience' and platform scalability, while the LLM claims specific named integrations were added in specific years—a fundamentally different narrative that appears to be fabricated. The answer fails the primary evaluation criterion of factual correctness by introducing unverified product names and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 467,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Texas Instruments consistently framed embedded‑processing as a core pillar of its strategy in 2022, 2023 and 2024, with each MD&A stating that its strategic focus is on analog and embedded‑processing products and that it places additional emphasis on industrial and automotive markets (2022 page 18; 2023 page 20; 2024 page 20).  While embedded‑processing revenue rose modestly from $3.26 B in 2022 to $3.37 B in 2023 and then fell to $2.53 B in 2024, the company’s narrative remained unchanged, underscoring its long‑term positioning as a leading analog‑and‑embedded‑processing provider and a key player in high‑margin semiconductor markets (2022 page 18; 2023 page 20; 2024 page 20).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative that embedded processing remained a consistent strategic pillar across 2022-2024, matching the ground truth's emphasis on this consistency. The answer appropriately cites page numbers and correctly identifies the three-year period. The qualitative reasoning about TI's long-term positioning as an analog-and-embedded-processing provider is sound and relevant to the question. CRITICAL WEAKNESSES: The LLM introduces specific revenue figures ($3.26B in 2022, $3.37B in 2023, $2.53B in 2024) that are NOT present in the ground truth answer and cannot be verified against it. These numbers appear to be fabricated or sourced from unverified data. This is a significant factual error that undermines credibility. The ground truth makes no mention of specific revenue figures for embedded processing products, focusing instead on the strategic framing and the 'four sustainable competitive advantages' framework. QUANTITATIVE ACCURACY ISSUE: The introduction of unverified financial data without grounding in the provided ground truth represents a major quantitative accuracy failure. Even if these numbers were accurate in the actual filings, they go beyond what the ground truth establishes and represent unsupported claims. REASONING ASSESSMENT: The multi-hop synthesis is partially sound - the answer does connect the strategic narrative across three years and relates it to market positioning. However, the addition of revenue data that diverges from the ground truth's focus on strategic framing rather than financial metrics suggests the model may have conflated different types of information or hallucinated data. The ground truth emphasizes the 'four sustainable competitive advantages' framework specifically, which the LLM answer omits entirely. CONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and long-term positioning inquiry, but the inclusion of unverified revenue figures suggests a misunderstanding of what constitutes relevant evidence for this particular question about strategic emphasis evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 567,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Fleet‑support costs stayed essentially flat, being expensed as incurred and historically about 1 % of total consolidated product and service costs with no material change from 2022 through 2024 (page 40). In contrast, the 787 program accumulated significant abnormal production costs—$2.7 billion through 2023 and an additional $256 million in 2024 (pages 36, 39)—and delivery delays, with production slowed to below five aircraft per month in 2024 because of supply‑chain constraints and business‑class seat issues, leaving 25 aircraft in inventory for rework that are expected to be delivered in 2025 (pages 36, 39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE VERIFICATION: All key numbers are correct - fleet support services at ~1% of consolidated costs (2022-2024), $2.7 billion cumulative abnormal production costs through 2023, $256 million in 2024 rework costs, 25 inventoried aircraft, and expected 2025 delivery timeline. The progression of costs is accurately captured. COMPLETENESS: The answer addresses all major components of the question: (1) fleet support services cost profile evolution (flat at ~1%), (2) 787 abnormal production costs evolution (2022 delays noted, 2023 cumulative $2.7B disclosed, 2024 $256M expensed), (3) delivery delays and their resolution trajectory. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple years and connects fleet support services (separate metric) with 787 program abnormal costs (distinct issue), showing proper understanding that these are related but separate cost categories. ENTITY ACCURACY: Boeing correctly identified, years properly sequenced (2022-2024), metrics properly distinguished (fleet support vs. abnormal production costs). MINOR CONSIDERATIONS: The LLM adds contextual details about supply-chain constraints and business-class seat issues that, while accurate and relevant, go slightly beyond the ground truth answer's scope but enhance understanding without introducing errors. The reference to \"below five aircraft per month\" production rate is a reasonable inference from the delivery delay context. Page citations (40, 36, 39) demonstrate source documentation. The semantic equivalence is strong - the LLM conveys the same progression of cost reduction and gradual resolution of delivery delays as the ground truth. No calculation errors detected. The answer is well-structured and clearly communicates the evolution of both metrics across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 521,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian subsidiary on December 31 2021 for roughly $51 million cash, recording a $167 million loss (2023 10‑K, p. 73).  After the sale, Pfizer and the buyer entered into interim transition‑service agreements and a three‑year manufacturing‑service agreement (with a two‑year extension) to keep a post‑sale relationship; the amounts recorded under those agreements were immaterial in 2022 and 2023 and none were recorded in 2024, indicating the relationship had largely ended (2023 10‑K, p. 73‑74; 2024 10‑K, p. 2‑6).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key facts about Pfizer's Meridian relationship evolution: (1) Sale date of December 31, 2021 is correct; (2) $167 million loss figure is accurate; (3) TSAs and three-year MSA with two-year extension option are correctly identified; (4) Immaterial amounts in 2022-2023 and none in 2024 are accurate. However, there are notable issues: (1) The LLM introduces a $51 million cash sale price that is NOT mentioned in the ground truth answer, and this specific figure cannot be verified from the provided context - this is a potential factual error or unsupported claim; (2) The LLM states 'none were recorded in 2024' which goes slightly beyond the ground truth's more cautious statement that amounts were 'not material' - the ground truth doesn't explicitly state zero amounts in 2024, only that Meridian was referenced in the glossary; (3) The LLM's conclusion that 'the relationship had largely ended' is a reasonable inference but slightly stronger than the ground truth's more measured statement about 'limited but structured supplier relationship.' The multi-hop reasoning is sound - the answer correctly synthesizes information about the sale, post-sale agreements, and their evolution through 2024. The answer addresses all parts of the question regarding financial implications and contractual arrangements. The main weakness is the introduction of the $51 million figure without clear sourcing, which could be a significant factual error if unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 412,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, “hello” is consistently listed as a global trademark within the Oral, Personal and Home Care segment (page 77 of each filing).  The filings contain no mention of a repositioning or strategic shift for the brand relative to the other product lines, indicating that its positioning has remained essentially unchanged over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates accurate understanding of the ground truth. Strengths: (1) Correctly identifies 'hello' as consistently listed across 2022-2024 10-K filings; (2) Accurately notes the brand's positioning within the Oral, Personal and Home Care segment; (3) Correctly concludes that positioning remained essentially unchanged over the period; (4) Appropriately cites page 77 as the source location. The answer directly addresses the core question about how 'hello' brand positioning evolved (or didn't evolve) relative to other product lines. Quantitative accuracy is high - all years (2022, 2023, 2024) and the segment classification are correct. Minor differences from ground truth: (1) The LLM answer is more concise and states 'no repositioning' explicitly, while the ground truth emphasizes 'consistent visibility' and 'sustained strategic emphasis' - these are semantically equivalent conclusions but framed slightly differently; (2) The ground truth provides slightly more context by mentioning specific comparisons (e.g., 'alongside major brands like Colgate and Palmolive' and 'despite the addition of Darlie') which the LLM answer omits. However, these omissions don't constitute factual errors - they're simply less detailed. The LLM's conclusion that positioning 'remained essentially unchanged' accurately captures the essence of the ground truth's finding of 'consistent visibility' and 'maintained strategic position.' The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings to reach a valid conclusion about brand evolution (or lack thereof).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 451,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "The Non‑Qualified Defined Benefit Pension Plan has remained unfunded and closed to new participants throughout 2022‑2024.  The U.S. defined‑benefit plan’s funded status, which includes the non‑qualified plan, fell from a $100 million deficit at year‑end 2022 to $87 million in 2023 and slipped to $93 million in 2024, while participant contributions stayed at zero each year【page_45】.  This steady underfunding and lack of employee contributions indicate that Texas Instruments continues to carry significant long‑term pension obligations for the non‑qualified plan and that employee participation in it remains minimal, reflecting the company’s shift toward defined‑contribution options.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and provides substantially different information than the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites funded status deficits of $100M (2022), $87M (2023), and $93M (2024) for the defined-benefit plan, but the ground truth makes no mention of these specific deficit figures. Instead, the ground truth focuses on defined contribution plan metrics: TI common stock holdings (6M shares/$940M in 2022, 5M shares/$873M in 2023, 5M shares/$852M in 2024) and dividends ($28M, $27M, $26M respectively). The LLM appears to have cited different pension plan data entirely. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes the defined contribution plan evolution and expense growth ($70M→$75M→$76M), which the LLM completely omits. The ground truth provides a comprehensive multi-year progression of DC plan metrics showing the strategic shift away from DB obligations. The LLM instead focuses on DB plan funding status deficits that don't appear in the ground truth. (3) ENTITY CONFUSION: The LLM conflates or misidentifies which pension plan metrics are being discussed. The ground truth clearly distinguishes between the unfunded non-qualified DB plan (legacy liability) and the active DC plans (primary retirement vehicle). The LLM's deficit figures appear to reference different plan data. (4) MISSING KEY DATA: The LLM completely omits the critical DC plan metrics (stock holdings, dividends, expense trends) that form the core of the ground truth answer and directly address the 'participant engagement trends' aspect of the question. (5) REASONING: While the LLM's conclusion about the strategic shift toward DC options is directionally correct, it's based on incorrect supporting data. The ground truth provides concrete evidence of this shift through DC plan metrics; the LLM relies on DB plan deficit figures that don't match the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 519,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost declined from **$800 million in 2022** to **$755 million in 2023** and further to **$719 million in 2024** (see 2023 10‑K, p. 86 and 2024 10‑K, p. 83). This steady downward trend indicates a deliberate reduction in the company’s allocation to private‑equity, suggesting a portfolio rebalancing or strategic shift toward other asset classes or liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The 2022 figure is fundamentally wrong. LLM states $800 million for 2022, but ground truth shows $623 million. This is a $177 million error (28% discrepancy). The 2023 and 2024 figures ($755M and $719M) are correct. (2) TRAJECTORY MISCHARACTERIZATION - Because the 2022 baseline is wrong, the entire trajectory analysis is incorrect. Ground truth shows: $623M → $755M → $719M (increase then decrease). LLM shows: $800M → $755M → $719M (steady decline). These tell completely different stories about Pfizer's strategic allocation. (3) REASONING QUALITY - The LLM's interpretation of a 'steady downward trend' and 'deliberate reduction' is based on the incorrect 2022 figure. The actual trajectory shows a strategic increase in 2023 followed by a partial pullback in 2024, which is materially different from a consistent reduction strategy. (4) MULTI-HOP SYNTHESIS - While the LLM correctly cites page references (2023 10-K p. 86, 2024 10-K p. 83), it appears to have misread or misreported the 2022 baseline figure, which is a fundamental data extraction error. (5) SEMANTIC EQUIVALENCE - The qualitative conclusions about 'measured approach' vs. 'deliberate reduction' are semantically opposite and both cannot be correct given the actual data. The ground truth's characterization of a 'short-term strategic increase in 2023 followed by partial reduction' is the accurate interpretation of the actual numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 405,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022, under the 2019 IDA agreement, Schwab could move up to $10 billion of IDA balances each year, but only floating‑rate balances and it had to keep a minimum $50 billion IDA balance and at least 80 % of balances as fixed‑rate through June 2026. The 2023 IDA agreement replaced those terms; Schwab still had a $10 billion annual migration option, but the 80 % fixed‑rate rule was removed and it had to maintain balances above the total of unmatured fixed‑rate obligations with a $30 billion ceiling (and after Sept 10 2025 a $60 billion minimum and $90 billion maximum), with withdrawals limited to customer‑initiated withdrawals until that date. Schwab did not exercise the migration in 2023 or 2024, so the same 2023 constraints applied in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - 2022: LLM claims $10 billion annual migration option with 'minimum $50 billion IDA balance' and '80% fixed-rate requirement through June 2026' - these specific constraints are NOT mentioned in ground truth for 2022\n   - 2023: LLM claims '$10 billion annual migration option' still existed - ground truth states the 2023 agreement introduced 'new constraints' with no mention of a $10 billion annual option continuing\n   - 2024: LLM introduces '$60 billion minimum and $90 billion maximum' thresholds after Sept 10, 2025 - ground truth only mentions '$30 billion above' the unmatured fixed-rate obligation amounts through September 10, 2025, with no mention of $60B/$90B figures\n   - LLM adds 'withdrawals limited to customer-initiated withdrawals until that date' - not mentioned in ground truth\n\n2. STRUCTURAL ERRORS:\n   - Ground truth clearly states Schwab had 'the option...to migrate up to $10 billion...annually' in 2022 under the 2019 agreement\n   - Ground truth explicitly states 'Schwab did not move any IDA balances' in 2023 and 2024\n   - LLM conflates the 2022 terms with additional constraints that appear to be from later agreements\n   - LLM incorrectly suggests the $10 billion option persisted into 2023 under the new agreement\n\n3. MULTI-HOP REASONING:\n   - The LLM failed to properly synthesize the evolution across years\n   - Ground truth shows clear progression: 2022 (flexible $10B option) → 2023 (new constraints, no migration) → 2024 (same constraints, no migration)\n   - LLM muddled this timeline by mixing constraints from different periods\n\n4. CORE NARRATIVE:\n   - Ground truth emphasizes 'tightening of flexibility' from annual $10B option to 'constrained and conditional framework'\n   - LLM suggests continuity of $10B option while adding constraints, which contradicts the tightening narrative\n   - LLM's claim that 2023 agreement 'still had a $10 billion annual migration option' directly contradicts the ground truth's emphasis on new constraints replacing the prior terms\n\n5. MISSING/INCORRECT DETAILS:\n   - Ground truth mentions $10.1 billion already moved by December 31, 2021 - LLM omits this\n   - LLM introduces specific percentages (80%) and dates (June 2026) not in ground truth\n   - LLM adds complexity about 'floating-rate balances' not mentioned in ground truth\n\nThe answer demonstrates fundamental misunderstanding of how the IDA agreements evolved and introduces unsupported details while missing key ground truth elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 697,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments has listed Melaka, Malaysia as an analog‑manufacturing site in every 10‑K for 2022, 2023 and 2024 (see the property tables on page 16 of each filing).  The designation and leased status ( * in 2022/23, ** in 2024 —both indicating a leased facility) remained unchanged, showing a stable, long‑term investment in that location.  This multi‑year consistency signals that Melaka is a strategically important, reliable hub for TI’s analog product production, likely chosen for its cost, talent pool or supply‑chain advantages.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Melaka, Malaysia was listed as an analog manufacturing site across all three years (2022, 2023, 2024), capturing the core multi-year consistency theme. The answer appropriately synthesizes information across multiple filings and correctly notes the strategic importance of this location. The reasoning about cost, talent, and supply-chain advantages is logical and contextually relevant.\n\nWEAKNESSES - CRITICAL FACTUAL ERROR: The LLM makes a significant error in interpreting the designation symbols. The ground truth states: 2022 had †, 2023 had *, and 2024 had **. The LLM incorrectly claims that * in 2022/23 and ** in 2024 both indicate 'leased facility' status. This is problematic because: (1) The ground truth explicitly notes these are DIFFERENT markings across years (†, *, **), suggesting potential escalation or changing emphasis, not unchanged status. (2) The LLM's interpretation that both * and ** mean the same thing (leased facility) contradicts the ground truth's suggestion of 'possible escalation.' (3) The LLM states the designation 'remained unchanged' when the ground truth clearly shows three different symbols across the three years.\n\nADDITIONAL ISSUES: The LLM provides a page reference ('page 16 of each filing') that cannot be verified from the ground truth and may be inaccurate. The ground truth emphasizes the potential escalation signaled by the changing markings (†→*→**), while the LLM dismisses this as 'unchanged,' missing a key insight about the evolution of TI's commitment to this location.\n\nMULTI-HOP REASONING: The synthesis across three years is present but incomplete. The LLM correctly identifies the multi-year presence but fails to properly analyze the evolution indicated by the changing symbols, which is central to the question about how the footprint 'evolved.'\n\nSCORING JUSTIFICATION: The answer gets the basic facts right (location, years, analog manufacturing) but makes a material error in interpreting the symbol progression, which directly impacts the assessment of strategic importance and evolution. This is a quantitative/factual error that affects the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 585,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit Card (RedCard/Target Circle Card) penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024** (RedCard Penetration data, 2024 10‑K p. 27; 2023 10‑K p. 27). This downward trend indicates that fewer purchases are being made with the card, suggesting a modest erosion of its incremental‑sales contribution over time, even though it remains a key driver of Target’s sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL ERROR: The LLM provides 18.6% for 2024, but the ground truth states 17.8% for 2024. This is a factual error of 0.8 percentage points on a key metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUALITATIVE ASSESSMENT: The LLM correctly identifies the card as RedCard/Target Circle Card and recognizes the downward trend across all three years. The reasoning about 'fewer purchases being made with the card' and 'erosion of incremental-sales contribution' aligns with the ground truth's interpretation that the trend suggests 'diminishing role' and 'reduced effectiveness in driving incremental sales.' The LLM appropriately cites 10-K filings (page 27) as sources. MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years (2022-2024) and connects the penetration rate trend to its business implications regarding incremental sales. SEMANTIC EQUIVALENCE: The LLM's conclusion that the trend indicates 'modest erosion of its incremental-sales contribution' is semantically equivalent to the ground truth's assessment of 'diminishing role' and 'reduced effectiveness.' However, the LLM states the card 'remains a key driver of Target's sales,' which is a slightly more optimistic characterization than the ground truth's emphasis on declining effectiveness. OVERALL: The answer is substantially correct in structure, reasoning, and interpretation, but the 2024 penetration rate error (18.6% vs. 17.8%) is a material factual mistake that prevents a higher score. This is a critical number in a financial analysis context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 438,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "From 2022 through 2024 the Texas Instruments 2003 Director Compensation Plan had **zero shares remaining available for future issuance**.  The plan is not listed in the “available for future issuance” column of the equity‑compensation tables for those years (see footnote (c) on pages 59 and 61).  This indicates the plan has been fully utilized and not replenished, and TI has shifted to newer plans—such as the 2018 Director Plan and the 2024 LTIP—to provide future equity incentives to directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. The ground truth clearly states specific share counts for the 2003 Director Compensation Plan: 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM claims 'zero shares remaining available for future issuance' and states the plan is 'not listed in the available for future issuance column,' which directly contradicts the ground truth data showing substantial shares available in all three years. The LLM's assertion that the plan 'has been fully utilized' is factually incorrect—the plan clearly had millions of shares available throughout the period. While the LLM correctly identifies that TI has newer plans (2018 Director Plan, 2024 LTIP), this observation about plan migration does not salvage the answer, as it is based on a false premise about the 2003 plan being depleted. The quantitative accuracy is critically flawed—all three year-over-year figures are wrong (claiming zero instead of the actual declining amounts). The reasoning about plan exhaustion and shift to newer plans may be partially logical in isolation, but it is built on incorrect data interpretation. The answer fails to address the actual trend shown in the ground truth: a consistent decline from 35.4M to 25.3M to 24.5M shares, which suggests active utilization without replenishment—exactly what the ground truth states. The LLM appears to have misread or misinterpreted the SEC filing data, possibly confusing the presence of the plan in equity tables with its absence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 428,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022, Visa integrated virtual accounts into its Visa Direct platform via Currencycloud, adding real‑time FX, virtual accounts and liquidity settlement to support cross‑border flows (page_10 2022). In 2023, the company launched Visa+, enabling P2P transfers between apps and further embedding virtual accounts and digital capabilities within Visa Direct (page_10 2023). By 2024, Visa Direct had expanded cross‑border use cases with Visa Treasury as a Service and enhanced Currencycloud features—real‑time FX, virtual accounts, and liquidity settlement—supporting nearly 10 billion transactions across 550 partners (page_10 2024; page_12 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and inconsistencies when compared to the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - Ground truth states virtual accounts support \"over 11 billion endpoints\" in 2024; LLM states \"nearly 10 billion transactions across 550 partners\" - these are different metrics (endpoints vs transactions) and the number is lower\n   - The LLM conflates transactions with endpoints, which are distinct concepts\n   - No mention of the \"$20 trillion in annual B2B cross-border opportunities\" cited in ground truth\n\n2. ENTITY AND TIMELINE ERRORS:\n   - LLM incorrectly places Currencycloud integration in 2022 as part of Visa Direct, when ground truth indicates it was introduced as part of \"Visa Treasury as a Service\" in 2022\n   - LLM introduces \"Visa+\" in 2023 for P2P transfers, which is not mentioned in the ground truth answer and appears to be an unsupported claim\n   - The progression of integration is muddled - ground truth shows clearer evolution from 2022 (Currencycloud/Treasury as a Service) → 2023 (deeper Visa Direct integration + Cross-Border Solutions) → 2024 (digitally native capabilities)\n\n3. MISSING KEY INFORMATION:\n   - Ground truth emphasizes \"Visa Cross-Border Solutions\" expansion in 2023, which is completely absent from LLM answer\n   - Ground truth highlights the strategic focus on \"$20 trillion in annual B2B cross-border opportunities\" in 2024, not mentioned in LLM\n   - Ground truth mentions \"digitally native capabilities\" and \"11 billion endpoints across cards, bank accounts, and digital wallets\" - LLM provides different metrics\n\n4. MULTI-HOP REASONING:\n   - LLM attempts to synthesize across three years but makes errors in the synthesis\n   - The connection between Currencycloud, Visa Direct, and Treasury as a Service is not clearly articulated\n   - LLM conflates different product offerings and their relationships\n\n5. SEMANTIC ISSUES:\n   - While LLM correctly identifies virtual accounts as a core component, it misrepresents their integration pathway\n   - The emphasis on \"550 partners\" and \"10 billion transactions\" shifts focus from the strategic endpoint reach and cross-border opportunity size emphasized in ground truth\n\nThe answer demonstrates partial understanding but contains material factual errors, unsupported claims (Visa+), and misaligned metrics that significantly diverge from the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 653,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s 2023 international sales fell 1 % due to a lower net price, signaling revenue pressure that prompted Pfizer to strengthen its lifecycle‑management strategy.  This investment is reflected in the April 2024 EU approval of Xtandi for the same indication—an indication expansion that extends the product’s market reach—and in the 2022 intangible‑asset carrying amount of $73.3 billion for developed‑technology rights that include Xtandi, underscoring the asset’s valuation within Pfizer’s intangible portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Xtandi's revenue pressures in 2023 and Pfizer's lifecycle management response, but contains a critical factual error that undermines accuracy. STRENGTHS: (1) Correctly identifies the 1% revenue decline in 2023 due to lower net pricing; (2) Accurately references the April 2024 EU approval for indication expansion; (3) Properly identifies the indication as extending market reach; (4) Correctly cites the $73.3 billion figure for developed-technology rights in 2022; (5) Demonstrates sound multi-hop reasoning connecting 2023 pressures to 2024 strategic response. CRITICAL ERROR: The LLM states the 2024 approval was for 'the same indication' rather than a NEW indication. The ground truth explicitly identifies this as an expansion to 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis'—a new indication, not the same one. This is a significant semantic error that misrepresents the nature of Pfizer's lifecycle management strategy. QUANTITATIVE ISSUES: While the $73.3 billion figure is cited, the LLM doesn't clarify whether this represents the total developed-technology rights portfolio or Xtandi's specific valuation, creating ambiguity about the asset's individual valuation within the portfolio. MULTI-HOP SYNTHESIS: The answer successfully connects three temporal elements (2022 valuation, 2023 revenue pressure, 2024 approval) and demonstrates understanding of the causal relationship between market challenges and strategic investment. However, the mischaracterization of the indication as 'the same' rather than 'new' weakens the demonstration of lifecycle management strategy. The answer would score higher (8-9) if the indication expansion were correctly characterized as a new indication rather than a market-reach extension of an existing one.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 507,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "From 2022 to 2024 the penetration of Target’s MasterCard‑branded credit card fell from 20.5 % (2022) to 19.8 % (2023) to 18.6 % (2024)【page_27】.  The gradual decline suggests a modest shift in consumer preference away from the MasterCard credit card, even as overall loyalty‑program engagement remains strong (penetration stays above 18 %).  This trend indicates that while Target’s loyalty benefits continue to attract shoppers, customers are increasingly choosing alternative payment methods or cards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All three penetration rate figures are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024), matching the ground truth exactly. The numerical trend is accurately captured. ENTITY ACCURACY: The card is correctly identified as Target's MasterCard-branded credit card, with appropriate acknowledgment of the rebranding context (noting it's part of Target Circle Cards). The time period (2022-2024) is correct. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) presenting the three-year trend, (2) interpreting the consistent decline as indicating a shift in consumer preferences, and (3) noting that loyalty program engagement remains relatively strong despite the decline. The logic is sound - a decline from 20.5% to 18.6% does suggest reduced penetration while still maintaining meaningful engagement. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a modest shift in consumer preference away from the MasterCard credit card' and that 'customers are increasingly choosing alternative payment methods' is semantically equivalent to the ground truth's statement about 'a shift in consumer payment preferences or a weakening in loyalty program engagement.' MINOR CONSIDERATIONS: The LLM adds the interpretive note that 'penetration stays above 18%' which, while not explicitly stated in the ground truth, is a reasonable and accurate observation that adds context. The inclusion of the page reference (page_27) demonstrates source attribution. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 459,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022, Currencycloud’s virtual accounts were introduced to enable real‑time FX, liquidity and settlement for cross‑border payments, reaching more than 190 countries (page 11). By FY 2023, the platform was fully integrated into Visa Direct, expanding its cross‑border reach to over 195 countries and adding additional real‑time payment schemes (page 10). In FY 2024, the network reach remained at 195+ countries while continuing to provide virtual accounts and real‑time FX, sustaining a $20 trillion cross‑border opportunity (page 10).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims virtual accounts reached '190 countries' in FY2022 and '195+ countries' in FY2023-2024, but the ground truth specifies the network reach was '11 billion endpoints' (cards, bank accounts, digital wallets) and mentions 'more than 100 countries' for Visa B2B Connect - these are fundamentally different metrics. The LLM conflates country reach with endpoint reach and provides unsupported country numbers. (2) MISSING KEY INFORMATION: The ground truth emphasizes the strategic evolution of virtual accounts' role - from enabling FX/liquidity in 2022, to integration into Visa Direct Platform in 2023, to supporting 'new flows' and 'digitally native Currencycloud capabilities' in 2024. The LLM misses this progression of functional enhancement. (3) INCORRECT SYNTHESIS: The LLM introduces a '$20 trillion cross-border opportunity' figure not mentioned in the ground truth, suggesting reliance on external knowledge rather than the filing data. (4) INCOMPLETE MULTI-HOP REASONING: The question asks about evolution 'particularly in terms of cross-border payment capabilities and network reach' - the LLM addresses country numbers (which are wrong) but misses the actual network endpoint metrics (11 billion) and the functional evolution of virtual account capabilities across the three years. (5) ENTITY CONFUSION: While the LLM correctly identifies Currencycloud and Visa Direct, it fails to properly distinguish between different types of network reach metrics and misrepresents the data structure. The answer reads as plausible but is factually incorrect on the specific numbers that define the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 480,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 10‑K filings for 2022, 2023 and 2024 all list “difficulties in protecting our intellectual property” as a key risk tied to its global operations, with the risk language unchanged across the three years (2022 page 39; 2023 page 41; 2024 page 42).  The company continues to rely on third‑party wafer foundries in the U.S., Europe and Asia and on manufacturing facilities in China, Malaysia and Taiwan, and the percentage of revenue from international sales has remained high (72 % in 2022, 65 % in 2023, 66 % in 2024).  Thus, AMD’s exposure to IP‑protection risks has persisted without substantive change, while geopolitical and export‑control concerns—particularly around China‑Taiwan tensions—remain highlighted as potential amplifiers of that risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that AMD cited 'difficulties in protecting our intellectual property' across all three years (2022, 2023, 2024). (2) The international revenue percentages are accurate (72% in 2022, 65% in 2023, 66% in 2024). (3) The LLM correctly identifies third-party manufacturing locations (China, Malaysia, Taiwan, plus U.S. and Europe). (4) The mention of geopolitical tensions (China-Taiwan) and export controls is appropriate. WEAKNESSES: (1) The LLM states the risk language was 'unchanged across the three years,' which contradicts the ground truth that shows EVOLUTION and INCREASING EMPHASIS. The ground truth explicitly states the company 'expanded this risk' in 2023 by linking it to specific third-party manufacturing dependencies and geopolitical instability, and 'reiterated these concerns and added' new elements in 2024 regarding export control regulations and sanctions related to Ukraine-Russia and Israel-Hamas conflicts. (2) The LLM misses the key finding that there was a DEEPENING CONCERN OVER TIME with GROWING SPECIFICITY around geopolitical and regulatory pressures. (3) The LLM fails to capture the evolution from general IP protection concerns (2022) to specific manufacturing dependency linkages (2023) to expanded regulatory/sanctions concerns (2024). (4) The LLM's conclusion that exposure 'persisted without substantive change' directly contradicts the ground truth's finding of increasing emphasis and deepening concern. MULTI-HOP REASONING: The LLM partially synthesizes information across years but fails to identify the temporal evolution pattern that is central to the question. The question specifically asks 'how has...evolved,' requiring identification of changes over time, which the LLM largely misses. The LLM treats the three years as static rather than dynamic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 498,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s pension plan shifted its corporate‑stock holdings from a largely Level‑2 (with a small Level‑3) portfolio in 2022 ($1.11 B) to a mix dominated by Level‑1 common shares and Level‑2 preferred shares in 2023 ($226 M) and continues to classify common shares as Level‑1 in 2024 (page 56).  The dollar amount of corporate stock fell from $1.11 B in 2022 to $226 M in 2023 and is expected to be lower in 2024 as equity allocation targets drop from 48 % in 2022 to 20‑30 % in 2024 (page 58).  This evolution signals a deliberate de‑risking strategy, reducing equity exposure and market volatility while increasing debt weighting to meet a lower expected return target.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect dollar amounts that contradict the ground truth. Ground truth states: 2022 Corporate Stock = $1,990 million (not $1.11B/$1,110M as LLM claims), 2023 = $181 million (not $226M as LLM states). The LLM's figures are significantly off - the 2022 amount is understated by ~$880M and the 2023 amount is overstated by ~$45M. These are not minor rounding differences but substantial discrepancies that undermine the entire analysis. VALUATION CLASSIFICATION ERRORS: The LLM incorrectly characterizes 2022 as 'largely Level-2 (with small Level-3)' when ground truth clearly shows 2022 had $1,980M in Level 1 and only $10M in Level 2 - meaning it was overwhelmingly Level 1, not Level 2. This is a fundamental mischaracterization of the valuation hierarchy. MISSING/INCORRECT DETAILS: The LLM provides equity allocation percentages (48% to 20-30%) that are not mentioned in the ground truth answer, suggesting potential confusion with different data or unsupported claims. The ground truth makes no mention of these specific allocation targets. REASONING QUALITY: While the LLM's interpretation of a 'de-risking strategy' is reasonable and aligns with the ground truth's mention of 'strategic shift toward more stable or diversified pension investments,' this correct interpretation cannot compensate for the severely inaccurate underlying numbers. The multi-hop synthesis is attempted but built on incorrect data. WHAT WAS CORRECT: The general direction of the trend (decline from 2022 to 2023) and the classification of common stock as Level 1 and preferred stock as Level 2 in later years are directionally correct, but the specific magnitudes are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 472,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott has continued to disclose the 4.75 % Senior Notes due 2043 in the same fashion in each of its 2022, 2023 and 2024 Form 10‑K filings – the note’s form is filed as Exhibit 4.6 and the accompanying officers’ certificate as Exhibit 4.7 (see the exhibit tables on 2022 page 86, 2023 page 86 and 2024 page 86).  This unchanged presentation signals a deliberate emphasis on regulatory‑compliant, transparent disclosure of long‑term debt, underscoring Abbott’s preference for consistency in debt management and clear communication with investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the disclosure remained 'unchanged' across 2022-2024, but the ground truth explicitly describes an evolution from 2022 (legacy referencing via St. Jude Medical's Fourth Supplemental Indenture from April 2, 2013) to 2023 (formalized with Form 4.75% Notes due 2043 as Exhibit 4.6 from March 22, 2017 Form 8-K) to 2024 (maintained structured disclosure). The LLM's assertion of consistency contradicts the ground truth's clear narrative of evolution. (2) MISSING CONTEXT: The LLM fails to mention the St. Jude Medical integration context from 2022, which is central to understanding the legacy-based referencing that characterized that year. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'shift from legacy-based referencing to a standardized, transparent disclosure approach,' but the LLM only notes 'unchanged presentation' and 'consistency,' missing the actual progression. (4) EXHIBIT REFERENCES: While the LLM correctly identifies Exhibits 4.6 and 4.7 and page 86 references, these details don't compensate for the fundamental mischaracterization of the disclosure evolution. (5) STRATEGIC INTERPRETATION: The ground truth connects the evolution to 'investor expectations for clarity in long-term liabilities,' while the LLM's interpretation of 'unchanged presentation' signals a misunderstanding of the multi-year progression. The LLM answer demonstrates poor multi-hop reasoning by failing to synthesize the documented changes across the three-year period and instead incorrectly characterizing them as static.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 457,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration of Target’s branded credit card fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024【page_27】.  The decline signals a modest slowdown in customer adoption of the RedCard/Target Credit Card, yet Target notes that a meaningful portion of card‑used purchases are incremental sales, so the product still contributes appreciably to revenue growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match ground truth exactly. (2) Numeric accuracy is perfect with no calculation errors. (3) Entity identification is correct (Target Credit Card/RedCard/Target Circle Card). (4) The LLM correctly identifies the downward trend and characterizes it as a 'decline' or 'slowdown.' (5) The answer appropriately notes that despite the decline, the card contributes to incremental sales and revenue growth.\n\nWEAKNESSES: (1) The LLM answer is less comprehensive than the ground truth. It omits the characterization of this as a 'gradual decline in customer adoption or usage' over the three-year period, instead using softer language like 'modest slowdown.' (2) The ground truth explicitly states the card 'remained a key part of Target's loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts' - the LLM answer mentions incremental sales but doesn't address the broader strategic context of loyalty programs and profit sharing. (3) The LLM answer doesn't fully synthesize the multi-hop reasoning about what the trend 'indicates about customer adoption' - it notes the decline signals slowdown but doesn't deeply explore the implications for the company's branded payment product strategy. (4) The phrase 'meaningful portion of card-used purchases are incremental sales' is somewhat vague compared to the ground truth's clearer statement about historical linkage to incremental sales.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend and connects it to customer adoption and revenue impact, but the synthesis is somewhat surface-level. The answer addresses the core question but lacks the strategic depth of the ground truth regarding loyalty strategy and profit sharing implications.\n\nOVERALL: The answer is factually accurate on all numbers and correctly identifies the trend direction and basic implications. However, it lacks the completeness and strategic context of the ground truth answer, making it a solid but not comprehensive response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 573,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s Multiple‑Purpose locomotive fleet shrank by roughly 115 units (from 7,008 units in 2023 to 6,893 units in 2024) and the average age rose by about 0.9 years (from 24.3 years in 2023 to 25.2 years in 2024). This gradual reduction in size coupled with a higher average age indicates a deliberate asset‑management strategy that phases out older locomotives while keeping the fleet lean and efficient.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) FLEET SIZE NUMBERS: Ground truth shows 2022: 7,242 units → 2024: 6,893 units (349-unit decrease). LLM claims 2023: 7,008 units → 2024: 6,893 units (115-unit decrease). The LLM provides only a partial 2-year comparison (2023-2024) instead of the requested 2022-2024 comparison, and the 2023 baseline of 7,008 units is not verified against ground truth. (2) AVERAGE AGE NUMBERS: Ground truth shows 2022: 22.5 years → 2024: 25.2 years (2.7-year increase). LLM claims 2023: 24.3 years → 2024: 25.2 years (0.9-year increase). Again, the LLM only captures the final year-over-year change, missing the full 2022-2024 evolution. (3) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about change 'from 2022 to 2024,' requiring comparison of both endpoints. The LLM failed to synthesize the complete 2022 baseline data, instead jumping to 2023 data. This is a fundamental failure in multi-hop reasoning across the required time period. (4) INTERPRETATION ISSUE: The LLM's interpretation that the company is 'phasing out older locomotives while keeping the fleet lean and efficient' contradicts the ground truth's assessment of 'deferral of fleet modernization' and 'cost-conscious asset management.' The increasing average age (22.5→25.2 years) suggests aging assets, not active modernization. (5) COMPLETENESS: The LLM addresses the question structure but with incomplete and incorrect data spanning only 2023-2024 rather than the requested 2022-2024 period. The quantitative errors are severe and disqualify this answer from being considered substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 466,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell steadily: $590 million at December 31 2022, $555 million at December 31 2023, and $540 million at December 31 2024 (see Note 14, page 70 of the 2023 and 2024 10‑Ks). This gradual decline signals a deliberate shift toward tighter liquidity and risk control while still maintaining a diversified exposure to illiquid alternative assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE: The LLM states the 2022 figure as $590 million, but the ground truth specifies $585 million. This is a $5 million discrepancy on a key data point. The 2023 ($555 million) and 2024 ($540 million) figures are correct. The LLM correctly identifies the downward trend and the $15 million annual decline pattern, but the incorrect starting point undermines the accuracy of the trend analysis. COMPLETENESS: The LLM addresses the main question about how unfunded commitments evolved and provides interpretation of the trend. However, it provides less detailed analysis than the ground truth regarding what the trend suggests about long-term investment strategy. The ground truth explicitly notes 'continued long-term participation through fund distributions rather than active capital deployment,' which adds important strategic context that the LLM's answer lacks. ENTITY ACCURACY: Company name (Abbott Laboratories) and years (2022-2024) are correct. The metric (unfunded commitments to private real estate funds) is correctly identified. REASONING: The LLM correctly synthesizes the multi-hop information showing the three-year trend and provides reasonable interpretation about liquidity and risk control. However, the interpretation is somewhat generic and doesn't capture the nuance in the ground truth about the company maintaining 'significant unfunded commitment' despite the decline, or the distinction between 'gradual reduction' versus 'deliberate shift.' SEMANTIC EQUIVALENCE: The LLM's interpretation of the trend as signaling 'tighter liquidity and risk control' is reasonable but slightly different from the ground truth's characterization of a 'measured approach' with 'continued long-term participation.' Both convey similar ideas but with different emphasis. The critical issue is the $590M vs $585M discrepancy in the 2022 baseline figure, which is a factual error that affects the credibility of the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 529,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "From FY 2022 to FY 2024, NVIDIA’s 3.50% Notes Due 2050 carried $1.604 billion (FY 2022) → $1.637 billion (FY 2023) → $2.000 billion (FY 2024) 【page_78】【page_67】【page_72】. The modest rise reflects a small increase in the outstanding balance of this long‑term note, but the carrying amount has remained essentially flat, indicating that NVIDIA’s long‑term debt profile has been stable with no significant shift in its debt mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely incorrect numbers. Ground truth shows: FY2022: $2,147M → FY2023: $1,604M → FY2024: $2,000M. LLM states: FY2022: $1.604B → FY2023: $1.637B → FY2024: $2.000B. The FY2022 figure is wrong ($1.604B vs $2.147B - off by $543M or 25%), and FY2023 is wrong ($1.637B vs $1.604B). These are substantial errors in a multi-year comparison. (2) MULTI-HOP REASONING - The LLM failed to correctly synthesize the three-year progression. It misidentified which year had which value, fundamentally breaking the temporal analysis. (3) INTERPRETATION ERROR - The LLM concludes the carrying amount 'remained essentially flat' and describes a 'modest rise,' which contradicts the actual pattern of significant decline (2022→2023: -$543M or -25%) followed by substantial recovery (2023→2024: +$396M or +25%). The ground truth correctly identifies this as a 'fluctuation' and 'rebound,' not a flat trend. (4) MISSING CONTEXT - The LLM fails to address the strategic implications mentioned in the ground truth regarding refinancing, market interest rate adjustments, or debt management strategy changes. The answer provides page citations but the underlying data is incorrect, suggesting citation hallucination or data retrieval failure. (5) SEMANTIC MISMATCH - The conclusion that debt profile is 'stable with no significant shift' directly contradicts the actual $543M swing in 2023 and $396M rebound in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 406,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD has consistently identified the risk of “loss or modification of exemptions for taxes and tariffs” in its 10‑K filings—listed on page 37 of the 2022 filing, page 41 of the 2023 filing, and again on page 41 of the 2024 filing. While the core risk statement remained unchanged, the 2024 disclosure expands the context to include a broader array of sanctions and geopolitical tensions (U.S. sanctions on Russia, Belarus, Ukraine, China‑Taiwan disputes, and Israel‑Hamas conflicts), underscoring a more intricate regulatory landscape. This evolution indicates that AMD’s exposure to tax‑and‑tariff exemption risk is increasingly intertwined with a dynamic, multifaceted global regulatory environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core risk statement ('loss or modification of exemptions for taxes and tariffs') and accurately notes that it appears across 2022, 2023, and 2024 filings. The answer appropriately recognizes the evolution from a generic risk statement to one with more specific geopolitical context. The synthesis of multiple geopolitical tensions (Russia, Belarus, Ukraine, China-Taiwan, Israel-Hamas) is accurate and well-articulated. The conclusion about increasing regulatory complexity is sound and well-supported.\n\nWEAKNESSES: (1) PAGE NUMBER ACCURACY: The LLM provides specific page numbers (page 37 for 2022, page 41 for 2023 and 2024) but these cannot be verified against the ground truth, which does not provide page citations. This is a significant issue because page numbers are quantitative claims that should be accurate. (2) INCOMPLETE TEMPORAL PROGRESSION: The ground truth explicitly describes a three-stage evolution: 2022 (broad international risks), 2023 (specific geopolitical tensions with supply chain impact), and 2024 (China-Taiwan focus affecting third-party manufacturers). The LLM answer treats the evolution more as a 2022-2024 comparison rather than capturing the distinct 2023 intermediate stage with its specific supply chain disruption concerns. (3) MISSING CONTEXT: The ground truth emphasizes the impact on 'global supply chain and regulatory landscape' and specifically mentions 'third-party manufacturing partners' in 2024, which the LLM answer does not explicitly address. (4) CHARACTERIZATION ISSUE: The LLM states 'the core risk statement remained unchanged' which is technically accurate but somewhat misleading—the ground truth shows the risk evolved in scope and specificity, not just in contextual framing.\n\nMULTI-HOP REASONING: The answer demonstrates adequate multi-hop synthesis by connecting AMD's risk disclosures across three years and linking them to geopolitical events. However, it misses the nuanced progression of how the risk became more operationally specific (supply chain impact, third-party manufacturers).\n\nQUANTITATIVE ISSUES: The page numbers provided cannot be verified and represent unsubstantiated quantitative claims. This is a material concern for a financial document evaluation task.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 612,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosures in 2022, 2023 and 2024 all repeat the same statement that its ability to return capital—whether through dividends or share repurchases—is subject to board discretion and may be limited by U.S. banking laws and regulations, including capital‑planning rules and Delaware law, and that failure to pay full and timely dividends on preferred stock could restrict these returns. The wording and emphasis have not changed across the three filings, indicating that the company’s exposure to regulatory constraints on dividend payments and share repurchases has remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core finding that BNY Mellon's regulatory constraints on capital returns remained essentially unchanged from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022, 2023, 2024) with no date errors; (2) Accurately identifies the key regulatory constraints: U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividend obligations; (3) Correctly synthesizes the multi-hop finding that constraints remained consistent across all three years; (4) Properly identifies both dividend payments and share repurchases as affected capital return mechanisms; (5) No quantitative errors or miscalculations. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth, which provides slightly more contextual detail about 2023's emphasis on credit rating reductions and Title I/II resolution strategies, and 2024's expansion to include liquidity management and strategic initiatives; (2) The ground truth explicitly notes 'stable regulatory environment with persistent constraints' while the LLM uses 'essentially unchanged,' which is semantically equivalent but slightly less nuanced; (3) The LLM answer doesn't explicitly mention the evolution of context (credit ratings, resolution strategies, liquidity management) that the ground truth highlights, though it does capture the core finding of consistency. The LLM answer correctly addresses the multi-hop synthesis requirement by comparing constraints across three separate years and drawing a conclusion about their evolution (or lack thereof). The reasoning is sound and the conclusion is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 455,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 2.950 % Note due 2025 has been consistently disclosed as **Exhibit 99.6** of the 8‑K filed March 5 2015.  That same reference appears unchanged in the 10‑K Exhibit Tables for 2022, 2023 and 2024, with no new exhibit or updated documentation added in any of those years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about Abbott Laboratories' disclosure evolution of the 2.950% Note due 2025 from 2022-2024. STRENGTHS: (1) All numeric values are correct - the 2.950% interest rate, the 2025 maturity date, Exhibit 99.6 designation, and March 5, 2015 filing date all match the ground truth. (2) The multi-hop synthesis is sound - the answer correctly identifies that the same exhibit reference appeared consistently across 2022, 2023, and 2024 10-K filings with no changes. (3) The conclusion about stability and lack of amendments/refinancing is logically derived from the consistent disclosure pattern. (4) Entity identification is accurate - Abbott Laboratories, the specific note, and the relevant years are all correctly identified. (5) The answer captures the core finding that disclosure remained static across the three-year period. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, focusing on the key facts without explicitly stating \"no amendments or refinancing actions taken,\" though this conclusion is reasonably implied by the consistency statement. The phrasing \"10-K Exhibit Tables\" is semantically equivalent to \"exhibit filings\" in the original question. The answer effectively conveys that the documentation structure remained unchanged, which is the essential insight. No factual errors, calculation errors, or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 406,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s carrying value of the 1.55% Notes Due 2028 was $1.25 billion at each year‑end for FY 2022, FY 2023, and FY 2024 (page 72 shows $1.25 billion for FY 2024 and FY 2023). The unchanged balance over three years indicates a deliberate long‑term debt strategy of maintaining a stable, low‑interest debt load to fund growth while preserving financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims the carrying value was $1.25 billion for all three years (FY 2022, FY 2023, FY 2024), but the ground truth shows: FY 2022: $1,200 million ($1.2 billion), FY 2023: $1,099 million, FY 2024: $1,250 million. The LLM incorrectly states FY 2022 was $1.25 billion when it was actually $1.2 billion - a $50 million error. The LLM also incorrectly claims FY 2023 was $1.25 billion when it was actually $1,099 million - a $151 million error. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to properly track the evolution across three fiscal years. The ground truth shows a clear progression: decrease from FY 2022 to FY 2023 ($1,200M to $1,099M), then increase to FY 2024 ($1,250M). The LLM's claim of 'unchanged balance over three years' is factually incorrect. (3) REASONING QUALITY - While the LLM's interpretation about 'deliberate long-term debt strategy' and 'maintaining stable, low-interest debt load' is reasonable in tone, it is based on false premises (the balance was NOT unchanged). The ground truth correctly identifies this as 'fluctuation' indicating 'strategic management,' which is more accurate than claiming stability. (4) ENTITY ACCURACY - The company (NVIDIA) and debt instrument (1.55% Notes Due 2028) are correctly identified, but the financial metrics are wrong. The LLM's citation to 'page 72' cannot be verified against the ground truth data provided. The answer demonstrates a fundamental failure in quantitative accuracy on a question specifically asking about numerical evolution across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 457,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "AMD’s approach to AIB partners has stayed essentially the same from 2022 through 2024: it continues to supply component‑level graphics and chipset products, and its agreements with AIBs explicitly protect their inventory from price cuts (2022, 2023, 2024).  In each filing the company also stresses that system integrators use discrete graphics solutions to differentiate their board‑level products and add value for customers (2022, 2023, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in addressing the full scope of the question. CORRECT ELEMENTS: (1) The LLM correctly identifies that AMD maintained inventory protection policies across 2022-2024 that shielded AIBs from price reductions. (2) The LLM correctly notes that discrete graphics solutions were emphasized as a differentiation tool across all three years. (3) The dates and year references (2022, 2023, 2024) are accurate. (4) The general characterization of consistency in strategy is partially correct. SIGNIFICANT GAPS AND ISSUES: (1) The LLM fails to capture the EVOLUTION aspect that is central to the question. The ground truth explicitly describes how the emphasis shifted over time - from basic inventory protection language in 2022-2023 to a greater emphasis on discrete graphics differentiation by 2024. The LLM states the approach 'stayed essentially the same' and treats all three years as equivalent, missing this important evolution. (2) The LLM misses the nuance about 'timely product introductions and market competitiveness' language that appeared in 2023 filings, which the ground truth identifies as reinforcing AIB partnerships. (3) The LLM's phrasing 'component-level graphics and chipset products' and 'board-level products' is somewhat imprecise compared to the ground truth's clearer focus on discrete graphics solutions specifically. (4) The LLM doesn't adequately convey that the 2024 shift represented an adaptation to market pressures, which is a key insight in the ground truth. The answer reads as a static summary rather than capturing the strategic evolution requested. MULTI-HOP REASONING: The LLM demonstrates basic multi-hop synthesis by connecting inventory protection policies and discrete graphics across multiple years, but fails to synthesize the temporal evolution dimension that requires comparing how emphasis shifted across the three-year period. This is a critical failure for a question explicitly asking about 'evolution.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 543,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD first flagged “difficulties in protecting our intellectual property” as a general foreign‑operations risk on page 37 of the 2022 10‑K. By 2023 (page 41) the company still listed IP protection as a risk but added explicit concern over China‑Taiwan tensions and its reliance on third‑party wafer foundries. In the 2024 filing (pages 38–40) the risk was expanded to include sanctions, export‑control revisions and geopolitical conflicts (Russia‑Ukraine, Israel‑Hamas) that could disrupt Taiwan‑, China‑ and Malaysia‑based manufacturing, while noting that 66 % of revenue is international and most assembly/testing occurs in those politically sensitive regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of AMD filings. STRENGTHS: (1) Correctly identifies the 66% international revenue figure for 2024, matching the ground truth exactly. (2) Accurately traces the evolution of IP protection risk disclosure from 2022 (general foreign operations risk) through 2023 (China-Taiwan tensions added) to 2024 (expanded to include sanctions, export controls, and multiple geopolitical conflicts). (3) Properly identifies the geographic concentration of manufacturing risks (Taiwan, China, Malaysia) and their connection to IP protection concerns. (4) Correctly notes the progression from general IP protection concerns to region-specific geopolitical risks. (5) Appropriately cites specific page numbers from filings, adding credibility. MINOR WEAKNESSES: (1) The answer mentions 'Israel-Hamas' conflict but the ground truth references 'Middle East' more broadly - while not incorrect, this is slightly more specific than the ground truth stated. (2) The answer doesn't explicitly mention the 65% international sales figure for 2023 that appears in the ground truth, though this is a minor omission. (3) The ground truth notes international sales were 'an unspecified but lower figure in 2022' - the LLM doesn't address this comparison point, though it's not critical to the core answer. QUANTITATIVE VERIFICATION: The 66% figure is correct and properly attributed to 2024. The multi-hop reasoning correctly synthesizes information about IP protection risks, geopolitical tensions, manufacturing locations, and revenue exposure across the three-year period. The answer effectively conveys how the risk evolved from general to specific and regionally concentrated, matching the ground truth's core thesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 492,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "BK continued to award both performance‑share and restricted‑stock units under its 2019 Long‑Term Incentive Plan each year: in 2022 it introduced a 2022 Form of Restricted Stock Unit Agreement (Exhibit 10.19) and a 2022 Form of Performance Share Unit Agreement (Exhibit 10.21) (page 19 of 2022); in 2023 it added a 2023 Form of Performance Share Unit Agreement (Exhibit 10.23) and a 2023 Form of Restricted Stock Unit Agreement (Exhibit 10.24) (page 19 of 2023); and in 2024 it continued the pattern with a 2024 Form of Performance Share Unit Agreement (Exhibit 10.28) and a 2024 Form of Restricted Stock Unit Agreement (Exhibit 10.29) (page 20 of 2024). This steady, year‑over‑year use of both incentive and retention equity under the 2019 LTI Plan indicates a consistent strategy of aligning executive pay with long‑term performance while maintaining a balanced mix of equity awards.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG FORMS CITED: The LLM claims 2022 introduced '2022 Form of Restricted Stock Unit Agreement' and '2022 Form of Performance Share Unit Agreement,' but the ground truth indicates 2022 referenced the '2021 Form of Performance Share Unit Agreement.' The LLM incorrectly attributes 2022-dated forms to 2022, when the ground truth shows the pattern was actually: 2022 used 2021 forms, 2023 used 2020 forms, and 2024 used 2022 forms. (2) INCOMPLETE PATTERN RECOGNITION: The ground truth emphasizes a 'layered approach' with legacy structures being maintained while new forms were introduced (e.g., 2023 introduced 2020 forms while maintaining earlier references). The LLM misses this crucial insight about how older forms were retained alongside newer ones. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a deliberate strategy of 'continuity with periodic enhancements,' showing that new forms were introduced periodically (not annually as the LLM suggests). The LLM's claim of 'year-over-year' introduction of new forms contradicts the actual pattern where forms were introduced less frequently. (4) MISSING CONTEXT: The ground truth emphasizes that the 2019 plan served as the foundational framework throughout, with periodic updates to align with 'evolving performance metrics or market conditions.' The LLM focuses on restricted stock units alongside PSUs but misses the strategic evolution of which form versions were actually in use. (5) EXHIBIT REFERENCES: While the LLM provides specific exhibit numbers, these cannot be verified against the ground truth and appear to be fabricated details that don't match the actual filing structure described in the original answer. The fundamental error is the incorrect dating of which forms were introduced in which years, which is critical to answering the question about how the plan's use 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 530,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s original cost of diagnostics instruments leased to customers increased from **$3.6 B in 2022 to $3.9 B in 2023** and remained at **$3.9 B in 2024** (net book values rose from $1.6 B to $1.8 B and then held steady)【page_64】【page_62】. This modest, steady growth shows the company is maintaining and slightly expanding its diagnostics equipment base rather than pursuing aggressive capital outlays, indicating a focus on sustaining existing capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - Multiple significant factual inaccuracies: (1) ORIGINAL COST NUMBERS WRONG: LLM states original cost was '$3.6B in 2022 to $3.9B in 2023' but ground truth shows $3.3B in 2022 to $3.6B in 2023 - the LLM has shifted all years forward by one year. (2) NET BOOK VALUE NUMBERS WRONG: LLM claims net book values 'rose from $1.6B to $1.8B' but ground truth shows $1.4B in 2022 to $1.6B in 2023 - again, numbers are shifted and incorrect. (3) 2024 DATA MISALIGNMENT: LLM correctly states $3.9B for 2024 original cost, but this is only correct because the prior years were wrong; the net book value claim of '$1.8B then held steady' contradicts ground truth of $1.6B in both 2023 and 2024. (4) MULTI-HOP SYNTHESIS FAILED: The LLM failed to correctly synthesize the three-year trend across 2022-2024. (5) INTERPRETATION ISSUE: LLM's characterization of 'modest, steady growth' and 'maintaining rather than pursuing aggressive capital outlays' contradicts the ground truth's emphasis on 'consistent growth' and 'strategic emphasis on expanding access.' The ground truth shows clear year-over-year increases in both metrics through 2023, then stabilization in 2024, which the LLM misrepresented. All numeric values are materially incorrect, making this answer fundamentally unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 367,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Lumentum Holdings is consistently named in NVIDIA’s competitor list as a rival in the interconnect, switch, and cable solutions segment in fiscal 2022 (page 15), 2023 (pages 9‑11), and 2024 (pages 7‑11)【page_15】【page_9】【page_10】【page_11】【page_7】【page_8】【page_9】【page_10】【page_11】. NVIDIA’s strategic shift toward AI‑driven networking and interconnect technologies has amplified the importance of this category, yet Lumentum’s competitive positioning has remained largely unchanged, indicating a stable but increasingly contested landscape as NVIDIA expands its AI networking portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. CRITICAL ERRORS: (1) The LLM claims Lumentum's competitive positioning 'remained largely unchanged' across the three fiscal years, directly contradicting the ground truth which documents a clear evolution: FY2022 (foundational presence in general interconnect/switch/cable), FY2023 (repositioned to specialized high-performance interconnect segment aligned with AI/accelerated computing), and FY2024 (sharpened corporate identity recognition). This is a fundamental mischaracterization of the competitive positioning trajectory. (2) The LLM states positioning was 'stable but increasingly contested' when the ground truth explicitly describes a 'progression' showing 'rising prominence' and strategic repositioning across years. (3) The LLM provides page citations but does not substantiate the claimed 'unchanged' positioning claim - the ground truth indicates specific repositioning occurred between FY2022 and FY2023 related to NVIDIA's AI focus shift. PARTIAL CREDIT: The LLM correctly identifies Lumentum as appearing in competitor lists across all three fiscal years (FY2022, 2023, 2024) and correctly notes the interconnect/switch/cable solutions segment. The LLM also appropriately acknowledges NVIDIA's strategic shift toward AI-driven networking. However, the core analytical conclusion is inverted - the answer should emphasize evolution and rising prominence, not stability. The multi-hop reasoning fails because it does not synthesize the year-over-year changes in positioning context that the ground truth clearly documents. The answer reads as a surface-level observation rather than the nuanced competitive positioning analysis the question requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 475,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In 2022 Emerson listed pipe cutters under its Tools & Home Products segment as part of its Professional Tools offering (see the 2022 10‑K “Professional Tools” description on page 9). By 2024 the same product line was positioned in the Safety & Productivity segment, where the 2024 10‑K segment description on page 73 lists pipe‑working tools—including cutters—as part of that segment’s portfolio. This shift shows Emerson consolidating its professional‑tool lineup into a safety‑and‑productivity‑focused segment, underscoring a strategy that frames pipe cutters as essential safety and productivity solutions for professionals.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core factual shift—pipe cutters moved from Tools & Home Products (2022) to Safety & Productivity (2024). The dates and segment names are accurate. The LLM appropriately cites specific 10-K page references (page 9 for 2022, page 73 for 2024), demonstrating document-specific knowledge. The characterization of the shift as a 'consolidation' into a 'safety-and-productivity-focused segment' is semantically sound.\n\nWEAKNESSES: The LLM answer is significantly incomplete relative to the ground truth. It omits critical contextual information that directly answers 'what does this reveal about its professional tool strategy': (1) No mention of the InSinkErator divestiture in late 2022, which is explicitly identified in the ground truth as a key strategic signal; (2) Missing the specific grouping context in Safety & Productivity—the ground truth notes pipe cutters were repositioned alongside 'battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras,' which reveals the strategic intent toward infrastructure and industrial-grade tools; (3) No discussion of the shift away from consumer-focused home products, which is central to understanding the strategic realignment; (4) The LLM's framing of the shift as emphasizing 'safety and productivity solutions for professionals' is somewhat generic and doesn't capture the deeper strategic pivot toward high-value industrial/infrastructure tools that the ground truth emphasizes.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years (2022 and 2024) and identifies the segment repositioning. However, it fails to synthesize the broader strategic context (InSinkErator divestiture, portfolio realignment away from consumer products) that would fully answer the 'what does this reveal' portion of the question. The reasoning is surface-level rather than comprehensive.\n\nNUMERIC/DATE ACCURACY: All dates (2022, 2024) and segment names are correct. Page references appear plausible though cannot be independently verified from the provided context.\n\nJUSTIFICATION: The answer is partially correct on the core fact (segment shift) but substantially incomplete on the strategic implications. It reads as a basic factual statement rather than a comprehensive analysis of what the shift reveals about Emerson's professional tool strategy. The omission of the InSinkErator divestiture and the lack of detail about the specific product groupings in Safety & Productivity represent significant gaps in addressing the full question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 691,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 to 2024 Schwab’s RIA platform evolved from a basic website that offered account‑servicing, multi‑year archival, document search, and a free, intuitive portfolio‑management tool (Schwab Advisor Portfolio Connect) with interactive tools and educational content【page_7】 to a more integrated ecosystem that added Ameritrade’s thinkpipes trading engine, iRebal rebalancing, and in 2023 the Schwab Trading Powered by Ameritrade platform—providing a full trading and allocation experience for RIAs【page_7】【page_8】. The website continued to provide the same core account‑servicing and third‑party integration capabilities while now supporting the expanded trading and rebalancing features, and advisor‑support offerings (consulting, benchmarking, and thought‑leadership content) remained robust and unchanged in scope【page_7】【page_8】. Thus, the platform’s functionality grew through added trading and rebalancing tools, its integration deepened with Ameritrade’s technology, and its advisor support offerings stayed consistently comprehensive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) MAJOR ERROR - The LLM introduces 'Ameritrade's thinkpipes trading engine' and 'Schwab Trading Powered by Ameritrade platform' as part of the RIA tools evolution, which are NOT mentioned in the ground truth answer. The ground truth focuses on Advisor Services website, Schwab Advisor Portfolio Connect, third-party integrations, and compliance/archiving features - not trading engines or Ameritrade-specific platforms. (2) MISSING CORE ELEMENTS - The LLM fails to mention several key evolution points from the ground truth: (a) expanded educational and consulting services for RIA independence transition (2023), (b) outbound data feeds for compliance systems (2024), (c) prospect consulting offer expansion (2024), (d) the strategic shift toward managing investment AND compliance workflows seamlessly. (3) INCORRECT CHARACTERIZATION - The LLM describes the 2022 platform as 'basic' and suggests major additions of trading/rebalancing tools, but the ground truth indicates the platform already had robust third-party integrations and account servicing in 2022, with evolution focused on compliance, archiving, and consulting services rather than trading tools. (4) INCOMPLETE SYNTHESIS - While the LLM attempts to address functionality, integration, and advisor support, it does so with incorrect information about what actually changed. The ground truth shows evolution in compliance/operational domains, while the LLM incorrectly emphasizes trading/rebalancing domains. (5) CITATION ISSUES - The LLM cites 'page_7' and 'page_8' but these references don't validate the claims about Ameritrade trading engines or thinkpipes, which appear to be hallucinated details. The answer demonstrates poor multi-hop reasoning by introducing unsupported information rather than synthesizing the actual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 528,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10‑K (Exhibit 4.16, issued March 24 2021) and treated them as long‑term debt with a fixed 1.650 % coupon maturing in 2026. The 2023 and 2024 10‑K filings (Exhibit 4.14 on page 111 of each) continue to list the same notes unchanged, with no amendments, repayments or conversion. This consistency shows Oracle’s strategy of maintaining a stable, low‑rate long‑term debt base to fund short‑to‑intermediate‑term needs, keeping interest costs predictable and avoiding the volatility of short‑term borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Oracle's 1.650% Notes due 2026 were first disclosed in the 2022 10-K (Exhibit 4.16), reaffirmed in 2023 and 2024 10-Ks (Exhibit 4.14), with no modifications across the three-year period. The reasoning about Oracle's stable debt strategy is sound and relevant to the question.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. INCORRECT DATE: The LLM states the notes were \"issued March 24 2021\" but the ground truth indicates they were first introduced in the 2022 10-K filing, suggesting an issuance date in 2021 or earlier is plausible, but this specific date (March 24, 2021) is not verified in the ground truth and appears to be an unsupported detail.\n\n2. EXHIBIT NUMBER INCONSISTENCY: The LLM claims Exhibit 4.14 appears \"on page 111 of each\" 2023 and 2024 filing. The ground truth confirms Exhibit 4.14 for 2023 and 2024, but does not specify page numbers. Adding unverified page numbers introduces potential inaccuracy.\n\n3. CHARACTERIZATION ISSUE: The LLM describes these as \"long-term debt\" while the question and ground truth focus on \"short-to-intermediate term\" debt (maturing in 2026, which is 2-4 years away depending on filing year). This is a semantic distinction but important for debt classification.\n\nSTRENGTHS:\n- Correctly identifies all three years (2022, 2023, 2024)\n- Correctly identifies the coupon rate (1.650%)\n- Correctly identifies the maturity year (2026)\n- Correctly identifies the exhibit numbers (4.16 for 2022, 4.14 for 2023/2024)\n- Correctly notes no amendments, repayments, or conversions\n- Provides sound strategic analysis about stable debt management\n\nWEAKNESSES:\n- Introduces unsupported specific date (March 24, 2021)\n- Adds unverified page number details\n- Minor characterization of debt horizon (long-term vs. short-to-intermediate)\n\nThe answer demonstrates good multi-hop synthesis across three years of filings and sound reasoning about Oracle's strategy, but the introduction of specific details not in the ground truth (exact issuance date, page numbers) and the debt horizon characterization reduce overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 579,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson moved electrical‑distribution equipment out of its Industrial Solutions segment and into the Discrete Automation portfolio.  In the 2022 10‑K the equipment is described as part of Industrial Solutions (page 76), whereas the 2023 and 2024 10‑Ks list it explicitly within Discrete Automation (page 73).  This shift signals a deliberate focus on electrifying discrete‑manufacturing processes, underscoring the company’s strategy to embed industrial‑electrification solutions into its core automation offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core evolution of Electrical Distribution Equipment positioning from 2022 to 2024. STRENGTHS: (1) Correctly identifies the segment shift from Industrial Solutions (2022) to Discrete Automation (2023-2024); (2) Accurately cites specific 10-K page references (page 76 for 2022, page 73 for 2023-2024); (3) Properly synthesizes the multi-hop information across three fiscal years; (4) Correctly interprets the strategic significance of the shift toward industrial electrification and automation integration; (5) Uses appropriate terminology ('discrete-manufacturing processes,' 'industrial-electrification solutions'). MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it doesn't explicitly mention that in 2023-2024 the equipment was positioned 'alongside solenoid valves and programmable control systems,' which provides additional context about the integrated automation approach; (2) The phrase 'core component of industrial automation infrastructure' from the ground truth captures a nuance about positioning that the LLM answer implies but doesn't explicitly state; (3) The ground truth emphasizes the shift from 'general-purpose offering' to 'core component,' which the LLM answer doesn't directly address. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page references appear reasonable for 10-K filings; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two segments, correctly identifying the directional change and its strategic implications. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information and strategic insight, though with slightly less detail than the ground truth regarding the specific products grouped with Electrical Distribution Equipment in the Discrete Automation segment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 532,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate funds rose modestly from **$540 million in 2022 to $555 million in 2023** and then fell back to **$540 million in 2024**【page_68】.  The near‑flat trajectory indicates that Abbott is maintaining a steady, cautiously‑managed exposure to illiquid alternative assets within its pension portfolio, balancing diversification benefits with liquidity considerations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that directly contradict the ground truth: (1) REVERSED NUMBERS: The LLM states unfunded commitments 'rose modestly from $540 million in 2022 to $555 million in 2023' but ground truth shows they DECREASED from $585M (2022) to $555M (2023). The LLM has the 2022 figure completely wrong ($540M vs. $585M). (2) MISSING DATA POINT: The LLM omits the 2022 baseline of $585 million entirely, which is critical for understanding the three-year trend. (3) INCORRECT TREND CHARACTERIZATION: The LLM describes the trajectory as 'near-flat' and 'steady, cautiously-managed exposure,' but the ground truth shows a consistent DECLINE of $45M over three years ($585M→$555M→$540M), representing a deliberate de-risking strategy. (4) INCOMPLETE ANALYSIS: The LLM fails to address key aspects of the ground truth answer: (a) the measured de-risking/rebalancing strategy, (b) the strategic shift away from illiquid alternatives, (c) the long time horizon through 2034 indicating continued belief in long-term value despite reduced exposure, (d) the deliberate approach to managing liquidity risk. (5) SEMANTIC MISINTERPRETATION: By characterizing the trend as 'near-flat' and 'steady,' the LLM fundamentally misrepresents what is actually a consistent three-year reduction pattern. The quantitative errors are severe and non-recoverable - the 2022 figure is off by $45M, and the directional trend is inverted in the narrative. This is a multi-hop question requiring synthesis of three years of data, and the LLM failed to correctly identify or synthesize any of the three data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 447,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently reported the 1.650% Notes due 2026 as part of Exhibit 4.14 in all three filings—2022 (page 111), 2023 (page 109), and 2024 (page 109)—with identical terms and no changes to the maturity or interest rate. The note remains part of the same 2021‑issued series of long‑term notes, indicating Oracle’s preference for a stable, low‑cost debt structure rather than frequent short‑term borrowing. This continuity reflects a short‑term debt strategy that relies on long‑term financing to manage interest costs and maturity risk while preserving liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM cites specific page numbers (111, 109, 109) and Exhibit 4.14 references that cannot be verified against the ground truth and appear to be fabricated details. The ground truth makes no mention of these specific exhibit numbers or page citations. (2) The LLM characterizes the 1.650% Notes as 'long-term notes' and describes the strategy as relying on 'long-term financing,' which contradicts the question's focus on 'short-term debt strategy.' The ground truth correctly identifies these as short-term debt obligations (due 2026, which would be short-term from 2024 perspective). (3) The LLM states the notes are 'part of the same 2021-issued series of long-term notes,' but the ground truth indicates they were established via March 24, 2021 8-K filing—the LLM conflates the establishment date with characterization. (4) The LLM's reasoning about 'preference for stable, low-cost debt structure rather than frequent short-term borrowing' is speculative and not supported by the ground truth, which focuses on the consistency of referencing the original 8-K across three years. WHAT WAS CORRECT: The LLM correctly identifies the 1.650% interest rate, the 2026 maturity date, and the fact that Oracle maintained consistent treatment across 2022, 2023, and 2024 filings. The core insight about continuity and stability is directionally correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the key insight from the ground truth—that Oracle's consistent referencing of the original March 2021 8-K across three annual reports demonstrates a deliberate strategy of maintaining stable short-term debt without modification. Instead, the LLM pivoted to an unsupported characterization of this as 'long-term financing.' The answer demonstrates partial understanding but introduces fabricated details and mischaracterizes the debt classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 529,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014, and the same terms are documented in Exhibit 4.09, which is referenced in the 2022 10‑K (page 113) and re‑filed in the 2023 and 2024 10‑Ks (page 110). The repeated appearance of this long‑maturity instrument over three consecutive filing periods shows Oracle’s intent to keep a stable, diversified debt portfolio with predictable, long‑term financing and to provide consistent disclosure to investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The note is correctly identified as the 4.30% Note due 2034; (2) The multi-year filing pattern across 2022, 2023, and 2024 is correctly identified; (3) The conclusion about stable, diversified debt strategy is semantically aligned with the ground truth; (4) The reasoning about consistent disclosure and investor communication is sound. PROBLEMATIC ASPECTS: (1) The LLM introduces the issuance date of 2014, which is NOT mentioned in the ground truth and cannot be verified from the provided context - this is an unsupported factual claim; (2) The LLM cites specific page numbers (page 113 for 2022, page 110 for 2023 and 2024) which are NOT provided in the ground truth and appear to be hallucinated details; (3) The LLM references 'Exhibit 4.09' for 2023 and 2024, which matches the ground truth, but claims it was in 'Exhibit 4.11' in 2022 according to ground truth - the LLM doesn't mention this exhibit number variation; (4) The ground truth explicitly notes the exhibit changed from 4.11 (2022) to 4.09 (2023-2024), suggesting a structural change in documentation, but the LLM states 'showing no structural changes' which contradicts the exhibit number shift. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and draws appropriate conclusions about debt strategy, but the introduction of unverified details (2014 issuance, specific page numbers) undermines credibility. The answer is directionally correct but contains factual inaccuracies that would be problematic in a financial analysis context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 452,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab used the 2019 IDA agreement to migrate up to $10 billion of IDA balances to its balance sheet each year, while keeping a minimum $50 billion balance and an 80 % fixed‑rate requirement. In 2023 the new 2023 IDA agreement replaced the 2019 terms; Schwab did not move balances that year, the 80 % fixed‑rate rule was eliminated, and new minimum/maximum balance limits ($30 billion above fixed‑rate amounts until Sept 10 2025, then $60 billion min/$90 billion max) and a $5 billion buy‑down option were introduced, but withdrawal restrictions were imposed. In 2024 Schwab again did not migrate IDA balances, and the contractual constraints remained those of the 2023 agreement, with no further changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc (active migration in 2022 → no migration in 2023-2024) and correctly identifies key structural changes (elimination of 80% fixed-rate requirement, introduction of new balance limits and buy-down option). However, there are significant quantitative accuracy issues:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states a \"minimum $50 billion balance\" for 2022, which is not mentioned in the ground truth\n   - The LLM provides specific 2023 balance limits ($30B above fixed-rate amounts until Sept 10 2025, then $60B min/$90B max) and a $5 billion buy-down option that are NOT in the ground truth, suggesting potential hallucination or confusion with other sources\n   - The ground truth mentions $10.1 billion migrated by Dec 31, 2021, and $10 billion subsequent to that date, but the LLM doesn't clearly distinguish these figures\n\n2. COMPLETENESS:\n   - The LLM provides more granular detail about 2023 contractual terms than the ground truth, which is problematic if those details are inaccurate\n   - The LLM correctly notes no migration in 2023 and 2024\n   - The LLM correctly identifies the shift from active to passive approach\n\n3. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies Schwab, IDA agreements (2019 and 2023), and the key metrics\n   - Correctly identifies the 80% fixed-rate requirement elimination\n   - Correctly identifies the $10 billion annual migration capacity in 2022\n\n4. REASONING:\n   - The multi-hop synthesis is sound in structure (comparing 2022 vs 2023 vs 2024)\n   - However, the introduction of unverified specific numbers (balance limits, buy-down option) undermines the reasoning quality\n   - The conclusion about \"increased contractual flexibility\" is supported by the elimination of the 80% requirement, matching the ground truth\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative matches: migration occurred in 2022, stopped in 2023-2024, with contractual changes\n   - However, the specific contractual details provided by the LLM cannot be verified against the ground truth and appear to be either hallucinated or from different sources\n\nThe answer demonstrates good understanding of the overall evolution but introduces unverified quantitative details that significantly reduce confidence in its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 617,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott Laboratories continued to file the same Officer’s Certificate (Exhibit 4.18) for its 2.000% Senior Notes due 2018 in each of the 2022, 2023 and 2024 10‑K filings, all of which referenced the original 2017 indenture. No new supplemental indenture, amendment or refinancing of the 2018 notes was disclosed in any of the three years (page 86, 2022; page 86, 2023; page 86, 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and discrepancies with the ground truth. Key issues: (1) EXHIBIT NUMBER ERROR: The LLM states the notes were filed in 'Exhibit 4.18' while the ground truth indicates 'Exhibit 4.21' - this is a material factual error in document identification. (2) INDENTURE DATE ERROR: The LLM references a '2017 indenture' while the ground truth specifically identifies the 'Fifth Supplemental Indenture dated September 23, 2015' - this is a significant date discrepancy that affects the accuracy of the historical context. (3) INCOMPLETE SYNTHESIS: The LLM answer focuses narrowly on Officer's Certificate filings and lacks the broader context provided in the ground truth about the evolution of documentation practices and the notes' position within Abbott's capital structure across the three years. (4) MISSING CONTEXT: The ground truth emphasizes the continuity of disclosure practices and the notes' status as a 'gradually maturing' component, while the LLM answer merely states no refinancing occurred without addressing the evolution aspect requested in the question. (5) PAGE REFERENCES: While the LLM provides specific page numbers (86, 86, 86), these cannot be verified against the ground truth and may be inaccurate. (6) PARTIAL CORRECTNESS: The LLM correctly identifies that no new supplemental indentures, amendments, or refinancing occurred across the three years, which aligns with the ground truth's conclusion. However, the specific exhibit designation and indenture date errors undermine the credibility of the response. The answer demonstrates incomplete multi-hop reasoning by failing to synthesize the documentation evolution narrative across the three years as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 471,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% Notes due 2041 in 2021, with the officers’ certificate dated March 24 2021 (exhibit 4.14)【page_111】. The same note series is still listed in the 2023 and 2024 10‑K filings (exhibit 4.14) with no new issuance or amendment, indicating the debt remains on the books for its full 20‑year term【page_111】. This multi‑year pattern shows Oracle’s long‑term debt strategy of issuing long‑dated, fixed‑rate notes to lock in borrowing costs and spread maturities over a multi‑decade horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM states Oracle first issued the 3.650% Notes due 2041 in 2021, but the ground truth explicitly states the notes were 'first introduced...in 2022.' This is a fundamental factual error on a key date that directly contradicts the ground truth. The LLM also incorrectly claims the notes have a '20-year term' (which would be 2041-2021=20 years if 2021 were correct, but is actually 2041-2022=19 years based on ground truth). The LLM's statement about 'no new issuance or amendment' and the note remaining 'on the books for its full 20-year term' is speculative and not supported by the ground truth, which focuses on the pattern of continued reference across filings rather than technical maturity calculations. The LLM does correctly identify the note series (3.650% Notes due 2041) and correctly notes its appearance in 2023 and 2024 filings. The reasoning about Oracle's long-term debt strategy (locking in borrowing costs, spreading maturities) is sound and aligns with the ground truth's conclusion about 'stable long-term financing approach.' However, the core temporal error (2021 vs 2022 introduction) is a significant factual mistake that undermines the entire answer's credibility. The ground truth emphasizes the 'consistent inclusion over three years' (2022-2024) as evidence of strategic use, while the LLM's framing around a 2021 introduction and 20-year maturity shifts the narrative incorrectly. The answer demonstrates partial understanding of Oracle's debt strategy but fails on basic factual accuracy regarding the introduction date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 433,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were first issued in 2021 and remained outstanding through 2022, as shown in the 2023 10‑K’s officer certificate (Exhibit 4.14, page_111). In 2023, Oracle issued new 4.500% Notes due 2028 (Exhibit 4.16, page_111), indicating a shift to a higher coupon for the same maturity. By 2024, the 4.500% Notes remained the primary 2028 debt, with no new 2.300% issuance, reflecting a strategy of refinancing existing debt at higher rates to capture favorable market conditions while maintaining a diversified maturity mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. CRITICAL DATE ERROR: The LLM states the 2.300% Notes were 'first issued in 2021,' but the ground truth clearly indicates they were 'first introduced in 2022' with terms set by an Officers' Certificate issued March 24, 2021 (the certificate date is not the issuance date). This is a fundamental factual error.\n\n2. EXHIBIT REFERENCE ERRORS: The LLM cites 'Exhibit 4.14, page_111' for the 2023 10-K officer certificate, but the ground truth references 'Exhibit 4.16' for the debt instruments. The exhibit numbers appear to be incorrect or confused.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth clearly states that in 2023, Oracle issued 'additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16,' indicating EXPANSION of the debt portfolio. The LLM mischaracterizes this as a 'shift' and suggests the 4.500% Notes became 'the primary 2028 debt,' which contradicts the ground truth's emphasis on maintaining BOTH instruments as part of a diversified strategy.\n\n4. MISINTERPRETATION OF STRATEGY: The LLM claims the pattern reflects 'refinancing existing debt at higher rates to capture favorable market conditions,' but the ground truth indicates a 'stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure.' These are fundamentally different interpretations—diversification vs. refinancing.\n\n5. MISSING KEY INSIGHT: The LLM fails to note that by 2024, Oracle 'maintained the same structure for the 2.300% Notes due 2028,' which is crucial to understanding the consistency and stability of the strategy.\n\n6. CONSISTENCY CLAIM ERROR: The LLM states 'no new 2.300% issuance' in 2024, but the ground truth indicates the 2.300% Notes were maintained, not abandoned.\n\nThe answer demonstrates partial understanding of the debt instruments but makes critical errors in dates, exhibit references, and strategic interpretation that significantly undermine its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 553,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022, Visa integrated virtual accounts into its Currencycloud platform as part of the Visa Direct Platform, adding real‑time FX, virtual accounts and liquidity for cross‑border flows (2022 10‑K, page_10). By 2024, that integration deepened—Visa Direct now incorporated Visa Cross‑Border Solutions and Currencycloud capabilities that support new and existing cross‑border consumer payments, expanding the service to more than 195 countries and processing nearly 10 billion transactions (2024 10‑K, page_10).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant issues when compared to the ground truth:\n\n1. CHRONOLOGICAL ACCURACY: The LLM claims virtual accounts were integrated into Currencycloud/Visa Direct Platform in 2022, but the ground truth indicates this was a 2023 development (\"By 2023, virtual accounts were fully integrated into the Visa Direct Platform\"). The LLM conflates the 2022 introduction with the 2023 integration, which is a material factual error in the timeline.\n\n2. QUANTITATIVE ERRORS: The LLM states \"nearly 10 billion transactions\" for 2024, but the ground truth specifies \"more than 11 billion endpoints\" - these are different metrics (transactions vs. endpoints). The LLM appears to have confused or misrepresented the metric entirely. The 195 countries figure is not mentioned in the ground truth, making it unverifiable from the provided context.\n\n3. MISSING CONTEXT: The LLM omits the 2022 Treasury as a Service initiative context that the ground truth emphasizes. It also fails to clearly distinguish the evolution across the three-year period (2022→2023→2024), instead presenting a 2022-to-2024 comparison that obscures the 2023 integration milestone.\n\n4. INCOMPLETE SYNTHESIS: The LLM does not adequately address the \"Treasury as a Service\" framing from 2022 or the progression of how virtual accounts evolved from introduction to full integration to continued core component status. The multi-hop reasoning across the three years is weak.\n\n5. PARTIAL CREDIT: The LLM correctly identifies Currencycloud, Visa Direct Platform, cross-border capabilities, and real-time FX as relevant elements. The general direction of integration and expansion is correct, but the execution and specific details are problematic.\n\nThe answer demonstrates partial understanding but contains a critical chronological error (2022 vs. 2023 integration), metric confusion (transactions vs. endpoints), and incomplete multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 534,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2024 the ME&T dealer network that carries EMD‑branded engines grew from 152 dealers in 187 countries to 160 dealers in 193 countries in 2023, then slightly contracted to 156 dealers in 191 countries in 2024【page_66】【page_65】【page_64】.  This pattern shows Caterpillar’s intent to broaden its global reach for EMD while fine‑tuning dealer coverage to improve efficiency and focus on high‑growth markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly all quantitative metrics. Specific errors: (1) DEALER/DISTRIBUTOR NUMBERS: Ground truth states 110 distributors in 2022, 110 in 2023, and 108 in 2024. LLM claims 152 dealers in 2022, 160 in 2023, and 156 in 2024 - all numbers are wrong and significantly higher than actual. (2) COUNTRY COVERAGE: Ground truth shows 109 countries in 2022-2023, expanding to 158 in 2024. LLM claims 187 countries in 2022, 193 in 2023, and 191 in 2024 - all numbers are substantially incorrect and show the opposite trend (declining rather than expanding). (3) PRODUCT CATEGORY CONFUSION: Ground truth specifically references FG Wilson branded electric power generation systems (a specific product line within EMD). LLM vaguely references 'ME&T dealer network' and 'EMD-branded engines' without proper product specification. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the geographic distribution data across the three-year period. The ground truth shows a clear pattern of optimization (slight decrease in distributors from 110 to 108) coupled with geographic expansion (109 to 158 countries). The LLM's numbers suggest a different pattern entirely. (5) STRATEGIC INTERPRETATION: While both answers attempt to characterize the strategy as optimization plus expansion, the LLM's interpretation is based on completely incorrect underlying data, making the conclusion unreliable. The answer appears to have fabricated or severely misread the source data, as evidenced by the page citations that don't align with the actual numbers provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 444,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s investment in diagnostics instruments leased to customers grew modestly from 2022 to 2023, with the original cost rising from **$3.6 billion to $3.9 billion** and the net book value climbing from **$1.6 billion to $1.8 billion**.  The figures then held steady through 2024, remaining at **$3.9 billion** for original cost and **$1.8 billion** for net book value (page_64 2022, page_63 2023, page_64 2024).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Abbott's investment evolution. (1) CRITICAL ERRORS - Numbers are substantially wrong: The LLM states original cost rose from $3.6B to $3.9B (2022-2023), but ground truth shows $3.3B to $3.6B for those years. The LLM completely omits the 2022 baseline figures ($3.3B original cost, $1.4B net book value) which are essential to answering 'how did it evolve from 2022 to 2024.' (2) INCOMPLETE TIMELINE - The LLM incorrectly claims figures 'held steady through 2024' at $3.9B and $1.8B, but ground truth shows continued growth to $3.9B (original cost) and $1.8B (net book value) in 2024 - these ARE the 2024 figures, not a plateau. The answer fails to properly characterize the three-year progression. (3) MULTI-HOP SYNTHESIS FAILURE - The question explicitly asks about evolution 'from 2022 to 2024' requiring all three years' data. The LLM only addresses 2023-2024 and misses the crucial 2022 starting point. (4) CALCULATION/COMPARISON ERRORS - The LLM's characterization of 'modest growth' and 'held steady' contradicts the actual consistent year-over-year increases shown in ground truth ($3.3B→$3.6B→$3.9B and $1.4B→$1.6B→$1.8B). The answer demonstrates fundamental misunderstanding of the data structure and fails to provide the complete three-year evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 377,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo’s 10‑K filings for 2022, 2023 and 2024 all list the 3.450% Senior Note due 2046 in Exhibit 4 (see page 126 of each filing), showing that the note remains an outstanding long‑term debt instrument. This consistent disclosure signals that the company continues to rely on this fixed‑rate, 2046‑maturity note as a core component of its capital‑structure mix, helping to maintain a diversified debt maturity profile and a stable interest‑expense base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 3.450% Senior Note due 2046 and its consistent presence across 2022, 2023, and 2024 10-K filings, and provides reasonable interpretation of what this consistency indicates about PepsiCo's capital structure strategy. However, there are significant issues with quantitative accuracy: (1) The LLM claims the note appears in 'Exhibit 4 (see page 126 of each filing)' but the ground truth specifies different exhibit numbers for each year (Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024). This is a material factual error regarding the specific exhibit locations. (2) The page reference to 'page 126 of each filing' is not verified against ground truth and appears to be a generalization that may not be accurate across all three years. (3) The LLM does not mention the specific exhibit numbers at all, which were explicitly noted in the ground truth as important details showing the consistent tracking of this instrument. On the positive side: (1) The semantic interpretation of the note's role is sound—both answers recognize it as a stable, long-term, fixed-rate debt component. (2) The LLM correctly identifies the note's maturity date (2046) and interest rate (3.450%). (3) The reasoning about capital structure diversification and stable interest expense is logical and relevant. (4) The multi-hop synthesis across three years is present and appropriate. The main weakness is the inaccuracy regarding exhibit numbers and page references, which undermines the factual precision expected in financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 434,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 as part of a structured debt program (see 2022 10‑K Exhibit 4.16). The same terms and maturity were disclosed unchanged in the 2023 10‑K (Exhibit 4.14) and the 2024 10‑K (Exhibit 4.14)【page_114】【page_111】【page_109】. This continuity across three fiscal years indicates Oracle’s strategy of maintaining a stable, long‑term debt profile with staggered maturities and moderate coupon rates, allowing it to manage refinancing risk and interest costs without frequent restructuring.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) ISSUANCE DATE DISCREPANCY: LLM states the 2.300% Notes were 'issued in 2021,' but the ground truth indicates they were 'first introduced in 2022' as part of Exhibit 4.16. This is a factual error regarding when the instrument first appeared in Oracle's disclosures. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly mentions that Oracle layered in NEW issuances with higher yields (4.500% Notes due 2028) in 2023 and 2024, reflecting changing market conditions. The LLM answer completely omits this critical comparative analysis of the broader debt strategy, which is central to answering the question about 'evolution' and 'broader debt financing strategy.' (3) MISSING CONTEXT: The ground truth references specific exhibits (4.16 in 2022, 4.14 in 2023-2024) and mentions other concurrent debt instruments (1.650% Notes due 2026, 2.875% Notes due 2031), providing a richer picture of Oracle's debt portfolio evolution. The LLM only mentions the 2.300% Notes in isolation. (4) INCOMPLETE PATTERN ANALYSIS: While the LLM correctly identifies 'continuity,' it fails to capture the key insight from the ground truth: Oracle was 'maintaining a consistent approach to referencing prior debt instruments while LAYERING IN NEW ISSUANCES WITH POTENTIALLY HIGHER YIELDS.' This layering strategy is the crucial pattern that explains Oracle's financing approach during this period. (5) REASONING QUALITY: The LLM's conclusion about 'stable, long-term debt profile' is reasonable but misses the dynamic aspect of adding higher-yielding instruments, which suggests Oracle was responding to market conditions rather than maintaining a purely static strategy. CORRECT ELEMENTS: The LLM correctly identifies the 2.300% coupon rate, the 2028 maturity date, and the presence of the notes in 2023 and 2024 filings. The general concept of staggered maturities and refinancing risk management is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 517,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has continued to designate its Series B Convertible Participating Preferred Stock in the 2022, 2023, and 2024 10‑K filings, with the certificate of designation appearing unchanged in each report (see Exhibit 4.4 on page_109 and page_114). This consistency indicates that Visa prioritizes a stable, flexible capital structure and keeps convertible preferred equity as a long‑term financing option for future capital needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Visa's Series B Convertible Participating Preferred Stock remained unchanged across 2022-2024 filings and references the same Certificate of Designations. The core factual claim about consistency is accurate. However, there are several significant issues: (1) The LLM provides specific exhibit references (Exhibit 4.4, page_109, page_114) that cannot be verified from the ground truth and appear to be hallucinated details - the ground truth does not provide these specific page numbers or exhibit citations. (2) The LLM answer is substantially less comprehensive than the ground truth. It omits important contextual details such as: the specific date of the Certificate of Designations (June 21, 2016), the connection to unchanged Bylaws in the 2022 filing, and the 2024 update to the Certificate of Incorporation without changes to Series B structure. (3) The reasoning is somewhat superficial - the LLM states the consistency 'indicates' stable capital structure but doesn't explain the deeper significance about 'deliberate choice to preserve existing shareholder rights' or the broader pattern of stability in capital management. (4) The LLM's interpretation about 'keeps convertible preferred equity as a long-term financing option for future capital needs' is reasonable but represents inference rather than explicit ground truth content. The answer is directionally correct on the main point but lacks the depth, specificity, and supporting details present in the ground truth, and includes unverifiable exhibit citations that suggest hallucination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 438,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In 2022 Caterpillar disclosed that its Cat Financial segment had significant LIBOR‑based loans and derivatives and that a cross‑functional team was formed to assess the impact of LIBOR reform and the transition to SOFR. By 2023 the company had begun shifting variable‑rate exposures to SOFR, continued to use currency‑hedging instruments to mitigate exchange‑rate risk, and warned that ineffective hedges could hurt earnings. In 2024 the disclosures reiterated the use of SOFR‑linked instruments and hedging strategies, noting that while hedges protect against adverse currency moves they can also forgo favorable fluctuations and may still be ineffective, underscoring an ongoing focus on managing the transition and associated risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the 2022 formation of a cross-functional team to assess LIBOR reform impacts, (2) Accurately captures the 2023 shift to SOFR-based instruments, (3) Properly notes the 2024 continuation of SOFR-linked hedging strategies, (4) Appropriately emphasizes the dual nature of hedges (protection against adverse moves but forgoing favorable ones), (5) Correctly identifies Cat Financial as the relevant segment, (6) No quantitative errors or incorrect dates. MINOR GAPS: (1) The original answer emphasizes 'consistent reliance on currency hedging instruments' as a through-line across all three years more explicitly than the LLM answer does - the LLM focuses more on the LIBOR-to-SOFR transition narrative, (2) The original answer mentions 'match funding, selective derivatives, and diversified funding' as specific 2023 strategies, which the LLM answer does not detail, (3) The original answer notes 'no significant changes in approach' in 2024, whereas the LLM answer focuses more on the risks and limitations of hedges. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly traces the evolution from LIBOR assessment (2022) through SOFR transition (2023) to ongoing SOFR management (2024). The connection between currency hedging and interest rate risk management is appropriately maintained. The answer correctly identifies that the company's hedging strategy evolved in response to regulatory/market changes while maintaining core risk management objectives. No calculation errors or factual inaccuracies detected. The semantic meaning aligns well with the ground truth, though with slightly different emphasis on the currency hedging consistency theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 504,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "After the 2021 LTL bankruptcy filing, J&J funded a $2 billion trust and set a matching reserve to cover LTL’s talc liabilities. The bankruptcy was dismissed in 2022, and a second filing was dismissed in 2023, prompting J&J to shift to a consensual pre‑packaged Chapter 11 plan that would resolve 99.75 % of claims for a present‑value $9 billion (including the $2 billion trust) over 25 years. By 2024 the company had increased the plan’s value by $1.75 billion, restructured the debtor into LLT and created new entities (Red River, Pecos River) to isolate specific claim classes while maintaining the $2 billion trust as part of the overall reserve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. TIMELINE ERRORS: The LLM states the 'first LTL bankruptcy filing' occurred in 2021, but the ground truth indicates it was already established by 2022 with litigation stayed due to LTL's Chapter 11 filing. The LLM's 2021 date is not corroborated.\n\n2. DISMISSAL SEQUENCE CONFUSION: The LLM claims 'the bankruptcy was dismissed in 2022' but the ground truth states the Third Circuit reversed the bankruptcy court's decision in 2023, leading to dismissal of the initial LTL bankruptcy. The timing is off by one year.\n\n3. UNSUPPORTED FINANCIAL CLAIMS: The LLM introduces a '$9 billion' present-value figure and claims J&J 'increased the plan's value by $1.75 billion' by 2024. These specific numbers do not appear in the ground truth and cannot be verified. The ground truth only confirms the $2 billion trust established in 2022.\n\n4. ENTITY NAME ERRORS: The LLM refers to 'LLT' as a restructured debtor entity and mentions 'Red River' and 'Pecos River' entities. These specific entity names and restructuring details are not mentioned in the ground truth, which only references 'LTL Management LLC' and 'LTL 2'.\n\n5. MISSING KEY INFORMATION: The LLM fails to mention the Third Circuit's reversal in 2023, which was a critical turning point in the legal strategy evolution. It also doesn't clearly articulate the shift from initial bankruptcy dismissal to subsequent refiling.\n\n6. INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution across years, it introduces speculative details about 'consensual pre-packaged Chapter 11 plans' and entity restructuring that go beyond what the ground truth establishes.\n\nThe answer demonstrates partial understanding of the general trajectory (bankruptcy filings, trust establishment, ongoing litigation) but fails on specific dates, financial figures, and entity details that are critical to answering this multi-hop question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 541,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "In 2022, Adobe positioned the Photography Plan as a targeted bundle inside its Creative Cloud subscription, giving photographers access to Photoshop, Lightroom and Lightroom Classic【page_5】. By 2023 the plan remained a focused package but Adobe deepened its appeal by embedding generative‑AI tools—such as Generative Fill/Expand in Photoshop, Firefly integration and other AI‑powered features—across the Creative Cloud suite【page_3】【page_5】. In 2024 the plan was re‑branded as a distinct, more limited cloud‑based offering aimed at photographers and photo enthusiasts, adding AI‑powered tools like Generative Remove in Lightroom and broader Firefly integration across Photoshop and other apps, sharpening its positioning and value for creative professionals【page_10】【page_12】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's Photography Plan evolution from 2022-2024 and correctly identifies the core strategic shifts. STRENGTHS: (1) Accurately captures the three-year progression with correct year-by-year positioning; (2) Correctly identifies the core products (Photoshop, Lightroom, Lightroom Classic) in 2022; (3) Properly recognizes the AI integration strategy across 2023-2024, mentioning specific features like Generative Fill, Firefly integration, and Generative Remove; (4) Accurately reflects the shift toward AI-powered enhancements as a key strategic differentiator; (5) Correctly notes the Photography Plan's positioning as a more limited alternative to full Creative Cloud. MINOR ISSUES: (1) The LLM states the plan was 're-branded as a distinct, more limited cloud-based offering' in 2024, which adds interpretive language not explicitly confirmed in ground truth—the ground truth says it was 'further refined' rather than 're-branded'; (2) The LLM mentions 'Generative Remove in Lightroom' specifically for 2024, while ground truth mentions 'Lens Blur' and 'People Masking' as 2024 enhancements—there's a slight feature attribution difference, though both represent AI-powered enhancements; (3) The answer includes page citations that cannot be verified against the ground truth source. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression from basic bundling (2022) → AI integration emphasis (2023) → refined AI-powered offering (2024). The semantic meaning aligns well with ground truth regarding strategic positioning and evolution. The core narrative of increasing AI integration and refined positioning for photographers is accurately conveyed. No significant calculation or quantitative errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 497,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s specimen certificate for class C common stock has remained unchanged from 2022 through 2024.  In 2022 the certificate appears as Exhibit 4.3 (8‑A, file 000‑53572, filed 1/28/2009)【page_114】, while in 2023 and 2024 it is listed as Exhibit 4.2 with the identical description, form type, and file number【page_109 (2023)】【page_109 (2024)}.  This consistency signals Visa’s deliberate focus on stable, transparent governance and investor communication, reassuring shareholders that its foundational corporate documents remain reliable even as regulatory and market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IDENTIFIED: The LLM answer contains a significant factual error regarding the exhibit number in 2022. The LLM states that in 2022 the certificate appears as Exhibit 4.3, while the ground truth clearly indicates it was Exhibit 4.2 across all three years (2022, 2023, and 2024). This is a material error that undermines the core claim of consistency. The ground truth explicitly states 'Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024' with 'each year citing Exhibit 4.2.' The LLM's assertion of an Exhibit 4.3 in 2022 contradicts this. CORRECT ELEMENTS: The LLM correctly identifies the filing date (January 28, 2009), the file number (000-53572), the form type (8-A), and the fact that the certificate remained unchanged across the three-year period. The qualitative interpretation about stable governance and investor relations is appropriate and aligns with the ground truth's assessment. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly interprets what the consistency suggests about corporate governance. However, the factual error about the exhibit number in 2022 is a quantitative accuracy failure that significantly impacts the answer's reliability. The ground truth also notes that the Certificate of Incorporation was revised in 2024, providing important context about selective updates to governance documents—this contextual detail is absent from the LLM answer but not critical to answering the specific question about the stock certificate. OVERALL ASSESSMENT: While the LLM demonstrates sound reasoning about governance implications and correctly identifies most factual elements, the exhibit number discrepancy for 2022 is a material factual error that prevents a higher score. The answer is partially correct but contains a significant quantitative inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 525,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million at December 31, 2022** to **$1,091 million at December 31, 2023** and further to **$993 million at December 31, 2024** – a net decline of $116 million over two years. The reductions were driven by settlements outpacing new guarantees issued (2024: 216 issued vs. 247 settled, 67 other; 2023: 305 issued vs. 308 settled, 15 other; 2022: 264 issued vs. 284 settled, 28 other). This trend indicates that RTX is actively trimming its exposure to future guarantee costs, reflecting more effective risk management and potentially improved product performance in its commercial aerospace contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference entirely different financial data than the ground truth. Critical issues: (1) WRONG NUMBERS: The LLM cites $1,109M (2022), $1,091M (2023), and $993M (2024) for total performance and operating cost guarantees, while the ground truth specifies $140M (2022), $135M (2023), and $131M (2024) for collaboration partners' share of financing guarantees. These are off by a factor of approximately 8x. (2) WRONG METRIC: The LLM appears to be discussing total performance and operating cost guarantees (likely a broader category), while the ground truth specifically addresses the collaboration partners' share of financing guarantees - a distinct and much smaller liability component. (3) CALCULATION ERROR: The LLM claims a $116M decline over two years ($1,109M - $993M = $116M), which is arithmetically correct for its numbers but irrelevant since the numbers themselves are wrong. (4) MISALIGNED CONTEXT: While the LLM's reasoning about settlements outpacing new guarantees issued is logically sound and shows understanding of risk management dynamics, it is applied to the wrong financial figures. (5) MISSING CORE ANSWER: The ground truth emphasizes a 'relatively stable' and 'gradual reduction' pattern ($140M→$135M→$131M), while the LLM describes a more dramatic decline from a much larger base. The LLM has either confused different line items in RTX's financial statements or referenced incorrect source data entirely. The answer fails on quantitative accuracy (wrong numbers by orders of magnitude) and entity accuracy (wrong liability component), making it unsuitable despite reasonable analytical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 457,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s 10‑K disclosures for FY 2022, 2023 and 2024 all describe free‑rent periods as being recognized on a straight‑line basis over the lease’s original term and any extension options that the Company is reasonably certain to exercise. The lease term is consistently defined as the non‑cancelable period plus such options, and right‑of‑use assets continue to be measured at the present value of discounted minimum lease payments using the incremental borrowing rate. Consequently, there were no material changes in the accounting treatment or disclosure of free‑rent periods or their impact on ROU asset valuations across these fiscal years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and misses critical evolution details that the ground truth identifies. CORRECT ELEMENTS: (1) The LLM correctly identifies that Costco used straight-line basis for free-rent periods across all three years, (2) correctly notes the lease term definition including extension options the company is reasonably certain to exercise, (3) correctly identifies use of incremental borrowing rate for ROU asset valuation. CRITICAL ERRORS AND OMISSIONS: (1) The LLM states 'there were no material changes in the accounting treatment or disclosure' - this directly contradicts the ground truth which explicitly documents evolution in disclosures across the three years, (2) The LLM completely misses the 2023 expansion of disclosure regarding variable lease payments tied to price indices or sales volume - a key evolution point, (3) The LLM fails to capture the 2024 shift in emphasis toward impairment evaluation of long-lived assets and heightened focus on lease-related asset valuations in context of facility relocations/closures - another critical evolution, (4) The LLM misses the contextual evolution showing 'growing operational complexity in lease management' that the ground truth emphasizes. MULTI-HOP REASONING ISSUE: The question specifically asks about evolution 'from fiscal years 2022 through 2024' - this requires synthesizing changes across three years. The LLM incorrectly concludes no material changes occurred, when the ground truth clearly documents progressive evolution in disclosure emphasis and context. The LLM's conclusion that the 'core accounting policy remained stable' is technically correct but fundamentally incomplete - the question asks about evolution in 'accounting treatment AND disclosure' and 'impact on right-of-use asset valuations,' not just core policy stability. The answer reads as a static description rather than a dynamic analysis of how things evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 523,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe’s AI‑powered document strategy grew from 2022 to 2024, shifting from basic AI tweaks in Acrobat to a full AI‑powered ecosystem. In 2022, Acrobat was enhanced by Sensei‑driven AI and API integration (pages 6‑7). By 2023, Acrobat added Liquid Mode, generative tools under the new “Adobe Firefly” brand, and increased R&D spend to support these capabilities (pages 2‑5). In 2024, Acrobat remains the core AI‑powered engine, now integrated with Sign and Scan and highlighted as “Adobe Acrobat” in the product line, while Firefly continues as the formal brand for generative AI, reflecting deeper AI R&D investment (pages 94‑95).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the general trajectory of Adobe's AI strategy evolution from 2022-2024 and mentions key products (Acrobat, Firefly, Liquid Mode). It appropriately addresses the three main question components: Acrobat's role, R&D investments, and product branding. The semantic direction matches the ground truth (evolution from foundational document role to AI-enhanced productivity). CRITICAL WEAKNESSES: (1) FACTUAL ERRORS - The LLM claims 'Sensei-driven AI and API integration' in 2022, but the ground truth emphasizes Acrobat's foundational document leadership role and PDF creation volume (trillions annually), not Sensei specifics. (2) PRODUCT BRANDING CONFUSION - The LLM states 'Adobe Firefly' was introduced in 2023 as a generative AI brand, but the ground truth specifically highlights 'Acrobat AI Assistant' as the formal branded product extension in 2024, not Firefly as the primary document AI branding. This is a significant distinction for answering the 'formal product branding' component. (3) INCOMPLETE SYNTHESIS - The LLM mentions 'increased R&D spend' but provides no specific numbers or context, whereas the ground truth emphasizes 'multi-year investment in integrating AI capabilities.' The LLM references specific page numbers (6-7, 2-5, 94-95) that cannot be verified against the ground truth knowledge graph. (4) MISSING KEY CONTEXT - The ground truth emphasizes the 2023 formal introduction of AI as a 'core strategic focus' signaling evolution in product development plans, which the LLM mentions only tangentially. The ground truth's emphasis on 'document intelligence' as a market opportunity is absent from the LLM response. QUANTITATIVE ACCURACY: Very low (3/10) - No specific R&D investment figures provided; page references cannot be verified; no quantitative metrics about PDF volume or market data. QUALITATIVE ACCURACY: Moderate (6/10) - Correct general trajectory but confused product branding (Firefly vs. Acrobat AI Assistant) and missing strategic context about formal AI focus introduction. CONTEXTUAL RELEVANCE: Good (7/10) - Addresses all three question components but with incomplete and partially inaccurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 587,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "From 2022 through 2024 Schwab expanded the amount of client securities it could pledge, with the fair value of securities available to be pledged rising from $120.3 B in 2021 to higher levels in subsequent years, and the fair value of securities actually pledged for margin, short‑sale collateral, and securities‑lending activities increasing from $31.4 B in 2021 to $?? B in 2024 (see the margin‑lending table on page 108). This upward trend reflects a balance‑sheet strategy that leverages client collateral to support margin lending and securities‑lending programs, generating interest income and liquidity while encouraging client leverage (see page 107 and page 78). The continued use of client securities as collateral indicates Schwab’s focus on maintaining liquidity and income generation through securities lending, even as it offers margin facilities that raise the firm’s exposure to client‑driven leverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative about Schwab's evolution in pledging client securities from 2022-2024, mentions the connection to margin lending and securities lending activities, and appropriately discusses balance sheet strategy and client leverage. The answer correctly cites specific page references (107, 108, 78) and identifies the key financial metrics (securities available to be pledged vs. securities actually pledged). The qualitative reasoning about liquidity generation and income through securities lending is sound.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific numbers ($120.3B in 2021 for securities available to be pledged, $31.4B in 2021 for securities actually pledged) but then uses '??' for the 2024 figure, indicating incomplete data retrieval. This is a significant gap since the question specifically asks about the evolution 'through 2024.' The answer cannot be fully evaluated without the 2024 pledged securities figure. (2) INCOMPLETE TEMPORAL ANALYSIS: While the original answer provides a year-by-year progression (2022 → 2023 → 2024) with qualitative details about disclosure evolution and formalization, the LLM answer jumps from 2021 baseline data to a general statement about 2022-2024 without clearly delineating the year-by-year changes. (3) MISSING DISCLOSURE EVOLUTION: The original answer emphasizes the progression in disclosure quality and formalization (from unquantified in 2022 to explicit statements in 2024 about OCC options clearing and securities lending collateral requirements). The LLM answer focuses primarily on quantitative growth but misses this important disclosure/transparency evolution. (4) INCOMPLETE SYNTHESIS: The LLM references page numbers but doesn't synthesize the specific regulatory and operational details mentioned in the original answer regarding OCC options clearing and the formalization of collateral practices.\n\nCALCULATION/VERIFICATION ISSUES: The numbers provided ($120.3B, $31.4B) cannot be verified against the original answer, which provides no specific figures. The original answer explicitly states 'specific pledged amounts were not quantified' in 2022, suggesting the LLM may be citing data from different years or sources than what the ground truth references. The missing 2024 figure ('??') is a critical omission that prevents full evaluation of the trend analysis.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the connection between client securities pledging, margin lending, securities lending, and balance sheet strategy. However, it fails to complete the full temporal synthesis by not providing the 2024 endpoint data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 712,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "In 2022 the 1.375% Senior Notes due June 2027 were recorded as long‑term debt (carrying $1,250) and contributed to a total long‑term debt of $6,590 (excluding a $73 current portion). By 2024 the notes were still classified as long‑term debt at the same $1,250, but total long‑term debt had fallen to $5,919 (excluding a $103 current portion) because the 2.750% Senior Notes were repaid and other long‑term debt rose from $590 to $919, shifting the debt mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) MAJOR NUMBER ERRORS: The LLM states 2022 long-term debt (excluding current) was $6,590 million, but ground truth shows $6,484 million - a $106 million discrepancy. For 2024, LLM claims $5,919 million vs. ground truth of $5,794 million - a $125 million error. These are not minor rounding differences but material misstatements. (2) INCORRECT REASONING ON DEBT COMPOSITION: The LLM claims 'other long-term debt rose from $590 to $919' and that '2.750% Senior Notes were repaid,' but the ground truth explanation focuses on reclassification (moving from long-term to current portion) rather than repayment. The LLM's explanation of the debt mix shift is fundamentally different and appears incorrect. (3) PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies that the 1.375% Senior Notes remained at $1,250 million across all three years and correctly notes the notes stayed classified as long-term debt. The general direction of long-term debt decline is correct. (4) MULTI-HOP SYNTHESIS WEAKNESS: While the LLM attempts to synthesize information about debt classification and composition changes, the specific numbers and causal explanations are inaccurate, suggesting the model either misread the source data or made calculation errors. The ground truth emphasizes reclassification of the 2.750% notes due to approaching maturity, while the LLM suggests repayment - a meaningful distinction. (5) MISSING CONTEXT: The LLM doesn't clearly explain that the decline in long-term debt was primarily driven by reclassification mechanics rather than debt reduction, which is a key insight from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 469,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe’s 10‑K filings from 2022 through 2024 consistently list a large catalog of free online self‑service learning on learning.adobe.com as a core element of its Digital Learning Services (page 17). By 2024 the description places this offering squarely within the broader Customer Solutions portfolio—alongside fee‑based training, custom learning, consulting and technical support—highlighting its role in enterprise enablement. The 2024 filing also stresses that solution‑specific skills assessments and custom learning services are used by Customer Success Managers to assess enterprise teams and tailor learning priorities, tightening the link between free self‑service learning and enterprise customer‑success strategies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Adobe's evolution in free online self-service learning from 2022-2024 and correctly identifies key elements: (1) consistent positioning as a core component across all three years, (2) integration within the broader Customer Solutions/learning services portfolio, (3) the role of skills assessments and custom learning in enterprise customer success strategies, and (4) the tightening link between free self-service learning and enterprise enablement. The answer appropriately references learning.adobe.com and Digital Learning Services. However, there are some minor issues: (1) The LLM cites 'page 17' as a source, which is a specific reference not verified in the ground truth and may be overly precise without confirmation; (2) The ground truth mentions 'learning and enablement services' while the LLM uses 'Digital Learning Services' and 'Customer Solutions portfolio'—these appear to be equivalent concepts but the terminology differs slightly; (3) The LLM answer is somewhat more concise than the ground truth, omitting the explicit year-by-year progression narrative (2022 introduction, 2023 reinforcement, 2024 maturation) that the ground truth provides, though the core facts remain accurate; (4) The ground truth emphasizes 'democratizing product knowledge' as a strategic commitment, which the LLM answer doesn't explicitly mention. The multi-hop reasoning is sound—the answer correctly synthesizes information about how free learning evolved within the broader portfolio and its integration with enterprise strategies. No numerical errors or calculation issues are present. The answer is semantically equivalent to the ground truth on the main points but lacks some of the nuanced progression narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 479,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 were $1,044 million at the end of 2022 (unchanged in 2023) and rose modestly to $1,057 million by the end of 2024, a 1.2 % increase【page_78】【page_67】. The near‑flat exposure over three years shows the company is deliberately keeping long‑term debt levels stable, using its AI‑driven cash‑flow growth to service debt without expanding leverage【page_67】, reflecting a conservative long‑term debt‑management strategy amid rapid revenue acceleration.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM states 2022 value as $1,044 million (ground truth: $1.20 billion/$1,200 million) - a $156M discrepancy. The LLM claims 2023 was 'unchanged' at $1,044M (ground truth: $1.057 billion/$1,057 million). The LLM states 2024 was $1,057 million (ground truth: $1.25 billion/$1,250 million) - a $193M error. The LLM's claimed 1.2% increase calculation is based on wrong numbers ($1,044M to $1,057M = 1.24%, but both values are incorrect). (2) PATTERN MISIDENTIFICATION: The LLM describes the trend as 'near-flat' and 'stable,' when the actual pattern shows: 2022 ($1,200M) → 2023 ($1,057M, -12% decrease) → 2024 ($1,250M, +18% increase). This is a dynamic, fluctuating pattern, not stable. (3) REASONING FAILURE: The LLM's interpretation of 'conservative debt management' contradicts the ground truth's more nuanced analysis of strategic debt optimization and refinancing opportunities. The LLM missed the key insight that NVIDIA initially reduced exposure then increased it again. (4) MULTI-HOP SYNTHESIS: Failed to correctly synthesize the three-year trend across multiple filings. The answer demonstrates fundamental data retrieval errors rather than reasoning errors. The page citations provided cannot validate the incorrect numbers stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 385,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson’s multi‑year, enterprise‑wide initiative has remained essentially unchanged from 2022 through 2024, consistently describing the same goal of “integrating, simplifying and standardizing processes and systems for HR, IT, procurement, supply chain and finance” to grow its financial shared‑service capabilities and standardize financial systems【2022 page 118】【2023 page 118】【2024 page 118】.  Each filing reiterates the ongoing alignment and streamlining of the financial control environment, underscoring a sustained strategic emphasis on standardizing financial processes and tightening control alignment to support efficient, governed operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the multi-year initiative spanning 2022-2024 and accurate page references (page 118 across all three years). The core narrative about process integration, simplification, and standardization is correct, and the emphasis on financial shared services and control environment alignment matches the ground truth. However, there are notable differences in completeness and framing: (1) The LLM expands the scope beyond what the ground truth emphasizes by including HR, IT, procurement, and supply chain alongside finance, which may be accurate but represents a broader interpretation than the ground truth's focus on 'key functions, including finance.' (2) The LLM answer is more concise and direct, stating the initiative 'remained essentially unchanged,' which captures the consistency message but lacks the nuanced progression narrative present in the ground truth that distinguishes between 2022 (proactive effort), 2023 (reiteration with alignment emphasis), and 2024 (continuity affirmation). (3) The ground truth emphasizes the non-reactive nature of the initiative ('without being prompted by any internal control deficiencies'), which the LLM answer omits entirely. (4) The LLM's characterization of 'tightening control alignment' is semantically equivalent to the ground truth's 'reinforcing internal controls through process standardization,' though slightly different in emphasis. The multi-hop reasoning is sound—the LLM correctly synthesizes information across three years and identifies the consistent strategic focus. Quantitative accuracy is high with correct year citations and page numbers. The main weakness is incomplete capture of the nuanced evolution narrative and missing context about the proactive (non-reactive) nature of the initiative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 499,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 2022 10‑K states that it competes with BJ’s Wholesale Club and that its private‑label brand, Kirkland Signature, “offers lower prices, helps lower costs, differentiates our merchandise offerings, and generally earns higher margins” while the company expects to grow its private‑label sales penetration (page 8). The 2024 filing repeats that same wording, again highlighting Kirkland Signature as a key differentiator and noting the continued focus on increasing private‑label sales (page 8). Across 2022‑2024, Costco’s competitive‑positioning language has remained essentially unchanged, consistently framing Kirkland Signature as the strategic edge against BJ’s in the warehouse‑club market.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution of competitive positioning language from 2022 to 2024. STRENGTHS: (1) Correctly identifies Kirkland Signature as the private-label brand in question; (2) Accurately cites the 2022 language about Kirkland Signature offering lower prices, helping lower costs, differentiating merchandise, and earning higher margins; (3) Correctly notes that 2024 repeats similar wording; (4) Properly identifies BJ's Wholesale Club as the competitor. CRITICAL WEAKNESSES: (1) The LLM claims the language 'remained essentially unchanged' and 'has remained essentially unchanged' across 2022-2024, which directly contradicts the ground truth that shows evolution in tone and emphasis. The ground truth explicitly states 'While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures.' (2) The LLM completely misses the 2023 data point and the addition of sustainability initiatives language in that year, failing to address the full 2022-2024 timeline comprehensively. (3) The LLM fails to capture the 'stronger tone around differentiating our merchandise offerings in the context of increasingly competitive metropolitan markets' that emerged by 2024 according to the ground truth. (4) The answer lacks nuance about the evolution in surrounding language and strategic emphasis, instead presenting a static view. MULTI-HOP REASONING: The LLM failed to synthesize information across three years (2022, 2023, 2024) to identify the evolution pattern. It only compared 2022 and 2024, missing the intermediate year and the contextual shifts. The question specifically asks about 'evolution' and the LLM's conclusion that nothing evolved is factually incorrect per the ground truth. SEMANTIC ISSUE: While the LLM correctly identifies that Kirkland Signature remained 'core to the competitive strategy,' it misses the key insight that the surrounding language and tone evolved to emphasize differentiation more strongly in response to competitive pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 573,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab’s U.S. state‑and‑municipal holdings fell from **$638 million in 2022** (2022 10‑K, page 52) to **$579 million in 2023** (2023 10‑K, page 113) and further to **$100 million in 2024** (2024 10‑K, page 50).  Across all three years the firm repeatedly notes that “substantially all securities in the investment portfolios were rated investment‑grade” (2022 10‑K, page 52; 2024 10‑K, page 48), underscoring a fixed‑income strategy that prioritizes credit quality and capital preservation over higher‑yield, higher‑risk assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims $638 million in 2022, $579 million in 2023, and $100 million in 2024. However, the ground truth explicitly states that $638 million was disclosed in 2023, not 2022. The LLM has misaligned the years with the dollar amounts. The ground truth does not provide specific dollar amounts for 2022 or 2024—it only mentions that 2022 had U.S. State and Municipal Securities as part of the portfolio (without quantification), $638 million was disclosed in 2023, and 2024 reaffirmed investment-grade focus without specific amounts. (2) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesized information across years, assigning the $638 million figure to 2022 when it actually belongs to 2023. This is a critical error in temporal mapping across the three-year period. (3) INCOMPLETE GROUND TRUTH REPRESENTATION: The ground truth emphasizes that 2023 provided a 'specific' and 'quantifiable' $638 million allocation, implying this was the only year with explicit numbers. The LLM's presentation of three specific dollar amounts across all years misrepresents the actual disclosure pattern. (4) QUALITATIVE ACCURACY: While the LLM correctly identifies the investment-grade emphasis and the strategic preference for high-quality fixed income, this correct qualitative assessment cannot offset the severe quantitative errors. (5) CITATION ISSUES: The LLM provides specific page numbers (e.g., 'page 52,' 'page 113,' 'page 50') that cannot be verified against the ground truth, and the year-to-amount mapping is demonstrably wrong. The answer fails on the primary metric of factual correctness regarding the evolution of holdings across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 491,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum‑potential exposure to commercial‑aerospace customer financing guarantees declined from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【page_100】.  Correspondingly, the collaboration partners’ share of those guarantees fell from $140 million in 2022 to $135 million in 2023 and to $131 million in 2024【page_100】【page_101】.  This downward trend reflects a deliberate risk‑transfer strategy, with RTX progressively shifting more guarantee liability to partners and reducing its own exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY: The LLM correctly cites the collaboration partners' share figures ($140M in 2022, $135M in 2023, $131M in 2024), which match the ground truth exactly. However, the LLM introduces additional maximum-potential exposure figures ($304M, $288M, $274M) that are NOT mentioned in the original question or ground truth answer. These appear to be extraneous data points. (2) REASONING ERROR - FUNDAMENTAL MISINTERPRETATION: The LLM states 'RTX progressively shifting more guarantee liability to partners and reducing its own exposure.' This is BACKWARDS and contradicts the ground truth. A DECLINING collaboration partners' share ($140M→$135M→$131M) means LESS of the guarantee is being borne by partners, not more. This indicates RTX is INCREASING its own exposure or reducing reliance on third-party risk sharing, which aligns with the ground truth's interpretation of 'reducing RTX's reliance on third-party risk sharing.' The LLM's conclusion is semantically opposite to the correct interpretation. (3) MISSING CONTEXT: The LLM fails to mention the ground truth's important observation that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management.' (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize data across years, it fundamentally misinterprets what the declining collaboration partners' share means for RTX's risk transfer strategy. The correct interpretation is that declining partner share = increasing RTX retention, not the reverse. This is a critical logical error that undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 462,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 through 2024 Adobe’s Frame.io remained positioned as a cloud‑native collaboration hub that supports the same core file types—video, still images, design files and PDFs—and is tightly integrated with the same set of Adobe creative apps (Premiere Pro, After Effects, Photoshop, Lightroom and Workfront). Its role in content‑production workflows stayed consistent, providing real‑time upload, review, frame‑accurate commenting and camera‑to‑cloud capture, and it continues to be embedded in Adobe GenStudio to streamline pre‑production, post‑production and marketing‑campaign workflows. No new file‑type support or app integrations were disclosed, and the platform’s core function as a real‑time collaboration engine remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) EVOLUTION CLAIM: The LLM claims Frame.io remained 'positioned...the same' and 'stayed consistent' from 2022-2024, directly contradicting the ground truth which explicitly describes significant evolution and expansion. (2) 2022 STATUS ERROR: The LLM lists integrations with Photoshop, Lightroom, and Workfront as present throughout the period, but ground truth indicates these were NOT integrated until 2024. The LLM incorrectly backdates these integrations. (3) WORKFLOW EXPANSION MISSED: The ground truth clearly states Frame.io 'expanded its integration' and 'broadened its role beyond post-production into casting, location scouting, and marketing campaign management' by 2024. The LLM completely fails to capture this expansion, instead claiming 'no new file-type support or app integrations were disclosed' and 'the platform's core function...remained unchanged.' (4) 2023 DETAILS OMITTED: The ground truth specifies 2023 positioning with Premiere Pro and After Effects integration plus Camera-to-Cloud functionality. The LLM mentions Camera-to-Cloud but doesn't distinguish the 2023 state from 2022 or 2024. (5) ROLE EXPANSION IGNORED: The ground truth explicitly identifies new use cases (casting, location scouting, marketing) added by 2024. The LLM's claim that 'the platform's core function as a real-time collaboration engine remained unchanged' misses the critical expansion into new workflow domains. The LLM answer demonstrates a fundamental failure to identify and synthesize the evolution requested in the question, instead presenting a static view that contradicts the ground truth's clear narrative of expansion and deepening integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 480,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "RMS’s 2024 10‑K reports that VH‑92A production volume was lower than in 2023, after a period of higher volume in 2023 (VH‑92A is listed among the major helicopter programs in the 2023 10‑K). This shift indicates that while the VH‑92A remains a strategically important Marine One transport helicopter, the segment is reallocating production emphasis toward other helicopter and systems programs, underscoring its continued importance but not as the primary growth driver within RMS. (page_5, page_41)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) QUANTITATIVE ACCURACY ISSUES: The LLM claims 'VH-92A production volume was lower than in 2023' but provides no actual numbers or data to support this claim. The ground truth makes no mention of production volume comparisons or decreases. The LLM cites 'page_5, page_41' but these references appear to be fabricated or misinterpreted, as the ground truth does not reference specific page numbers with production volume data. (2) FACTUAL CONTRADICTION: The ground truth states the VH-92A 'remained a consistent part' of RMS with 'sustained strategic importance' and 'stable, long-term commitment' across 2022-2024. The LLM answer suggests a decline in production emphasis ('production volume was lower than in 2023'), which directly contradicts the ground truth's narrative of consistency. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024 and strategic importance. The ground truth addresses all three years with consistent messaging. The LLM only mentions 2023-2024 comparison and fails to address the 2022 baseline or the three-year progression. (4) UNSUPPORTED CLAIMS: The LLM makes specific assertions about production volume trends without citing actual data from the filings. The ground truth emphasizes consistent listing across years, not production volume fluctuations. (5) PARTIAL CREDIT: The LLM correctly identifies VH-92A as a Marine One transport helicopter and acknowledges it remains strategically important, which aligns with ground truth. However, the core narrative about declining production emphasis is not supported by the ground truth and appears to be an inference without factual basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 476,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "MDLZ’s 2022, 2023 and 2024 10‑Ks all describe sales and media‑marketing restrictions—limits on promotions or advertising of products with specified nutrient profiles on certain channels or times—that apply in every jurisdiction where the company operates, including the EU and emerging markets (page_15, page_11, page_11). The filings show no change in the geographic scope or the stringency of these restrictions over the three years; the same regulatory language is repeated in each filing, indicating a consistent regulatory environment (page_11, page_11, page_11).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core question. (1) FACTUAL ERRORS: The LLM claims 'the filings show no change in the geographic scope or the stringency of these restrictions over the three years' and that 'the same regulatory language is repeated in each filing, indicating a consistent regulatory environment.' This directly contradicts the ground truth, which documents clear evolution and expansion: 2022 had 25+ EU countries with EPR policies; 2023 added data privacy concerns and expanded to India, Vietnam, and U.S. states; 2024 saw formal EU Packaging and Packaging Waste Directive adoption and continued global spread. (2) QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates, or metrics from the filings. The ground truth cites concrete data points (25+ EU countries in 2022, specific countries in 2023, formal directive in 2024). The LLM's vague page references without substantive data extraction fail to capture the quantitative evolution documented in the filings. (3) MULTI-HOP REASONING: The question asks about evolution 'from 2022 through 2024' with specific focus on geographic scope and regulatory stringency changes. The LLM fails to synthesize information across the three years to show progression. Instead, it incorrectly concludes stasis. The ground truth demonstrates proper multi-hop synthesis showing expansion in both geographic reach (EU → emerging markets → global) and intensity (EPR policies → data privacy → formal directives). (4) SEMANTIC CONTRADICTION: The LLM's core claim that restrictions remained 'consistent' across three years is semantically opposite to the ground truth's narrative of 'expanding scope and increasing stringency.' This is not a wording difference but a fundamental factual disagreement. (5) MISSING CONTEXT: The LLM mentions 'sales and media-marketing restrictions' but fails to address the specific regulatory mechanisms (EPR policies, plastic bans/taxes, data privacy, formal directives) that the ground truth identifies as evolving. The answer demonstrates poor document synthesis and reaches an incorrect conclusion unsupported by the filing evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 583,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700% Notes due 2046 are consistently disclosed as part of the Eleventh Supplemental Indenture (Exhibit 4.14) in the 2022, 2023 and 2024 10‑K filings, with no amendments, repayments or new indentures reported in any of the three periods【page_106】.  The unchanged treatment indicates that Microsoft is maintaining these long‑term, fixed‑rate notes within its existing debt structure rather than refinancing or repaying them, reflecting a strategy of preserving a diversified maturity ladder and predictable interest expense over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Microsoft's 3.700% Notes due 2046 across three fiscal years. STRENGTHS: (1) All numeric values are correct - the interest rate (3.700%), maturity year (2046), and indenture date (August 8, 2016) are accurately stated. (2) The multi-hop synthesis is sound - the answer correctly identifies that the notes appear consistently across 2022, 2023, and 2024 10-K filings with no modifications. (3) Entity identification is precise - Microsoft, the specific debt instrument, and the Eleventh Supplemental Indenture are all correctly identified. (4) The reasoning about strategic implications is logically sound and semantically equivalent to the ground truth: both answers conclude that the unchanged treatment reflects a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. (5) The answer appropriately references the source document (Exhibit 4.14, page 106). MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'preserving a diversified maturity ladder' vs. 'core component of capital structure'), but these represent semantically equivalent interpretations of the same strategic pattern. The LLM answer is actually more specific in mentioning 'no amendments, repayments or new indentures reported,' which adds precision. Both answers correctly identify the absence of modifications as the key finding and draw appropriate conclusions about Microsoft's debt strategy. No calculation errors, date errors, or factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 447,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s Eleventh Supplemental Indenture (4.14) first introduced 2.000 % Notes due 2023 in the 2022 10‑K (page 105) and the same indenture is still listed in the 2023 and 2024 10‑Ks, showing that the 2023 maturity remained unchanged (page 105).  The 2023 10‑K added a Twelfth Supplemental Indenture (4.15) that introduced 2.875 % Notes due 2024 and later maturities, extending the debt ladder while leaving the 2023 notes intact (page 106).  By the 2024 10‑K, the Eleventh Supplemental Indenture still contains the 2.000 % Notes due 2023, and a new Fifteenth Supplemental Indenture (4.18) adds notes due 2025, 2035, 2045, and 2055, further pushing the maturity profile forward without altering the 2023 maturity (page 106).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and provides accurate core information about Microsoft's debt maturity structure evolution. STRENGTHS: (1) Correctly identifies the 2.000% Notes due 2023 across all three years (2022, 2023, 2024); (2) Accurately references Exhibit 4.14 (Eleventh Supplemental Indenture) as the consistent location; (3) Correctly identifies the Twelfth Supplemental Indenture (4.15) introduced in 2023 with 2.875% Notes due 2024; (4) Accurately notes the Fifteenth Supplemental Indenture (4.18) in 2024 with notes due 2025, 2035, 2045, and 2055; (5) Properly synthesizes the multi-hop information showing progression across three years; (6) Correctly interprets the debt ladder extension strategy. WEAKNESSES: (1) The LLM answer provides more specific exhibit numbers and supplemental indenture details than the ground truth, which is actually more informative but creates a slight divergence in scope - the ground truth focuses on the 2.000% Notes' consistency while the LLM expands to show the broader debt maturity structure evolution; (2) The LLM answer doesn't explicitly address the ambiguity about the 2023 notes remaining in 2024 filings (whether due to rollover, delayed maturity, or disclosure requirements), which the ground truth mentions; (3) Page references (105, 106) are provided by LLM but cannot be verified against ground truth. QUANTITATIVE ACCURACY: All percentages (2.000%, 2.875%) and years (2023, 2024, 2025, 2035, 2045, 2055) are correct. Exhibit numbers (4.14, 4.15, 4.18) appear accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple supplemental indentures, showing how the debt structure evolved while maintaining the 2023 notes. The logic is sound and the progression is clearly explained. The answer goes beyond the ground truth by providing more granular detail about the supplemental indentures introduced in each year, which enhances understanding of the debt maturity strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 545,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Medtronic’s 2022, 2023 and 2024 10‑K filings all list the same underlying plan for its Non‑Employee Restricted Stock Unit Award Agreements – the Amended and Restated 2013 Stock Award and Incentive Plan (see Exhibit 10.65 in each filing).  The 2022 filing also cites the 2021 Medtronic plc Long‑Term Incentive Plan for other award types (Exhibit 10.78), but the Non‑Employee Restricted Stock Unit Award Agreements themselves did not shift to a newer plan in 2023 or 2024.  Thus, the underlying plan for these agreements remained unchanged across the three years【page_115】【page_114】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM claims the Non-Employee Restricted Stock Unit Award Agreements are in Exhibit 10.65 across all three years, but the ground truth explicitly states Exhibit 10.45 for 2022. This is a factual error in exhibit citation. (2) INCOMPLETE PLAN IDENTIFICATION: The LLM mentions the 2021 Medtronic plc Long-Term Incentive Plan (Exhibit 10.78) for 'other award types' but fails to clarify whether this is relevant to the Non-Employee RSU Agreements specifically, creating ambiguity. (3) MISSING KEY DETAIL: The ground truth specifies the plan's effective date as December 8, 2017, which the LLM omits entirely. (4) PARTIAL ACCURACY ON CORE FINDING: The LLM correctly identifies that the underlying plan (Amended and Restated 2013 Stock Award and Incentive Plan) remained consistent across 2022-2024, which aligns with the ground truth's conclusion about 'long-term stability.' However, this correct conclusion is undermined by the exhibit number error. (5) REASONING QUALITY: The LLM's logic that 'the form agreement remained consistent' is sound, but the factual foundation is compromised by the exhibit citation error. The multi-hop synthesis across three years is attempted but marred by inaccuracy. (6) CONTEXTUAL RELEVANCE: The answer addresses the evolution question appropriately in structure, but the factual errors reduce its reliability. The mention of the 2021 plan adds context but may introduce confusion about which plan applies to the RSU agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 419,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated **17 %** of assets to buy‑in annuity policies in 2022, **16 %** in 2023, and **17 %** again in 2024【page_105】【page_104】. The modest dip in 2023 followed by a return to the 2022 level indicates that the company maintains a stable target allocation for these contracts while periodically rebalancing to reflect market conditions or plan‑specific needs, underscoring a disciplined liability‑management strategy that keeps international pension obligations adequately covered.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. According to the original answer, MDLZ's allocation to buy-in annuity policies was 17% in 2022, 16% in 2023, and was 'effectively discontinued by 2024.' However, the LLM claims the allocation was 17% again in 2024, which is factually incorrect. This is a major quantitative accuracy failure on a core metric of the question. The LLM also fundamentally misinterprets the strategic significance of the trend. The ground truth indicates a strategic shift away from insurer-backed annuities toward direct liability management and valuation control, suggesting a de-risking or restructuring effort. The LLM instead characterizes this as a 'stable target allocation' with 'periodic rebalancing,' which is semantically opposite to the actual trend of discontinuation. The LLM's reasoning that the company 'maintains a stable target allocation' is contradicted by the fact that the allocation was discontinued in 2024. The multi-hop synthesis is flawed because the LLM failed to recognize that the 2024 data point represents a discontinuation rather than a return to 17%. The answer demonstrates a fundamental misunderstanding of the pension liability management strategy, mischaracterizing a de-risking move as routine rebalancing. While the 2022 and 2023 percentages are correct, the 2024 figure and the entire interpretive framework are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 396,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued 2.000 % notes due 2023 under the Eleventh Supplemental Indenture (Exhibit 4.14, filed 8/5/2016).  Those notes were still outstanding through fiscal year 2022, matured and were retired in fiscal year 2023, and no longer appear on the 2024 balance sheet.  This pattern shows Microsoft’s disciplined debt‑maturity strategy: it uses short‑term notes to meet liquidity needs and then retires them as they mature, keeping a balanced long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that the 2.000% Notes due in 2023 were 'consistently referenced in all three annual reports (2022, 2023, and 2024)' and that 'Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached.' The LLM answer claims the notes 'matured and were retired in fiscal year 2023, and no longer appear on the 2024 balance sheet.' This is directly contradicted by the ground truth, which confirms the notes remained in disclosures under Exhibit 4.14 in the 2024 report. The LLM also incorrectly dates the Eleventh Supplemental Indenture as 8/5/2016 when the ground truth specifies 8/8/2016 (minor date error). The LLM's interpretation of Microsoft's debt strategy as retiring notes upon maturity is fundamentally incorrect based on the evidence that these notes remained on the books through 2024. The LLM failed to synthesize the multi-hop information correctly across the three fiscal years, misrepresenting the evolution of these notes. The only correct element is the identification of the 2.000% Notes, the due date of 2023, and the Eleventh Supplemental Indenture reference. The answer demonstrates a failure in multi-hop reasoning and factual accuracy regarding the key claim about whether the notes were retired in 2023 or remained outstanding through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 395,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 were originally issued under the Third Supplemental Indenture (Feb 8 2011) and were still listed in the 2022 and 2023 10‑Ks (page_104). By the 2024 10‑K the notes had been retired, as they no longer appear in subsequent supplemental indentures (Ninth, Tenth, Eleventh, and Fifteenth) that now cover newer notes with different maturities and coupon rates (page_105 and page_106). This shift shows Microsoft’s debt structure moving away from the older 4.000 % Notes toward newer issues under later supplemental indentures.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 4.000% Notes due 2021 'had been retired' by 2024 and 'no longer appear in subsequent supplemental indentures,' but the ground truth explicitly states they 'continued to appear in Exhibit 4.6' in the 2024 filing. This is a fundamental mischaracterization of the notes' status. (2) INCORRECT REASONING - The LLM incorrectly infers retirement based on the notes not appearing in newer supplemental indentures (Ninth, Tenth, Eleventh, Fifteenth), but the ground truth shows the notes remained under the Third Supplemental Indenture consistently across all three years. The LLM conflates the introduction of new debt instruments under later supplemental indentures with the retirement of the 4.000% Notes. (3) INCOMPLETE SYNTHESIS - The LLM fails to recognize that Microsoft's debt structure involved BOTH maintaining older instruments (like the 4.000% Notes) AND introducing new ones under subsequent supplemental indentures. The ground truth explicitly states 'the specific notes due 2021 remained unchanged' while 'Microsoft introduced new debt instruments.' (4) CORRECT ELEMENTS - The LLM correctly identifies the Third Supplemental Indenture date (Feb 8, 2011) and correctly notes that new debt instruments were introduced with different maturities and rates. However, these correct elements are overshadowed by the major error regarding the notes' retirement status. (5) MULTI-HOP REASONING FAILURE - The question requires synthesizing information across three years (2022, 2023, 2024) to show consistency/evolution. The LLM failed to properly synthesize this, instead making an unsupported conclusion about retirement. The ground truth shows consistency (unchanged treatment), while the LLM incorrectly portrays a change (retirement).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 507,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes consistently state that its 40,000 authorized Euro Deferred Shares have never been issued or outstanding: in 2022 the filing notes “At April 29, 2022, no Euro Deferred Shares were issued or outstanding” (page 81), in 2023 the same wording appears for “At April 28, 2023” (page 81), and in 2024 the statement is repeated for “At April 26, 2024” (page 81). This unchanged disclosure shows the company does not use Euro Deferred Shares as a financing or dilution tool, instead relying on ordinary shares and its share‑repurchase program, reflecting a conservative, stable capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across three fiscal years. STRENGTHS: (1) All numeric values are correct - 40,000 authorized shares, €1.00 par value, and the three fiscal years (2022, 2023, 2024) are accurately cited. (2) The specific dates are correct: April 29, 2022; April 28, 2023; and April 26, 2024. (3) The core finding is accurate - no Euro Deferred Shares were issued or outstanding in all three years. (4) The multi-hop synthesis correctly identifies the pattern across all three years and draws appropriate conclusions about capital structure strategy. (5) The answer goes beyond the ground truth by providing specific page references (page 81) and exact quote language, adding credibility. (6) The reasoning about strategic implications is sound - the consistent absence suggests deliberate non-utilization and preference for alternative financing mechanisms. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'share-repurchase program' and 'conservative, stable capital-structure strategy' that, while logically sound and consistent with the ground truth's mention of 'strategic preference for other forms of equity or debt financing,' represents slight elaboration beyond what the ground truth explicitly states. However, this elaboration is reasonable inference from the disclosed facts and enhances rather than detracts from the answer. (2) The ground truth uses the phrase 'lack of demand for this particular instrument in investor markets' while the LLM focuses on company choice ('does not use'), which are subtly different framings but both valid interpretations of the same underlying fact. Overall, the LLM answer is factually precise, comprehensively addresses the question's multi-part structure, and provides sound reasoning for the capital structure implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 510,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "On page 104 of each filing, Microsoft lists **Exhibit 4.6 – the Third Supplemental Indenture** that contains the 4.000 % Notes due 2021. The description and indenture details are identical in the 2022, 2023, and 2024 10‑K filings, indicating no restructuring, retirement, or re‑issuance of the note. This consistency shows that Microsoft treats the 4.000 % Notes due 2021 as a stable component of its long‑term debt portfolio throughout the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Microsoft consistently referenced the 4.000% Notes due 2021 across 2022, 2023, and 2024 filings, (2) Exhibit 4.6 (Third Supplemental Indenture) was listed in all three years, (3) the descriptions remained identical with no material changes, and (4) this indicates stable treatment of the debt instrument. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years of filings and drawing appropriate conclusions about consistency and stability. However, there are minor gaps: (1) The LLM specifies 'page 104' which is a specific detail not verified in the ground truth and may be formatting-dependent across different filing versions, (2) The ground truth explicitly mentions the indenture was 'dated February 8, 2011, and incorporated by reference from a prior 8-K filing' - details the LLM omits, (3) The ground truth notes the Notes were 'matured or fully accounted for' which provides additional context about why they appear consistently without changes - the LLM describes them as 'stable component of long-term debt portfolio' which is slightly different framing. The LLM's characterization of the notes as a 'stable component of long-term debt portfolio' is semantically reasonable but differs from the ground truth's implication that the notes had matured. The quantitative accuracy is strong (correct percentage, correct years, correct exhibit number), and the qualitative reasoning about consistency indicating no restructuring is sound. The answer adequately addresses the evolution question by showing consistency across years, though it could have been more explicit about what the consistency implies regarding the maturity status of the notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 476,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s 2021 pension‑risk‑transfer transaction moved $4.9 billion of gross defined‑benefit pension obligations into group annuity contracts (GACs).  The 2022‑through‑2024 filings do not disclose additional transfer amounts, but the company notes that it continues to “evaluate such transactions” and “purchase GACs … for portions of our outstanding defined‑benefit pension obligations.”  This consistent use of risk‑transfer indicates a deliberate strategy to reduce pension‑liability volatility and manage long‑term obligations, even if the exact dollar amounts for each year are not specified in the provided pages.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM introduces a $4.9 billion figure from a 2021 transaction that is NOT mentioned in the ground truth answer. The ground truth specifically states $11.6 billion in cumulative transfers since December 2018 (as of 2022), but the LLM's $4.9 billion appears to be a single-year transaction that contradicts or misrepresents the cumulative figure. This is a significant factual error. (2) MISSING KEY DATA - The LLM fails to mention the $11.6 billion cumulative figure that is central to the ground truth answer and the $69 million in annual PBGC premium savings, both critical quantitative metrics. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2022-2024 pattern of 'continued evaluation' and intent to pursue additional transactions, it does not synthesize the evolution narrative effectively. The ground truth emphasizes a trajectory from $11.6B (2022) through ongoing commitment (2024), showing sustained strategy. The LLM acknowledges the pattern but lacks the quantitative anchoring. (4) TEMPORAL ACCURACY - The LLM references a 2021 transaction outside the 2022-2024 timeframe specified in the question, which is somewhat relevant context but introduces confusion about which transaction amounts apply to which years. (5) CORRECT ELEMENTS - The LLM correctly identifies: (a) the use of group annuity contracts (GACs), (b) the company's continued evaluation of such transactions, (c) the strategic intent to reduce pension liability volatility, and (d) the multi-year nature of the strategy. However, these correct qualitative elements cannot offset the quantitative errors and omissions. The answer is partially correct in reasoning but fundamentally flawed in the specific financial data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 481,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The 2022 10‑K contains no reference to the 0.125% Notes due 2029, indicating the note had not yet been issued (page_134). The 2023 10‑K lists the note in Exhibit 4.4, citing 8‑K filings of 2020 and 2021 (page_136), and the 2024 10‑K likewise cites the same exhibit (page_130). This consistent disclosure and identical coupon‑maturity structure across filings shows Coca‑Cola’s debt‑instrument strategy remains stable and repeatable over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the 0.125% Notes due 2029 appeared consistently across all three years (2022, 2023, and 2024) in Exhibits 4.23 and 4.31, with identical source references to Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. The LLM answer claims the 2022 10-K contains 'no reference' to the note, suggesting it had not yet been issued. This is directly contradicted by the ground truth, which confirms the note was disclosed in 2022 in the same exhibits as subsequent years. The LLM correctly identifies that the 2023 and 2024 filings cite the same exhibit and 8-K filings, but this partial correctness cannot offset the major error regarding 2022 disclosure. The LLM's conclusion about stable debt-instrument strategy is reasonable in isolation, but it is based on incomplete and inaccurate data (missing the 2022 disclosure entirely). The multi-hop reasoning fails because it does not synthesize information across all three years as required by the question. The answer demonstrates a failure to identify the consistent pattern across all three consecutive reporting cycles, which is the core insight the question seeks. The page references provided (134, 136, 130) cannot be verified against the ground truth but appear to be fabricated or misidentified, as they do not correspond to the actual exhibit locations stated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 409,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million** at the end of 2022 to **$1,091 million** at the end of 2023 and further to **$993 million** at the end of 2024 (a net decline of $116 million over two years). The drop reflects fewer warranties issued and fewer settlements in 2024, indicating a lower expected future cost of long‑term product performance guarantees. While the liability remains sizable, the downward trend suggests a reduced exposure to long‑term product performance risks in RTX’s commercial aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides completely different numbers than the ground truth, indicating a fundamental factual error. Ground truth shows collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024). The LLM instead reports total liabilities of $1,109M (2022), $1,091M (2023), and $993M (2024) - these are entirely different figures and likely refer to a different liability category altogether. The LLM's calculation of a $116M decline over two years is mathematically correct for its stated numbers ($1,109M - $993M = $116M), but these numbers do not match the ground truth data. The ground truth explicitly states RTX's own liabilities were 'not explicitly stated' and focuses on the collaboration partners' share, which decreased modestly from $141M to $131M (a $10M decline). The LLM appears to have cited a different metric entirely - possibly total warranty liabilities or a broader performance guarantee category - rather than the specific performance and operating cost guarantees referenced in the question. The LLM's interpretation that the trend indicates 'reduced exposure to long-term product performance risks' contradicts the ground truth's assessment of 'stable long-term product performance expectations' with 'controlled liability posture.' The LLM failed to synthesize the correct multi-hop information from RTX's filings and instead provided numbers that cannot be verified against the stated ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 409,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic continues to value its non‑qualified options with the Black‑Scholes model, but the input assumptions have shifted upward: volatility rose from 23.0 % in 2022 to 24.3 % in 2024, the risk‑free rate climbed from 0.9 % to 4.2 %, and the dividend yield increased from 1.95 % to 3.18 % (expected life grew slightly to 6.1 years). These changes reflect a more conservative, market‑adjusted risk model that incorporates higher implied volatility and a higher cost of capital, which lowered the weighted‑average fair value of options from $22.83 m in 2022 to $17.76 m in 2023 and then modestly rebounded to $18.49 m in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that diverges significantly from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific volatility percentages (23.0% to 24.3%), risk-free rates (0.9% to 4.2%), dividend yields (1.95% to 3.18%), and fair values ($22.83M, $17.76M, $18.49M) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these specific numerical values. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth focuses on the evolution of disclosure methodology and transparency around volatility assumptions (historical vs. implied, market-traded options clarification), not on the actual numerical changes in volatility inputs themselves. The LLM conflates disclosure evolution with input assumption changes. (3) INCOMPLETE ADDRESSING OF CORE QUESTION: The question asks about the evolution of approach and what it suggests about changing assumptions. The ground truth correctly identifies this as a methodological/disclosure evolution toward more market-informed and transparent risk modeling. The LLM instead provides a narrative about input values changing without establishing whether these changes represent a true methodological shift or merely normal year-to-year variations. (4) MISSING KEY INSIGHT: The ground truth's key finding—that Medtronic added explicit disclosure about implied volatility being derived from market-traded options in 2023-2024—is entirely absent from the LLM answer. This is the core evidence of the company's evolving approach. (5) CALCULATION CONCERNS: The LLM claims fair values decreased from $22.83M to $17.76M then rebounded to $18.49M, but provides no basis for these figures or explanation of how the input changes would produce these specific outputs. The semantic meaning of the two answers is fundamentally different: ground truth = disclosure/methodology evolution; LLM = input parameter changes with financial impact. Without access to the actual 10-K filings, the specific numbers provided by the LLM cannot be verified and appear unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 574,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 1.000 % note due 2028 that Coca‑Cola issued in 2020 is listed unchanged in each filing: the 2022 10‑K (page 136) cites the note as “Form of Note for 1.000 % Notes due 2028…exhibit 4.7” (filed 9/18/2020)【page_136】, the 2023 10‑K (page 134) repeats the same reference【page_134】, and the 2024 10‑K (page 130) again lists the identical note【page_130】.  No new tranches or amendments appear in any of the three years, indicating that the company has maintained this low‑interest, long‑term debt instrument through 2024 rather than issuing additional 1.000 % notes.  This consistency reflects a conservative debt strategy that prioritizes stable, low‑cost financing and avoids frequent refinancing of the same instrument.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question:\n\n1. CRITICAL OMISSION - Missing Key Strategic Shift: The ground truth explicitly states that in 2024, Coca-Cola introduced 'significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054)' and that this represents 'a broader strategic shift toward issuing higher-interest debt.' The LLM answer completely fails to mention these 2024 issuances, which are central to understanding the company's debt strategy evolution. This is a major gap in addressing the question's core requirement to explain how the pattern 'suggests about the company's debt strategy.'\n\n2. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the evolution across three years AND what the pattern suggests about debt strategy. The LLM only addresses the consistency of the 1.000% Notes themselves but ignores the broader context of what other debt instruments were issued in each year, particularly the strategic shift in 2024.\n\n3. MISCHARACTERIZATION OF STRATEGY: The LLM characterizes the strategy as 'conservative debt strategy that prioritizes stable, low-cost financing and avoids frequent refinancing.' However, the ground truth indicates the opposite - that the company pursued 'more aggressive borrowing terms in 2024,' suggesting a shift away from purely conservative positioning.\n\n4. QUANTITATIVE ACCURACY - PARTIAL: The LLM correctly identifies that the 1.000% Notes due 2028 appear consistently across 2022, 2023, and 2024 filings. The page references (136, 134, 130) and the 2020 issuance date appear reasonable, though not verified against ground truth. The interest rate (1.000%) is correct.\n\n5. MISSING COMPARATIVE ANALYSIS: The ground truth emphasizes the contrast between maintaining the 1.000% Notes while introducing much higher-yielding instruments (5.000% and 5.300%). The LLM fails to make this critical comparison that reveals the actual strategic evolution.\n\n6. REASONING QUALITY: While the LLM's logic about consistency is internally sound, it fundamentally misses the question's intent by not addressing the broader debt strategy evolution that the pattern of 1.000% Notes (maintained) versus new higher-yield notes (introduced in 2024) reveals.\n\nThe answer is partially correct about the 1.000% Notes' consistency but fails to address the strategic implications and the critical 2024 shift toward higher-interest debt instruments that are essential to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 662,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In all three filings the 2.125 % notes were issued under supplemental indentures that named **The Bank of New York Mellon Trust Company, N.A.** as trustee – the Seventh Supplemental Indenture (4.1) for the 2021/2028 notes and the Fourth Supplemental Indenture (4.7) for the 2022/2042 notes. The 2022 10‑K disclosed only those indentures; the 2023 10‑K added a new Fifteenth Supplemental Indenture (4.18) with the same trustee but no new 2.125 % notes, while the 2024 10‑K introduced a Twelfth Supplemental Indenture (4.15) covering higher‑yield 2.400 % and 2.875 % notes, indicating a shift toward higher‑rate debt while the 2.125 % notes remained governed by the same trustee arrangement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) INCORRECT SUPPLEMENTAL INDENTURE REFERENCES: The LLM claims the 'Fourth Supplemental Indenture (4.7)' covers '2022/2042 notes' - this appears to be fabricated or confused, as the ground truth only mentions the Seventh Supplemental Indenture for 2021/2028 notes. The LLM introduces indentures (Fourth, Fifteenth, Twelfth) that are not mentioned in the ground truth. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth explicitly states the structure 'remained consistent' across all three years with 'no changes in the structure or administration' - the LLM incorrectly claims there was a 'shift toward higher‑rate debt' with new indentures in 2023 and 2024, contradicting the ground truth's finding of stability. (3) INCORRECT DEBT INSTRUMENTS: The LLM introduces 2.400% and 2.875% notes in 2024 that are not mentioned in the ground truth answer, which focuses solely on the 2.125% Notes. (4) TRUSTEE ACCURACY: While the LLM correctly identifies The Bank of New York Mellon Trust Company, N.A. as trustee, this is the only element that aligns with ground truth. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year comparison, instead inventing a narrative of change where the ground truth documents stability. The answer demonstrates fundamental misunderstanding of the filing data and appears to contain fabricated exhibit numbers and indenture references not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 427,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in IAE remained at **57 %** and in IAE LLC at **51 %** from 2022 through 2024 (the 2023 10‑K note shows 57 %/51 %【page_101】, and the 2024 10‑K note repeats the same percentages【page_102】).  The unchanged stake indicates that RTX continues to be the primary beneficiary and key partner in both the V2500 and PW1100G‑JM engine programs, reinforcing its strategic leadership and influence over these core commercial‑aircraft engine platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE ACCURACY: The LLM answer claims that net program share interest remained constant at 57%/51% from 2022 through 2024, but the ground truth explicitly states a significant evolution: In 2022, the program share interest was 61% for IAE and 59% for IAE LLC (not 57%/51%). By 2023, these decreased to 57% for IAE and 51% for IAE LLC. The LLM fundamentally misrepresents the 2022 baseline figures, claiming they were already at the 2023-2024 levels. This is a major factual error that contradicts the core premise of the question about 'evolution' from 2022 to 2024. The ground truth shows a clear progression: 61%→57% (IAE) and 59%→51% (IAE LLC) from 2022 to 2023, then stabilization in 2024. The LLM's claim of 'unchanged stake' from 2022-2024 is incorrect; there was a material change in 2023. COMPLETENESS ISSUES: The LLM fails to address the 2022 baseline and the 2023 transition year, which are essential to understanding the 'evolution' requested in the question. It only addresses 2023-2024 stability, missing half the story. REASONING ISSUES: While the LLM correctly identifies that the 2023-2024 figures remained stable at 57%/51%, it incorrectly extrapolates this backward to 2022, suggesting no evolution occurred. The ground truth indicates a strategic recalibration in 2023 (after accounting for sub-collaborator shares), which the LLM completely misses. POSITIVE ASPECTS: The LLM correctly identifies the 2023-2024 percentages (57%/51%), correctly names the engine programs (V2500, PW1100G-JM), and appropriately contextualizes RTX's strategic positioning. However, these correct elements cannot overcome the fundamental mischaracterization of the 2022 baseline and the evolution trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 472,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s expense for its 401(k) savings and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023** (Note 7, page 53) and then fell modestly to **$443 million in 2024** (Note 14, page 66). The 16 % jump in 2023 followed by a ~5 % dip in 2024 suggests the company is maintaining a high level of investment in employee benefits, with the slight decline likely reflecting adjustments in contribution formulas or participation rates rather than a shift away from employee‑benefit support.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's contributions were $402 million in 2022, but the ground truth clearly shows $299 million in 2022. This is a significant discrepancy of $103 million (34% error). The 2023 ($468 million) and 2024 ($443 million) figures are correct. CALCULATION ERROR: The LLM calculates a '16% jump in 2023' based on the incorrect $402M baseline. Using the correct $299M baseline, the actual increase is ($468M - $299M) / $299M = 56.5%, not 16%. The 2024 decline calculation (~5%) is approximately correct based on the stated figures ($468M to $443M = 5.4% decline). ENTITY ACCURACY: TMO ticker is correct, years are correct, and the metric (defined contribution plans/401(k)) is correctly identified. REASONING QUALITY: The qualitative interpretation about 'dynamic approach to workforce investment' and 'adjustments in contribution formulas' is reasonable and aligns with the ground truth's characterization, though the LLM's specific percentage analysis is based on the wrong 2022 baseline. COMPLETENESS: The answer addresses the evolution trajectory and spending implications as requested. However, the fundamental error in the 2022 baseline number undermines the entire quantitative analysis and makes the percentage calculations misleading. The semantic interpretation of the trend is directionally sound but built on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 382,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "The 3.000% Notes due 2051 were issued in 2021 (see Exhibit 4.6 referenced on page 130 of the 2024 10‑K) and remained outstanding in 2022 (page 134), 2023, and 2024 (page 130), with no new issuance of the same instrument in those years (page 130).  The company has issued other long‑term debt (e.g., 2.500% Notes due 2051, 2.600% Notes due 2050, 2.750% Notes due 2060) to diversify its maturity profile (page 130), reflecting a capital‑structure strategy that balances long‑term debt with a mix of maturities and rates to manage interest‑rate exposure and maturity risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 3.000% Notes due 2051 were indeed issued in 2021 and remained outstanding through 2024 - this is factually accurate. (2) The identification of other debt instruments (2.500% Notes due 2051, 2.600% Notes due 2050, 2.750% Notes due 2060) is correct. (3) The general capital structure strategy explanation about balancing maturities and rates is sound. (4) Page references appear reasonable for a 10-K filing. PROBLEMATIC ELEMENTS: (1) The LLM answer CONTRADICTS the ground truth regarding higher-coupon instruments. Ground truth explicitly mentions 5.000% Notes due 2034 and 5.300% Notes due 2054 as new instruments introduced by 2024, but the LLM lists different instruments (2.500%, 2.600%, 2.750%) with no mention of the 5.000% or 5.300% notes. This is a significant factual discrepancy. (2) The LLM answer states 'no new issuance of the same instrument in those years' which is correct but somewhat obvious and doesn't add much analytical value. (3) The LLM answer lacks the temporal progression narrative that the ground truth provides - it doesn't clearly show how the debt portfolio EVOLVED across the three years, instead presenting it more as a static state. (4) The ground truth emphasizes the strategic shift toward 'higher-yielding instruments' in response to 'current market interest rate conditions,' which the LLM answer doesn't capture. MULTI-HOP REASONING: The LLM answer attempts to synthesize information across years but fails to identify the key strategic shift (introduction of higher-coupon debt) that the ground truth highlights. The reasoning about maturity diversification is present but incomplete. QUANTITATIVE ACCURACY: The coupon rates mentioned are accurate where stated, but the omission of the 5.000% and 5.300% notes represents a significant gap in completeness rather than a calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 518,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle issued the 2.875 % Notes due 2031 in March 2021 (Exhibit 4.14).  The 2022, 2023 and 2024 10‑Ks list the same notes as outstanding long‑term debt with no amendments or additional issuances, showing that Oracle has kept the terms unchanged.  This steady, fixed‑rate, long‑maturity structure reflects Oracle’s strategy of locking in moderate yields and maintaining a stable, diversified debt mix over the long term.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.875% Notes due 2031 are correctly identified; (2) The notes appear consistently in 2022, 2023, and 2024 10-Ks as stated; (3) The characterization of the notes as fixed-rate, long-maturity debt is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces a specific issuance date (March 2021, Exhibit 4.14) that is not mentioned in the ground truth and cannot be verified from the question context - this is an unsupported factual claim; (2) The LLM states 'no amendments or additional issuances' which is too narrow - the ground truth indicates Oracle issued NEWER notes (4.500% due 2028, 4.900% due 2033) alongside the 2.875% notes, representing portfolio diversification; (3) The LLM completely misses the key strategic insight from the ground truth: the evolution shows Oracle layering in higher-yielding debt instruments as market conditions changed, not merely maintaining a static debt structure; (4) The phrase 'locking in moderate yields' is vague and doesn't capture the strategic shift toward higher-cost borrowing reflected in newer issuances; (5) The LLM fails to address the multi-hop synthesis required - comparing the 2.875% notes against the newer, higher-yielding instruments issued in 2024 to show strategic evolution. MULTI-HOP REASONING: The question asks about 'evolution' and what it 'indicates about Oracle's long-term debt strategy.' The ground truth shows a 3-year progression with strategic diversification into higher-yielding notes. The LLM instead presents a static view of unchanged terms, missing the comparative analysis across the debt portfolio. The LLM's answer is partially correct on basic facts but fundamentally misses the strategic narrative and introduces unverified details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 490,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 2.000% Notes due 2023 in Exhibit 4.14 (the Eleventh Supplemental Indenture)【page 105】.  The repeated disclosure shows that the company keeps a stable long‑term debt profile and proactively reports upcoming maturities, reflecting a disciplined debt‑management policy and a commitment to transparent communication with investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's consistent disclosure of the 2.000% Notes due 2023 across 2022, 2023, and 2024 10-K filings, the reference to Exhibit 4.14 and the Eleventh Supplemental Indenture, and the interpretation that this reflects stable debt management and transparent communication. The numeric values (2.000%, 2023 maturity date) and document references are accurate. The reasoning about what consistent disclosure suggests (stable debt profile, disciplined management, transparency) aligns with the ground truth. However, the LLM answer is somewhat less comprehensive than the original answer. Specifically: (1) The LLM does not mention the specific date of the Eleventh Supplemental Indenture (August 8, 2016), which provides important historical context; (2) The LLM does not explicitly note that the details remained 'unchanged' across all three years, which is a key indicator of stability; (3) The LLM does not mention the connection to investor confidence and credit ratings, which are important implications of the transparency strategy. The LLM's interpretation is sound and the core message is correct, but it lacks some of the deeper contextual details and implications present in the ground truth answer. The answer is semantically equivalent in its main conclusions but less thorough in supporting evidence and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 383,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour payments to Rolls‑Royce, which are part of its “Other commercial aerospace commitments,” climbed from **$735 million in 2022 to $1.053 billion in 2023** and then fell to **$765 million in 2024** as V2500‑powered aircraft accrued hours and payments were made (see the 2021‑maturity table on page 74). These figures, tied to each hour flown through June 2027, show the obligation is being gradually satisfied, shrinking RTX’s exposure over time, yet a still‑material long‑term liability remains under the 2012 IAE acquisition agreement (see note on flight‑hour payments on page 112).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides specific dollar amounts ($735M in 2022, $1.053B in 2023, $765M in 2024) that cannot be verified against the ground truth and appear to be fabricated. The ground truth explicitly states that the payments were 'categorized under Other commercial aerospace commitments' and discusses the accounting treatment (capitalization and amortization), but does NOT provide these specific numerical values. The LLM has invented precise figures with page references (pages 74 and 112) that are presented as factual but are not supported by the ground truth. REASONING ISSUES: While the LLM correctly identifies the 2012 IAE acquisition agreement, the V2500-powered aircraft connection, and the June 2027 maturity date, it fundamentally misinterprets the trend. The ground truth indicates a 'stable long-term financial exposure' with consistent recognition and amortization patterns across 2022-2024. The LLM claims the obligation is 'gradually satisfied, shrinking RTX's exposure over time' based on the fabricated numbers showing a decline from 2023 to 2024. This contradicts the ground truth's characterization of stability. ACCOUNTING TREATMENT: The LLM mentions payments being made as hours accrue, which aligns with the ground truth's discussion of capitalization and amortization, but the specific dollar amounts and their trajectory are entirely unsupported. The LLM appears to have hallucinated specific financial figures rather than acknowledging that the ground truth focuses on the accounting methodology and structural consistency rather than precise year-over-year dollar amounts. The answer demonstrates a fundamental failure to distinguish between what can be verified in the source material versus invented details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 478,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "From 2022 to 2024 the fair‑value of U.S. equity funds in the domestic pension plans rose from **$89 million (≈9.5 % of $937 million total domestic assets)** in 2022 to **$91 million (≈10.2 % of $895 million)** in 2024, with an intermediate 2023 level of $93 million (≈9.8 %). This gradual uptick—about a 0.7‑percentage‑point increase over three years—suggests TMO is modestly shifting its domestic pension portfolio toward a slightly higher equity exposure while still maintaining the core 80/10/10 fixed‑income‑equity framework.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics. QUANTITATIVE ERRORS: (1) The LLM states 2022 value as $89 million, but ground truth shows $125 million—a $36 million discrepancy (29% error). (2) The LLM states 2023 value as $93 million, but ground truth shows $89 million—a $4 million error. (3) The LLM states 2024 value as $91 million, but ground truth shows $93 million—a $2 million error. (4) The LLM reverses the directional trend entirely: it claims values rose from $89M to $91M (upward trend), when the actual trajectory is $125M → $89M → $93M (downward then modest recovery). REASONING ERRORS: (1) The LLM concludes TMO is 'modestly shifting toward higher equity exposure,' which contradicts the ground truth interpretation of 'cautious reduction in exposure to U.S. equities.' (2) The LLM's characterization of a 0.7 percentage-point increase is based on incorrect underlying numbers. (3) The LLM introduces unsupported details about an '80/10/10 fixed-income-equity framework' not mentioned in the ground truth. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trajectory, presenting inverted numbers and reaching opposite strategic conclusions. The answer demonstrates either data retrieval failure or fundamental misunderstanding of the pension plan allocation data. All three years' values are materially incorrect, making this response factually unreliable for investment analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 413,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "In 2022, Coca‑Cola’s long‑term debt mix still featured the low‑yield 1.000% Notes due 2041 (issued in 2021) as a key component of its capital structure (Exhibit 4.6, page 134). By 2024 the company shifted toward a more diversified, higher‑yield portfolio, issuing a series of new notes ranging from 3.125% to 5.400% with maturities from 2032 to 2064 (Exhibits 4.39–4.47, page 130). This evolution reflects a strategic move to broaden maturity and yield profiles, taking advantage of favorable market conditions to refinance or extend its debt base.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: (1) EXHIBIT CITATIONS ARE INCORRECT: The LLM cites Exhibit 4.6 (page 134) and Exhibits 4.39-4.47 (page 130), but the ground truth consistently references Exhibit 4.33 for the 1.000% Notes due 2041 across all three years (2022, 2023, 2024). The exhibit numbers and page references provided by the LLM do not match the knowledge graph. (2) INCOMPLETE IDENTIFICATION OF SPECIFIC INSTRUMENTS: The ground truth explicitly names three high-yield notes introduced in 2024: 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. The LLM provides a vague range ('3.125% to 5.400%') without naming the specific instruments, which is less precise and potentially inaccurate. The ground truth also identifies lower-yield instruments from earlier years (0.400% Notes due 2030 in 2022; 0.950% Notes due 2036 in 2023) that the LLM completely omits. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the general evolution from lower to higher yields, it fails to provide the specific year-by-year progression that the ground truth establishes. The LLM's statement about 'favorable market conditions' is interpretive rather than factual. (4) QUANTITATIVE ACCURACY: The yield ranges and maturity dates provided are partially correct but lack the specificity of the ground truth. The LLM does not verify the exact percentages and dates for the instruments mentioned. (5) POSITIVE ASPECTS: The LLM correctly identifies the overall strategic shift from low-yield to high-yield instruments and understands the multi-year evolution. The semantic understanding of the strategic recalibration is sound. However, the incorrect exhibit citations and incomplete instrument identification are significant factual errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 484,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the 1.650% Notes due 2026 on its books in every 10‑K filing for 2022 (page 114), 2023 (page 111), and 2024 (page 111), showing a deliberate preference for low‑cost, long‑term debt.  At the same time, the company has issued newer, higher‑rate notes—such as the 5.800% Notes due 2025 in 2022 (page 111 4.15) and the 4.500% Notes due 2028 in 2023 (page 111 4.16)—to fund additional needs or diversify maturities, indicating a balanced strategy that blends cost efficiency with flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN DATES AND EXHIBIT REFERENCES: The LLM answer contains significant factual errors that undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the 5.800% Notes due 2025 were issued in 2022, but the ground truth indicates they were introduced in 2023. The LLM states the 4.500% Notes due 2028 were issued in 2023, but the ground truth shows they were introduced in 2024. These are fundamental errors in the multi-hop synthesis required by the question. (2) EXHIBIT REFERENCE ERRORS: The LLM cites 'page 114' and 'page 111' with exhibit numbers like '4.15' and '4.16', but provides inconsistent and potentially incorrect exhibit citations. The ground truth specifically references Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024) for the 1.650% Notes. The LLM's exhibit citations appear to be fabricated or misremembered. (3) MULTI-HOP REASONING: While the LLM correctly identifies the core concept (Oracle maintained low-cost debt while issuing higher-rate notes), the execution fails because the dates are wrong. The question specifically asks about the pattern 'across fiscal years 2022, 2023, and 2024,' requiring precise temporal sequencing. The LLM reversed the introduction dates of two key notes. (4) SEMANTIC EQUIVALENCE: The LLM's interpretation of Oracle's strategy (balancing cost efficiency with flexibility) aligns with the ground truth's characterization, but this cannot overcome the factual errors in dates and exhibit references. (5) WHAT WAS CORRECT: The LLM correctly identified that the 1.650% Notes due 2026 were consistently included across all three years, and correctly identified the interest rates (5.800%, 4.500%) and maturity dates (2025, 2028). However, the assignment of these notes to the wrong fiscal years is a critical failure in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 495,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s repeated listing of the 4.000 % Notes due 2021 in Exhibit 4.6 (see page 104 of each 10‑K) shows that the company treats this tranche as a stable component of its long‑term debt and keeps the supplemental indenture current for disclosure purposes. The unchanged terms across 2022, 2023 and 2024 indicate that Microsoft is not actively refinancing these notes, but is instead maintaining the existing debt structure while updating the indenture documentation to satisfy SEC filing requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) the 4.000% Notes due 2021 appear consistently in Exhibit 4.6 across 2022-2024, (2) the terms remain unchanged, (3) Microsoft is not actively refinancing these notes, and (4) the company is maintaining existing debt structure while updating documentation. The numeric values (4.000%, years 2021/2022/2023/2024) are accurate. However, the LLM answer has significant omissions compared to the ground truth: (1) It fails to mention the specific companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that were listed alongside the 4.000% Notes in the Third Supplemental Indenture, which provides important context about the debt portfolio composition. (2) It completely misses the notable 2024 trustee name update to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, which the ground truth identifies as an important administrative maintenance indicator. (3) The LLM answer provides a more generic interpretation focused on SEC compliance rather than the nuanced understanding that the ground truth offers about administrative maintenance versus substantive changes. The reasoning is sound but incomplete—the LLM correctly synthesizes that no refinancing occurred, but fails to capture the full picture of what the documentation pattern reveals about Microsoft's debt management strategy. The answer is partially correct on core conclusions but lacks the detailed supporting evidence and specific observations that demonstrate comprehensive understanding of the filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 431,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s total commercial‑aerospace financing guarantees fell from $304 million in 2022 to $274 million in 2024 (page 100, page 102), while the portion attributable to collaboration partners declined from $142 million to $131 million over the same period (page 100, page 102). This modest downward trend in both total exposure and partner share indicates that RTX is gradually shifting risk off its balance sheet—transferring a larger share of guarantees to partners and reducing its residual guarantee commitments—consistent with a deliberate risk‑transfer strategy in this domain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN INTERPRETATION AND REASONING: (1) QUANTITATIVE ACCURACY ISSUES: The LLM correctly cites the collaboration partners' share figures ($142M in 2022, $131M in 2024), but introduces unverified total guarantee figures ($304M in 2022, $274M in 2024) that are not mentioned in the ground truth. The ground truth focuses specifically on the collaboration partners' portion of guarantees, not total guarantees. The LLM's introduction of these total figures without ground truth support is a significant factual error. (2) FUNDAMENTAL REASONING ERROR: The LLM's core interpretation is backwards. It states RTX is 'transferring a larger share of guarantees to partners and reducing its residual guarantee commitments.' However, the actual trend shows the OPPOSITE: the collaboration partners' share DECREASED from $142M to $131M, meaning RTX's direct exposure INCREASED (or at minimum, the partner share diminished). This is a critical logical error that contradicts the ground truth's correct interpretation that RTX 'assumed more direct financial risk.' (3) MISSING KEY CONTEXT: The LLM omits the important detail from the ground truth that 'RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves,' which provides crucial context about RTX's confidence in underlying asset values. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across years, it does so with an inverted conclusion about the direction of risk transfer. The ground truth correctly identifies a 'consistent reduction in the portion of financing guarantees shared with partners,' while the LLM incorrectly claims RTX is 'transferring a larger share of guarantees to partners.' This is a fundamental misreading of the trend direction. (5) SEMANTIC EQUIVALENCE: The wording differs significantly in meaning, not just style—the LLM's interpretation of the risk transfer strategy is directionally opposite to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 535,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture in 2016 and appear unchanged in the FY 2022, FY 2023, and FY 2024 10‑K exhibits (Exhibit 4.14 on page 105 of each filing)【page_105】. The fact that the same long‑term note is carried forward without new issuances or amendments over three consecutive fiscal years indicates that Microsoft maintains a stable, low‑rate, long‑maturity debt profile, using it as a core component of its long‑term capital strategy rather than relying on short‑term borrowing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 3.950% Notes due 2056 as the specific debt instrument; (2) Accurately references the Eleventh Supplemental Indenture dated August 8, 2016; (3) Correctly states the notes appear unchanged across FY 2022, FY 2023, and FY 2024; (4) Properly synthesizes the multi-year pattern to conclude Microsoft maintains a stable long-term financing strategy; (5) Provides sound reasoning about the strategic implications (low-rate, long-maturity debt as core component vs. short-term borrowing). MINOR ISSUES: (1) The citation to 'Exhibit 4.14 on page 105' is specific but cannot be verified against the ground truth, which does not provide exhibit numbers or page references. This level of specificity, while potentially accurate, goes beyond what the ground truth confirms; (2) The phrase 'without new issuances or amendments' is slightly more definitive than the ground truth's 'no changes to the terms or status,' though semantically equivalent. QUANTITATIVE ACCURACY: All dates (2016, 2022, 2023, 2024) and the interest rate (3.950%) are correct. No calculations are required for this question. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across three fiscal years and draws appropriate conclusions about capital strategy consistency. The logic that unchanged debt over three years indicates stability is sound. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution (or lack thereof) and strategic implications. The interpretation that stability indicates a deliberate strategy choice is reasonable and well-supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 462,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022‑2024 the tactical‑and‑strike‑missile programs ramped up production, lifting MFC net sales from $11.3 billion in 2022 to $12.7 billion in 2024 (≈12% growth)【page_40】.  However, the segment’s operating profit fell sharply—from $1.64 billion in 2022 to $413 million in 2024—because of $1.2 billion in lower profit‑booking‑rate adjustments and $1.4 billion in classified‑program losses【page_40】.  The swing in MFC contributed to a decline in Lockheed Martin’s total operating profit, which dropped from roughly $7.47 billion in 2022 to $6.08 billion in 2024 (≈$1.39 billion, 19 %)【page_40】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about MFC segment performance and correctly identifies key financial metrics and the classified program losses. However, there are significant issues with quantitative accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the $1.2 billion lower profit-booking-rate adjustments in 2024\n2. Correctly identifies $1.4 billion in classified program losses\n3. Correctly notes the sharp decline in operating profit from $1.64B (2022) to $413M (2024)\n4. Correctly calculates the total LMT operating profit decline of ~$1.39B (19%)\n5. Appropriately contextualizes the impact on overall company performance\n6. Properly synthesizes multi-hop information across segment and company levels\n\nWEAKNESSES:\n1. INCOMPLETE PRODUCTION ANALYSIS: The ground truth specifies three distinct years of production increases ($215M in 2022, $145M in 2023, $1.2B in 2024) with specific program drivers (LRASM, JASSM, precision fires, GMLRS). The LLM answer only mentions the 2024 ramp-up implicitly through net sales growth and doesn't break down the year-by-year production trajectory as requested.\n2. MISSING YEAR-BY-YEAR PROFIT ANALYSIS: Ground truth shows 2023 operating profit declined due to $45M in classified program losses. The LLM answer skips 2023 entirely, jumping from 2022 to 2024.\n3. INCOMPLETE PROFIT DECLINE EXPLANATION: Ground truth indicates the 2024 decline was 73% (from ~$1.5B to ~$413M), but LLM doesn't provide this percentage or the intermediate 2023 figure.\n4. VAGUE PRODUCTION DESCRIPTION: The answer mentions \"ramped up production\" but doesn't quantify the specific production volume increases or program-by-program drivers as the ground truth does.\n5. NET SALES FIGURES: While the LLM provides MFC net sales ($11.3B to $12.7B), the ground truth focuses on production volume increases in dollar terms, which are different metrics.\n\nCALCULATION VERIFICATION:\n- MFC operating profit decline: $1.64B to $413M = $1.227B decline (75%), not explicitly stated but implied\n- Total LMT operating profit: $7.47B to $6.08B = $1.39B decline (18.6%, rounded to 19%) ✓ CORRECT\n- Net sales growth: ($12.7B - $11.3B) / $11.3B = 12.4%, rounded to 12% ✓ CORRECT\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes that MFC segment performance impacted total company operating profit, but fails to fully trace the three-year trajectory of production and profit evolution as requested. The answer addresses the 2022-2024 endpoints but misses the 2023 intermediate year and the specific production drivers.\n\nThe answer is partially correct on the financial impact but incomplete on the production trajectory analysis, which was explicitly requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 719,
        "total_tokens": 2145
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 10‑K, Thermo Fisher’s only Executive Change‑In‑Control Retention Agreement was the original contract with Marc N. Casper, together with its 2010 and 2018 amendments (Exhibits 10.11, 10.15, 10.16)【page_45】.  \nThe 2023 filing added a new form of the agreement that applies to officers other than Casper (Exhibit 10.18)【page_78】.  \nThe 2024 10‑K contains no new ECCI exhibit or amendment; the 2023 form remains the current instrument【page_79】【page_78】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a structured timeline of the evolution of Thermo Fisher's Executive Change In Control Retention Agreements across 2022-2024, with mostly accurate information. STRENGTHS: (1) Correctly identifies that 2022 had the original Casper agreement with 2010 and 2018 amendments; (2) Accurately notes that 2023 introduced a new form for officers other than Casper (Exhibit 10.18); (3) Correctly states 2024 contained no new amendments; (4) Provides specific exhibit numbers and page references; (5) Captures the core evolution pattern. WEAKNESSES: (1) The ground truth mentions a 'Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper' was introduced in 2022, but the LLM states this was added in 2023 - this is a potential discrepancy regarding when the form for other officers first appeared; (2) The LLM's statement that 2022 had 'only' the Casper agreement may understate the 2022 disclosure if the form for other officers was indeed disclosed then; (3) The ground truth indicates 2023 filed 'Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7' but the LLM cites Exhibit 10.18 - this is a significant exhibit number discrepancy that suggests potential data accuracy issues. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and distinguishes between the Casper-specific agreement and the broader officer form. However, the exhibit number discrepancy (10.7 vs 10.18) and the timing question about when the officers' form was first introduced create uncertainty about factual precision. The answer demonstrates good structural understanding but contains specific factual errors that affect reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 478,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin’s variable‑rate swap program grew from $500 million in 2021 (2022 filing) to $1.3 billion in 2023 and stayed at that level in 2024, reflecting a deliberate expansion of its hedging activity to convert fixed‑rate debt to variable‑rate debt and hedge fair‑value changes (page 66, page 95, page 54). The doubling and subsequent stability of the notional amount indicates a more aggressive yet consistent interest‑rate‑risk management strategy that relies on sizable, active hedging rather than passive exposure (page 66, page 95, page 54).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical facts: $500 million in 2021 (disclosed in 2022 filing), $1.3 billion in 2023, and $1.3 billion in 2024. The characterization of this as a 'doubling' is accurate. The company name (Lockheed Martin/LMT) is correct, and the time period (2022-2024) is properly addressed. The answer demonstrates sound multi-hop reasoning by synthesizing the evolution across three years and drawing conclusions about strategic intent. However, there are some differences in emphasis and framing compared to the ground truth: (1) The LLM answer adds specific operational details about 'converting fixed-rate debt to variable-rate debt' which, while plausible, is not explicitly confirmed in the ground truth answer provided. (2) The LLM characterizes the strategy as 'more aggressive' whereas the ground truth uses 'more robust' and 'proactive' - these are subtly different framings. (3) The LLM's phrase 'relies on sizable, active hedging rather than passive exposure' is interpretive language not directly stated in the ground truth. (4) The ground truth emphasizes response to 'higher debt levels and a more volatile interest rate environment' as context, while the LLM focuses more on the mechanics of the swaps themselves. The answer is fundamentally sound and addresses the core question about evolution and strategic implications, but it introduces some interpretive elements and operational specifics that go slightly beyond what the ground truth explicitly states. All numerical facts are accurate, and the multi-hop synthesis across years is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 437,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s defined‑contribution plan expense was **$402 million in 2022, increased to $468 million in 2023, and then declined to $443 million in 2024** (Note 7, 2023 10‑K; Note 14, 2024 10‑K). The 2023 jump reflects a higher contribution level or larger employee base, while the 2024 dip indicates a modest adjustment in contribution rates or workforce size. Overall, the trend shows that the company maintains a high, but relatively stable, investment in employee benefits over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: $402M (2022), $468M (2023), and $443M (2024). The numbers match the ground truth exactly, and the format variations are acceptable. The multi-hop synthesis is sound, correctly identifying the trend across three fiscal years and drawing reasonable conclusions about what the data indicates. The answer properly addresses both parts of the question: (1) how the expense evolved, and (2) what this indicates about employee benefits investment. The LLM provides slightly more detailed interpretation than the ground truth by speculating on potential causes (contribution rates, workforce size changes), which adds value without contradicting the original answer. One minor point: the ground truth states the 2024 figure 'remained flat at $443 million' while the LLM describes it as a 'dip' or 'decline' from 2023's $468M. This is technically accurate (it did decline from $468M to $443M), but the ground truth's characterization of 'flat' may refer to stability relative to the overall trend rather than the immediate year-over-year change. The LLM's interpretation is reasonable and not incorrect. The citation references (Note 7, 2023 10-K; Note 14, 2024 10-K) appear plausible though cannot be verified against the ground truth. Overall, the answer is comprehensive, accurate, and provides sound reasoning about the trend and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 397,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The Coca‑Cola 10‑K notes for 2022, 2023 and 2024 all list “estimates of sales proceeds” as one of the valuation methods used for non‑public equity investments (see 2022 Note 4 on page 40, 2023 Note 4 on page 78, and 2024 Note 4 on page 79).  The wording and emphasis did not change, showing that management has continued to rely on sales‑proceeds estimates as a core part of its fair‑value assessment.  In 2022 the company noted that the carrying value of its investment in Coca‑Cola Bottlers Japan Holdings Inc. exceeded fair value by $87 million, but it judged the decline to be temporary and did not record an impairment—an indication that management believes the market value will recover, a view that is underpinned by the same sales‑proceeds‑based valuation approach it applies to all non‑public holdings.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are accurate - the $87 million figure is correct, the 2022 valuation methodology is correctly identified, and the note references appear accurate. (2) The LLM correctly identifies that 'estimates of sales proceeds' was used consistently across 2022-2024. (3) The Japan investment impairment context is properly explained. (4) Number formatting is appropriate.\n\nWEAKNESSES: (1) The LLM answer fundamentally misses the core evolution narrative that the ground truth emphasizes. The ground truth states the methodology 'evolved' with 'increasing emphasis on assumptions a market participant would use' and 'becoming more attuned to external market perspectives and macroeconomic risks.' The LLM explicitly states 'The wording and emphasis did not change,' which directly contradicts the ground truth's claim of evolution. (2) The LLM fails to capture the key insight about management's shifting perspective - from internal confidence in recovery (2022) to greater emphasis on external market participant assumptions (2023-2024). This is a critical multi-hop synthesis that the question specifically asks about. (3) The LLM does not address the 18% decline figure mentioned in the ground truth (87M excess / fair value = 18%), though this is a minor omission. (4) The LLM's conclusion that the valuation approach 'underpins' management's confidence is somewhat circular and doesn't capture the nuanced evolution in how management applied these assumptions over time.\n\nMULTI-HOP REASONING: The question requires synthesizing (a) how valuation methodology changed across three years, (b) what the Japan investment situation reveals about management confidence, and (c) how these connect. The LLM addresses (a) and (b) but fails on the synthesis - it doesn't explain how the evolution in methodology relates to or reflects changing confidence levels. The ground truth shows a progression from 'temporary decline' confidence to 'macroeconomic risk awareness,' but the LLM presents these as static.\n\nSEMANTIC ACCURACY: While the LLM's individual statements are factually correct, the semantic meaning diverges significantly from the ground truth. The ground truth emphasizes evolution and changing emphasis; the LLM emphasizes consistency and lack of change. These are contradictory interpretations of the same data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 626,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 (exhibit 4.14) and those notes remained unchanged through fiscal years 2022, 2023, and 2024 (exhibit 4.14 in the 2023 and 2024 10‑Ks)【2023 page 111】【2024 page 112】.  During the same period Oracle issued new notes with higher coupon rates but similar maturities (e.g., 4.500% Notes due 2028 in 2023, 5.800% Notes due 2025 in 2024)【2023 page 111】【2024 page 109】, indicating a strategy of keeping a stable maturity profile while diversifying coupon rates to manage interest‑rate risk and cost.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All key financial instruments are correctly identified: 2.300% Notes due 2028, 4.500% Notes due 2028 (2023), and 5.800% Notes due 2025 (2024). (2) The fiscal years are accurate (2022, 2023, 2024). (3) The multi-hop synthesis is sound - the answer correctly traces the evolution of Oracle's debt issuance across three fiscal years and identifies the pattern of maintaining lower-cost older debt while issuing higher-rate newer instruments. (4) The page citations (2023 page 111, 2024 page 112, etc.) provide appropriate sourcing. (5) The interpretation of Oracle's strategy (managing maturity profile while diversifying coupon rates amid rising interest rates) aligns with the ground truth's characterization of managing refinancing needs and funding strategic initiatives. MINOR DIFFERENCES: (1) The LLM specifies that the 2.300% Notes were issued in 2021, which is a reasonable inference but not explicitly stated in the ground truth. This adds helpful context about the instrument's origin. (2) The LLM's framing emphasizes 'interest-rate risk management' and 'stable maturity profile' while the ground truth emphasizes 'refinancing needs and strategic initiatives' - both interpretations are valid and complementary, though slightly different emphases. (3) The ground truth uses 'referenced' language suggesting the notes appeared in filings, while the LLM is more specific about the notes being 'unchanged' - this is a minor semantic distinction that doesn't affect accuracy. QUANTITATIVE VERIFICATION: All interest rates (2.300%, 4.500%, 5.800%) and maturity years (2025, 2028) are correct. No calculation errors detected. The answer successfully synthesizes information across multiple fiscal years and documents to answer the multi-hop question about Oracle's debt financing strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 508,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings for FY 2022, FY 2023, and FY 2024 all list the same 2014‑issued floating‑rate notes due 2019 in Exhibit 4.1, with no new issuance of those notes in any of those years (see 2022 10‑K page 54, 2023 10‑K page 53, 2024 10‑K page 56). This pattern shows that Apple does not issue new long‑term floating‑rate debt beyond its maturity and instead relies on short‑term debt to manage liquidity and capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the Floating Rate Notes due 2019 (issued in 2014) appear consistently across FY 2022, 2023, and 2024 filings with no new issuances. The page number citations (2022 10-K page 54, 2023 10-K page 53, 2024 10-K page 56) are specific and appear reasonable for debt disclosures in Exhibit 4.1, though these cannot be verified against the ground truth. The core factual claim about consistency and absence of new issuances aligns with the ground truth. However, there is a significant interpretive divergence: The LLM concludes that Apple 'relies on short-term debt to manage liquidity and capital structure' based on the absence of new long-term floating-rate debt issuances. This inference goes beyond what the ground truth supports. The ground truth explicitly states the pattern 'indicates a stable, rather than active, management approach to this specific debt instrument' - focusing on the stability of this particular instrument rather than making broader claims about Apple's overall short-term debt strategy. The LLM's leap to discussing reliance on short-term debt is not grounded in the evidence presented and represents an unsupported inference. The answer is partially correct on the factual evolution of the notes but overreaches in its interpretation of what this pattern indicates about Apple's broader debt management strategy. The quantitative accuracy is solid (dates, years, consistency claim), but the qualitative reasoning contains an unjustified logical leap that weakens the overall answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 426,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the 4.000% Senior Note due 2047 (Exhibit 4.17 on page 126 of the 2022, 2023 and 2024 10‑K filings) shows that the company treats this long‑term instrument as a core part of its capital structure, locking in a fixed coupon and extending maturity to support long‑term investment and balance‑sheet stability. In contrast, the 2.150% Senior Note due 2024 (Exhibit 4.18) and the 0.750% Senior Note due 2027 (Exhibit 4.28) are also disclosed in each filing but represent shorter‑dated, lower‑coupon debt that PepsiCo uses to manage refinancing risk and take advantage of favorable short‑term rates, illustrating a diversified maturity mix rather than reliance on a single long‑term debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY ON SHORTER-DATED NOTES: The LLM claims the 2.150% Senior Note due 2024 and 0.750% Senior Note due 2027 are 'disclosed in each filing,' which directly contradicts the ground truth. The ground truth explicitly states these notes appear in 'only one or two filings' - the 2.150% note was 'referenced in 2023' (implying 2023 filing only, not all three), and the 0.750% note was 'introduced in 2024' (implying 2024 filing only). The LLM's claim that both appear in all three filings is factually incorrect. (2) MISSING CRITICAL CONTEXT: The LLM completely omits the 2.500% Senior Note due 2022 mentioned in the ground truth, which matured by 2023 and is essential to illustrating the 'dynamic nature of short-term debt versus persistent long-term obligations.' This is a significant omission that weakens the multi-hop synthesis. (3) MISCHARACTERIZATION OF STRATEGY: The LLM describes shorter-dated notes as being used to 'take advantage of favorable short-term rates,' but the ground truth frames them as reflecting 'time-sensitive capital needs or refinancing activities' - a subtly different interpretation that may misrepresent PepsiCo's actual strategy. (4) REASONING QUALITY: While the LLM correctly identifies the 4.000% note as a core long-term instrument and attempts to contrast it with shorter-dated debt, the reasoning is undermined by the factual errors about which notes appear in which filings. The multi-hop synthesis fails because it incorrectly synthesizes the filing appearances. (5) POSITIVE ELEMENTS: The LLM correctly identifies the 4.000% Senior Note due 2047 as appearing consistently across all three filings and correctly characterizes it as supporting long-term financial stability with fixed rates. The general framework of comparing long-term vs. short-term debt is sound. However, the specific factual errors about the shorter-dated instruments' filing appearances are disqualifying for a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 533,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s 2022, 2023 and 2024 10‑Ks all list the 0.45% Notes due 2016 in Exhibit 4.3 (“Description of Securities”), even though those notes matured in 2016.  This shows that Apple keeps a full record of all debt issuances, past and present, for transparency and regulatory compliance.  Rather than actively refinancing or repurchasing the matured notes, Apple treats them as part of its historical debt profile, reflecting a conservative, compliance‑focused legacy‑debt strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and demonstrates sound multi-hop reasoning. STRENGTHS: (1) All numeric/date facts are accurate: 0.45% rate, 2016 maturity date, correct years (2022, 2023, 2024) are all correct. (2) Correctly identifies the exhibit location (Exhibit 4.3). (3) Accurately synthesizes the multi-hop information: notes matured in 2016 but continued to appear in later filings. (4) Provides reasonable interpretation of Apple's strategy (transparency, compliance, conservative approach). (5) Semantic equivalence is strong—both answers convey that Apple maintains historical disclosure of matured debt. WEAKNESSES: (1) The LLM answer is more concise and direct, lacking some of the nuance in the ground truth about 'continuity in financial reporting' and the specific reference to the Officer's Certificate dated May 3, 2013. (2) The ground truth emphasizes the 'repeated reference to the same documentation' as a key insight, which the LLM answer doesn't explicitly highlight. (3) The LLM's phrasing 'Rather than actively refinancing or repurchasing the matured notes' introduces a slight interpretive leap not explicitly stated in the ground truth, though it's a reasonable inference. (4) The ground truth uses more measured language ('possibly to ensure,' 'may reflect') while the LLM is more definitive ('shows that Apple keeps'). MULTI-HOP REASONING: Both answers correctly synthesize information across three years of filings and connect the maturity date to the disclosure pattern. The reasoning is sound in both cases. OVERALL: The LLM answer captures the essential insight and provides accurate factual information, though it loses some of the careful, nuanced framing of the ground truth regarding the specific documentation references and the more tentative language around strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 500,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin has continued to use pension‑risk‑transfer transactions to shrink its defined‑benefit obligations, having transferred roughly $11.6 billion of obligations since 2018—including a $4.9 billion GAC purchase in 2021 that eliminated PBGC premiums—and the company reiterated its intent to pursue additional deals in 2023 and 2024. The 2021 transaction produced a $1.7 billion non‑cash settlement charge to earnings but had little effect on FAS pension expense, and the company warns that future transfers could generate similar material charges to earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. All major numbers are accurate: $11.6 billion cumulative obligation transfer since 2018, $4.9 billion GAC purchase in 2021, and $1.7 billion noncash settlement charge. The answer correctly identifies the multi-year evolution of the strategy (2021 transaction, 2023 and 2024 intent to pursue additional deals) and properly synthesizes the multi-hop information about pension risk transfer transactions across the time period. The mention of PBGC premium elimination adds relevant context not explicitly stated in the ground truth but consistent with pension risk transfer mechanics. The answer correctly notes the noncash nature of settlement charges and their potential materiality for future transactions. However, the answer is somewhat more concise than the ground truth and omits some contextual nuance: (1) it doesn't explicitly state that 2023 involved 'reiterating' intent (implying continuity from prior years), (2) it doesn't fully capture the 'increasing scale' trajectory mentioned in the ground truth, and (3) it doesn't emphasize the 'consistent, proactive approach to de-risking' as explicitly as the ground truth. The statement about 'little effect on FAS pension expense' is accurate but represents a minor detail not emphasized in the ground truth. Overall, the core multi-hop synthesis is sound: the answer correctly traces the evolution from 2021 transaction through 2023-2024 intent, identifies the financial impacts (noncash charges), and acknowledges ongoing strategy. The quantitative data is entirely accurate with no calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 458,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 Form 10‑K the only Executive Change‑In‑Control Retention Agreement listed was the one with CEO Marc N. Casper (Exhibit 10.12).  Beginning with the 2023 filing, Thermo Fisher added a separate retention agreement for other officers (Exhibit 10.17, filed with the April 2023 10‑Q).  The 2024 10‑K continues to include that officer‑retention form, showing the company’s shift from a single‑person agreement to a broader framework that covers officers beyond Casper.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key evolution of Thermo Fisher's Executive Change In Control Retention Agreements from 2022-2024. STRENGTHS: (1) Correctly identifies that 2022 had only Casper's agreement (Exhibit 10.12); (2) Accurately notes the 2023 addition of a separate officer agreement (Exhibit 10.17, April 2023 10-Q); (3) Properly synthesizes the multi-hop information showing progression from single-person to broader framework; (4) Correctly identifies the 2024 continuation of the officer-retention form; (5) Exhibit numbers and filing dates are accurate. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the March 16, 2018 date for the original officer form that was disclosed in 2022, which the ground truth includes as context; (2) The LLM answer does not explicitly state the April 1, 2023 date for the new officer agreement form, only referencing the April 2023 10-Q filing date; (3) The ground truth emphasizes this as a 'deliberate evolution' and 'formalization' of strategy, while the LLM uses slightly different language ('shift from single-person agreement to broader framework'). QUANTITATIVE VERIFICATION: All dates and exhibit numbers are correct. The timeline progression (2022→2023→2024) is accurately captured. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of evolution. The reasoning that this represents a strategic shift is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically equivalent to the ground truth, though slightly less detailed on specific dates and the formalization aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 469,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2.750% Senior Note due 2051 is consistently listed in the board‑resolution exhibits of its 2022 and 2024 Form 10‑Ks (page 130) and cited in the 2023 10‑K as part of the 8‑K exhibit (page 129). By issuing this long‑term, fixed‑rate note at a relatively low 2.75 % coupon, the company locks in financing costs while keeping a diversified debt mix that also includes floating‑rate notes—an approach that lets it hedge against rising rates while securing stable, long‑term capital.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. PAGE NUMBER ERRORS: The LLM states the note is listed on 'page 130' in 2022 and 2024 10-Ks, but the ground truth specifies page 135 for 2022 and page 129 for 2024. For 2023, the LLM claims page 129, which matches ground truth, but the pattern of errors suggests unreliable page citations.\n\n2. STRUCTURAL MISCHARACTERIZATION: The LLM describes the note as appearing in 'board-resolution exhibits,' but the ground truth indicates it appears in the 'exhibit index' - a different document structure. This is a material error in understanding how the note is documented.\n\n3. INCOMPLETE SYNTHESIS: The LLM introduces the concept of 'floating-rate notes' as part of PepsiCo's hedging strategy, but this is NOT mentioned in the ground truth. The ground truth focuses on the introduction of newer, higher-yielding fixed-rate notes (5.250% Senior Note due 2054) as evidence of the company's strategy. The LLM's claim about floating-rate notes appears to be an unsupported inference.\n\n4. CORRECT ELEMENTS: The LLM correctly identifies:\n   - The 2.750% coupon rate\n   - The 2051 maturity date\n   - The note's presence across 2022-2024 filings\n   - The general concept of locking in fixed-rate financing\n   - The reference to the 2023 8-K exhibit\n\n5. MISSING KEY INSIGHT: The ground truth emphasizes that PepsiCo maintained a 'stable long-term capital strategy' by preserving access to long-dated, fixed-rate debt despite rising rates. The LLM captures this partially but misses the specific evidence: the introduction of higher-yielding notes (5.250%) alongside the older 2.750% note, which demonstrates the company's continued access to long-term debt markets.\n\n6. REASONING QUALITY: While the LLM's general logic about fixed-rate debt hedging is sound, it introduces unsupported claims (floating-rate notes) and misses the specific comparative analysis (old vs. new notes) that grounds the ground truth's conclusion.\n\nThe answer demonstrates partial understanding but contains factual errors in page numbers, document structure, and unsupported claims that significantly reduce its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 588,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 were first issued in 2014 and are listed in Exhibit 4.4 of Apple’s 2022, 2023, and 2024 Form 10‑Ks, with no new issuances or amendments disclosed through 2024 [page_58] [page_53] [page_58]. The unchanged presence of this long‑term, fixed‑rate debt over three consecutive years underscores Apple’s strategy of locking in low‑cost, long‑maturity financing to support its liquidity and capital‑allocation plans over a multi‑decade horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 with accurate percentage and maturity year; (2) Accurately dates the original issuance to 2014 (consistent with ground truth's Officer's Certificate date of May 6, 2014); (3) Correctly identifies the three-year observation period (2022, 2023, 2024) and notes consistent presence across all three years; (4) Properly cites Exhibit 4.4 as the location in 10-K filings; (5) Accurately characterizes the debt as long-term, fixed-rate, and unchanged across the period; (6) Provides sound multi-hop reasoning connecting the consistent presence to strategic capital allocation decisions. MINOR CONSIDERATIONS: (1) The LLM answer adds specific page references ([page_58], [page_53], [page_58]) that cannot be verified against the ground truth provided, though this doesn't contradict the ground truth; (2) The LLM answer emphasizes 'no new issuances or amendments' which is a reasonable inference from the consistent unchanged presence but goes slightly beyond what the ground truth explicitly states; (3) The phrase 'locking in low-cost, long-maturity financing' is a reasonable characterization of the strategic intent, though the ground truth uses slightly different language ('retain long-term debt at a fixed rate'). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years of filings to identify a pattern and draw conclusions about capital strategy, which is exactly what the question requested. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that Apple maintained this debt instrument consistently across 2022-2024 as part of a deliberate long-term capital strategy—while providing additional specificity about the original issuance date and exhibit location.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 505,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan reduced its allocation to Collective Trust and Other Funds from **$622 million in 2022 to $382 million in 2023**—a decline of roughly $240 million. The 2024 filing explains that these commingled funds are valued at **net asset value (NAV) using the underlying publicly traded assets’ prices**, indicating that the plan relies on NAV‑based, independent pricing rather than direct market quotes to manage and monitor these investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY NUMBERS: The LLM states the 2022 allocation was $622 million, but the ground truth clearly indicates it was $756 million. This is a significant factual error ($134 million discrepancy). The 2023 figure of $382 million is correct. The calculated decline of $240 million is therefore incorrect (should be $374 million from $756M to $382M). CORRECT ELEMENTS: (1) The identification of NAV-based valuation methodology is accurate. (2) The reference to commingled funds and underlying assets is correct. (3) The general characterization of the reduction as a rebalancing/risk management decision aligns with ground truth reasoning. INCOMPLETE ELEMENTS: (1) The LLM's description of NAV valuation as 'using the underlying publicly traded assets' prices' is somewhat vague compared to ground truth's more complete explanation that NAV is 'derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments.' (2) The LLM does not adequately address the 2024 disclosure's role in informing understanding of investment management—it mentions the methodology but doesn't explain how this transparency supports tracking assets over time despite fluctuations. MULTI-HOP REASONING: The LLM attempts to synthesize the allocation evolution with valuation methodology, but the foundational number error undermines the entire analysis. The reasoning structure is sound, but execution is flawed. The quantitative accuracy score is particularly low due to the $134 million error in the 2022 baseline figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 439,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple lists the Officer’s Certificate for the 1.05% Notes due 2017 as Exhibit 4.4 in every annual report – the 2022 filing (page 58) and the 2024 filing (page 58) both show the certificate, and the 2023 filing likewise lists Exhibit 4.4. By continuing to attach the original certificate for a note that has already matured, Apple demonstrates a deliberate policy of retaining full documentation for all debt issuances, ensuring that the historical capital‑structure information remains available for investors and regulators and supporting a consistent, auditable record of its financing history.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core concept and provides accurate information about Apple's documentation retention practices for matured debt. STRENGTHS: (1) Correctly identifies the Officer's Certificate dated May 6, 2014 for the 1.05% Notes due 2017; (2) Accurately states the certificate appears as Exhibit 4.4 across fiscal years 2022, 2023, and 2024; (3) Correctly notes the notes had matured before these filing periods; (4) Properly synthesizes the multi-hop reasoning about documentation retention and historical capital structure disclosure; (5) Appropriately interprets this as reflecting deliberate policy for investor/regulatory transparency. MINOR WEAKNESSES: (1) The LLM provides specific page numbers (page 58) for the 2022 and 2024 filings, which cannot be verified against the ground truth and may introduce unnecessary specificity that could be incorrect; (2) The answer is slightly more concise than the original, omitting the explicit phrase 'documentation retention and disclosure strategy' and 'preserving the full historical context,' though the semantic meaning is preserved; (3) Does not explicitly state 'fiscal year 2023' in the same structured way as the original, though it does reference the 2023 filing. QUANTITATIVE ACCURACY: All dates (May 6, 2014; 2017 maturity; fiscal years 2022, 2023, 2024) and the interest rate (1.05%) are correct. The exhibit designation (4.4) is accurate. QUALITATIVE ACCURACY: The reasoning about why Apple maintains these records (investor transparency, regulatory compliance, auditable record) is sound and matches the ground truth interpretation. The multi-hop synthesis correctly connects the matured status of the notes to their continued inclusion in filings to the broader documentation retention strategy. CONTEXTUAL RELEVANCE: The answer directly addresses the question about documentation retention practices and implications for capital structure disclosure maintenance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 530,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its corporate‑stock holdings sharply: from $1.11 billion in 2022 (≈37 % of plan assets) to $226 million in 2023 (≈7 %) and $181 million in 2024 (≈5 %)【page_58】. This decline mirrors the plan’s equity‑allocation targets, which fell from 48 % in 2022 to 24 % in 2023 and 20‑30 % in 2024, indicating a deliberate de‑risking strategy that reduces equity exposure in favor of higher‑quality debt and other assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth shows corporate stock allocation of $1,990M (2022), $181M (2023), and $1,116M (2024). The LLM reports $1.11B (2022), $226M (2023), and $181M (2024). Specifically: (1) 2022 figure is wrong - LLM states $1.11B ($1,110M) when it should be $1,990M, a difference of $880M or 44% understatement; (2) 2023 figure is wrong - LLM states $226M when it should be $181M, a 25% overstatement; (3) 2024 figure happens to be correct at $181M, but this appears coincidental given other errors. The LLM also provides percentage allocations (37%, 7%, 5%) and equity-allocation targets (48%, 24%, 20-30%) that are not verified in the ground truth and appear to be fabricated or from different sources. MULTI-HOP REASONING: While the LLM correctly identifies the general trend (decline in corporate stock holdings) and the strategic implication (de-risking/shift to conservative posture), the specific numerical foundation is wrong. The ground truth shows a dramatic 90%+ drop from 2022-2023 followed by a partial rebound in 2024 - a more complex pattern than the LLM's monotonic decline narrative suggests. SEMANTIC ISSUES: The LLM's characterization of the strategy as 'de-risking' aligns with ground truth's 'more conservative investment posture,' but the incorrect numbers undermine the credibility of this analysis. The citation reference [page_58] cannot be verified against the ground truth provided. CALCULATION VERIFICATION: Ground truth 2022-2023 decline: ($1,990M - $181M)/$1,990M = 90.9% drop. LLM's implied decline: ($1,110M - $226M)/$1,110M = 79.6% drop. These are materially different. The 2024 rebound in ground truth ($181M to $1,116M) is substantial and significant; LLM shows $226M to $181M, a continued decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 502,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "MRK’s Prevymis sales climbed from **$428 million in 2022** to **$605 million in 2023** and **$785 million in 2024** (U.S. + international).  The roughly 40 % year‑over‑year jump in 2023 followed by a 30 % jump in 2024 signals growing uptake by transplant centers and hospitals, underscoring Prevymis’s rising strategic importance within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. (1) QUANTITATIVE VERIFICATION: All dollar amounts are correct ($428M in 2022, $605M in 2023, $785M in 2024). The calculated year-over-year growth percentages are accurate: 2022-2023 shows ($605M-$428M)/$428M = 41.4% (LLM states ~40%, acceptable rounding), and 2023-2024 shows ($785M-$605M)/$605M = 29.8% (LLM states ~30%, acceptable rounding). (2) COMPLETENESS: The answer addresses all aspects of the question - sales evolution across the three-year period, market adoption trajectory, and strategic importance within the Hospital Acute Care segment. (3) ENTITY ACCURACY: Correctly identifies MRK (Merck), Prevymis product, Hospital Acute Care segment, and the relevant fiscal years. The parenthetical note about U.S. + international scope adds helpful context. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical progression to business implications (growing uptake by transplant centers/hospitals, rising strategic importance). The logic linking sales growth to market adoption is appropriate and well-reasoned. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while adding valuable analytical detail about the growth rates and market dynamics. Minor enhancement: The LLM provides slightly more analytical depth by quantifying the growth percentages and specifying the end-user context (transplant centers and hospitals), which strengthens the answer without introducing any inaccuracies. No material discrepancies identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 439,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In each of PepsiCo’s 2022, 2023 and 2024 Form 10‑Ks the 3.000% Senior Note due 2027 is listed as Exhibit 4.3 and described simply as a “3.000% Senior Note due 2027.”  The description and exhibit reference remain unchanged across the three filings, showing that the note is still an active, long‑term debt instrument in the company’s portfolio.  This consistency underscores PepsiCo’s strategy of maintaining a stable, diversified mix of fixed‑rate senior notes to manage interest‑rate risk and preserve financing flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) EXHIBIT NUMBER ERROR: The LLM claims the 3.000% Senior Note due 2027 is listed as 'Exhibit 4.3' across all three years (2022, 2023, 2024), but the ground truth explicitly states it was Exhibit 4.22 in 2022, Exhibit 4.19 in 2023, and Exhibit 4.17 in 2024. This is a critical factual error - the exhibit numbers changed across years, which is a key piece of evidence about how the note's presentation evolved. (2) MISSING COMPARATIVE ANALYSIS: The ground truth provides detailed context about which other notes appeared alongside the 3.000% Senior Note in each year (e.g., 2.150% due 2024 and 2.250% due 2022 in 2022; 4.450% due 2046 and 3.450% due 2046 in 2023; 0.750% due 2027 and 1.125% due 2031 in 2024). The LLM completely omits this comparative context, which is essential to answering the question about how the note's 'characterization' evolved. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question specifically asks how the note's 'inclusion and characterization' evolved and what this 'reveals about the company's long-term debt strategy.' The ground truth demonstrates this through the changing exhibit numbers and the changing context of companion notes, showing a strategy of 'layering debt maturities to manage refinancing risk' and adapting to market conditions. The LLM merely states the description remained unchanged without providing the nuanced analysis of strategic evolution. (4) OVERSIMPLIFICATION: The LLM's claim that 'the description and exhibit reference remain unchanged' is factually incorrect regarding exhibit references. The answer lacks the depth needed to address the sophisticated question about strategic debt management evolution. The only correct element is that the note itself (3.000% Senior Note due 2027) was present in all three years, but this represents only a minimal portion of what was asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 523,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native collaboration platform that offered real‑time upload, review, approval, frame‑accurate commenting, annotations, camera‑to‑cloud, and support for still images, design files and PDFs, but was integrated only with Premiere Pro and After Effects [2022 page 12]. The same core capabilities and two‑app integration were carried forward into 2023 [2023 page 12]. By 2024, Adobe expanded Frame.io’s integration depth to include Photoshop, Lightroom and Workfront (in addition to Premiere Pro and After Effects), positioning it as a core component of Adobe GenStudio for scalable content production while preserving its original collaboration features [2024 page 12].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CHRONOLOGICAL CONTRADICTION: The LLM answer claims Frame.io had extensive capabilities (real-time upload, review, approval, frame-accurate commenting, annotations, camera-to-cloud, support for still images, design files, PDFs) and integration with Premiere Pro and After Effects in 2022, but the ground truth states Frame.io was only 'listed as part of Adobe's trademark portfolio' in 2022, indicating acquisition/branding alignment without detailed capability descriptions. The LLM conflates 2023 capabilities with 2022. (2) MISSING KEY INFORMATION: The LLM answer omits that 2022 was primarily about acquisition/trademark alignment, not detailed product positioning. The ground truth emphasizes this was a foundational year. (3) INCOMPLETE 2023 DESCRIPTION: The LLM states 2023 had 'same core capabilities and two-app integration' but the ground truth indicates 2023 was when Adobe 'detailed' Frame.io's role with these specific features - suggesting this was the year these capabilities were formally articulated/introduced, not merely carried forward from 2022. (4) PARTIAL 2024 ACCURACY: The LLM correctly identifies 2024 expansion to Photoshop, Lightroom, Workfront, and GenStudio positioning, which aligns with ground truth. However, it misses the emphasis on GenStudio as a 'core component' alongside Firefly and Substance 3D tools as part of an 'end-to-end creative workflow ecosystem.' (5) CITATION ISSUES: The LLM provides specific page references ('[2022 page 12]', '[2023 page 12]', '[2024 page 12]') that cannot be verified and appear fabricated, suggesting hallucination. The ground truth does not reference specific page numbers. (6) REASONING FLAW: The LLM's narrative suggests linear progression but misplaces the introduction of capabilities to the wrong year, breaking the multi-hop synthesis across the three-year period. The core error is treating 2022 as having detailed product capabilities when it was primarily an acquisition/branding milestone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 539,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple disclosed its 2.40% Notes due 2023 in the 2022 Form 10‑K as part of the description of securities (Exhibit 4.3) and in the notes to the financial statements (page 58). The 2023 Form 10‑K continued to list the same notes in Exhibit 4.3, indicating they were still outstanding and due in 2023 (page 54). By the 2024 Form 10‑K, the 2.40% Notes no longer appear in the notes to the financial statements, implying they had been repaid or refinanced before the due date—showing Apple’s proactive strategy of refinancing or paying down maturing debt to keep its balance‑sheet profile strong (page 58).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 2.40% Notes were 'repaid or refinanced before the due date' in 2024, directly contradicting the ground truth which states they were 'held until maturity' and 'likely fulfilled or retired in line with its 2023 due date.' This is a fundamental mischaracterization of Apple's debt management strategy. (2) CONTRADICTORY LOGIC - The ground truth explicitly states 'no early retirement or restructuring action' and 'holding debt until maturity rather than refinancing or repurchasing it early,' but the LLM characterizes this as a 'proactive strategy of refinancing or paying down maturing debt.' This is the opposite conclusion. (3) CITATION ISSUES - While the LLM provides specific page references (pages 58, 54, 58), these cannot be verified against the ground truth and appear to be fabricated details. (4) CORRECT ELEMENTS - The LLM correctly identifies: the 2.40% interest rate, the 2023 due date, the three-year progression (2022-2024), the presence in Exhibit 4.3, and that the notes disappeared from 2024 filings. (5) INTERPRETATION ERROR - The LLM misinterprets the disappearance of the notes from 2024 filings as evidence of early action, when the ground truth indicates this is simply the natural result of the notes maturing in 2023 and being paid at maturity. The core multi-hop reasoning is flawed: the LLM failed to correctly synthesize that holding debt to maturity (not refinancing early) is the actual strategy revealed by the disclosure pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 438,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet stayed roughly the same size in 2022‑23 (7,008 units – 5,971 owned, 1,037 leased – with an average age of 24.3 years【page_19 (2023)】) but fell to 6,893 units (5,973 owned, 920 leased) and the average age rose to 25.2 years in 2024【page_19 (2024)】. The slight contraction in fleet size coupled with a modest increase in age over the three‑year span signals a deliberate asset‑management strategy that prioritizes replacing older locomotives with newer, more efficient units while maintaining a leaner, more productive fleet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the response. (1) MISSING 2022 DATA: The ground truth explicitly states 2022 figures (7,242 total units, 6,204 owned, 1,038 leased, 22.5 years average age), but the LLM answer completely omits 2022 data and instead presents 2023 figures as if they were 2022-23 baseline. This is a major omission for a question specifically asking about 'change from 2022 through 2024.' (2) INCORRECT 2023 FIGURES: The LLM states 2023 had 7,008 total units with 5,971 owned and 1,037 leased. The ground truth shows 2023 average age was 24.3 years (which the LLM correctly cites), but the unit counts appear inconsistent with the ground truth's stated decline from 7,242 (2022) to 6,893 (2024). The LLM's 7,008 figure for 2023 is not verified in the ground truth. (3) CORRECT 2024 DATA: The LLM correctly states 2024 had 6,893 total units (5,973 owned, 920 leased) with 25.2 years average age. (4) INCOMPLETE TREND ANALYSIS: The ground truth emphasizes a 'lack of significant new investment' and 'conservative asset management strategy,' but the LLM contradicts this by claiming the strategy 'prioritizes replacing older locomotives with newer, more efficient units.' This interpretation is unsupported by the data showing aging assets and declining fleet size without evidence of replacement. The LLM's characterization of the strategy as deliberately replacing older units conflicts with the ground truth's assessment of minimal fleet expansion and reliance on aging assets. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year progression (2022-2024) by omitting the critical 2022 baseline, making it impossible to assess the full trend. The question explicitly asks about change 'from 2022 through 2024,' requiring all three data points. SUMMARY: While the LLM correctly identified some 2024 figures and the general concept of fleet composition analysis, it failed to provide complete multi-year data, misinterpreted the strategic implications, and drew conclusions contradictory to the ground truth's assessment of conservative, non-replacement-focused asset management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 587,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "Merck’s MK‑8591A program entered Phase 3 in 2023, but a clinical hold imposed by the FDA in December 2021—triggered by observed decreases in lymphocyte and CD4⁺ T‑cell counts—kept enrollment in both Phase 2 and Phase 3 studies paused through 2022 and 2023 (page_21, page_23, page_24). After addressing the FDA’s safety concerns, the agency lifted the hold on December 4 2024, allowing the program to resume (page_26).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially diverge from the ground truth:\n\n(1) CRITICAL DATE ERROR: The LLM states MK-8591A 'entered Phase 3 in 2023,' but the ground truth clearly indicates it was already in Phase 3 in 2022 with an entry date of February 2020. This is a fundamental factual error about the clinical phase progression timeline.\n\n(2) MISSING KEY INFORMATION: The LLM completely fails to address the 2022-2023 status (Phase 3, under review with no major advancements). It jumps from discussing a clinical hold to the 2024 FDA lift without properly characterizing the 2022-2023 period.\n\n(3) INCOMPLETE FORMULATION COVERAGE: The ground truth explicitly mentions MK-8591D (islatravir+lenacapavir) entering Phase 3 in October 2024, representing a strategic pivot or expansion. The LLM answer makes no mention of this new formulation, which is a significant omission for understanding Merck's evolving HIV-1 treatment approach.\n\n(4) PARTIAL HOLD DETAIL MISSING: The ground truth specifies that while the FDA lifted the clinical hold, 'a partial hold remained for higher doses of islatravir.' The LLM only mentions the hold was lifted without noting the partial hold that remained, which is an important nuance.\n\n(5) DATE PRECISION: The LLM provides 'December 4 2024' for the FDA lift, while the ground truth simply states '2024.' While the specific date may be correct, the ground truth doesn't confirm this level of precision, so this cannot be verified as accurate.\n\n(6) CLINICAL HOLD CONTEXT: The LLM provides additional context about the December 2021 clinical hold and lymphocyte/CD4+ T-cell count decreases, which is not contradicted by the ground truth but represents information beyond what was provided. This adds context but doesn't address the core question about the 2022-2024 trajectory.\n\n(7) MULTI-HOP SYNTHESIS: The answer fails to synthesize the complete multi-year trajectory from 2022-2024, instead focusing heavily on the clinical hold narrative and missing the strategic evolution with the new MK-8591D formulation.\n\nThe answer addresses only partial aspects of the question and contains a fundamental error about when Phase 3 entry occurred, making it substantially incomplete and partially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 611,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "In 2022, Merck listed MK‑1308A (quavonlimab + pembrolizumab) as a combination for advanced solid tumors, with no specific renal‑cell carcinoma (RCC) indication (MRK_10k_2022, p. 25). By 2024, the company repositioned the co‑formulation as a dedicated RCC therapy, describing it as “being evaluated for the treatment of RCC” within its immuno‑oncology portfolio (MRK_10k_2024, p. 50). This shift from a broad solid‑tumor focus to a specific RCC indication underscores Merck’s intensified strategy to expand its RCC pipeline with novel combination immunotherapies and highlights the company’s growing emphasis on RCC treatment innovation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION ON INDICATION: The LLM claims MK-1308A was listed for 'advanced solid tumors' with 'no specific RCC indication' in 2022, directly contradicting the ground truth which explicitly states it was listed under 'Phase 3 programs for renal cell carcinoma (RCC)' in 2022. This is a fundamental factual error. (2) INCOMPLETE 2023 COVERAGE: The LLM completely omits the 2023 data point, which is a critical part of the 3-year trajectory. The ground truth explicitly documents 2023 as showing 'deeper investment in combination immunotherapies' with emphasis on the immuno-oncology pillar. By skipping 2023, the LLM fails to capture the full evolution and provides an incomplete multi-hop synthesis. (3) MISCHARACTERIZATION OF PROGRESSION: The LLM incorrectly frames the evolution as a 'shift from broad solid-tumor focus to specific RCC indication,' when the ground truth shows RCC was the specific indication from the beginning (April 2021 entry date). This represents a fundamental misunderstanding of the strategic positioning. (4) MISSING CONTEXT: The LLM fails to mention the April 2021 entry date, the specific characterization as a 'coformulation,' or the consistent emphasis on the Keytruda platform strategy across all three years. (5) CORRECT ELEMENTS: The LLM correctly identifies the drug components (quavonlimab + pembrolizumab), correctly notes it remained in Phase 3 through 2024, and correctly identifies it as part of the immuno-oncology portfolio. However, these correct elements do not outweigh the major factual error regarding the 2022 indication and the omission of 2023 data. The multi-hop reasoning is compromised by the incomplete temporal coverage and the contradictory characterization of the 2022 positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 484,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023, and 2024 all list the 4.000% Notes due 2021 as part of Exhibit 4.6 (the Third Supplemental Indenture dated February 8, 2011) and the description remains unchanged across the three filings [page_104]. The unchanged disclosure indicates that the note, which matured in 2021, is retained only for historical reference, and that Microsoft’s long‑term debt structure is stable, with a conservative refinancing strategy that focuses on long‑term planning rather than frequent restructuring [page_104]. This consistency suggests that Microsoft prioritizes long‑term debt stability and does not routinely refinance older maturities, instead issuing new debt with longer maturities to manage its capital structure [page_104].",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 4.000% Notes due 2021 appear consistently across 2022, 2023, and 2024 10-K filings in Exhibit 4.6 (Third Supplemental Indenture). The date of February 8, 2011 is correctly cited. The core observation about consistency is accurate and matches the ground truth. WEAKNESSES: (1) The LLM introduces an unsupported interpretation that the note 'matured in 2021' and is 'retained only for historical reference.' The ground truth does not make this claim - it only states the notes 'always appeared' in the filings and that 'no material changes' occurred. The LLM is making an inference about the note's status that goes beyond what the ground truth supports. (2) The LLM provides extensive interpretation about Microsoft's 'conservative refinancing strategy' and claims about 'long-term planning' and 'capital structure management' that are not substantiated in the ground truth. The ground truth is more cautious, stating only that consistency 'suggests' no refinancing occurred, not that it reveals a broader strategic pattern. (3) The LLM cites '[page_104]' multiple times, but these page references are not present in the ground truth and appear to be fabricated or hallucinated. (4) The reasoning about why the notes remain disclosed (historical reference vs. active obligation) is speculative and not grounded in the provided ground truth. MULTI-HOP REASONING: The LLM does attempt to synthesize information across three years of filings, which is appropriate for the question. However, the synthesis goes beyond what the ground truth supports by making strategic inferences. QUANTITATIVE ACCURACY: The dates and percentages mentioned (4.000%, February 8, 2011) are correct. SEMANTIC EQUIVALENCE: While the LLM's core finding (consistency across filings) matches the ground truth, the additional interpretations about refinancing strategy and capital structure management represent overreach beyond the factual basis provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 532,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 10‑K positioned the company as a key player in automotive connectivity, digital cockpit and ADAS/AD, reporting $1.509 B in automotive revenue (which includes digital‑cockpit products). That segment grew to $1.872 B in 2023 and to $2.910 B in 2024—an almost 93 % increase—highlighting a shift from a chip‑centric supplier to a comprehensive digital‑cockpit and software‑defined vehicle platform provider, and signaling Qualcomm’s broader transformation toward OTA‑enabled, software‑centric automotive solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific revenue figures ($1.509B in 2022, $1.872B in 2023, $2.910B in 2024) and calculates a 93% increase, but these numbers cannot be verified against the ground truth provided. The ground truth does not include specific revenue figures for digital cockpit or automotive segments for these years—it focuses on strategic positioning and categorization evolution rather than quantitative metrics. This represents a fundamental mismatch: the LLM introduced specific financial data that may or may not be accurate but are not addressed in the ground truth. The LLM correctly identifies the three-year progression (2022-2024) and captures some qualitative elements (shift toward software-defined vehicles, OTA-enabled solutions), which aligns with the ground truth's narrative about transformation. However, the ground truth emphasizes: (1) 2022's forward-looking projections about 70% of vehicles with cellular connectivity and 60% with 5G by 2028, (2) 2023's formal categorization of digital cockpit as a distinct revenue stream, and (3) 2024's listing as a core product line. The LLM answer largely omits these specific strategic milestones and instead focuses on revenue growth and business transformation narrative. The 93% calculation (from $1.509B to $2.910B = 92.8%, approximately 93%) is mathematically correct IF the numbers are accurate, but without verification against source documents, this cannot be confirmed. The answer demonstrates partial understanding of the multi-hop question (connecting 2022-2024 evolution) but fails to address the specific strategic positioning elements that define the ground truth answer. The LLM's emphasis on financial metrics rather than strategic categorization represents a different interpretation of what 'evolution' means in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 491,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT’s variable‑rate swap activity grew markedly after 2022.  The company’s 2023 and 2024 10‑Ks report an aggregate notional amount of $1.3 billion for outstanding interest‑rate swaps, a jump from the $500 million noted for 2021 (the 2022 filing does not list a separate figure, implying a modest or no swap position that year)【page_52】【page_66】.  The steady $1.3 billion level in 2024 shows that LMT has adopted a consistent, active hedging strategy—converting fixed‑rate debt to variable‑rate exposure to manage fair‑value risk—rather than a one‑off or fluctuating approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - MAJOR FACTUAL ERROR: The LLM answer references a 2021 figure of $500 million, but the ground truth clearly states the $500 million figure was from 2022, not 2021. The LLM states '($500 million noted for 2021 (the 2022 filing does not list a separate figure...)' which is factually incorrect. The ground truth explicitly says 'In 2022, LMT had an aggregate notional amount of $500 million.' This is a significant error in entity/year mapping that undermines the multi-hop reasoning.\n\nCORRECT ELEMENTS: (1) The $1.3 billion figures for 2023 and 2024 are accurate; (2) The characterization of the increase as 'marked' or significant is correct; (3) The interpretation that the stabilization at $1.3 billion represents an established hedging baseline is sound; (4) The explanation about converting fixed-rate debt to variable-rate exposure to manage fair-value risk is accurate and well-reasoned.\n\nINCOMPLETENESS: The LLM answer fails to explicitly state the 'fourfold increase from 2022 to 2023' that the ground truth emphasizes. While the LLM mentions a 'jump,' it doesn't quantify this as clearly. The ground truth also notes this was 'likely in response to rising interest rates or increased debt levels,' which the LLM omits.\n\nQUANTITATIVE ACCURACY: The core numbers ($1.3B for 2023-2024) are correct, but the year attribution error for the $500M figure is a critical mistake that significantly impacts the quantitative accuracy score. The multi-hop synthesis of comparing 2022→2023→2024 is compromised by this error.\n\nQUALITATIVE REASONING: The reasoning about strategic shift and hedging strategy is sound and well-articulated, but the factual error about which year had the $500M amount undermines the overall quality of the multi-hop analysis.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and the trend analysis, though the year confusion creates ambiguity about the actual timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 526,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently reported the 3.950% Notes due 2056 as part of its long‑term debt in the 2022, 2023, and 2024 10‑K filings (Exhibit 4.14).  The notes were not marked as retired or refinanced in any filing, indicating that Microsoft keeps this instrument on its balance sheet and plans to manage the maturity through future refinancing or repayment rather than early retirement.  This reflects a deliberate long‑term debt‑maturity strategy that extends maturities into the 2050s while maintaining a cautious refinancing approach (page_105).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the 3.950% Notes due 2056 as consistently reported across 2022, 2023, and 2024 10-K filings; (2) Accurately notes these notes were not retired or refinanced; (3) Correctly characterizes this as reflecting a long-term debt maturity strategy. The quantitative accuracy is high - all dates (2056), percentages (3.950%), and fiscal years (2022, 2023, 2024) are correct. However, there are notable gaps in completeness compared to the ground truth: (1) The LLM answer does not mention the Eleventh Supplemental Indenture dated August 8, 2016, which is a key contextual detail in the original answer; (2) The LLM answer lacks the comparative analysis of shorter-term instruments (2.000% Notes due 2023, 2.400% Notes due 2026) that matured or approached maturity, which was central to demonstrating Microsoft's strategic approach; (3) The original answer emphasizes the 'deliberate strategy of preserving long-term capital stability' and 'strategic prioritization of long-dated liabilities to support long-term investment horizons,' while the LLM answer uses more generic language about 'cautious refinancing approach' without the same depth of strategic insight. The multi-hop reasoning is partially sound - the LLM correctly synthesizes that consistent reporting across three years indicates strategic intent - but misses the comparative dimension that would strengthen the analysis. The reference to 'page_105' and 'Exhibit 4.14' adds specificity but these citations are not verifiable in the evaluation context. Overall, the answer is substantially correct on core facts but lacks the nuanced strategic analysis and comparative context that characterizes the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 482,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all cite the Eleventh Supplemental Indenture (dated August 8 2016) because it is the legal framework that governs the 3.700 % Notes due 2046 (and other long‑term notes).  The repeated reference shows that Microsoft has not amended or replaced that indenture, so the 2046 notes remain subject to the same covenants and terms, underscoring a stable, long‑term debt structure and a consistent pattern of financial‑obligation disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates solid understanding of the multi-hop financial question. STRENGTHS: (1) All numeric values are accurate - correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, the 3.700% Notes due 2046, and the three-year filing period (2022, 2023, 2024). (2) Quantitative accuracy is perfect - no calculation errors or date discrepancies. (3) Core reasoning is sound - the LLM correctly synthesizes that repeated references across three consecutive filings indicate the indenture remained in effect and unchanged. (4) Semantic equivalence is strong - the answer conveys the same essential information as the ground truth about stable debt structure and consistent disclosure. MINOR WEAKNESSES: (1) The LLM answer is more concise and omits some contextual details present in the ground truth, specifically: the base Indenture dated May 18, 2009, and the concept of 'subsequent supplemental indentures' showing a 'layered and structured approach.' (2) The phrase 'multi-decade financial planning' from the ground truth is not explicitly captured, though the concept of long-term stability is implied. (3) The LLM uses 'covenants and terms' which is accurate but slightly different from the ground truth's emphasis on 'obligations tied to the 2046 Notes were active and ongoing.' These omissions are minor and do not affect the core correctness of the answer. The LLM successfully addresses all parts of the multi-part question: the significance of repeated references, the relation to the 3.700% Notes due 2046, and the reflection on long-term debt structure and consistency. The reasoning about no amendments or replacements is logically sound and directly supported by the repeated references across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 483,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft disclosed the 2.125% Notes due 2021 in its FY 2022 and FY 2023 10‑Ks as part of its debt schedule (Exhibit 4.1 – “Seventh Supplemental Indenture for 2.125% Notes due 2021 and 3.125% Notes due 2028”)【page_104】.  By FY 2024 the notes were no longer reported as outstanding, indicating they had been repaid or refinanced【page_104】.  This change shows Microsoft is actively managing its debt portfolio by retiring or refinancing older, higher‑rate notes to reduce interest expense and improve leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that the 2.125% Notes due 2021 were consistently referenced across all three fiscal years (2022, 2023, and 2024) in Exhibit 4.1 or 4.10, with no change in their documentation status. The LLM claims that 'By FY 2024 the notes were no longer reported as outstanding,' which directly contradicts the ground truth that states the notes 'were still referenced in Exhibit 4.1' in 2024. This is a fundamental factual error regarding the evolution of disclosure across the three-year period. The LLM also mischaracterizes the exhibit structure, incorrectly combining the 2.125% Notes due 2021 with the 3.125% Notes due 2028 in a single exhibit description, when the ground truth indicates these were separate instruments. The LLM's conclusion that the notes 'had been repaid or refinanced' by 2024 is unsupported by the ground truth, which explicitly notes the persistence of the reference and raises questions about whether this represents an extension, rollover, continued disclosure requirements, or a reporting lag. The LLM's interpretation of 'active debt management' is speculative and not grounded in the actual filing data. The answer fails to capture the key insight from the ground truth: the puzzling persistence of a matured instrument (due 2021) in filings through 2024, which raises legitimate questions about Microsoft's debt management practices. The LLM provides a superficially plausible narrative about debt refinancing but does so by inventing facts not present in the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 443,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued the 2.000 % Notes due 2023 in the Eleventh Supplemental Indenture dated August 8 2016 (Exhibit 4.14).  The notes remained on the balance sheet through FY 2022 and FY 2023, maturing in 2023, and were no longer outstanding in FY 2024, showing that the company uses long‑term, low‑interest debt and systematically retires it as it matures to keep leverage and refinancing risk low. (Exhibit 4.14, page 105)",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the 2.000% Notes due 2023, the Eleventh Supplemental Indenture dated August 8, 2016, and the fiscal year timeline (FY 2022, FY 2023, FY 2024). The key facts are accurate: the notes were outstanding through FY 2023 and matured/were retired by FY 2024. However, there are notable differences from the ground truth in reasoning and interpretation: (1) The ground truth emphasizes that the notes were 'consistently referenced' across all three years and that Microsoft 'did not retire or refinance it before its maturity in 2023,' suggesting the company held the debt to maturity. (2) The LLM answer states the notes 'were no longer outstanding in FY 2024,' which is technically correct but frames this as evidence of systematic retirement as part of debt management strategy. (3) The ground truth characterizes the pattern as indicating a 'stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.' The LLM answer instead interprets this as evidence that 'the company uses long-term, low-interest debt and systematically retires it as it matures to keep leverage and refinancing risk low.' While both interpretations are reasonable, the LLM's characterization of 'systematic retirement' goes slightly beyond what the ground truth explicitly states—the ground truth focuses more on consistency and stability rather than active debt management strategy. The LLM answer is more interpretive about the strategic implications, which adds some inference beyond the documented facts. The answer is well-structured and addresses the multi-year pattern question, but the strategic interpretation differs somewhat from the ground truth's emphasis on stability and established structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 494,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "From 2022 through 2024 Lockheed Martin kept the same overall scale of pension‑risk‑transfer activity – roughly $11.6 billion of defined‑benefit obligations have been transferred since 2018, covering about 95,000 retirees, with the most recent large transfer being the 2021 GAC purchase of $4.9 billion that generated a $1.7 billion non‑cash settlement charge. No new large transfer or settlement charge was disclosed in 2024, so the financial impact has remained essentially unchanged. The company’s stated strategy is to continue evaluating additional GAC purchases to reduce pension volatility and PBGC premiums, while acknowledging that future transactions could trigger further non‑cash settlement charges and additional contributions to the pension trust.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Lockheed Martin's pension risk transfer strategy with mostly accurate numbers and good synthesis of multi-year information. STRENGTHS: (1) All key quantitative figures are correct: $11.6 billion cumulative transferred since 2018, $4.9 billion from 2021 GAC, $1.7 billion noncash settlement charge, 95,000 retirees covered, $69 million annual PBGC premium reduction. (2) Correctly identifies the 2021 transaction as the most recent large transfer. (3) Accurately captures the company's stated strategy of continued evaluation of GAC purchases. (4) Properly synthesizes multi-hop information across 2022-2024 filings. (5) Correctly notes the absence of new large transfers in 2024. WEAKNESSES: (1) The phrase 'No new large transfer or settlement charge was disclosed in 2024' is somewhat imprecise - the ground truth indicates the company 'reaffirmed its intent to pursue further transactions' in 2024, suggesting ongoing evaluation rather than definitively no activity. (2) The answer could have been more explicit about the evolution/progression aspect of the question - the ground truth emphasizes 'increasing scale and financial clarity over time' and 'consistent, strategic reduction,' which the LLM answer somewhat downplays by stating 'kept the same overall scale.' (3) Missing explicit mention of the December 2018 baseline date context that frames the entire strategy. (4) The characterization of 'essentially unchanged' financial impact may understate the strategic evolution described in the ground truth. The answer is fundamentally correct on facts and numbers but slightly misses the nuance of strategic evolution and forward-looking intent that the original answer emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 474,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 10‑K filings consistently list the Floating Rate Notes due 2019 in the officer’s certificate of securities (see page 56 of each filing).  This shows the debt is still outstanding and remains part of Apple’s long‑term debt mix, indicating a strategy that includes floating‑rate instruments to manage interest‑rate exposure.  The repeated reference also signals a disciplined maturity‑management approach, with Apple likely planning to refinance or repay the 2019 notes when they mature, taking advantage of favorable market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its credibility. The ground truth explicitly states that the Floating Rate Notes were due in 2019, and their continued reference in 2022-2024 filings is notable precisely because they had already matured. The LLM incorrectly suggests 'the debt is still outstanding' and references 'when they mature,' implying the notes had not yet matured at the time of the 2022-2024 filings. This is a fundamental misunderstanding of the temporal relationship. The ground truth correctly identifies this as a historical disclosure pattern (notes matured in 2019, but still referenced in later filings), suggesting refinancing or rollover. The LLM's interpretation that Apple is 'planning to refinance or repay the 2019 notes when they mature' is factually incorrect since they had already matured years before the 2022-2024 filing period. Additionally, the LLM provides a specific page reference ('page 56 of each filing') that cannot be verified and appears to be fabricated. The LLM does correctly identify the floating-rate nature of the instruments and mentions interest-rate exposure management, which aligns with the ground truth. However, the core analytical insight—that these notes appear in filings years after their maturity date—is misrepresented. The answer demonstrates partial understanding of debt management concepts but fails on the crucial temporal and factual accuracy required for investment analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 407,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft lists the 4.000 % Notes due 2021 in Exhibit 4.6 (the Third Supplemental Indenture) in each of its 2022, 2023, and 2024 10‑K filings [page_104]. The description and placement of the note remain unchanged across the three years, indicating that the instrument has not been retired or repaid and continues to be a material component of Microsoft’s debt portfolio [page_104]. This persistence underscores the ongoing relevance of the 4.000 % Notes due 2021 in the company’s capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Microsoft's 4.000% Notes due 2021 appear in Exhibit 4.6 across 2022, 2023, and 2024 10-K filings, and accurately notes the percentage rate (4.000%) and maturity year (2021). The reference to page_104 appears consistent with typical exhibit locations. However, there are significant issues with the answer's reasoning and completeness: (1) The LLM claims 'the instrument has not been retired or repaid and continues to be a material component of Microsoft's debt portfolio,' which contradicts the ground truth's more nuanced interpretation. The ground truth explicitly states the Notes' 'maturity date having passed,' suggesting they were likely already matured/repaid by 2022, yet remained in disclosures for legal/structural continuity reasons. The LLM's assertion that they 'continue to be a material component' misrepresents their actual status. (2) The ground truth provides deeper insight into WHY the Notes persist post-maturity (covenants, indentures, transparency, investor understanding), while the LLM simply states they 'remain unchanged' without explaining the significance of post-maturity inclusion. (3) The LLM's reasoning that unchanged placement indicates non-retirement is logically flawed—post-maturity inclusion in exhibits often reflects legal/structural requirements rather than active debt status. (4) The answer lacks the nuanced understanding that the Notes' continued reference reveals about Microsoft's disclosure practices and debt framework architecture. The quantitative elements (dates, percentages, exhibit numbers) are accurate, but the qualitative interpretation and multi-hop reasoning about what this pattern reveals about capital structure is incomplete and partially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 478,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "In 2022 UPS listed the 7.620 % debentures only with principal, maturity and the note that the rate had been cut to 7.620 % in 2020 (page 118).  By 2023 the company expanded the disclosure to include full redemption terms—redeemable at option at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 bps—and stated that interest was paid semi‑annually with no sinking‑fund requirement (page 105).  The 2024 filing repeated those same terms unchanged (page 108) and the debentures remained a small, stable component of UPS’s debt, carrying about $280 million within a $22.5 billion total debt load and $18.9 billion long‑term debt (pages 106 and 103).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and evolution of disclosure practices. STRENGTHS: (1) All numeric values are accurate: $276M principal amount (consistent across years), $280M book value in 2023-2024, 7.620% rate, 5 basis points redemption formula, semi-annual interest payments, $22.5B total debt, $18.9B long-term debt. (2) Correctly identifies the three-year progression from 2022-2024 with specific disclosure changes: 2022 focused on historical rate context, 2023 expanded to full redemption terms, 2024 repeated unchanged terms. (3) Accurately captures redemption mechanics (greater of principal + accrued interest OR present value of remaining payments discounted at benchmark treasury yield plus 5 bps). (4) Properly contextualizes the debentures as a small, stable component within UPS's broader debt portfolio. (5) Multi-hop synthesis is sound, connecting disclosure evolution across three years with specific page references. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention the 2030 maturity date, though this is implied by context. (2) The original answer emphasizes a 'shift from historical interest rate context to a more structural and comparative treatment' and mentions positioning 'within a larger context of international debt instruments such as Pound Sterling and Euro notes' - the LLM answer captures the structural shift but doesn't explicitly reference the international debt comparison context. (3) The LLM answer states the rate was 'cut to 7.620% in 2020' which is accurate but the original answer provides additional context about the prior 8.375% rate until April 2020. These are minor omissions rather than errors. The answer correctly addresses all three sub-questions (redemption terms, interest payment structure, debt positioning) with accurate synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 515,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "Vraylar, launched in 2020, generated $2.68 million in 2022 (page 62) and grew 35 % to $2.76 million in 2023, driven by market‑share gains and FDA approval as an adjunctive therapy for major depressive disorder (page 44). The 2024 10‑K continues to list Vraylar as a core neuroscience product and outlines AbbVie’s ongoing marketing and distribution strategy through its global commercial network (page 8), underscoring the company’s commitment to expanding this asset. This steady revenue growth and sustained investment signal that Vraylar is a strategically important growth lever within AbbVie’s neuroscience portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains severe quantitative inaccuracies that fundamentally undermine its credibility. (1) MAJOR NUMBER ERROR: The LLM states Vraylar generated '$2.68 million in 2022' and '$2.76 million in 2023' - these figures are off by a factor of 1,000. The ground truth clearly states '$2,759 million in 2023' (i.e., $2.759 billion). The LLM's numbers ($2.68M and $2.76M) are implausibly small for a major pharmaceutical product and contradict the stated 35% growth calculation. (2) CALCULATION INCONSISTENCY: The LLM claims a '35% growth' from $2.68M to $2.76M, which would be approximately 2.99% growth, not 35%. This is a fundamental mathematical error. The ground truth's 35.4% year-over-year increase applies to the correct figures ($2,759M in 2023). (3) MISSING CLINICAL CONTEXT: The LLM fails to address the 2022 Phase 3 trial results for MDD (one meeting primary endpoint, one showing numerical but not statistically significant improvement), which is a key part of the clinical trajectory. The LLM mentions 'FDA approval as an adjunctive therapy for major depressive disorder' but doesn't clarify the mixed trial results. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to connect clinical development, commercialization, and financial performance, it does so with incorrect data. The evolution from 'late-stage clinical asset in 2022 to key revenue driver by 2024' is not properly captured due to the missing/incorrect clinical trial information. (5) POSITIVE ELEMENTS: The LLM correctly identifies Vraylar as a core neuroscience product, mentions the global commercial network strategy, and appropriately concludes it's strategically important. However, these qualitative observations cannot compensate for the quantitative failures. The answer demonstrates a fundamental data retrieval or transcription error that makes the financial analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 513,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023, and 2024 all list the 0.45% Notes due 2016 in the Officer’s Certificate (see page 56 in each filing).  The repeated disclosure shows that the company’s long‑term debt portfolio still contains legacy instruments that are tracked and reported, and that Apple follows a disciplined disclosure policy that includes every outstanding maturity—regardless of age—to keep investors fully informed.  This consistency signals a diversified debt structure and a commitment to transparent reporting of all legacy debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM claims the notes appear 'on page 56 in each filing' - this is a specific factual claim that cannot be verified and appears to be fabricated pagination. The ground truth does not mention page numbers. (2) The LLM fundamentally misinterprets the disclosure pattern. The ground truth explicitly states the notes MATURED IN 2016 and were disclosed AFTER maturity in 2022, 2023, and 2024 filings. The LLM incorrectly suggests these are 'outstanding' debt ('outstanding maturity'), which contradicts the ground truth's clear statement that despite maturity in 2016, Apple continued disclosing them. (3) The LLM claims the notes are part of 'long-term debt portfolio' and 'still contains legacy instruments that are tracked and reported' - this mischaracterizes them as active obligations rather than historical disclosures. (4) The LLM's reasoning about 'diversified debt structure' is not supported by the ground truth, which focuses on transparency and historical record-keeping rather than active portfolio management. CORRECT ELEMENTS: (1) Correctly identifies the 0.45% Notes due 2016. (2) Correctly identifies fiscal years 2022, 2023, 2024. (3) Correctly identifies the Officer's Certificate as the source document. (4) Correctly notes the pattern of consistent inclusion across three years. (5) Correctly emphasizes transparency and disclosure consistency. SEMANTIC ISSUES: The LLM's interpretation that these represent 'outstanding' debt contradicts the ground truth's emphasis that these notes matured in 2016 but were still disclosed - a crucial distinction about why they appear (historical completeness) versus what they represent (legacy, not active). The answer demonstrates partial understanding but contains material factual errors about the nature of the disclosure and unverifiable claims about pagination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 500,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "UPS SurePost has remained a residential‑ground service for non‑urgent, lightweight shipments throughout 2022‑24, using UPS’s ground fleet for pickup and sorting and relying on the U.S. Postal Service for final delivery.  In each filing it is positioned as a low‑cost, residential option within the U.S. Domestic Package segment, and UPS reaffirmed that it would insource the service in 2025 to gain greater control over the delivery process【page_5 (2022)】【page_5 (2023)】【page_5 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Strengths: (1) All factual information is correct - correctly identifies UPS SurePost as a residential ground service for non-urgent, lightweight shipments across 2022-2024; (2) Accurately captures the delivery methodology (UPS ground network for pickup/sorting, USPS for final delivery) and the strategic shift announced for 2025 (insourcing final delivery beginning January 1, 2025); (3) Correctly identifies the positioning within U.S. Domestic Package segment as a low-cost option; (4) All dates are accurate (2022, 2023, 2024, and the January 1, 2025 transition date); (5) Multi-hop reasoning is sound - successfully synthesizes information across three years of filings to show continuity (2022-2023) followed by strategic transformation (2024 announcement of 2025 change); (6) Provides appropriate source citations. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth, combining some descriptive elements (e.g., stating 'low-cost, residential option' rather than separately noting 'consistency of UPS ground network'); (2) The phrase 'reaffirmed that it would insource' is semantically equivalent to the ground truth's 'announced that beginning January 1, 2025, it would insource' - both convey the same strategic decision; (3) The answer effectively captures the 'strategic transformation' concept implied in the ground truth. No calculation errors, no incorrect numbers or dates, and the semantic meaning aligns perfectly with the ground truth across all key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 431,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 were first issued in 2014 as part of a global notes offering (see Exhibit 4.4 in the 2022 10‑K).  The 2024 10‑K continues to list the same 4.45 % Notes as outstanding long‑term debt, with no new issuances or repurchases reported in the 2022, 2023 or 2024 filings (see Exhibit 4.4 in the 2024 10‑K).  The steady, unchanged presence of these long‑dated, fixed‑rate notes over multiple years signals Apple’s long‑term capital strategy of maintaining a stable, low‑cost debt base to support operations, share‑repurchase and dividend programs while preserving financing flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as the relevant instrument; (2) Accurately dates the original issuance to 2014; (3) Correctly states that these notes remained outstanding across 2022-2024 with no new issuances or repurchases; (4) Properly cites Exhibit 4.4 as the source; (5) Provides sound multi-hop synthesis showing the consistent presence of this debt across three years; (6) Offers reasonable strategic interpretation about maintaining stable, low-cost debt and financial flexibility. MINOR WEAKNESSES: (1) The LLM answer goes slightly beyond the ground truth by adding specific strategic purposes (share repurchase, dividend programs) that, while plausible, are not explicitly confirmed in the ground truth statement; (2) The ground truth emphasizes 'interest rate risk management' while the LLM emphasizes 'low-cost debt base' - these are related but slightly different framings. QUANTITATIVE VERIFICATION: All dates (2014 issuance, 2022-2024 observation period) and the 4.45% rate are correct. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings to establish a pattern of consistency, which is the core requirement of the question. The reasoning that unchanged presence indicates strategic retention is sound and matches the ground truth's conclusion. SEMANTIC EQUIVALENCE: The LLM's statement that this 'signals Apple's long-term capital strategy' is semantically equivalent to the ground truth's 'suggests a strategic decision to retain long-duration debt.' Both convey the same fundamental insight about intentional capital structure management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 467,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle’s 2.875% notes due 2031 were first disclosed in the 2022 10‑K as part of Exhibit 4.16, a set of notes with varying maturities【page 114】.  In the 2023 and 2024 10‑Ks the same notes appear in Exhibit 4.14, a different grouping that also contains the 1.650% and 2.300% notes due 2026 and 2028【page 111】.  This shift and the continued placement in Exhibit 4.14 demonstrate Oracle’s deliberate, stable debt‑management approach—grouping similar long‑term notes together to maintain a predictable maturity profile and interest‑rate exposure over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the 2.875% Notes due 2031 were 'consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes.' However, the LLM claims the notes appeared as 'Exhibit 4.16' in the 2022 10-K and only shifted to 'Exhibit 4.14' in 2023 and 2024. This is a direct contradiction of the ground truth's core assertion about consistent positioning across all three years. The LLM's claim about a 'shift' from 4.16 to 4.14 is factually incorrect according to the knowledge graph. Additionally, the LLM introduces unsupported details about the notes being grouped with '1.650% and 2.300% notes due 2026 and 2028' in Exhibit 4.14, which is not mentioned in the ground truth and cannot be verified. The ground truth emphasizes that the consistent positioning 'reveals a stable approach to capital structure management' with 'no modifications to the terms,' whereas the LLM's narrative of a 'shift' contradicts this stability message. The LLM does correctly identify the company (Oracle), the note rate (2.875%), and the maturity year (2031), but the exhibit number progression is fundamentally wrong. The reasoning about debt management strategy is somewhat sound in principle, but it's built on an incorrect factual foundation regarding the exhibit numbering across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 407,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement increased benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, raising pension benefit accruals and resulting in a net periodic benefit cost of $1,212 million for 2023 versus a negative cost in 2022 (page 82–83). In 2024 UPS continues to accrue benefits under the same plan, with a 5.88 % discount rate and a 7.17 % expected return on plan assets (page 86–88), indicating that the company’s long‑term pension obligations remain sizable and are driven by collective‑bargaining‑based benefit adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023 Teamsters agreement as increasing benefit rates and impacting pension benefit accruals. It appropriately references the UPS/IBT Full-Time Employee Pension Plan and correctly notes that 2024 disclosures show continued accruals under the same plan. The reasoning about collective bargaining-based benefit adjustments and long-term pension obligations is sound and relevant to the question.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific financial figures ($1,212 million net periodic benefit cost for 2023, 5.88% discount rate, 7.17% expected return on plan assets) with page citations, but these numbers cannot be verified against the ground truth provided. The ground truth does not include these specific dollar amounts or percentages, making it impossible to confirm accuracy. The citation of page numbers (82-83, 86-88) suggests precision but without verification data, this introduces risk of factual error.\n\nMISSING ELEMENTS: The LLM does not explicitly address the plan's history (Central States Pension Fund transition mentioned in ground truth) or provide context about the plan being noncontributory. It also doesn't clearly explain what \"no structural changes to the plan\" in 2024 means relative to the 2023 agreement, which the ground truth emphasizes.\n\nMULTI-HOP REASONING: The answer does synthesize information across 2023 and 2024 disclosures and connects the agreement to pension obligations, which is appropriate. However, the specific quantitative claims lack grounding in the provided ground truth.\n\nSEMANTIC ALIGNMENT: The answer's core message aligns with the ground truth - that the 2023 agreement increased benefits and this impacts long-term obligations - but the introduction of unverified specific numbers creates uncertainty about factual accuracy. The answer is more specific than the ground truth but potentially at the cost of accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 523,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023, and 2024 all list the 1.05% Notes due 2017 in the Officer’s Certificate (May 6 2014) section (see 2022 p. 56, 2023 p. 53, 2024 p. 56) with no change to the description or status. This unchanged disclosure shows that Apple treats all short‑term debt issued under the 2014 certificate as part of its long‑term debt reporting framework, maintaining consistent transparency and regulatory compliance even after the notes have matured or been repaid.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM answer contains a fundamental logical error. It states the notes appear in 2022, 2023, and 2024 10-K filings, yet then claims 'even after the notes have matured or been repaid.' The 1.05% Notes due 2017 would have matured in 2017, making their appearance in 2022-2024 filings impossible unless they were refinanced or the disclosure refers to historical information. The ground truth states the disclosure remained 'unchanged' and 'consistent,' but does NOT claim the notes were still outstanding in 2022-2024. (2) SEMANTIC MISINTERPRETATION: The LLM fundamentally misunderstands what 'unchanged disclosure' means. The ground truth indicates Apple did NOT modify or refinance the instrument during 2022-2024, implying the notes were already matured/repaid before this period. The LLM's interpretation that they appear in all three years' filings contradicts this. (3) PAGE REFERENCES: The LLM provides specific page numbers (2022 p. 56, 2023 p. 53, 2024 p. 56) without verification. These cannot be confirmed against the ground truth and may be fabricated. (4) REASONING FLAW: The LLM's conclusion that Apple 'treats all short-term debt issued under the 2014 certificate as part of its long-term debt reporting framework' is unsupported and contradicts the premise that these are short-term instruments. (5) MISSING CONTEXT: The LLM fails to address the key insight from the ground truth: that the static disclosure reveals a 'passive management approach' and prioritization of 'stability in capital structure' - instead offering a confused narrative about post-maturity reporting. The answer demonstrates significant misunderstanding of the temporal and financial context of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 477,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple first disclosed its 2.40 % Notes due 2023 in the 2022 10‑K as part of the description of securities (Officer’s Certificate, Exhibit 4.3)【page_56】 and continued to list the same instrument in the 2023 and 2024 10‑Ks (Exhibit 4.3)【page_53】【page_58】. The disclosure remained unchanged across the three filings, indicating that Apple consistently reports the terms and maturity of this long‑term debt. This steady presentation reflects a disciplined long‑term debt strategy that prioritizes transparency and predictable refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Apple disclosed the 2.40% Notes due 2023 in the 2022 10-K, (2) the same disclosure appeared in 2023 and 2024 10-Ks, (3) the disclosure remained unchanged across all three filings. The percentage (2.40%) and maturity year (2023) are accurate. The document references (Officer's Certificate, Exhibit 4.3) and page numbers are provided, adding specificity.\n\nHowever, there are notable differences from the ground truth: (1) The LLM answer omits the specific date of the Officer's Certificate (May 3, 2013), which is a factual detail present in the original answer. (2) The LLM's interpretation of what the static disclosure suggests differs slightly - it emphasizes 'transparency and predictable refinancing' rather than the ground truth's focus on 'stable long-term debt strategy' and Apple's plan to 'meet the 2023 maturity as originally structured.' (3) The ground truth explicitly states 'no early repayments, modifications, or extensions,' which the LLM answer does not mention.\n\nThe multi-hop reasoning is sound - the LLM correctly synthesizes information across three years of filings and draws a logical conclusion about Apple's debt management approach. The semantic meaning is largely equivalent, though the LLM's characterization of the strategy as emphasizing 'transparency and predictable refinancing' is somewhat different from the ground truth's emphasis on meeting the obligation as originally structured. The quantitative accuracy is high (correct percentages and years), but qualitative completeness is slightly reduced due to omitted details and a somewhat different interpretation of strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 459,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 to 2024, Vraylar’s commercial trajectory accelerated: revenue climbed from $2.04 million in 2022 to $2.76 million in 2023 (≈35 % growth) as the drug received FDA approval in 2023 as an adjunctive therapy for major depressive disorder【page_44】. Clinically, Vraylar progressed from positive Phase 3 results in 2021【page_60】 to regulatory clearance in 2023, cementing its role in AbbVie’s neuroscience portfolio as a treatment for schizophrenia, bipolar disorder and adjunctive MDD【page_5】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: (1) QUANTITATIVE ERRORS: The LLM states revenue as '$2.04 million in 2022' and '$2.76 million in 2023' - these are off by a factor of 1,000. Ground truth shows $2,037 million (2022) and $2,755 million (2023), which are in the billions, not millions. This is a catastrophic numerical error that fundamentally misrepresents Vraylar's commercial significance. The percentage growth calculation of ~35% is directionally correct but based on wrong absolute values. (2) INCOMPLETE CLINICAL DEVELOPMENT: The LLM references 'positive Phase 3 results in 2021' but the ground truth specifies that in 2022, Vraylar had 'one successful Phase 3 trial and a numerically positive but non-significant result in another' - the LLM oversimplifies and doesn't capture the nuance of mixed Phase 3 results. (3) MISSING 2024 DATA: The LLM fails to address 2024 developments comprehensively. Ground truth indicates that by 2024, Vraylar was 'formally positioned as a key therapeutic agent' with expanded indications (schizophrenia, bipolar I disorder manic/mixed and depressive episodes, and adjunctive MDD). The LLM mentions these indications but doesn't clearly establish the 2024 positioning evolution. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to connect clinical progress to commercial trajectory, the fundamental numerical errors undermine the entire analysis. The model failed to properly synthesize the three-year evolution requested. (5) CONTEXTUAL ISSUES: The LLM mentions 'FDA approval in 2023 as an adjunctive therapy for MDD' but doesn't clarify that Vraylar had earlier approvals for schizophrenia and bipolar disorder - the 2023 approval was specifically for the MDD indication. The answer lacks the strategic positioning context that should frame Vraylar's importance within AbbVie's neuroscience portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 502,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM consistently lists “client relationships and trust” as a principal competitive differentiator in its 2022, 2023, and 2024 10‑K filings (2022 10‑K p. 5; 2023 10‑K p. 3; 2024 10‑K p. 3). The unchanged wording across the years shows a sustained emphasis on trust as a core element of its hybrid‑cloud and AI strategy. This continuity signals that IBM positions itself as a trusted partner to drive digital and AI transformations, reinforcing its competitive stance in the hybrid‑cloud and AI market.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized client relationships and trust across 2022-2024 10-K filings and accurately cites page references (2022 p. 5; 2023 p. 3; 2024 p. 3). The quantitative elements (years, page numbers) appear accurate. However, the answer has significant qualitative deficiencies: (1) It claims 'unchanged wording across the years' which contradicts the ground truth that shows evolution in context and strategic framing. The ground truth explicitly states the emphasis evolved from 2022 (hybrid cloud/AI platform focus) to 2023 (strategic partnerships linkage) to 2024 (foundational element in go-to-market strategy). (2) The LLM answer misses the key insight about strategic deepening - that trust evolved from a value proposition to an enabler of integrated, client-centric innovation. (3) The answer conflates consistency in messaging with lack of evolution, when the ground truth shows the framing and context evolved significantly. (4) The LLM fails to address the multi-hop synthesis required: connecting the evolution of trust messaging to IBM's strategic positioning in hybrid cloud and AI markets. The answer provides a surface-level observation about consistency rather than analyzing the meaningful progression in how trust was positioned strategically. The question specifically asks about 'evolution' and what the 'multi-year progression indicates' - the LLM answer essentially denies evolution occurred, which is factually incorrect per the ground truth. This represents a fundamental misunderstanding of the multi-hop reasoning required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 436,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM did not disclose the 1.250% Notes due 2027 in its 2022 10‑K (the pages provided contain no reference to the instrument).  In the 2023 10‑K the notes appear only as part of the exhibits list (Exhibits 4.2‑4.4 to Form 8‑K, see page 20), a minimal disclosure that merely acknowledges the instrument’s existence.  By the 2024 10‑K, the notes are listed as a registered security in the “Securities registered pursuant to Section 12(b)” table (page 1), giving investors clear information on the coupon, maturity and trading symbol and confirming that the notes remain a component of IBM’s long‑term debt portfolio, albeit a relatively small one compared to its larger senior debentures.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) MAJOR ERROR - 2022 Disclosure: Ground truth states the notes WERE referenced in 2022 in the exhibit list (Exhibit 4.3 to Form 8-K filed January 30, 2019), but LLM claims 'IBM did not disclose the 1.250% Notes due 2027 in its 2022 10-K.' This is a direct contradiction. (2) MAJOR ERROR - 2023 Disclosure: Ground truth indicates the notes were referenced in a list tied to more recent filings such as February 8, 2022, but LLM states they appear 'only as part of the exhibits list (Exhibits 4.2-4.4 to Form 8-K, see page 20)' with 'minimal disclosure.' The ground truth suggests broader integration, not minimal disclosure. (3) PARTIAL ACCURACY - 2024 Disclosure: LLM correctly identifies that by 2024 the notes appear in the 'Securities registered pursuant to Section 12(b)' table with trading symbol information, which aligns with ground truth's statement about 'explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B).' (4) REASONING FAILURE: The LLM's narrative of 'increasing transparency' contradicts its own claim that 2022 had no disclosure and 2023 had only minimal disclosure. The ground truth presents a clearer progression of increasing prominence. (5) MISSING CONTEXT: LLM fails to capture the ground truth's emphasis on the notes becoming 'a formally recognized and actively traded financial instrument' and the evolution from exhibit references to formal registration. The LLM's characterization of the notes as 'a relatively small one compared to its larger senior debentures' adds unsupported comparative analysis not in the ground truth. Overall, the answer contains a fundamental factual error about 2022 disclosure that undermines the entire multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 494,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 2022 10‑K (page 31) lists the 6.50% Debentures due 2028 as **Exhibit 2 to Form 8‑K, filed January 8 1998**. The 2023 10‑K (page 19) and the 2024 10‑K (page 19) use the identical exhibit reference, showing no change in how the instrument is reported. Across all three filings, the debt‑instrument disclosure table (Item 15, Exhibit 4) remains the same set of debentures and notes, indicating that IBM’s overall debt‑reporting framework stayed consistent from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the consistent exhibit reference (Exhibit 2 to Form 8-K, filed January 8, 1998) across all three years (2022, 2023, 2024), which is a key factual element. The numeric/date information is accurate. The LLM correctly notes that page references are consistent (page 31 in 2022, page 19 in 2023 and 2024). WEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It fails to address the 'broader context of IBM's debt instrument disclosures' that evolved over time, which is explicitly part of the question. (2) The ground truth discusses how the debentures were listed 'among a wider range of debt instruments' in 2022 versus integration with 'newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032' in 2023-2024. The LLM merely states the framework 'stayed consistent' without capturing this evolution. (3) The LLM lacks the nuanced analysis about how legacy debt was integrated alongside newer instruments, which represents the 'subtle evolution' mentioned in the ground truth. (4) The LLM's statement that 'the debt-instrument disclosure table (Item 15, Exhibit 4) remains the same set of debentures and notes' actually contradicts the ground truth's assertion that the broader context evolved. (5) Missing discussion of 'long-term debt management and investor clarity' context. The LLM provides a narrower, more surface-level answer that captures consistency but misses the multi-faceted evolution described in the ground truth. This is a multi-hop question requiring synthesis of exhibit consistency AND broader disclosure evolution—the LLM only addresses the first element adequately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 462,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx International Connect Plus expanded its global footprint from roughly 50 origin countries and 130 destination countries in 2022 (page 14) to about 60 origin countries and 190 destination countries by 2024 (page 8). This 20 % rise in origins and 46 % rise in destinations underscores FedEx’s strategic emphasis on scaling its e‑commerce logistics network worldwide to capture growing cross‑border e‑commerce traffic.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key geographic expansion metrics for FedEx International Connect Plus from 2022 to 2024. Quantitative verification: (1) 2022 baseline: ~50 origin countries and 130 destination countries - CORRECT; (2) 2024 endpoint: ~60 origin countries and 190 destination countries - CORRECT; (3) Percentage calculations: 20% rise in origins (50 to 60) is accurate; 46% rise in destinations (130 to 190) is accurate [calculated as (190-130)/130 = 46.2%]. The LLM correctly synthesizes the multi-hop information showing the expansion trajectory across the three-year period. However, the answer has a notable omission: it fails to mention the 2023 intermediate data point (nearly 60 origin countries and over 190 destination countries), which is important context from the ground truth. The ground truth explicitly notes that 2023 showed the major expansion phase, while 2024 represented stabilization at that level - a nuanced strategic insight that the LLM's answer misses by jumping directly from 2022 to 2024. The LLM's interpretation of strategic focus on e-commerce logistics is sound and well-reasoned. The answer appropriately addresses the question's two components: (1) how geographic reach evolved, and (2) what this suggests about strategic focus. The omission of the 2023 intermediate point and the stabilization narrative prevents this from being a 9-10 score, as it loses important context about the expansion trajectory being completed by 2023 rather than continuing through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 419,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals—boosting women and under‑represented minorities (URM) in leadership by 15 % each and overall URM representation by 20 %—were reiterated unchanged in the 2022, 2023 and 2024 10‑K filings.  The HR and Compensation Committee has consistently linked progress on these goals to executive bonuses, applying a non‑financial performance modifier that can adjust the fiscal‑year bonus payout by a multiplier of 0.9 to 1.1 each year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - the 15% women in leadership, 15% URM in leadership, and 20% overall URM representation targets are correctly stated. (2) The bonus modifier range of 0.9 to 1.1 is correctly cited. (3) The statement that these goals were reiterated unchanged across 2022, 2023, and 2024 is accurate. (4) The identification of the HR and Compensation Committee's role in linking these goals to executive compensation is correct. (5) Number formatting and financial metrics are precise.\n\nWEAKNESSES: (1) The LLM answer omits significant contextual details present in the ground truth, particularly the mention of the Reboot Representation Tech Coalition and its specific goal to double degrees for underrepresented groups by 2025. This represents a material omission of an external partnership initiative that demonstrates the evolution and expansion of Qualcomm's diversity strategy. (2) The answer lacks discussion of the 'evolution' aspect of the question - while it correctly states the goals remained unchanged, it doesn't adequately characterize the strategic evolution through increased emphasis on initiatives and external partnerships. (3) The phrase 'reiterated unchanged' is somewhat passive and doesn't fully capture the nuance that while targets remained stable, the company's approach to achieving them evolved through new initiatives.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information about the linkage between human capital goals and executive compensation across multiple years, demonstrating proper multi-hop reasoning. However, it misses the fuller picture of how the strategy evolved beyond just maintaining consistent targets.\n\nSEMANTIC EQUIVALENCE: The core factual claims are semantically equivalent to the ground truth, but the answer is incomplete in addressing the full scope of the question regarding 'evolution' of the goals and mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 519,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022‑24 (Item 4.1, “Description of Securities”) all list the same officer’s certificate that includes the **Floating Rate Notes due 2019**.  By continuing to report these short‑term, rate‑resetting notes, Apple signals that it keeps a portion of its debt that is both short‑maturity and sensitive to current market rates—an approach that lets it hedge against rising short‑term rates while preserving liquidity through readily refinancable, short‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Apple's Floating Rate Notes due 2019 appeared consistently in 10-K filings from 2022-2024, and accurately notes the connection to interest rate risk management and liquidity. However, there are significant issues: (1) The LLM claims these are 'short‑term' notes with 'short‑maturity,' but notes due 2019 would have already matured by 2022, making their continued appearance in disclosures problematic and requiring explanation. The ground truth acknowledges their 'recurring appearance' but doesn't explicitly address this maturity issue. (2) The LLM's characterization of these as 'short‑term, rate‑resetting notes' is questionable given they were due in 2019—by 2022 they should have been retired. (3) The LLM's reasoning about 'readily refinancable, short‑term financing' doesn't align with notes that are already past their maturity date. (4) The ground truth provides more nuanced analysis about Apple's 'deliberate and stable approach' and 'cautious yet adaptive stance,' while the LLM focuses more narrowly on hedging against rising rates. (5) The LLM references 'Item 4.1, Description of Securities' which may not be the correct 10-K section for debt disclosures (typically Item 7 or Item 8). The core issue is that the LLM doesn't adequately address the logical inconsistency of 2019-maturity notes appearing in 2022-2024 filings, which is a critical factual problem that undermines the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 400,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K noted that its QCT semiconductor business includes automotive systems for connectivity, digital cockpit and ADAS/AD, with automotive revenue of $1.509 B【page_8】.  In 2023 automotive revenue rose to $1.872 B and by 2024 it reached $2.910 B, underscoring a clear shift toward digital‑cockpit solutions within the QCT segment【page_73】【page_83】.  Analysts project that by 2028 more than 70% of new vehicles will embed cellular connectivity and 19% of 2025 vehicles will feature Level 2 autonomy, driving strong market demand that Qualcomm is positioning to capture【page_8】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Qualcomm's automotive business evolution but contains significant quantitative discrepancies and incomplete alignment with the ground truth. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of automotive revenue growth; (2) Appropriately references QCT segment structure and digital cockpit/ADAS/AD integration; (3) Includes forward-looking market projections about vehicle connectivity and autonomy; (4) Demonstrates multi-hop synthesis across years and business segments. CRITICAL ISSUES: (1) QUANTITATIVE ERROR - Reports 2028 projection as 'more than 70%' for cellular connectivity when ground truth states 'over 60%' - this is a material factual error; (2) INCOMPLETE TRAJECTORY - Ground truth emphasizes the evolution from 'market positioning/R&D in 2022' to 'revenue generation in 2023' to 'full strategic integration in 2024.' The LLM answer jumps directly to revenue figures without capturing the qualitative evolution of strategic positioning and the transition from conceptual development to commercialization; (3) MISSING CONTEXT - Does not explicitly address how digital cockpit moved from being highlighted as a 'transformational force' in 2022 to becoming formally integrated into segment structure by 2024; (4) AUTONOMY PROJECTION - Introduces Level 2 autonomy statistic (19% of 2025 vehicles) not mentioned in ground truth, which may be accurate but represents information beyond the specific question scope. The automotive revenue figures ($1.509B, $1.872B, $2.910B) appear plausible and show correct directional growth, but cannot be verified against ground truth which does not provide these specific numbers. The answer demonstrates adequate understanding of the business evolution but fails to fully capture the strategic positioning narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 507,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million at year‑end 2022** to **$555 million at year‑end 2023** and further to **$540 million at year‑end 2024**. The modest, steady decline shows the company is trimming its exposure to illiquid alternatives in a controlled way, suggesting a long‑term strategy that balances the higher‑return potential of private real‑estate with liquidity and risk management.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is perfectly accurate - the three-year progression ($569M → $555M → $540M) is correct, and the year-end dates are properly identified. (2) The LLM correctly identifies the consistent downward trend and characterizes it as 'modest, steady decline.' (3) The format variations are handled appropriately. (4) The interpretation that this represents controlled trimming of illiquid alternative exposure is reasonable. WEAKNESSES: (1) The LLM omits the specific annual decline pattern ($15 million per year) that the ground truth explicitly identifies as a key insight. (2) Missing the liquidation period information (2025-2034) that provides important context about the long-term nature of these commitments and suggests Abbott is managing exposure rather than exiting entirely. (3) The phrase 'balances the higher-return potential of private real-estate with liquidity and risk management' is somewhat speculative and less grounded than the ground truth's more measured interpretation of 'strategic de-risking or rebalancing.' (4) The LLM doesn't explicitly state that Abbott continues to maintain exposure to private real estate through existing investments, which is an important nuance about the strategy. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year data points and draws a reasonable conclusion about strategy, but misses some of the deeper contextual details that would strengthen the analysis. The core insight about de-risking is present but less fully developed than in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 427,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 were issued in 2013 and matured in 2016; the 10‑K “Description of Securities of the Registrant” in each filing (2022, 2023, 2024 – pages 58 and 56) lists the 0.45% Notes only as part of that 2013 issuance, with no new issuance recorded in those years (2024 p. 58; 2023 p. 56; 2022 p. 58). This steady absence of new 0.45% Notes shows that Apple systematically retires older debt as it matures and replaces it with newer debt that has longer maturities and higher coupon rates, underscoring a disciplined long‑term debt‑management strategy that balances maturity diversification and interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental chronological impossibility that contradicts both the ground truth and basic logic. The LLM states that the 0.45% Notes due 2016 'matured in 2016' but then claims they appear in the 2022, 2023, and 2024 10-K filings. This is logically impossible—a debt instrument that matured in 2016 cannot be listed in filings from 2022-2024 unless it was refinanced or rolled over, which the LLM does not explain. The ground truth correctly states that Apple 'maintained this debt instrument as part of its capital structure across all three years' (2022-2024), implying the notes were still outstanding. The LLM's interpretation that the notes 'matured in 2016' directly contradicts the evidence that they appear in three subsequent annual reports. Additionally, the LLM's claim about 'steady absence of new 0.45% Notes' is unsupported by the ground truth, which makes no such claim about new issuances. The LLM appears to have confused the original issuance date (May 3, 2013) with a maturity date of 2016, creating an internal contradiction. The ground truth emphasizes the CONSISTENT INCLUSION across three years as evidence of a stable debt strategy, while the LLM misinterprets this as evidence of debt retirement and replacement. The page references provided (58, 56, 58) cannot be verified against the ground truth but appear to be fabricated specificity. The reasoning about 'disciplined long-term debt-management strategy' is speculative and not supported by the ground truth's simpler observation about maintaining a mix of debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 439,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM’s 2022 filing positioned trust as a core component of its hybrid‑cloud platform, noting that the platform “integrates … (4) trust and security” (page_4). By 2024, trust appears as a principal competitive method alongside technology, performance, and client relationships, framing it as a broader value proposition rather than a platform feature (page_3). This evolution signals IBM’s strategy to strengthen its brand as a trusted partner in hybrid‑cloud and AI, leveraging incumbency, security, and deep expertise to differentiate from hyperscalers and new entrants.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct observations but has significant gaps in addressing the full scope of the question. STRENGTHS: (1) Correctly identifies the evolution of trust positioning from 2022 to 2024, (2) Accurately notes the shift from trust as a platform feature to a broader competitive method, (3) Appropriately contextualizes IBM's differentiation strategy against hyperscalers, (4) Page references appear plausible. WEAKNESSES: (1) The answer is incomplete - it only covers 2022 and 2024, missing the critical 2023 transition year that the ground truth identifies as important for understanding the progression, (2) Fails to address the explicit evolution of trust's linkage with consulting services and mission-critical infrastructure (2023 development), (3) Does not mention the strategic partnerships angle that became prominent in 2024 according to ground truth, (4) The answer focuses narrowly on hybrid-cloud platform positioning rather than the broader ecosystem collaboration and innovation leadership themes highlighted in the ground truth, (5) Missing the nuance that trust evolved from 'part of a broader portfolio' to 'integrated with ecosystem collaboration.' MULTI-HOP REASONING: The LLM successfully synthesizes information across two years but fails to complete the three-year progression required by the question. The reasoning about differentiation strategy is sound but incomplete. SEMANTIC ISSUES: While the LLM's framing of trust as a 'broader value proposition' aligns with ground truth, it misses the specific strategic evolution through 2023 and the ecosystem/partnership dimension that became central by 2024. The answer reads as a partial analysis rather than a comprehensive multi-year progression assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 477,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 2023 and 2024 10‑K filings show that the 4.250% Note due 2030 is supported by a liquidity‑provider revolving credit agreement that was amended in May 2023 (Amendment No. 1, see page 123 of the 2023 filing and page 124 of the 2024 filing).  The 2024 filing continues to reference the same amendment, indicating that the company has maintained a stable, proactively updated liquidity arrangement for the note and has not needed further changes, underscoring a disciplined, consistent approach to ensuring adequate credit support for this obligation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about FedEx's liquidity arrangements for the 4.250% Note due 2030: (1) the revolving credit agreement with Wilmington Trust Company and BNP Paribas, (2) Amendment No. 1 filed in May 2023, and (3) the maintenance of this arrangement through 2024 without further amendments. The dates and amendment information are accurate. However, the answer has some notable omissions compared to the ground truth: (1) It does not mention the foundational agreements established in 2022 (Intercreditor Agreement and original Revolving Credit Agreement dated August 13, 2020), which is important context for understanding the evolution from 2022-2024. (2) It does not explicitly reference the 2022 baseline, making the 'evolution' aspect of the question less comprehensively addressed. The LLM answer focuses primarily on 2023-2024 rather than the full 2022-2024 period requested. The reasoning about FedEx's 'disciplined, consistent approach' is sound and well-supported by the facts presented, and the semantic interpretation of what the evolution indicates is appropriate. The page references (123 and 124) are provided but cannot be verified from the ground truth. The answer demonstrates good multi-hop synthesis of the amendment history and its implications, but incompletely addresses the full temporal scope of the question by not adequately covering the 2022 baseline and foundational structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 398,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % notes due 2044 were first issued in 2014 and are still listed in the description of securities in the 2022, 2023 and 2024 10‑Ks (page 56).  Across those years the coupon and maturity of the instrument did not change, and the notes remained a core part of the company’s long‑term debt with only modest principal repayments or new issuances that kept the overall balance largely stable.  This steady presence of a long‑term, fixed‑rate note indicates Apple’s strategy of locking in low, predictable interest costs over a long horizon to support its capital‑allocation decisions while preserving liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - the 4.45% Notes were indeed first issued in 2014 and appeared consistently in 2022, 2023, and 2024 10-Ks; (2) The coupon rate (4.45%) and maturity date (2044) are correctly stated; (3) The multi-hop synthesis is sound - the answer correctly identifies the consistency across three years and draws appropriate conclusions about Apple's financing strategy; (4) The interpretation about 'locking in low, predictable interest costs' and 'preserving liquidity' is a reasonable and insightful extension of the ground truth's observation about 'stable component of capital structure'; (5) The reference to page 56 adds helpful specificity. MINOR WEAKNESSES: (1) The LLM answer goes slightly beyond the ground truth by making claims about 'modest principal repayments or new issuances' and 'overall balance largely stable' - while these are reasonable inferences, they are not explicitly confirmed in the ground truth statement, which only notes the notes 'remained consistent' without discussing principal repayment details; (2) The phrase 'only modest principal repayments or new issuances' could be interpreted as adding detail not explicitly verified in the ground truth; (3) The ground truth uses simpler language ('maintained its long-term financing strategy, retaining...without early redemption or restructuring') while the LLM adds interpretive layers about 'locking in low, predictable interest costs' - this is reasonable but slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: All numbers are correct (4.45%, 2044, 2014, years 2022-2024). No calculations required. MULTI-HOP REASONING: Correctly synthesizes information across three years and connects to financing strategy implications. The reasoning is sound and logical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 504,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In 2022 FedEx International Connect Plus was available from about 50 origin countries to more than 130 destination countries, whereas by 2024 it had expanded to roughly 60 origin countries and over 190 destination countries【page_14】【page_8】. This widening of coverage shows FedEx is aggressively scaling its global e‑commerce logistics network, prioritizing cross‑border day‑definite service and positioning itself to capture a larger share of the rapidly growing e‑commerce market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 baseline (nearly 50 origin countries to over 130 destination countries) and the 2024 endpoint (roughly 60 origin countries and over 190 destination countries). The numeric values are accurate and properly formatted. The answer correctly synthesizes the geographic expansion data across the two-year period.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly mentions 2023 data as a critical waypoint showing the expansion trajectory (nearly 60 origin countries and over 190 destination countries in 2023), which is essential for understanding the evolution pattern. The LLM jumps directly from 2022 to 2024, missing the intermediate year that demonstrates the expansion occurred primarily in 2022-2023, followed by stabilization in 2024. This is a significant omission for a question specifically asking about 'evolution' and 'trajectory.' (2) INCOMPLETE STRATEGIC ANALYSIS: The ground truth provides nuanced strategic interpretation - that the expansion was followed by a 'phase of consolidation and optimization' in 2024. The LLM only describes 'aggressive scaling' without capturing the stabilization phase or the shift in strategic focus from expansion to optimization. The phrase 'aggressively scaling' actually mischaracterizes the 2024 position, as the footprint remained consistent (not expanding). (3) MISSING CONTEXT: The ground truth's mention of 'emerging markets' as a particular focus is absent from the LLM answer. (4) REASONING QUALITY: While the LLM correctly identifies e-commerce logistics as the strategic focus, it doesn't fully explain what the stabilization in 2024 suggests about FedEx's strategic priorities shifting from expansion to consolidation.\n\nCALCULATION VERIFICATION: No calculations required; all numeric values are correct.\n\nMULTI-HOP REASONING: Partially successful. The LLM synthesizes 2022 and 2024 data but fails to incorporate the 2023 intermediate data point, which is crucial for understanding the evolution trajectory. The question asks about 'evolution from 2022 to 2024,' which implicitly requires understanding the path taken, not just endpoints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 582,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were fully repaid by the end of 2017 and are not reported as outstanding debt in the consolidated balance sheets for FY 2022, FY 2023, or FY 2024 (Apple 10‑K 2024, p. 56; Apple 10‑K 2023, p. 56; Apple 10‑K 2022, p. 56).  The notes continue to appear in each filing’s “Description of Securities” section, illustrating Apple’s practice of keeping a complete historical debt register and proactively managing debt maturities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The notes were indeed fully repaid by end of 2017 and do not appear as outstanding debt in the balance sheets for FY 2022-2024 - this is factually accurate. (2) The notes do continue to appear in disclosure sections across the three fiscal years mentioned. (3) The general characterization of Apple maintaining historical debt documentation is reasonable. PROBLEMATIC ASPECTS: (1) The LLM cites specific page numbers (p. 56) for all three years' consolidated balance sheets without verification - while the general claim about non-appearance in balance sheets is likely correct, the specific page citations are unverified and may be inaccurate. (2) The LLM states the notes appear in a 'Description of Securities' section, but the ground truth specifically identifies them as appearing in 'Exhibit 4.4' with an 'Officer's Certificate dated May 6, 2014' - this is a material difference in the specific disclosure location/exhibit. (3) The LLM's interpretation that this reflects 'proactively managing debt maturities' is somewhat speculative and differs from the ground truth's more cautious assessment that Apple 'may have retained historical references...possibly to maintain continuity.' (4) The LLM does not mention the specific exhibit number (4.4) or the Officer's Certificate dating, which are concrete details from the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes that the notes appear across all three years and are not on the balance sheet, but misses the specific disclosure mechanism (Exhibit 4.4) and provides less precise characterization of Apple's disclosure strategy. The answer is directionally correct but lacks the specificity and precision of the ground truth regarding where and how these notes are disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 497,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm’s 2022 10‑K underscored a strategic pivot to 5G and the connected‑intelligent edge, with R&D and licensing focused on expanding beyond handsets into automotive, IoT and XR while licensing revenue—primarily from OFDMA‑based products—remained a core driver (page 13). In 2023 the company deepened its 5G portfolio and continued to invest heavily in new applications, but faced mounting U.S./China trade tensions and the revocation of export licenses to Huawei, which cut $560 million of licensing revenue (page 22) and heightened supply‑chain risk. By fiscal 2024 Qualcomm’s focus sharpened on 5G across new verticals, with significant R&D spend and a continued reliance on licensing revenue, yet its exposure to geopolitical risk intensified, as reflected in the concentration of revenue in China and the broader restrictions on Chinese OEMs and suppliers (pages 18‑22).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All key numeric values are correct: the $560 million Huawei licensing revenue loss is accurately cited and properly contextualized as occurring prior to fiscal 2024; (2) The temporal progression across fiscal years 2022-2024 is correctly traced with appropriate strategic evolution noted at each stage; (3) Multi-hop synthesis is sound: the answer successfully integrates information about licensing revenue, R&D investments, new applications (automotive, IoT, XR, AI), and geopolitical risks across the three-year period; (4) Entity identification is accurate: Qualcomm, Huawei, QTL, OFDMA-based products, and relevant business segments are all correctly identified; (5) The answer captures the core narrative of deepening commitment to 5G despite rising geopolitical exposure. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the '27 billion IoT devices by 2026' projection from fiscal 2022, which was included in the ground truth as a specific forward-looking metric; (2) The reference to 'Qualcomm Ventures' strategic investments is absent from the LLM answer, though this is a relatively minor omission; (3) Page citations (13, 22, 18-22) are provided but cannot be verified against the actual filings in this evaluation context. QUANTITATIVE VERIFICATION: The $560 million figure is correctly stated and properly attributed to the Huawei export license revocation impact. The answer correctly identifies OFDMA-based licensing as a primary revenue driver. REASONING QUALITY: The multi-hop reasoning effectively connects strategic focus evolution, financial commitments, and geopolitical risk exposure across the three-year period, demonstrating sound synthesis of complex information. The answer appropriately emphasizes the tension between deepening 5G commitment and rising external risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 522,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan’s U.S. equity allocation rose from 9.5 % ($89 M) to 10.2 % ($91 M), international equity fell slightly from 9.7 % ($91 M) to 9.9 % ($89 M), and fixed‑income declined from 78.9 % ($739 M) to 77.3 % ($692 M) (2022: page 57; 2024: page 71). These modest shifts keep the portfolio near its stated 10‑10‑80 target, indicating a slight tilt toward equity exposure while still preserving a dominant fixed‑income, liability‑hedged strategy that has remained largely unchanged over the three‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it almost entirely incorrect:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - 2022 U.S. equity: LLM states $89M, but ground truth shows $125M (32% error)\n   - 2022 international equity: LLM states $91M, but ground truth shows $126M (28% error)\n   - 2022 fixed income: LLM states $739M, but ground truth shows $1,001M (26% error)\n   - 2024 U.S. equity: LLM states $91M, but ground truth shows $93M (2% error - minor)\n   - 2024 international equity: LLM states $89M, but ground truth shows $93M (4% error)\n   - 2024 fixed income: LLM states $692M, but ground truth shows $739M (6% error)\n   - The LLM appears to have confused 2023 values with 2022 values for the starting point\n\n2. PERCENTAGE CALCULATIONS:\n   - LLM's percentages are internally inconsistent with the dollar amounts provided\n   - The percentages don't match the stated dollar amounts when verified\n   - Ground truth shows 2022: U.S. equity 9.9% ($125M), international 9.9% ($126M), fixed income 79.0% ($1,001M)\n\n3. MULTI-HOP SYNTHESIS FAILURE:\n   - The LLM failed to correctly identify the 2022 baseline values\n   - The comparison from 2022 to 2024 is fundamentally flawed because the starting numbers are wrong\n   - The analysis misses the critical 2023 data point entirely, which showed the most significant shift\n   - Ground truth shows total assets declined from $1,267M (2022) to $937M (2023) to $947M (2024) - a major strategic shift the LLM completely missed\n\n4. STRATEGIC INTERPRETATION ERROR:\n   - LLM claims 'modest shifts' and 'largely unchanged' strategy, but ground truth reveals a significant reduction in total pension assets in 2023 followed by partial recovery\n   - LLM misses the key insight: the company reduced equity exposure significantly in 2023 (from $251M to $180M combined) and then stabilized in 2024\n   - The characterization of strategy evolution is incorrect\n\n5. COMPLETENESS:\n   - LLM fails to address the full three-year period properly by using wrong 2022 baseline\n   - Missing analysis of the 2023 transition year, which is crucial to understanding strategy evolution\n   - Does not properly explain the 'significant reduction' that occurred in 2023\n\nThe LLM answer appears to have transposed 2023 values as 2022 values, creating a cascade of errors throughout the analysis. This is a fundamental data retrieval and synthesis failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 645,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking portfolio in 2022—mobile broadband, wireless access points, Wi‑Fi 6/6E and 5G NR‑Unlicensed—generated $7.353 B of IoT revenue (a key part of its edge‑networking mix)【page 73】. By 2024 that segment had fallen to $5.423 B, but the company had expanded its technology stack to include Wi‑Fi 7 and further 5G NR‑Unlicensed solutions, underscoring a shift from a revenue‑heavy edge‑networking focus to a more technology‑driven positioning that supports operators’ high‑speed, low‑latency needs【page 8】【page 10】. This evolution reflects Qualcomm’s pivot toward next‑generation connectivity standards while the revenue contribution from edge‑networking products has declined.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific revenue figures ($7.353B in 2022 and $5.423B in 2024) that are not present in the ground truth answer\n   - These numbers appear to be fabricated or misattributed, as the ground truth makes no mention of specific IoT revenue figures\n   - The LLM incorrectly attributes these figures to \"IoT revenue\" rather than edge networking specifically\n   - No verification of these numbers is possible from the ground truth provided\n\n2. DIRECTIONAL CONTRADICTION:\n   - Ground truth: Qualcomm showed \"consistent and maturing strategic focus on edge networking as a key growth area\"\n   - LLM answer: Claims the segment \"had fallen\" from $7.353B to $5.423B, suggesting decline\n   - This is a fundamental contradiction in the narrative direction\n\n3. INCOMPLETE ALIGNMENT WITH GROUND TRUTH:\n   - Ground truth emphasizes: identification of market drivers (hybrid work, 5G adoption), explicit listing as key revenue contributor, and consistent emphasis\n   - LLM answer focuses on: specific revenue numbers (unverified), technology stack evolution (Wi-Fi 6/6E to Wi-Fi 7), and a pivot narrative\n   - The LLM introduces technology details and revenue decline that contradict the ground truth's emphasis on consistent strategic focus\n\n4. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize across years but does so with unverified numerical claims\n   - The reasoning about \"pivot toward next-generation connectivity\" is not supported by the ground truth\n   - The ground truth indicates consistent emphasis, not a pivot away from edge networking\n\n5. ENTITY AND METRIC CONFUSION:\n   - The LLM conflates \"IoT revenue\" with \"edge networking revenue\" without clear justification\n   - Page citations (page 73, page 8, page 10) cannot be verified against the ground truth\n   - The specific product technologies mentioned (Wi-Fi 7, 5G NR-Unlicensed) are not discussed in the ground truth\n\n6. SEMANTIC MISALIGNMENT:\n   - Ground truth narrative: Strategic positioning matured and remained consistent\n   - LLM narrative: Strategic positioning shifted with revenue decline\n   - These are fundamentally different interpretations of Qualcomm's evolution\n\nThe answer appears to contain fabricated or misattributed financial data and contradicts the core finding of the ground truth regarding consistent strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 660,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple consistently lists the 0.45% Notes due 2016 in the Officer’s Certificate (Exhibit 4.3) in its 2022, 2023 and 2024 10‑Ks. By continuing to disclose a debt that matured in 2016, the company demonstrates a disciplined, transparent approach to tracking all fixed‑rate maturities—whether repaid, refinanced or still outstanding—so investors see a fully disclosed and stable capital‑structure profile. This practice underscores Apple’s proactive management of debt timing and mix, reinforcing capital‑structure stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of the multi-hop question. STRENGTHS: (1) All quantitative elements are correct - the 0.45% interest rate, the 2016 maturity date, and the three fiscal years (2022, 2023, 2024) are accurately stated. (2) The entity identification is precise: Apple, the specific debt instrument, and the filing years are all correct. (3) The multi-hop reasoning is sound - the answer correctly synthesizes that the notes appear in multiple filings despite maturing in 2016, and interprets this as reflecting Apple's disclosure practices. (4) The semantic meaning aligns well with the ground truth: both answers convey that Apple's consistent inclusion of these notes demonstrates transparent debt disclosure and structured capital management. (5) The reference to Exhibit 4.3 (Officer's Certificate) adds specific documentary evidence. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing than the ground truth - it emphasizes 'disciplined, transparent approach' and 'proactive management' while the ground truth emphasizes 'comprehensive debt disclosure and historical tracking.' However, these are semantically equivalent interpretations of the same phenomenon. (2) The ground truth explicitly notes the notes are 'no longer outstanding,' while the LLM answer says 'whether repaid, refinanced or still outstanding' - this is a minor difference in emphasis but both convey the same understanding. (3) Both answers correctly address the core question about how the consistent inclusion reflects Apple's approach to managing fixed-rate debt and capital structure stability. The answer is comprehensive, accurate, and appropriately addresses all aspects of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 478,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "In 2022, Caterpillar’s EMD brand distribution network reached 193 countries. By 2024 that number had fallen to 187 countries, a contraction of six countries in its geographic reach.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative metrics. Ground truth shows: 2022: 130 countries, 2023: 130 countries, 2024: 109 countries (21-country decline, ~16% reduction). LLM answer claims: 2022: 193 countries, 2024: 187 countries (6-country decline). Every single number is wrong - the 2022 baseline is off by 63 countries (193 vs 130), the 2024 figure is off by 78 countries (187 vs 109), and the calculated change is off by 15 countries (6 vs 21). The LLM also failed to address the 2023 data point mentioned in the ground truth. While the question is appropriately addressed in terms of topic relevance (asking about EMD brand geographic reach changes 2022-2024), the answer contains completely fabricated numbers with no basis in the actual SEC filing data. This represents a critical failure in factual accuracy for a financial question requiring precise data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 263,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "The 1.750% 7‑year senior notes were $700 million at December 31 2022 (page 62), stayed $700 million at December 31 2023 (page 62), and remained $700 million at December 31 2024 (page 48). This flat trajectory shows Thermo Fisher is deliberately keeping a steady medium‑term debt load, leveraging low‑cost, long‑maturity financing to support its growth and R&D while preserving financial flexibility in the healthcare sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($700 million for all three years: 2022, 2023, 2024). The dates are accurate (December 31 for each year). The note characteristics (1.750%, 7-year, due October 15, 2028) are correctly identified. Page references provided (62, 62, 48) add credibility though cannot be independently verified here. COMPLETENESS: The answer addresses the core question about the evolution of outstanding value across the three-year period and provides interpretation of what this indicates about debt strategy. ENTITY ACCURACY: TMO/Thermo Fisher correctly identified; the specific debt instrument properly characterized; fiscal years correctly sequenced. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the consistent $700 million value across all three years and drew a logical conclusion that this represents a deliberate, steady approach to medium-term debt management. The interpretation that this reflects 'low-cost, long-maturity financing to support growth and R&D while preserving financial flexibility' is a reasonable inference from the stable debt pattern, though slightly more interpretive than the ground truth's more conservative statement. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - stable $700 million value across 2022-2024 indicating consistent capital structure management. The additional context about leveraging low-cost financing and supporting growth is reasonable elaboration rather than contradiction. Minor difference: Ground truth emphasizes 'without retiring or increasing' while LLM emphasizes 'deliberately keeping steady' - semantically equivalent. No calculation errors detected. All facts align with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 508,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From 2022 to 2024 Caterpillar maintained a robust use of currency‑hedging instruments to protect against exchange‑rate swings, but its risk‑management focus shifted as LIBOR was phased out and SOFR became the new benchmark for variable‑rate financing.  In 2024 the company disclosed a cross‑functional team that evaluates floating‑rate exposure—including SOFR—alongside a selective use of derivatives, a match‑funding strategy and a diversified funding program to manage both currency and interest‑rate risk.  This evolution demonstrates Caterpillar’s proactive adaptation to global financial reforms by aligning its hedging practices with new benchmark rates while preserving a flexible, multi‑layered risk‑management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core narrative of Caterpillar's transition from LIBOR to SOFR across 2022-2024. (2) It accurately captures that the company used currency hedging instruments throughout the period. (3) The characterization of the shift as 'proactive adaptation to global financial reforms' aligns with the ground truth. (4) The mention of a cross-functional team and multi-layered risk management framework is factually sound.\n\nWEAKNESSES: (1) TEMPORAL SEQUENCING ERROR: The LLM states 'In 2024 the company disclosed a cross-functional team' but the ground truth indicates the cross-functional team was formed in 2022 and expanded by 2023. The LLM conflates the timeline by placing this disclosure only in 2024. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth provides specific regulatory milestones (FCA announcement to stop LIBOR after 2021, IBA's plan to cease USD LIBOR on June 30, 2023) that contextualize Caterpillar's response. The LLM omits these specific dates and regulatory drivers. (3) MISSING YEAR-BY-YEAR EVOLUTION: The ground truth explicitly traces the 2022→2023→2024 progression (2022: uncertainty and team formation; 2023: transition to SOFR emphasis; 2024: complete pivot away from LIBOR). The LLM presents this more as a general trend rather than a clear chronological evolution. (4) VAGUE ATTRIBUTION: The LLM says 'In 2024 the company disclosed a cross-functional team' without clarifying whether this was a new disclosure or continuation of prior disclosures. (5) MISSING SPECIFIC DISCLOSURE DETAILS: The ground truth notes that by 2023 disclosures 'emphasized the use of SOFR' and by 2024 'no longer referenced LIBOR at all'—these specific disclosure shifts are not captured in the LLM answer.\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. Both answers avoid quantitative claims. Score reflects that no errors were made but also no specific metrics were verified.\n\nQUALITATIVE ACCURACY: The LLM demonstrates understanding of the general concept but fails to capture the precise temporal sequence and regulatory context that define Caterpillar's strategic adaptation. The multi-hop reasoning is incomplete—it doesn't fully synthesize how regulatory timelines drove the company's disclosure and risk management evolution.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core themes (currency hedging, LIBOR-to-SOFR transition, strategic adaptation) but lacks the depth of regulatory context and year-by-year progression that would fully answer the question about how the company's approach 'evolved' from 2022 through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 714,
        "total_tokens": 2251
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "From its 2022 filing, Thermo Fisher’s Executive Change‑in‑Control Retention Agreement (ECCRA) was a CEO‑specific contract (Exhibit 10.11) with a separate, standardized form for all other officers (Exhibit 10.18)【page_46】.  In the 2023 10‑K the company adopted a single, uniform ECCRA for every officer other than the CEO (Exhibit 10.17)【page_77】, and the 2024 filing continued to reference that same standardized form (Exhibit 10.17)【page_76】, indicating a consistent, standardized approach to ECCRAs for non‑CEO officers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains multiple factual inaccuracies that contradict the ground truth: (1) EXHIBIT NUMBERS WRONG: LLM cites Exhibit 10.11 and 10.18 for 2022, but ground truth specifies Exhibit 10.12 for CEO agreement and Exhibit 10.17 for officers form. (2) 2022 CHARACTERIZATION INCORRECT: LLM claims 2022 had 'a separate, standardized form for all other officers (Exhibit 10.18)' but ground truth indicates the standardized form for officers beyond CEO was introduced in 2023, not 2022. (3) TIMELINE MISREPRESENTATION: Ground truth shows clear evolution from CEO-specific (2022) → standardized for officers introduced (2023) → reaffirmed (2024). LLM incorrectly suggests the standardized form existed in 2022. (4) EXHIBIT CONSISTENCY: Ground truth consistently references Exhibit 10.17 for the standardized officer form across 2023-2024, while LLM incorrectly cites 10.18 for 2022. (5) SEMANTIC ISSUE: LLM's framing of '2022 had separate standardized form' contradicts the ground truth narrative of evolution/introduction in 2023. The LLM answer fails to capture the key insight that standardization for non-CEO officers was a NEW development in 2023, not an existing practice in 2022. While the LLM correctly identifies the general concept of standardization and the 2023-2024 consistency, the fundamental mischaracterization of 2022 and wrong exhibit citations represent significant factual errors that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 406,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In 2023 Intel announced PowerVia as a breakthrough backside‑power technology for the upcoming Intel 20A node, projecting up to 15 % performance‑per‑watt gains (page 14). By 2024 the technology had moved into Intel 18A, the first high‑volume commercial implementation, and is now a core differentiator for the next‑generation process (page 10). This shift—from a future‑tech concept in 2022 to a commercial enabler in 2024—shows that PowerVia has become a central pillar of Intel’s advanced process roadmap, driving performance and power efficiency while underpinning its IDM 2.0 foundry strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of PowerVia technology and its strategic importance, but contains a critical factual error regarding the timeline of introduction. MAJOR ERROR: The LLM states 'In 2023 Intel announced PowerVia' when the ground truth clearly indicates PowerVia was first introduced in 2022 as part of Intel's future process roadmap. This is a significant dating error that undermines the accuracy of the 3-year evolution narrative. CORRECT ELEMENTS: (1) PowerVia is correctly identified as backside-power technology; (2) The connection to Intel 20A is accurate; (3) The shift to Intel 18A in 2024 is correct; (4) The characterization of PowerVia as a 'core pillar' of the advanced process roadmap is semantically equivalent to ground truth; (5) The mention of performance-per-watt gains (15%) is a reasonable technical detail, though not explicitly verified in ground truth. MISSING ELEMENTS: (1) The answer omits the 2022 introduction date entirely, which is a key part of the 3-year progression; (2) The answer does not mention RibbonFET, which was positioned alongside PowerVia in 2022; (3) The answer lacks the specific detail about 'eliminating front-side power routing' that was emphasized in 2023; (4) The answer does not mention the 2025 high-volume manufacturing timeline as clearly as ground truth. MULTI-HOP REASONING: The answer does synthesize information across the 2022-2024 period and correctly identifies the strategic shift from 20A to 18A, but the incorrect starting date (2023 vs 2022) creates a flawed foundation for the evolution narrative. The connection to IDM 2.0 foundry strategy is a reasonable inference but not explicitly verified in ground truth. QUANTITATIVE ISSUES: The 15% performance-per-watt figure is presented without source verification and may be accurate but cannot be confirmed against ground truth. The timeline compression (starting from 2023 instead of 2022) represents a factual error in temporal sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 534,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple continues to list the 1.05 % Notes due 2017 in the “Description of Securities” (Exhibit 4.1) of each 10‑K, with the same wording and terms appearing on page 56 of the 2022, 2023 and 2024 filings【page_56】【page_56】【page_56】.  The unchanged disclosure shows the note remains outstanding and has not been retired or re‑structured, indicating that Apple’s debt‑management policy is to keep a diversified, long‑term debt portfolio and to report all material debt instruments consistently for investor transparency.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that undermine its credibility. Key issues: (1) CRITICAL ERROR - The LLM claims the 1.05% Notes due 2017 appear in 'Description of Securities' (Exhibit 4.1) on page 56 of 2022, 2023, and 2024 filings. The ground truth specifies the disclosure was in the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4), not Exhibit 4.1. This is a fundamental misidentification of the source document. (2) LOGICAL CONTRADICTION - The LLM states the note 'remains outstanding and has not been retired or re-structured,' but this contradicts the ground truth which indicates the notes matured in 2017 (before the 2022 filing). The LLM's interpretation that the note remains outstanding is factually incorrect. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The ground truth explicitly addresses the paradox of why a 2017-maturity note appears in post-2017 filings, suggesting either a rollover or maintenance in capital structure. The LLM fails to acknowledge this temporal inconsistency and instead assumes the note is still outstanding, which is implausible. (4) MISCHARACTERIZATION OF DEBT MANAGEMENT - The LLM's conclusion about Apple's debt management policy (maintaining a diversified long-term portfolio) is speculative and not supported by the ground truth. The ground truth suggests deliberate reporting of a post-maturity instrument, which is a different phenomenon than simply maintaining outstanding debt. (5) CITATION ISSUES - The LLM provides page references (page 56) without verification against actual filing locations, and the exhibit designation (4.1 vs 4.4) is demonstrably wrong. The answer shows superficial understanding of the disclosure evolution and fails to grapple with the substantive question about why a matured note continues to appear in filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 498,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 to 2024 Intel broadened the 2006 Equity Incentive Plan’s award mix. In 2022 the plan granted RSUs with retirement‑vesting terms, RSUs without retirement‑vesting terms, and performance‑based RSUs to grandfathered executives, all vesting on a standard time‑based or retirement schedule (Exhibit 10.1.3–10.1.5, page 107). By 2024 it also issued performance‑based RSUs to non‑grandfathered executives and RSUs to non‑employee directors, with vesting tied to performance metrics in addition to the existing retirement and time‑based schedules (Exhibit 10.1.6–10.1.7, page 108).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) CHRONOLOGICAL INVERSION: The LLM claims 2022 had RSUs with retirement-vesting terms, RSUs without retirement-vesting terms, and performance-based RSUs to grandfathered executives. However, the ground truth states these broader award types were introduced in 2023 after the plan amendment on May 11, 2023. In 2022, the plan was referenced primarily for strategic growth performance-based RSUs and stock options. (2) MISSING 2023 AMENDMENT: The LLM completely omits the critical May 11, 2023 amendment and restatement of the plan, which is a major structural change highlighted in the ground truth. (3) INCORRECT AWARD PROGRESSION: The LLM suggests 2024 introduced performance-based RSUs to non-grandfathered executives and RSUs to non-employee directors, but the ground truth indicates these were already part of the 2023 expanded offerings. The 2024 evolution was about consolidation and streamlining, not introduction of new award types. (4) CITATION ISSUES: The LLM provides specific exhibit references (10.1.3-10.1.5, page 107; 10.1.6-10.1.7, page 108) that cannot be verified against the ground truth and appear to be fabricated. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes a shift toward 'more nuanced performance alignment and simplified documentation,' while the LLM incorrectly frames the evolution as a broadening from 2022-2024 when the major expansion occurred in 2023. The answer fails to capture the actual timeline and nature of the plan's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 435,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s 10‑K notes for 2022, 2023 and 2024 all report the same authorized capital—40 000 Euro Deferred Shares with a €1.00 par value—and each year’s disclosure states that no shares were issued or outstanding (see page 81 for 2024, 2023 and 2022). The unchanged, zero‑issuance pattern indicates that the company has not pursued Euro‑denominated deferred equity as a financing tool, instead relying on other instruments (e.g., ordinary shares, preferred shares or debt) and maintaining a conservative, stable capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—40 thousand Euro Deferred Shares, €1.00 par value, zero issuance across 2022-2024. The consistent disclosure pattern is accurately captured. ENTITY ACCURACY: Medtronic correctly identified, fiscal years 2022-2024 properly specified, Euro Deferred Shares correctly named and characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to identify the consistent pattern and draws appropriate conclusions about financing strategy. The logic is sound: zero issuance across multiple years → instrument not utilized → preference for alternative capital tools. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as ground truth. Both identify: (1) consistent authorization of 40k shares, (2) zero issuance/outstanding shares across all three years, (3) implications for financing strategy. The LLM adds slightly more specificity by mentioning alternative instruments (ordinary shares, preferred shares, debt) compared to ground truth's more general reference to 'other capital structure tools.' MINOR DIFFERENCES: The LLM characterizes the strategy as 'conservative, stable' which is a reasonable inference from the data but represents slight interpretive elaboration beyond the ground truth's more neutral statement about 'preference.' The reference to 'page 81' is a helpful citation detail not in ground truth. Overall, the answer is factually accurate, complete, well-reasoned, and appropriately addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 456,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s advanced‑packaging risk moved from a peripheral concern in 2022—where disaggregated design and novel packaging technologies added cost and complexity (page 56, 54, 55)—to a core pillar of its IDM 2.0 strategy by 2024, with R&D spending staying high (≈$17.5 B in 2022, $16.0 B in 2023, $16.5 B in 2024) and increasingly focused on multi‑chip packaging (page 35, 36, 34, 35, 36). The added manufacturing complexity of combining components across different process nodes has heightened yield, timing, and cost risks, culminating in a $3.1 B impairment charge in 2024 and ongoing operating losses tied to packaging and capacity investments (page 34, 36).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $3.1B impairment charge in 2024, matching the ground truth exactly. (2) R&D spending figures are accurate ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024), demonstrating proper multi-year synthesis. (3) The answer correctly captures the evolution from peripheral concern to core strategy component. (4) Manufacturing complexity and yield/timing/cost risks are appropriately identified. (5) The answer properly synthesizes information across multiple years and documents. WEAKNESSES: (1) The LLM answer lacks specific mention of Intel 4 and 10nm process delays cited in 2022, which were explicitly noted in the ground truth as key execution risks. (2) Missing reference to the Universal Chiplet Interconnect Express (UCIe) standard demonstration in silicon in 2023, which was highlighted as technical progress in the ground truth. (3) The answer doesn't explicitly mention 'disaggregated designs' as a specific technical challenge, though it references 'multi-chip packaging' which is semantically similar. (4) The ground truth emphasizes the progression from 'initial strategic bet → technical progress → financial/operational setbacks,' while the LLM answer focuses more on the risk escalation narrative without as clearly delineating the technical progress phase. QUANTITATIVE VERIFICATION: All dollar amounts and years are correct. R&D figures are accurate and properly formatted. The $3.1B impairment is correctly cited. MULTI-HOP REASONING: The answer successfully synthesizes R&D investment trends across three years, connects manufacturing complexity to specific risks, and ties financial impact to strategic positioning. However, it could have better integrated the technical milestones (UCIe) into the narrative arc. SEMANTIC EQUIVALENCE: The answer conveys the core message about risk evolution and financial strain, though with less granular detail on specific technical achievements and process node challenges mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 539,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In its 2022 10‑K Intel positioned PowerVia as a breakthrough backside‑power delivery technology in the Intel 20A node, projecting up to a 15 % performance‑per‑watt gain over Intel 3. The 2023 roadmap reaffirmed PowerVia as a key innovation in the Intel 20A node, maintaining the same 15 % performance‑per‑watt expectation. By 2024 Intel disclosed that PowerVia is ready for high‑volume manufacturing as part of the Intel 18A node, with high‑volume production of the new Panther Lake client family slated to begin in 2025.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key metrics and timeline progression but contains a significant factual error regarding the initial positioning of PowerVia. CORRECT ELEMENTS: (1) The 15% performance-per-watt improvement figure is accurate and consistently maintained across 2022-2023. (2) The Intel 20A node association in 2022-2023 is correct. (3) The shift to Intel 18A in 2024 is accurate. (4) The 2025 high-volume manufacturing timeline is correct. (5) The characterization of PowerVia as a backside power delivery solution is accurate. CRITICAL ERROR: The LLM states PowerVia was positioned in the 2022 10-K as part of the Intel 20A node, but the ground truth indicates it was introduced in 2022 as a 'future packaging and process technology' without specific node assignment until 2023 when it was 'solidified' to Intel 20A. This represents a temporal/sequencing error in how the technology evolved. ADDITIONAL ISSUE: The LLM mentions 'Panther Lake client family' production in 2025, which adds specific product information not present in the ground truth answer. While this may be factually accurate from the 10-K, it goes beyond the scope of the original answer's focus on the technology roadmap evolution itself. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022, 2023, 2024) and correctly traces the evolution from introduction through roadmap solidification to manufacturing readiness. The logical progression is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative of PowerVia's maturation, though with the noted sequencing error regarding initial positioning. The core insight about transition from conceptual to production-ready is present but less explicitly stated than in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 487,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s U.S. employee Restricted Stock Unit (RSU) agreement has not been revised between FY 2022 and FY 2024.  The 2024 10‑K (page 112) lists the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (Exhibit 10.3) that appears in the 2022 10‑K (page 114) and the 2023 10‑K (page 112).  This lack of change suggests a deliberate, stable equity‑compensation strategy that prioritizes continuity and long‑term alignment over frequent plan adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that Medtronic has NOT updated its U.S. employee RSU agreements between FY2022 and FY2024; (2) Accurately references the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan across all three years; (3) Provides specific exhibit references (Exhibit 10.3) and page numbers (2024: page 112, 2022: page 114, 2023: page 112) that demonstrate multi-hop synthesis across three annual filings; (4) Correctly interprets the consistency as indicating a stable, deliberate equity compensation strategy focused on continuity and long-term alignment. Minor observation: The ground truth mentions the original filing date (August 27, 2013, File No. 001-07707), which the LLM answer does not include, though this is a minor omission that doesn't affect the core answer. The LLM's interpretation of what this consistency 'suggests' about strategy (deliberate, stable, prioritizing continuity and long-term alignment) is semantically equivalent to the ground truth's characterization (stable and consistent strategy maintaining approach without structural changes). The reasoning is sound, entities are correctly identified, and the multi-hop synthesis across three fiscal years is properly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 377,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022, Intel’s 2006 Equity Incentive Plan was used to award performance‑based RSUs to executives under a single grant agreement, as reflected in the plan’s definition in the 2022 filing (page 113). By 2024, the plan had been refined to issue separate grant agreements: one specifically for performance‑based RSUs granted to non‑grandfathered executives (and another for grandfathered executives) and distinct agreements for RSUs with and without retirement‑vesting terms (page 108). This shift shows a move toward a more granular, differentiated structuring of RSU grants under the plan.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of the 2006 Equity Incentive Plan as the vehicle for performance-based RSUs is accurate; (2) The reference to page numbers (113, 108) suggests document-specific citations; (3) The general concept of evolution toward more granular structuring is reasonable. PROBLEMATIC ELEMENTS: (1) The answer claims a shift from 'single grant agreement' in 2022 to 'separate grant agreements' by 2024, but the ground truth indicates the company used 'separate agreements for grandfathered and non-grandfathered executives' already in 2023, not as a new development by 2024; (2) The answer omits critical information from the ground truth: the May 11, 2023 amendment and restatement of the plan, and the September 26, 2023 S-8 registration filing - these are significant milestones in the plan's evolution; (3) The answer fails to adequately address the 2023 year, which is a critical middle point showing continuity and the introduction of separate agreements; (4) The characterization of the evolution is incomplete - the ground truth emphasizes 'consistent strategic focus on performance-based compensation aligned with long-term corporate objectives,' while the LLM focuses narrowly on structural differentiation. MULTI-HOP REASONING: The answer attempts to synthesize across years but misses the temporal progression and key regulatory/administrative actions (amendment, S-8 filing). The answer provides a partial narrative but lacks the comprehensive three-year evolution that the ground truth documents. The page citations appear to be fabricated or unverified, which raises accuracy concerns about the specific sourcing claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 470,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s 2022 filing (pages 52‑56) does not emphasize advanced‑packaging, but the 2023 filing (page 35) reports a surge in activity—five new AI‑centric design wins and a growing IFS accelerator ecosystem—indicating a ramp‑up of capital and focus on chip‑let packaging. By 2024, Intel continues to invest heavily in advanced packaging as a core element of its disaggregated‑design strategy, yet the filing (pages 35‑36) also highlights significant R&D and manufacturing risks and the need for new packaging technologies. This trajectory shows Intel is aggressively pursuing chip‑let packaging to compete in AI workloads, but the persistent risks reveal that execution remains challenging and will require sustained investment to achieve market leadership.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the general trajectory of Intel's advanced packaging evolution across 2022-2024, recognizes the shift toward AI-centric focus, and appropriately characterizes execution challenges. The semantic understanding of chiplet/disaggregated design strategy is sound. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies $16.5 billion in R&D investment in 2024 and $3.1 billion in charges related to non-cash impairments and accelerated depreciation—neither figure appears in the LLM answer. These are material financial metrics essential to answering the question about investment evolution and financial pressures. (2) INCOMPLETE MILESTONE DOCUMENTATION: The ground truth explicitly mentions the 2023 demonstration of the Universal Chiplet Interconnect Express (UCIe) standard in silicon, a concrete technical achievement that the LLM answer omits. This is a specific, verifiable milestone that demonstrates progress. (3) VAGUE REFERENCES: The LLM cites 'five new AI-centric design wins' without source verification and references 'pages 35-36' without providing the specific financial or technical data from those pages. The ground truth provides concrete numbers and specific technical achievements. (4) INCOMPLETE RISK CHARACTERIZATION: While the LLM mentions 'risks,' it fails to quantify the financial impact ($3.1 billion in charges) that the ground truth identifies as revealing 'persistent execution challenges and high financial stakes.' This omission weakens the answer's ability to demonstrate Intel's actual financial pressures. MULTI-HOP REASONING: The LLM demonstrates adequate synthesis across years but fails to integrate the critical financial data that would complete the narrative of investment evolution and execution challenges. The answer reads as a qualitative assessment rather than a data-driven analysis. VERDICT: The answer captures directional accuracy but lacks the quantitative precision and specific technical milestones necessary for a complete answer to this multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 561,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel amended its 2006 Equity Incentive Plan in 2022 to authorize RSU awards to non‑employee directors, as evidenced by the grant agreement dated May 12 2022 (Exhibit 10.1.7, page 108). In 2023 the plan continued to be used for RSU awards to executives, with a performance‑based RSU grant agreement dated January 30 2019 (Exhibit 10.1.6, page 108). By 2024 the plan remained unchanged but was still employed for both non‑employee director and executive RSU awards, with no new amendments disclosed (Exhibits 10.1, 10.1.6, 10.1.7 on pages 107‑108).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misrepresentations that substantially undermine its accuracy:\n\n1. CRITICAL DATE ERROR: The LLM states an amendment occurred in 2022 with a grant agreement dated 'May 12 2022' (Exhibit 10.1.7). However, the ground truth clearly indicates the amended and restated plan was effective May 11, 2023, not 2022. This is a fundamental factual error about when the amendment occurred.\n\n2. INCORRECT GRANT AGREEMENT DATE: The LLM references a 'performance-based RSU grant agreement dated January 30 2019' for 2023. This date (2019) predates the year being discussed (2023) and appears to be an incorrect citation. The ground truth mentions 2023 filings with specific RSU grant agreements but does not cite a 2019 date for 2023 activity.\n\n3. MISCHARACTERIZATION OF 2024 STATUS: The LLM states 'By 2024 the plan remained unchanged but was still employed' and 'with no new amendments disclosed.' However, the ground truth indicates 2024 showed 'ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age.' The LLM's claim of 'no new amendments' may be correct, but the framing misses the evolution narrative.\n\n4. INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes the evolution showing 'consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.' The LLM's answer fails to capture this narrative of evolution and maturation across the three-year period.\n\n5. EXHIBIT CITATIONS: While the LLM provides specific exhibit numbers and page references, these cannot be verified against the ground truth and appear potentially inaccurate given the date errors noted above.\n\n6. MISSING CONTEXT: The LLM answer lacks discussion of the broader context of plan usage across different participant types (executives, non-employee directors, performance-based awards) that the ground truth emphasizes.\n\nThe answer demonstrates some understanding of the topic (mentioning RSUs, amendments, and the three-year period) but contains material factual errors regarding dates and the timing of amendments that significantly compromise its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 597,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm has kept the same accounting treatment for wireless‑access‑point revenue, reporting it under the QCT “IoT” stream that is defined as edge networking (mobile broadband + wireless access points) in both the 2022 10‑K (page 7) and the 2024 10‑K (page 73).  The 2024 filing, however, stresses edge‑networking as a strategic growth focus, highlighting the company’s role in mobile‑broadband and Wi‑Fi (Wi‑Fi 6/6E) access‑point markets and positioning Qualcomm as a leading supplier of edge‑computing infrastructure (page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and potential inaccuracies compared to the ground truth. STRENGTHS: (1) Correctly identifies that wireless access points are categorized under edge networking segment in both 2022 and 2024; (2) Correctly notes the consistent accounting treatment across years; (3) Appropriately references specific 10-K pages (7 and 73); (4) Accurately describes the strategic emphasis on edge networking in 2024 with Wi-Fi 6/6E positioning. WEAKNESSES: (1) The LLM answer omits the critical 2023 data point showing explicit categorization under edge networking revenue segment - the ground truth emphasizes 2023 as a key year for formal financial classification, but the LLM only addresses 2022 and 2024; (2) Missing the specific IoT projection detail (doubling of IoT devices between 2022-2026 to over 27 billion) that the ground truth highlights as important context for understanding strategic emphasis; (3) The LLM references 'QCT IoT stream' terminology which is not mentioned in the ground truth and may be imprecise or non-standard; (4) The answer is somewhat narrower in scope - it focuses more on accounting consistency than on the evolution of strategic emphasis over the three-year period. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings but fails to incorporate the 2024 filing's reference to 2023 data or the broader IoT ecosystem context. The reasoning about consistent categorization is sound but incomplete. QUANTITATIVE ISSUES: No specific revenue figures are provided by either answer (both acknowledge non-disclosure), but the LLM omits the quantitative projection (27 billion IoT devices) that provides important context for understanding market positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 487,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (all figures in millions of dollars)【page_130】. The steady year‑over‑year growth signals that the drug is consolidating its role as a leading CMV‑prophylaxis in the Hospital Acute Care segment, indicating increasing adoption by hospitals and a strengthening market position for Merck in that niche.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial figures that are the primary focus of the question. Specifically: (1) The 2022 figure is stated as $428 million, but the ground truth shows $370 million - this is a $58 million error (15.7% overstatement). (2) The 2023 figure is stated as $605 million, but the ground truth shows $428 million - this is a $177 million error (41.4% overstatement). (3) The 2024 figure of $785 million is correct. The LLM has essentially shifted all years forward by one position, presenting 2023's actual figure ($428M) as 2022's figure, and an incorrect $605M as 2023's figure. This represents a fundamental data accuracy failure. CALCULATION IMPACT: The ground truth CAGR of approximately 46% over 2022-2024 cannot be verified from the LLM's numbers ($428M to $785M would yield ~35% CAGR), and the LLM did not calculate or mention the growth rate at all. QUALITATIVE ASSESSMENT: The reasoning about market positioning and CMV prophylaxis adoption is sound and semantically appropriate, and the contextual interpretation about Hospital Acute Care segment positioning is relevant. However, this qualitative accuracy cannot compensate for the severe quantitative errors in the primary data points. The question explicitly asks 'how did MRK's sales of Prevymis evolve from 2022 through 2024' - getting the baseline year (2022) wrong by $58 million is a critical failure in answering the core question. MULTI-HOP SYNTHESIS: The answer does not demonstrate multi-hop reasoning across documents; it appears to present a single data series with incorrect values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 451,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel’s IDM 2.0 strategy has shifted from a 2022 focus on “risk‑laden” R&D and limited manufacturing history for advanced packaging (page 56, page 54) to a 2023 period where packaging revenue rose sharply and new design wins and a silicon‑demonstrated interconnect standard underscored tangible progress (page 38, page 37, page 36, page 35). By 2024 the company still lists advanced packaging as a “unique advantage” while continuing large, long‑term capital outlays and acknowledging ongoing delays and inventory write‑downs (page 34, page 36), revealing that Intel is committed to IDM 2.0 but must still overcome significant execution risk from manufacturing lag and constrained cash flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year trajectory (2022-2024) and captures the core narrative: 2022 as risk-laden/limited history, 2023 as progress with silicon-demonstrated standards, and 2024 as continued commitment amid execution challenges. The semantic understanding of IDM 2.0 strategy evolution is sound, and the answer appropriately emphasizes manufacturing delays and capital constraints as key challenges. The reference to page numbers suggests document grounding.\n\nCRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies $16.5 billion in R&D investments for 2024 and $3.1 billion in non-cash impairments in Q3 2024—both concrete, verifiable numbers that directly support the argument about capital constraints and execution challenges. The LLM answer mentions 'large, long-term capital outlays' and 'inventory write-downs' but provides NO SPECIFIC NUMBERS. This is a significant omission for a financial question. (2) INCOMPLETE ENTITY SPECIFICITY: The ground truth mentions specific product delays (4th Gen Xeon Scalable processors) and specific process nodes (Intel 4, Intel 7) affected by impairments. The LLM answer generalizes to 'ongoing delays' without naming specific products or process nodes. (3) MISSING STRATEGIC DETAILS: The ground truth explicitly mentions UCIe (Universal Chiplet Interconnect Express) as a 2023 silicon-demonstrated standard—a concrete strategic achievement. The LLM answer references 'silicon-demonstrated interconnect standard' but does not name UCIe. (4) VAGUE CHARACTERIZATION: 'Inventory write-downs' is less precise than 'non-cash impairments' and doesn't capture the magnitude or specificity of the $3.1B Q3 2024 charge.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects strategic positioning to execution challenges. However, the reasoning lacks the quantitative rigor needed to fully support claims about 'capital constraints'—the specific R&D and impairment figures would strengthen this argument significantly.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the overall narrative arc and key themes (risk → progress → continued challenges), it falls short on the precision expected for a financial analysis question. The absence of specific dollar amounts, product names, and process node details represents a material gap in answering a question about Intel's 'multi-year trajectory' and 'ability to execute.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 655,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023 and 2024 all list “client relationships and trust” as a core competitive differentiator, with the same wording and placement in the competition section (2022 p.6; 2023 p.3; 2024 p.3). The unchanged emphasis signals that IBM is positioning its hybrid‑cloud and AI strategy around trusted, long‑term client relationships, using that trust to differentiate from hyperscalers and other competitors.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that IBM consistently emphasized 'client relationships and trust' across 2022-2024 in its 10-K filings, and accurately notes the page references (2022 p.6; 2023 p.3; 2024 p.3). The core observation about unchanged emphasis is factually sound. The connection to hybrid cloud and AI strategy differentiation is appropriate.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM answer fails to capture the evolution/progression that the ground truth emphasizes. The ground truth explicitly describes how the framing evolved: 2022 tied trust to hybrid cloud platform and AI for production; 2023 reinforced trust as part of broader competitive methods (service, support, innovation, talent); 2024 expanded to include strategic partnerships with Palo Alto Networks. The LLM states the emphasis was 'unchanged' which contradicts the ground truth's narrative of evolution and deepening. (2) MISSING KEY DETAILS: The LLM omits the Palo Alto Networks partnership mentioned in 2024, which the ground truth identifies as significant for signaling 'deepening of trust-based collaboration.' (3) INCOMPLETE MULTI-HOP REASONING: The question asks about evolution/progression 'from 2022 through 2024' - the LLM acknowledges consistency but misses the qualitative shifts in how trust was positioned across these years. The ground truth shows trust was progressively integrated into broader competitive methods and strategic partnerships, not merely static. (4) SHALLOW ANALYSIS: The LLM's conclusion that unchanged emphasis 'signals' positioning is less insightful than the ground truth's observation that the 3-year consistency demonstrates 'strategic commitment' and shows how trust became foundational to client acquisition/retention in the AI and hybrid cloud market.\n\nNUMERIC/DATE VERIFICATION: Page numbers and years are correct. No calculation errors present.\n\nMULTI-HOP ASSESSMENT: The answer fails to synthesize the evolution across the three years as required by the question. It treats the data as static rather than showing progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 556,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "From 2022 to 2023, IBM disclosed the 0.950% Notes due 2025 only as part of the instrument definition (Exhibit 4.1/4.2) incorporated by reference (pages 30 of the 2022 10‑K and 20 of the 2023 10‑K), indicating the notes were already outstanding and not newly issued. In 2024 the notes appear as a registered security (IBM25B) in the 10‑K (page 1), reflecting a more explicit disclosure of the instrument as part of IBM’s debt portfolio. This progression signals IBM’s focus on maintaining a stable, low‑coupon, long‑term debt mix while consistently and transparently reporting its existing debt obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the 3-year progression of IBM's disclosure strategy for the 0.950% Notes due 2025, with mostly accurate information and sound reasoning. STRENGTHS: (1) Correctly identifies the core progression from 2022-2023 (instrument definition via Exhibit 4.1 incorporated by reference) to 2024 (registered security listing as IBM25B on NYSE); (2) Accurately notes the notes were already outstanding and not newly issued; (3) Correctly identifies the coupon rate (0.950%) and maturity year (2025); (4) Provides specific page references (pages 30 of 2022 10-K, page 20 of 2023 10-K, page 1 of 2024 10-K) that align with typical disclosure patterns; (5) Draws reasonable conclusions about stable debt management and transparent reporting. MINOR WEAKNESSES: (1) The LLM answer mentions 'Exhibit 4.1/4.2' but the ground truth specifically references 'Exhibit 4.1 to Form 8-K filed May 22, 2017' - the LLM conflates exhibits without the specific Form 8-K date reference; (2) The ground truth emphasizes 'ongoing transparency and regulatory continuity' as a key insight, while the LLM focuses more on the shift from incorporated-by-reference to registered security listing, which is a slightly different analytical angle but still valid; (3) The LLM's characterization of the 2024 listing as 'more explicit disclosure' is reasonable but the ground truth emphasizes it as showing the instrument remained 'live and traded' - subtle difference in emphasis. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the evolution pattern. The reasoning that this reflects 'stable, low-coupon, long-term debt mix' is sound and supported by the facts. QUANTITATIVE ACCURACY: All numbers and dates are correct (0.950%, 2025 maturity, 2022-2024 timeframe, page numbers). No calculation errors. OVERALL ASSESSMENT: The answer is substantially correct with minor gaps in specific exhibit references and slight differences in analytical emphasis. The core narrative of the progression is accurate and the conclusions about debt management strategy are well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 574,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In 2022 Intel announced PowerVia as a breakthrough backside‑power delivery technology for its next‑generation Intel 20A node (see 2022 10‑K, pages 5‑9).  By 2023 the company reiterated PowerVia’s role—describing it as an industry‑first that would be introduced in 20A and slated for high‑volume manufacturing in 2025 (2023 10‑K, page 14).  In 2024 Intel moved PowerVia to the earlier Intel 18A node, with high‑volume production of PowerVia‑enabled Panther Lake processors expected in 2025 (2024 10‑K, page 10), underscoring a roadmap that accelerates backside power delivery across successive advanced nodes as part of its IDM 2.0 strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. Key strengths: (1) Correctly identifies PowerVia's introduction in 2022 as a breakthrough backside power delivery technology for Intel 20A; (2) Accurately captures the 2023 positioning as an industry-first with 2025 high-volume manufacturing timeline; (3) Correctly identifies the strategic pivot in 2024 to Intel 18A (not 20A) with Panther Lake processors; (4) Properly synthesizes the progression from concept announcement → technical integration → commercial deployment. The answer adds valuable context by mentioning IDM 2.0 strategy and specific processor names (Panther Lake), which enhances understanding without contradicting ground truth. Minor differences from ground truth: The LLM states PowerVia was 'moved to the earlier Intel 18A node' while ground truth says Intel 'canceled the productization of Intel 20A in favor of Intel 18A'—these are semantically equivalent but the LLM's phrasing is slightly less explicit about the cancellation decision. The LLM also includes specific 10-K page references and processor names not in ground truth, which adds credibility and detail. All dates (2022, 2023, 2024, 2025) are correct. The multi-hop reasoning correctly synthesizes information across three fiscal years showing strategic evolution. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 395,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022‑2024 10‑K filings all reference the same 2021 Medtronic plc Long‑Term Incentive Plan for Restricted Stock Unit (RSU) awards, with identical vesting schedules (100 % at the third anniversary and ratably over four years)【page 116 of 2024】【page 116 of 2023】【page 116 of 2022】.  The unchanged plan and vesting structure across three years indicates a stable U.S. equity‑compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Date Reference: The ground truth states the RSU Award Agreement references August 27, 2013, but the LLM claims it references a 2021 Long-Term Incentive Plan. These are fundamentally different documents and dates. (2) CRITICAL ERROR - Document Type: The ground truth specifically identifies Exhibit 10.54 (Restricted Stock Unit Award Agreement for U.S. Employees), while the LLM references the 2021 Long-Term Incentive Plan, which appears to be a different document entirely. (3) VESTING SCHEDULE DISCREPANCY: The LLM provides specific vesting details (100% at third anniversary AND ratably over four years), which appears contradictory and is not mentioned in the ground truth. The ground truth makes no mention of these specific vesting percentages or schedules. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that the documentation remained unchanged across 2022-2024 and correctly concludes this demonstrates strategic stability in equity compensation. However, this correct conclusion is based on incorrect underlying facts. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three years (2022-2024), it does so using incorrect source documents and dates. The core insight about stability is correct, but the evidence cited is wrong. The answer demonstrates a fundamental misidentification of which document/plan is being referenced across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 416,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "From 2022‑24 Intel positioned advanced packaging as a core differentiator of its IDM‑2.0 strategy, with packaging revenue rising from $469 million in 2022 to $952 million in 2023 and continuing into 2024 (pages 38–39, 2023 10‑K; page 38, 2024 10‑K).  However, execution lagged: delays in 10 nm, Intel 4 (7 nm) and the 4th‑Gen Xeon launch, plus capital‑intensive facility expansions that were postponed or scaled back (pages 34–36, 2024 10‑K), constrained the pace of new‑node and packaging roll‑outs; the disaggregated design approach added further complexity and risk, with potential delays in component integration and packaging (pages 53–56, 2022 10‑K and pages 35–36, 2024 10‑K).  Consequently, while advanced packaging helped offset some margin pressure, the combination of delayed process nodes, capital constraints, and the nascent disaggregated design strategy continued to challenge Intel’s ability to deliver timely, high‑margin products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc of Intel's advanced packaging evolution from 2022-2024, accurately capturing: (1) positioning of advanced packaging as a strategic differentiator; (2) delays in process nodes (10nm, Intel 4/7nm); (3) capital constraints and facility expansion postponements; (4) the complexity and risks of disaggregated design approaches; (5) the tension between packaging revenue growth and execution challenges. The multi-hop synthesis across years and connecting strategic positioning to execution challenges is sound. Page citations are appropriately specific.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides packaging revenue figures ($469M in 2022, $952M in 2023) that cannot be verified against the ground truth, which does not cite specific packaging revenue numbers. While these numbers may be accurate from the 10-K filings cited, they represent unverified quantitative claims. The ground truth does not provide these specific revenue figures, making it impossible to confirm accuracy.\n\nWEAKNESSES - COMPLETENESS: The LLM answer omits the critical $3.1 billion impairment charge mentioned in the ground truth as a key 2024 execution challenge tied to underutilized manufacturing assets for Intel 7 node. This is a significant quantitative indicator of execution failure and capital constraint impact that should have been included. The ground truth explicitly highlights this as evidence of \"risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.\"\n\nWEAKNESSES - ENTITY/METRIC ACCURACY: The LLM mentions \"4th-Gen Xeon launch\" delays but the ground truth does not reference this specific product. While not necessarily incorrect, it introduces a detail not in the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022, 2023, and 2024 filings, connecting strategic positioning (packaging as differentiator) to execution challenges (delays, capital constraints, disaggregated design complexity). However, the synthesis is incomplete without the $3.1B impairment charge, which is a crucial quantitative manifestation of the execution challenges.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically aligned with ground truth - acknowledging both the strategic importance and the execution difficulties. The phrase \"nascent disaggregated design strategy\" appropriately captures the complexity and risk noted in ground truth.\n\nJUSTIFICATION: Score of 7 reflects correct overall narrative and multi-hop reasoning, but significant omission of the $3.1B impairment charge (a key quantitative fact) and unverified packaging revenue figures prevent a higher score. The answer is substantially correct in direction and reasoning but incomplete in critical execution metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 753,
        "total_tokens": 2253
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s target mix for non‑U.S. defined‑benefit plans moved from 21 % equity and 50 % debt in FY 2022 to 27 % equity and 48 % debt in FY 2023, then eased to 23 % equity and 42 % debt in FY 2024 (U.S. plans remained 100 % debt throughout). This gradual tilt toward higher‑return equities and lower‑duration fixed income shows a deliberate, market‑responsive strategy that seeks to enhance risk‑adjusted returns while still matching liability duration.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data about Accenture's target asset allocation across the three fiscal years requested, which is a significant strength. The numbers provided (21% equity/50% debt in FY2022, 27% equity/48% debt in FY2023, 23% equity/42% debt in FY2024 for non-U.S. plans, with U.S. plans at 100% debt) are presented with precision and the distinction between U.S. and non-U.S. plans adds important context. The multi-year trend analysis is sound: the answer correctly identifies the shift toward equities from FY2022 to FY2023 (21% to 27%), then a pullback in FY2024 (to 23%), and accurately characterizes this as a 'market-responsive strategy.' The reasoning about risk-adjusted returns and liability duration matching is logically sound and relevant to the question. However, there are some limitations: (1) The original answer emphasizes evolving flexibility and adaptation to market conditions across the three years, while the LLM answer focuses more narrowly on the specific percentage allocations without explicitly discussing the strategic flexibility aspect mentioned in the ground truth. (2) The original answer discusses the introduction of a 'target allocation for fiscal 2025' in FY2024, which the LLM answer does not mention. (3) The LLM answer provides concrete numbers that the original answer does not explicitly state, suggesting the LLM may have accessed more detailed filing data, but this cannot be verified against the ground truth provided. The quantitative data appears accurate and well-presented, the multi-hop synthesis across three years is correct, and the interpretation of the trend is reasonable. The main gap is the less explicit discussion of strategic flexibility and market adaptation that the original answer emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 485,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s repeated mention of the 1.05% Notes due 2017 (see Exhibit 4.4, page 54) shows the company’s commitment to fully disclose all outstanding debt, even older maturities, underscoring a consistent, transparent debt‑reporting policy. By contrast, Apple’s debt‑issuance activity during 2022–2024 has focused on new, higher‑coupon, longer‑term notes (e.g., 4.421% Notes due 2026, 4.000% Notes due 2028, etc., see Exhibit 4.28, page 58), reflecting a strategy to diversify maturities and capture favorable market rates for financing and share‑repurchase programs.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces specific debt instruments (4.421% Notes due 2026, 4.000% Notes due 2028) that are NOT mentioned in the ground truth answer. The ground truth references 'Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024' as examples of Apple's broader debt issuance strategy. The LLM has fabricated or misidentified specific coupon rates and maturity dates that cannot be verified against the original answer. This is a critical error in financial reporting accuracy. CITATION ISSUES: The LLM cites specific exhibits (Exhibit 4.4, page 54; Exhibit 4.28, page 58) without verification that these citations are accurate or that the referenced documents support the claims made. CONCEPTUAL ALIGNMENT: The LLM correctly captures the core concept that Apple maintains transparent disclosure of historical debt (1.05% Notes due 2017) while issuing new debt instruments with varying terms. The reasoning about diversifying maturities and capturing favorable market rates is logically sound and aligns with the ground truth's characterization of Apple's debt management strategy. COMPLETENESS: The LLM addresses both parts of the multi-part question (historical disclosure approach + comparison to broader strategy), but the specific examples provided are problematic. The ground truth explicitly lists different debt instruments than those cited by the LLM. SEMANTIC EQUIVALENCE: While the overall narrative structure and conceptual framework match the ground truth, the introduction of unverified specific financial data significantly undermines credibility and accuracy. The answer would be stronger if it either used the exact examples from the ground truth or acknowledged uncertainty about specific coupon rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 485,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12,180,917 shares for $4.1 million, and the board added $3.0 billion in additional authority, raising total outstanding authority to $6.129 billion (page_94, page_95). In fiscal 2024 the company bought 2,072,563 shares for $605 million under its open‑market program and approved $4.0 billion in new authority, bringing total outstanding authority to $6.694 billion (page_39). The steady use of the repurchase program coupled with incremental increases in available authorization over these years signals a disciplined, flexible capital‑return strategy that balances regular shareholder payouts with a sizable pool of repurchase capacity for future market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - LLM states fiscal 2022 repurchases were '$4.1 million' for 12.18M shares, which is mathematically impossible and contradicts ground truth showing $605M in fiscal 2024 repurchases for only 2.07M shares. This represents a ~150x error in the fiscal 2022 figure. (2) MISSING KEY DATA - LLM fails to mention the fiscal 2022 available authorization of $3.13 billion or the fiscal 2024 available authorization of $2.69 billion, which are critical to understanding the multi-year evolution. Ground truth explicitly states these figures. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution 'from fiscal 2022 through fiscal 2024' but LLM only addresses fiscal 2022 and fiscal 2024, completely omitting fiscal 2023 data that ground truth indicates 'mirrors the 2024 disclosures.' (4) CALCULATION VERIFICATION - LLM's total outstanding authority figures ($6.129B for 2022, $6.694B for 2024) are close to ground truth but the supporting share repurchase numbers are fundamentally wrong. The $4.1M figure for fiscal 2022 is implausible given the scale of operations. (5) REASONING QUALITY - While the final conclusion about 'disciplined, flexible capital-return strategy' is reasonable, it's built on incorrect foundational data, undermining the analysis. The answer demonstrates some understanding of capital allocation strategy but fails on core factual accuracy required for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 403,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Bristol‑Myers Squibb issued $1 billion of 4.350 % senior notes due 2047 in each of the 2022, 2023, and 2024 10‑Ks (2022 10‑K p. 137; 2023 10‑K p. 133; 2024 10‑K p. 136). The consistent issuance of the same coupon and maturity each year shows a deliberate strategy of maintaining a stable, long‑term debt profile—using moderate‑rate, long‑dated notes to finance growth and acquisitions while preserving predictable interest costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that undermines the entire response. The LLM claims BMY 'issued $1 billion of 4.350% senior notes due 2047 in each of the 2022, 2023, and 2024 10-Ks,' implying three separate issuances of $1 billion each year. However, the ground truth indicates the 4.350% Senior Notes due 2047 were issued once (under the Eleventh Supplemental Indenture dated November 22, 2019) and then consistently referenced/remained outstanding across all three years. The LLM misinterpreted 'referenced in filings' as 'issued in each year,' which is a major distinction in debt financing analysis. The ground truth explicitly states the notes 'remained a core part of its long-term debt portfolio' and were 'listed among' and 'included in the list of outstanding debt instruments'—not newly issued each year. QUANTITATIVE ACCURACY: The $1 billion figure appears to be invented or misinterpreted; the ground truth does not specify the original issuance amount for the 2047 notes. The LLM also failed to mention the other significant debt issuances mentioned in the ground truth ($1.75B 2.950% Notes due 2032, $2B 3.700% Notes due 2052, $3.75B 4.250% Notes due 2049), which are crucial to understanding the diversified maturity strategy. MULTI-HOP REASONING: The LLM failed to synthesize the multi-year pattern correctly. The ground truth shows a strategy of maintaining the 2047 notes while adding new issuances with different maturities and coupons—a diversification strategy. The LLM's interpretation suggests repetitive issuances of identical instruments, which contradicts sound debt management practice and the actual filing evidence. SEMANTIC EQUIVALENCE: While the LLM's conclusion about 'stable, long-term debt profile' and 'predictable interest costs' is reasonable, it is based on an incorrect premise about the nature and frequency of issuances. The answer demonstrates a fundamental misunderstanding of how debt instruments are tracked in SEC filings versus when they are actually issued.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 549,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple consistently listed the 2.40% Notes due 2023 in the “Description of Securities” section of each filing.  The 2022 filing (page 56) and the 2023 filing (page 53) both include the note, and the 2024 filing (page 56) continues to list it, showing no change in the level of detail or presentation as the notes approached maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core conclusion that Apple's disclosure approach was consistent across the three years, which aligns with the ground truth. However, there are significant issues with specificity and accuracy: (1) The LLM cites specific page numbers (page 56 for 2022, page 53 for 2023, page 56 for 2024) that cannot be verified against the ground truth and may be inaccurate. The ground truth specifies the notes were listed under 'Exhibit 4.3' with references to an 'Officer's Certificate dated May 3, 2013,' but the LLM places them in a 'Description of Securities' section without mentioning the exhibit location or the specific certificate date. (2) The LLM fails to mention the Exhibit 4.3 designation, which is a key detail in the ground truth's description of how the disclosure was structured. (3) The LLM does not reference the Officer's Certificate dated May 3, 2013, which is explicitly noted in the ground truth as part of the consistent disclosure approach. (4) The LLM's statement about 'no change in the level of detail or presentation' is correct in spirit but lacks the specific evidence (identical descriptions, consistent exhibit placement) that supports this conclusion. (5) The quantitative accuracy is compromised by the unverified page number citations, which represent factual claims that may be incorrect. The answer demonstrates understanding of the multi-hop synthesis required (comparing disclosure across three years) but lacks the precision and specific supporting details that characterize the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 428,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "Accenture authorized 127 million Class A shares for the Amended 2010 Share Incentive Plan in FY 2022 (page 91). By FY 2024 that authorization had risen to 141 million shares (page 98), a 14 million‑share increase. The upward trend reflects a deliberate expansion of the share‑based compensation pool to better align employee incentives with shareholder value and support long‑term talent retention.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - 127 million shares in FY2022, 141 million in FY2024, and the 14 million increase calculation is accurate. (2) Entity identification is correct - Accenture plc, Class A ordinary shares, Amended 2010 SIP. (3) Years are correctly identified (FY2022 and FY2024). (4) Number formatting is acceptable ($127M vs 127 million). WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM answer skips FY2023 entirely, which is a critical data point in the ground truth. The original answer explicitly states the progression: 2022 (127M) → 2023 (141M) → 2024 (141M). The LLM only shows 2022 → 2024, missing the intermediate year and the important insight that the increase occurred in 2023 and then stabilized in 2024. (2) REASONING QUALITY - While the LLM provides reasonable interpretation about 'deliberate expansion' and 'talent retention,' it misses the key strategic insight from the ground truth: the stabilization pattern (increase then plateau) suggests the new level became 'sufficient to meet award needs.' The LLM's interpretation is plausible but less precise than the ground truth's observation about stabilization. (3) CONTEXTUAL COMPLETENESS - The question specifically asks about evolution 'from fiscal year 2022 through 2024,' which implies tracking the full progression. The LLM answer only captures endpoints, not the full trajectory. This is a material omission for a multi-hop question requiring synthesis across three fiscal years. CALCULATION VERIFICATION: 141M - 127M = 14M ✓ (correct). MULTI-HOP ASSESSMENT: Partially successful - correctly synthesized data across two years but failed to include the critical intermediate year that would complete the full picture of the company's strategic decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 481,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "In 2022 Intel’s 10‑K did not reference PowerVia, indicating the technology was still in early research stages (page 9, 2022). By the 2023 filing, PowerVia was announced as a breakthrough backside‑power delivery feature for the Intel 20A node, projected to deliver up to a 15 % performance‑per‑watt improvement over Intel 3 (page 14, 2023). In the 2024 filing, Intel positioned PowerVia as a core component of the next‑generation Intel 18A node and continued to develop it for the 14A roadmap, underscoring its growing centrality to power‑efficiency and signal‑integrity goals in Intel’s advanced process strategy (page 10, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy. CORRECT ELEMENTS: (1) The general timeline progression of PowerVia from 2022-2024 is directionally accurate; (2) The 2023 positioning of PowerVia as a backside power delivery feature for Intel 20A is correct; (3) The 2024 mention of Intel 18A retaining PowerVia is accurate; (4) The emphasis on power-efficiency and signal-integrity goals is appropriate. CRITICAL ERRORS: (1) The claim that '2022 Intel 10-K did not reference PowerVia' contradicts the ground truth, which explicitly states Intel 'first introduced PowerVia in 2022' - this is a factual error about when PowerVia was first disclosed; (2) The 15% performance-per-watt improvement figure is not verified in the ground truth and appears to be an unsupported specific claim; (3) The mention of '14A roadmap' is not present in the ground truth, which focuses on 20A and 18A; (4) The page citations (page 9, 14, 10) cannot be verified against the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression from early stages to core component status. However, the claim about 2022 non-mention is problematic since the ground truth indicates PowerVia was introduced in 2022. The answer misses the key detail about Intel 20A cancellation in favor of 18A, which is strategically important context. SEMANTIC ISSUES: The answer conflates 'not referenced' with 'in early research stages' - these are different claims. The ground truth indicates PowerVia was introduced in 2022 as part of roadmap announcements, not that it was absent from filings. The answer provides reasonable interpretation of strategic importance but undermines this with the factual error about 2022 disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 489,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s pension‑plan assets in mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then rose sharply to **$273,699** in 2024.  The dip in 2023 followed by the rebound in 2024 signals a deliberate, flexible asset‑allocation strategy: the company reduced equity exposure amid market volatility, then increased it when conditions improved, underscoring a long‑term focus on equity‑based growth within its pension‑plan portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that completely invalidates the response. The ground truth clearly states that Accenture's mutual fund equity securities allocation was $196,226 million in BOTH fiscal years 2023 and 2024 (unchanged). However, the LLM claims the 2024 figure was $273,699 million, which is INCORRECT and contradicts the ground truth. This is not a minor discrepancy but a major factual error that changes the entire narrative. The LLM's interpretation of a 'sharp rebound' in 2024 is therefore false. The 2022-2023 decline from $239,293M to $196,226M is correctly stated, but the fabricated 2024 increase to $273,699M is completely wrong. The LLM's reasoning about 'deliberate, flexible asset-allocation strategy' responding to market conditions is speculative and unsupported by the actual data, which shows no change from 2023 to 2024. The ground truth indicates a strategic rebalancing AWAY from mutual fund equity securities (consistent reduction), while the LLM incorrectly suggests a rebound indicating 'long-term focus on equity-based growth.' This is a fundamental misrepresentation of the company's actual investment trajectory. The quantitative accuracy is severely compromised by the incorrect 2024 figure, and the qualitative reasoning is built on this false premise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 371,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck’s treatment of Dificid has been largely consistent but has shown modest financial growth.  The intangible asset net value recorded at acquisition was $145 million in 2021 (page 115) and no impairment charge or write‑down has been reported for 2022‑2024, indicating a stable asset valuation.  Therapeutically, Dificid remains a targeted antibiotic for Clostridioides difficile‑associated diarrhea and continues to be positioned within the Hospital Acute Care segment (page 4) without any noted repositioning.  Its global revenue contribution has risen steadily—from $263 million in 2022 to $302 million in 2023 and $340 million in 2024 (U.S. $303 m/37 m, $274 m/28 m, $241 m/22 m respectively) (page 130), increasing its share of the $1,685 million (2022‑23) to $1,764 million (2024) hospital‑acute‑care sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the multi-part question about Dificid's evolution from 2022-2024 across asset valuation, therapeutic positioning, and revenue contribution. However, there are significant quantitative errors that undermine the response.\n\nCORRECT ELEMENTS:\n- Correctly identifies the $145 million intangible asset valuation (though dates it to 2021 rather than 2022)\n- Correctly identifies Dificid as a C. difficile antibiotic positioned in Hospital Acute Care segment\n- Correctly reports 2024 revenue of $340 million total ($303M U.S., $37M international)\n- Correctly notes no impairment charges reported\n- Appropriately synthesizes information across multiple dimensions (asset, therapeutic, revenue)\n\nCRITICAL ERRORS:\n- Revenue figures for 2022 and 2023 are INCORRECT. LLM states \"$263 million in 2022 to $302 million in 2023\" but ground truth shows these figures are not verified in the provided context. The ground truth only confirms 2024 figures.\n- The breakdown provided for 2023 ($274M U.S./$28M international) and 2022 ($241M U.S./$22M international) cannot be verified against ground truth and appear to be fabricated or misread\n- The hospital acute care segment totals ($1,685M for 2022-23, $1,764M for 2024) are not confirmed in ground truth\n- The statement about \"no impairment charge or write-down\" cannot be verified from the provided ground truth\n\nMULTI-HOP REASONING:\nThe LLM correctly attempts to synthesize information across three dimensions (asset valuation, therapeutic positioning, revenue), which is appropriate for the question. However, the execution is flawed due to unverified numerical claims.\n\nSEMANTIC ISSUES:\nThe LLM's characterization of Dificid's evolution as \"largely consistent\" with \"modest financial growth\" differs from the ground truth's narrative of evolution from \"relatively minor asset to strategically recognized product.\" While both perspectives could be valid, the LLM's emphasis on consistency contradicts the ground truth's emphasis on progression.\n\nThe answer demonstrates reasonable understanding of the question structure and attempts comprehensive coverage, but the quantitative inaccuracies (particularly the 2022-2023 revenue figures and segment totals) are significant enough to warrant a lower correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 616,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel has kept advanced packaging as a cornerstone of its IDM 2.0 strategy, investing roughly $17 B in R&D in 2022, $16 B in 2023, and $16.5 B in 2024 (page 34).  Yet execution lag persisted— the 4th‑Gen Xeon launch was delayed in 2022, disaggregated‑design setbacks stalled packaging roll‑outs, and a $922 M inventory charge for Gaudi AI accelerators appeared in 2024 (page 35).  Financial risk has risen as penalties ($755 M) for Ireland construction delays and a $3.1 B impairment of Intel 7 assets were recorded in 2024, underscoring the cost of delayed packaging and process‑node implementation (page 36).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Intel's advanced packaging evolution from 2022-2024 and correctly identifies key financial challenges. However, there are significant quantitative accuracy issues that lower the overall score.\n\nCORRECT ELEMENTS:\n- Correctly identifies advanced packaging as cornerstone of IDM 2.0 strategy\n- Accurately cites the $3.1B impairment charge for Intel 7 assets in 2024 (matches ground truth)\n- Correctly mentions execution delays and disaggregated design setbacks\n- Appropriately references 4th-Gen Xeon launch delays in 2022\n- Correctly identifies financial pressures mounting through the period\n- Good synthesis of multi-hop information across years and financial metrics\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. R&D INVESTMENT NUMBERS: The LLM cites \"roughly $17B in 2022, $16B in 2023, and $16.5B in 2024\" but these appear to be total R&D figures, not specifically tied to advanced packaging. The ground truth does not provide these specific R&D breakdowns by year, and the LLM presents them as fact without qualification.\n\n2. $922M INVENTORY CHARGE: The LLM attributes this to \"Gaudi AI accelerators\" in 2024, but the ground truth does not mention this specific charge or its attribution to Gaudi. This appears to be an unsupported claim.\n\n3. $755M PENALTY: The LLM cites \"$755M penalties for Ireland construction delays\" but the ground truth does not mention this specific figure or Ireland-related penalties. This is a potential hallucination.\n\n4. PAGE REFERENCES: The LLM cites specific pages (34, 35, 36) but these cannot be verified against the ground truth provided.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022-2024 and connects R&D investment, execution delays, and financial impacts. The logical flow from strategic emphasis to operational strain is sound and matches the ground truth trajectory.\n\nSEMANTIC EQUIVALENCE:\nThe answer conveys the general narrative of the ground truth (strategic optimism shifting to financial/operational strain), but introduces specific numbers that are either unverified or potentially incorrect.\n\nJUSTIFICATION:\nThe answer demonstrates good understanding of the multi-hop question and correctly identifies major themes, but the introduction of unverified financial figures ($922M, $755M) and unsupported attributions significantly undermines credibility. The R&D figures, while plausible, are presented without clear sourcing. These quantitative inaccuracies prevent a higher score despite good qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 681,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "Merck’s HIV‑1 candidate MK‑8591A entered Phase 3 in 2022 but was stalled by an FDA clinical hold that cited lymphocyte‑count reductions (2022 10‑K, p. 23). The hold remained through 2023 while a Phase 2 study ended enrollment, and the program stayed in Phase 3 (2023 10‑K, pp. 22‑23). In 2024 the FDA lifted the hold on December 4, 2024, allowing new studies and the addition of a related combination (MK‑8591D) into development, underscoring Merck’s long‑term strategy to expand its HIV portfolio with novel once‑daily therapies (2024 10‑K, pp. 23‑24).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key regulatory milestone (FDA clinical hold lifted December 4, 2024), correctly names the compound (MK-8591A with doravirine+islatravir components), and accurately captures Merck's strategic commitment to HIV therapeutics. The mention of lymphocyte-count reductions as the reason for the hold adds appropriate clinical context. The reference to MK-8591D as a related combination and the emphasis on once-daily therapies aligns with Merck's strategic direction.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL FACTUAL ERROR: The LLM states MK-8591A \"entered Phase 3 in 2022\" but the ground truth clearly indicates it entered Phase 3 in February 2020, meaning it was already in Phase 3 by 2022 (not entering in 2022). This is a significant mischaracterization of the timeline. (2) INCOMPLETE HOLD DESCRIPTION: The ground truth specifies that while the FDA lifted the clinical hold on December 4, 2024, \"the compound remained under a partial clinical hold for higher doses.\" The LLM fails to mention this important nuance about the partial hold remaining. (3) MISSING CONTEXT: The ground truth emphasizes the 3-year trajectory (2022-2024) showing persistent commitment despite challenges; the LLM focuses more on the 2024 resolution without adequately emphasizing the 2022-2023 stalled period as part of the overall narrative.\n\nMULTI-HOP REASONING: The LLM does synthesize information across multiple years and documents (2022, 2023, 2024 10-Ks), but the synthesis contains the critical error about Phase 3 entry timing. The connection between regulatory challenges and strategic persistence is present but weakened by the factual error.\n\nQUANTITATIVE ACCURACY: The date December 4, 2024 is correct. However, the Phase 3 entry date error (stating 2022 instead of 2020) is a significant quantitative/temporal inaccuracy.\n\nSEMANTIC EQUIVALENCE: While the LLM conveys the general narrative of regulatory challenges followed by resolution, the specific claim about Phase 3 entry timing contradicts the ground truth and undermines the accuracy of the developmental timeline analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 569,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "Merck’s strategy for MK‑1308A has shifted from a broad advanced‑solid‑tumor portfolio in 2022 (colorectal, hepatocellular, melanoma, small‑cell lung) to a single, Phase 3 program focused on renal cell carcinoma (RCC) in 2023–24, still as a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab (Keytruda) (page 25, page 18, page 50).  The combination therapy remains the core of the program, and regulatory progress has kept the drug in Phase 3 clinical development with no approvals yet, but the program is actively pursued under Merck’s immuno‑oncology pillar (page 50).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains a critical factual error that contradicts the ground truth. The LLM claims MK-1308A had a 'broad advanced-solid-tumor portfolio in 2022 (colorectal, hepatocellular, melanoma, small-cell lung)' but the ground truth explicitly states that in 2022, MK-1308A was 'specifically for renal cell carcinoma (RCC)' - not a broad portfolio across multiple tumor types. This is a fundamental mischaracterization of the 2022 development strategy. CORRECT ELEMENTS: (1) The LLM correctly identifies MK-1308A as a coformulation of quavonlimab (anti-CTLA-4) with pembrolizumab - matches ground truth; (2) Correctly identifies RCC as the therapeutic focus in 2023-2024 - matches ground truth; (3) Correctly states Phase 3 development status with no regulatory approval yet - matches ground truth; (4) Correctly identifies it as part of immuno-oncology portfolio - matches ground truth. MULTI-HOP REASONING ISSUE: The LLM failed to correctly synthesize the evolution narrative. Rather than showing 'increasing specificity in formulation and therapeutic strategy over time' as the ground truth indicates, the LLM incorrectly portrays a shift FROM a broad portfolio TO RCC focus, when the ground truth shows RCC was the specific focus from 2022 onward. MISSING/INCOMPLETE: The LLM does not adequately convey the 'consistent focus on RCC with increasing specificity in formulation' that characterizes the actual evolution. The narrative of progression is inverted. The page citations provided cannot be verified but appear to be fabricated or misinterpreted. QUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this is not a differentiator, but the LLM's characterization of the 2022 status is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 481,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture’s share‑repurchase activity jumped from $4.1 million in fiscal 2022 (total purchases of $4.111 million, including $3.152 million in open‑market buys) to $4.5 billion in fiscal 2024 (share purchases of $4.5 billion, per the 2024 key metrics) while its available authorization grew from $3.1 million at the end of 2022 to $2.694 billion after a $4 billion boost in 2024 (aggregate available authorization of $2.694 billion and total outstanding authority of $6.694 billion, page 39). This multi‑year trend shows Accenture is aggressively expanding its buy‑back program, underscoring a capital‑return strategy that increasingly relies on share repurchases to reward shareholders. (page 94, page 93, page 41, page 39)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains severe quantitative inaccuracies that fundamentally misrepresent Accenture's share repurchase activity: (1) FISCAL 2022 REPURCHASES: LLM claims $4.1 million in fiscal 2022 repurchases ($4.111 million open-market), but ground truth shows $3,129,296 thousand (~$3.13 billion) in AVAILABLE AUTHORIZATION, not repurchase amounts. This is a magnitude error of ~1000x. (2) FISCAL 2024 REPURCHASES: LLM claims $4.5 billion in share purchases, but ground truth clearly states 2,000,308 shares purchased for $605 million in fiscal 2024, not $4.5 billion. This is another massive error (~7.4x overstatement). (3) AVAILABLE AUTHORIZATION CONFUSION: LLM conflates available authorization ($3.1 million at end of 2022 per LLM, but should be $3.13 billion) with actual repurchase amounts. The ground truth shows $2.694 billion available authorization by fiscal 2024, which LLM does cite correctly in one place but misinterprets elsewhere. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly distinguish between: (a) available authorization remaining, (b) total outstanding authority, and (c) actual repurchases executed. These are three different metrics that require careful synthesis. (5) CHARACTERIZATION ERROR: LLM describes this as 'aggressively expanding' buybacks, but ground truth indicates 'sustained but measured' strategy with periodic replenishment. The actual fiscal 2024 repurchase of $605 million is modest, not aggressive. (6) CORRECT ELEMENTS: LLM does correctly identify the $4 billion authorization boost in September 2024 and the $6.694 billion total outstanding authority figure. However, these correct citations cannot offset the fundamental misstatement of actual repurchase amounts. The answer demonstrates a critical failure to accurately extract and synthesize multi-hop financial data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 505,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb has kept the $750 million 2.350% senior notes due 2040 on its books in the 12th, 13th and 14th Supplemental Indentures disclosed in the 2022, 2023 and 2024 10‑Ks (page 136 of each filing).  By retaining this long‑term, fixed‑rate instrument rather than refinancing or retiring it, BMS signals a deliberate strategy to lock in a low coupon for a 20‑year horizon, provide predictable interest expense and reduce refinancing risk as rates rise.  The persistence of the note therefore reflects BMS’s preference for a stable, diversified debt mix that supports its long‑term growth and acquisition plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the $750 million 2.350% Notes due 2040 and their persistence across 2022, 2023, and 2024 filings. The quantitative details are accurate: the dollar amount ($750M/$750,000,000), coupon rate (2.350%), and maturity year (2040) all match the ground truth. The reference to specific page numbers (page 136) and supplemental indentures adds credible specificity. The multi-hop reasoning is sound—the answer correctly synthesizes information across three years of filings to demonstrate strategic consistency in debt management. The interpretation of the strategy is well-reasoned: the LLM identifies that retention of this fixed-rate instrument reflects deliberate interest rate risk management, predictable expense planning, and refinancing risk reduction. The answer goes slightly beyond the ground truth by explicitly mentioning the 20-year horizon and connecting the strategy to 'long-term growth and acquisition plans,' which represents reasonable inference from the data but is not explicitly stated in the ground truth. The semantic equivalence is strong—both answers convey that BMS maintained this debt consistently across years as a strategic choice for fixed-rate stability. Minor differences: the ground truth uses 'Bristol-Myers Squibb' while LLM uses 'BMS' (acceptable abbreviation), and the LLM provides more specific filing references (supplemental indentures, page numbers) which enhances credibility. No calculation errors detected. The answer fully addresses the question about how the persistence reflects strategy in managing long-term fixed-rate debt obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 454,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb has kept the coupon on its Senior Notes due 2047 fixed at 4.350 % in every recent filing.  The 4.350% Senior Notes are referenced in the 2024 10‑K (Exhibit 4.19 – page 134), the 2024 10‑K (page 136), and the 2024 10‑K (page 137), and the same rate appears in the 2022 10‑K (page 137).  The unchanged rate across filings signals a deliberate, stable long‑term debt strategy that relies on predictable, moderate financing costs to support the company’s capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility: (1) EXHIBIT REFERENCES ARE INCORRECT: The ground truth specifies Exhibit 4bbb (2022), Exhibit 4ff (2023), and Exhibit 4ff (2024), but the LLM claims Exhibit 4.19 for 2024 and provides vague page references without exhibit numbers. The specific exhibit designations are critical details in SEC filing analysis and the LLM has misidentified them. (2) INDENTURE DATES MISSING: The ground truth provides specific supplemental indenture dates (Twelfth Supplemental Indenture dated November 13, 2020; Fourteenth Supplemental Indenture dated November 13, 2023; Form 8-K from November 22, 2019), which are important for understanding the debt's legal structure and history. The LLM completely omits these dates. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the 4.350% rate consistency across years, it fails to synthesize the complete picture of how the debt was documented across different filings and indentures. The ground truth shows a progression through supplemental indentures, which the LLM misses entirely. (4) PAGE REFERENCES ARE VAGUE: The LLM lists multiple page references (134, 136, 137) without clear differentiation of which filing year each refers to, creating confusion. The ground truth provides specific exhibit references that are more precise. (5) CORRECT ELEMENTS: The LLM does correctly identify that the 4.350% rate remained constant across recent filings and correctly interprets this as indicating a stable long-term debt strategy. The semantic interpretation of what this pattern reveals is reasonable. (6) QUANTITATIVE ACCURACY: The 4.350% figure is correct, but the exhibit and indenture references are factually wrong, which significantly impacts the quantitative accuracy score. The LLM appears to have confused or misidentified the specific SEC filing exhibits.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 512,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In FY 2022 Nike listed FlyEase as one of many “innovative technologies” in its product research and development section, noting it as part of the company’s broader technology portfolio. By FY 2024 the same technology is still mentioned in that section, but the filing now adds manufacturing data that shows FlyEase is produced at scale—Nike’s footwear is made by 15 contract manufacturers operating 96 finished‑goods factories worldwide (with 50 % of production in Vietnam, 27 % in Indonesia and 18 % in China) and apparel by 68 contract manufacturers in 285 factories—demonstrating its integration into the global supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All manufacturing percentages are correct (Vietnam 50%, Indonesia 27%, China 18%), matching the ground truth exactly. (2) The evolution narrative is accurate—FlyEase progressed from early-stage introduction in FY2022 to established technology by FY2024. (3) The multi-hop synthesis correctly connects FlyEase technology mentions across years to manufacturing scale data. (4) Additional context about contract manufacturers (15 for footwear, 96 factories; 68 for apparel, 285 factories) is accurate and relevant, providing concrete evidence of scale. (5) The answer properly addresses both parts of the question: evolution of reporting AND quantitative evidence of production scale. MINOR WEAKNESSES: (1) The ground truth explicitly mentions FlyEase being mentioned 'alongside established technologies like Nike Air and Dri-FIT' in FY2023, showing growing integration—the LLM answer omits this intermediate step detail, though it captures the overall progression. (2) The LLM answer doesn't explicitly state that FY2023 showed FlyEase mentioned alongside other established technologies, which was part of the evolution narrative. (3) The ground truth emphasizes the 'geographic manufacturing distribution demonstrates the technology's full-scale integration,' while the LLM answer states it more directly without the interpretive framing. These are minor omissions of contextual nuance rather than factual errors. The quantitative data is entirely accurate, the multi-hop reasoning connecting technology evolution to manufacturing scale is sound, and the answer directly addresses the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 473,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "RedCard penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (the 2024 figure is the most recent year‑end data)【page_27】. The decline of roughly 1.9 percentage points over two years indicates that the loyalty‑driven payment strategy is losing traction, suggesting the 5 % discount incentive and card offerings are becoming less effective at driving incremental purchases and may need to be re‑evaluated.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the 2024 penetration rate is 18.6%, but the ground truth shows it should be 17.8%. This is a significant factual error of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. CALCULATION ERROR: The LLM claims 'roughly 1.9 percentage points over two years' but the actual decline from 2022 to 2024 should be 2.7 percentage points (20.5% - 17.8%), not 1.9 percentage points. Even if using the LLM's incorrect 2024 figure of 18.6%, the decline would be 1.9 percentage points, which happens to match their stated calculation, but this is based on the wrong number. STRENGTHS: (1) Correctly identified the three-year trend of declining penetration rates; (2) Appropriately interpreted the trend as indicating weakening effectiveness of the loyalty strategy; (3) Provided relevant context about the 5% discount incentive; (4) Correctly identified RedCard as the loyalty-driven payment product; (5) Sound reasoning about competitive pressures and customer engagement. WEAKNESSES: (1) Wrong 2024 figure (18.6% vs. 17.8%); (2) Incorrect calculation of total decline; (3) Only addressed two years of decline in the calculation when the question asks about 2022-2024 (three years). The qualitative analysis is sound and the reasoning about strategy effectiveness is appropriate, but the quantitative errors are material and undermine the credibility of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 395,
        "total_tokens": 1624
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 798,
    "successful_evaluations": 796,
    "failed_evaluations": 2,
    "average_correctness_score": 5.31,
    "average_quantitative_accuracy": 5.57,
    "average_qualitative_accuracy": 5.59,
    "average_contextual_relevance": 6.55,
    "score_distribution": {
      "excellent": 104,
      "good": 174,
      "fair": 266,
      "poor": 252
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 798,
    "failed": 2,
    "elapsed_seconds": 37944.25,
    "timestamp": "2026-02-03T11:36:18.533329"
  }
}